PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wagner, S; Gresser, AL; Torello, AT; Dulac, C				Wagner, Shlomo; Gresser, Amy L.; Torello, A. Thomas; Dulac, Catherine			Multireceptor genetic approach uncovers an ordered integration of VNO sensory inputs in the accessory olfactory bulb	NEURON			English	Article							AXONAL PROJECTIONS; VOMERONASAL SYSTEM; RECEPTOR GENES; ANTENNAL LOBE; MUTANT MICE; PHEROMONE; EXPRESSION; NEURONS; MOUSE; MAP	Pheromone detection by the vomeronasal organ (VNO) is thought to rely on activation of specific receptors from the V1R and V2R gene families, but the central representation of pheromone receptor activation remains poorly understood. We generated transgenic mouse lines in which projections from multiple populations of VNO neurons, each expressing a distinct V1R, are differentially labeled with fluorescent proteins. This approach revealed that inputs from neurons expressing closely related V1Rs intermingle within shared, spatially conserved domains of the accessory olfactory bulb (AOB). Mitral cell-glomerular connectivity was examined by injecting intracellular dyes into AOB mitral cells and monitoring dendritic contacts with genetically labeled glomeruli. We show that individual mitral cells extend dendrites to glomeruli associated with different, but likely closely related, V1Rs. This organization differs from the labeled line of OR signaling in the main olfactory system and suggests that integration of information may already occur at the level of the AOB.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Harvard University; Howard Hughes Medical Institute	Wagner, S (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	shlomo@lobster.ls.huji.ac.il; dulac@fas.harvard.edu		Wagner, Shlomo/0000-0002-7618-0752; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003903] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Conzelmann S, 2001, EUR J NEUROSCI, V14, P1623, DOI 10.1046/j.0953-816x.2001.01788.x; DA LY, 2005, NATURE, V434, P470; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dulac Catherine, 2005, Novartis Foundation Symposium, V268, P100; GANGRADE BK, 1984, BIOL REPROD, V31, P89, DOI 10.1095/biolreprod31.1.89; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; KABA H, 1989, NEUROSCIENCE, V32, P657, DOI 10.1016/0306-4522(89)90287-X; KANZAKI R, 1989, J COMP PHYSIOL A, V165, P427, DOI 10.1007/BF00611233; KUMAR A, 1993, PHYSIOL BEHAV, V54, P1169, DOI 10.1016/0031-9384(93)90343-E; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sadek MM, 2002, J EXP BIOL, V205, P1363; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strotmann J, 1999, GENE, V236, P281, DOI 10.1016/S0378-1119(99)00275-9; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; TAKAMI S, 1990, BRAIN RES, V510, P339, DOI 10.1016/0006-8993(90)91387-V; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	45	90	90	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					697	709		10.1016/j.neuron.2006.04.033	http://dx.doi.org/10.1016/j.neuron.2006.04.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731509	Bronze			2022-12-24	WOS:000238165000006
J	Adcock, RA; Thangavel, A; Whitfield-Gabrieli, S; Knutson, B; Gabrieli, JDE				Adcock, R. Alison; Thangavel, Arul; Whitfield-Gabrieli, Susan; Knutson, Brian; Gabrieli, John D. E.			Reward-motivated learning: Mesolimbic activation precedes memory formation	NEURON			English	Article							NUCLEUS-ACCUMBENS; PARAHIPPOCAMPAL CORTEX; PREFRONTAL CORTEX; HIPPOCAMPAL CA1; BRAIN ACTIVITY; DOPAMINE; FMRI; RAT; ANTICIPATION; POTENTIATION	We examined anticipatory mechanisms of reward-motivated memory formation using event-related FMRI. In a monetary incentive encoding task, cues signaled high- or low-value reward for memorizing an upcoming scene. When tested 24 hr postscan, subjects were significantly more likely to remember scenes that followed cues for high-value rather than low-value reward. A monetary incentive delay task independently localized regions responsive to reward anticipation. In the encoding task, high-reward cues preceding remembered but not forgotten scenes activated the ventral tegmental area, nucleus accumbens, and hippocampus. Across subjects, greater activation in these regions predicted superior memory performance. Within subject, increased correlation between the hippocampus and ventral tegmental area was associated with enhanced long-term memory for the subsequent scene. These findings demonstrate that brain activation preceding stimulus encoding can predict declarative memory formation. The findings are consistent with the hypothesis that reward motivation promotes memory formation via dopamine release in the hippocampus prior to learning.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Adcock, RA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	alison.adcock@ucsf.edu	Gabrieli, John/AAJ-2869-2020; Adcock, R Alison/AAX-6649-2020	Adcock, R Alison/0000-0002-7859-5484; Knutson, Brian/0000-0002-7669-426X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940, R25MH060482] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59940] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKIL M, 1994, NEUROSCIENCE, V60, P857, DOI 10.1016/0306-4522(94)90268-2; AKIL M, 1993, CEREB CORTEX, V3, P533, DOI 10.1093/cercor/3.6.533; AMARAL DG, 1980, J COMP NEUROL, V189, P573, DOI 10.1002/cne.901890402; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; GOLDSMITH SK, 1994, HIPPOCAMPUS, V4, P354, DOI 10.1002/hipo.450040318; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hommer DW, 2003, ANN NY ACAD SCI, V985, P476; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JORK R, 1982, PHARMACOL BIOCHEM BE, V17, P11, DOI 10.1016/0091-3057(82)90254-4; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu Z, 2004, P NATL ACAD SCI USA, V101, P12336, DOI 10.1073/pnas.0403639101; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; PENNARTZ CMA, 1991, J NEUROSCI, V11, P2838; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; SAMSON Y, 1990, J COMP NEUROL, V298, P250, DOI 10.1002/cne.902980209; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010	49	648	655	8	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					507	517		10.1016/j.neuron.2006.03.036	http://dx.doi.org/10.1016/j.neuron.2006.03.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675403	Bronze			2022-12-24	WOS:000237726800018
J	Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR				Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR			Bidirectional behavioral plasticity of memory reconsolidation depends on amygdalar protein kinase A	NATURE NEUROSCIENCE			English	Article							EXTINCTION; CONSOLIDATION; RETRIEVAL	Reconsolidation-the stabilization of a memory after retrieval is hypothesized to be a critical and distinct component of memory processing, the disruption of which results in memory impairment. In the rat, we found that activation of amygdalar protein kinase A ( PKA) was sufficient to enhance memory only when it was retrieved; in contrast, PKA inhibition impaired reconsolidation. This study demonstrates both a selective enhancement and an impairment of memory reconsolidation dependent on amygdalar PKA.	Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, New Haven, CT 06508 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University; Yale University	Taylor, JR (corresponding author), Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, 34 Pk St, New Haven, CT 06508 USA.	jane.taylor@yale.edu		Wiseman, Shari/0000-0001-7868-9723; Tronson, Natalie/0000-0001-5676-1579	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15222] Funding Source: Medline; NIMH NIH HHS [MH25642] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; GORDON WC, 1977, PHYSIOL BEHAV, V19, P95; Jentsch JD, 2002, BIOL PSYCHIAT, V52, P111, DOI 10.1016/S0006-3223(02)01358-6; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PAXINOS G, 1996, RAT BRAIN ATLAS STER; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004	11	204	206	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					167	169		10.1038/nn1628	http://dx.doi.org/10.1038/nn1628			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415868				2022-12-24	WOS:000234990100009
J	Eljaschewitsch, E; Witting, A; Mawrin, C; Lee, T; Schmidt, PM; Wolf, S; Hoertnagl, H; Raine, CS; Schneider-Stock, R; Nitsch, R; Ullrich, O				Eljaschewitsch, E; Witting, A; Mawrin, C; Lee, T; Schmidt, PM; Wolf, S; Hoertnagl, H; Raine, CS; Schneider-Stock, R; Nitsch, R; Ullrich, O			The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells	NEURON			English	Article							CB1 CANNABINOID RECEPTORS; SIGNAL-REGULATED KINASE; FOCAL CEREBRAL-ISCHEMIA; ACTIVATION; INHIBITION; EXPRESSION; INCREASES; RELEASE; 2-ARACHIDONOYLGLYCEROL; STIMULATION	Endocannabinoids are released after brain injury and believed to attenuate neuronal damage by binding to CB, receptors and protecting against excitotoxicity. Such excitotoxic brain lesions initially result in primary destruction of brain parenchyma, which attracts macrophages and microglia. These inflammatory cells release toxic cytokines and free radicals, resulting in secondary neuronal damage. In this study, we show that the endocannabinoid system is highly activated during CNS inflammation and that the endocannabinoid anandamide (AEA) protects neurons from inflammatory damage by CB1/2 receptor-mediated rapid induction of mitogen-activated protein kinase phosphatase-1 (MKP-1) in microglial cells associated with histone H3 phoshorylation of the mkp-1 gene sequence. As a result, AEA-induced rapid MKP-1 expression switches off MAPK signal transduction in microglial cells activated by stimulation of pattern recognition receptors. The release of AEA in injured CNS tissue might therefore represent a new mechanism of neuro-immune communication during CNS injury, which controls and limits immune response after primary CNS damage.	Otto Von Guericke Univ, Fac Med, Inst Immunol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Fac Med, Inst Pathol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Fac Med, Inst Neuropathol, D-39120 Magdeburg, Germany; Charite, Ctr Anat, D-10098 Berlin, Germany; Charite, Inst Pharmacol, D-10098 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Albert Einstein Coll Med, Bronx, NY 10461 USA; Univ Washington, Magnuson Hlth Sci Ctr, Seattle, WA 98105 USA	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Ullrich, O (corresponding author), Otto Von Guericke Univ, Fac Med, Inst Immunol, Leipzig Str 44, D-39120 Magdeburg, Germany.	oliver.ullrich@medizin.uni-magdeburg.de	Schmidt, Peter/V-3882-2019; Wolf, Susanne/AAA-6598-2022; Nitsch, Robert/AAI-9129-2021; Wolf, Susanne/A-1907-2011; Schneider-Stock, Regine/H-8863-2012	Schmidt, Peter/0000-0003-1340-9086; Wolf, Susanne/0000-0003-0922-8418	NHLBI NIH HHS [N01-HO-3284] Funding Source: Medline; NIMH NIH HHS [R24MH59724] Funding Source: Medline; NINDS NIH HHS [NS11920, NS08952] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011920, P01NS011920, R01NS008952] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; BOUABOULA M, 1995, J BIOL CHEM, V270, P13973, DOI 10.1074/jbc.270.23.13973; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chaperon F, 1999, CRIT REV NEUROBIOL, V13, P243, DOI 10.1615/CritRevNeurobiol.v13.i3.20; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 1996, SCIENCE, V273, P1719, DOI 10.1126/science.273.5282.1719; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Franklin A, 2003, J NEUROSCI, V23, P7767; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; GALLILY R, 2002, EUR J PHARMACOL, V406, P5; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Guo YL, 1998, J BIOL CHEM, V273, P10362, DOI 10.1074/jbc.273.17.10362; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HOWLETT AC, 1984, LIFE SCI, V35, P1803, DOI 10.1016/0024-3205(84)90278-9; Jackson SJ, 2005, J NEUROL SCI, V233, P21, DOI 10.1016/j.jns.2005.03.002; Jacobsson SOP, 2000, BIOCHEM PHARMACOL, V60, P1807, DOI 10.1016/S0006-2952(00)00492-5; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kuwae T, 1999, FEBS LETT, V459, P123, DOI 10.1016/S0014-5793(99)01226-0; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1988, MOL PHARM, V34, P605; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; Pryce G, 2005, TRENDS NEUROSCI, V28, P272, DOI 10.1016/j.tins.2005.03.006; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sarker KP, 2000, FEBS LETT, V472, P39, DOI 10.1016/S0014-5793(00)01425-3; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Shapiro PS, 1998, J BIOL CHEM, V273, P1788, DOI 10.1074/jbc.273.3.1788; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Thompson AJ, 2002, NEUROLOGY, V58, P1323, DOI 10.1212/WNL.58.9.1323; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trettel J, 2003, J NEUROPHYSIOL, V89, P2334, DOI 10.1152/jn.01037.2002; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Witting A, 2004, J NEUROCHEM, V89, P1555, DOI 10.1111/j.1471-4159.2004.02544.x; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101	74	344	352	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					67	79		10.1016/j.neuron.2005.11.027	http://dx.doi.org/10.1016/j.neuron.2005.11.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387640	Bronze			2022-12-24	WOS:000236699300010
J	Daw, ND; Niv, Y; Dayan, P				Daw, ND; Niv, Y; Dayan, P			Uncertainty-based competition between prefrontal and dorsolateral striatal systems for behavioral control	NATURE NEUROSCIENCE			English	Article							LINKING BASAL GANGLIA; REINFORCER DEVALUATION; COMPUTATIONAL MODEL; CEREBRAL-CORTEX; HABIT FORMATION; LESIONS; REWARD; DOPAMINE; MEMORY; SENSITIVITY	A broad range of neural and behavioral data suggests that the brain contains multiple systems for behavioral choice, including one associated with prefrontal cortex and another with dorsolateral striatum. However, such a surfeit of control raises an additional choice problem: how to arbitrate between the systems when they disagree. Here, we consider dual-action choice systems from a normative perspective, using the computational theory of reinforcement learning. We identify a key trade-off pitting computational simplicity against the flexible and statistically efficient use of experience. The trade-off is realized in a competition between the dorsolateral striatal and prefrontal systems. We suggest a Bayesian principle of arbitration between them according to uncertainty, so each controller is deployed when it should be most accurate. This provides a unifying account of a wealth of experimental evidence about the factors favoring dominance by either system.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Daw, ND (corresponding author), UCL, Gatsby Computat Neurosci Unit, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	daw@gatsby.ucl.ac.uk		Dayan, Peter/0000-0003-3476-1839				ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; Baum EB, 1997, ARTIF INTELL, V97, P195, DOI 10.1016/S0004-3702(97)00059-3; Blundell P, 2003, J NEUROSCI, V23, P7702; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chavarriaga R, 2005, NEUROINFORMATICS, V3, P223, DOI 10.1385/NI:3:3:223; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P520, DOI 10.1037/0097-7403.11.4.520; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DAW ND, 2003, ADV NEURAL INFORM PR, V15, P99; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dearden R, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P761; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Hartley T, 2005, TRENDS NEUROSCI, V28, P169, DOI 10.1016/j.tins.2005.02.004; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Houk JC, 1995, MODELS INFORMATION P, P249; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kahneman D, 2011, THINKING FAST SLOW; Killcross A.S., 2002, EMOTIONAL COGNITION, P35; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Lieberman M.D., 2003, SOCIAL JUDGMENTS IMP, P44; LOEWENSTEIN G, 2004, 0414 CORN U CTR AN E; MANNOR S, 2004, P 21 INT C MACH LEAR, P568; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parkinson JA, 2005, Q J EXP PSYCHOL-B, V58, P19, DOI 10.1080/02724990444000023; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; Suri RE, 2001, EXP BRAIN RES, V140, P234, DOI 10.1007/s002210100814; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	1411	1426	1	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1704	1711		10.1038/nn1560	http://dx.doi.org/10.1038/nn1560			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286932				2022-12-24	WOS:000233576200019
J	Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F				Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F			Dissociation between physical and mental number line bisection in right hemisphere brain damage	NATURE NEUROSCIENCE			English	Article							UNILATERAL NEGLECT; SPACE; REPRESENTATION; HEMIANOPIA; MAGNITUDE; ANATOMY; CORTEX	To compare numeric quantities, humans make use of a 'mental number line' with smaller quantities located to the left of larger ones; it is unclear, however, whether orienting along the number line is like orienting along a physical line. We found that in brain-damaged subjects with defective leftward orienting, rightward deviation in the bisection of numeric and physical intervals is doubly dissociated. Deviation in numeric interval bisection was associated with prefrontal damage and spatial working memory deficit.	IRCCS, LENA, Fdn Santa Lucia, Rome, Italy; Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Sci Neurol Cattedra 5, Rome, Italy; Auxilium Vitae Volterra, Pisa, Italy	IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome	Doricchi, F (corresponding author), IRCCS, LENA, Fdn Santa Lucia, Rome, Italy.	Fabrizio.Doricchi@uniroma1.it	Tomaiuolo, Francesco/AAC-1534-2019	Tomaiuolo, Fancesco/0000-0003-1230-2770				Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Della Sala S, 2004, NEUROPSYCHOLOGIA, V42, P1358, DOI 10.1016/j.neuropsychologia.2004.02.011; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Malhotra P, 2005, BRAIN, V128, P424, DOI 10.1093/brain/awh372; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Rizzuto DS, 2005, NAT NEUROSCI, V8, P415, DOI 10.1038/nn1424; Rossetti Y, 2004, PSYCHOL SCI, V15, P426, DOI 10.1111/j.0956-7976.2004.00696.x; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	15	144	146	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1663	1665		10.1038/nn1563	http://dx.doi.org/10.1038/nn1563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261135				2022-12-24	WOS:000233576200013
J	Maximov, A; Sudhof, TC				Maximov, A; Sudhof, TC			Autonomous function of synaptotagmin 1 in triggering synchronous release independent of asynchronous release	NEURON			English	Article							CORE VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; SYNAPTIC VESICLES; CA2+ BINDING; I FUNCTIONS; NEUROTRANSMITTER; DEPRESSION; DROSOPHILA; SENSOR	Ca2+ triggers neurotransmitter release in at least two principal modes, synchronous and asynchronous release. Synaptotagmin 1 functions as a Ca2+ sensor for synchronous release, but its role in asynchronous release remains unclear. We now show that in cultured cortical neurons stimulated at low frequency (<= 0.1 Hz), deletion of synaptotagmin 1 blocks synchronous GABA and glutamate release without significantly increasing asynchronous release. At higher stimulation frequencies (>= 4 Hz), deletion of synaptotagmin 1 also alters only synchronous, not asynchronous, release during the stimulus train, but dramatically enhances "delayed asynchronous release" following the stimulus train. Thus synaptotagmin 1 functions as an autonomous Ca2+ sensor independent of asynchronous release during isolated action potentials and action potential trains, but restricts asynchronous release induced by residual Ca2+ after action potential trains. We propose that synaptotagmin 1 occupies release "slots" at the active zone, possibly in a Ca2+- independent complex with SNARE proteins that are freed when action potential-induced Ca2+ influx activates synaptotagmin 1.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu						Atluri PP, 1998, J NEUROSCI, V18, P8214; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Cummings DD, 1996, J NEUROSCI, V16, P5312; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kirischuk S, 2003, J PHYSIOL-LONDON, V548, P753, DOI 10.1113/jphysiol.2002.037036; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; PERIN MS, 1991, J BIOL CHEM, V266, P615; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; Tokuoka H, 2003, NEURON, V38, P521, DOI 10.1016/S0896-6273(03)00290-3; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	27	170	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					547	554		10.1016/j.neuron.2005.09.006	http://dx.doi.org/10.1016/j.neuron.2005.09.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301172	Bronze			2022-12-24	WOS:000233677300009
J	Kassai, H; Aiba, A; Nakao, K; Nakamura, K; Katsuki, M; Xiong, WH; Yau, KW; Imai, H; Shichida, Y; Satomi, Y; Takao, T; Okano, T; Fukada, Y				Kassai, H; Aiba, A; Nakao, K; Nakamura, K; Katsuki, M; Xiong, WH; Yau, KW; Imai, H; Shichida, Y; Satomi, Y; Takao, T; Okano, T; Fukada, Y			Farnesylation of retinal transducin underlies its translocation during light adaptation	NEURON			English	Article							PROTEIN GAMMA-SUBUNIT; CARBOXYL METHYLTRANSFERASE; CRAYFISH PHOTORECEPTORS; DEPENDENT TRANSLOCATION; ALPHA-SUBUNIT; BETA; CELLS; PHOTOTRANSDUCTION; COMPLEX; BINDING	G proteins are posttranslationally modified by isoprenylation: either farnesylation or geranylgeranylation. The gamma subunit of retinal transducin (T alpha/T beta gamma) is selectively farnesylated, and the farnesylation is required for light signaling mediated by transducin in rod cells. However, whether and how this selective isoprenylation regulates cellular functions remain poorly understood. Here we report that knockin mice expressing geranylgeranylated T gamma showed normal rod responses to dim flashes under dark-adapted conditions but exhibited impaired properties in light adaptation. Of note, geranylgeranylation of T gamma suppressed light-induced transition of T beta gamma from membrane to cytosol, and also attenuated its light-dependent translocation from the outer segment to the inner region, an event contributing to retinal light adaptation. These results indicate that, while the farnesylation of transducin is interchangeable with the geranylgeranylation in terms of the light signaling, the selective farnesylation is important for visual sensitivity regulation by providing sufficient but not excessive membrane anchoring of T beta gamma.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan; RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Okazaki Natl Res Inst, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Lab Prot & Profiling & Funct Proteom, Inst Prot Res, Suita, Osaka 5650871, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Kobe University; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Johns Hopkins University; Kyoto University; Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST)	Fukada, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014	Aiba, Atsu/0000-0002-8192-0778; zhong wei, he gui/0000-0002-3066-3564; Satomi, Yoshinori/0000-0002-8991-1040; Imai, Hiroo/0000-0003-0729-0322; Okano, Toshiyuki/0000-0001-6740-6265	NATIONAL EYE INSTITUTE [R01EY014596, R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15S1, R01 EY006837-17, R01 EY006837, R37 EY006837-15, R01 EY006837-18, R01 EY014596-03, R01 EY014596-01, R01 EY014596, R01 EY006837-16A1, R01 EY014596-02, R37 EY006837] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-01, R01 DC006904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chen FY, 1997, BIOCHEM BIOPH RES CO, V233, P370, DOI 10.1006/bbrc.1997.6460; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fogg VC, 2001, J BIOL CHEM, V276, P41797, DOI 10.1074/jbc.M107661200; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; FUKADA Y, 1989, J BIOL CHEM, V264, P5937; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Hardie R, 2002, NEURON, V34, P3, DOI 10.1016/S0896-6273(02)00650-5; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; Kassai H, 2005, RAPID COMMUN MASS SP, V19, P269, DOI 10.1002/rcm.1782; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; KUO CH, 1989, MOL BRAIN RES, V6, P1, DOI 10.1016/0169-328X(89)90022-3; KUO CH, 1989, BIOCHEM BIOPH RES CO, V162, P1063, DOI 10.1016/0006-291X(89)90781-X; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Matsuda T, 2000, METHOD ENZYMOL, V316, P465; Matsuda T, 1998, BIOCHEMISTRY-US, V37, P9843, DOI 10.1021/bi973194c; Mendez A, 2003, J NEUROSCI, V23, P3124; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh Jr EN, 2000, HDB BIOL PHYS, V3; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tanaka H, 1996, BIOCHEM BIOPH RES CO, V223, P587, DOI 10.1006/bbrc.1996.0939; Terakita A, 1996, VISUAL NEUROSCI, V13, P539, DOI 10.1017/S095252380000821X; Terakita A, 1998, J COMP PHYSIOL A, V183, P411, DOI 10.1007/s003590050267; WILLIAMS DE, 1964, ANN NY ACAD SCI, V121, P373, DOI 10.1111/j.1749-6632.1964.tb14210.x; Zhang HB, 2003, MOL VIS, V9, P231	52	38	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					529	539		10.1016/j.neuron.2005.07.025	http://dx.doi.org/10.1016/j.neuron.2005.07.025			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102536	Green Accepted, Bronze			2022-12-24	WOS:000231411100010
J	Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M				Hoogenraad, CC; Milstein, AD; Ethell, IM; Henkemeyer, M; Sheng, M			GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOMAIN PROTEIN GRIP1; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; KINESIN; EPHRINS; MICROTUBULES	The function of the multi-PDZ domain scaffold protein GRIP1 (glutamate receptor interacting protein 1) in neurons is unclear. To explore the function of GRIP1 in hippocampal neurons, we used RNA interference (RNAi) to knock down the expression of GRIP1. Knockdown of GRIP1 by small interfering RNA (siRNA) in cultured hippocampal neurons caused a loss of dendrites, associated with mislocalization of the GRIP-interacting proteins GluR2 (AMPA receptor subunit), EphB2 (receptor tyrosine kinase) and KIF5 (also known as kinesin 1; microtubule motor). The loss of dendrites by GRIP1-siRNA was rescued by overexpression of the extracellular domain of EphB2, and was phenocopied by overexpression of the intracellular domain of EphB2 and extracellular application of ephrinB-Fc fusion proteins. Neurons from EphB1-EphB2-EphB3 triple knockout mice showed abnormal dendrite morphogenesis. Disruption of the KIF5-GRIP1 interaction inhibited EphB2 trafficking and strongly impaired dendritic growth. These results indicate an important role for GRIP1 in dendrite morphogenesis by serving as an adaptor protein for kinesin-dependent transport of EphB receptors to dendrites.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of California System; University of California Riverside; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.	msheng@mit.edu	Hoogenraad, Casper/B-8866-2011	Hoogenraad, Casper/0000-0002-2666-0758; Milstein, Aaron/0000-0002-7186-5779; Henkemeyer, Mark/0000-0002-7525-1061; Ethell, Iryna/0000-0002-1324-6611; Sheng, Morgan/0000-0002-8703-5366	NIMH NIH HHS [R01 MH067121-03, MH66332, R01 MH066332] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332, R01MH067121] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Burette A, 1999, J COMP NEUROL, V411, P601; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hering H, 2003, J NEUROSCI, V23, P11759; Horton AC, 2003, J NEUROSCI, V23, P6188; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	50	162	169	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					906	915		10.1038/nn1487	http://dx.doi.org/10.1038/nn1487			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965473				2022-12-24	WOS:000230137100018
J	Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ				Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ			Glutamate receptor dynamics organizing synapse formation in vivo	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; LATERAL MOVEMENTS; QUANTAL CONTENT; PLASTICITY; PROTEINS; LOCALIZATION	Insight into how glutamatergic synapses form in vivo is important for understanding developmental and experience-triggered changes of excitatory circuits. Here, we imaged postsynaptic densities (PSDs) expressing a functional, GFP-tagged glutamate receptor subunit (GluR-IIA(GFP)) at neuromuscular junctions of Drosophila melanogaster larvae for several days in vivo. New PSDs, associated with functional and structural presynaptic markers, formed independently of existing synapses and grew continuously until reaching a stable size within hours. Both in vivo photoactivation and photobleaching experiments showed that extrasynaptic receptors derived from diffuse, cell-wide pools preferentially entered growing PSDs. After entering PSDs, receptors were largely immobilized. In comparison, other postsynaptic proteins tested (PSD-95, NCAM and PAK homologs) exchanged faster and with no apparent preference for growing synapses. We show here that new glutamatergic synapses form de novo and not by partitioning processes from existing synapses, suggesting that the site-specific entry of particular glutamate receptor complexes directly controls the assembly of individual PSDs.	European Neurosci Inst Gottingen, Max Planck Soc, D-37073 Gottingen, Germany; IMB, Graz, Austria; Inst Physiol, D-79104 Freiburg, Germany	Max Planck Society	Sigrist, SJ (corresponding author), European Neurosci Inst Gottingen, Max Planck Soc, Waldweg 33, D-37073 Gottingen, Germany.	heckmann@physiologie.uni-freiburg.de; ssigris@gwdg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Schmidt, Manuela/0000-0003-1972-3519; Heckmann, Manfred/0000-0002-4874-1735; Madeo, Frank/0000-0002-5070-1329				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Renger JJ, 2000, J NEUROSCI, V20, P3980; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Sone M, 2000, DEVELOPMENT, V127, P4157; Stewart BA, 1996, J NEUROSCI, V16, P3877; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	138	141	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					898	905		10.1038/nn1484	http://dx.doi.org/10.1038/nn1484			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136672				2022-12-24	WOS:000230137100017
J	Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH				Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH			In vivo auditory brain mapping in mice with Mn-enhanced MRI	NATURE NEUROSCIENCE			English	Article							RESONANCE-IMAGING MEMRI; INFERIOR COLLICULUS; OTITIS-MEDIA; MOUSE-BRAIN; ACTIVATION; RESPONSES; NEURONS; HEARING; NUCLEI	There are currently no noninvasive imaging methods available for auditory brain mapping in mice, despite the increasing use of genetically engineered mice to study auditory brain development and hearing loss. We developed a manganese-enhanced MRI (MEMRI) method to map regions of accumulated sound-evoked activity in awake, normally behaving mice. To demonstrate its utility for high-resolution (100-mu m) brain mapping, we used MEMRI to show the tonotopic organization of the mouse inferior colliculus. To test its efficacy in an experimental setting, we acquired data from mice experiencing unilateral conductive hearing loss at different ages. Larger and persistent changes in auditory brainstem activity resulted when hearing loss occurred before the onset of hearing, showing that early hearing loss biases the response toward the functional ear. Thus, MEMRI provides a sensitive and effective method for mapping the mouse auditory brainstem and has great potential for a range of functional neuroimaging studies in normal and mutant mice.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Grad Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Turnbull, DH (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	turnbull@saturn.med.nyu.edu	Wadghiri, Youssef Zaim/Q-5110-2019; Wadghiri, Youssef/E-6848-2016	Wadghiri, Youssef Zaim/0000-0001-7175-9397; Wadghiri, Youssef/0000-0001-7175-9397; Turnbull, Daniel/0000-0003-0889-5155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006864, R21DC006892] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC006892, DC06892, R01 DC006864-03, R01 DC006864] Funding Source: Medline; NINDS NIH HHS [NS38461, R01 NS038461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Ehret G, 1976, J Am Audiol Soc, V1, P179; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; HALL JW, 1995, ARCH OTOLARYNGOL, V121, P847; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KENNEDY C, 1975, SCIENCE, V187, P850, DOI 10.1126/science.1114332; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; ROMAND R, 1990, DEV BRAIN RES, V54, P221, DOI 10.1016/0165-3806(90)90145-O; RYUGO DK, 1981, BRAIN RES, V210, P342, DOI 10.1016/0006-8993(81)90907-0; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SANES DH, 1985, J NEUROSCI, V5, P1152; SCHILDER AGM, 1993, CLIN OTOLARYNGOL, V18, P234; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Shnerson A, 1983, AUDITORY PSYCHOBIOLO, P395; Shukakidze A, 2003, Neurosci Behav Physiol, V33, P263; Sterbing SJ, 2003, HEARING RES, V177, P91, DOI 10.1016/S0378-5955(02)00805-5; Tai YC, 2003, PHYS MED BIOL, V48, P1519, DOI 10.1088/0031-9155/48/11/303; Tindemans I, 2003, EUR J NEUROSCI, V18, P3352, DOI 10.1111/j.1460-9568.2003.03056.x; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; WEBSTER DB, 1977, ARCH OTOLARYNGOL, V103, P392; WILLOTT JF, 1978, J COMP PHYSIOL, V127, P175, DOI 10.1007/BF01352302	30	231	236	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					961	968		10.1038/nn1477	http://dx.doi.org/10.1038/nn1477			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924136	Green Accepted			2022-12-24	WOS:000230137100025
J	Vigh, J; Li, GL; Hull, C; von Gersdorff, L				Vigh, J; Li, GL; Hull, C; von Gersdorff, L			Long-term plasticity mediated by mGluR1 at a retinal reciprocal synapse	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TIGER SALAMANDER RETINA; TEMPORAL CONTRAST ADAPTATION; ROD BIPOLAR CELLS; AMACRINE CELLS; GANGLION-CELLS; RAT RETINA; EXOCYTOSED PROTONS; GABA(C) RECEPTORS; FEEDBACK	The 1 low of information across the retina is controlled by reciprocal synapses between bipolar cell terminals and amacrine cells. However, the synaptic delays and proparties of plasticity at these synapses are not known. Here we report that glutamate release from goldfish Mb-type bipolar cell terminals can trigger fast (delay of 2-3 ms) and transient GABA(A) IPSCs and a much slower and more sustained GABA(C) feedback. Synaptically released glutamate activated mGIuR1 receptors on amacrine cells and, depending on the strength of presynaptic activity, potentiated subsequent feedback. This poststimulus enhancement of GABAergic feedback lasted for up to 10 min. This form of mGluR1-mediated long-term synaptic plasticity may provide retinal reciprocal synapses with adaptive capabilities.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	von Gersdorff, L (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	vongersd@ohsu.edu	Vigh, Jozsef/F-7531-2012; Li, Geng-Lin/I-7998-2014	Li, Geng-Lin/0000-0001-7053-4284; Hull, Court/0000-0002-0360-8367; Vigh, Jozsef/0000-0001-9862-5049	NEI NIH HHS [R01 EY014043] Funding Source: Medline; NINDS NIH HHS [F31 NS042506] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS042506] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bruno V, 1999, NEUROPHARMACOLOGY, V38, P199, DOI 10.1016/S0028-3908(98)00159-2; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Cook PB, 2000, J NEUROSCI, V20, P806, DOI 10.1523/JNEUROSCI.20-02-00806.2000; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Freed MA, 2003, NEURON, V38, P89, DOI 10.1016/S0896-6273(03)00166-1; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Hoffpauir BK, 2002, J NEUROPHYSIOL, V88, P1766, DOI 10.1152/jn.2002.88.4.1766; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; JOHNSON RG, 1987, ANN NY ACAD SCI, V493, P162, DOI 10.1111/j.1749-6632.1987.tb27198.x; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Koulen P, 1997, J NEUROSCI, V17, P2200; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Kreimborg KM, 2001, J NEUROCHEM, V77, P452, DOI 10.1046/j.1471-4159.2001.00225.x; Lapointe V, 2004, J PHYSIOL-LONDON, V555, P125, DOI 10.1113/jphysiol.2003.053603; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pang JJ, 2002, VISION RES, V42, P19, DOI 10.1016/S0042-6989(01)00258-9; Protti DA, 1998, J NEUROSCI, V18, P3715; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Roska B, 1998, J NEUROSCI, V18, P3451; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; Shen W, 2001, J PHYSIOL-LONDON, V530, P55, DOI 10.1111/j.1469-7793.2001.0055m.x; Singer JH, 2003, J NEUROSCI, V23, P10923; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; TABB JS, 1992, J BIOL CHEM, V267, P15412; TAKAHASHI KI, 1992, J NEUROPHYSIOL, V67, P1633, DOI 10.1152/jn.1992.67.6.1633; Tozzi A, 2001, J NEUROPHYSIOL, V85, P2490, DOI 10.1152/jn.2001.85.6.2490; Vigh J, 2003, EUR J NEUROSCI, V17, P2237, DOI 10.1046/j.1460-9568.2003.02652.x; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Watanabe S, 2000, J NEUROPHYSIOL, V84, P1826, DOI 10.1152/jn.2000.84.4.1826; Werner, 2004, VISUAL NEUROSCIENCES, P320; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; Yang XL, 2002, J PHYSIOL-LONDON, V539, P239, DOI 10.1113/jphysiol.2001.013110; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005; Zhang J, 2002, J NEUROSCI, V22, P10871; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219	66	26	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					469	482		10.1016/j.neuron.2005.03.027	http://dx.doi.org/10.1016/j.neuron.2005.03.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882646	Green Accepted, Bronze			2022-12-24	WOS:000229011400018
J	Saghatelyan, A; Roux, P; Migliore, M; Rochefort, C; Desmaisons, D; Charneau, P; Shepherd, GM; Lledo, PM				Saghatelyan, A; Roux, P; Migliore, M; Rochefort, C; Desmaisons, D; Charneau, P; Shepherd, GM; Lledo, PM			Activity-dependent adjustments of the inhibitory network in the olfactory bulb following early postnatal deprivation	NEURON			English	Article							NARIS-OCCLUDED RATS; NMDA RECEPTORS; GRANULE CELLS; MITRAL CELLS; GABA RELEASE; INTRINSIC EXCITABILITY; RECIPROCAL SYNAPSES; SUBVENTRICULAR ZONE; GENERATED NEURONS; CALCIUM INFLUX	The first-order sensory relay for olfactory processing, the main olfactory bulb (MOB), retains the ability to acquire new interneurons throughout life. It is therefore a particularly appropriate region for studying the role of experience in sculpting neuronal networks. We found that nostril closure decreased the number of newborn granule cells in the MOB, the complexity of their dendritic arborization, and their spine density, without affecting the preexisting population of granule cells. Accordingly, the frequency of miniature synaptic inhibitory events received by mitral cells was reduced. However, due to a compensatory increase in newborn granule cell excitability, action potential-dependent GABA release was dramatically enhanced, thus counteracting the reduction in spine density and leading to an unaltered synchronization of mitral cell firing activity. Together, this study reveals a unique form of adaptive response brought about exclusively by the cohort of newborn cells and used to maintain normal functioning of the MOB.	Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France; Inst Pasteur, Platform Dynam Imaging, F-75015 Paris, France; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Inst Pasteur, Lab Mol Virol & Vectorol, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France.	pmlledo@pasteur.fr	CHARNEAU, Pierre/M-1565-2017; Migliore, Michele/D-7448-2011	CHARNEAU, Pierre/0000-0003-1184-5773; Migliore, Michele/0000-0002-7584-6292; Saghatelyan, Armen/0000-0003-4962-0465; rochefort, christelle/0000-0001-8466-5218				Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; Baker H, 1999, J NEUROSCI, V19, P9313; BENSON TE, 1984, J NEUROSCI, V4, P638; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BRUNJES PC, 1985, DEV BRAIN RES, V22, P1, DOI 10.1016/0165-3806(85)90063-X; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Cang JH, 2003, J NEUROSCI, V23, P4108; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Castillo PE, 1999, J NEUROSCI, V19, P9180; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Egger V, 2003, J NEUROSCI, V23, P7551; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Fiske BK, 2001, J COMP NEUROL, V431, P311; FRAZIERCIERPIAL L, 1989, J COMP NEUROL, V289, P481, DOI 10.1002/cne.902890312; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; GUTHRIE KM, 1991, SYNAPSE, V8, P61, DOI 10.1002/syn.890080109; Halabisky B, 2000, J NEUROSCI, V20, P5124; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Johnson BA, 1996, DEV BRAIN RES, V92, P24, DOI 10.1016/0165-3806(95)00197-2; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leon M, 1998, ANN NY ACAD SCI, V855, P104, DOI 10.1111/j.1749-6632.1998.tb10551.x; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Matsutani S, 2000, J COMP NEUROL, V418, P402; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; MEISAMI E, 1981, BRAIN RES, V221, P81, DOI 10.1016/0006-8993(81)91065-9; MEISAMI E, 1986, INT J DEV NEUROSCI, V4, P431, DOI 10.1016/0736-5748(86)90025-0; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Nakajima T, 1998, ANAT RECORD, V250, P238; Petreanu L, 2002, J NEUROSCI, V22, P6106; Philpot BD, 1998, NEUROSCIENCE, V85, P969, DOI 10.1016/S0306-4522(97)00667-2; PRICE JL, 1970, J CELL SCI, V7, P91; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROSSELLIAUSTIN L, 1990, DEV BRAIN RES, V51, P135, DOI 10.1016/0165-3806(90)90267-3; Saghatelyan A, 2003, J PHYSIOL-PARIS, V97, P517, DOI 10.1016/j.jphysparis.2004.01.009; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schrader LA, 2002, MOL NEUROBIOL, V25, P51; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; STAHL B, 1990, CELL TISSUE RES, V259, P275, DOI 10.1007/BF00318449; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; WILSON DA, 1992, NEUROSCIENCE, V49, P183, DOI 10.1016/0306-4522(92)90086-H; WILSON DA, 1990, NEUROSCI LETT, V116, P250, DOI 10.1016/0304-3940(90)90082-K; WILSON DA, 1995, BRAIN RES, V677, P238, DOI 10.1016/0006-8993(95)00151-F; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	67	122	128	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					103	116		10.1016/j.neuron.2005.02.016	http://dx.doi.org/10.1016/j.neuron.2005.02.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820697	Bronze			2022-12-24	WOS:000228228600012
J	Yazawa, I; Giasson, BI; Sasaki, R; Zhang, B; Joyce, S; Uryu, K; Trojanowski, JQ; Lee, VMY				Yazawa, I; Giasson, BI; Sasaki, R; Zhang, B; Joyce, S; Uryu, K; Trojanowski, JQ; Lee, VMY			Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration	NEURON			English	Article							PARKINSONS-DISEASE; CYTOPLASMIC INCLUSIONS; NEUROFILAMENT PHOSPHORYLATION; LEWY BODIES; WILD-TYPE; PROTEIN; DEMENTIA; MICE; TRANSECTION; MICROGLIA	Transgenic (Tg) mice overexpressing human wild-type alpha-synuclein in oligodendrocytes under the control of the 2,' 3'-cyclic nucleotide X-phosphodiesterase (CNP) promoter are shown here to recapitulate features of multiple system atrophy (MSA), including the accumulation of filamentous human alpha-synuclein aggregates in oligodendrocytes linked to their degeneration and autophagocytosis of myelin. Significantly, endogenous mouse (x-synuclein also accumulated in normal and degenerating axons and axon terminals in association with oligodendroglia and neuron loss and slowly progressive motor impairments. Our studies demonstrate that overexpression of alpha-synuclein in oligodendrocytes of mice results in MSA-like degeneration in the CNS and that a-synuclein inclusions in oligodendrocytes participate in the degeneration of neurons in MSA.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu			NIA NIH HHS [AG-09215] Funding Source: Medline; NINDS NIH HHS [NS-044233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Baba M, 1998, AM J PATHOL, V152, P879; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; GLASSON BI, 2002, NEURON, V34, P521; GLASSON BI, 2000, J NEUROSCI RES, V59, P528; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Gravel M, 1998, J NEUROSCI RES, V53, P393; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; HEDREEN JC, 1994, J NEUROPATH EXP NEUR, V53, P663, DOI 10.1097/00005072-199411000-00013; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KLOSEN P, 1990, BRAIN RES, V526, P259, DOI 10.1016/0006-8993(90)91230-E; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuo A, 1998, AM J PATHOL, V153, P735, DOI 10.1016/S0002-9440(10)65617-9; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; NAKAZATO Y, 1990, J NEUROPATH EXP NEUR, V49, P521, DOI 10.1097/00005072-199009000-00007; PAPP MI, 1994, BRAIN, V117, P235, DOI 10.1093/brain/117.2.235; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PETERS A, 1991, FINE STRUCTURE NERVO, P298; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; YAMADA T, 1990, NEUROSCI LETT, V120, P163, DOI 10.1016/0304-3940(90)90028-8	43	229	236	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					847	859		10.1016/j.neuron.2005.01.032	http://dx.doi.org/10.1016/j.neuron.2005.01.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797547	Bronze			2022-12-24	WOS:000228031300007
J	Engel, D; Jonas, P				Engel, D; Jonas, P			Presynaptic action potential amplification by voltage-gated Na+ channels in hippocampal mossy fiber boutons	NEURON			English	Article							MOTOR-NERVE TERMINALS; SHORT-TERM PLASTICITY; SODIUM-CHANNEL; RAT HIPPOCAMPUS; PYRAMIDAL NEURONS; AUXILIARY SUBUNIT; MEMORY SEQUENCES; SLOW RECOVERY; GRANULE CELLS; CA3 REGION	Action potentials in central neurons are initiated near the axon initial segment, propagate into the axon, and finally invade the presynaptic terminals, where they trigger transmitter release. Voltage-gated Na+ channels are key determinants of excitability, but Na+ channel density and properties in axons and presynaptic terminals of cortical neurons have not been examined yet. In hippocampal mossy fiber boutons, which emerge from parent axons en passant, Na+ channels are very abundant, with an estimated number of similar to2000 channels per bouton. Presynaptic Na+ channels show faster inactivation kinetics than somatic channels, suggesting differences between subcellular compartments of the same cell. Computational analysis of action potential propagation in axon-multibouton structures reveals that Na+ channels in boutons preferentially amplify the presynaptic action potential and enhance Ca2+ inflow, whereas Na+ channels in axons control the reliability and speed of propagation. Thus, presynaptic and axonal Na+ channels contribute differentially to mossy fiber synaptic transmission.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Engel, Dominique/0000-0002-5962-3152				Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1997, J NEUROSCI, V17, P6512; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DREYER F, 1987, J PHYSIOL-LONDON, V386, P455, DOI 10.1113/jphysiol.1987.sp016544; Efron B, 1998, INTRO BOOTSTRAP; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V533, P921; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Geiger JRP, 2002, PFLUG ARCH EUR J PHY, V443, P491, DOI 10.1007/s00424-001-0735-3; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GOLDMAN L, 1973, J GEN PHYSIOL, V61, P361, DOI 10.1085/jgp.61.3.361; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Gong B, 1999, J COMP NEUROL, V412, P342; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jung HY, 1997, J NEUROSCI, V17, P6639; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P453, DOI 10.1098/rspb.1965.0015; Katz B., 1969, RELEASE NEURAL TRANS; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUSCHER HR, 1990, BIOPHYS J, V58, P1377, DOI 10.1016/S0006-3495(90)82484-X; LUSCHER HR, 1990, BIOPHYS J, V58, P1389, DOI 10.1016/S0006-3495(90)82485-1; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Marty Alain, 1995, P31; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; OXFORD GS, 1981, J GEN PHYSIOL, V77, P1, DOI 10.1085/jgp.77.1.1; RITCHIE JM, 1957, J PHYSIOL-LONDON, V136, P80, DOI 10.1113/jphysiol.1957.sp005744; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sakmann Bert, 1995, P637; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; Sangrey TD, 2004, J NEUROPHYSIOL, V91, P2541, DOI 10.1152/jn.00646.2003; Schaller KL, 2000, J COMP NEUROL, V420, P84; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Smith MR, 1998, J NEUROSCI, V18, P6093; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Waxman Stephen G., 1995, P218; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Yu FH, 2003, J NEUROSCI, V23, P7577	70	152	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					405	417		10.1016/j.neuron.2004.12.048	http://dx.doi.org/10.1016/j.neuron.2004.12.048			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694327	Bronze			2022-12-24	WOS:000226787700013
J	Steffenach, HA; Witter, M; Moser, MB; Moser, EI				Steffenach, HA; Witter, M; Moser, MB; Moser, EI			Spatial memory in the rat requires the dorsolateral band of the entorhinal cortex	NEURON			English	Article							POSITIONAL FIRING PROPERTIES; NUCLEUS-REUNIENS-THALAMI; FREELY MOVING RATS; VENTRAL HIPPOCAMPUS; WORKING-MEMORY; FUNCTIONAL-DIFFERENTIATION; RETROHIPPOCAMPAL LESIONS; PARAHIPPOCAMPAL REGION; PARASUBICULUM DISRUPT; EXCITOTOXIC LESIONS	The extensive connections of the entorhinal cortex with the hippocampus and the neocortex point to this region as a major interface in the hippocampal-neocortical interactions underlying memory. We asked whether hippocampal-dependent recall of spatial memory depends on the entorhinal cortex, and, if so, which parts are critical. After training in a Morris water maze, rats received fiber-sparing lesions in the dorsolateral band of the entorhinal cortex, which mediates much of the visuospatial input to the dorsal hippocampus. These lesions entirely disrupted retention and retarded new learning. Spatial memory was spared by lesions in the ventromedial band, which connects primarily with ventral hippocampus, but these lesions reduced defensive behavior on an elevated plus maze, mirroring the effects of damage to ventral hippocampus. The results suggest that the functional differences between dorsal and ventral hippocampus reflect their connectivity with modules of the entorhinal cortex that are differently linked to the rest of the cortex.	Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway; Vrije Univ Amsterdam, Med Ctr, Dept Anat, Res Inst Neurosci, NL-1007 MB Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no						Aggleton JP, 2000, HIPPOCAMPUS, V10, P466, DOI 10.1002/1098-1063(2000)10:4<466::AID-HIPO13>3.3.CO;2-P; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bannerman DM, 2001, EXP BRAIN RES, V141, P281; Bannerman DM, 2001, EXP BRAIN RES, V141, P304; BOUFFARD JP, 1988, BEHAV NEUROSCI, V102, P828, DOI 10.1037/0735-7044.102.6.828; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; CHO YH, 1994, EUR J NEUROSCI, V6, P1265, DOI 10.1111/j.1460-9568.1994.tb00316.x; de Hoz L, 2004, PLOS BIOL, V2, P1233, DOI 10.1371/journal.pbio.0020225; de Hoz L, 2003, HIPPOCAMPUS, V13, P587, DOI 10.1002/hipo.10079; DOLLEMANVANDERWEEL, 1996, J COMP NEUROL, V364, P637; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Galani R, 2002, NEUROBIOL LEARN MEM, V77, P1, DOI 10.1006/nlme.2000.3998; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; HOLSCHER C, 1994, BEHAV BRAIN RES, V63, P187, DOI 10.1016/0166-4328(94)90090-6; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; JARRARD LE, 1984, BEHAV NEUROSCI, V98, P946, DOI 10.1037/0735-7044.98.6.946; Jarrard LE, 2004, HIPPOCAMPUS, V14, P434, DOI 10.1002/hipo.10194; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kesner RP, 1998, HIPPOCAMPUS, V8, P416, DOI 10.1002/(SICI)1098-1063(1998)8:4<416::AID-HIPO9>3.0.CO;2-E; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Liu P, 2004, HIPPOCAMPUS, V14, P107, DOI 10.1002/hipo.10161; Liu P, 2001, BEHAV NEUROSCI, V115, P112, DOI 10.1037/0735-7044.115.1.112; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Naber PA, 1999, EUR J NEUROSCI, V11, P4119, DOI 10.1046/j.1460-9568.1999.00835.x; Naber PA, 2001, HIPPOCAMPUS, V11, P105; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Oswald CJP, 2003, BEHAV NEUROSCI, V117, P588, DOI 10.1037/0735-7044.117.3.588; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Pouzet B, 1999, EUR J NEUROSCI, V11, P123, DOI 10.1046/j.1460-9568.1999.00413.x; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SCHENK F, 1985, EXP BRAIN RES, V58, P11; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WITTER MP, 1989, NEUROLOGY NEUROBIOLO, V52, P53; Witter MP, 1988, NEUROSCI RES COMMUN, V2, P61; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202	68	240	251	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					301	313		10.1016/j.neuron.2004.12.044	http://dx.doi.org/10.1016/j.neuron.2004.12.044			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664181	Bronze			2022-12-24	WOS:000226451500016
J	Ng, JL; Luo, LQ				Ng, JL; Luo, LQ			Rho GTPases regulate axon growth through convergent and divergent signaling pathways	NEURON			English	Article							ACTIN-DEPOLYMERIZING FACTOR; ABL TYROSINE KINASE; LIM-KINASE; EXCHANGE FACTOR; FAMILY GTPASES; FACTOR COFILIN; CELL POLARITY; RAC; PHOSPHORYLATION; POLYMERIZATION	Rho GTPases are essential regulators of cytoskeletal reorganization, but how they do so during neuronal morphogenesis in vivo is poorly understood. Here we show that the actin depolymerization factor cofilin is essential for axon growth in Drosophila neurons. Cofilin function in axon growth is inhibited by LIM kinase and activated by Slingshot phosphatase. Dephosphorylating cofilin appears to be the major function of Slingshot in regulating axon growth in vivo. Genetic data provide evidence that Rho or Rac/Cdc42, via effector kinases Rok or Pak, respectively, activate LIM kinase to inhibit axon growth. Importantly, Rac also activates a Pak-independent pathway that promotes axon growth, and different RacGEFs regulate these distinct pathways. These genetic analyses reveal convergent and divergent pathways from Rho GTPases to the cytoskeleton during axon growth in vivo and suggest that different developmental outcomes could be achieved by biases in pathway selection.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Ng, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	julian.ng@kcl.ac.uk; lluo@stanford.edu	Ng, Julian/C-5747-2009	Ng, Julian/0000-0002-1908-4414; Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fehon RG, 1997, GENETICS, V146, P245; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Mizuno T, 2002, DEVELOPMENT, V129, P1215; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	59	145	155	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					779	793		10.1016/j.neuron.2004.11.014	http://dx.doi.org/10.1016/j.neuron.2004.11.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572110	Bronze			2022-12-24	WOS:000225548400007
J	Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K				Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K			Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; EXPERIENCE-DEPENDENT PLASTICITY; FILAMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; RAT BARREL CORTEX; DENDRITIC SPINES; IN-VIVO; F-ACTIN; RECEPTOR ACTIVATION; GLUTAMATE RECEPTORS	We explored the relationship between regulation of the spine actin cytoskeleton, spine morphogenesis, and synapse formation by manipulating expression of the actin binding protein Nrbl and its deletion mutants. In pyramidal neurons of cultured rat hippocampal slices, Nrbl is concentrated in dendritic spines by binding to the actin cytoskeleton. Expression of one Nrbl deletion mutant, containing the actin binding domain, dramatically increased the density and length of dendritic spines with synapses. This hyperspinogenesis was accompanied by enhanced actin polymerization and spine motility. Synaptic strengths were reduced to compensate for extra synapses, keeping total synaptic input per neuron constant. Our data support a model in which synapse formation is promoted by actin-powered motility.	Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Duke University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010	Knott, Graham W/0000-0002-2956-9052; Zito, Karen/0000-0002-0799-0460				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2003, J NEUROSCI, V23, P11759; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAllister AK, 2000, SCI STKE; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MULY EC, 2004, IN PRESS CORTEX; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	78	149	154	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					321	334		10.1016/j.neuron.2004.09.022	http://dx.doi.org/10.1016/j.neuron.2004.09.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473970	Bronze			2022-12-24	WOS:000224635800014
J	Shintani, T; Ihara, M; Sakuta, H; Takahashi, H; Watakabe, I; Noda, M				Shintani, Takafumi; Ihara, Masaru; Sakuta, Hiraki; Takahashi, Hiroo; Watakabe, Ikuko; Noda, Masaharu			Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O	NATURE NEUROSCIENCE			English	Article							GANGLION-CELL AXONS; RETINOTECTAL PROJECTION; MULTIPLE MECHANISMS; REPULSIVE GUIDANCE; RETROVIRAL VECTORS; ZETA/RPTP-BETA; EXPRESSION; KINASE; LIGANDS; BINDING	Eph receptors are activated by the autophosphorylation of tyrosine residues upon the binding of their ligands, the ephrins; however, the protein tyrosine phosphatases (PTPs) responsible for the negative regulation of Eph receptors have not been elucidated. Here, we identified protein tyrosine phosphatase receptor type O (Ptpro) as a specific PTP that efficiently dephosphorylates both EphA and EphB receptors as substrates. Biochemical analyses revealed that Ptpro dephosphorylates a phosphotyrosine residue conserved in the juxtamembrane region, which is required for the activation and signal transmission of Eph receptors. Ptpro thus seems to moderate the amount of maximal activation of Eph receptors. Using the chick retinotectal projection system, we show that Ptpro controls the sensitivity of retinal axons to ephrins and thereby has a crucial role in the establishment of topographic projections. Our findings explain the molecular mechanism that determines the threshold of the response of Eph receptors to ephrins in vivo.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Shintani, Takafumi/0000-0002-6165-2307; Sakuta, Hiraki/0000-0003-2375-0528				Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bell EJD, 1997, MOL BIOTECHNOL, V7, P289, DOI 10.1007/BF02740819; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Chen CMA, 1999, DEV BIOL, V214, P370, DOI 10.1006/dbio.1999.9432; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1997, CELL, V90, P403; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Ledig MM, 1999, J NEUROBIOL, V39, P81, DOI 10.1002/(SICI)1097-4695(199904)39:1<81::AID-NEU7>3.0.CO;2-K; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Shintani T, 2004, J NEUROBIOL, V59, P34, DOI 10.1002/neu.10338; Stepanek L, 2001, J CELL BIOL, V154, P867, DOI 10.1083/jcb.200105019; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	48	79	81	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					761	769		10.1038/nn1697	http://dx.doi.org/10.1038/nn1697			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680165				2022-12-24	WOS:000237895200016
J	Wojcik, SM; Katsurabayashi, S; Guillemin, I; Friauf, E; Rosenmund, C; Brose, N; Rhee, JS				Wojcik, Sonja M.; Katsurabayashi, Shutaro; Guillemin, Isabelle; Friauf, Eckhard; Rosenmund, Christian; Brose, Nils; Rhee, Jeong-Seop			A shared vesicular carrier allows synaptic corelease of GABA and glycine	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; MOUSE HIPPOCAMPAL-NEURONS; AUDITORY BRAIN-STEM; DEVELOPMENTAL SWITCH; EXCITATORY ACTIONS; SPINAL NEURONS; CLEFT-PALATE; RAT; VESICLES	The type of vesicular transporter expressed by a neuron is thought to determine its neurotransmitter phenotype. We show that inactivation of the vesicular inhibitory amino acid transporter (Viaat, VGAT) leads to embryonic lethality, an abdominal defect known as omphalocele, and a cleft palate. Loss of Viaat causes a drastic reduction of neurotransmitter release in both GABAergic and glycinergic neurons, indicating that glycinergic neurons do not express a separate vesicular glycine transporter. This loss of GABAergic and glycinergic synaptic transmission does not impair the development of inhibitory synapses or the expression of KCC2, the K+-Cl- cotransporter known to be essential for the establishment of inhibitory neurotransmission. In the absence of Viaat, GABA-synthesizing enzymes are partially lost from presynaptic terminals. Since GABA and glycine compete for vesicular uptake, these data point to a close association of Viaat with GABA-synthesizing enzymes as a key factor in specifying GABAergic neuronal phenotypes.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Kaiserslautern, Dept Anim Physiol, D-67653 Kaiserslautern, Germany	Max Planck Society; Baylor College of Medicine; Baylor College of Medicine; University of Kaiserslautern	Wojcik, SM (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	wojcik@em.mpg.de; rhee@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Jansen, Heiko T./A-5770-2008; Friauf, Eckhard/D-7529-2012	Rosenmund, Christian/0000-0002-3905-2444; Jansen, Heiko T./0000-0003-0178-396X; Friauf, Eckhard/0000-0002-1833-1698				Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bedet C, 2000, J NEUROCHEM, V75, P1654, DOI 10.1046/j.1471-4159.2000.0751654.x; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; CHEN G, 1995, J NEUROPHYSIOL, V74, P1473, DOI 10.1152/jn.1995.74.4.1473; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHRISTENSEN H, 1991, NEUROSCI LETT, V129, P217, DOI 10.1016/0304-3940(91)90465-6; CHRISTENSEN H, 1991, EUR J PHARM-MOLEC PH, V207, P73, DOI 10.1016/S0922-4106(05)80040-9; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Colin I, 1998, J COMP NEUROL, V398, P359; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Ebihara S, 2003, MOL BRAIN RES, V110, P126, DOI 10.1016/S0169-328X(02)00648-4; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Katz LA, 2004, AM J MED GENET A, V130A, P277, DOI 10.1002/ajmg.a.30329; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Leitch E, 2005, J NEUROSCI, V25, P4801, DOI 10.1523/JNEUROSCI.0172-05.2005; Lim R, 2000, J PHYSIOL-LONDON, V525, P447, DOI 10.1111/j.1469-7793.2000.t01-1-00447.x; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; SEILER N, 1980, PHYSIOL CHEM PHYS M, V12, P411; SOLIMENA M, 1993, P NATL ACAD SCI USA, V90, P3073, DOI 10.1073/pnas.90.7.3073; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Titz S, 2003, J PHYSIOL-LONDON, V550, P719, DOI 10.1113/jphysiol.2003.041863; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; WALTON MK, 1993, J NEUROSCI, V13, P2068; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	58	258	269	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					575	587		10.1016/j.neuron.2006.04.016	http://dx.doi.org/10.1016/j.neuron.2006.04.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701208	Bronze			2022-12-24	WOS:000237875200009
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			Mechanisms underlying cross-orientation suppression in cat visual cortex	NATURE NEUROSCIENCE			English	Article							CORTICAL SIMPLE CELLS; STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; CONTRAST ADAPTATION; COMPLEX CELLS; INHIBITION; NEURONS; EXCITATION; INPUT	In simple cells of the cat primary visual cortex, null-oriented stimuli, which by themselves evoke no response, can completely suppress the spiking response to optimally oriented stimuli. This cross-orientation suppression has been interpreted as evidence for cross-orientation inhibition: synaptic inhibition among cortical cells with different preferred orientations. In intracellular recordings from simple cells, however, we found that cross-oriented stimuli suppressed, rather than enhanced, synaptic inhibition and, at the same time, suppressed synaptic excitation. Much of the suppression of excitation could be accounted for by the behavior of geniculate relay cells: contrast saturation and rectification in relay cell responses, when applied to a linear feed-forward model, predicted cross-orientation suppression of the modulation (F1) component of excitation evoked in simple cells. In addition, we found that the suppression of the spike output of simple cells was almost twice the suppression of their synaptic inputs. Thus, cross-orientation suppression, like orientation selectivity, is strongly amplified by threshold.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2145 N Sheridan Rd, Evanston, IL 60208 USA.	ferster@northwestern.edu			NATIONAL EYE INSTITUTE [R01EY004726, F32EY014499] Funding Source: NIH RePORTER; NEI NIH HHS [EY-04726, EY-014499] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REIG R, 2005, CEREB CORTEX    0817; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SMITH MA, 2006, IN PRESS J NEUROSCI; Sokal R. R., 2012, BIOMETRY; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351	50	127	129	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					552	561		10.1038/nn1660	http://dx.doi.org/10.1038/nn1660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520737				2022-12-24	WOS:000236310700023
J	Stranahan, AM; Khalil, D; Gould, E				Stranahan, AM; Khalil, D; Gould, E			Social isolation delays the positive effects of running on adult neurogenesis	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; DENTATE GYRUS; CELL-PROLIFERATION; VOLUNTARY EXERCISE; HIPPOCAMPAL NEUROGENESIS; INDUCED INCREASES; MESSENGER-RNA; STRESS; RATS; BEHAVIOR	Social isolation can exacerbate the negative consequences of stress and increase the risk of developing psychopathology. However, the influence of living alone on experiences generally considered to be beneficial to the brain, such as physical exercise, remains unknown. We report here that individual housing precludes the positive influence of short-term running on adult neurogenesis in the hippocampus of rats and, in the presence of additional stress, suppresses the generation of new neurons. Individual housing also influenced corticosterone levels-runners in both housing conditions had elevated corticosterone during the active phase, but individually housed runners had higher levels of this hormone in response to stress. Moreover, lowering corticosterone levels converted the influence of short-term running on neurogenesis in individually housed rats from negative to positive. These results suggest that, in the absence of social interaction, a normally beneficial experience can exert a potentially deleterious influence on the brain.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu	Stranahan, Alexis/AAF-3559-2020; Winwood, Peter/A-6363-2008		NIA NIH HHS [F31 AG024690, F31 AG024690-04, F31 AG024690-03, F31 AG024690-02, F31 AG024690-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F31AG024690] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Ambrogini P, 2002, NEUROENDOCRINOLOGY, V76, P366, DOI 10.1159/000067581; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cassano WJ, 2001, NEUROENDOCRINOLOGY, V74, P167, DOI 10.1159/000054683; CHALMERS DT, 1993, J NEUROSCI, V13, P914; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; GOULD E, 1992, J NEUROSCI, V12, P3642; HOFFMANN P, 1987, BEHAV NEURAL BIOL, V47, P346, DOI 10.1016/S0163-1047(87)90461-4; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Perfilieva E, 2001, J CEREBR BLOOD F MET, V21, P211, DOI 10.1097/00004647-200103000-00004; Persson AI, 2004, EUR J NEUROSCI, V19, P1847, DOI 10.1111/j.1460-9568.2004.03268.x; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Roy MP, 1998, J PERS SOC PSYCHOL, V75, P1273, DOI 10.1037/0022-3514.75.5.1273; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schiller L, 2003, BRAIN RES, V980, P169, DOI 10.1016/S0006-8993(03)02832-4; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Selye Hans, 1976, STRESS LIFE; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; WEISS JM, 1971, J COMP PHYSIOL PSYCH, V77, P22, DOI 10.1037/h0031581; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6	47	351	358	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					526	533		10.1038/nn1668	http://dx.doi.org/10.1038/nn1668			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531997	Green Accepted			2022-12-24	WOS:000236310700020
J	Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW				Lobo, MK; Karsten, SL; Gray, M; Geschwind, DH; Yang, XW			FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains	NATURE NEUROSCIENCE			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; D2 DOPAMINE; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; GANGLIA ANTIBODIES; RECEPTOR PROTEINS; TRANSGENIC MICE; TRANSCRIPTION; NEUROBIOLOGY	A major challenge in systems neuroscience is to perform precise molecular genetic analyses of a single neuronal population in the context of the complex mammalian brain. Existing technologies for profiling cell type-specific gene expression are largely limited to immature or morphologically identifiable neurons. In this study, we developed a simple method using fluorescent activated cell sorting (FACS) to purify genetically labeled neurons from juvenile and adult mouse brains for gene expression profiling. We identify and verify a new set of differentially expressed genes in the striatonigral and striatopallidal neurons, two functionally and clinically important projection neuron subtypes in the basal ganglia. We further demonstrate that Ebf1 is a lineage-specific transcription factor essential to the differentiation of striatonigral neurons. Our study provides a general approach for profiling cell type-specific gene expression in the mature mammalian brain and identifies a set of genes critical to the function and dysfunction of the striatal projection neuron circuit.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, XW (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Lobo, Mary Kay/K-7734-2015; Karsten, Stan/AAI-4076-2021	Lobo, Mary Kay/0000-0002-9419-2079; Karsten, Stanislav/0000-0001-7387-4874	NICHD NIH HHS [5T32HD007032] Funding Source: Medline; NIDA NIH HHS [P50 DA005010, P50DA05010] Funding Source: Medline; NINDS NIH HHS [U24 NS43562, NS049501, NS047391, 5T32NS048004] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS043562, R01NS049501, T32NS048004, R21NS047391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Cao YX, 2001, CURR OPIN NEUROBIOL, V11, P615, DOI 10.1016/S0959-4388(00)00258-0; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Church AJ, 2002, NEUROLOGY, V59, P227, DOI 10.1212/WNL.59.2.227; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; FISHELL G, 1991, J COMP NEUROL, V312, P33, DOI 10.1002/cne.903120104; Garel S, 1999, DEVELOPMENT, V126, P5285; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Ince E, 1997, SYNAPSE, V27, P357, DOI 10.1002/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kamme F, 2003, J NEUROSCI, V23, P3607; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Martino D, 2004, CURR OPIN NEUROL, V17, P425, DOI 10.1097/01.wco.0000137532.76491.19; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rogers MA, 1998, BRAIN RES BULL, V47, P297, DOI 10.1016/S0361-9230(98)00126-9; Sabatti C, 2002, MATH BIOSCI, V176, P17, DOI 10.1016/S0025-5564(01)00102-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; TECOTT LH, 1989, DEV BRAIN RES, V49, P75, DOI 10.1016/0165-3806(89)90060-6; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wichmann T, 2003, ANN NY ACAD SCI, V991, P199, DOI 10.1111/j.1749-6632.2003.tb07477.x; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	315	322	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					443	452		10.1038/nn1654	http://dx.doi.org/10.1038/nn1654			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491081				2022-12-24	WOS:000235645600025
J	Brankatschk, M; Dickson, BJ				Brankatschk, M; Dickson, BJ			Netrins guide Drosophila commissural axons at short range	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE ATTRACTION; C-ELEGANS; HOMOLOGOUS RECOMBINATION; MORPHOGEN GRADIENT; COLORECTAL-CANCER; GENETIC-ANALYSIS; SONIC HEDGEHOG; MOTOR AXONS; CNS MIDLINE; GUIDANCE	Netrins are secreted axon guidance molecules required for commissure formation in a wide range of animal species, including Caenorhabditis elegans, Drosophila melanogaster and mice. They are generally thought to function as chemoattractants, acting at a distance to direct commissural axon growth toward the midline of the central nervous system. We show here, however, that D. melanogaster commissural axons still orient normally and reach the midline even in the complete absence of netrins, though some of them fail to cross the midline. Tethering endogenous netrin to the membrane selectively disrupts its long-range but not short- range activity, yet still allows normal commissure formation. We therefore propose that netrins act in commissural axon guidance as short-range cues that promote midline crossing, not as long-range chemoattractants.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Brankatschk, Marko/0000-0001-5274-4552				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schmid A, 1999, DEVELOPMENT, V126, P4653; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Strigini M, 1997, DEVELOPMENT, V124, P4697; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	50	112	114	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					188	194		10.1038/nn1625	http://dx.doi.org/10.1038/nn1625			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429137				2022-12-24	WOS:000234990100013
J	Griffith, LC				Griffith, LC			Watching the fly brain learn	NEURON			English	Editorial Material							MEMORY TRACE; DROSOPHILA; NEURONS; DOPAMINE	The peptidergic dorsal paired medial (DPM) neurons, which innervate the mushroom bodies in Drosophila, have been widely hypothesized to be part of the unconditioned stimulus (US) pathway of odor-shock classical conditioning. In the December 2 issue of Cell, Yu et al., using functional imaging techniques, report the surprising finding that DPMs contain odor-specific memory traces and send integrated information about the conditioned stimulus (CS) to the mushroom bodies. These findings provide important new insight into the circuitry of learning in Drosophiia.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav & Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, 415 S St, Waltham, MA 02454 USA.			Griffith, Leslie/0000-0003-3164-9876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054408-10, R01 GM054408] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McGuire SE, 2004, SCI STKE, V2004, pp16; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	15	0	0	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 19	2006	49	2					171	174		10.1016/j.neuron.2006.01.001	http://dx.doi.org/10.1016/j.neuron.2006.01.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423691	Bronze			2022-12-24	WOS:000234979900004
J	Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A				Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A			A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle	NEURON			English	Article							QUANTAL SIZE; NEUROMUSCULAR-JUNCTION; RELEASE; EXPRESSION; LOCALIZATION; RECEPTORS; SYNAPSES; VGLUT1; SITES	Quantal size is the postsynaptic response to the release of a single synaptic vesicle and is determined in part by the amount of transmitter within that vesicle. At glutamatergic synapses, the vesicular glutamate transporter (VGLUT) fills vesicles with glutamate. While elevated VGLUT expression increases quantal size, the minimum number of transporters required to fill a vesicle is unknown. In Drosophila DVGLUT mutants, reduced transporter levels lead to a dose-dependent reduction in the frequency of spontaneous quantal release with no change in quantal size. Quantal frequency is not limited by vesicle number or impaired exocytosis. This suggests that a single functional unit of transporter is both necessary and sufficient to fill a vesicle to completion and that vesicles without DVGLUT are empty. Consistent with the presence of empty vesicles, at dvglut mutant synapses synaptic vesicles are smaller, suggesting that vesicle filling and/or transporter level is an important determinant of vesicle size.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	diantonio@wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Collins, Catherine/0000-0002-1608-6692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453, R01NS043171, R01NS045628] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM08151, T32 GM008151] Funding Source: Medline; NINDS NIH HHS [R01 NS045628-03, R01 NS043171, R01 NS051453, R01 NS045628, R01 NS045628-04, NS043171, NS045628, NS041543, R01 NS045628-01, R01 NS045628-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Franks KM, 2003, J NEUROSCI, V23, P3186; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gong LW, 2003, J NEUROSCI, V23, P7917; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pothos EN, 2000, J NEUROSCI, V20, P7297; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	18	131	143	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					11	16		10.1016/j.neuron.2005.11.032	http://dx.doi.org/10.1016/j.neuron.2005.11.032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387635	Green Accepted, Bronze			2022-12-24	WOS:000236699300005
J	Deuel, TAS; Liu, JS; Corbo, JC; Yoo, SY; Rorke-Adams, LB; Walsh, CA				Deuel, TAS; Liu, JS; Corbo, JC; Yoo, SY; Rorke-Adams, LB; Walsh, CA			Genetic interactions between doublecortin and doublecortin-like kinase in neuronal migration and axon outgrowth	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; CYCLIN-DEPENDENT KINASE-5; LISSENCEPHALY SYNDROME; CEREBRAL-CORTEX; MESSENGER-RNA; BRAIN; MICE; GROWTH; DOMAIN; DCX	Although mutations in the human doublecortin gene (DCX) cause profound defects in cortical neuronal migration, a genetic deletion of Dcx in mice produces a milder defect. A second locus, doublecortin-like kinase (Dclk), encodes a protein with similar "doublecortin domains" and microtubule stabilization properties that may compensate for Dcx. Here, we generate a mouse with a Dclk mutation that causes no obvious migrational abnormalities but show that mice mutant for both Dcx and Dclk demonstrate perinatal lethality, disorganized neocortical layering, and profound hippocampal cytoarchitectural disorganization. Surprisingly, Dcx(-/y);Dclk(-/-) mutants have widespread axonal defects, affecting the corpus callosum, anterior commissure, subcortical fiber tracts, and internal capsule. Dcx/Dclk-deficient dissociated neurons show abnormal axon outgrowth and dendritic structure, with defects in axonal transport of synaptic vesicle proteins. Dcx and Dclk may directly or indirectly regulate microtubule-based vesicle transport, a process critical to both neuronal migration and axon outgrowth.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr,Div Genet,Childrens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr,Div Genet,Childrens, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Corbo, Joseph/0000-0002-9323-7140; Walsh, Christopher/0000-0002-0156-2238	NINDS NIH HHS [P01 NS40043] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Berg MJ, 1998, NEUROLOGY, V50, P1143, DOI 10.1212/WNL.50.4.1143; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 2001, J BIOL CHEM, V276, P36397, DOI 10.1074/jbc.M105153200; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Caviness V S Jr, 1982, Brain Res, V256, P293; Corbo JC, 2002, J NEUROSCI, V22, P7548; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P9264, DOI 10.1021/bi025934+; Lin PT, 2000, J NEUROSCI, V20, P9152; LoTurco J, 2004, NEURON, V41, P175, DOI 10.1016/S0896-6273(04)00006-6; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mizuguchi M, 1999, AM J PATHOL, V155, P1713, DOI 10.1016/S0002-9440(10)65486-7; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Ross ME, 1997, HUM MOL GENET, V6, P555, DOI 10.1093/hmg/6.4.555; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shirasu M, 2000, NEUROSCI RES, V37, P265, DOI 10.1016/S0168-0102(00)00125-5; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sossey-Alaoui K, 1999, GENOMICS, V56, P121, DOI 10.1006/geno.1998.5718; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Viot G, 2004, AM J MED GENET A, V126A, P123, DOI 10.1002/ajmg.a.20569; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X	49	219	224	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					41	53		10.1016/j.neuron.2005.10.038	http://dx.doi.org/10.1016/j.neuron.2005.10.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387638	Bronze			2022-12-24	WOS:000236699300008
J	MacLean, JN; Watson, BO; Aaron, GB; Yuste, R				MacLean, JN; Watson, BO; Aaron, GB; Yuste, R			Internal dynamics determine the cortical response to thalamic stimulation	NEURON			English	Article							CAT VISUAL-CORTEX; MEMBRANE-POTENTIAL FLUCTUATIONS; RAT SOMATOSENSORY CORTEX; BARREL CORTEX; SPINY STELLATE; SYNAPTIC CONNECTIONS; RECURRENT ACTIVITY; LAYER 4; NEURONS; CELLS	Although spontaneous activity occurs throughout the neocortex, its relation to the activity produced by external or sensory inputs remains unclear. To address this, we used calcium imaging of mouse thalamocortical slices to reconstruct, with single-cell resolution, the spatiotemporal dynamics of activity of layer 4 in the presence or absence of thalamic stimulation. We found spontaneous neuronal coactivations corresponded to intracellular UP states. Thalamic stimulation of sufficient frequency (>10 Hz) triggered cortical activity, and UP states, indistinguishable from those arising spontaneously. Moreover, neurons were activated in identical and precise spatiotemporal patterns in thalamically triggered and spontaneous events. The similarities between cortical activations indicate that intracortical connectivity plays the dominant role in the cortical response to thalamic inputs. Our data demonstrate that precise spatiotemporal activity patterns can be triggered by thalamic inputs and indicate that the thalamus serves to release intrinsic cortical dynamics.	Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	MacLean, JN (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.	jm2107@columbia.edu	Watson, Brendon/GON-4927-2022	MacLean, Jason/0000-0002-8021-8063				Abeles M., 1991, CORTICONICS; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Beierlein M, 2002, J NEUROSCI, V22, P9885; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FERSTER D, 1992, PROG BRAIN RES, V90, P423; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Fregnac Y, 1996, J PHYSIOL-PARIS, V90, P113, DOI 10.1016/S0928-4257(97)81412-X; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Llinas R., 2002, I VORTEX NEURONS SEL; MACLEAN JN, 2004, LOADING ACUTE BRAIN; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Varga C, 2002, J NEUROSCI, V22, P6186; Wilson CJ, 1996, J NEUROSCI, V16, P2397; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	45	284	285	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					811	823		10.1016/j.neuron.2005.09.035	http://dx.doi.org/10.1016/j.neuron.2005.09.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337918	Bronze			2022-12-24	WOS:000233927300019
J	Laurent, P; Becker, JAJ; Valverde, O; Ledent, C; d'Exaerde, AD; Schiffmann, SN; Maldonado, R; Vassart, G; Parmentier, M				Laurent, P; Becker, JAJ; Valverde, O; Ledent, C; d'Exaerde, AD; Schiffmann, SN; Maldonado, R; Vassart, G; Parmentier, M			The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROPEPTIDE FF; MORPHINE-WITHDRAWAL; FOOD-INTAKE; PAIN; MECHANISMS; NOCICEPTIN; MICE; PHARMACOLOGY; TOLERANCE	Prolactin-releasing peptide (PrRP) and its receptor G protein - coupled receptor 10 (GPR10) are expressed in brain areas involved in the processing of nociceptive signals. We investigated the role of this new neuropeptidergic system in GPR10-knockout mice. These mice had higher nociceptive thresholds and stronger stress-induced analgesia than wild-type mice, differences that were suppressed by naloxone treatment. In addition, potentiation of morphine-induced antinociception and reduction of morphine tolerance were observed in mutants. Intracerebroventricular administration of PrRP in wild-type mice promoted hyperalgesia and reversed morphine-induced antinociception. PrRP administration had no effect on GPR10-mutant mice, showing that its effects are mediated by GPR10. Anti-opioid effects of neuropeptide FF were found to require a functional PrRP-GPR10 system. Finally, GPR10 deficiency enhanced the acquisition of morphine-induced conditioned place preference and decreased the severity of naloxone-precipitated morphine withdrawal syndrome. Altogether, our data identify the PrRP-GPR10 system as a new and potent negative modulator of the opioid system.	Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; Univ Pompeu Fabra, Fac Ciences Salut & Vida, Lab Neurofarmacol, Barcelona, Spain; Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium	Universite Libre de Bruxelles; Pompeu Fabra University; Universite Libre de Bruxelles	Parmentier, M (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,Route Lennik 808, Brussels, Belgium.	mparment@ulb.ac.be	Becker, Jerome/I-7879-2016; Maldonado, Rafael/F-5657-2014; de Kerchove d'Exaerde, Alban/R-6984-2019; Valverde, Olga/D-8654-2012; laurent, patrick/ABD-9373-2021	Becker, Jerome/0000-0002-0039-0067; Maldonado, Rafael/0000-0002-4359-8773; Valverde, Olga/0000-0003-2264-7852; laurent, patrick/0000-0001-5360-5597; Schiffmann, Serge/0000-0002-0118-9816; de Kerchove d'Exaerde, Alban/0000-0002-0682-5877; Parmentier, Marc/0000-0001-8081-4685				ALLARD M, 1995, J PHARMACOL EXP THER, V274, P577; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Kalliomaki ML, 2004, NEUROPHARMACOLOGY, V46, P412, DOI 10.1016/j.neuropharm.2003.09.021; King MA, 1997, NEUROSCI LETT, V223, P113, DOI 10.1016/S0304-3940(97)13414-0; Langmead CJ, 2000, BRIT J PHARMACOL, V131, P683, DOI 10.1038/sj.bjp.0703617; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Lawrence CB, 2000, NAT NEUROSCI, V3, P645, DOI 10.1038/76597; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P360, DOI 10.1210/en.143.2.360; Lin SHS, 2002, BRAIN RES, V952, P15, DOI 10.1016/S0006-8993(02)03183-9; MALIN DH, 1990, PEPTIDES, V11, P277, DOI 10.1016/0196-9781(90)90082-G; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Maruyama M, 1999, NEUROSCI LETT, V276, P193, DOI 10.1016/S0304-3940(99)00831-9; Maruyama M, 2001, ENDOCRINOLOGY, V142, P2032, DOI 10.1210/en.142.5.2032; Meunier Jean-Claude, 2003, Am J Pharmacogenomics, V3, P117, DOI 10.2165/00129785-200303020-00005; Mogil Jefrey S., 1996, Physiology and Behavior, V59, P123, DOI 10.1016/0031-9384(95)02073-X; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Murphy NP, 1999, BRAIN RES, V832, P168, DOI 10.1016/S0006-8993(99)01425-0; Noble F, 2003, DRUGS TODAY, V39, P897, DOI 10.1358/dot.2003.39.11.799467; Noble F, 1999, PROG NEUROBIOL, V58, P349, DOI 10.1016/S0301-0082(98)00090-2; NOBLE F, 1993, BRIT J PHARMACOL, V109, P1064, DOI 10.1111/j.1476-5381.1993.tb13730.x; PACAK K, 1993, HYPERTENSION, V22, P467, DOI 10.1161/01.HYP.22.4.467; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Passik SD, 2000, ADV THER, V17, P70, DOI 10.1007/BF02854840; Pommier B, 2002, J NEUROSCI, V22, P2005, DOI 10.1523/JNEUROSCI.22-05-02005.2002; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; SEMENOVA S, 1995, PHARMACOL BIOCHEM BE, V50, P17, DOI 10.1016/0091-3057(94)00221-4; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sundblom DM, 1999, PEPTIDES, V20, P319, DOI 10.1016/S0196-9781(99)00038-8; Ueda H, 2003, LIFE SCI, V74, P313, DOI 10.1016/j.lfs.2003.09.018; Ueda H, 1997, NEUROSCI LETT, V237, P136, DOI 10.1016/S0304-3940(97)00832-X; Ueda H, 2000, J NEUROSCI, V20, P7640	38	39	42	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1735	1741		10.1038/nn1585	http://dx.doi.org/10.1038/nn1585			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299503				2022-12-24	WOS:000233576200023
J	Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G				Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G			The temporal and spatial origins of cortical interneurons predict their physiological subtype	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC CELL SUBTYPES; DOUBLE BOUQUET CELLS; MORPHOLOGICAL-CHARACTERISTICS; PYRAMIDAL CELLS; VISUAL-CORTEX; BRAIN-SLICES; NEURONS; EXPRESSION; DIVERSITY	Interneurons of the cerebral cortex represent a heterogeneous population of cells with important roles in network function. At present, little is known about how these neurons are specified in the developing telencephalon. To explore whether this diversity is established in the early progenitor populations, we conducted in utero fate-mapping of the mouse medial and caudal ganglionic eminences (MGE and CGE, respectively), from which most cortical interneurons arise. Mature interneuron subtypes were assessed by electrophysiological and immunological analysis, as well as by morphological reconstruction. At E13.5, the MGE gives rise to fast-spiking (FS) interneurons, whereas the CGE generates predominantly regular-spiking interneurons (RSNP). Later at E15.5, the CGE produces RSNP classes distinct from those generated from the E13.5 CGE. Thus, we provide evidence that the spatial and temporal origin of interneuron precursors in the developing telencephalic eminences predicts the intrinsic physiological properties of mature interneurons.	NYU, Med Ctr, Dev Gen Program, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; Columbia University; Columbia University	Fishell, G (corresponding author), NYU, Med Ctr, Dev Gen Program, 550 1St Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Butt, Simon/I-2689-2019; Nery, Susana Vaz/P-4518-2014	Butt, Simon/0000-0002-2399-0102; Fishell, Gordon/0000-0002-9640-9278; Fuccillo, Marc/0000-0002-6569-706X; Vaz Nery, Susana/0000-0002-2399-7785				Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chow A, 1999, J NEUROSCI, V19, P9332; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Dodt HU, 1998, HISTOCHEM J, V30, P141, DOI 10.1023/A:1003291218707; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sussel L, 1999, DEVELOPMENT, V126, P3359; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	48	412	417	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					591	604		10.1016/j.neuron.2005.09.034	http://dx.doi.org/10.1016/j.neuron.2005.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301176	Bronze			2022-12-24	WOS:000233677300013
J	Lu, W; Ziff, EB				Lu, W; Ziff, EB			PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking	NEURON			English	Article							LONG-TERM DEPRESSION; KINASE-C-ALPHA; DOMAIN-CONTAINING PROTEINS; BINDING-PROTEIN; HIPPOCAMPAL-NEURONS; DIFFERENTIAL PALMITOYLATION; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; SUBUNIT	PICK1 and ABP/GRIP bind to the AMPA receptor (AMPAR) GluR2 subunit C terminus. Transfer of the receptor from ABP/GRIP to PICK1, facilitated by GluR2 S880 phosphorylation, may initiate receptor trafficking. Here we report protein interactions that regulate these steps. The PICK1 BAR domain interacts intermolecularly with the ABP/GRIP linker 11 region and intramolecularly with the PICK1 PDZ domain. Binding of PKC alpha or GluR2 to the PICK1 PDZ domain disrupts the intramolecular interaction and facilitates the PICK1 BAR domain association with ABP/GRIP. Interference with the PICK1-ABP/GRIP interaction impairs S880 phosphorylation of GluR2 by PKC and decreases the constitutive surface expression of GluR2, the NMDA-induced endocytosis of GluR2, and recycling of internalized GluR2. We suggest that the PICK1 interaction with ABP/GRIP is a critical step in controlling GluR2 trafficking.	NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA.	edward.ziff@med.nyu.edu	Lu, Wei/E-8110-2011; Lu, Wei/S-5617-2018	Lu, Wei/0000-0001-6668-8432; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067229] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fu J, 2003, J NEUROSCI, V23, P7592; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9	49	174	191	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					407	421		10.1016/j.neuron.2005.07.006	http://dx.doi.org/10.1016/j.neuron.2005.07.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055064	Bronze			2022-12-24	WOS:000231051900011
J	Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C				Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C			Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter	NATURE NEUROSCIENCE			English	Article							POLYMORPHISM; PROJECTIONS; STIMULI	Major depression is conditionally linked to a polymorphism of the human serotonin transporter gene (SLC6A4). During the presentation of aversive, but not pleasant, pictures, healthy carriers of the SLC6A4 short (s) allele showed stronger activation of the amygdala on functional magnetic resonance imaging. s carriers also showed greater coupling between the amygdala and the ventromedial prefrontal cortex, which may contribute to the abnormally high activity in the amygdala and medial prefrontal cortex seen in major depression.	Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; Univ Med Ctr, Dept Psychiat, NeuroImage Nord, D-20246 Hamburg, Germany; Cent Inst Mental Hlth, D-68159 Mannheim, Germany; Charite Univ Med Berlin, Dept Med Psychol, D-10117 Berlin, Germany; Univ Med Ctr, Dept Neurol, NeuroImage Nord, D-20246 Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heinz, A (corresponding author), Charite Univ Med Berlin, Dept Psychiat, Campus Charite Mitte,Schumannstr 20-21, D-10117 Berlin, Germany.	andreas.heinz@charite.de	anand, amit/A-7222-2009; Heinz, Andreas/ABB-7736-2020; Smolka, Michael/B-4865-2011; Vollstädt-Klein, Sabine/C-6744-2012; Schumann, Gunter/H-1013-2013	Heinz, Andreas/0000-0001-5405-9065; Smolka, Michael/0000-0001-5398-5569; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Flor, Herta/0000-0003-4809-5398; Hermann, Derik/0000-0003-4434-1221				AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Irwin W, 2004, NEUROIMAGE, V21, P674, DOI 10.1016/j.neuroimage.2003.09.057; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; *NAT I MENT HLTH C, 1999, PHOT SLID; Pinto AO, 2003, ANN NY ACAD SCI, V985, P542; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3	14	554	573	0	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					20	21		10.1038/nn1366	http://dx.doi.org/10.1038/nn1366			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592465				2022-12-24	WOS:000225967600009
J	Kalia, SK; Lee, S; Smith, PD; Liu, L; Crocker, SJ; Thorarinsdottir, TE; Glover, JR; Fon, EA; Park, DS; Lozano, AM				Kalia, SK; Lee, S; Smith, PD; Liu, L; Crocker, SJ; Thorarinsdottir, TE; Glover, JR; Fon, EA; Park, DS; Lozano, AM			BAG5 inhibits parkin and enhances dopaminergic neuron degeneration	NEURON			English	Article							UBIQUITIN-PROTEIN LIGASE; DISEASE GENE-PRODUCT; HEAT-SHOCK PROTEINS; ALPHA-SYNUCLEIN; MOLECULAR CHAPERONES; CELL-DEATH; POLYGLUTAMINE PROTEINS; OVER-EXPRESSION; S-NITROSYLATION; MOUSE MODEL	Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). Decreases in parkin activity may also contribute to neurodegeneration in sporadic forms of PD. Here, we show that bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacts with parkin and the chaperone Hsp70. Within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function. Finally, BAG5 enhances dopamine neuron death in an in vivo model of PD, whereas a mutant that inhibits BAG5 activity attenuates dopaminergic neurodegeneration. This contrasts with the antideath functions ascribed to BAG family members and suggests a potential role for BAG5 in promoting neurodegeneration in sporadic PD through its functional interactions with parkin and Hsp70.	Univ Toronto, Toronto Western Hosp, Inst Res, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; Univ Ottawa, Neurosci Res Inst, Ottawa, ON K1H 8M5, Canada; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; McGill University; University of Toronto	Lozano, AM (corresponding author), Univ Toronto, Toronto Western Hosp, Inst Res, Univ Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	lozano@uhnres.utoronto.ca	Lozano, Andres M/A-5058-2012	Kalia, Suneil/0000-0003-2054-1915; Park, David/0000-0002-4490-3784; Smith, Patrice/0000-0002-0731-2803; Lozano, Andres M./0000-0001-8257-3694				Adachi H, 2003, J NEUROSCI, V23, P2203; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kermer P, 2003, BRAIN PATHOL, V13, P495; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Nollen EAA, 2002, J CELL SCI, V115, P2809; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Oluwatosin-Chigbu Y, 2003, BIOCHEM BIOPH RES CO, V309, P679, DOI 10.1016/j.bbrc.2003.08.059; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ren Y, 2003, J NEUROSCI, V23, P3316; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	67	152	158	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					931	945		10.1016/j.neuron.2004.11.026	http://dx.doi.org/10.1016/j.neuron.2004.11.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603737	Bronze			2022-12-24	WOS:000225842300008
J	Yin, YQ; Henzl, MT; Lorber, B; Nakazawa, T; Thomas, TT; Jiang, F; Langer, R; Benowitz, LI				Yin, Yuqin; Henzl, Michael T.; Lorber, Barbara; Nakazawa, Toru; Thomas, Tommy T.; Jiang, Fan; Langer, Robert; Benowitz, Larry I.			Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RAT OPTIC-NERVE; CILIARY NEUROTROPHIC FACTOR; DEATH IN-VIVO; CALCIUM-BINDING; SENSORY NEURONS; GROWTH-STATE; ADULT-RATS; SURVIVAL; INJURY; INHIBITION	The optic nerve, like most mature CNS pathways, does not regenerate after injury. Through unknown mechanisms, however, macrophage activation in the eye stimulates retinal ganglion cells (RGCs) to regenerate long axons beyond the site of optic nerve injury. Here we identify the calcium (Ca2+)-binding protein oncomodulin as a potent macrophage-derived growth factor for RGCs and other neurons. Oncomodulin binds to rat RGCs with high affinity in a cyclic AMP (cAMP)-dependent manner and stimulates more extensive outgrowth than other known trophic agents. Depletion of oncomodulin from macrophage-conditioned media (MCM) eliminates the axon-promoting activity of MCM. The effects of oncomodulin involve downstream signaling via Ca2+/calmodulin kinase and gene transcription. In vivo, oncomodulin released from microspheres promotes regeneration in the mature rat optic nerve. Oncomodulin also stimulates outgrowth from peripheral sensory neurons. Thus, oncomodulin is a new growth factor for neurons of the mature central and peripheral nervous systems.	Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; MIT, Dept Chem & Biomed Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Missouri System; University of Missouri Columbia; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Benowitz, LI (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	larry.benowitz@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222; Lorber, Barbara/0000-0001-9986-4543	NEI NIH HHS [EY05690] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; BUXSER S, 1990, J BIOL CHEM, V265, P12701; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal S., 1991, DEGENERATION REGENER; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chierzi S, 1999, J NEUROSCI, V19, P8367; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HAPAK RC, 1989, J BIOL CHEM, V264, P18751; Henzl MT, 2004, BIOCHEMISTRY-US, V43, P2747, DOI 10.1021/bi035890k; Henzl MT, 1997, HEARING RES, V106, P105, DOI 10.1016/S0378-5955(97)00005-1; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; Kermer P, 1998, J NEUROSCI, V18, P4656; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li YM, 2003, J NEUROSCI, V23, P7830; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lorber B, 2002, MOL CELL NEUROSCI, V21, P301, DOI 10.1006/mcne.2002.1175; LU X, 1991, J NEUROSCI, V11, P972; MACMANUS JP, 1982, ONCODEV BIOL MED, V3, P79; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Otori Y, 1998, INVEST OPHTH VIS SCI, V39, P972; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; PERNET V, 2006, BRAIN; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; STREILEIN JW, 1992, CURR EYE RES, V11, P41, DOI 10.3109/02713689208999510; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	50	379	402	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					843	852		10.1038/nn1701	http://dx.doi.org/10.1038/nn1701			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699509				2022-12-24	WOS:000237895200025
J	Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD				Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD			Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage	NATURE NEUROSCIENCE			English	Article							ANTERIOR MEDULLARY VELUM; DORSAL SPINAL-CORD; SONIC-HEDGEHOG; NEURAL-TUBE; CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; BASAL FOREBRAIN; PRECURSOR CELLS; TRANSGENIC MICE	The developmental origin of oligodendrocyte progenitors ( OLPs) in the forebrain has been controversial. We now show, by Cre-lox fate mapping in transgenic mice, that the first OLPs originate in the medial ganglionic eminence ( MGE) and anterior entopeduncular area ( AEP) in the ventral forebrain. From there, they populate the entire embryonic telencephalon including the cerebral cortex before being joined by a second wave of OLPs from the lateral and/or caudal ganglionic eminences ( LGE and CGE). Finally, a third wave arises within the postnatal cortex. When any one population is destroyed at source by the targeted expression of diphtheria toxin, the remaining cells take over and the mice survive and behave normally, with a normal complement of oligodendrocytes and myelin. Thus, functionally redundant populations of OLPs compete for space in the developing brain. Notably, the embryonic MGE- and AEP-derived population is eliminated during postnatal life, raising questions about the nature and purpose of the competition.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of London; University College London; University of London; University College London; University of Erlangen Nuremberg	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	n.tekki-kessaris@ucl.ac.uk; w.richardson@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019; Kessaris, Nicoletta/C-7249-2008; Messier, Claude/A-2322-2008; Richardson, William/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Kessaris, Nicoletta/0000-0003-1191-6009; Messier, Claude/0000-0002-4791-1763; Richardson, William/0000-0001-7261-2485; Wegner, Michael/0000-0002-4586-3294	MRC [G9708005, G0501173] Funding Source: UKRI; Medical Research Council [G0501173, G0800575, G9708005] Funding Source: Medline; Wellcome Trust [066745] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BUTT AM, 1995, GLIA, V14, P185, DOI 10.1002/glia.440140304; Butt AM, 1997, J NEUROCYTOL, V26, P327, DOI 10.1023/A:1018556702353; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, DEVELOPMENT, V105, P595; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2002, J NEUROSCI, V22, P9821; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Orentas DM, 1999, DEVELOPMENT, V126, P2419; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2001, DEVELOPMENT, V128, P4993; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	746	757	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					173	179		10.1038/nn1620	http://dx.doi.org/10.1038/nn1620			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388308	Green Accepted			2022-12-24	WOS:000234990100011
J	Marmigere, F; Montelius, A; Wegner, M; Groner, Y; Reichardt, LF; Ernfors, P				Marmigere, F; Montelius, A; Wegner, M; Groner, Y; Reichardt, LF; Ernfors, P			The Runx1/AML1 transcription factor selectively regulates development and survival of TrkA nociceptive sensory neurons	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT-GANGLIA; CREST STEM-CELLS; NERVOUS-SYSTEM; OSTEOBLAST DIFFERENTIATION; RECEPTOR EXPRESSION; MOTOR-NEURONS; GENE; AML1; AFFERENTS; BRN-3.0	Neural crest cells ( NCCs) can adopt different neuronal fates. In NCCs, neurogenin-2 promotes sensory specification but does not specify different subclasses of sensory neurons. Understanding the gene cascades that direct Trk gene activation may reveal mechanisms generating sensory diversity, because different Trks are expressed in different sensory neuron subpopulations. Here we show in chick and mouse that the Runt transcription factor Runx1 promotes axonal growth, is selectively expressed in neural crest-derived TrkA(+) sensory neurons and mediates TrkA transactivation in migratory NCCs. Inhibition of Runt activity depletes TrkA expression and leads to neuronal death. Moreover, Runx1 overexpression is incompatible with multipotency in the migratory neural crest but does not induce expression of pan-neuronal genes. Instead, Runx1-induced neuronal differentiation depends on an existing neurogenin2 proneural gene program. Our data show that Runx1 directs, in a context-dependent manner, key aspects of the establishment of the TrkA(+) nociceptive subclass of neurons.	Karolinska Inst, Lab Mol Neurobiol, MBB, Stockholm, Sweden; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Karolinska Institutet; University of Erlangen Nuremberg; Weizmann Institute of Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ernfors, P (corresponding author), Karolinska Inst, Lab Mol Neurobiol, MBB, Scheeles Vag 1, Stockholm, Sweden.	Patrik.Ernfors@ki.se	Montelius, Andreas/B-3990-2009	MARMIGERE, FREDERIC/0000-0002-0515-7483; Ernfors, Patrik/0000-0002-1140-3986; Wegner, Michael/0000-0002-4586-3294	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-22, NS 16033, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; CARR PA, 1993, BRAIN RES BULL, V30, P209, DOI 10.1016/0361-9230(93)90246-8; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kasemeier-Kulesa JC, 2005, DEVELOPMENT, V132, P235, DOI 10.1242/dev.01553; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Lefcort F, 1996, J NEUROSCI, V16, P3704; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Ma L, 2000, DEVELOPMENT, V127, P3777; Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; Nibu K, 2000, BIOCHEM BIOPH RES CO, V279, P172, DOI 10.1006/bbrc.2000.3899; Oakley RA, 1997, J NEUROSCI, V17, P4262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Perez SE, 1999, DEVELOPMENT, V126, P1715; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SHOLL DA, 1953, J ANAT, V87, P387; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TANAKA K, 1995, BIOCHEM BIOPH RES CO, V211, P1023, DOI 10.1006/bbrc.1995.1913; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; vonBartheld CS, 1996, J NEUROSCI, V16, P2995; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	50	103	108	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					180	187		10.1038/nn1631	http://dx.doi.org/10.1038/nn1631			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429136	Green Accepted			2022-12-24	WOS:000234990100012
J	O'Doherty, JP; Buchanan, TW; Seymour, B; Dolan, RJ				O'Doherty, JP; Buchanan, TW; Seymour, B; Dolan, RJ			Predictive neural coding of reward preference involves dissociable responses in human ventral midbrain and ventral striatum	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; ACTIVATION; FMRI	Food preferences are acquired through experience and can exert strong influence on choice behavior. In order to choose which food to consume, it is necessary to maintain a predictive representation of the subjective value of the associated food stimulus. Here, we explore the neural mechanisms by which such predictive representations are learned through classical conditioning. Human subjects were scanned using fMRI while learning associations between arbitrary visual stimuli and subsequent delivery of one of five different food flavors. Using a temporal difference algorithm to model learning, we found predictive responses in the ventral midbrain and a part of ventral striatum (ventral putamen) that were related directly to subjects' actual behavioral preferences. These brain structures demonstrated divergent response profiles, with the ventral midbrain showing a linear response profile with preference, and the ventral striatum a bivalent response. These results provide insight into the neural mechanisms underlying human preference behavior.	UCL, Wellcome Dept Imaging Neurosci, Inst Neurol, London WC1N 3BG, England; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of London; University College London; California Institute of Technology; University of Iowa	O'Doherty, JP (corresponding author), UCL, Wellcome Dept Imaging Neurosci, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	jdoherty@hss.caltech.edu	O'Doherty, John P/F-1204-2013	Dolan, Ray/0000-0001-9356-761X; Seymour, Ben/0000-0003-1724-5832; Buchanan, Tony/0000-0002-9166-8457	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Cox SML, 2005, J NEUROSCI, V25, P2733, DOI 10.1523/JNEUROSCI.3360-04.2005; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Duvernoy HM, 1999, HUMAN BRAIN; GORN GJ, 1982, J MARKETING, V46, P94, DOI 10.2307/1251163; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Karachi C, 2002, J COMP NEUROL, V450, P122, DOI 10.1002/cne.10312; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wilkinson D, 2004, NAT REV NEUROSCI, V5, P67, DOI 10.1038/nrn1302	25	251	254	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					157	166		10.1016/j.neuron.2005.11.014	http://dx.doi.org/10.1016/j.neuron.2005.11.014			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387647	Bronze, Green Submitted			2022-12-24	WOS:000236699300017
J	Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB				Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB			Molecular taxonomy of major neuronal classes in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GABAERGIC INTERNEURONS; TRANSGENIC MICE; VISUAL-CORTEX; MESSENGER-RNA; DLX GENES; EXPRESSION; NEOCORTEX; PROTEIN; SUBTYPES	Identifying the neuronal cell types that comprise the mammalian forebrain is a central unsolved problem in neuroscience. Global gene expression profiles offer a potentially unbiased way to assess functional relationships between neurons. Here, we carried out microarray analysis of 12 populations of neurons in the adult mouse forebrain. Five of these populations were chosen from cingulate cortex and included several subtypes of GABAergic interneurons and pyramidal neurons. The remaining seven were derived from the somatosensory cortex, hippocampus, amygdala and thalamus. Using these expression profiles, we were able to construct a taxonomic tree that reflected the expected major relationships between these populations, such as the distinction between cortical interneurons and projection neurons. The taxonomic tree indicated highly heterogeneous gene expression even within a single region. This dataset should be useful for the classification of unknown neuronal subtypes, the investigation of specifically expressed genes and the genetic manipulation of specific neuronal circuit elements.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Brandeis University; Brandeis University; Cold Spring Harbor Laboratory	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Huang, Z. Josh/0000-0003-0592-028X	NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gewin V, 2005, PLOS BIOL, V3, P13, DOI 10.1371/journal.pbio.0030024; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jongen-Relo AL, 2000, J NEUROSCI METH, V101, P9, DOI 10.1016/S0165-0270(00)00240-5; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mott DD, 2003, TRENDS NEUROSCI, V26, P484, DOI 10.1016/S0166-2236(03)00200-5; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	50	421	426	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					99	107		10.1038/nn1618	http://dx.doi.org/10.1038/nn1618			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369481				2022-12-24	WOS:000234288000023
J	Jo, YH; Chen, YJJ; Chua, SC; Talmage, DA; Role, LW				Jo, YH; Chen, YJJ; Chua, SC; Talmage, DA; Role, LW			Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit	NEURON			English	Article							CB1 CANNABINOID RECEPTOR; LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; FOOD-INTAKE; HYPOTHALAMIC CONTROL; ENERGY-BALANCE; REPORTER GENE; SR 141716; IN-VITRO	Recently developed therapeutics for obesity, targeted against cannabinoid receptors, result in decreased appetite and sustained weight loss. Prior studies have demonstrated CB1 receptors (CB1 Rs) and leptin modulation of cannabinoid synthesis in hypothalamic neurons. Here, we show that depolarization of perifornical lateral hypothalamus (LH) neurons elicits a CB1R-mediated suppression of inhibition in local circuits thought to be involved in appetite and "natural reward." The depolarization-induced decrease in inhibitory tone to LH neurons is blocked by leptin. Leptin inhibits voltage-gated calcium channels in LH neurons via the activation of janus kinase 2 (JAK2) and of mitogen-activated protein kinase (MAPK). Leptin-deficient mice are characterized by both an increase in steady-state voltage-gated calcium currents in LH neurons and a CB1R-mediated depolarization-induced suppression of inhibition that is 6-fold longer than that in littermate controls. Our data provide direct electrophysiological support for the involvement of endocannabinoids and leptin as modulators of hypothalamic circuits underlying motivational aspects of feeding behavior.	Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA.	yjo@aecom.yu.edu	Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Jo, Young-Hwan/0000-0001-6939-8000; Talmage, David/0000-0003-4627-3007	NATIONAL CANCER INSTITUTE [R01CA079737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022061] Funding Source: NIH RePORTER; NCI NIH HHS [CA79737] Funding Source: Medline; NIDDK NIH HHS [DK57621, R01 DK057621] Funding Source: Medline; NINDS NIH HHS [R01 NS022061, NS22061, R01 NS022061-22, R01 NS022061-21, R01 NS022061-23] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Broberger C, 1998, J COMP NEUROL, V402, P460; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cvetkovic V, 2003, NEUROSCIENCE, V116, P31, DOI 10.1016/S0306-4522(02)00557-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Funahashi H, 1999, NEUROSCI LETT, V264, P117, DOI 10.1016/S0304-3940(99)00186-X; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gao XB, 2003, J NEUROPHYSIOL, V90, P3978, DOI 10.1152/jn.00593.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Isokawa M, 2005, J PHYSIOL-LONDON, V567, P1001, DOI 10.1113/jphysiol.2005.094219; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kim J, 2002, J NEUROSCI, V22, P10182; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Ladyman SR, 2004, ENDOCRINOLOGY, V145, P3704, DOI 10.1210/en.2004-0338; Lawrence CB, 1999, CURR OPIN NEUROBIOL, V9, P778, DOI 10.1016/S0959-4388(99)00032-X; Lee JW, 2003, EXP BIOL MED, V228, P175, DOI 10.1177/153537020322800207; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Williams CM, 2002, PHYSIOL BEHAV, V76, P241, DOI 10.1016/S0031-9384(02)00725-4; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	55	178	181	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1055	1066		10.1016/j.neuron.2005.10.021	http://dx.doi.org/10.1016/j.neuron.2005.10.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364907	Bronze, Green Accepted			2022-12-24	WOS:000234301700019
J	Shmuelof, L; Zohary, E				Shmuelof, L; Zohary, E			Dissociation between ventral and dorsal fMRl activation during object and action recognition	NEURON			English	Article							FUNCTIONAL-PROPERTIES; CORTEX; PERCEPTION; ANTERIOR; AREAS; REPRESENTATION; ORGANIZATION; MECHANISMS; IMITATION; PATHWAYS	Neuropsychological case studies suggest the existence of two functionally separate visual streams: the ventral pathway, central for object recognition; and the dorsal pathway, engaged in visually guided actions. However, a clear dissociation between the functions of the two streams has not been decisively shown in intact humans. In this study, we demonstrate dissociation between dorsal and ventral fMRI activation patterns during observation of object manipulation video clips. Parietal areas, such as anterior intraparietal sulcus (aIPS) display grasp viewing-dependent adaptation (i.e., fMR adaptation during repeated viewing of the same object-grasping movement) as well as a contralateral preference for the viewed manipulating hand. Ventral regions, such as the fusiform gyrus, show similar characteristics (i.e., adaptation, contralateral preference), but these depend on object identity. Our results support the hypothesized functional specialization in the visual system and suggest that parietal areas (such as aIPS) are engaged in action recognition, as well as in action planning.	Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel.	udiz@lobster.ls.huji.ac.il						AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; LEICHT R, 1977, EXP BRAIN RES, V27, P479; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MOUNTCASTLE VB, 1981, J NEUROSCI, V1, P1218; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Nitschke MF, 1996, BRAIN, V119, P1023; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405	28	168	172	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					457	470		10.1016/j.neuron.2005.06.034	http://dx.doi.org/10.1016/j.neuron.2005.06.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055068	Bronze			2022-12-24	WOS:000231051900015
J	Kim, CH; Takamiya, K; Petralia, RS; Sattler, R; Yu, S; Zhou, WG; Kalb, R; Wenthold, R; Huganir, R				Kim, CH; Takamiya, K; Petralia, RS; Sattler, R; Yu, S; Zhou, WG; Kalb, R; Wenthold, R; Huganir, R			Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; SYNAPSES; SUBUNIT	The C-terminal PDZ ligand of the AMPA receptor GluR1 subunit may be important for expression of CA1 hippocampal long-term potentiation. To test this directly in vivo, we generated a knock-in mouse lacking the last seven residues of GluR1, comprising the PDZ ligand. This deletion did not affect basal GluR1 synaptic localization, basal synaptic transmission, long-term potentiation or long-term depression, indicating that the ligand is not required for CA1 hippocampal synaptic plasticity.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Huganir, R (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Takamiya, Kogo/0000-0001-7240-6307	NINDS NIH HHS [R01 NS036715, NS36715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9	12	77	80	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					985	987		10.1038/nn1432	http://dx.doi.org/10.1038/nn1432			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007085				2022-12-24	WOS:000230760200007
J	Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS				Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS			Deficits in perceptual noise exclusion in developmental dyslexia	NATURE NEUROSCIENCE			English	Article							READING-DISABILITY; SENSITIVITY; INSIGHTS; CHILDREN	We evaluated signal-noise discrimination in children with and without dyslexia, using magnocellular and parvocellular visual stimuli presented either with or without high noise. Dyslexic children had elevated contrast thresholds when stimuli of either type were presented in high noise, but performed as well as non-dyslexic children when either type was displayed without noise. Our findings suggest that deficits in noise exclusion, not magnocellular processing, contribute to the etiology of dyslexia.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Wisconsin, Madison, WI 53706 USA	Georgetown University; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Sperling, AJ (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW,Bldg D,Room 207E, Washington, DC 20057 USA.	ajs76@georgetown.edu		Lu, Zhong-Lin/0000-0002-7295-727X	NICHD NIH HHS [HD29891] Funding Source: Medline; NIMH NIH HHS [P50-MH64445, KO2-MH01188] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445, K02MH001188] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Demb JB, 1998, J NEUROSCI, V18, P6939; Gottardo A, 1996, J EXP CHILD PSYCHOL, V63, P563, DOI 10.1006/jecp.1996.0062; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MANIS FR, 2004, CONNECTIONS LANGUAGE; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368	13	209	212	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					862	863		10.1038/nn1474	http://dx.doi.org/10.1038/nn1474			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	940IK	15924138				2022-12-24	WOS:000230137100012
J	Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML				Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML			Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; CELL-DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION FACTORS; VERTEBRATE RETINA; EYE DEVELOPMENT; LENS INDUCTION; HOMEOBOX GENE; WNT-SIGNAL	Progenitors in the developing central nervous system acquire neural potential and proliferate to expand the pool of precursors competent to undergo neuronal differentiation. The formation and maintenance of neural-competent precursors are regulated by SoxB1 transcription factors, and evidence that their expression is regionally regulated suggests that specific signals regulate neural potential in subdomains of the developing nervous system. We show that the frizzled (Fz) transmembrane receptor Xfz5 selectively governs neural potential in the developing Xenopus retina by regulating the expression of Sox2. Blocking either Xfz5 or canonical Writ signaling within the developing retina inhibits Sox2 expression, reduces cell proliferation, inhibits the onset of proneural gene expression, and biases individual progenitors toward a nonneural fate, without altering the expression of multiple progenitor markers. Blocking Sox2 function mimics these effects. Rescue experiments indicate that Sox2 is downstream of Xfz5. Thus, Fz signaling can regulate the neural potential of progenitors in the developing nervous system.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Utah System of Higher Education; University of Utah; University of Cambridge; Baylor College of Medicine; Baylor College of Medicine	Vetter, ML (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	monica.vetter@neuro.utah.edu	Van Raay, Terry/AAA-7342-2021	Moore, Kathryn/0000-0002-6993-152X; Vetter, Monica/0000-0001-6262-8504; Van Raay, Terence/0000-0003-0196-1041	NEI NIH HHS [EY122074, R01 EY014954-03, R01 EY014954, EY14954] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014954] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BELECKYADAMS T, 1997, OPHTHALMOL VIS SCI, V38, P1298; Buescher M, 2002, DEVELOPMENT, V129, P4193; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Burns CJ, 2002, DEV DYNAM, V225, P536, DOI 10.1002/dvdy.10189; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Harris WA, 1998, INT J DEV BIOL, V42, P299; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HERMAN JP, 1993, DEV DYNAM, V197, P307, DOI 10.1002/aja.1001970408; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HUANG S, 1993, J NEUROSCI, V13, P3193; Hutcheson DA, 2002, METHODS, V28, P402, DOI 10.1016/S1046-2023(02)00259-1; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Levine EM, 2004, SEMIN CELL DEV BIOL, V15, P63, DOI 10.1016/j.semcdb.2003.09.001; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Overton PM, 2002, DEVELOPMENT, V129, P4219; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sasai Y, 2001, INT J DEV BIOL, V45, P321; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; VANRAAY T, 2004, IN PRESS DEV NEUROSC, V5, P367; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Zhang L, 2003, DEVELOPMENT, V130, P4177, DOI 10.1242/dev.00626; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	76	138	145	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					23	36		10.1016/j.neuron.2005.02.023	http://dx.doi.org/10.1016/j.neuron.2005.02.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820691	Bronze			2022-12-24	WOS:000228228600006
J	Zhang, J; Lefebvre, JL; Zhao, SX; Granato, M				Zhang, J; Lefebvre, JL; Zhao, SX; Granato, M			Zebrafish unplugged reveals a role for muscle-specific kinase homologs in axonal pathway choice	NATURE NEUROSCIENCE			English	Article							IN-VIVO; IDENTIFIED MOTONEURONS; CHONDROITIN SULFATE; GENE CONTROLS; MOTOR AXONS; GUIDANCE; RECEPTOR; EMBRYOS; SELECTION; CELLS	En route to their target, pioneering motor growth cones repeatedly encounter choice points at which they make pathway decisions. In the zebrafish mutant unplugged, two of the three segmental motor axons make incorrect decisions at a somitic choice point. Using positional cloning, we show here that unplugged encodes a homolog of muscle-specific kinase ( MuSK) and that, unlike mammalian MuSK, unplugged has only a limited role in neuromuscular synaptogenesis. We demonstrate that unplugged is transiently expressed in cells adjacent to the choice point and that unplugged signaling before the arrival of growth cones induces changes in the extracellular environment. In addition, we find that the unplugged locus generates three different transcripts. The splice variant 1 (SV1) isoform lacks the extracellular modules essential for agrin responsiveness, and signaling through this isoform mediates axonal pathfinding, independent of the MuSK downstream component rapsyn. Our results demonstrate a new role for MuSK homologs in axonal pathway selection.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu						Beattie CE, 2000, BRAIN RES BULL, V53, P489, DOI 10.1016/S0361-9230(00)00382-8; Bernhardt RR, 1998, DEV DYNAM, V213, P334, DOI 10.1002/(SICI)1097-0177(199811)213:3<334::AID-AJA9>3.0.CO;2-4; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; Chung KY, 2000, DEVELOPMENT, V127, P2673; Coers C., 1967, International Review of Cytology, V22, P239, DOI 10.1016/S0074-7696(08)61837-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Du SJ, 2003, COMP BIOCHEM PHYS B, V134, P123, DOI 10.1016/S1096-4959(02)00194-X; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; FERNS MJ, 1993, J NEUROSCI, V13, P2463, DOI 10.1523/JNEUROSCI.13-06-02463.1993; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Giger RJ, 2001, CELL, V105, P1, DOI 10.1016/S0092-8674(01)00290-2; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hesser BA, 1999, FEBS LETT, V442, P133, DOI 10.1016/S0014-5793(98)01641-X; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; Landgraf M, 1999, CURR BIOL, V9, P589, DOI 10.1016/S0960-9822(99)80262-0; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Melancon E, 1997, J NEUROSCI, V17, P7796; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ono F, 2002, J NEUROSCI, V22, P6491; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; Walz A, 2002, J NEUROBIOL, V53, P330, DOI 10.1002/neu.10113; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhang J, 2001, DEV BIOL, V240, P560, DOI 10.1006/dbio.2001.0492; Zhang J, 2000, DEVELOPMENT, V127, P2099; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	48	72	72	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1303	1309		10.1038/nn1350	http://dx.doi.org/10.1038/nn1350			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543140				2022-12-24	WOS:000225353900010
J	Schluter, OM; Xu, WF; Malenka, RC				Schlueter, Oliver M.; Xu, Weifeng; Malenka, Robert C.			Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; OUT MICE REVEAL; EXCITATORY SYNAPSES; DISTINCT MECHANISMS; PLASTICITY; POTENTIATION; TRAFFICKING; CHANNEL; GENE; MULTIMERIZATION	PSD-95 and SAP97 are scaffolding proteins that have been implicated in regulating AMPA receptor incorporation and function at synapses. Gain- and loss-of-function approaches, however, have generated conflicting results. To minimize adaptations during development and potential dominant-negative effects of overexpression, we have combined silencing of endogenous PSD-95 in mature neurons with heterologous expression of specific SAP97 or PSD-95 isoforms. We find that both PSD-95 and SAP97 contain alternative N termini expressing either double cysteines that normally are palmitoylated (alpha-isoforms) or an L27 domain (beta-isoforms). Whereas alpha-isoforms of PSD-95 and SAP97 influence AMPA receptor-mediated synaptic strength independent of activity, the effects of beta-isoforms are regulated by activity in a CaMKII-dependent manner. Importantly, the synaptic effects of the beta-isoforms are masked by the endogenous alpha-isoform of PSD-95. These results demonstrate that the different N termini of the predominant endogenous forms of PSD-95 (alpha-isoform) and SAP97 (beta-isoform) govern their role in regulating synaptic function.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394, F32MH075220] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394, MH075220] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klocker N, 2002, EUR J NEUROSCI, V16, P1517, DOI 10.1046/j.1460-9568.2002.02228.x; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	53	187	188	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					99	111		10.1016/j.neuron.2006.05.016	http://dx.doi.org/10.1016/j.neuron.2006.05.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815335	Bronze			2022-12-24	WOS:000239037700013
J	Burdakov, D; Jensen, LT; Alexopoulos, H; Williams, RH; Fearon, IM; O'Kelly, I; Gerasimenko, O; Fugger, L; Verkhratsky, A				Burdakov, Denis; Jensen, Lise T.; Alexopoulos, Haris; Williams, Rhiannan H.; Fearon, Ian M.; O'Kelly, Ita; Gerasimenko, Oleg; Fugger, Lars; Verkhratsky, Alexei			Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose	NEURON			English	Article							POTASSIUM CHANNELS; HYPOTHALAMIC NEURONS; SYNAPTIC PLASTICITY; HYPOCRETIN NEURONS; SENSING NEURONS; PLASMA-MEMBRANE; TASK-1 KCNK3; RAT; NARCOLEPSY; EXPRESSION	Glucose-inhibited neurons orchestrate behavior and metabolism according to body energy levels, but how glucose inhibits these cells is unknown. We studied glucose inhibition of orexin/hypocretin neurons, which promote wakefulness (their loss causes narcolepsy) and also regulate metabolism and reward. Here we demonstrate that their inhibition by glucose is mediated by ion channels not previously implicated in central or peripheral glucose sensing: tandem-pore K+ (K-2P) channels. Importantly, we show that this electrical mechanism is sufficiently sensitive to encode variations in glucose levels reflecting those occurring physiologically between normal meals. Moreover, we provide evidence that glucose acts at an extracellular site on orexin neurons, and this information is transmitted to the channels by an intracellular intermediary that is not ATP, Ca2+, or glucose itself. These results reveal an unexpected energy-sensing pathway in neurons that regulate states of consciousness and energy balance.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Aarhus Univ Hosp, Dept Clin Immunol, Skejby, Denmark; Univ Oxford, Univ Lab Physiol, Oxford, England; Univ Liverpool, Physiol Lab, Liverpool, Merseyside, England; Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Weatherall Inst Mol Med, Oxford, England	University of Manchester; Aarhus University; University of Oxford; University of Liverpool; University of Oxford; University of Oxford	Burdakov, D (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	dib22@cam.ac.uk	Verkhratsky, Alexei/J-4527-2013; Gerasimenko, Oleg/A-6622-2010	Verkhratsky, Alexei/0000-0003-2592-9898; Gerasimenko, Oleg/0000-0003-2573-8258; Alexopoulos, Harry/0000-0002-8672-7619; Burdakov, Denis/0000-0002-9134-9165	Medical Research Council [MC_U137881016, G0401222] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0401222, MC_U137881016] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; ANAND BK, 1964, AM J PHYSIOL, V207, P1146, DOI 10.1152/ajplegacy.1964.207.5.1146; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Burdakov D, 2004, EUR J NEUROSCI, V20, P3281, DOI 10.1111/j.1460-9568.2004.03815.x; Burdakov D, 2003, J NEUROSCI, V23, P4951; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DODT HU, 2002, INFRARED GUIDED LASE; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gribkoff VK, 2001, NEUROSCIENTIST, V7, P166, DOI 10.1177/107385840100700211; Han J, 2003, J PHYSIOL-LONDON, V546, P625, DOI 10.1113/jphysiol.2002.032094; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hopwood SE, 2005, J PHYSIOL-LONDON, V568, P145, DOI 10.1113/jphysiol.2005.093070; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kindler CH, 2000, MOL BRAIN RES, V80, P99, DOI 10.1016/S0169-328X(00)00136-4; Kintner DB, 2000, NEUROCHEM RES, V25, P1385, DOI 10.1023/A:1007664700661; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Meuth SG, 2003, J NEUROSCI, V23, P6460; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; O'Connell AD, 2002, BBA-BIOMEMBRANES, V1566, P152, DOI 10.1016/S0005-2736(02)00597-7; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; OOMURA Y, 1974, NATURE, V247, P284, DOI 10.1038/247284a0; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; PELLERIN L, 1994, NEUROSCIENTIST, V56, P297; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PHILLIPSON EA, 1986, HDB PHYSL 3, V2, P649; PHILPOTT HG, 1979, NATURE, V281, P684, DOI 10.1038/281684a0; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Rusznak Z, 2004, CELL MOL LIFE SCI, V61, P1532, DOI 10.1007/s00018-004-4082-3; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Selbach O, 2004, NEUROSCIENCE, V127, P519, DOI 10.1016/j.neuroscience.2004.05.012; SILVER IA, 1994, J NEUROSCI, V14, P5068; Smith Nicola P, 2002, Paediatr Respir Rev, V3, P339, DOI 10.1016/S1526-0542(02)00262-2; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamamoto Y, 2003, HISTOCHEM CELL BIOL, V120, P335, DOI 10.1007/s00418-003-0577-5; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	72	222	224	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					711	722		10.1016/j.neuron.2006.04.032	http://dx.doi.org/10.1016/j.neuron.2006.04.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731510	Bronze			2022-12-24	WOS:000238165000007
J	Mitchell, JP; Macrae, CN; Banaji, MR				Mitchell, JP; Macrae, CN; Banaji, MR			Dissociable medial prefrontal contributions to judgments of similar and dissimilar others	NEURON			English	Article							TEMPORO-PARIETAL JUNCTION; IMPLICIT ASSOCIATION TEST; EVENT-RELATED FMRI; SOCIAL COGNITION; EMOTIONAL STATE; MIND; SELF; CORTEX; SIMULATION; MEMORY	Human social interaction requires the recognition that other people are governed by the same types of mental states-beliefs, desires, intentions-that guide one's own behavior. We used functional neurolmaging to examine how perceivers; make mental state inferences when such self-other overlap can be assumed (when the other is similar to oneself) and when it cannot (when the other is dissimilar from oneself). We observed a double dissociation such that mentalizing about a similar other engaged a region of ventral mPFC linked to self-referential thought, whereas mentalizing about a dissimilar other engaged a more dorsal subregion of mPFC. The overlap between judgments of self and similar others suggests the plausibility of "simulation" accounts of social cognition, which posit that perceivers can use knowledge about themselves to infer the mental states of others.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Harvard University; University of Aberdeen	Mitchell, JP (corresponding author), Harvard Univ, Dept Psychol, William James Hall,33 Kirkland St, Cambridge, MA 02138 USA.	mitchell@wjh.harvard.edu	Macrae, Neil/C-4761-2008		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P340, DOI 10.1037/0022-3514.87.3.340; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Davies M., 1995, FOLK PSYCHOL THEORY; Davies M., 1995, FOLK PSYCHOL; DEMOULIN S, 2004, EUROPEAN REV SOCIAL, P259; DENNETT DC, 1987, INT STANCE; Fazio R.H., 1990, RES METHODS PERSONAL, V11, P74; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; GORDON RM, 1992, MIND LANG, V1, P158, DOI DOI 10.1111/J.1468-0017.1986.TB00324.X; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Heal J, 1986, LANGUAGE MIND LOGIC, P135; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Meltzoff A. N., 2001, INTENTIONS INTENTION, P171; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2005, TRENDS COGN SCI, V9, P363, DOI 10.1016/j.tics.2005.06.010; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Monin B, 2003, J PERS SOC PSYCHOL, V85, P1035, DOI 10.1037/0022-3514.85.6.1035; MORAN JM, 2006, IN PRESS J COGN NEUR; Nickerson RS, 1999, PSYCHOL BULL, V125, P737, DOI 10.1037/0033-2909.125.6.737; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; NORTHOFF G, 2006, IN PRESS NEUROI 0205; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RUFFMAN T, 1996, MIND LANG, V11, P387; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tomasello M., 2009, CULTURAL ORIGINS HUM; Vaes J, 2003, J PERS SOC PSYCHOL, V85, P1016, DOI 10.1037/0022-3514.85.6.1016; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	52	717	733	1	72	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					655	663		10.1016/j.neuron.2006.03.040	http://dx.doi.org/10.1016/j.neuron.2006.03.040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701214	Bronze			2022-12-24	WOS:000237875200015
J	Williams, ZM; Eskandar, EN				Williams, ZM; Eskandar, EN			Selective enhancement of associative learning by microstimulation of the anterior caudate	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NEURONAL-ACTIVITY; PRIMATE STRIATUM; MONKEY STRIATUM; DOPAMINE; REPRESENTATIONS; ORGANIZATION; STIMULATION; EXPECTATION; SIGNAL	Primates have the remarkable ability to rapidly adjust or modify associations between visual cues and specific motor responses. Whereas little is known as to how such adjustments in behavioral policy are implemented, recent learning models suggest that the anterior striatum is optimally positioned to have a role in this process. We recorded from single units and delivered microstimulation in the striatum of rhesus monkeys performing an associative learning task. Caudate activity during reinforcement was closely correlated with the rate of learning and peaked during the steepest portion of the learning curve when new associations were being acquired. Moreover, delivering microstimulation in the caudate during the reinforcement period significantly increased the rate of learning without altering the monkeys' ultimate performance. These findings suggest that the caudate is responsible for implementing selective adjustments to the 'associative weights' between sensory cues and motor responses during learning, thus enhancing the likelihood of selecting profitable actions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Eskandar, EN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	eeskandar@partners.org						ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; ALEXANDER GE, 1994, J CLIN NEUROPHYSIOL, V11, P420, DOI 10.1097/00004691-199407000-00004; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; Cragg SJ, 2000, J NEUROSCI, V20, P8209; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HOUK J, 1995, MODELS INFORMATION P; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Press WH., 2002, NUMERICAL RECIPES C, V2; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schraudolph NN, 2002, NEURAL COMPUT, V14, P1723, DOI 10.1162/08997660260028683; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	29	184	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					562	568		10.1038/nn1662	http://dx.doi.org/10.1038/nn1662			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501567				2022-12-24	WOS:000236310700024
J	Gutig, R; Sompolinsky, H				Gutig, R; Sompolinsky, H			The tempotron: a neuron that learns spike timing-based decisions	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; RETINAL GANGLION-CELLS; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; DEPENDENT PLASTICITY; TEMPORAL INFORMATION; DEPRESSION; NETWORKS; MEMORY	The timing of action potentials in sensory neurons contains substantial information about the eliciting stimuli. Although the computational advantages of spike timing-based neuronal codes have long been recognized, it is unclear whether, and if so how, neurons can learn to read out such representations. We propose a new, biologically plausible supervised synaptic learning rule that enables neurons to efficiently learn a broad range of decision rules, even when information is embedded in the spatiotemporal structure of spike patterns rather than in mean firing rates. The number of categorizations of random spatiotemporal patterns that a neuron can implement is several times larger than the number of its synapses. The underlying nonlinear temporal computation allows neurons to access information beyond single-neuron statistics and to discriminate between inputs on the basis of multineuronal spike statistics. Our work demonstrates the high capacity of neural systems to learn to decode information embedded in distributed patterns of spike synchrony.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; Charite Med Fac Berlin, Neurosci Res Ctr, D-10117 Berlin, Germany; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University	Gutig, R (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	guetig@cc.huji.ac.il; haim@fiz.huji.ac.il	Sompolinsky, Haim/ABB-8398-2021					ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BRESSLOFF PC, 1992, J PHYS A-MATH GEN, V25, P4373, DOI 10.1088/0305-4470/25/16/014; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Foehring RC, 1999, CAN J EXP PSYCHOL, V53, P45, DOI 10.1037/h0087299; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P257, DOI 10.1088/0305-4470/21/1/030; Gutig R, 2003, J NEUROSCI, V23, P3697; Guyonneau R, 2005, NEURAL COMPUT, V17, P859, DOI 10.1162/0899766053429390; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kuhn A, 2003, NEURAL COMPUT, V15, P67, DOI 10.1162/089976603321043702; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Minsky M., 1969, PERCEPTRONS; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	475	485	1	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					420	428		10.1038/nn1643	http://dx.doi.org/10.1038/nn1643			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474393				2022-12-24	WOS:000235645600022
J	Schoppa, NE				Schoppa, NE			Synchronization of olfactory bulb mitral cells by precisely timed inhibitory inputs	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; GAP-JUNCTIONS; GAMMA-OSCILLATIONS; DENDRODENDRITIC INHIBITION; GABAERGIC INTERNEURONS; SYNAPTIC-INTERACTIONS; RECEPTOR ACTIVATION; NEURAL ASSEMBLIES; OUTPUT NEURONS; ODOR	Synchronized oscillatory activity at the gamma frequency (30-70 Hz) is thought to be important for information processing in many sensory systems. Here, I used patch-clamp recordings in neuron pairs in rat olfactory bulb slices to assess the mechanisms underlying such "gamma" activity in the olfactory system. Patterned electrical stimulation of afferents that mimicked a natural odor stimulus elicited rapidly synchronized spikes (lag <= 5 ms) in mitral cells, along with oscillatory activity at the gamma (similar to 50 Hz) frequency. Analysis of coupling potentials, combined with dendritic sectioning, indicated that mitral cell synchrony was mainly driven by inhibitory postsynaptic potentials (IPSPs) imposed by GABAergic granule cells. Recordings in granule cell pairs indicated that granule cells were themselves synchronized by their excitatory inputs from mitral cells, providing a means to coordinate GABA release. These results demonstrate that rapid synchrony can emerge in a network through the precise back-and-forth interplay between neuronal populations.	Univ Colorado, Dept Physiol & Biophys, Ctr Hlth Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Schoppa, NE (corresponding author), Univ Colorado, Dept Physiol & Biophys, Ctr Hlth Sci, Aurora, CO 80045 USA.	nathan.schoppa@uchsc.edu			NIDCD NIH HHS [DC006640] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006640] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Cang JH, 2003, J NEUROSCI, V23, P4108; Carlson GC, 2000, J NEUROSCI, V20, P2011; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P762, DOI 10.1152/jn.1972.35.6.762; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Khazipov R, 2003, J NEUROSCI, V23, P5337; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; REYHER CKH, 1991, J NEUROSCI, V11, P1485; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	52	151	157	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					271	283		10.1016/j.neuron.2005.11.038	http://dx.doi.org/10.1016/j.neuron.2005.11.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423700	Bronze			2022-12-24	WOS:000234979900013
J	Shinza-Kameda, M; Takasu, E; Sakurai, K; Hayashi, S; Nose, A				Shinza-Kameda, M; Takasu, E; Sakurai, K; Hayashi, S; Nose, A			Regulation of layer-specific targeting by reciprocal expression of a cell adhesion molecule, capricious	NEURON			English	Article							AXON GUIDANCE; DROSOPHILA; MOTONEURONS; FLAMINGO; PROTEIN; LAR	Layer-specific innervation is a major form of synaptic targeting in the central nervous system. In the Drosophila visual system, photoreceptors R7 and R8 connect to targets in distinct layers of the medulla, a ganglion of the optic lobe. We show here that Capricious (CAPS), a transmembrane protein with leucine-rich repeats (LRRs), is a layer-specific cell adhesion molecule that regulates photoreceptor targeting in the medulla. During the period of photoreceptor targeting, caps is specifically expressed in R8 and its target layer but not in R7 or its recipient layer. caps loss-of-function mutations cause local targeting errors by R8 axons, including layer change. Conversely, ectopic expression of caps in R7 redirects R7 axons to terminate in the CAPS-positive R8 recipient layer. CAPS promotes homophilic cell adhesion in transfected S2 cells. These results suggest that CAPS regulates layer-specific targeting by mediating specific axon-target interaction.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Riken Ctr Dev Biol, Morphogenet Signaling Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Tokyo; University of Tokyo; RIKEN	Nose, A (corresponding author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	nose@phys.s.u-tokyo.ac.jp	Hayashi, Shigeo/N-5128-2015; Hayashi, Shigeo/J-9628-2019	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Makiko, Kameda/0000-0002-9867-3195				Abrell S, 2001, MECH DEVELOP, V109, P3, DOI 10.1016/S0925-4773(01)00511-1; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Butler SJ, 1997, DEVELOPMENT, V124, P781; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; MEINERTZHAGEN IA, 1991, DEV DROSOPHILA MELAN, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Stowers RS, 1999, GENETICS, V152, P1631; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Sun Q, 2000, DEVELOPMENT, V127, P801; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019	29	74	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					205	213		10.1016/j.neuron.2005.11.013	http://dx.doi.org/10.1016/j.neuron.2005.11.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423695	Bronze			2022-12-24	WOS:000234979900008
J	Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME				Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME			Calcium-dependent interaction of Lis1 with IQGAP1 and Cdc42 promotes neuronal motility	NATURE NEUROSCIENCE			English	Article							INTRACELLULAR CA2+ FLUCTUATIONS; RHO-GTPASES; NMDA RECEPTORS; ACTIN CYTOSKELETON; SPINE MORPHOLOGY; CELL-MIGRATION; RAT-BRAIN; MICROTUBULE; BINDING; CALMODULIN	Lis1 gene defects impair neuronal migration, causing the severe human brain malformation lissencephaly. Although much is known about its interactions with microtubules, microtubule-binding proteins such as CLIP-170, and with the dynein motor complex, the response of Lis1 to neuronal motility signals has not been elucidated. Lis1 deficiency is associated with deregulation of the Rho-family GTPases Cdc42, Rac1 and RhoA, and ensuing actin cytoskeletal defects, but the link between Lis1 and Rho GTPases remains unclear. We report here that calcium influx enhances neuronal motility through Lis1-dependent regulation of Rho GTPases. Lis1 promotes Cdc42 activation through interaction with the calcium sensitive GTPase scaffolding protein IQGAP1, maintaining the perimembrane localization of IQGAP1 and CLIP170 and thereby tethering microtubule ends to the cortical actin cytoskeleton. Lis1 thus is a key component of neuronal motility signal transduction that regulates the cytoskeleton by complexing with IQGAP1, active Cdc42 and CLIP-170 upon calcium influx.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Univ Calif San Diego, San Diego Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Wisconsin, Sch Med, Dept Neurosci, Madison, WI 53706 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	Cornell University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Ross, ME (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	mer2005@med.cornell.edu	Letourneau, Paul C/A-6764-2009	Gomez, Timothy/0000-0002-1515-8228	NICHD NIH HHS [R01HD19950] Funding Source: Medline; NINDS NIH HHS [R01NS35515, P01NS39404] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD019950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035515, P01NS039404] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GASSER UE, 1990, J NEUROSCI, V10, P1276; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Li QW, 2004, BIOCHEM BIOPH RES CO, V317, P787, DOI 10.1016/j.bbrc.2004.03.119; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; Schell MJ, 1997, J NEUROSCI, V17, P1604; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101	48	140	144	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					50	57		10.1038/nn1619	http://dx.doi.org/10.1038/nn1619			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369480				2022-12-24	WOS:000234288000017
J	Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U				Behrens, CJ; van den Boom, LP; de Hoz, L; Friedman, A; Heinemann, U			Induction of sharp wave-ripple complexes in vitro and reorganization of hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY OSCILLATIONS; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; MEMORY CONSOLIDATION; NEURONS; SLICES; DEPRESSION; PLASTICITY; SLEEP	Hippocampal sharp wave-ripple complexes (SPW-Rs) occur during slow-wave sleep and behavioral immobility and are thought to represent stored information that is transferred to the neocortex during memory consolidation. Here we show that stimuli that induce long-term potentiation (LTP), a neurophysiological correlate of learning and memory, can lead to the generation of SPW-Rs in rat hippocampal slices. The induced SPW-Rs have properties that are identical to spontaneously generated SPW-Rs: they originate in CA3, propagate to CA1 and subiculum and require AMPA/kainate receptors. Their induction is dependent on NMDA receptors and involves changes in interactions between clusters of neurons in the CA3 network. Their expression is blocked by low-frequency stimulation but not by NMDA receptor antagonists. These data indicate that induction of LTP in the recurrent CA3 network may facilitate the generation of SPW-Rs.	Charite Univ Med Berlin, Inst Neurophysiol, D-10117 Berlin, Germany; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Heinemann, U (corresponding author), Charite Univ Med Berlin, Inst Neurophysiol, Tucholskystr 2, D-10117 Berlin, Germany.	uwe.heinemann@charite.de		de Hoz, Livia/0000-0002-5782-1120				Amaral David G., 1995, P443; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ASHTON D, 1989, BRAIN RES, V487, P368, DOI 10.1016/0006-8993(89)90842-1; Axmacher N, 2004, J PHYSIOL-LONDON, V555, P713, DOI 10.1113/jphysiol.2003.052225; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAGDON AC, 1986, BRAIN RES, V378, P169, DOI 10.1016/0006-8993(86)90300-8; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BUZSAKI G, 1984, BRAIN RES, V300, P179, DOI 10.1016/0006-8993(84)91356-8; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; BUZSAKI G, 1987, BRAIN RES, V435, P331, DOI 10.1016/0006-8993(87)91618-0; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dudek F E, 1986, Adv Neurol, V44, P593; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; Heinemann U., 1992, P206; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Moser MB, 2000, NEURON, V26, P559, DOI 10.1016/S0896-6273(00)81192-7; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Ponomarenko AA, 2003, NEUROSCIENCE, V121, P759, DOI 10.1016/S0306-4522(03)00524-4; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wong R K, 1986, Adv Neurol, V44, P583; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	49	183	187	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1560	1567		10.1038/nn1571	http://dx.doi.org/10.1038/nn1571			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222227				2022-12-24	WOS:000232966600031
J	Oesch, N; Euler, T; Taylor, WR				Oesch, N; Euler, T; Taylor, WR			Direction-selective dendritic action potentials in rabbit retina	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; GANGLION-CELLS; RECEPTIVE-FIELDS; CALCIUM SIGNALS; GRANULE CELLS; MITRAL CELLS; PROPAGATION; MECHANISMS; INHIBITION; INITIATION	Dendritic spikes that propagate toward the soma are well documented, but their physiological role remains uncertain. Our in vitro patch-clamp recordings and two-photon calcium imaging show that direction-selective retinal ganglion cells (DSGCs) utilize orthograde dendritic spikes during physiological activity. DSGCs signal the direction of image motion. Excitatory subthreshold postsynaptic potentials are observed in DSGCs for motion in all directions and provide a weakly tuned directional signal. However, spikes are generated over only a narrow range of motion angles, indicating that spike generation greatly enhances directional tuning. Our results indicate that spikes are initiated at multiple sites within the dendritic arbors of DSGCs and that each dendritic spike initiates a somatic spike. We propose that dendritic spike failure, produced by local inhibitory inputs, might be a critical factor that enhances directional tuning of somatic spikes.	Oregon Hlth Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Oregon Health & Science University; Max Planck Society	Taylor, WR (corresponding author), Oregon Hlth Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA.	taylorw@ohsu.edu		Taylor, William/0000-0002-6806-3249; Oesch, Nicholas/0000-0001-6972-0741; Euler, Thomas/0000-0002-4567-6966	NEI NIH HHS [EY014888] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014888] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; AMTHOR FR, 1991, VISUAL NEUROSCI, V6, P197, DOI 10.1017/S0952523800006210; AMTHOR FR, 1993, J NEUROPHYSIOL, V69, P2174, DOI 10.1152/jn.1993.69.6.2174; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GRZYWACZ NM, 1990, BIOL CYBERN, V64, P41, DOI 10.1007/BF00203629; GRZYWACZ NM, 1994, VISUAL NEUROSCI, V11, P1019, DOI 10.1017/S0952523800003953; GRZYWACZ NM, 1987, SYNAPSE, V1, P417, DOI 10.1002/syn.890010506; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; He SG, 1999, J NEUROSCI, V19, P8049; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hu EH, 2003, J NEUROSCI, V23, P6768; HUGUENARD J, 1998, P NATL ACAD SCI USA, V86, P2473; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; KASUGA A, 1993, NEUROSCIENCE, V118, P899; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Lowe G, 2002, J NEUROPHYSIOL, V88, P64, DOI 10.1152/jn.2002.88.1.64; MACVICAR BA, 1982, J NEUROPHYSIOL, V47, P579, DOI 10.1152/jn.1982.47.4.579; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; Pinato G, 2005, J NEUROPHYSIOL, V93, P1285, DOI 10.1152/jn.00807.2004; POGGIO T, 1973, KYBERNETIK, V13, P223, DOI 10.1007/BF00274887; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TURNER RW, 1989, J NEUROPHYSIOL, V62, P1375, DOI 10.1152/jn.1989.62.6.1375; TURNER RW, 1991, J NEUROSCI, V11, P2270; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; VANEY DI, 1994, J NEUROSCI, V14, P6301; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920	64	113	114	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					739	750		10.1016/j.neuron.2005.06.036	http://dx.doi.org/10.1016/j.neuron.2005.06.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129402	Green Submitted, Bronze			2022-12-24	WOS:000231782700014
J	Person, AL; Perkel, DJ				Person, AL; Perkel, DJ			Unitary IPSPs drive precise thalamic spiking in a circuit required for learning	NEURON			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; SONG SYSTEM; FOREBRAIN NUCLEUS; BASIC PROCESS; NEURONS; PROJECTION; DISINHIBITION; STIMULATION; MECHANISMS; EXPRESSION	Song learning in birds requires a basal ganglia-thalamo-pallial loop that contains a calyceal GABAergic synapse in the thalamus. Information processing within this circuit is critical for proper song development; however, it is unclear whether activation of the inhibitory output of the basal ganglia structure Area X can drive sustained activity in its thalamic target, the medial portion of the dorsolateral thalamic nucleus (DLM). We show that high-frequency, random activation of this GABAergic synapse can drive precisely timed firing in DLM neurons in brain slices in the absence of excitatory input. Complex IPSP trains, including spike trains recorded in vivo, drive spiking in slices with high reproducibility, even between animals. Using a simple model, we can predict much of DLM's response to natural stimulus trains. These data elucidate basic rules by which thalamic relay neurons translate IPSPs into suprathreshold output and demonstrate extrathalamic GABAergic activation of thalamus.	Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Perkel, DJ (corresponding author), Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA.	perkel@u.washington.edu			NIDCD NIH HHS [P30 DC04661] Funding Source: Medline; NIGMS NIH HHS [T-32 GM07108] Funding Source: Medline; NIMH NIH HHS [MH066128] Funding Source: Medline; NINDS NIH HHS [F31 NS049732] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066128, R56MH066128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BERGER TW, 1987, ADV METHODS PHYSL SY, V1; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DENIAU JM, 1985, BRAIN RES, V334, P227, DOI 10.1016/0006-8993(85)90214-8; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Dobrunz LE, 1999, NEURON, V22, P157, DOI 10.1016/S0896-6273(00)80687-X; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Gauck V, 2000, J NEUROSCI, V20, P3006; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hessler NA, 1999, J NEUROSCI, V19, P10461; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2002, J NEUROPHYSIOL, V88, P1903, DOI 10.1152/jn.2002.88.4.1903; Luo MM, 2001, J NEUROSCI, V21, P6836, DOI 10.1523/JNEUROSCI.21-17-06836.2001; Luo MM, 1999, J COMP NEUROL, V403, P68; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Porcello DM, 2003, J NEUROPHYSIOL, V89, P177, DOI 10.1152/jn.00667.2002; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 2001, EXPLORING THALAMUS, P263; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; THOMSON AM, 1988, NEUROSCIENCE, V25, P491, DOI 10.1016/0306-4522(88)90253-9; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; UEKI A, 1983, EXP BRAIN RES, V49, P116; Ulrich D, 1997, J NEUROSCI, V17, P2348; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; Vates GE, 1997, J COMP NEUROL, V380, P275; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346; ZHOU N, 1992, HEARING RES, V60, P20, DOI 10.1016/0378-5955(92)90054-Q	52	94	97	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					129	140		10.1016/j.neuron.2004.12.057	http://dx.doi.org/10.1016/j.neuron.2004.12.057			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820699	Bronze			2022-12-24	WOS:000228228600014
J	Vallstedt, A; Klos, JM; Ericson, J				Vallstedt, A; Klos, JM; Ericson, J			Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; HOMEODOMAIN TRANSCRIPTION FACTOR; PDGF ALPHA-RECEPTOR; SONIC HEDGEHOG; MOTOR-NEURON; PROGENITOR CELLS; STEM-CELLS; SUBVENTRICULAR ZONE; ROOF PLATE	Studies have indicated that oligodendrocytes in the spinal cord originate from a ventral progenitor domain defined by expression of the oligodendrocyte-determining bHLH proteins Olig1 and Olig2. Here, we provide evidence that progenitors in the dorsal spinal cord and hindbrain also produce oligodendrocytes and that the specification of these cells may result from a dorsal evasion of BMP signaling over time. Moreover, we show that the generation of ventral oligodendrocytes in the spinal cord depends on Nkx6.1 and Nkx6.2 function, while these homeodomain proteins in the anterior hindbrain instead suppress oligodendrocyte specification. The opposing roles for Nkx6 proteins in the spinal cord and hindbrain, in turn, appear to reflect that oligodendrocytes are produced by distinct ventral progenitor domains at these axial levels. Based on these findings, we propose that oligodendrocytes derive from several distinct positional origins and that the activation of Olig1/2 at different positions is controlled by distinct genetic programs.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ericson, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@cmb.ki.se	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Ericson, Johan/0000-0002-8019-7127				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gorski JA, 2002, J NEUROSCI, V22, P6309; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hall A, 1996, DEVELOPMENT, V122, P4085; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Liem KF, 2000, DEVELOPMENT, V127, P4855; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qi YC, 2001, DEVELOPMENT, V128, P2723; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Sussman CR, 2000, J NEUROSCI RES, V59, P413, DOI 10.1002/(SICI)1097-4547(20000201)59:3<413::AID-JNR16>3.3.CO;2-7; VALERIUS MT, 1995, DEV DYNAM, V203, P337, DOI 10.1002/aja.1002030306; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	61	239	242	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					55	67		10.1016/j.neuron.2004.12.026	http://dx.doi.org/10.1016/j.neuron.2004.12.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629702	Bronze			2022-12-24	WOS:000226217100009
J	Yovel, G; Kanwisher, N				Yovel, G; Kanwisher, N			Face perception: Domain specific, not process specific	NEURON			English	Article							HUMAN FUSIFORM GYRUS; UPSIDE-DOWN FACES; CONFIGURAL INFORMATION; INVERTED FACES; RECOGNITION; INVERSION; OBJECT; AREA; CORTEX; EXPERTISE	Evidence that face perception is mediated by special cognitive and neural mechanisms comes from fMRI studies of the fusiform face area (FFA) and behavioral studies of the face inversion effect. Here, we used these two methods to ask whether face perception mechanisms are stimulus specific, process specific, or both. Subjects discriminated pairs of upright or inverted faces or house stimuli that differed in either the spatial distance among parts (configuration) or the shape of the parts. The FFA showed a much higher response to faces than to houses, but no preference for the configuration task over the part task. Similarly, the behavioral inversion effect was as large in the part task as the configuration task for faces, but absent in both part and configuration tasks for houses. These findings indicate that face perception mechanisms are not process specific for parts or configuration but are domain specific for face stimuli per se.	MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Yovel, G (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Sci, Cambridge, MA 02139 USA.	galit@mit.edu	Yovel, Galit/GPT-4409-2022	Yovel, Galit/0000-0003-0971-2357	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, R01RR016594] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR14075, R01 RR16594-01A1] Funding Source: Medline; NEI NIH HHS [EY13455] Funding Source: Medline; PHS HHS [66696] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, 2003, VISUAL NEUROSCIENCES, P1179; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MALCOM G, 2005, IN PRESS PERCEPTION; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MCKONE E, 2005, IN PRESS MONKEY BRAI; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; RHODES G, 1994, VIS COGN, V1, P275, DOI DOI 10.1080/13506289408402303; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; RIESENHUBER M, 2004, IN PRESS BIOL LETT; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Tanaka J.W., 2006, PERCEPTION FACES OBJ, P53, DOI [10.1093/acprof:oso/9780195313659.003.0003, DOI 10.1093/ACPROF:OSO/9780195313659.003.0003]; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Wada Y, 2001, J NEUROL NEUROSUR PS, V71, P254, DOI 10.1136/jnnp.71.2.254; Williams MA, 2004, COGNITION, V91, P155, DOI 10.1016/j.cognition.2003.08.002; XU Y, 2005, IN PRESS NEUROPSYCHO; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; YOVEL G, IN PRESS VIS COGN	47	374	383	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					889	898		10.1016/S0896-6273(04)00728-7	http://dx.doi.org/10.1016/S0896-6273(04)00728-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572118	Bronze			2022-12-24	WOS:000225548400015
J	Greene, JD; Nystrom, LE; Engell, AD; Darley, JM; Cohen, JD				Greene, JD; Nystrom, LE; Engell, AD; Darley, JM; Cohen, JD			The neural bases of cognitive conflict and control in moral judgment	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; FMRI; ACTIVATION; INSIGHTS	Traditional theories of moral psychology emphasize reasoning and "higher cognition," while more recent work emphasizes the role of emotion. The present fMRI data support a theory of moral judgment according to which both "cognitive" and emotional processes play crucial and sometimes mutually competitive roles. The present results indicate that brain regions associated with abstract reasoning and cognitive control (including dorsolateral prefrontal cortex and anterior cingulate cortex) are recruited to resolve difficult personal moral dilemmas in which utilitarian values require "personal" moral violations, violations that have previously been associated with increased activity in emotion-related brain regions. Several regions of frontal and parietal cortex predict intertrial differences in moral judgment behavior, exhibiting greater activity for utilitarian judgments. We speculate that the controversy surrounding utilitarian moral philosophy reflects an underlying tension between competing subsystems in the brain.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University; Princeton University	Greene, JD (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	jdgreene@princeton.edu	Engell, Andrew/V-6521-2019	Engell, Andrew/0000-0002-4852-4909	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH067410] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067410] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COLES MGH, 1995, ACTA PSYCHOL, V90, P129, DOI 10.1016/0001-6918(95)00020-U; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio A.R., 1994, DESCARTES ERROR EMOT; de Waal F., 1996, GOOD NATURED ORIGINS; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Greene J, 2003, NAT REV NEUROSCI, V4, P846, DOI 10.1038/nrn1224; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; GREENE J, 2004, IN PRESS PHILOS T R; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kant I., 1959, FDN METAPHYSICS MORA; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; MCCLURE SM, 2004, IN PRESS SCIENCE; Mill JohnStuart., 1957, UTILITARIANISM; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Posner M. I., 1975, ATTENTION COGNITIVE, P55, DOI 10.1007/978-1-4613-2985-5; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomson J Jarvis, 1986, RIGHTS RESTITUTION R; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	46	1444	1495	23	339	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					389	400		10.1016/j.neuron.2004.09.027	http://dx.doi.org/10.1016/j.neuron.2004.09.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	864LU	15473975	Bronze			2022-12-24	WOS:000224635800019
J	Mevorach, C; Humphreys, GW; Shalev, L				Mevorach, C; Humphreys, GW; Shalev, L			Opposite biases in salience-based selection for the left and right posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							VISUAL-ATTENTION; BRAIN; LATERALIZATION; SEARCH; FOREST; TREES	Visual selection is determined in part by the saliency of stimuli. We assessed the brain mechanisms determining attentional responses to saliency. Repetitive transcranial magnetic stimulation (rTMS) was applied to the left and right posterior parietal cortices (PPC) immediately before participants were asked to identify a compound letter. rTMS to the right PPC disrupted the guidance of attention toward salient stimuli, whereas rTMS to the left PPC affected the ability to bias selection away from salient stimuli. We conclude that right and left PPC have opposite roles in biasing selection to and from salient stimuli in the environment.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England; Open Univ Israel, Dept Educ & Psychol, Raanana, Israel	University of Birmingham; Open University Israel	Mevorach, C (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.	c.mevorach@bham.ac.uk	Shalev, Lilach/ABA-8783-2021; Mevorach, Carmel/AAT-9229-2021	Mevorach, Carmel/0000-0003-1596-1026	BBSRC [BB/E000134/1] Funding Source: UKRI; MRC [G9806428] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000134/1] Funding Source: Medline; Medical Research Council [G9806428] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Evans MA, 2000, NEUROPSYCHOLOGIA, V38, P225, DOI 10.1016/S0028-3932(99)00080-9; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HUMPHREYS GW, 1994, NATURE, V372, P357, DOI 10.1038/372357a0; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; LAMB MR, 1988, PERCEPT PSYCHOPHYS, V44, P172, DOI 10.3758/BF03208710; Mevorach C, 2006, NEUROPSYCHOLOGIA, V44, P307, DOI 10.1016/j.neuropsychologia.2005.04.015; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; POSNER MI, 1984, J NEUROSCI, V4, P25; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492	15	141	144	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					740	742		10.1038/nn1709	http://dx.doi.org/10.1038/nn1709			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699505				2022-12-24	WOS:000237895200013
J	Yanai, A; Huang, K; Kang, RJ; Singaraja, RR; Arstikaitis, P; Gan, L; Orban, PC; Mullard, A; Cowan, CM; Raymond, LA; Drisdel, RC; Green, WN; Ravikumar, B; Rubinsztein, DC; El-Husseini, A; Hayden, MR				Yanai, Anat; Huang, Kun; Kang, Rujun; Singaraja, Roshni R.; Arstikaitis, Pamela; Gan, Lu; Orban, Paul C.; Mullard, Asher; Cowan, Catherine M.; Raymond, Lynn A.; Drisdel, Renaldo C.; Green, William N.; Ravikumar, Brinda; Rubinsztein, David C.; El-Husseini, Alaa; Hayden, Michael R.			Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function	NATURE NEUROSCIENCE			English	Article							YAC128 MOUSE MODEL; MUTANT HUNTINGTIN; PROTEIN PALMITOYLATION; NUCLEAR-LOCALIZATION; INCLUSION-BODIES; PLASMA-MEMBRANE; NEURONAL DEATH; IN-VIVO; DISEASE; PHOSPHORYLATION	Post-translational modification by the lipid palmitate is crucial for the correct targeting and function of many proteins. Here we show that huntingtin (htt) is normally palmitoylated at cysteine 214, which is essential for its trafficking and function. The palmitoylation and distribution of htt are regulated by the palmitoyl transferase huntingtin interacting protein 14 (HIP14). Expansion of the polyglutamine tract of htt, which causes Huntington disease, results in reduced interaction between mutant htt and HIP14 and consequently in a marked reduction in palmitoylation. Mutation of the palmitoylation site of htt, making it palmitoylation resistant, accelerates inclusion formation and increases neuronal toxicity. Downregulation of HIP14 in mouse neurons expressing wild-type and mutant htt increases inclusion formation, whereas overexpression of HIP14 substantially reduces inclusions. These results suggest that the expansion of the polyglutamine tract in htt results in decreased palmitoylation, which contributes to the formation of inclusion bodies and enhanced neuronal toxicity.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; British Columbia Childrens Hosp, Childrens & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; University of Chicago; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; BC Childrens Hospital; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	alaa@interchange.ubc.ca; mrh@cmmt.ubc.ca	Raymond, Lynn A./R-6707-2016; Rubinsztein, David C/C-3472-2011; Raymond, Lynn A/A-6664-2010; Cowan, Catherine/F-4181-2010; Hayden, Michael R/D-8581-2011	Raymond, Lynn A./0000-0002-8610-1042; Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867; Yanai, Anat/0000-0002-0792-6901	NINDS NIH HHS [R01 NS043782-04, R01 NS043782-02, R01 NS043782-01A2, R01 NS043782-05, R01 NS043782-03, R01 NS043782] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	36	217	224	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					824	831		10.1038/nn1702	http://dx.doi.org/10.1038/nn1702			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699508	Green Accepted			2022-12-24	WOS:000237895200023
J	Mushiake, H; Saito, N; Sakamoto, K; Itoyama, Y; Tanji, J				Mushiake, Hajime; Saito, Naohiro; Sakamoto, Kazuhiro; Itoyama, Yasuto; Tanji, Jun			Activity in the lateral prefrontal cortex reflects multiple steps of future events in action plans	NEURON			English	Article							PRECENTRAL MOTOR CORTEX; PRIMATE FRONTAL-CORTEX; NEURONAL-ACTIVITY; WORKING-MEMORY; CUE LOCATION; REPRESENTATION; MOVEMENTS; TASK; MACAQUE; INFORMATION	To achieve a behavioral goal in a complex environment, we must plan multiple steps of motor behavior. On planning a series of actions, we anticipate future events that will occur as a result of each action and mentally organize the temporal sequence of events. To investigate the involvement of the lateral prefrontal cortex (PFC) in such multistep planning, we examined neuronal activity in the PFC of monkeys performing a maze task that required the planning of stepwise cursor movements to reach a goal. During the preparatory period, PFC neurons reflected each of all forthcoming cursor movements, rather than arm movements. In contrast, in the primary motor cortex, most neuronal activity reflected arm movements but little of cursor movements during the preparatory period, as well as during movement execution. Our data suggest that the PFC is involved primarily in planning multiple future events that occur as a consequence of behavioral actions.	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi 9808575, Japan; Tamagawa Univ, Brain Sci Res Inst, Res Inst, Tokyo 1948610, Japan	Tohoku University; Tohoku University; Tohoku University	Mushiake, H (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan.	hmushiak@mail.tains.tohoku.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Fukushima T, 2004, J NEUROPHYSIOL, V91, P1367, DOI 10.1152/jn.00306.2003; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hasegawa RP, 2000, SCIENCE, V290, P1786, DOI 10.1126/science.290.5497.1786; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Mushiake H, 2001, COGNITIVE BRAIN RES, V11, P165, DOI 10.1016/S0926-6410(00)00067-7; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	40	170	173	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					631	641		10.1016/j.neuron.2006.03.045	http://dx.doi.org/10.1016/j.neuron.2006.03.045			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701212	Bronze			2022-12-24	WOS:000237875200013
J	Jazayeri, M; Movshon, JA				Jazayeri, M; Movshon, JA			Optimal representation of sensory information by neural populations	NATURE NEUROSCIENCE			English	Article							VISUAL AREA MT; PERCEPTUAL DECISION; PSYCHOPHYSICAL PERFORMANCE; MOTION DIRECTION; PARIETAL CORTEX; MACAQUE MT; NEURONS; MICROSTIMULATION; DISCRIMINATION; RESPONSES	Sensory information is encoded by populations of neurons. The responses of individual neurons are inherently noisy, so the brain must interpret this information as reliably as possible. In most situations, the optimal strategy for decoding the population signal is to compute the likelihoods of the stimuli that are consistent with an observed neural response. But it has not been clear how the brain can directly compute likelihoods. Here we present a simple and biologically plausible model that can realize the likelihood function by computing a weighted sum of sensory neuron responses. The model provides the basis for an optimal decoding of sensory information. It explains a variety of psychophysical observations on detection, discrimination and identification, and it also directly predicts the relative contributions that different sensory neurons make to perceptual judgments.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Movshon, JA (corresponding author), NYU, Ctr Neural Sci, 4 Wasington Pl,Room 809, New York, NY 10003 USA.	movshon@nyu.edu			NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY2017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Groh JM, 1997, J NEUROSCI, V17, P4312; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Roitman JD, 2002, J NEUROSCI, V22, P9475; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	41	350	350	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					690	696		10.1038/nn1691	http://dx.doi.org/10.1038/nn1691			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617339				2022-12-24	WOS:000237417200021
J	Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC				Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC			CREB modulates excitability of nucleus accumbens neurons	NATURE NEUROSCIENCE			English	Article							COCAINE; ADDICTION	Drugs of abuse cause activation of the cyclic AMP response element binding protein (CREB) in the nucleus accumbens (NAc). Expression of active CREB in rat NAc medium spiny neurons (MSNs) increased their excitability, whereas dominant-negative CREB had the opposite effect. Decreasing excitability of NAc MSNs in vivo by overexpression of potassium channels enhanced locomotor responses to cocaine, suggesting that the increased NAc MSN excitability caused by CREB helped to limit behavioral sensitivity to cocaine.	Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Dept Genet, Cambridge, MA 02478 USA; Harvard Univ, McClean Hosp, Cambridge, MA 02478 USA	Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University	Malenka, RC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011; Dong, Yan/A-4154-2016	Marie, Hélène/0000-0003-2310-6097; Dong, Yan/0000-0003-0016-9028				Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Johns DC, 1999, J NEUROSCI, V19, P1691; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488	13	244	248	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					475	477		10.1038/nn1661	http://dx.doi.org/10.1038/nn1661			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520736				2022-12-24	WOS:000236310700010
J	Kraves, S; Weitz, CJ				Kraves, S; Weitz, CJ			A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity	NATURE NEUROSCIENCE			English	Article							LEUKEMIA INHIBITORY FACTOR; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; EFFERENT PROJECTIONS; TARGETED DISRUPTION; SIGNAL TRANSDUCER; FACTOR-RECEPTOR; GOLDEN-HAMSTER; CNTF RECEPTOR; CLOCK NEURONS	The suprachiasmatic nucleus ( SCN) drives circadian rhythms of locomotor behavior by releasing factors that act on receptor sites near the third ventricle. Here we show that cardiotrophin-like cytokine ( CLC) satisfies multiple criteria for a circadian regulator of locomotor activity. In the mouse, CLC is expressed in a subpopulation of SCN vasopressin neurons with a circadian rhythm that peaks during the daily period of locomotor quiescence. CLC receptors flank the third ventricle, and acute infusion of CLC into the third ventricle produced a transient blockade of locomotor activity without affecting the circadian clock. The hypothalamic infusion of neutralizing antibodies to the CLC receptor produced extra daily locomotor activity at the time when CLC is maximally expressed. These results suggest that CLC is probably an SCN output signal important for shaping daily rhythms of behavior; moreover, they indicate an unexpected role for a cytokine in adult brain function.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Auernhammer CJ, 1999, ENDOCRINOLOGY, V140, P1559, DOI 10.1210/en.140.4.1559; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chesnokova V, 2002, ENDOCRINOLOGY, V143, P1571, DOI 10.1210/en.143.5.1571; DAVIS FC, 1980, AM J PHYSIOL, V239, pR149, DOI 10.1152/ajpregu.1980.239.1.R149; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Fukada T, 1999, GROWTH FACTORS, V17, P81, DOI 10.3109/08977199909103518; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kramer A, 2005, METHOD ENZYMOL, V393, P645, DOI 10.1016/S0076-6879(05)93034-6; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; LeSauter J, 1997, J BIOL RHYTHM, V12, P327, DOI 10.1177/074873049701200405; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; Wang ZY, 1996, ENDOCRINOLOGY, V137, P2947, DOI 10.1210/en.137.7.2947; WARE CB, 1995, DEVELOPMENT, V121, P1283; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	46	117	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					212	219		10.1038/nn1633	http://dx.doi.org/10.1038/nn1633			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429135				2022-12-24	WOS:000234990100016
J	Park, YY; Jo, J; Isaac, JTR; Cho, K				Park, YY; Jo, J; Isaac, JTR; Cho, K			Long-term depression of kainate receptor-mediated synaptic transmission	NEURON			English	Article							MOSSY FIBER SYNAPSES; PROTEIN-KINASE-C; DEPENDENT REGULATION; AMPA RECEPTORS; EXPRESSION; PICK1; ACID; POTENTIATION; TRAFFICKING; ACTIVATION	Kainate receptors (KARs) have been shown to be involved in hippocampal mossy fiber long-term potentiation (LTP); however, it is not known if KARs are involved in the induction or expression of long-term depression (LTD), the other major form of long-term synaptic plasticity. Here we describe LTD of KAR-mediated synaptic transmission (EPSCKA LTD) in perirhinal cortex layer II/III neurons that is distinct from LTD of AMPAR-mediated transmission, which also coexists at the same synapses. Induction of EPSCKA LTD requires a rise in postsynaptic Ca2+ but is independent of NMDARs or T-type voltage-gated Ca2+ channels; however, it requires synaptic activation of inwardly rectifying KARs and release of Ca2+ from stores. The synaptic KARs are regulated by tonically activated mGluR5, and expression of EPSCKA LTD occurs via a mechanism involving mGluR5, PKC, and PICK1 PDZ domain interactions. Thus, we describe the induction and expression mechanism of a form of synaptic plasticity, EPSCKA LTD.	Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Bristol, Dept Anat, Sch Med Sci, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Sheffield; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cho, K (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	k.cho@sheffield.ac.uk		Cho, Kwangwook/0000-0001-6724-7073	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BAHN S, 1994, J NEUROSCI, V14, P5525; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Cho K, 2000, NAT NEUROSCI, V3, P150, DOI 10.1038/72093; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Chung HJ, 2000, J NEUROSCI, V20, P7258; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Frerking M, 2002, J NEUROSCI, V22, P7434; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; More JCA, 2004, NEUROPHARMACOLOGY, V47, P46, DOI 10.1016/j.neuropharm.2004.03.005; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WISDEN W, 1993, J NEUROSCI, V13, P3582	39	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					95	106		10.1016/j.neuron.2005.11.035	http://dx.doi.org/10.1016/j.neuron.2005.11.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387642	Bronze			2022-12-24	WOS:000236699300012
J	Shu, TZ; Tseng, HC; Sapir, T; Stern, P; Zhou, Y; Sanada, K; Fischer, A; Coquelle, FM; Reiner, O; Tsai, LH				Shu, TZ; Tseng, HC; Sapir, T; Stern, P; Zhou, Y; Sanada, K; Fischer, A; Coquelle, FM; Reiner, O; Tsai, LH			Doublecortin-like kinase controls neurogenesis by regulating mitotic spindles and M phase progression	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; DIEKER LISSENCEPHALY GENE; CYTOPLASMIC DYNEIN; NEURONAL POLARITY; PROGENITOR CELLS; LIS1; PHOSPHORYLATION; ENCODES; TAU; MUTATIONS	The mechanisms controlling neurogenesis during brain development remain relatively unknown. Through a differential protein screen with developmental versus mature neural tissues, we identified a group of developmentally enriched microtubule-associated proteins (MAPs) including doublecortin-like kinase (DCLK), a protein that shares high homology with doublecortin (DCX). DCLK, but not DCX, is highly expressed in regions of active neurogenesis in the neocortex and cerebellum. Through a dynein-dependent mechanism, DCLK regulates the formation of bipolar mitotic spindles and the proper transition from prometaphase to metaphase during mitosis. In cultured cortical neural progenitors, DCLK RNAi Lentivirus disrupts the structure of mitotic spindles and the progression of M phase, causing an increase of cell-cycle exit index and an ectopic commitment to a neuronal fate. Furthermore, both DCLK gain and loss of function in vivo specifically promote a neuronal identity in neural progenitors. These data provide evidence that DCLK controls mitotic division by regulating spindle formation and also determines the fate of neural progenitors during cortical neurogenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Reiner, Orly/E-9455-2010; SANADA, YOSHIKADO/G-5014-2014	Reiner, Orly/0000-0001-7560-9599; Fischer, Andre/0000-0001-8546-1161; Sanada, Kamon/0000-0002-0280-8957; COQUELLE, Frederic/0000-0002-5483-8787	FOGARTY INTERNATIONAL CENTER [R03TW007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER; FIC NIH HHS [R03TW007048] Funding Source: Medline; NINDS NIH HHS [NS37007] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Beghini A, 2003, ONCOGENE, V22, P2581, DOI 10.1038/sj.onc.1206336; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Edelman AM, 2005, J BIOL CHEM, V280, P8531, DOI 10.1074/jbc.M411027200; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HOEHI M, 1992, EUR J BIOCHEM, V203, P43; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lin PT, 2000, J NEUROSCI, V20, P9152; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SLOBODA RD, 1998, CELL LAB MANUEL; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6	67	112	116	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					25	39		10.1016/j.neuron.2005.10.039	http://dx.doi.org/10.1016/j.neuron.2005.10.039			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387637	Bronze			2022-12-24	WOS:000236699300007
J	Liu, JX; Asuncion-Chin, M; Liu, PC; Dopico, AM				Liu, JX; Asuncion-Chin, M; Liu, PC; Dopico, AM			CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE; MOLECULAR MECHANISMS; GLYCINE RECEPTORS; LARGE-CONDUCTANCE; ALCOHOL ACTION; K CHANNEL; CELLS; SENSITIVITY	High-conductance, Ca2+-activated and voltage-gated (BK) channels set neuronal firing. They are almost universally activated by alcohol, leading to reduced neuronal excitability and neuropeptide release and to motor intoxication. However, several BK channels are inhibited by alcohol, and most other voltage-gated K+ channels are refractory to drug action. BK channels are homotetramers (encoded by Slo1) that possess a unique transmembrane segment (S0), leading to a cytosolic S0-S1 loop. We identified Thr107 of bovine slo (bslo) in this loop as a critical residue that determines BK channel responses to alcohol. In addition, the activity of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in the cell controlled channel activity and alcohol modulation. Incremental CaMKII-mediated phosphorylation of Thr107 in the BK tetramer progressively increased channel activity and gradually switched the channel alcohol responses from robust activation to inhibition. Thus, CaMKII phosphorylation of slo Thr107 works as a 'molecular dimmer switch' that could mediate tolerance to alcohol, a form of neuronal plasticity.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Dopico, AM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	adopico@utmem.edu			NHLBI NIH HHS [R01 HL077424-02, HL77424, R01 HL077424] Funding Source: Medline; NIAAA NIH HHS [AA11560, R01 AA011560-08, R29 AA011560, R01 AA011560, R37 AA011560] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011560, R37AA011560, R29AA011560] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Borghese CM, 2002, ALCOHOL CLIN EXP RES, V26, P1764, DOI 10.1097/01.ALC.0000042012.58231.D9; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Crowder CM, 2004, TRENDS NEUROSCI, V27, P579, DOI 10.1016/j.tins.2004.07.006; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Eshete F, 2001, J NEUROSCI, V21, P6694, DOI 10.1523/JNEUROSCI.21-17-06694.2001; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim I, 2000, J PHYSIOL-LONDON, V526, P367, DOI 10.1111/j.1469-7793.2000.00367.x; Knott TK, 2002, MOL PHARMACOL, V62, P135, DOI 10.1124/mol.62.1.135; Krnjevic K., 1972, CELLULAR BIOL TOXICI, P3; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liu PC, 2004, P NATL ACAD SCI USA, V101, P18217, DOI 10.1073/pnas.0406096102; Liu PC, 2003, ALCOHOL CLIN EXP RES, V27, P1640, DOI 10.1097/01.ALC.0000094756.41638.5D; MAMIYA N, 1993, BIOCHEM BIOPH RES CO, V195, P608, DOI 10.1006/bbrc.1993.2089; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Mascia MP, 1996, MOL PHARMACOL, V50, P402; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Muller M, 1996, NEUROPHARMACOLOGY, V35, P877, DOI 10.1016/0028-3908(96)00091-3; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Randby AT, 1999, J DAIRY SCI, V82, P420, DOI 10.3168/jds.S0022-0302(99)75248-3; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sessoms-Sikes JS, 2003, J PHARMACOL EXP THER, V306, P595, DOI 10.1124/jpet.103.050542; Smith TL, 1999, NEUROSCI LETT, V269, P145, DOI 10.1016/S0304-3940(99)00438-3; Solem M, 1997, J PHARMACOL EXP THER, V282, P1487; Stevens N, 2001, J BIOCHEM, V129, P551, DOI 10.1093/oxfordjournals.jbchem.a002890; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Valenzuela CF, 1998, ALCOHOL CLIN EXP RES, V22, P1292; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Weiger TM, 2002, J COMP PHYSIOL A, V188, P79, DOI 10.1007/s00359-002-0281-2; Zakhari S, 1997, ALCOHOL HEALTH RES W, V21, P21; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	47	57	60	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					41	49		10.1038/nn1602	http://dx.doi.org/10.1038/nn1602			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341213	Green Accepted			2022-12-24	WOS:000234288000016
J	Goodchild, RE; Kim, CE; Dauer, WT				Goodchild, RE; Kim, CE; Dauer, WT			Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope	NEURON			English	Article							MODEL; ATPASES; MOUSE	An enigmatic feature of many genetic diseases is that mutations in widely expressed genes cause tissue-specific illness. One example is DYT1 dystonia, a neurodevelopmental disease caused by an in-frame deletion (Delta gag) in the gene encoding torsinA. Here we show that neurons from both torsinA null (Tor1a(-/-)) and homozygous disease mutant "knockin" mice (Tor1a(Delta gag/Delta gag)) contain severely abnormal nuclear membranes, although non-neuronal cell types appear normal. These membrane abnormalities develop in postmigratory embryonic neurons and subsequently worsen with further neuronal maturation, a finding evocative of the developmental dependence of DYT1 dystonia. These observations demonstrate that neurons have a unique requirement for nuclear envelope localized torsinA function and suggest that loss of this activity is a key molecular event in the pathogenesis of DYT1 dystonia.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dauer, WT (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.	wtd3@columbia.edu		Dauer, William/0000-0003-1775-7504	NICHD NIH HHS [R01 HD045708-01A1] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altman J, 2001, DEV HUMAN SPINAL COR; Bandmann O, 2002, NEUROPEDIATRICS, V33, P1, DOI 10.1055/s-2002-23590; Basham SE, 1999, DEV BIOL, V215, P253, DOI 10.1006/dbio.1999.9447; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Gerace L, 2004, P NATL ACAD SCI USA, V101, P8839, DOI 10.1073/pnas.0402441101; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Peters A., 1991, FINE STRUCTURE NERVO; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; SHALE H, 1987, MOVEMENT DISORD, V2, P321, DOI 10.1002/mds.870020411; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13	28	291	300	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					923	932		10.1016/j.neuron.2005.11.010	http://dx.doi.org/10.1016/j.neuron.2005.11.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364897	Bronze			2022-12-24	WOS:000234301700009
J	Dean, I; Harper, NS; McAlpine, D				Dean, I; Harper, NS; McAlpine, D			Neural population coding of sound level adapts to stimulus statistics	NATURE NEUROSCIENCE			English	Article							AUDITORY-NERVE FIBERS; RATE-INTENSITY FUNCTIONS; SHORT-TERM ADAPTATION; CONTRAST GAIN-CONTROL; DYNAMIC-RANGE; GUINEA-PIG; INFERIOR COLLICULUS; CORTICAL-NEURONS; NOISE; CATS	Mammals can hear sounds extending over a vast range of sound levels with remarkable accuracy. How auditory neurons code sound level over such a range is unclear; firing rates of individual neurons increase with sound level over only a very limited portion of the full range of hearing. We show that neurons in the auditory midbrain of the guinea pig adjust their responses to the mean, variance and more complex statistics of sound level distributions. We demonstrate that these adjustments improve the accuracy of the neural population code close to the region of most commonly occurring sound levels. This extends the range of sound levels that can be accurately encoded, fine-tuning hearing to the local acoustic environment.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, Ear Inst, London WC1E 6BT, England; UCL, Ctr Math & Phys Life Sci & Expt Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Dean, I (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	i.dean@ucl.ac.uk		McAlpine, David/0000-0001-5467-6725; Harper, Nicol/0000-0002-7851-4840	Medical Research Council [G0300417] Funding Source: Medline; RNID [G16] Funding Source: Medline; MRC [G0300417] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; AVAN P, 1992, HEARING RES, V59, P59, DOI 10.1016/0378-5955(92)90102-S; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARMEL PW, 1963, J NEUROPHYSIOL, V26, P598, DOI 10.1152/jn.1963.26.4.598; Colburn HS, 2003, JARO, V4, P294, DOI 10.1007/s10162-002-1090-6; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Dayan P., 2001, THEORETICAL NEUROSCI; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; EVANS EF, 1980, EXP BRAIN RES, V40, P115; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GIBSON DJ, 1985, J NEUROPHYSIOL, V53, P940, DOI 10.1152/jn.1985.53.4.940; HOUTSMA AJM, 1980, J ACOUST SOC AM, V68, P807, DOI 10.1121/1.384819; Ingham NJ, 2004, J NEUROPHYSIOL, V91, P632, DOI 10.1152/jn.00779.2003; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Kirk EC, 2003, JARO-J ASSOC RES OTO, V4, P445, DOI 10.1007/s10162-002-3013-y; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MAY BJ, 1992, J NEUROPHYSIOL, V68, P1589, DOI 10.1152/jn.1992.68.5.1589; NUTTALL AL, 1974, J ACOUST SOC AM, V56, P1239, DOI 10.1121/1.1903414; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1986, J ACOUST SOC AM, V80, P177, DOI 10.1121/1.394178; Popelar J, 2003, PHYSIOL RES, V52, P615; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; REES A, 1988, J ACOUST SOC AM, V83, P1488, DOI 10.1121/1.395904; SACHS MB, 1974, J ACOUST SOC AM, V56, P1835, DOI 10.1121/1.1903521; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SIMMONS JA, 1971, SCIENCE, V171, P212, DOI 10.1126/science.171.3967.212; SMITH RL, 1980, HEARING RES, V2, P123, DOI 10.1016/0378-5955(80)90034-9; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; VIEMEISTER NF, 1974, J ACOUST SOC AM, V56, P1594, DOI 10.1121/1.1903483; VIEMEISTER NF, 1988, HEARING RES, V34, P267, DOI 10.1016/0378-5955(88)90007-X; VIEMEISTER NF, 1983, SCIENCE, V221, P1206, DOI 10.1126/science.6612337; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; WINTER IM, 1991, J ACOUST SOC AM, V90, P1958, DOI 10.1121/1.401675; YATES GK, 1985, HEARING RES, V17, P1, DOI 10.1016/0378-5955(85)90124-8	36	346	357	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1684	1689		10.1038/nn1541	http://dx.doi.org/10.1038/nn1541			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286934				2022-12-24	WOS:000233576200016
J	Lengyel, M; Kwag, J; Paulsen, O; Dayan, P				Lengyel, M; Kwag, J; Paulsen, O; Dayan, P			Matching storage and recall: hippocampal spike timing-dependent plasticity and phase response curves	NATURE NEUROSCIENCE			English	Article							NEURAL NETWORKS; SYNAPTIC MODIFICATION; THETA-OSCILLATIONS; GRADED-RESPONSE; PYRAMIDAL CELLS; OLFACTORY-BULB; NEURONS; SLEEP; RETRIEVAL; MEMORY	Hippocampal area CA3 is widely considered to function as an autoassociative memory. However, it is insufficiently understood how it does so. In particular, the extensive experimental evidence for the importance of carefully regulated spiking times poses the question as to how spike timing - based dynamics may support memory functions. Here, we develop a normative theory of autoassociative memory encompassing such network dynamics. Our theory specifies the way that the synaptic plasticity rule of a memory constrains the form of neuronal interactions that will retrieve memories optimally. If memories are stored by spike timing dependent plasticity, neuronal interactions should be formalized in terms of a phase response curve, indicating the effect of presynaptic spikes on the timing of postsynaptic spikes. We show through simulation that such memories are competent analog autoassociators and demonstrate directly that the attributes of phase response curves of CA3 pyramidal cells recorded in vitro qualitatively conform with the theory.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of London; University College London; University of Oxford	Lengyel, M (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	lmate@gatsby.ucl.ac.uk	Paulsen, Ole/ABB-4843-2020; Lengyel, Mate/A-6665-2013	Paulsen, Ole/0000-0002-2258-5455; Lengyel, Mate/0000-0001-7266-0049; Dayan, Peter/0000-0003-3476-1839				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; [Anonymous], 1998, NEURAL NETWORKS BRAI; BAIRD B, 1990, PHYSICA D, V42, P365, DOI 10.1016/0167-2789(90)90089-8; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; ENGEL A, 1989, EUROPHYS LETT, V8, P393, DOI 10.1209/0295-5075/8/4/016; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P225, DOI 10.1162/neco.1994.6.2.225; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hendin O, 1998, J COMPUT NEUROSCI, V5, P157, DOI 10.1023/A:1008813915992; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huhn Z, 2005, HIPPOCAMPUS, V15, P950, DOI 10.1002/hipo.20112; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LI Z, 1995, MODELS NEURAL NETWOR, V2, P221; Li ZP, 2000, NETWORK-COMP NEURAL, V11, P83, DOI 10.1088/0954-898X/11/1/305; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MACKAY DJC, 1991, FUND THEOR, V43, P237; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Scarpetta S, 2002, NEURAL COMPUT, V14, P2371, DOI 10.1162/08997660260293265; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sommer FT, 1998, IEEE T NEURAL NETWOR, V9, P705, DOI 10.1109/72.701183; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TREVES A, 1990, PHYS REV A, V42, P2418, DOI 10.1103/PhysRevA.42.2418; Wang DL, 1990, NEURAL COMPUT, V2, P94, DOI 10.1162/neco.1990.2.1.94	50	90	92	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1677	1683		10.1038/nn1561	http://dx.doi.org/10.1038/nn1561			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261136				2022-12-24	WOS:000233576200015
J	Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M				Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M			Independence of luminance and contrast in natural scenes and in the early visual system	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; LIGHT ADAPTATION; RECEPTIVE-FIELD; IMAGE-CONTRAST; SPATIAL SCALE; GAIN-CONTROL; CAT; NEURONS; STATISTICS	The early visual system is endowed with adaptive mechanisms that rapidly adjust gain and integration time based on the local luminance ( mean intensity) and contrast ( standard deviation of intensity relative to the mean). Here we show that these mechanisms are matched to the statistics of the environment. First, we measured the joint distribution of luminance and contrast in patches selected from natural images and found that luminance and contrast were statistically independent of each other. This independence did not hold for artificial images with matched spectral characteristics. Second, we characterized the effects of the adaptive mechanisms in lateral geniculate nucleus (LGN), the direct recipient of retinal outputs. We found that luminance gain control had the same effect at all contrasts and that contrast gain control had the same effect at all mean luminances. Thus, the adaptive mechanisms for luminance and contrast operate independently, reflecting the very independence encountered in natural images.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA	The Smith-Kettlewell Eye Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	matteo@ski.org	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008; Bonin, Vincent/AAQ-3833-2020	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Bonin, Vincent/0000-0002-9437-8092; Geisler, Wilson/0000-0003-4630-6614	NEI NIH HHS [R01EY11747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011747] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BONIN V, IN PRESS J NEUROSCI; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; DERRINGTON AM, 1982, J PHYSIOL-LONDON, V333, P343, DOI 10.1113/jphysiol.1982.sp014457; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; LANKHEET MJM, 1993, VISION RES, V33, P1153, DOI 10.1016/0042-6989(93)90205-B; LANKHEET MJM, 1991, VISION RES, V31, P1129, DOI 10.1016/0042-6989(91)90039-8; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LENNIE P, 1980, VISION RES, V20, P561, DOI 10.1016/0042-6989(80)90115-7; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; Rodieck R.W., 1998, 1 STEPS SEEING; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sahani M, 2003, ADV NEURAL INFORM PR, P125; SAITO H, 1986, VISION RES, V26, P391, DOI 10.1016/0042-6989(86)90182-3; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SHAPLEY R, 1986, VISION RES, V26, P45, DOI 10.1016/0042-6989(86)90070-2; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shapley RM, 1993, CONTRAST SENSITIVITY; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; TROY JB, 1993, EXP BRAIN RES, V93, P383; Troy JB, 1999, VISUAL NEUROSCI, V16, P1089, DOI 10.1017/S0952523899166094; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	42	267	268	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1690	1697		10.1038/nn1556	http://dx.doi.org/10.1038/nn1556			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286933				2022-12-24	WOS:000233576200017
J	Eaton, BA; Davis, GW				Eaton, BA; Davis, GW			LIM Kinase1 controls synaptic stability downstream of the type IIBMP receptor	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; MOTOR-NEURON DEGENERATION; DEVELOPING NERVOUS-SYSTEM; TUMOR-SUPPRESSOR GENE; WISHFUL-THINKING; II RECEPTOR; IN-VIVO; PRESYNAPTIC TERMINALS; SIGNAL-TRANSDUCTION; ZINC-FINGER	Here, we demonstrate that the BMP receptor Wishful Thinking (Wit) is required for synapse stabilization. In the absence of BMP signaling, synapse disassembly and retraction ensue. Remarkably, downstream Smad-mediated signaling cannot fully account for the stabilizing activity of the BMP receptor. We identify LIM Kinase1 (DLIMK1)-dependent signaling as a second, parallel pathway that confers the added synapse-stabilizing activity of the BMP receptor. We show that DLIMK1 binds a region of the Wit receptor that is necessary for synaptic stability but is dispensable for Smad-mediated synaptic growth. A genetic analysis demonstrates that DLIMK1 is necessary, presynaptically, for synapse stabilization, but is not necessary for normal synaptic growth or function. Furthermore, presynaptic expression of DLIMK1 in a wit or mad mutant significantly rescues synaptic stability, growth, and function. DLIMK1 localizes near synaptic micro-tubules and functions independently of ADF/cofilin, highlighting a novel requirement for DLIMK1 during synapse stabilization rather than actin-dependent axon outgrowth.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047342] Funding Source: NIH RePORTER; NINDS NIH HHS [NS047342] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CARONI P, 1992, J NEUROSCI, V12, P3849; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; CHENG AK, 1995, MECH DEVELOP, V52, P187, DOI 10.1016/0925-4773(95)00400-U; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; CRAYMER L, 1980, DROSOPH INF SERV, V55, P200; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Endo M, 2003, J NEUROSCI, V23, P2527; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Horch HW, 1999, NEURON, V23, P353; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Keshishian H, 2002, NEURON, V33, P491, DOI 10.1016/S0896-6273(02)00597-4; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lom B, 1999, J NEUROSCI, V19, P9928; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MIZUNO K, 1994, ONCOGENE, V9, P1605; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; PROSCHEL C, 1995, ONCOGENE, V11, P1271; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Stewart BA, 1996, J NEUROSCI, V16, P3877; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; Wu GY, 1999, J NEUROSCI, V19, P4472; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang EJ, 2004, J BIOL CHEM, V279, P8903, DOI 10.1074/jbc.M311913200; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	69	129	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					695	708		10.1016/j.neuron.2005.08.010	http://dx.doi.org/10.1016/j.neuron.2005.08.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129399	Bronze			2022-12-24	WOS:000231782700011
J	Thiagarajan, TC; Lindskog, M; Tsien, RW				Thiagarajan, TC; Lindskog, M; Tsien, RW			Adaptation to synaptic inactivity in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; GLUTAMATE-RECEPTOR SUBUNITS; AMPA RECEPTORS; QUANTAL SIZE; CREB PHOSPHORYLATION; NMDA RECEPTORS; CA2+ CHANNELS; EXPRESSION; RELEASE; PLASTICITY	In response to activity deprivation, CNS neurons undergo slow adaptive modification of unitary synaptic transmission. The changes are comparable in degree to those induced by brief intense stimulation, but their molecular basis is largely unknown. Our data indicate that prolonged AMPAR blockade acts through loss of Ca2+ entry through L-type Ca2+ channels to bring about an increase in both vesicle pool size and turnover rate, as well as a postsynaptic enhancement of the contribution of GluR1 homomers, concentrated at the largest synapses. The changes were consistent with a morphological scaling of overall synapse size, but also featured a dramatic shift toward synaptic drive contributed by the Ca2+-permeable homomeric GluR1 receptors. These results extend beyond "synaptic homeostasis" to involve more profound changes that can be better described as "metaplasticity."	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Beckman Ctr, Stanford, CA 94305 USA.	rwtsien@stanford.edu	Lindskog, Maria/F-1729-2011	Lindskog, Maria/0000-0002-4178-2825				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; De Sarro G, 2005, CURR TOP MED CHEM, V5, P31; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Eid T, 2002, EUR J NEUROSCI, V15, P517, DOI 10.1046/j.0953-816x.2001.01887.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Glavinovic MI, 1998, PFLUG ARCH EUR J PHY, V435, P193; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Johnston Tom H, 2004, Curr Opin Investig Drugs, V5, P720; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kingsbury TJ, 2003, J BIOL CHEM, V278, P40744, DOI 10.1074/jbc.M303082200; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; PASCHEN W, 1995, J NEUROSCI METH, V56, P21, DOI 10.1016/0165-0270(94)00085-U; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Perucca E, 1997, PHARMACOL RES, V35, P241, DOI 10.1006/phrs.1997.0124; Pickard L, 2000, J NEUROSCI, V20, P7922; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; TAVERNA FA, 1994, EUR J PHARM-MOLEC PH, V267, pR3, DOI 10.1016/0922-4106(94)90161-9; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Washburn MS, 1997, J NEUROSCI, V17, P9393; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Ying Z, 1998, BRAIN RES, V798, P239, DOI 10.1016/S0006-8993(98)00421-1	67	380	388	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					725	737		10.1016/j.neuron.2005.06.037	http://dx.doi.org/10.1016/j.neuron.2005.06.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129401	Bronze			2022-12-24	WOS:000231782700013
J	Huberman, AD; Murray, KD; Warland, DK; Feldheim, DA; Chapman, B				Huberman, AD; Murray, KD; Warland, DK; Feldheim, DA; Chapman, B			Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PRENATAL DEVELOPMENT; OCULAR DOMINANCE; AXON GUIDANCE; OPTIC TRACT; IN-VITRO; RETINOGENICULATE; SEGREGATION; FERRET; LIGANDS	Axon guidance cues contributing to the development of eye-specific visual projections to the lateral geniculate nucleus (LGN) have not previously been identified. Here we show that gradients of ephrin-As and their receptors (EphAs) direct retinal ganglion cell (RGC) axons from the two eyes into their stereotyped pattern of layers in the LGN. Overexpression of EphAs in ferret RGCs using in vivo electroporation induced axons from both eyes to misproject within the LGN. The effects of EphA overexpression were competition-dependent and restricted to the early postnatal period. These findings represent the first demonstration of eye-specific pathfinding mediated by axon guidance cues and, taken with other reports, indicate that ephrin-As can mediate several mapping functions within individual target structures.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Sinsheimer Labs 225, Santa Cruz, CA 95064 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Santa Cruz	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95616 USA.	bxchapman@ucdavis.edu			NEI NIH HHS [EY11369, P30 EY012576, R01 EY011369-11, EY015387, EY14689-01, EY12576, R01 EY014689, T32 EY015387, R01 EY011369] Funding Source: Medline; NINDS NIH HHS [R01 NS039094, NS39094] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012576, R01EY014689, T32EY015387, R01EY011369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039094] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CUCCHIARO JB, 1991, J COMP NEUROL, V312, P193, DOI 10.1002/cne.903120203; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GUILLERY RW, 1971, J COMP NEUROL, V143, P73, DOI 10.1002/cne.901430106; GUILLERY RW, 1973, SCIENCE, V179, P1014, DOI 10.1126/science.179.4077.1014; GUILLERY RW, 1982, J NEUROSCI, V2, P714; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; Hayes SG, 2003, J COMP NEUROL, V463, P45, DOI 10.1002/cne.10749; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; JEFFERY G, 1985, NATURE, V313, P575, DOI 10.1038/313575a0; JEFFERY G, 1989, DEV BRAIN RES, V46, P187, DOI 10.1016/0165-3806(89)90282-4; JOHNSON JK, 1993, VISUAL NEUROSCI, V10, P117, DOI 10.1017/S0952523800003266; JONES EG, 2005, THALAMUS REVISITED; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, J NEUROBIOL, V21, P197, DOI 10.1002/neu.480210113; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; THOMPSON I, 1989, J COMP NEUROL, V282, P371; WALSH C, 1985, J NEUROSCI, V5, P3061; WILLIAMS RW, 1994, NATURE, V367, P637, DOI 10.1038/367637a0	50	78	81	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1013	1021		10.1038/nn1505	http://dx.doi.org/10.1038/nn1505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025110	Green Accepted			2022-12-24	WOS:000230760200012
J	Tsuchiya, N; Koch, C				Tsuchiya, N; Koch, C			Continuous flash suppression reduces negative afterimages	NATURE NEUROSCIENCE			English	Article							MOTION-INDUCED BLINDNESS; PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; AFTER-IMAGES; COMPLEMENTARY AFTERIMAGES; INTEROCULAR SUPPRESSION; ADAPTATION; PERCEPTION; AWARENESS; ATTENTION	Illusions that produce perceptual suppression despite constant retinal input are used to manipulate visual consciousness. Here we report on a powerful variant of existing techniques, continuous flash suppression. Distinct images flashed successively at similar to 10 Hz into one eye reliably suppress an image presented to the other eye. The duration of perceptual suppression is at least ten times greater than that produced by binocular rivalry. Using this tool we show that the strength of the negative afterimage of an adaptor was reduced by half when it was perceptually suppressed by input from the other eye. The more completely the adaptor was suppressed, the more strongly the afterimage intensity was reduced. Paradoxically, trial-to-trial visibility of the adaptor did not correlate with the degree of reduction. Our results imply that formation of afterimages involves neuronal structures that access input from both eyes but that do not correspond directly to the neuronal correlates of perceptual awareness.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Computat & Neural Syst Program, M-S 139-74,1200 E Calif Blvd, Pasadena, CA 91125 USA.	naotsu@klab.caltech.edu	; Tsuchiya, Naotsugu/N-8153-2014	Koch, Christof/0000-0001-6482-8067; Tsuchiya, Naotsugu/0000-0003-4216-8701				ALPERN M, 1962, J OPT SOC AM, V52, P219, DOI 10.1364/JOSA.52.000219; ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Blake Randolph, 1995, P17; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BOSSINK CJH, 1993, VISION RES, V33, P1413, DOI 10.1016/0042-6989(93)90047-Z; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hofstoetter C, 2004, CONSCIOUS COGN, V13, P691, DOI 10.1016/j.concog.2004.06.007; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; Koch Christof, 2004, QUEST CONSCIOUSNESS; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LACK LC, 1978, SELECTIVE ATTENTION, P117; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BINOCULAR RIVALTY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; Lou L, 2001, PERCEPTION, V30, P1439, DOI 10.1068/p3127; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; SAKITT B, 1976, VISION RES, V16, P129, DOI 10.1016/0042-6989(76)90089-4; SCHILLER PH, 1994, VISUAL NEUROSCI, V11, P643, DOI 10.1017/S0952523800002960; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Suzuki S, 2003, J EXP PSYCHOL HUMAN, V29, P793, DOI 10.1037/0096-1523.29.4.793; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; Weiskrantz L, 1950, Q J EXP PSYCHOL, V2, P170, DOI 10.1080/17470215008416594; Weiskrantz L, 2002, CONSCIOUS COGN, V11, P568, DOI 10.1016/S1053-8100(02)00015-6; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	50	613	628	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1096	1101		10.1038/nn1500	http://dx.doi.org/10.1038/nn1500			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	15995700				2022-12-24	WOS:000230760200022
J	Holton, KL; Loder, MK; Melikian, HE				Holton, KL; Loder, MK; Melikian, HE			Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization	NATURE NEUROSCIENCE			English	Article							HUMAN DOPAMINE TRANSPORTER; AMINOBUTYRIC-ACID TRANSPORTER; AMPA RECEPTOR TRAFFICKING; TYROSINE PHOSPHORYLATION; MEDIATED INTERNALIZATION; MONOAMINE TRANSPORTERS; RECYCLING COMPARTMENT; PHORBOL ESTERS; EXPRESSION; DRUGS	Neurotransmitter transporters are critical for synaptic neurotransmitter inactivation. Transporter inhibitors markedly increase the duration and magnitude of synaptic transmission, underscoring the importance of transporter activity in neurotransmission. Recent studies indicate that membrane trafficking dynamically governs neuronal transporter cell-surface presentation in a protein kinase C-regulated manner, suggesting that transporter trafficking profoundly affects synaptic signaling. However, the molecular architecture coupling neurotransmitter transporters to the endocytic machinery is not defined. Here, we identify nonclassical, distinct endocytic signals in the dopamine transporter (DAT) that are necessary and sufficient to drive constitutive and protein kinase C-regulated DAT internalization. The DAT internalization signal is conserved across SLC6 neurotransmitter carriers and is functional in the homologous norepinephrine transporter, suggesting that this region is likely to be the endocytic signal for all SLC6 neurotransmitter transporters. The DAT endocytic signal does not conform to classic internalization motifs, suggesting that SLC6 neurotransmitter transporters may have evolved unique endocytic mechanisms.	Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01604 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Melikian, Haley/S-8301-2016	Melikian, Haley/0000-0002-9694-5556	NIDA NIH HHS [R01 DA015169, R01 DA015169-04] Funding Source: Medline; PHS HHS [15169] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; ALI SA, 1995, BIOTECHNIQUES, V18, P746; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Deken SL, 2003, J NEUROSCI, V23, P1563; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Johnson AO, 1996, J CELL BIOL, V135, P1749, DOI 10.1083/jcb.135.6.1749; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; LaRosa FG, 1997, CANCER LETT, V113, P55, DOI 10.1016/S0304-3835(96)04595-8; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; MADSEN KL, 2005, J BIOL CHEM     0317; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Mena MA, 1997, J NEUROCHEM, V69, P1398; Moron JA, 2003, J NEUROSCI, V23, P8480; Quick MW, 2004, J BIOL CHEM, V279, P15961, DOI 10.1074/jbc.M306924200; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schenk James O, 2002, Prog Drug Res, V59, P111; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Whitworth TL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0003.2002; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	43	102	105	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					881	888		10.1038/nn1478	http://dx.doi.org/10.1038/nn1478			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924135	Green Accepted			2022-12-24	WOS:000230137100015
J	Le, N; Nagarajan, R; Wang, JYT; Svaren, J; LaPash, C; Araki, T; Schmidt, RE; Milbrandt, J				Le, N; Nagarajan, R; Wang, JYT; Svaren, J; LaPash, C; Araki, T; Schmidt, RE; Milbrandt, J			Nab proteins are essential for peripheral nervous system myelination	NATURE NEUROSCIENCE			English	Article							SCHWANN-CELL DIFFERENTIATION; MARIE-TOOTH DISEASE; NGFI-A; BONE-FORMATION; TRANSCRIPTION; KROX-20; GENE; COREPRESSOR; EXPRESSION; GROWTH	Mutations that disrupt Egr2 transcriptional activity cause severe demyelinating peripheral neuropathies. Here we provide evidence that Nab1 and Nab2 proteins are critical transcriptional modulators of Egr2 in myelinating Schwann cells. Like Egr2, these proteins are essential for Schwann cell differentiation into the myelinating state. Mice lacking both Nab1 and Nab2 show severe congenital hypomyelination of peripheral nerves, with Schwann cell development arresting at the promyelinating stage, despite elevated Egr2 expression. As observed for Egr2, Nab proteins are necessary for Schwann cells to exit the cell cycle, downregulate suppressed cAMP-inducible protein (SCIP) expression and upregulate expression of critical myelination genes. The mRNA expression signature of Schwann cells deficient in both Nab1 and Nab2 is highly similar to that of Egr2-deficient Schwann cells, further indicating that the Egr2/Nab protein complex is a key regulator of the Schwann cell myelination program and that disruption of this transcriptional complex is likely to result in Schwann cell dysfunction in patients with Egr2 mutations.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	jeff@pathbox.wustl.edu	Araki, Toshiyuki/H-4289-2019; Svaren, John/A-1605-2010; LaPash Daniels, Christine/D-3199-2012	Araki, Toshiyuki/0000-0003-3625-2042; Svaren, John/0000-0003-2963-7921; LaPash Daniels, Christine/0000-0001-6797-7551; Wang, James/0000-0003-2711-0827; Milbrandt, Jeffrey/0000-0002-5477-7689	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R37DK019645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010299] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG10299] Funding Source: Medline; NICHD NIH HHS [R01 HD041590] Funding Source: Medline; NIDDK NIH HHS [R37 DK19645, P60 DK20579] Funding Source: Medline; NINDS NIH HHS [NS4074] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; ANGRAND PO, 1999, NUCLEIC ACIDS RES, V27, P16; Bellone E, 1999, Hum Mutat, V14, P353, DOI 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.3.CO;2-W; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Bottomley SS., 1998, AM J HUM GENET, V63, pA352; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; Clements M, 2003, DEV DYNAM, V226, P67, DOI 10.1002/dvdy.10209; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Foley J, 1998, J INVEST DERMATOL, V111, P1122, DOI 10.1046/j.1523-1747.1998.00428.x; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gondre M, 1998, J CELL BIOL, V141, P493, DOI 10.1083/jcb.141.2.493; Grose R, 2002, DEV DYNAM, V223, P371, DOI 10.1002/dvdy.10064; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Kurihara S, 2002, NEUROEPIDEMIOLOGY, V21, P246, DOI 10.1159/000065643; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Levi G, 1996, DEVELOPMENT, V122, P113; LUPSKI JR, 1997, HOSP PRACT OFF ED, V32, P84; LUPSKI JR, 1997, HOSP PRACT, V32, P89; LUPSKI JR, 1997, HOSP PRACT, V32, P94; Magyar JP, 1996, J NEUROSCI, V16, P5351; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; Morocutti C, 2002, NEUROEPIDEMIOLOGY, V21, P241, DOI 10.1159/000065642; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nagasawa K, 2001, CURR DRUG METAB, V2, P355, DOI 10.2174/1389200013338243; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venken K, 2002, NEUROGENETICS, V4, P37, DOI 10.1007/s10048-001-0124-2; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Werner T, 2000, Methods Mol Biol, V132, P337; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	100	100	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					932	940		10.1038/nn1490	http://dx.doi.org/10.1038/nn1490			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136673				2022-12-24	WOS:000230137100021
J	Thomas, P; Mortensen, M; Hosie, AM; Smart, TG				Thomas, P; Mortensen, M; Hosie, AM; Smart, TG			Dynamic mobility of functional GABA(A) receptors at inhibitory synapses	NATURE NEUROSCIENCE			English	Article							ADULT-RAT BRAIN; GAMMA-2 SUBUNIT; BENZODIAZEPINE-RECEPTORS; SYNAPTIC-TRANSMISSION; GLYCINE RECEPTORS; BREFELDIN-A; TRAFFICKING; EXPRESSION; SUBTYPES; LOCALIZATION	Importing functional GABA(A) receptors into synapses is fundamental for establishing and maintaining inhibitory transmission and for controlling neuronal excitability. By introducing a binding site for an irreversible inhibitor into the GABA(A) receptor alpha 1 subunit channel lining region that can be accessed only when the receptor is activated, we have determined the dynamics of receptor mobility between synaptic and extrasynaptic locations in hippocampal pyramidal neurons. We demonstrate that the cell surface GABA(A) receptor population shows no fast recovery after irreversible inhibition. In contrast, after selective inhibition, the synaptic receptor population rapidly recovers by the import of new functional entities within minutes. The trafficking pathways that promote rapid importation of synaptic receptors do not involve insertion from intracellular pools, but reflect receptor diffusion within the plane of the membrane. This process offers the synapse a rapid mechanism to replenish functional GABA(A) receptors at inhibitory synapses and a means to control synaptic efficacy.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Mortensen, Martin/0000-0002-5873-7107	Medical Research Council [G0601529] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnes EM, 1996, INT REV NEUROBIOL, V39, P53, DOI 10.1016/S0074-7742(08)60663-7; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Rasmussen H, 2002, MOL CELL NEUROSCI, V19, P201, DOI 10.1006/mcne.2001.1074; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TEHRANI MHJ, 1991, J NEUROCHEM, V57, P1307, DOI 10.1111/j.1471-4159.1991.tb08295.x; Tovar KR, 2002, NEURON, V34, P253; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; VELAZQUEZ JL, 1989, J NEUROSCI, V9, P2163; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	45	132	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					889	897		10.1038/nn1483	http://dx.doi.org/10.1038/nn1483			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951809				2022-12-24	WOS:000230137100016
J	Kreher, SA; Kwon, JY; Carlson, JR				Kreher, SA; Kwon, JY; Carlson, JR			The molecular basis of odor coding in the Drosophila larva	NEURON			English	Article							OLFACTORY SENSORY MAP; ANTENNAL LOBE; MELANOGASTER MEIGEN; NERVOUS-SYSTEM; FLY BRAIN; RECEPTORS; NEURONS; ORGANIZATION; INFORMATION; EXPRESSION	We hive analyzed the molecular basis of odor coding in the Drosophila larva. A subset of Or genes is found to be expressed in larval olfactory receptor neurons (ORNs). Using an in vivo expression system and electrophysiology, we demonstrate that these genes encode functional odor receptors and determine their response spectra with 27 odors. The receptors vary in their breadth of tuning, exhibit both excitation and inhib tion, and show different onset and termination kinetics. An individual receptor appears to transmit signa Is via a single ORN to a single glomerulus in the larval antennal lobe. We provide a spatial map of odor information in the larval brain and find that ORNs with related functional specificity map to related spatial positions. The results show how one family of receptors underlies odor coding in two markedly different olfactory systems; they also provide a molecular mechanism to explain longstanding observations of larval odor discrimination.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu			NIDCD NIH HHS [DC04729] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Cobb M, 1996, GENETICS, V144, P1577; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fox AN, 2002, CHEM SENSES, V27, P453, DOI 10.1093/chemse/27.5.453; Friedrich RW, 2004, NATURE, V430, P511, DOI 10.1038/430511a; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Hertweck H, 1931, Z WISS ZOOL ABT A, V139, P559; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Park Y, 1997, J NEUROBIOL, V33, P199, DOI 10.1002/(SICI)1097-4695(199708)33:2<199::AID-NEU8>3.0.CO;2-Y; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; RODRIGUES V, 1980, OLFACTORY BEHAV DROS; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SIDDIQI O, 1983, OLFACTORY NEUROGENET; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7	52	223	227	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					445	456		10.1016/j.neuron.2005.04.007	http://dx.doi.org/10.1016/j.neuron.2005.04.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882644	Bronze			2022-12-24	WOS:000229011400016
J	He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE				He, F; Ge, WH; Martinowich, K; Becker-Catania, S; Coskun, V; Zhu, WY; Wu, H; Castro, D; Guillemot, F; Fan, GP; de Vellis, J; Sun, YE			A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; EPIDERMAL-GROWTH-FACTOR; ASTROCYTE DIFFERENTIATION; SERINE PHOSPHORYLATION; NEURONAL DIFFERENTIATION; MAXIMAL ACTIVATION; MAMMALIAN BRAIN; GLIAL IDENTITY	During development of the CNS, neurons and glia are generated in a sequential manner. The mechanism underlying the later onset of gliogenesis is poorly understood, although the cytokine-induced Jak-STAT pathway has been postulated to regulate astrogliogenesis. Here, we report that the overall activity of Jak-STAT signaling is dynamically regulated in mouse cortical germinal zone during development. As such, activated STAT1/3 and STAT-mediated transcription are negligible at early, neurogenic stages, when neurogenic factors are highly expressed. At later, gliogenic periods, decreased expression of neurogenic factors causes robust elevation of STAT activity. Our data demonstrate a positive autoregulatory loop whereby STAT1/3 directly induces the expression of various components of the Jak-STAT pathway to strengthen STAT signaling and trigger astrogliogenesis. Forced activation of Jak-STAT signaling leads to precocious astrogliogenesis, and inhibition of this pathway blocks astrocyte differentiation. These observations suggest that autoregulation of the Jak-STAT pathway controls the onset of astrogliogenesis.	Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; MRC National Institute for Medical Research	Sun, YE (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	ysun@mednet.ucla.edu	Martinowich, Keri/F-9841-2012; Castro, Diogo S/I-6217-2016; Wu, Hao/G-4145-2013	Castro, Diogo S/0000-0001-8178-9565; Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929; Fan, Guoping/0000-0001-5235-6410; Martinowich, Keri/0000-0002-5237-0789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405] Funding Source: NIH RePORTER; NICHD NIH HHS [HD006576, P01 HD006576] Funding Source: Medline; NIMH NIH HHS [R01 MH066196] Funding Source: Medline; NINDS NIH HHS [R01 NS044405, NS44405] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bayer S.A., 1991, NEOCORTICAL DEV; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Chambers CB, 2001, DEVELOPMENT, V128, P689; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Li WW, 1998, J NEUROSCI, V18, P8853; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Sun YE, 2003, SEMIN CELL DEV BIOL, V14, P161, DOI 10.1016/S1084-9521(03)00007-7; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Viti J, 2003, J NEUROSCI, V23, P3385; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	49	291	300	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					616	625		10.1038/nn1440	http://dx.doi.org/10.1038/nn1440			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852015	Green Accepted			2022-12-24	WOS:000228895100022
J	Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE				Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE			PI(4,5)P-2 regulates the activation and desensitization of TRPM8 channels through the TRP domain	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRUCTURAL DETERMINANTS; CAPSAICIN RECEPTOR; POTASSIUM CHANNELS; PIP2; INHIBITION; PHOSPHOINOSITIDES; IDENTIFICATION	The subjective feeling of cold is mediated by the activation of TRPM8 channels in thermoreceptive neurons by cold or by cooling agents such as menthol. Here, we demonstrate a central role for phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in the activation of recombinant TRPM8 channels by both cold and menthol. Moreover, we show that Ca2+ influx through these channels activates a Ca2+-sensitive phospholipase C and that the subsequent depletion of PI(4,5)P-2 limits channel activity, serving as a unique mechanism for desensitization of TRPM8 channels. Finally, we find that mutation of conserved positive residues in the highly conserved proximal C-terminal TRP domain of TRPM8 and two other family members, TRPM5 and TRPV5, reduces the sensitivity of the channels for PI(4,5)P-2 and increases inhibition by PI(4,5)P-2 depletion. These data suggest that the TRP domain of these channels may serve as a PI(4,5)P-2-interacting site and that regulation by PI(4,5)P-2 is a common feature of members of the TRP channel family.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Dodier Y, 2004, J BIOL CHEM, V279, P6853, DOI 10.1074/jbc.M310534200; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luzzi V, 1998, J BIOL CHEM, V273, P28657, DOI 10.1074/jbc.273.44.28657; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Ridefelt P, 1998, ANTICANCER RES, V18, P1819; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; SCHAFER K, 1982, J NEUROPHYSIOL, V47, P1017, DOI 10.1152/jn.1982.47.6.1017; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	50	442	470	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					626	634		10.1038/nn1451	http://dx.doi.org/10.1038/nn1451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852009				2022-12-24	WOS:000228895100023
J	Conner, JM; Chiba, AA; Tuszynski, MH				Conner, JM; Chiba, AA; Tuszynski, MH			The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury	NEURON			English	Article							PRIMARY MOTOR CORTEX; ALZHEIMERS-DISEASE; NUCLEUS BASALIS; SOMATOSENSORY CORTEX; MAGNETIC STIMULATION; AUDITORY-CORTEX; DOUBLE-BLIND; REORGANIZATION; RAT; NEURONS	A reorganization of cortical representations is postulated as the basis for functional recovery following many types of nervous system injury. Neuronal mechanisms underlying this form of cortical plasticity are poorly understood. The present study investigated the hypothesis that the basal forebrain cholinergic system plays an essential role in enabling the cortical reorganization required for functional recovery following brain injury. The results demonstrate that functional recovery following cortical injury requires basal forebrain cholinergic mechanisms and suggest that the basis for this recovery is the cholinergic-dependent reorganization of motor representations. These findings raise the intriguing possibility that deficits in cholinergic function may limit functional outcomes following nervous system injury.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Conner, JM (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	jmconner@ucsd.edu			NIA NIH HHS [5P01 AG10435] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010435] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Baxter MG, 2001, METH MOL B, V166, P249; BOOK AA, 1992, BRAIN RES, V590, P350, DOI 10.1016/0006-8993(92)91121-T; CASTROALAMANCOS MA, 1992, EUR J NEUROSCI, V4, P853, DOI 10.1111/j.1460-9568.1992.tb00195.x; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; COHEN LG, 1991, J CLIN NEUROPHYSIOL, V8, P56, DOI 10.1097/00004691-199101000-00007; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; DONOGHUE JP, 1987, BRAIN RES, V408, P367, DOI 10.1016/0006-8993(87)90407-0; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; Geula C, 1996, CEREB CORTEX, V6, P165, DOI 10.1093/cercor/6.2.165; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; JONES TA, 1994, J NEUROSCI, V14, P2140; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas JH, 2000, PROG BRAIN RES, V128, P173; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN BE, 1988, BRAIN RES, V443, P261, DOI 10.1016/0006-8993(88)91620-4; Loubinoux I, 2002, NEUROIMAGE, V15, P26, DOI 10.1006/nimg.2001.0957; Manunta Y, 2004, J NEUROPHYSIOL, V92, P1445, DOI 10.1152/jn.00079.2004; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; MCGEER PL, 1984, NEUROLOGY, V34, P741, DOI 10.1212/WNL.34.6.741; METHERATE R, 1990, SYNAPSE, V6, P133, DOI 10.1002/syn.890060204; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Rouiller EM, 1998, EUR J NEUROSCI, V10, P729, DOI 10.1046/j.1460-9568.1998.00075.x; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893; SMITH ML, 1995, NEUROSCIENCE, V67, P679, DOI 10.1016/0306-4522(95)00076-U; TORRES EM, 1994, NEUROSCIENCE, V63, P95, DOI 10.1016/0306-4522(94)90010-8; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2	53	170	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 21	2005	46	2					173	179		10.1016/j.neuron.2005.03.003	http://dx.doi.org/10.1016/j.neuron.2005.03.003			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848797	Bronze			2022-12-24	WOS:000228674800005
J	Sakurai, T; Nagata, R; Yamanaka, A; Kawamura, H; Tsujino, N; Muraki, Y; Kageyama, H; Kunita, S; Takahashi, S; Goto, K; Koyama, Y; Shioda, S; Yanagisawa, M				Sakurai, T; Nagata, R; Yamanaka, A; Kawamura, H; Tsujino, N; Muraki, Y; Kageyama, H; Kunita, S; Takahashi, S; Goto, K; Koyama, Y; Shioda, S; Yanagisawa, M			Input of orexin/hypocretin by a genetically encoded neurons revealed tracer in mice	NEURON			English	Article							BASAL FOREBRAIN; OREXIN NEURONS; ADENOSINERGIC MODULATION; HYPOCRETIN NEURONS; ACTIVE NEURONS; SLEEP; RAT; EXPRESSION; NARCOLEPSY; HYPOTHALAMUS	The finding of orexin/hypocretin deficiency in narcolepsy patients suggests that this hypothalamic neuropeptide plays a crucial role in regulating sleep/wakefulness states. However, very little is known about the synaptic input of orexin/hypocretin-producing neurons (orexin neurons). We applied a transgenic method to map upstream neuronal populations that have synaptic connections to orexin neurons and revealed that orexin neurons receive input from several brain areas. These include the amygdala, basal forebrain cholinergic neurons, GABAergic neurons in the preoptic area, and serotonergic neurons in the median/paramedian raphe nuclei. Monoamine-containing groups that are innervated by orexin neurons do not receive reciprocal connections, while cholinergic neurons in the basal forebrain have reciprocal connections, which might be important for consolidating wakefulness. Electrophysiological study showed that carbachol excites almost one-third of orexin neurons and inhibits a small population of orexin neurons. These neuroanatomical findings provide important insights into the neural pathways that regulate sleep/ wakefulness states.	Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Lab Animal Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; Japan Sci & Technol Corp, ERATO, Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan; Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; Fukushima Univ, Sch Med, Fac Symbiot Syst Sci, Fukushima 9601295, Japan; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); Showa University; Fukushima Medical University; Fukushima University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan.	stakeshi@md.tsukuba.ac.jp	Yamanaka, Akihiro/F-2914-2011; Oka, Yoshitaka/C-9670-2010; Yamanaka, Akihiro/AAD-8641-2021	Oka, Yoshitaka/0000-0002-3482-3051; Yamanaka, Akihiro/0000-0001-6099-7306; Muraki, Yo/0000-0001-6891-3074				Adrien J, 2002, SLEEP MED REV, V6, P341, DOI 10.1053/smrv.2001.0200; Alam MN, 1999, J PHYSIOL-LONDON, V521, P679, DOI 10.1111/j.1469-7793.1999.00679.x; ALAM MN, 1995, AM J PHYSIOL-REG I, V269, pR1240, DOI 10.1152/ajpregu.1995.269.5.R1240; Benca RM, 2000, BRAIN RES, V879, P130, DOI 10.1016/S0006-8993(00)02761-X; Broberger C, 1998, J COMP NEUROL, V402, P460; Chamberlin NL, 2003, NEUROSCIENCE, V119, P913, DOI 10.1016/S0306-4522(03)00246-X; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Glass JD, 2003, J NEUROSCI, V23, P7451; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Jouvet M, 1999, NEUROPSYCHOPHARMACOL, V21, pS24, DOI 10.1038/sj.npp.1395333; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; KOYAMA Y, 1994, NEUROSCI RES, V19, P31, DOI 10.1016/0168-0102(94)90005-1; Leander P, 1998, J COMP NEUROL, V399, P73; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; McGinty D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1074, DOI 10.2741/1159; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Muraki Y, 2004, J NEUROSCI, V24, P7159, DOI 10.1523/JNEUROSCI.1027-04.2004; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2003, CURR OPIN CLIN NUTR, V6, P353, DOI 10.1097/00075197-200307000-00001; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Satoh S, 2004, NEUROREPORT, V15, P1127, DOI 10.1097/00001756-200405190-00009; Strecker RE, 2000, BEHAV BRAIN RES, V115, P183, DOI 10.1016/S0166-4328(00)00258-8; Szymusiak R, 2000, BEHAV BRAIN RES, V115, P171, DOI 10.1016/S0166-4328(00)00257-6; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; Thakkar MM, 2003, NEUROSCIENCE, V122, P1107, DOI 10.1016/j.neuroscience.2003.08.006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	46	355	367	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					297	308		10.1016/j.neuron.2005.03.010	http://dx.doi.org/10.1016/j.neuron.2005.03.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848807	Bronze			2022-12-24	WOS:000228674800015
J	Niell, CM; Smith, SJ				Niell, CM; Smith, SJ			Functional imaging reveals rapid development of visual response properties in the zebrafish tectum	NEURON			English	Article							IN-VIVO; RETINOTECTAL PROJECTION; SYNAPSE FORMATION; DENDRITIC ARBOR; MAP FORMATION; VERTEBRATE; SYNAPTOGENESIS; PSYCHOPHYSICS; CONNECTIONS; MODULATION	The visual pathway from the retina to the optic tectum in fish and frogs has long been studied as a model for neural circuit formation. Although morphological aspects, such as axonal and dendritic arborization, have been well characterized, less is known about how this translates into functional properties of tectal neurons during development. We developed a system to provide controlled visual stimuli to larval zebrafish, while performing two-photon imaging of tectal neurons loaded with a fluorescent calcium indicator, allowing us to determine visual response properties in intact fish. In relatively mature larvae, we describe receptive field sizes, visual topography, and direction and size selectivity. We also characterize the onset and development of visual responses, beginning when retinal axons first arborize in the tectum. Surprisingly, most of these properties are established soon after dendrite growth and synaptogenesis begin and do not require patterned visual experience or a protracted period of refinement.	Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cell Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	sjsmith@stanford.edu		Smith, Stephen/0000-0002-2290-8701	NINDS NIH HHS [NS043461] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043461] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Baier H, 1996, DEVELOPMENT, V123, P415; Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; Chapman B, 1996, J NEUROSCI, V16, P6443; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Easter SS, 1996, DEV BIOL, V180, P646; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; Fraser S E, 1992, Curr Opin Neurobiol, V2, P83, DOI 10.1016/0959-4388(92)90167-J; Hutson LD, 2002, CURR OPIN NEUROBIOL, V12, P87, DOI 10.1016/S0959-4388(02)00294-5; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; VANEGAS H, 1984, DEV RETINOTECTAL PRO; Westerfield M, 1993, ZEBRAFISH BOOK; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	32	158	161	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					941	951		10.1016/j.neuron.2005.01.047	http://dx.doi.org/10.1016/j.neuron.2005.01.047			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797554	Bronze			2022-12-24	WOS:000228031300014
J	Robinson, JM; Deutsch, C				Robinson, JM; Deutsch, C			Coupled tertiary folding and oligomerization of the T1 domain of Kv channels	NEURON			English	Article							SHAKER K+ CHANNEL; GATED POTASSIUM CHANNEL; TETRAMERIZATION DOMAIN; INACTIVATION; SUBUNIT; BETA; DETERMINANTS; ACTIVATION; INTERFACE; PROTEINS	Acquisition of secondary, tertiary, and quaternary structure is critical to the fabrication, assembly, and function of ion channels, yet the relationship between these biogenic events remains unclear. We now address this issue in voltage-gated K+ channels (Kv) for the T1 domain, an N-terminal Kv recognition domain that is responsible for subfamily-specific, efficient assembly of Kv subunits. This domain forms a 4-fold symmetric tetramer. We have identified residues along the axial T1-T1 interface that are critical for tertiary and quaternary structure, shown that mutations at one end of the axial T1 interface can perturb the crosslinking of an intersubunit cysteine pair at the other end, and demonstrated that tertiary folding and tetramerization of this Kv domain are coupled. A threshold level of tertiary folding is required for monomers to oligomerize. Coupling between tertiary and quaternary structure formation may be a common feature in the biogenesis of multimeric proteins.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	cid@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 52302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hebert DN, 1998, BIOCHEM CELL BIOL, V76, P867, DOI 10.1139/bcb-76-5-867; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; SHEN NV, 1993, NEURON, V11, P67; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	38	45	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					223	232		10.1016/j.neuron.2004.12.043	http://dx.doi.org/10.1016/j.neuron.2004.12.043			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664174				2022-12-24	WOS:000226451500009
J	O'Hagan, R; Chalfie, M; Goodman, MB				O'Hagan, R; Chalfie, M; Goodman, MB			The MEC-4 DEG/ENaC channel of Caenorhabditis elegans touch receptor neurons transduces mechanical signals	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; MECHANOSENSORY TRANSDUCTION; SUBUNIT; PROTEIN; LOCALIZATION; MICROTUBULES; SENSITIVITY; LOCOMOTION; MUTATIONS; SENSATION	Transformation of mechanical energy into ionic currents is essential for touch, hearing and nociception. Although DEG/ENaC proteins are believed to form sensory mechanotransduction channels, the evidence for this role remains indirect. By recording from C. elegans touch receptor neurons in vivo, we found that external force evokes rapidly activating mechanoreceptor currents (MRCs) carried mostly by Na+ and blocked by amiloride-characteristics consistent with direct mechanical gating of a DEG/ENaC channel. Like mammalian Pacinian corpuscles, these neurons depolarized with both positive and negative changes in external force but not with sustained force. Null mutations in the DEG/ENaC gene mec-4 and in the accessory ion channel subunit genes mec-2 and mec-6 eliminated MRCs. In contrast, the genetic elimination of touch neuron-specific microtubules reduced, but did not abolish, MRCs. Our findings link the application of external force to the activation of a molecularly defined metazoan sensory transduction channel.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu; mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019; O'Hagan, Robert/AAE-9789-2020	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030997, GM20997] Funding Source: Medline; NINDS NIH HHS [R01 NS047715-01A1, R01 NS047715] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; ALVAREZBUYLLA R, 1953, AM J PHYSIOL, V172, P237, DOI 10.1152/ajplegacy.1952.172.1.237; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; DIAMOND J, 1958, J PHYSIOL-LONDON, V142, P382, DOI 10.1113/jphysiol.1958.sp006024; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRAY JAB, 1953, J PHYSIOL-LONDON, V122, P610, DOI 10.1113/jphysiol.1953.sp005025; Hardie RC, 2001, J EXP BIOL, V204, P3403; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hoger U, 1997, J NEUROPHYSIOL, V78, P2079, DOI 10.1152/jn.1997.78.4.2079; Hong K, 2000, J NEUROSCI, V20, P2575; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Johnston D., 1995, FDN CELLULAR NEUROPH; JUUSOLA M, 1994, J NEUROPHYSIOL, V72, P3026, DOI 10.1152/jn.1994.72.6.3026; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Mello C, 1995, METHOD CELL BIOL, V48, P451; OTTOSON D, 1964, J PHYSIOL-LONDON, V171, P109, DOI 10.1113/jphysiol.1964.sp007365; PLASTERK RHA, 1995, CAENORHABDITIS ELEGA, P59; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Rankin CH, 2000, J NEUROSCI, V20, P4337; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAVAGE C, 1994, J CELL SCI, V107, P2165; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; ZHANG S, 2004, IN PRESS CURR BIOL; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	40	345	360	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					43	50		10.1038/nn1362	http://dx.doi.org/10.1038/nn1362			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580270				2022-12-24	WOS:000225967600014
J	Emtage, L; Gu, GQ; Hartwieg, E; Chalfie, M				Emtage, L; Gu, GQ; Hartwieg, E; Chalfie, M			Extracellular proteins organize the mechanosensory channel complex in C-elegans touch receptor neurons	NEURON			English	Article							INTEGRIN ADHESION COMPLEXES; MESSENGER-RNA SURVEILLANCE; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; GENE-EXPRESSION; MOLECULAR-BASIS; CELL ADHESION; HAIR-CELLS; MUSCLE; MECHANOTRANSDUCTION	Specialized extracellular matrix (ECM) is associated with virtually every mechanosensory system studied. C. elegans touch receptor neurons have specialized ECM and attach to the surrounding epidermis. The mec-1 gene encodes an ECM protein with multiple EGF and Kunitz domains. MEC-1 is needed for the accumulation of the collagen MEC-5 and other ECM components, attachment, and, separately, for touch sensitivity. MEC-1 and MEC-5 bind to touch processes uniformly and in puncta. These puncta colocalize with and localize the mechanosensory channel complex in the touch neurons. In turn, the production of the MEC-1 and MEC-5 puncta appears to rely on interactions with the neighboring epidermal tissue. These and other observations lead us to propose that extracellular, but not cytoskeletal, tethering of the degenerin channel is needed for mechanosensory transduction. Additionally, our experiments demonstrate an important role of the ECM in organizing the placement of the channel complex.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30997, R37 GM030997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1979, J CELL BIOL, V82, P278, DOI 10.1083/jcb.82.1.278; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; GU G, 1998, THESIS COLUMBIA U NE; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; JOE EH, 1992, NATURE, V356, P333, DOI 10.1038/356333a0; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; McMahon L, 2003, MOL BIOL CELL, V14, P1366, DOI 10.1091/mbc.E02-08-0479; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Taniguchi A, 1998, HUM GENET, V102, P197, DOI 10.1007/s004390050677; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vogel BE, 2001, DEVELOPMENT, V128, P883; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; ZHANG S, 2004, THESIS COLUMBIA U NY; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	48	88	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					795	807		10.1016/j.neuron.2004.11.010	http://dx.doi.org/10.1016/j.neuron.2004.11.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572111	Bronze			2022-12-24	WOS:000225548400008
J	Chavas, J; Forero, ME; Collin, T; Llano, I; Marty, A				Chavas, J; Forero, ME; Collin, T; Llano, I; Marty, A			Osmotic tension as a possible link between GABA(A) receptor activation and intracellular calcium elevation	NEURON			English	Article							GLYCINE-INDUCED DEPOLARIZATION; INHIBITORY SYNAPTIC CURRENTS; REGULATORY VOLUME DECREASE; RAT CEREBELLAR SLICES; DORSAL HORN NEURONS; PURKINJE-CELLS; NEUROBLASTOMA-CELLS; RYANODINE RECEPTORS; HIPPOCAMPAL SLICES; CA1 REGION	Intracellular calcium concentration rises have been reported following activation of GABA(A) receptors in neonatal preparations and attributed to activation of voltage-dependent Ca2+ channels. However, we show that, in cerebellar interneurons, GABA(A) agonists induce a somatodendritic Ca2+ rise that persists at least until postnatal day 20 and is not mediated by depolarization-induced Ca2+ entry. A local Ca2+ elevation can likewise be elicited by repetitive stimulation of presynaptic GABAergic afferent fibers. We find that, following GABA(A) receptor activation, bicarbonate-induced Cl- entry leads to cell depolarization, Cl- accumulation, and osmotic tension. We propose that this tension induces the intracellular Ca2+ rise as part of a regulatory volume decrease reaction. This mechanism introduces an unexpected link between activation of GABA(A) receptors and intracellular Call elevation, which could contribute to activity-driven synaptic plasticity.	Univ Paris 05, CNRS UMR 8118, Lab Physiol Cerebrale, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Marty, A (corresponding author), Univ Paris 05, CNRS UMR 8118, Lab Physiol Cerebrale, 45 Rue St Peres, F-75006 Paris, France.	alain.marty@univ-paris5.fr		Chavas, Joel/0000-0002-3559-5919; forero, maria elisa/0000-0002-2604-7013				BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BASAVAPPA S, 1995, J NEUROSCI, V15, P3662; Basavappa S, 2003, BIOCHEM BIOPH RES CO, V308, P759, DOI 10.1016/S0006-291X(03)01481-5; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borgdorff AJ, 2000, J NEUROPHYSIOL, V83, P81, DOI 10.1152/jn.2000.83.1.81; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Chavas J, 2003, J NEUROSCI, V23, P2019; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eilers J, 2001, J PHYSIOL-LONDON, V536, P429, DOI 10.1111/j.1469-7793.2001.0429c.xd; Franco R, 2000, J NEUROSCI RES, V61, P701, DOI 10.1002/1097-4547(20000915)61:6<701::AID-JNR14>3.3.CO;2-K; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Ishii T, 1996, J PHYSIOL-LONDON, V493, P371, DOI 10.1113/jphysiol.1996.sp021389; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; Kulik A, 2000, J NEUROSCI, V20, P7905; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; Morales-Mulia S, 1998, J NEUROCHEM, V71, P2330; Moran J, 1997, J NEUROSCI RES, V47, P144, DOI 10.1002/(SICI)1097-4547(19970115)47:2<144::AID-JNR3>3.0.CO;2-F; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Pouzat C, 1999, J NEUROSCI, V19, P1675; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SOLTESZ I, 1994, J NEUROSCI, V14, P2365; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takagi S, 2002, NEUROSCI RES, V44, P315, DOI 10.1016/S0168-0102(02)00153-0; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; TRAUTMANN A, 1984, P NATL ACAD SCI-BIOL, V81, P611, DOI 10.1073/pnas.81.2.611; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942	49	41	43	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					701	713		10.1016/j.neuron.2004.11.002	http://dx.doi.org/10.1016/j.neuron.2004.11.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541317	Bronze			2022-12-24	WOS:000225338100015
J	Gao, Y; Deng, KW; Hou, JW; Bryson, JB; Barco, A; Nikulina, E; Spencer, T; Mellado, W; Kandel, ER; Filbin, MT				Gao, Y; Deng, KW; Hou, JW; Bryson, JB; Barco, A; Nikulina, E; Spencer, T; Mellado, W; Kandel, ER; Filbin, MT			Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo	NEURON			English	Article							GILL-WITHDRAWAL REFLEX; NEURITE OUTGROWTH; NOGO RECEPTOR; CORD-INJURY; CYCLIC-AMP; TRANSCRIPTIONAL REGULATION; SENSORY NEURONS; NERVOUS-SYSTEM; GLYCOPROTEIN; GROWTH	Inhibitors in myelin play a major role in preventing spontaneous axonal regeneration after CNS injury. Elevation of cAMP overcomes this inhibition, in a transcription-dependent manner, through the upregulation of Arginase I (Arg I) and increased synthesis of polyamines. Here, we show that the cAMP effect requires activation of the transcription factor cAMP response element binding protein (CREB) to overcome myelin inhibitors; a dominant-negative CREB abolishes the effect, and neurons expressing a constitutively active form of CREB are not inhibited. Activation of CREB is also required for cAMP to upregulate Arg 1, and the ability of constitutively active CREB to overcome inhibition is blocked by an inhibitor of polyamine synthesis. Finally, expression of constitutively active CREB in DRG neurons is sufficient to promote regeneration of subsequently lesioned dorsal column axons. These results indicate that CREB plays a central role in overcoming myelin inhibitors and so encourages regeneration in vivo.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	City University of New York (CUNY) System; Hunter College (CUNY); Columbia University; Howard Hughes Medical Institute; Columbia University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Barco, Angel/ABF-1864-2021; Barco, Angel/C-3062-2008; Spencer, Tim/AAK-2094-2020	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751; Bryson, J. Barney/0000-0001-5486-0258	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037060, U54NS041073, R01NS037060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37060, NS 41073] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BONIECE IR, 1993, J NEUROSCI, V13, P4220; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch F, 1998, J NEUROSCI, V18, P4083; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gao Y, 2003, J NEUROSCI, V23, P11770; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; KUPFERMANN I, 1970, SCIENCE, V167, P1743, DOI 10.1126/science.167.3926.1743; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	48	271	287	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					609	621		10.1016/j.neuron.2004.10.030	http://dx.doi.org/10.1016/j.neuron.2004.10.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541310	Bronze			2022-12-24	WOS:000225338100008
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M				Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M			Astrocyte-mediated control of cerebral blood flow	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL HYPEREMIA; PHOSPHOLIPASE A(2); BRAIN ACTIVATION; ARACHIDONIC-ACID; CALCIUM; RAT; CYCLOOXYGENASE-1; INDOMETHACIN; INHIBITION; METABOLISM	Local increase in blood flow during neural activity forms the basis for functional brain imaging, but its mechanism remains poorly defined. Here we show that cortical astrocytes in vivo possess a powerful mechanism for rapid vasodilation. We imaged the activity of astrocytes labeled with the calcium ( Ca2+)-sensitive indicator rhod-2 in somatosensory cortex of adult mice. Photolysis of caged Ca2+ in astrocytic endfeet ensheathing the vessel wall was associated with an 18% increase in arterial cross-section area that corresponded to a 37% increase in blood flow. Vasodilation occurred with a latency of only 1-2 s, and both indomethacin and the cyclooxygenase-1 inhibitor SC-560 blocked the photolysis-induced hyperemia. These observations implicate astrocytes in the control of local microcirculation and suggest that one of their physiological roles is to mediate vasodilation in response to increased neural activity.	Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Jagiellonian Univ, Dept Neurosurg, Krakow, Poland	University of Rochester; Jagiellonian University	Takano, T (corresponding author), Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Takahiro_Takano@URMC.Rochester.edu		Takano, Takahiro/0000-0002-6235-6673				Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Bakalova RA, 2002, PROSTAG LEUKOTR ESS, V67, P379, DOI 10.1054/plef.2002.0445; Bruhn H, 2001, J MAGN RESON IMAGING, V13, P325, DOI 10.1002/jmri.1047; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; DAVALOS D, 2005, NAT NEUROSCI; del Zoppo GJ, 2000, THROMB RES, V98, pV73; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; ELLIS EF, 1979, AM J PHYSIOL, V237, pH381, DOI 10.1152/ajpheart.1979.237.3.H381; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; GORDON EL, 1995, J NEUROSURG, V83, P875, DOI 10.3171/jns.1995.83.5.0875; Grossman M, 2003, NEUROPSYCHOLOGY, V17, P658, DOI 10.1037/0894-4105.17.4.658; Hademenos GJ, 1996, NEUROSURGERY, V38, P1005, DOI 10.1097/00006123-199605000-00030; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Hirase H, 2005, TRENDS NEUROSCI, V28, P217, DOI 10.1016/j.tins.2005.03.002; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Rombouts SARB, 2002, J NEUROL NEUROSUR PS, V73, P665, DOI 10.1136/jnnp.73.6.665; SAKABE T, 1979, ACTA PHYSIOL SCAND, V107, P283, DOI 10.1111/j.1748-1716.1979.tb06476.x; Simard M, 2003, J NEUROSCI, V23, P9254; Smith CD, 1999, NEUROLOGY, V53, P1391, DOI 10.1212/WNL.53.7.1391; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	45	794	820	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					260	267		10.1038/nn1623	http://dx.doi.org/10.1038/nn1623			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388306				2022-12-24	WOS:000234990100022
J	Wong, KY; Dunn, FA; Berson, DM				Wong, KY; Dunn, FA; Berson, DM			Photoreceptor adaptation in intrinsically photosensitive retinal ganglion cells	NEURON			English	Article							PUPILLARY LIGHT REFLEX; SUPRACHIASMATIC NUCLEUS; MAMMALIAN PINEAL; DARK-ADAPTATION; VISUAL PATHWAY; PHASE-SHIFTS; TIME-SCALE; MELANOPSIN; SENSITIVITY; RESPONSES	A rare type of mammalian retinal ganglion cell (RGC) expresses the photopigment melanopsin and is a photoreceptor. These intrinsically photosensitive RGCs (ipRGCs) drive circadian-clock resetting, pupillary constriction, and other non-image-forming photic responses. Both the light responses of ipRGCs and the behaviors they drive are remarkably sustained, raising the possibility that, unlike rods and cones, ipRGCs do not adjust their sensitivity according to lighting conditions ("adaptation"). We found, to the contrary, that ipRGC sensitivity is plastic, strongly influenced by lighting history. When exposed to a constant, bright background, the background-evoked response decayed, and responses to superimposed flashes grew in amplitude, indicating light adaptation. After extinction of a light-adapting background, sensitivity recovered progressively in darkness, indicating dark adaptation. Because these adjustments in sensitivity persisted when synapses were blocked, they constitute "photoreceptor adaptation" rather than "network adaptation." Implications for the mechanisms generating various non-image-forming visual responses are discussed.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Wong, KY (corresponding author), Brown Univ, Dept Neurosci, 190 Thayer St,Box 1953, Providence, RI 02912 USA.	kwoon_wong@brown.edu		Wong, Kwoon/0000-0001-9279-7827	NEI NIH HHS [R01 EY017137, T01 EY102793, F32 EY016678] Funding Source: Medline; NIMH NIH HHS [5 T32 MH19118] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY016678, R01EY017137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; Behn D, 2003, DOC OPHTHALMOL, V106, P153, DOI 10.1023/A:1022511918823; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; CERVETTO L, 1985, EXP BIOL, V44, P147; Coogan AN, 2005, EUR J NEUROSCI, V22, P158, DOI 10.1111/j.1460-9568.2005.04193.x; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dowling J. E., 1987, RETINA APPROACHABLE; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; Gomez MD, 1997, J GEN PHYSIOL, V109, P371, DOI 10.1085/jgp.109.3.371; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Lisman JE, 2002, ADV EXP MED BIOL, V514, P507; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; MARTIN C, 1990, J NEURAL TRANSM-GEN, V79, P81, DOI 10.1007/BF01251003; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MEIJER JH, 1992, BRAIN RES, V598, P257, DOI 10.1016/0006-8993(92)90191-B; Meijer JH, 1998, J NEUROSCI, V18, P9078; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; OHBA N, 1972, VISION RES, V12, P953, DOI 10.1016/0042-6989(72)90017-X; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PERLMAN I, 1978, J PHYSIOL-LONDON, V278, P161, DOI 10.1113/jphysiol.1978.sp012298; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Rodieck R.W., 1998, 1 STEPS SEEING; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; SHIMOMURA K, 1994, J BIOL RHYTHM, V9, P97, DOI 10.1177/074873049400900201; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; THIELE G, 1987, BRAIN RES, V424, P10, DOI 10.1016/0006-8993(87)91187-5; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; Van Gelder R N, 2001, Ophthalmic Genet, V22, P195, DOI 10.1076/opge.22.4.195.2215; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x	57	155	161	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1001	1010		10.1016/j.neuron.2005.11.016	http://dx.doi.org/10.1016/j.neuron.2005.11.016			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364903	Bronze			2022-12-24	WOS:000234301700015
J	Safo, PK; Regehr, WG				Safo, PK; Regehr, WG			Endocannabinoids control the induction of cerebellar LTD	NEURON			English	Article							LONG-TERM DEPRESSION; NITRIC-OXIDE RELEASE; METABOTROPIC GLUTAMATE RECEPTORS; PHOSPHOLIPASE-C-BETA; ENDOGENOUS CANNABINOIDS; PURKINJE-CELLS; PARALLEL FIBERS; SYNAPTIC-TRANSMISSION; RETROGRADE INHIBITION; PRESYNAPTIC INHIBITION	The long-term depression (LTD) of parallel fiber (PF) synapses onto Purkinje cells plays a central role in motor learning. Endocannabinoid release and LTD induction both depend upon activation of the metabotropic glutamate receptor mGluR1, require postsynaptic calcium increases, are synapse specific, and have a similar dependence on the associative activation of PF and climbing fiber synapses. These similarities suggest that endocannabinoid release could account for many features of cerebellar LTD. Here we show that LTD induction is blocked by a cannabinoid receptor (CB1R) antagonist, by inhibiting the synthesis of the endocannabinoid 2-arachidonyl glycerol (2-AG), and is absent in mice lacking the CB1R. Although CB1Rs are prominently expressed presynaptically at PF synapses, LTD is expressed postsynaptically. In contrast, a previously described transient form of inhibition mediated by endocannabinoids is expressed presynaptically. This indicates that Purkinje cells release 2-AG that activates CB1Rs to both transiently inhibit release and induce a postsynaptic form of LTD.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044396] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM20444] Funding Source: Medline; NINDS NIH HHS [R01-NS044396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; CARROLL R, 1992, LIPIDS, V27, P305, DOI 10.1007/BF02536481; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dittman JS, 1996, J NEUROSCI, V16, P1623; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hillion P, 1999, J OPT A-PURE APPL OP, V1, P459, DOI 10.1088/1464-4258/1/4/307; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Kimura S, 1998, J NEUROSCI, V18, P8551; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; LevRam V, 1997, LEARN MEMORY, V4, P169, DOI 10.1101/lm.4.1.169; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Namiki S, 2005, J PHYSIOL-LONDON, V566, P849, DOI 10.1113/jphysiol.2005.088799; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; PITLER TA, 1992, J NEUROSCI, V12, P4122; Raymond JL, 1998, J NEUROSCI, V18, P9112; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Shibuki K, 1997, J PHYSIOL-LONDON, V498, P443, DOI 10.1113/jphysiol.1997.sp021870; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stefano GB, 2000, PHARMACOL RES, V42, P317, DOI 10.1006/phrs.2000.0702; Stefano George B, 2003, Med Sci Monit, V9, pRA63; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	87	201	208	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					647	659		10.1016/j.neuron.2005.09.020	http://dx.doi.org/10.1016/j.neuron.2005.09.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301180	Bronze			2022-12-24	WOS:000233677300017
J	Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA				Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA			Inhibitory postsynaptic potentials carry synchronized frequency information in active cortical networks	NEURON			English	Article							RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; NEURONS IN-VIVO; PYRAMIDAL CELLS; SOMATOSENSORY CORTEX; ELECTRICAL SYNAPSES; NEOCORTICAL NEURONS; AUDITORY-CORTEX; CEREBRAL-CORTEX; GABAERGIC INTERNEURONS	Temporal precision in spike timing is important in cortical function, interactions, and plasticity. We found that, during periods of recurrent network activity (UP states), cortical pyramidal cells in vivo and in vitro receive strong barrages of both excitatory and inhibitory postsynaptic potentials, with the inhibitory potentials showing much higher power at all frequencies above approximately 10 Hz and more synchrony between nearby neurons. Fast-spiking inhibitory interneurons discharged strongly in relation to higher-frequency oscillations in the field potential in vivo and possess membrane, synaptic, and action potential properties that are advantageous for transmission of higher-frequency activity. Intracellular injection of synaptic conductances having the characteristics of the recorded EPSPs and IPSPs reveal that IPSPs are Important in controlling the timing and probability of action potential generation in pyramidal cells. Our results support the hypothesis that inhibitory networks are largely responsible for the dissemination of higher-frequency activity in cortex.	Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Kobelt, Liza/F-5926-2011; Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876; Kraushaar, Udo/0000-0002-4660-1093; Haider, Bilal/0000-0002-6382-1426				BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Fellous JM, 2001, J NEUROPHYSIOL, V85, P1782, DOI 10.1152/jn.2001.85.4.1782; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Fregnac Y, 2003, J PHYSIOLOGY-PARIS, V97, P441, DOI 10.1016/j.jphysparis.2004.02.004; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gao WJ, 2003, P NATL ACAD SCI USA, V100, P2836, DOI 10.1073/pnas.262796399; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Varela JA, 1999, J NEUROSCI, V19, P4293; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	60	434	444	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					423	435		10.1016/j.neuron.2005.06.016	http://dx.doi.org/10.1016/j.neuron.2005.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055065	Bronze			2022-12-24	WOS:000231051900012
J	Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA				Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA			Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping	NATURE NEUROSCIENCE			English	Article							BETA-2 SUBUNIT; AXON GUIDANCE; SEGREGATION; PROJECTIONS; RECEPTORS; COMPETITION; REFINEMENT; EXPRESSION; INFUSION; COLUMNS	In mammals, retinal ganglion cell (RGC) projections initially intermingle and then segregate into a stereotyped pattern of eye-specific layers in the dorsal lateral geniculate nucleus (dLGN). Here we found that in mice deficient for ephrin-A2, ephrin-A3 and ephrin-A5, eye-specific inputs segregated but the shape and location of eye-specific layers were profoundly disrupted. In contrast, mice that lacked correlated retinal activity did not segregate eye-specific inputs. Inhibition of correlated neural activity in ephrin mutants led to overlapping retinal projections that were located in inappropriate regions of the dLGN. Thus, ephrin-As and neural activity act together to control patterning of eye-specific retinogeniculate layers.	Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Feldheim, DA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	feldheim@biology.ucsc.edu	Flanagan, John/AAM-2995-2020	Renteria, Rene/0000-0002-4490-0735	NCI NIH HHS [P01 CA23767, P01 CA023767] Funding Source: Medline; NEI NIH HHS [R01 EY014689, EY014689] Funding Source: Medline; NIDCD NIH HHS [R01 DC04209, R01 DC004209] Funding Source: Medline; NIGMS NIH HHS [GM08646, T32 GM008646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Demas J, 2003, J NEUROSCI, V23, P2851; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, CURR BIOL, V10, pR52, DOI 10.1016/S0960-9822(00)00293-1; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; METIN C, 1983, CR ACAD SCI III-VIE, V296, P157; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8	35	143	146	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1022	1027		10.1038/nn1508	http://dx.doi.org/10.1038/nn1508			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025107	Green Accepted			2022-12-24	WOS:000230760200013
J	Zhaoping, L				Zhaoping, L			Border ownership from intracortical interactions in visual area V2	NEURON			English	Article							CONTRAST POLARITY; CORTICAL AREAS; CORTEX; MONKEY; V1; INTEGRATION; MODEL; ATTENTION; NEURONS; CONTEXT	A border between two image regions normally belongs to only one of the regions; determining which one it belongs to is essential for surface perception and figure-ground segmentation. Border ownership is signaled by a class of V2 neurons, even though its value depends on information coming from well outside their classical receptive fields. I use a model of V2 to show that this visual area is able to generate the ownership signal by itself, without requiring any top-down mechanism or external explicit labels for figures, T junctions, or corners. In the model, neurons have spatially local classical receptive fields, are tuned to orientation, and receive information (from V1) about the location and orientation of borders. Border ownership signals that model physiological observations arise through finite range, intraareal interactions. Additional effects from surface features and attention are discussed. The model licenses testable predictions.	UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London	Zhaoping, L (corresponding author), UCL, Dept Psychol, Mortimer St, London WC1E 6BT, England.	z.li@ucl.ac.uk						Angelucci A, 2002, J NEUROSCI, V22, P8633; Bair W, 2003, J NEUROSCI, V23, P7690; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; FINKEL LH, 1994, AM SCI, V82, P224; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; He ZJ, 1998, PERCEPTION, V27, P313, DOI 10.1068/p270313; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; Kikuchi M, 2001, LECT NOTES COMPUT SC, V2130, P1069; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P59, DOI 10.1088/0954-898X/10/1/004; Li ZP, 2001, NEURAL COMPUT, V13, P1749, DOI 10.1162/08997660152469332; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nakayama K, 1995, VISUAL COGNITION INV, P1; Nishimura H, 2004, NEUROCOMPUTING, V58, P843, DOI 10.1016/j.neucom.2004.01.136; Popple AV, 2003, VISION RES, V43, P739, DOI 10.1016/S0042-6989(03)00080-4; Rubin E., 2001, VISUAL PERCEPTION ES, P225; Tamura H, 1996, EUR J NEUROSCI, V8, P300, DOI 10.1111/j.1460-9568.1996.tb01214.x; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; von der Heydt R, 2003, PERCEPTUAL ORGANIZATION IN VISION: BEHAVIORAL AND NEURAL PERSPECTIVES, P281; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4; Zhaoping L, 2002, PHILOS T R SOC B, V357, P1877, DOI 10.1098/rstb.2002.1158; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	29	106	107	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					143	153		10.1016/j.neuron.2005.04.005	http://dx.doi.org/10.1016/j.neuron.2005.04.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996554	Bronze, Green Submitted			2022-12-24	WOS:000230464000014
J	Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP				Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP			Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase E	NEURON			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; SYNAPTIC MODULATION; PATHWAY; CELLS; PROOPIOMELANOCORTIN; IDENTIFICATION	Activity-dependent secretion of BDNF is important in mediating synaptic plasticity, but how it is achieved is unclear. Here we uncover a sorting motif receptor-mediated mechanism for regulated secretion of BDNF. X-ray crystal structure analysis revealed a putative sorting Motif, l(16)E(18)l(105)D(106), in BDNF, which when mutated at the acidic residues resulted in missorting of proBDNF to the constitutive pathway in AtT-20 cells. A V20E mutation to complete a similar motif in NGF redirected a significant proportion of it from the constitutive to the regulated pathway. Modeling and binding studies showed interaction of the acidic residues in the BDNF motif with two basic residues in the sorting receptor, carboxypeptidase E (CPE). S-35 labeling experiments demonstrated that activity dependent secretion of BDNF from cortical neurons was obliterated in CPE knockout mice. Thus, we have identified a mechanism whereby a specific Motif l(16)E(18)l(105)D(106) interacts with CPIE to sort proBDNF into regulated pathway vesicles for activity-dependent secretion.	NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Medivir UK Ltd, Saffron Walden CB10 1XL, Essex, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Medivir	Loh, YP (corresponding author), NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714, Z01HD000056] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BALSCHMIDT P, 1991, ACTA CRYSTALLOGR B, V47, P975, DOI 10.1107/S010876819100842X; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; CAWLEY NX, 2004, BEHAV DEICITS ENDOCR, V145, P5807; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dhanvantari S, 2003, MOL ENDOCRINOL, V17, P1856, DOI 10.1210/me.2002-0380; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Haubensak W, 1998, J CELL SCI, V111, P1483; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Hibbert AP, 2003, J BIOL CHEM, V278, P48129, DOI 10.1074/jbc.M300961200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Loh YP, 2004, J MOL NEUROSCI, V22, P63, DOI 10.1385/JMN:22:1-2:63; LOH YP, 1988, FEBS LETT, V238, P142, DOI 10.1016/0014-5793(88)80244-8; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8; MCDONALD NQ, 1991, J MOL BIOL, V219, P595, DOI 10.1016/0022-2836(91)90655-P; Michael GJ, 1997, J NEUROSCI, V17, P8476; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shen FS, 1999, NEUROPEPTIDES, V33, P276, DOI 10.1054/npep.1999.0045; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Wang LC, 2004, J NEUROENDOCRINOL, V16, P19, DOI 10.1111/j.1365-2826.2004.01110.x; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Zhang CF, 1999, MOL ENDOCRINOL, V13, P527, DOI 10.1210/me.13.4.527; Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827	52	132	140	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					245	255		10.1016/j.neuron.2004.12.037	http://dx.doi.org/10.1016/j.neuron.2004.12.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664176	Bronze			2022-12-24	WOS:000226451500011
J	Xu, PX; Atkinson, R; Jones, DNM; Smith, DP				Xu, PX; Atkinson, R; Jones, DNM; Smith, DP			Drosophila OBP LUSH is required for activity of pheromone-sensitive neurons	NEURON			English	Article							ODORANT-BINDING-PROTEINS; CIS-VACCENYL ACETATE; ANTHERAEA-POLYPHEMUS; MOLECULAR-CLONING; MOTH; MELANOGASTER; FAMILY; SPECIFICITY; EXPRESSION	Odorant binding proteins (OBPs) are extracellular proteins localized to the chemosensory systems of most terrestrial species. OBPs are expressed by nonneuronal cells and secreted into the fluid bathing olfactory neuron dendrites. Several members have been shown to interact directly with odorants, but the significance of this is not clear. We show that the Drosophila OBP lush is completely devoid of evoked activity to the pheromone 11-cis vaccenyl acetate (VA), revealing that this binding protein is absolutely required for activation of pheromone-sensitive chemosensory neurons. lush mutants are also defective for pheromone-evoked behavior. Importantly, we identify a genetic interaction between lush and spontaneous activity in VA-sensitive neurons in the absence of pheromone. The defects in spontaneous activity and VA sensitivity are reversed by germline transformation with a lush transgene or by introducing recombinant LUSH protein into mutant sensilla. These studies directly link pheromone-induced behavior with OBP-dependent activation of a subset of olfactory neurons.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, Dallas, TX 75335 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Program Biomol Struct, Denver, CO 80262 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Smith, DP (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75335 USA.	dean.smith@utsouthwestern.edu	Jones, David N/C-5764-2013	Smith, Dean/0000-0002-4271-0436	NIAAA NIH HHS [R01 AA013618-05, R01 AA013618] Funding Source: Medline; NIDCD NIH HHS [R01 DC002539] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Galindo K, 2001, GENETICS, V159, P1059; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kaissling K.E., 1985, P173; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kim MS, 1998, GENETICS, V150, P711; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Leal WS, 1998, ANN NY ACAD SCI, V855, P301, DOI 10.1111/j.1749-6632.1998.tb10586.x; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STEINBRE.RA, 1971, Z ZELLFORSCH MIK ANA, V117, P570, DOI 10.1007/BF00330716; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; VANDERMEER RK, 1998, PHERMONE COMMUNICATI; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 1991, J NEUROSCI, V11, P2972; Vogt RG, 2003, INSECT PHEROMONE BIO, DOI 10.1016/B978-012107151-6/50016-5; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; WOODARD C, 1989, GENETICS, V123, P315; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7; ZIEGELBERGER G, 1995, EUR J BIOCHEM, V232, P706, DOI 10.1111/j.1432-1033.1995.tb20864.x	53	391	431	6	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					193	200		10.1016/j.neuron.2004.12.031	http://dx.doi.org/10.1016/j.neuron.2004.12.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664171	Bronze			2022-12-24	WOS:000226451500006
J	Lee, H; Simpson, GV; Logothetis, NK; Rainer, G				Lee, H; Simpson, GV; Logothetis, NK; Rainer, G			Phase locking of single neuron activity to theta oscillations during working memory in monkey extrastriate visual cortex	NEURON			English	Article							SHORT-TERM-MEMORY; PRIMATE PREFRONTAL CORTEX; GAMMA-BAND ACTIVITY; MNEMONIC PERSISTENT ACTIVITY; TASK; SYNCHRONIZATION; HUMANS; REPRESENTATION; PERFORMANCE; ASSOCIATION	Working memory has been linked to elevated single neuron discharge in monkeys and to oscillatory changes in the human EEG, but the relation between these effects has remained largely unexplored. We addressed this question by measuring local field potentials and single unit activity simultaneously from multiple electrodes placed in extrastriate visual cortex while monkeys were performing a working memory task. We describe a significant enhancement in theta band energy during the delay period. Theta oscillations had a systematic effect on single neuron activity, with neurons emitting more action potentials near their preferred angle of each theta cycle. Sample-selective delay activity was enhanced if only action potentials emitted near the preferred theta angle were considered. Our results suggest that extrastriate visual cortex is involved in short-term maintenance of information and that theta oscillations provide a mechanism for structuring the recurrent interaction between neurons in different brain regions that underlie working memory.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	Max Planck Society; University of California System; University of California San Francisco	Rainer, G (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	gregor.rainer@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Rainer, Gregor/B-5876-2012	Rainer, Gregor/0000-0002-5805-2220				Abeles M., 1982, LOCAL CORTICAL CIRCU; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Funahashi S, 2002, REV NEUROSCIENCE, V13, P313; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Gundel Alexander, 1992, Brain Topography, V5, P17, DOI 10.1007/BF01129966; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kaiser J, 2003, NEUROIMAGE, V20, P816, DOI 10.1016/S1053-8119(03)00350-1; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2002, NEUROSCIENTIST, V8, P6, DOI 10.1177/107385840200800104; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rols G, 2001, VISUAL NEUROSCI, V18, P527, DOI 10.1017/S0952523801184038; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; STARN CJ, 2002, INT J PSYCHOPHYSIOL, V46, P53; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Worden MS, 2000, J NEUROSCI, V20	56	274	278	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					147	156		10.1016/j.neuron.2004.12.025	http://dx.doi.org/10.1016/j.neuron.2004.12.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629709	Bronze			2022-12-24	WOS:000226217100016
J	Lee, SH; Blake, R; Heeger, DJ				Lee, SH; Blake, R; Heeger, DJ			Traveling waves of activity in primary visual cortex during binocular rivalry	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; PERCEPTION; DYNAMICS	When the two eyes view large, dissimilar patterns that induce binocular rivalry, alternating waves of visibility are experienced as one pattern sweeps the other out of conscious awareness. Here we combine psychophysics with functional magnetic resonance imaging to show tight linkage between dynamics of perceptual waves during rivalry and neural events in human primary visual cortex (V1).	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	New York University; New York University; Vanderbilt University	Heeger, DJ (corresponding author), NYU, Dept Psychol, 6 Washington Pl,8th Floor, New York, NY 10003 USA.	david.heeger@nyu.edu	Lee, Sang-Hun/B-9898-2008		NATIONAL EYE INSTITUTE [R01EY012741, R03EY014437] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY014437, EY14437, EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	15	179	181	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					22	23		10.1038/nn1365	http://dx.doi.org/10.1038/nn1365			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580269	Green Accepted			2022-12-24	WOS:000225967600010
J	Bishop, DL; Misgeld, T; Walsh, MK; Gan, WB; Lichtman, JW				Bishop, DL; Misgeld, T; Walsh, MK; Gan, WB; Lichtman, JW			Axon branch removal at developing synapses by axosome shedding	NEURON			English	Article							DEVELOPING NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; POLYNEURONAL INNERVATION; GLIAL-CELLS; ELECTRON-MICROSCOPY; TRANS-ENDOCYTOSIS; SCHWANN-CELLS; NEWBORN RATS; IN-VIVO; ELIMINATION	In many parts of the developing nervous system, the number of axonal inputs to each postsynaptic cell is dramatically reduced. This synapse elimination has been extensively studied at the neuromuscular junction, but how axons are lost is unknown. Here, we combine time-lapse imaging of fluorescently labeled axons and serial electron microscopy to show that axons at neuromuscular junctions are removed by an unusual cellular mechanism. As axons disappear, they shed numerous membrane bound remnants. These "axosomes" contain a high density of synaptic organelles and are formed by engulfment of axon tips by Schwann cells. After this engulfment, the axosome's contents mix with the cytoplasm of the glial cell. Axosome shedding might underlie other forms of axon loss and may provide a pathway for interactions between axons and glia.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Harvard University; Washington University (WUSTL)	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu						Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; Broadie K, 2004, CURR BIOL, V14, pR302, DOI 10.1016/j.cub.2004.03.049; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Conradt B, 2002, NAT CELL BIOL, V4, pE139, DOI 10.1038/ncb0602-e139; DENNIS MJ, 1974, J PHYSIOL-LONDON, V237, P431, DOI 10.1113/jphysiol.1974.sp010490; Denzer K, 2000, J CELL SCI, V113, P3365; ECKENHOFF MF, 1979, J NEUROCYTOL, V8, P623, DOI 10.1007/BF01208513; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Gan WB, 1999, J NEUROSCI METH, V93, P13, DOI 10.1016/S0165-0270(99)00096-5; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; He Y, 2002, J NEUROSCI, V22, P5982; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; KORNELIUSSEN H, 1976, J NEUROCYTOL, V5, P591, DOI 10.1007/BF01175572; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V301, P213, DOI 10.1113/jphysiol.1980.sp013200; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; MILEDI R, 1968, PROC R SOC SER B-BIO, V169, P289, DOI 10.1098/rspb.1968.0012; Nakao J, 1997, J NEUROCHEM, V68, P1853; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Parson SH, 2004, J NEUROSCI RES, V76, P64, DOI 10.1002/jnr.20016; Purves, 1985, PRINCIPLES NEURAL DE; Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; ROSENTHAL JL, 1977, J PHYSIOL-LONDON, V270, P299, DOI 10.1113/jphysiol.1977.sp011953; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wyatt RM, 2003, J NEUROCYTOL, V32, P777, DOI 10.1023/B:NEUR.0000020623.62043.33	50	197	204	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					651	661		10.1016/j.neuron.2004.10.026	http://dx.doi.org/10.1016/j.neuron.2004.10.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541313	Bronze			2022-12-24	WOS:000225338100011
J	Hartmann, B; Ahmadi, S; Heppenstall, PA; Lewin, GR; Schott, C; Borchardt, T; Seeburg, PH; Zeilhofer, HU; Sprengel, R; Kuner, R				Hartmann, B; Ahmadi, S; Heppenstall, PA; Lewin, GR; Schott, C; Borchardt, T; Seeburg, PH; Zeilhofer, HU; Sprengel, R; Kuner, R			The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain	NEURON			English	Article							DORSAL-HORN NEURONS; UP-REGULATION; CENTRAL SENSITIZATION; THERMAL NOCICEPTION; SPATIAL MEMORY; RAT; CORD; HYPERALGESIA; EXPRESSION; PHOSPHORYLATION	Ca2+-permeable AMPA receptors are densely expressed in the spinal dorsal horn, but their functional significance in pain processing is not understood. By disrupting the genes encoding GluR-A or GluR-B, we generated mice exhibiting increased or decreased numbers of Call-permeable AMPA receptors, respectively. Here, we demonstrate that AMPA receptors are critical determinants of nociceptive plasticity and inflammatory pain. A reduction in the number of Ca2+- permeable AMPA receptors and density of AMPA channel currents in spinal neurons of GluR-A-deficient mice is accompanied by a loss of nociceptive plasticity in vitro and a reduction in acute inflammatory hyperalgesia in vivo. In contrast, an increase in spinal Ca2+- permeable AMPA receptors in GluR-B-deficient mice facilitated nociceptive plasticity and enhanced long-lasting inflammatory hyperalgesia. Thus, AMPA receptors are not mere determinants of fast synaptic transmission underlying basal pain sensitivity as previously thought, but are critically involved in activity-dependent changes in synaptic processing of nociceptive inputs.	Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-61054 Erlangen, Germany; Univ Med Berlin, Charite, Clin Anesthesiol & Operat Intensivemed, D-12200 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Heidelberg Univ, Childrens Hosp, Dept Neonatol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Max Planck Society	Kuner, R (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	rohini.kuner@urz.uni-heidelberg.de	Lewin, Gary R/B-8028-2011; Zeilhofer, Hanns Ulrich/A-4600-2008; Kuner, Rohini/AGU-0204-2022	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Lewin, Gary/0000-0002-2890-6352				Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; BORCHARDT T, 2002, KONSTRUKTION MAUSEN; Brown KM, 2002, DEV BRAIN RES, V137, P127, DOI 10.1016/S0165-3806(02)00435-2; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CIRINO G, 1989, EUR J PHARMACOL, V166, P505, DOI 10.1016/0014-2999(89)90364-6; DAVIES J, 1983, EXP BRAIN RES, V49, P280; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Engelman HS, 1999, J NEUROSCI, V19, P2081; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Fang L, 2003, MOL BRAIN RES, V118, P160, DOI 10.1016/j.molbrainres.2003.08.002; Flor H, 2002, EMBO REP, V3, P288, DOI 10.1093/embo-reports/kvf080; Flor H, 2000, Prog Brain Res, V129, P313; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; KOLHEKAR R, 1993, NEUROSCIENCE, V57, P385, DOI 10.1016/0306-4522(93)90070-V; Laird JMA, 2001, PAIN, V90, P97, DOI 10.1016/S0304-3959(00)00394-8; Lee CJ, 2002, NEURON, V35, P135, DOI 10.1016/S0896-6273(02)00729-8; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu CR, 2002, J NEUROSCI, V22, P9522; Ma QP, 1996, PAIN, V67, P307, DOI 10.1016/0304-3959(96)03132-6; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sandkuhler J, 2002, LANCET, V360, P426, DOI 10.1016/S0140-6736(02)09683-6; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tinazzi M, 2000, J NEUROSCI, V20, P9277; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; TOLLE TR, 1993, J NEUROSCI, V13, P5009, DOI 10.1523/JNEUROSCI.13-12-05009.1993; VACCARINO AL, 1992, PAIN, V49, P257, DOI 10.1016/0304-3959(92)90150-A; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; Willis WD, 1997, NEUROREPORT, V8, pR3; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou QQ, 2001, MOL BRAIN RES, V88, P186, DOI 10.1016/S0169-328X(01)00041-9	58	166	175	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					637	650		10.1016/j.neuron.2004.10.029	http://dx.doi.org/10.1016/j.neuron.2004.10.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541312	Green Published, Bronze			2022-12-24	WOS:000225338100010
J	Shen, Q; Wang, Y; Dimos, JT; Fasano, CA; Phoenix, TN; Lemischka, IR; Ivanova, NB; Stifani, S; Morrisey, EE; Temple, S				Shen, Qin; Wang, Yue; Dimos, John T.; Fasano, Christopher A.; Phoenix, Timothy N.; Lemischka, Ihor R.; Ivanova, Natalia B.; Stifani, Stefano; Morrisey, Edward E.; Temple, Sally			The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; STEM-CELLS; CAENORHABDITIS-ELEGANS; NEURAL PROGENITORS; NEURONS ARISE; FERRET CORTEX; SELF-RENEWAL; ZONE CELLS; FATE; SPECIFICATION	In the developing cerebral cortex, neurons are born on a predictable schedule. Here we show in mice that the essential timing mechanism is programmed within individual progenitor cells, and its expression depends solely on cell-intrinsic and environmental factors generated within the clonal lineage. Multipotent progenitor cells undergo repeated asymmetric divisions, sequentially generating neurons in their normal in vivo order: first preplate cells, including Cajal-Retzius neurons, then deep and finally superficial cortical plate neurons. As each cortical layer arises, stem cells and neuroblasts become restricted from generating earlier-born neuron types. Growth as neurospheres or in co-culture with younger cells did not restore their plasticity. Using short-hairpin RNA (shRNA) to reduce Foxg1 expression reset the timing of mid- but not late-gestation progenitors, allowing them to remake preplate neurons and then cortical-plate neurons. Our data demonstrate that neural stem cells change neuropotency during development and have a window of plasticity when restrictions can be reversed.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Mol Cardiol Res Ctr, Philadelphia, PA 19104 USA	Albany Medical College; Princeton University; McGill University; University of Pennsylvania; University of Pennsylvania	Shen, Q (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	shenq@mail.amc.edu		Stifani, Stefano/0000-0002-2376-7701	NINDS NIH HHS [R37NS033529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bayer S.A., 1991, NEOCORTICAL DEV; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Desai AR, 2000, DEVELOPMENT, V127, P2863; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Isshiki T, 2004, CELL CYCLE, V3, P296; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Morrow T, 2001, DEVELOPMENT, V128, P3585; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Polleux F, 1997, J COMP NEUROL, V385, P95; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133	46	436	450	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					743	751		10.1038/nn1694	http://dx.doi.org/10.1038/nn1694			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680166				2022-12-24	WOS:000237895200014
J	Kwon, CH; Luikart, BW; Powell, CM; Zhou, J; Matheny, SA; Zhang, W; Li, YJ; Baker, SJ; Parada, LF				Kwon, Chang-Hyuk; Luikart, Bryan W.; Powell, Craig M.; Zhou, Jing; Matheny, Sharon A.; Zhang, Wei; Li, Yanjiao; Baker, Suzanne J.; Parada, Luis F.			Pten regulates neuronal arborization and social interaction in mice	NEURON			English	Article							TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR; MOLECULAR-GENETICS; COWDEN-SYNDROME; PROTEIN-KINASE; MOUSE MODEL; SOMA SIZE; AUTISM; PATHWAY; BRAIN	CNS deletion of Pten in the mouse has revealed its roles in controlling cell size and number, thus providing compelling etiology for macrocephaly and Lhermitte-Duclos disease. PTEN mutations in individuals with autism spectrum disorders (ASD) have also been reported, although a causal link between PTEN and ASD remains unclear. In the present study, we deleted Pten in limited differentiated neuronal populations in the cerebral cortex and hippocampus of mice. Resulting mutant mice showed abnormal social interaction and exaggerated responses to sensory stimuli. We observed macrocephaly and neuronal hypertrophy, including hypertrophic and ectopic dendrites and axonal tracts with increased synapses. This abnormal morphology was associated with activation of the Akt/mTor/S6k pathway and inactivation of Gsk3 beta. Thus, our data suggest that abnormal activation of the PI3K/AKT pathway in specific neuronal populations can underlie macrocephaly and behavioral abnormalities reminiscent of certain features of human ASD.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Warfield, Simon/B-3352-2009; Luikart, Bryan/D-2683-2012; Baker, Suzanne J/N-8167-2018; Kwon, Chang-hyuk/E-3450-2011	Warfield, Simon/0000-0002-7659-3880; Powell, Craig/0000-0001-5451-2165	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081164, K08MH065975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033199, R01NS044172] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH065975-05, MH06597503, K08 MH065975, K08 MH065975-03, R01 MH081164, K08 MH065975-04] Funding Source: Medline; NINDS NIH HHS [R37NS33199, NS44172, R37 NS033199, R01 NS044172] Funding Source: Medline; Autism Speaks [AS1270] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks		Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; *AM PSYCH ASS, 2000, TASK FORC DMS 4; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Andres C, 2002, BRAIN RES BULL, V57, P109, DOI 10.1016/S0361-9230(01)00642-6; Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cody H, 2002, INT J DEV NEUROSCI, V20, P421, DOI 10.1016/S0736-5748(02)00053-9; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Danscher G, 2004, J HISTOCHEM CYTOCHEM, V52, P1619, DOI 10.1369/jhc.4A6371.2004; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; de Vries P, 2005, EUR CHILD ADOLES PSY, V14, P183, DOI 10.1007/s00787-005-0443-1; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Li G, 2002, DEVELOPMENT, V129, P4159; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marui T, 2004, AM J MED GENET B, V131B, P43, DOI 10.1002/ajmg.b.20119; Mbarek O, 1999, AM J MED GENET, V88, P729, DOI 10.1002/(SICI)1096-8628(19991215)88:6<729::AID-AJMG26>3.3.CO;2-H; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Murcia CL, 2005, INT J DEV NEUROSCI, V23, P265, DOI 10.1016/j.ijdevneu.2004.07.001; Perandones C, 2004, MOL BRAIN RES, V128, P8, DOI 10.1016/j.molbrainres.2004.05.021; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.3.CO;2-F	63	697	712	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					377	388		10.1016/j.neuron.2006.03.023	http://dx.doi.org/10.1016/j.neuron.2006.03.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675393	Bronze, Green Accepted			2022-12-24	WOS:000237726800008
J	Demas, J; Sagdullaev, BT; Green, E; Jaubert-Miazza, L; McCall, MA; Gregg, RG; Wong, ROL; Guido, W				Demas, J; Sagdullaev, BT; Green, E; Jaubert-Miazza, L; McCall, MA; Gregg, RG; Wong, ROL; Guido, W			Failure to maintain eye-specific segregation in nob, a mutant with abnormally patterned retinal activity	NEURON			English	Article							STATIONARY NIGHT BLINDNESS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; VISUAL-SYSTEM DEVELOPMENT; RETINOGENICULATE PATHWAY; MAMMALIAN RETINA; GANGLION-CELLS; POSTNATAL-DEVELOPMENT; ELECTRICAL-ACTIVITY; BURSTING ACTIVITY	Axon terminals from the two eyes initially overlap in the dorsal-lateral geniculate nucleus (dLGN) but subsequently refine to occupy nonoverlapping territories. Retinal activity is required to establish and maintain this segregation. We show that despite the presence of retinal activity, segregated projections desegregate when the structure of activity is altered. Early in development, spontaneous retinal activity in the no b-wave (nob) mouse is indistinguishable from that of wildtype mice, and eye-specific segregation proceeds normally. But, around eye-opening, spontaneous and visually evoked activity in nob retinas become abnormal, coincident with a failure to preserve precise eye-specific territories. Dark-rearing studies suggest that altered visual experience is not responsible. Transgenic rescue of the mutated protein (nyctalopin) within nob retinal interneurons, without rescuing expression in either retinal projection neurons or their postsynaptic targets in the dLGN, restores spontaneous retinal activity patterns and prevents desegregation. Thus, normally structured spontaneous retinal activity stabilizes newly refined retinogeniculate circuitry.	Louisiana State Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40205 USA; Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40205 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Washington University (WUSTL); University of Louisville; University of Louisville	Guido, W (corresponding author), Louisiana State Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA.	wguido@vcu.edu		McCall, Maureen/0000-0002-9781-315X; Gregg, Ronald/0000-0001-5805-224X; Demas, Jay/0000-0001-7678-1905; Sagdullaev, Botir/0000-0002-0611-1479	NEI NIH HHS [R01 EY012354, R01 EY012354-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2004, J NEUROSCI, V24, P170, DOI 10.1523/JNEUROSCI.1002-03.2004; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Bansal A, 2000, J NEUROSCI, V20, P7672; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Candille SI, 1999, INVEST OPHTH VIS SCI, V40, P2748; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Demas J, 2003, J NEUROSCI, V23, P2851; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; GREGG RG, 2005, ARVO ABSTRACTS; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; IHAKA R, 1996, J GRAPHICAL COMPUTAT, V5, P491; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khan NW, 2005, J NEUROPHYSIOL, V93, P481, DOI 10.1152/jn.00365.2004; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; OLNEY JW, 1968, NATURE, V218, P281, DOI 10.1038/218281a0; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Pesch K, 2003, INVEST OPHTH VIS SCI, V44, P2260, DOI 10.1167/iovs.02-0115; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; Sernagor E, 2000, J NEUROSCI, V20, part. no.; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Tagawa Y, 1999, J NEUROSCI, V19, P2568; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 1998, J NEUROSCI, V18, P8839; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	63	99	101	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					247	259		10.1016/j.neuron.2006.03.033	http://dx.doi.org/10.1016/j.neuron.2006.03.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630836	Bronze			2022-12-24	WOS:000237176700012
J	Bacci, A; Huguenard, JR				Bacci, A; Huguenard, JR			Enhancement of spike-timing precision by autaptic transmission in neocortical inhibitory interneurons	NEURON			English	Article							CAT VISUAL-CORTEX; RAT FRONTAL-CORTEX; IN-VIVO; RESPONSE VARIABILITY; FEEDFORWARD INHIBITION; GABAERGIC INTERNEURONS; CORTICAL-NEURONS; PYRAMIDAL CELLS; SYNAPTIC CONNECTIONS; HIPPOCAMPAL-NEURONS	In vivo studies suggest that precise firing of neurons is important for correct sensory representation. Principal neocortical neurons fire imprecisely when repeatedly activated by fixed sensory stimuli or current depolarizations. Here we show that in contrast to pyramidal neurons, firing in neocortical GABAergic fast-spiking (FS) interneurons is quite precise. FS interneurons are self-innervated by powerful GABAergic autaptic connections reliably activated after each spike, suggesting that autapses strongly regulate FS-cell spike timing. Indeed, blockade of autaptic transmission degraded temporal precision in multiple ways. Under these conditions, realistic dynamic-clamp hyperpolarizing autapses restored precision of spike timing, even in the presence of synaptic noise. Furthermore, firing precision was increased in pyramidal neurons by artificial GABAergic autaptic conductances, suggesting that tightly coupled synaptic feedback inhibition regulates spike timing in principal cells. Thus, well-timed inhibition, whether autaptic or synaptic, facilitates precise spike timing and promotes synchronized cortical network oscillations relevant to several behaviors.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Huguenard, JR (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	john.huguenard@stanford.edu	Huguenard, John/K-6429-2019; Huguenard, John/I-5016-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bacci, Alberto/0000-0002-3355-5892	NINDS NIH HHS [NS39579] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039579] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacci A, 2003, J NEUROSCI, V23, P9664; Bacci A, 2003, J NEUROSCI, V23, P859; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Butera RJ, 2001, IEEE T BIO-MED ENG, V48, P1460, DOI 10.1109/10.966605; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fuhrmann G, 2002, J NEUROPHYSIOL, V88, P761, DOI 10.1152/jn.2002.88.2.761; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grothe B, 2000, CURR OPIN NEUROBIOL, V10, P467, DOI 10.1016/S0959-4388(00)00115-X; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Gur M, 1997, J NEUROSCI, V17, P2914; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Reinagel P, 2002, J NEUROSCI, V22, P6837; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stevens CF, 1995, CURR BIOL, V5, P1370, DOI 10.1016/S0960-9822(95)00273-9; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J NEUROSCI, V17, P6352; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740	58	172	175	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					119	130		10.1016/j.neuron.2005.12.014	http://dx.doi.org/10.1016/j.neuron.2005.12.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387644	Bronze			2022-12-24	WOS:000236699300014
J	Horton, AC; Racz, B; Monson, EE; Lin, AL; Weinberg, RJ; Ehlers, MD				Horton, AC; Racz, B; Monson, EE; Lin, AL; Weinberg, RJ; Ehlers, MD			Polarized secretory trafficking directs cargo for asymmetric dendrite growth and morphogenesis	NEURON			English	Article							ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; GOLGI TRANSPORT; PROTEIN GRASP65; CELL-SURFACE; BREFELDIN-A; STACKING; INHIBITION; ORGANELLES; APPARATUS	Proper growth of dendrites is critical to the formation of neuronal circuits, but the cellular machinery that directs the addition of membrane components to generate dendritic architecture remains obscure. Here, we demonstrate that post-Golgi membrane trafficking is polarized toward longer dendrites of hippocampal pyramidal neurons in vitro and toward apical dendrites in vivo. Small Golgi outposts partition selectively into longer dendrites and are excluded from axons. In dendrites, Golgi outposts concentrate at branchpoints where they engage in post-Golgi trafficking. Within the cell body, the Golgi apparatus orients toward the longest dendrite, and this Golgi polarity precedes asymmetric dendrite growth. Manipulations that selectively block post-Golgi trafficking halt dendrite growth in developing neurons and cause a shrinkage of dendrites in mature pyramidal neurons. Further, disruption of Golgi polarity produces neurons with symmetric dendritic arbors lacking a single longest principal dendrite. These results define a novel polarized organization of neuronal secretory trafficking and demonstrate a mechanistic link between directed membrane trafficking and asymmetric dendrite growth.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Phys, Durham, NC 27710 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Neurosci Ctr, Chapel Hill, NC 27599 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Weinberg, Richard/AAC-1898-2020; Rácz, Bence/J-4220-2019	Rácz, Bence/0000-0002-1933-5332; Weinberg, Richard/0000-0001-9689-7278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-35527] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; DASCHER C, 1994, J BIOL CHEM, V269, P1437; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton AC, 2003, J NEUROSCI, V23, P6188; Hu TH, 1999, MOL BIOL CELL, V10, P921, DOI 10.1091/mbc.10.4.921; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jareb M, 1997, J NEUROSCI, V17, P8955; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200	49	313	319	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					757	771		10.1016/j.neuron.2005.11.005	http://dx.doi.org/10.1016/j.neuron.2005.11.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337914	Bronze, Green Published			2022-12-24	WOS:000233927300015
J	Jarsky, T; Roxin, A; Kath, WL; Spruston, N				Jarsky, T; Roxin, A; Kath, WL; Spruston, N			Conditional dendritic spike propagation following distal synaptic activation of hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; CORTEX COMBINED SLICE; ENTORHINAL CORTEX; EXCITATORY SYNAPSES; IN-VITRO; AREA CA1; CELLS; RAT; BACKPROPAGATION; INPUTS	The perforant-path projection to the hippocampus forms synapses in the apical tuft of CA1 pyramidal neurons. We used computer modeling to examine the function of these distal synaptic inputs, which led to three predictions that we confirmed in experiments using rat hippocampal slices. First, activation of CA1 neurons by the perforant path is limited, a result of the long distance between these inputs and the soma. Second, activation of CA1 neurons by the perforant path depends on the generation of dendritic spikes. Third, the forward propagation of these spikes is unreliable, but can be facilitated by modest activation of Schaffer-collateral synapses in the upper apical dendrites. This 'gating' of dendritic spike propagation may be an important activation mode of CA1 pyramidal neurons, and its modulation by neurotransmitters or long-term, activity-dependent plasticity may be an important feature of dendritic integration during mnemonic processing in the hippocampus.	Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Univ Paris 05, CNRS, Unite Mixte Rech 8119, F-75270 Paris, France	Northwestern University; Northwestern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Spruston, N (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, 2205 Tech Dr, Evanston, IL 60208 USA.	spruston@northwestern.edu	Kath, William/B-6771-2009; Jarsky, Tim/S-1879-2019; Roxin, Alex/F-1742-2013	Roxin, Alex/0000-0003-1015-8138; Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783	NINDS NIH HHS [NS-35180, NS-045437, NS-46064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180, F31NS045437, R01NS046064] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1966, EXP BRAIN RES, V2, P247; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUZSAKI G, 1995, HIPPOCAMPUS, V5, P141, DOI 10.1002/hipo.450050210; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; Colbert CM, 1996, J NEUROSCI, V16, P6676; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DESMOND NL, 1994, HIPPOCAMPUS, V4, P594, DOI 10.1002/hipo.450040509; DOLLER HJ, 1982, BRAIN RES, V237, P1, DOI 10.1016/0006-8993(82)90553-4; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; PARE D, 1995, HIPPOCAMPUS, V5, P115, DOI 10.1002/hipo.450050205; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SOLTESZ I, 1995, HIPPOCAMPUS, V5, P120, DOI 10.1002/hipo.450050206; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	44	201	202	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1667	1676		10.1038/nn1599	http://dx.doi.org/10.1038/nn1599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299501				2022-12-24	WOS:000233576200014
J	Zylka, MJ; Rice, FL; Anderson, DJ				Zylka, MJ; Rice, FL; Anderson, DJ			Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd	NEURON			English	Article							GRIFFONIA-SIMPLICIFOLIA I; SUPERFICIAL DORSAL-HORN; PRIMARY SENSORY NEURONS; LECTIN-BINDING ANALYSIS; RAT SPINAL-CORD; MYSTACIAL PAD; COMPREHENSIVE IMMUNOFLUORESCENCE; IMMUNOCYTOCHEMICAL LOCALIZATION; DIFFERENTIAL DEPENDENCY; GENETIC APPROACH	The brain receives sensory input from diverse peripheral tissues, including the skin, the body's largest sensory organ. Using genetically encoded axonal tracers expressed from the Mrgprd locus, we identify a subpopulation of nonpeptidergic, nociceptive neurons that project exclusively to the skin, and to no other peripheral tissue examined. Surprisingly, Mrgprd(+) innervation is restricted to the epidermis and absent from specialized sensory structures. Furthermore, Mrgprd(+) fibers terminate in a specific layer of the epidermis, the stratum granulosum. This termination zone is distinct from that innervated by most CGRP(+) neurons, revealing that peptidergic and nonpeptidergic epidermal innervation is spatially segregated. The central projections deriving from these distinct epidermal innervation zones terminate in adjacent laminae in the dorsal spinal cord. Thus, afferent input from different layers of the epidermis is conveyed by topographically segregated sensory circuits, suggesting that at least some aspects of sensory information processing may be organized along labeled lines.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Albany Medical College; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034692] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34692] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender E, 2002, P NATL ACAD SCI USA, V99, P8573, DOI 10.1073/pnas.122016499; Bennett DL, 1996, NEUROSCI LETT, V206, P33, DOI 10.1016/0304-3940(96)12418-6; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Guo A, 2001, EUR J NEUROSCI, V14, P293, DOI 10.1046/j.0953-816x.2001.01665.x; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MCNEILL DL, 1988, EXP NEUROL, V99, P699, DOI 10.1016/0014-4886(88)90186-0; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Petruska JC, 1997, SOMATOSENS MOT RES, V14, P17, DOI 10.1080/08990229771187; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Rice FL, 1997, J COMP NEUROL, V385, P149; RICE FL, 1993, J COMP NEUROL, V337, P386, DOI 10.1002/cne.903370304; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Ulrich-Lai YM, 2001, AM J PHYSIOL-REG I, V280, pR137, DOI 10.1152/ajpregu.2001.280.1.R137; Wang HF, 1998, BRAIN RES, V811, P34, DOI 10.1016/S0006-8993(98)00916-0; Wang HF, 1998, NEUROSCIENCE, V87, P275, DOI 10.1016/S0306-4522(98)00061-X; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	42	464	470	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					17	25		10.1016/j.neuron.2004.12.015	http://dx.doi.org/10.1016/j.neuron.2004.12.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629699	Bronze			2022-12-24	WOS:000226217100006
J	Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S				Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S			Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation	NATURE NEUROSCIENCE			English	Article							KINASE INHIBITOR P27(KIP1); MYELIN BASIC-PROTEIN; CELL-CYCLE; TRANSLATIONAL REGULATOR; SIGNAL-TRANSDUCTION; ECTOPIC EXPRESSION; STAR PROTEIN; MUTANT MICE; C-ELEGANS; GLD-1	The quaking (Qk) locus expresses a family of RNA binding proteins, and the expression of several alternatively spliced isoforms coincides with the development of oligodendrocytes and the onset of myelination. Quaking viable (Qk(v)) mice harboring an autosomal recessive mutation in this locus have uncompacted myelin in the central nervous system owing to the inability of oligodendrocytes to properly mature. Here we show that the expression of two QKI isoforms, absent from oligodendrocytes of Qk(v) mice, induces cell cycle arrest of primary rat oligodendrocyte progenitor cells and differentiation into oligodendrocytes. Injection of retroviruses expressing QKI into the telencephalon of mouse embryos induced differentiation and migration of multipotential neural progenitor cells into mature oligodendrocytes localized in the corpus callosum. The mRNA encoding the cyclin-dependent kinase (CDK)-inhibitor p27(Kip1) was bound and stabilized by QKI, leading to an increased accumulation of p27(Kip1) protein in oligodendrocytes. Our findings demonstrate that QKI is upstream of p27(Kip1) during oligodendrocyte differentiation.	Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca						ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; [Anonymous], MYELIN; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Colognato H, 2004, CURR OPIN NEUROBIOL, V14, P37, DOI 10.1016/j.conb.2004.01.009; Darnell RB, 2004, ARCH NEUROL-CHICAGO, V61, P30, DOI 10.1001/archneur.61.1.30; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lorenzetti D, 2004, MAMM GENOME, V15, P210, DOI 10.1007/s00335-003-2333-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nery S, 2001, DEVELOPMENT, V128, P527; Okano H, 2002, J CELL SCI, V115, P1355; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Song J, 2001, MOL CELL NEUROSCI, V17, P624, DOI 10.1006/mcne.2001.0974; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhang YY, 2001, J NEUROCHEM, V77, P165, DOI 10.1046/j.1471-4159.2001.00224.x	48	131	134	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					27	33		10.1038/nn1359	http://dx.doi.org/10.1038/nn1359			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568022				2022-12-24	WOS:000225967600012
J	Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P				Storkebaum, E; Lambrechts, D; Dewerchin, M; Moreno-Murciano, MP; Appelmans, S; Oh, H; Van Damme, P; Rutten, B; Man, WY; De Mol, M; Wyns, S; Manka, D; Vermeulen, K; Van den Bosch, L; Mertens, N; Schmitz, C; Robberecht, W; Conway, EM; Collen, D; Moons, L; Carmeliet, P			Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LEUKEMIA INHIBITORY FACTOR; MOTOR-NEURON DEGENERATION; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PROLONGS SURVIVAL; GROWTH-FACTORS; MOUSE; MICE; GENE	Neurotrophin treatment has so far failed to prolong the survival of individuals affected with amyotrophic lateral sclerosis (ALS), an incurable motoneuron degenerative disorder. Here we show that intracerebroventricular (i.c.v.) delivery of recombinant vascular endothelial growth factor (Vegf) in a SOD1(G93A) rat model of ALS delays onset of paralysis by 17 d, improves motor performance and prolongs survival by 22 d, representing the largest effects in animal models of ALS achieved by protein delivery. By protecting cervical motoneurons, i.c.v. delivery of Vegf is particularly effective in rats with the most severe form of ALS with forelimb onset. Vegf has direct neuroprotective effects on motoneurons in vivo, because neuronal expression of a transgene expressing the Vegf receptor prolongs the survival of SOD1(G93A) mice. On i.c.v. delivery, Vegf is anterogradely transported and preserves neuromuscular junctions in SOD1(G93A) rats. Our findings in preclinical rodent models of ALS may have implications for treatment of neurodegenerative disease in general.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium; Katholieke Univ Leuven, Fac Med, Dept Neurol, B-3000 Leuven, Belgium; Maastricht Univ, Dept Psychiat & Neuropsychol, Div Cellular Neurosci, NL-6200 MD Maastricht, Netherlands; European Grad Sch Neurosci EURON, NL-6200 MD Maastricht, Netherlands; State Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Maastricht University; Maastricht University; Flanders Institute for Biotechnology (VIB); Ghent University	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Leuven, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Carmeliet, Peter/AAQ-5140-2020; Lambrechts, Diether/AAJ-3167-2020; Moreno, Paz/K-6870-2012; Storkebaum, Erik/B-5389-2017; Verdrengh, Evelien/H-4571-2012; Moreno-Murciano, Paz/D-7871-2018; Van Damme, Philip/A-6464-2009; Van Den Bosch, Ludo/B-7258-2012	Carmeliet, Peter/0000-0001-7961-1821; Lambrechts, Diether/0000-0002-3429-302X; Storkebaum, Erik/0000-0002-9519-5642; Van Damme, Philip/0000-0002-4010-2357; Rutten, Bart/0000-0002-9834-6346; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Van Den Bosch, Ludo/0000-0003-0104-4067; Conway, Edward/0000-0003-0081-0305				Aebischer P, 2004, GENE THER, V11, P429, DOI 10.1038/sj.gt.3302204; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Azari MF, 2003, BRAIN RES, V982, P92, DOI 10.1016/S0006-8993(03)02989-5; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Brown RH, 2001, SEMIN NEUROL, V21, P131; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Feeney SJ, 2003, CYTOKINE, V23, P108, DOI 10.1016/S1043-4666(03)00217-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; ORRELL RW, 1995, J NEUROL SCI, V132, P126, DOI 10.1016/0022-510X(95)00129-P; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Przedborski Serge, 2003, Curr Neurol Neurosci Rep, V3, P70, DOI 10.1007/s11910-003-0041-x; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Watson FL, 1999, J NEUROSCI, V19, P7889; WINDEBANK AJ, 1995, ADV NEUROL, V68, P229	33	390	437	1	26	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					85	92		10.1038/nn1360	http://dx.doi.org/10.1038/nn1360			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568021	Green Published			2022-12-24	WOS:000225967600020
J	Galimberti, I; Gogolla, N; Alberi, S; Santos, AF; Muller, D; Caroni, P				Galimberti, Ivan; Gogolla, Nadine; Alberi, Stefano; Santos, Alexandre Ferrao; Muller, Dominique; Caroni, Pico			Long-term rearrangements of hippocampal mossy fiber terminal connectivity in the adult regulated by experience	NEURON			English	Article							DENDRITIC SPINES; IN-VIVO; RAT HIPPOCAMPUS; FEEDFORWARD INHIBITION; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; BARN OWLS; SYNAPSES; CA3; BOUTONS	We investigated rearrangements of connectivity between hippocampal mossy fibers and CA3 pyramidal neurons. We found that mossy fibers establish 10-15 local terminal arborization complexes (LMT-Cs) in CA3, which exhibit major differences in size and divergence in adult mice. LMT-Cs exhibited two types of long-term rearrangements in connectivity in the adult: progressive expansion of LMT-C subsets along individual dendrites throughout life, and pronounced increases in LMT-C complexities in response to an enriched environment. In organotypic slice cultures, subsets of LMT-Cs also rearranged extensively and grew over weeks and months, altering the strength of preexisting connectivity, and establishing or dismantling connections with pyramidal neurons. Differences in LMT-C plasticity reflected properties of individual LMT-Cs, not mossy fibers. LMT-C maintenance and growth were regulated by spiking activity, mGluR2-sensitive transmitter release from LMTs, and PKC. Thus, subsets of terminal arborization complexes by mossy fibers rearrange their local connectivities in response to experience and age throughout life.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Geneva, Ctr Med Univ, Geneva, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Geneva	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gonzales RB, 2001, J COMP NEUROL, V430, P357, DOI 10.1002/1096-9861(20010212)430:3<357::AID-CNE1036>3.0.CO;2-K; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; ISHIDA M, 1993, BRIT J PHARMACOL, V109, P1169, DOI 10.1111/j.1476-5381.1993.tb13745.x; JOHNSTON D, 1998, HIPPOCAMPUS SYNAPITI, P417; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pleskacheva MG, 2000, HIPPOCAMPUS, V10, P17, DOI 10.1002/(SICI)1098-1063(2000)10:1<17::AID-HIPO2>3.0.CO;2-O; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Schopke R, 1991, Hippocampus, V1, P315, DOI 10.1002/hipo.450010322; SCHWEGLER H, 1991, J NEUROSCI, V11, P2102; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	112	129	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					749	763		10.1016/j.neuron.2006.04.026	http://dx.doi.org/10.1016/j.neuron.2006.04.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731513	Bronze			2022-12-24	WOS:000238165000010
J	Wang, ZF; Kai, L; Day, M; Ronesi, J; Yin, HH; Ding, J; Tkatch, T; Lovinger, DM; Surmeier, DJ				Wang, Zhongfeng; Kai, Li; Day, Michelle; Ronesi, Jennifer; Yin, Henry H.; Ding, Jun; Tkatch, Tatiana; Lovinger, David M.; Surmeier, D. James			Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons	NEURON			English	Article							RAT STRIATAL NEURONS; CA2+ CURRENTS; ENDOCANNABINOID RELEASE; COORDINATED EXPRESSION; BASAL GANGLIA; N-TYPE; RECEPTOR; MODULATION; CHANNELS; TRANSMISSION	Long-term depression (LTD) of the synapse formed between cortical pyramidal neurons and striatal medium spiny neurons is central to many theories of motor plasticity and associative learning. The induction of LTD at this synapse is thought to depend upon D-2 dopamine receptors localized in the postsynaptic membrane. If this were true, LTD should be inducible in neurons from only one of the two projection systems of the striatum. Using transgenic mice in which neurons that contribute to these two systems are labeled, we show that this is not the case. Rather, in both cell types, the D-2 receptor dependence of LTD induction reflects the need to lower M-1 muscarinic receptor activity-a goal accomplished by D-2 receptors on cholinergic interneurons. In addition to reconciling discordant tracts of the striatal literature, these findings point to cholinergic interneurons as key mediators of dopamine-dependent striatal plasticity and learning.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; NIAAA, Lab Integrat Neurosci, Div Intramural Clin & Basic Res, NIH, Rockville, MD 20852 USA	Northwestern University; Feinberg School of Medicine; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312; Tkatch, Tatiana/0000-0001-6626-7435	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000407] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [MH 074866] Funding Source: Medline; NINDS NIH HHS [NS 34696] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bennett BD, 1999, J NEUROSCI, V19, P5586; BERNARD V, 1992, J NEUROSCI, V12, P3591; CALABRESI P, 1994, J NEUROSCI, V14, P4871; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; DelleDonne KT, 1997, BRAIN RES, V746, P239, DOI 10.1016/S0006-8993(96)01226-7; DODT HU, 1986, J PHYSIOL-LONDON, V380, P593, DOI 10.1113/jphysiol.1986.sp016304; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez-Echeagaray E, 1998, NEUROPHARMACOLOGY, V37, P1493, DOI 10.1016/S0028-3908(98)00131-2; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HERSCH SM, 1994, J NEUROSCI, V14, P3351; HOWE AR, 1995, J NEUROSCI, V15, P458; HSU KS, 1995, NEUROSCI LETT, V197, P141, DOI 10.1016/0304-3940(95)11915-J; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; PATRIDGE JG, 2002, J NEUROSCI, V22, P2541; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Smith Y, 1998, NEUROSCIENCE, V86, P353; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Watanabe K, 1998, J NEUROPHYSIOL, V79, P2568, DOI 10.1152/jn.1998.79.5.2568; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005	49	381	392	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					443	452		10.1016/j.neuron.2006.04.010	http://dx.doi.org/10.1016/j.neuron.2006.04.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675398	Bronze			2022-12-24	WOS:000237726800013
J	Andermann, ML; Moore, CI				Andermann, ML; Moore, CI			A somatotopic map of vibrissa motion direction within a barrel column	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; RECEPTIVE-FIELDS; STRIATE CORTEX; IN-VIVO; RAT; PLASTICITY; PREFERENCE; NEURONS	Most mammals possess high-resolution visual perception, with primary visual cortices containing fine-scale, inter-related feature representations (for example, orientation and ocular dominance). Rats lack precise vision, but their vibrissa sensory system provides a precise tactile modality, including vibrissa-related 'barrel' columns in primary somatosensory cortex. Here, we examined the subcolumnar organization of direction preference and somatotopy using a new omni-directional, multi-vibrissa stimulator. We discovered a direction map that was systematically linked to somatotopy, such that neurons were tuned for motion toward their preferred surround vibrissa. This sub-barrel column direction map demonstrated an emergent refinement from layer IV to layer II/III. These data suggest that joint processing of multiple sensory features is a common property of high-resolution sensory systems.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Program Biophys, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 46 2171, Cambridge, MA 02139 USA.	cim@mit.edu	Moore, Christopher/C-5588-2009	Moore, Christopher/0000-0003-4534-1602				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bender KJ, 2003, J NEUROSCI, V23, P8759; BENISON AM, 2006, J NEUROPHYSIOL  0104; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carreira-Perpinan MA, 2004, J NEUROPHYSIOL, V92, P2947, DOI 10.1152/jn.00281.2004; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Head H., 1920, STUDIES NEUROLOGY; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Hubel D H, 1976, Cold Spring Harb Symp Quant Biol, V40, P581; Hubener M, 1997, J NEUROSCI, V17, P9270; Land PW, 2005, J COMP NEUROL, V490, P414, DOI 10.1002/cne.20677; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; MERZENICH MM, 1980, PROGR PSYCHOBIOL PHY, V9, P1; MOORE CI, SOMATOSENSORY PLASTI, P21; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Timofeeva E, 2003, J NEUROSCI, V23, P10717; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; WINESKI LE, 1985, J MORPHOL, V183, P199, DOI 10.1002/jmor.1051830208; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; Zar J. H., 1996, BIOSTATISTICAL ANAL	50	102	102	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					543	551		10.1038/nn1671	http://dx.doi.org/10.1038/nn1671			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547511				2022-12-24	WOS:000236310700022
J	Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD				Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD			Brain activity before an event predicts later recollection	NATURE NEUROSCIENCE			English	Article							MEMORY; ATTENTION; STATE	Neural activity elicited by an event can predict whether the event is successfully encoded into memory. Here we assessed whether memory encoding relies not only on neural activity that follows an event, but also on activity that precedes it. In two experiments we found that human brain activity elicited by a cue presented just before a word could predict whether the word would be recollected in a later memory test.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine; University of California System; University of California Irvine	Otten, LJ (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Otten, Leun/C-6036-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074528] Funding Source: NIH RePORTER; NIMH NIH HHS [1R01MH074528] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Driver J, 2000, NAT REV NEUROSCI, V1, P147, DOI 10.1038/35039083; Duzel E, 2005, NEUROIMAGE, V25, P690, DOI 10.1016/j.neuroimage.2004.11.038; MANGUN GR, 1995, OX PSYCH S, P40; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Uhl F, 1990, J Cogn Neurosci, V2, P373, DOI 10.1162/jocn.1990.2.4.373; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	15	122	123	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					489	491		10.1038/nn1663	http://dx.doi.org/10.1038/nn1663			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501566				2022-12-24	WOS:000236310700015
J	Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL				Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL			VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain	NATURE NEUROSCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT OPTIC-NERVE; STIMULATES AXONAL OUTGROWTH; IN-VITRO; LYMPHATIC VESSELS; PRECURSOR CELLS; SPINAL-CORD; STEM-CELLS; NEUROGENESIS; DIFFERENTIATION	Vascular endothelial growth factor C (VEGF-C) was first identified as a regulator of the vascular system, where it is required for the development of lymphatic vessels. Here we report actions of VEGF-C in the central nervous system. We detected the expression of the VEGF-C receptor VEGFR-3 in neural progenitor cells in Xenopus laevis and mouse embryos. In Xenopus tadpole VEGF-C knockdowns and in mice lacking Vegfc, the proliferation of neural progenitors expressing VEGFR-3 was severely reduced, in the absence of intracerebral blood vessel defects. In addition, Vegfc-deficient mouse embryos showed a selective loss of oligodendrocyte precursor cells (OPCs) in the embryonic optic nerve. In vitro, VEGF-C stimulated the proliferation of OPCs expressing VEGFR-3 and nestin-positive ventricular neural cells. VEGF-C thus has a new, evolutionary conserved function as a growth factor selectively required by neural progenitor cells expressing its receptor VEGFR-3.	INSERM, U711, F-75013 Paris, France; Univ Paris 06, Fac Med Pitie Salpetriere, IFR 70, F-75005 Paris, France; Catholic Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Univ Helsinki, Haartman Inst & Biomed, FIN-00014 Helsinki, Finland; Univ Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; INSERM, U679, F-75651 Paris, France; Coll France, F-75005 Paris, France; INSERM, U36x, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thomas, JL (corresponding author), INSERM, U711, F-75013 Paris, France.	jlthomas@ccr.jussieu.fr	Thomas, Jean-Leon/F-1151-2016; Carmeliet, Peter/AAQ-5140-2020; Alitalo, Kari K/J-5013-2014; Messier, Claude/A-2322-2008; Ny, Annelii/R-7712-2018; Barallobre, Maria Jose/L-9928-2014	Carmeliet, Peter/0000-0001-7961-1821; Alitalo, Kari K/0000-0002-7331-0902; Messier, Claude/0000-0002-4791-1763; Ny, Annelii/0000-0002-3678-5941; Barallobre, Maria Jose/0000-0002-0101-7803; Homman-Ludiye, Jihane/0000-0001-6689-1457; /0000-0003-3675-6961	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075183-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BREIER G, 1992, DEVELOPMENT, V114, P521; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Joukov V, 1996, EMBO J, V15, P1751; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Jussila L, 2002, PHYSIOL REV, V82, P673, DOI 10.1152/physrev.00005.2002; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mi HY, 1999, J NEUROSCI, V19, P1049; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi JY, 1998, J NEUROSCI, V18, P4627; Shibata T, 1997, J NEUROSCI, V17, P9212; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Spassky N, 2002, J NEUROSCI, V22, P5992; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun T, 2003, J NEUROSCI, V23, P9547; YANG K, 1996, J NEUROSCI, V16, P6089; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000	49	146	148	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					340	348		10.1038/nn1646	http://dx.doi.org/10.1038/nn1646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462734				2022-12-24	WOS:000235645600013
J	Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM				Paton, JFR; Abdala, APL; Koizumi, H; Smith, JC; St John, WM			Respiratory rhythm generation during gasping depends on persistent sodium current	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; PATTERNS; MODELS; EUPNEA	In severe hypoxia, homeostatic mechanisms maintain function of the brainstem respiratory network. We hypothesized that hypoxia involves a transition from neuronal mechanisms of normal breathing (eupnea) to a rudimentary pattern of inspiratory movements (gasping). We provide evidence for hypoxia-driven transformation within the central respiratory oscillator, in which gasping relies on persistent sodium current, whereas eupnea does not depend on this cellular mechanism.	Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England; NINDS, Cellular & Syst Neurobiol Sect, NIH, Bethesda, MD 20892 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Physiol, Lebanon, NH 03756 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Dartmouth College	Paton, JFR (corresponding author), Univ Bristol, Sch Med Sci, Bristol Heart Inst, Dept Physiol, Bristol BS8 1TH, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Paton, Julian/AAM-2121-2020; Sheikh, Ana Paula Abdala/G-9104-2014; Abdala, Ana Paula/G-9104-2014	Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Abdala, Ana Paula/0000-0001-6051-2591; Paton, Julian/0000-0001-7410-2913	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Hammarstrom AKM, 2000, J PHYSIOL-LONDON, V529, P107, DOI 10.1111/j.1469-7793.2000.00107.x; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Pena F, 2004, NEURON, V43, P105, DOI 10.1016/j.neuron.2004.06.023; Ramirez JM, 2005, RESP PHYSIOL NEUROBI, V147, P145, DOI 10.1016/j.resp.2005.05.003; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Rybak IA, 2003, EUR J NEUROSCI, V18, P239, DOI 10.1046/j.1460-9568.2003.02739.x; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; St-John WM, 2003, RESP PHYSIOL NEUROBI, V139, P97, DOI 10.1016/S1569-9048(03)00193-9; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8	15	170	170	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					311	313		10.1038/nn1650	http://dx.doi.org/10.1038/nn1650			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474390				2022-12-24	WOS:000235645600009
J	Averbeck, BB; Sohn, JW; Lee, D				Averbeck, BB; Sohn, JW; Lee, D			Activity in prefrontal cortex during dynamic selection of action sequences	NATURE NEUROSCIENCE			English	Article							COPYING GEOMETRICAL SHAPES; SUPPLEMENTARY EYE FIELD; NEURONAL-ACTIVITY; NEURAL ACTIVITY; TEMPORAL ORGANIZATION; CAUDATE-NUCLEUS; FRONTAL-LOBE; MOTOR; ACQUISITION; MONKEY	Completing everyday tasks often requires the execution of action sequences matched to a particular problem. To study the neural processes underlying these behaviors, we trained monkeys to produce a series of eye movements according to a sequence that changed unpredictably from one block of trials to the next. We then applied a decoding algorithm to estimate which sequence was being represented by the ensemble activity in prefrontal cortex. We found that the sequence predicted by this analysis changed gradually from the sequence that had been correct in the previous block to the sequence that was correct in the current block, closely following the fraction of executed movements that were consistent with the corresponding sequence. Thus, the neural activity dynamically tracked the monkeys' uncertainty about the correct sequence of actions. These results are consistent with prefrontal involvement in representing subjective knowledge of the correct action sequence.	Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Averbeck, BB (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	baverbeck@cvs.rochester.edu	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X	NEI NIH HHS [P30-EY01319] Funding Source: Medline; NIMH NIH HHS [T32-MH19942, R01-MH59216] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019942, R01MH059216] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2003, EXP BRAIN RES, V150, P142, DOI 10.1007/s00221-003-1417-5; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; BARONE P, 1989, EXP BRAIN RES, V78, P447; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166, DOI 10.1152/jn.1997.78.2.1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Jaynes E.T., 2003, PROBABILITY THEORY L; KERMADI I, 1993, EXP BRAIN RES, V94, P352; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Lee D, 1998, J NEUROSCI, V18, P1161; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MITZ AR, 1991, J NEUROSCI, V11, P1855; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631	31	107	108	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					276	282		10.1038/nn1634	http://dx.doi.org/10.1038/nn1634			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429134				2022-12-24	WOS:000234990100024
J	Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ				Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ			Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DOPAMINE-RECEPTORS; DENDRITIC SPINES; STRIATAL NEURONS; CA2+ CHANNELS; SYNAPTIC-TRANSMISSION; NEOSTRIATAL NEURONS; RAT NEOSTRIATUM; GENE-EXPRESSION	Parkinson disease is a common neurodegenerative disorder that leads to difficulty in effectively translating thought into action. Although it is known that dopaminergic neurons that innervate the striatum die in Parkinson disease, it is not clear how this loss leads to symptoms. Recent work has implicated striatopallidal medium spiny neurons ( MSNs) in this process, but how and precisely why these neurons change is not clear. Using multiphoton imaging, we show that dopamine depletion leads to a rapid and profound loss of spines and glutamatergic synapses on striatopallidal MSNs but not on neighboring striatonigral MSNs. This loss of connectivity is triggered by a new mechanism-dysregulation of intraspine Cav1.3 L-type Ca2+ channels. The disconnection of striatopallidal neurons from motor command structures is likely to be a key step in the emergence of pathological activity that is responsible for symptoms in Parkinson disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Edinburgh, Div Neurosci & Vet Biomed Sci, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37212 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37212 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011; Sesack, Susan R/H-8013-2018; Arbuthnott, Gordon W/A-4606-2015; Ding, Jun/B-2513-2009	Sesack, Susan R/0000-0002-2852-7440; Arbuthnott, Gordon W/0000-0002-3386-8362; Ding, Jun/0000-0003-0690-1312	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044282, R01NS034696, P50NS047085, R37NS034696, P01NS019608, P50NS019608] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19608, NS 44282, NS 047085, NS 34696] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dunah AW, 2000, MOL PHARMACOL, V57, P342; GALARRAGA E, 1987, NEUROSCI LETT, V81, P351, DOI 10.1016/0304-3940(87)90409-5; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gross CE, 1999, PROG NEUROBIOL, V59, P509, DOI 10.1016/S0301-0082(99)00015-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; INGHAM CA, 1993, EXP BRAIN RES, V93, P17, DOI 10.1007/BF00227776; Ingham CA, 1998, J NEUROSCI, V18, P4732; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lovinger DM, 2003, ANN NY ACAD SCI, V1003, P226, DOI 10.1196/annals.1300.014; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NISENBAUM ES, 1986, BRAIN RES, V398, P221, DOI 10.1016/0006-8993(86)91481-2; Oertner TG, 2005, CELL CALCIUM, V37, P477, DOI 10.1016/j.ceca.2005.01.016; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pang ZP, 2001, NEUROSCI LETT, V308, P201, DOI 10.1016/S0304-3940(01)02031-6; Picconi B, 2004, BRAIN, V127, P1661, DOI 10.1093/brain/awh190; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; SHOLL DA, 1953, J ANAT, V87, P387; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wichmann T, 2003, ADV NEUROL, V91, P9; WILSON CJ, 1994, MICROSC RES TECHNIQ, V29, P368, DOI 10.1002/jemt.1070290507; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	572	589	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					251	259		10.1038/nn1632	http://dx.doi.org/10.1038/nn1632			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415865				2022-12-24	WOS:000234990100021
J	Wong, LF; Yip, PK; Battaglia, A; Grist, J; Corcoran, J; Maden, M; Azzouz, M; Kingsman, SM; Kingsman, AJ; Mazarakis, ND; McMahon, SB				Wong, LF; Yip, PK; Battaglia, A; Grist, J; Corcoran, J; Maden, M; Azzouz, M; Kingsman, SM; Kingsman, AJ; Mazarakis, ND; McMahon, SB			Retinoic acid receptor beta 2 promotes functional regeneration of sensory axons in the spinal cord	NATURE NEUROSCIENCE			English	Article							F9 TERATOCARCINOMA CELLS; NERVOUS-SYSTEM; LENTIVIRAL VECTORS; CYCLIC-AMP; ADULT RATS; NEURITE OUTGROWTH; IN-VITRO; NEURONS; EXPRESSION; INJURY	The embryonic CNS readily undergoes regeneration, unlike the adult CNS, which has limited axonal repair after injury. Here we tested the hypothesis that retinoic acid receptor beta 2 ( RAR beta 2), critical in development for neuronal growth, may enable adult neurons to grow in an inhibitory environment. Overexpression of RAR beta 2 in adult rat dorsal root ganglion cultures increased intracellular levels of cyclic AMP and stimulated neurite outgrowth. Stable RAR beta 2 expression in DRG neurons in vitro and in vivo enabled their axons to regenerate across the inhibitory dorsal root entry zone and project into the gray matter of the spinal cord. The regenerated neurons enhanced second-order neuronal activity in the spinal cord, and RAR beta 2-treated rats showed highly significant improvement in sensorimotor tasks. These findings show that RAR beta 2 induces axonal regeneration programs within injured neurons and may thus offer new therapeutic opportunities for CNS regeneration.	Oxford BioMed UK Ltd, Medawar Ctr, Oxford OX4 4GA, England; Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London SE1 1UL, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Oxford Biomedica (UK) Ltd; University of London; King's College London; University of London; King's College London	Wong, LF (corresponding author), Oxford BioMed UK Ltd, Medawar Ctr, Robert Robinson Ave,Oxford Sci Pk, Oxford OX4 4GA, England.	l.wong@oxfordbiomedica.co.uk; n.mazarakis@oxfordbiomedica.co.uk	Azzouz, Mimoun/B-3979-2009	Azzouz, Mimoun/0000-0001-6564-5967; McMahon, Stephen/0000-0003-4656-5536; Shaw, Pamela/0000-0002-8925-2567	Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Appel B, 2003, NEURON, V40, P461, DOI 10.1016/S0896-6273(03)00688-3; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Azzouz M, 2002, J NEUROSCI, V22, P10302; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cajal S., 1928, DEGENERATION REGENER; CARLSTEDT T, 1985, BRAIN RES, V347, P188, DOI 10.1016/0006-8993(85)90911-4; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAN SDH, 1990, J BIOL CHEM, V265, P20081; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Corcoran J, 2002, J CELL SCI, V115, P3779, DOI 10.1242/jcs.00046; Corcoran J, 2000, J CELL SCI, V113, P2567; DUBUISSON D, 1989, TXB PAIN, P544; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Golding JP, 1999, GLIA, V26, P309, DOI 10.1002/(SICI)1098-1136(199906)26:4<309::AID-GLIA5>3.3.CO;2-S; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lipskaia L, 1997, FEBS LETT, V415, P275, DOI 10.1016/S0014-5793(97)01001-6; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Maden M, 2001, INT REV CYTOL, V209, P1; Martin-Rendon E, 2002, MOL THER, V5, P566, DOI 10.1006/mthe.2002.0576; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; MONTOYA GP, 1991, J NEUROSCI METH, V36, P219; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; RATTRAY M, 1998, IN SITU HYBRIDISATIO, P23; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Werner EA, 2002, AM J PHYSIOL-ENDOC M, V282, pE672, DOI 10.1152/ajpendo.00280.2001; Wong LF, 2004, MOL THER, V9, P101, DOI 10.1016/j.ymthe.2003.09.017; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; Zhang Y, 1998, J NEUROSCI RES, V54, P554; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	41	102	111	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					243	250		10.1038/nn1622	http://dx.doi.org/10.1038/nn1622			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388307				2022-12-24	WOS:000234990100020
J	Amedi, A; Malach, R; Pascual-Leone, A				Amedi, A; Malach, R; Pascual-Leone, A			Negative BOLD differentiates visual imagery and perception	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY AUDITORY-CORTEX; HUMAN CEREBRAL-CORTEX; DEFAULT-MODE; HUMAN BRAIN; VOLUME MEASUREMENT; MENTAL-IMAGERY; ACTIVATION; FMRI; ATTENTION	Recent studies emphasize the overlap between the neural substrates of visual perception and visual imagery. However, the subjective experiences of imagining and seeing are clearly different. Here we demonstrate that deactivation of auditory cortex (and to some extent of somatosensory and subcortical visual structures) as measured by BOLD functional magnetic resonance imaging unequivocally differentiates visual imagery from visual perception. During visual imagery, auditory cortex deactivation negatively correlates with activation in visual cortex and with the score in the subjective vividness of visual imagery questionnaire (VVIQ). Perception of the world requires the merging of multisensory information so that, during seeing, information from other sensory systems modifies visual cortical activity and shapes experience. We suggest that pure visual imagery corresponds to the isolated activation of visual cortical areas with concurrent deactivation of "irrelevant" sensory processing that could disrupt the image created by our "mind's eye."	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Weizmann Institute of Science	Amedi, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA.	aamedi@bidmc.harvard.edu; apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Amedi, Amir/0000-0001-5042-2533	NCRR NIH HHS [K24 RR018875] Funding Source: Medline; NEI NIH HHS [R01-EY-12091] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Baudewig J, 2000, MAGN RESON IMAGING, V18, P479, DOI 10.1016/S0730-725X(00)00122-3; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bestmann S, 2003, J MAGN RESON IMAGING, V17, P309, DOI 10.1002/jmri.10260; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Horwitz Barry, 1994, Human Brain Mapping, V2, P112, DOI 10.1002/hbm.460020111; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; KAWASHIMA R, 1993, J CEREB BLOOD FLOW M, V13, pS502; Klein I, 2004, COGNITIVE BRAIN RES, V22, P26, DOI 10.1016/j.cogbrainres.2004.07.006; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Lambert S, 2004, COGNITIVE BRAIN RES, V20, P1; Laurienti PJ, 2004, J COGNITIVE NEUROSCI, V16, P1481, DOI 10.1162/0898929042568596; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; MAZZIOTTA JC, 1982, NEUROLOGY, V32, P921, DOI 10.1212/WNL.32.9.921; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 2001, ANN NY ACAD SCI, V930, P315, DOI 10.1111/j.1749-6632.2001.tb05741.x; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; Sathian K, 2001, OPTOMETRY VISION SCI, V78, P276, DOI 10.1097/00006324-200105000-00010; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stein BE., 1993, MERGING SENSES; Talairach J., 1988, COPLANAR STEREOTAXIC; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; Weeks R, 2000, J NEUROSCI, V20, P2664; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	65	162	167	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					859	872		10.1016/j.neuron.2005.10.032	http://dx.doi.org/10.1016/j.neuron.2005.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337922	Bronze			2022-12-24	WOS:000233927300023
J	Mazor, O; Laurent, G				Mazor, O; Laurent, G			Transient dynamics versus fixed points in odor representations by locust antennal lobe projection neurons	NEURON			English	Article							DISCRIMINATION; OSCILLATIONS; SEQUENCES; RESPONSES; CORTEX; CODE; INFORMATION; PERCEPTION; FEATURES; FLIGHT	Projection neurons (PNs) in the locust antennal lobe exhibit odor-specific dynamic responses. We studied a PN population, stimulated with five odorants and pulse durations between 0.3 and 10 s. Odor representations were characterized as time series of vectors of PN activity, constructed from the firing rates of all PNs in successive 50 ms time bins. Odor representations by the PN population can be described as trajectories in PN state space with three main phases: an on transient, lasting 1-2 s; a fixed point, stable for at least 8 s; and an off transient, lasting a few seconds as activity returns to baseline. Whereas all three phases are odor specific, optimal stimulus separation occurred during the transients rather than the fixed points. In addition, the PNs' own target neurons respond least when their PN-population input stabilized at a fixed point. Steady-state measures of activity thus seem inappropriate to understand the neural code in this system.	CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Mazor, Ofer/0000-0002-6860-7242	NCRR NIH HHS [P41RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Afraimovich VS, 2004, CHAOS, V14, P1123, DOI 10.1063/1.1819625; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; Daly KC, 2004, J NEUROPHYSIOL, V92, P236, DOI 10.1152/jn.01132.2003; DuchampViret P, 1996, NEUROSCIENCE, V74, P885, DOI 10.1016/0306-4522(96)00194-7; Dulac C, 1997, NEURON, V19, P477, DOI 10.1016/S0896-6273(00)80363-3; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; Freeman W.J., 2000, NEURODYNAMICS EXPLOR, DOI 10.1007/978-1-4471-0371-4; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kanerva P., 1988, SPARSE DISTRIBUTED M; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Livermore A, 1996, J EXP PSYCHOL HUMAN, V22, P267, DOI 10.1037/0096-1523.22.2.267; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Menzel R., 1987, P310; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Slotnick B, 2002, J NEUROSCI, V22, P4205, DOI 10.1523/JNEUROSCI.22-10-04205.2002; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vickers NJ, 1996, J COMP PHYSIOL A, V178, P831, DOI 10.1007/BF00225831; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	59	333	335	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					661	673		10.1016/j.neuron.2005.09.032	http://dx.doi.org/10.1016/j.neuron.2005.09.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301181	Bronze			2022-12-24	WOS:000233677300018
J	Kalivas, PW				Kalivas, PW			How do we determine which drug-induced neuroplastic changes are important?	NATURE NEUROSCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; DELTA-FOSB; ADDICTION; COCAINE; MOTIVATION; MECHANISMS; SENSITIZATION; PATHOLOGY; ABUSE	Although many drug-induced neural changes are known, progress has been slow in identifying the ones that actually mediate addiction. Identifying changes that are specific to particular elements of the transition from initial to habitual to relapsing drug use may be a fruitful strategy for pinpointing which forms of drug-induced plasticity are critical for addiction.	Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu						Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Canales JJ, 2005, NEUROBIOL LEARN MEM, V83, P93, DOI 10.1016/j.nlm.2004.10.006; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Keitz M., 2003, Neural Plasticity, V10, P121, DOI 10.1155/NP.2003.121; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; SZUMLINSKI KK, 2005, NEUROPSYCHOPHAR 0914; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	20	54	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1440	1441		10.1038/nn1105-1440	http://dx.doi.org/10.1038/nn1105-1440			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251984				2022-12-24	WOS:000232966600012
J	Volkow, N; Li, TK				Volkow, N; Li, TK			The neuroscience of addiction	NATURE NEUROSCIENCE			English	Editorial Material							DRUG-USE; DEPENDENCE; ALCOHOL; ASSOCIATION; DOPAMINE; SEEKING; CORTEX; ONSET; ABUSE; RISK								NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Baumeister SE, 2005, EUR ADDICT RES, V11, P92, DOI 10.1159/000083038; Belluzzi JD, 2004, PSYCHOPHARMACOLOGY, V174, P389, DOI 10.1007/s00213-003-1758-6; BREESE GR, ALCOHOL CLIN EXP RES, V29, P185; Brook DW, 2002, ARCH GEN PSYCHIAT, V59, P1039, DOI 10.1001/archpsyc.59.11.1039; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Hiroi N, 2005, MOL PSYCHIATR, V10, P336, DOI 10.1038/sj.mp.4001622; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Pistis M, 2004, BIOL PSYCHIAT, V56, P86, DOI 10.1016/j.biopsych.2004.05.006; Ranaldi R, 2001, BEHAV PHARMACOL, V12, P527, DOI 10.1097/00008877-200111000-00014; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; VOLKOW N, IN PRESS PHARM THER; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005	19	179	183	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1429	1430		10.1038/nn1105-1429	http://dx.doi.org/10.1038/nn1105-1429			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251981	Green Submitted			2022-12-24	WOS:000232966600009
J	Coussen, F; Perrais, D; Jaskolski, F; Sachidhanandam, S; Normand, E; Bockaert, J; Marin, P; Mulle, C				Coussen, F; Perrais, D; Jaskolski, F; Sachidhanandam, S; Normand, E; Bockaert, J; Marin, P; Mulle, C			Coassembly of two GluR6 Kainate receptor splice variants within a functional protein complex	NEURON			English	Article							MOSSY-FIBER SYNAPSES; NMDA RECEPTORS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; SUBUNIT COMPOSITION; SURFACE EXPRESSION; AMPA RECEPTORS; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; GLUTAMATE RECEPTORS	Kainate receptors (KAR) are composed of several distinct subunits and splice variants, but the functional relevance of this diversity remains largely unclear. Here we show that two splice variants of the GluR6 subunit, GIuR6a and GIuR6b, which differ in their C-terminal domains, do not show distinct functional properties, but coassemble as heteromers in vitro and in vivo. Using a proteomic approach combining affinity purification and MALDI-TOF mass spectrometry, we found that GluR6a and GIuR6b interact with two distinct subsets of cytosolic proteins mainly involved in W regulation of channel function and intracellular trafficking. Guided by these results, we provide evidence that the regulation of native KAR function by NMDA receptors depends on the heteromerization of GIuR6a and GIuR6b and interaction of calcineurin with GIuR6b. Thus, GIuR6a and GIuR6b bring in close proximity two separate subsets of interacting proteins that contribute to the fine regulation of KAR trafficking and function.	Univ Bordeaux 2, Inst Francois Magendie, CNRS, UMR 5091,Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Inserm U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Mulle, C (corresponding author), Univ Bordeaux 2, Inst Francois Magendie, CNRS, UMR 5091,Lab Physiol Cellulaire Synapse, Rue C St Saens, F-33077 Bordeaux, France.	mulle@u-bordeaux2.fr	Perrais, David/W-9360-2019	Perrais, David/0000-0002-5878-5408; Sachidhanandam, Shankar/0000-0002-9359-6653; Mulle, Christophe/0000-0003-2709-6615				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BERNARD V, 1992, J NEUROSCI, V12, P3591; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chazot PL, 1997, J NEUROCHEM, V69, P2138; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Ghetti A, 2000, J NEUROSCI, V20, P2766; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Ren Z, 2003, J BIOL CHEM, V278, P52700, DOI 10.1074/jbc.M309585200; Ren Z, 2003, J NEUROSCI, V23, P6608; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	65	67	72	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					555	566		10.1016/j.neuron.2005.06.033	http://dx.doi.org/10.1016/j.neuron.2005.06.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102538	Bronze			2022-12-24	WOS:000231411100012
J	Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K				Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K			Contrast adaptation and representation in human early visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; STRIATE CORTICAL-NEURONS; CEREBRAL BLOOD OXYGENATION; EXTRASTRIATE AREA V4; FUNCTIONAL MRI; RESPONSE AMPLITUDE; GAIN-CONTROL; SELECTIVE ADAPTATION; SYNAPTIC DEPRESSION; SPATIAL ATTENTION	The human visual system can distinguish variations in image contrast over a much larger range than measurements of the static relationship between contrast and response in visual cortex would suggest. This discrepancy may be explained if adaptation serves to recenter contrast response functions around the ambient contrast, yet experiments on humans have yet to report such an effect. By using event-related fMRl and a data-driven analysis approach, we found that contrast response functions in V1, V2, and V3 shift to approximately center on the adapting contrast. Furthermore, we discovered that, unlike earlier areas, human V4 (hV4) responds positively to contrast changes, whether increments or decrements, suggesting that hV4 does not faithfully represent contrast, but instead responds to salient changes. These findings suggest that the visual system discounts slow uninformative changes in contrast with adaptation, yet remains exquisitely sensitive to changes that may signal important events in the environment.	RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	RIKEN; New York University; New York University	Gardner, JL (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	justin@cns.nyu.edu	Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016; Sun, Pei/B-5191-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015	Waggoner, Allen/0000-0002-4921-7521; Sun, Pei/0000-0003-4184-1079; Tanaka, Keiji/0000-0002-1910-3427; Gardner, Justin/0000-0003-2220-5050	NATIONAL EYE INSTITUTE [F32EY016260] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY016260-01, F32 EY016260] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; ANZAI A, 1995, VISUAL NEUROSCI, V12, P77, DOI 10.1017/S0952523800007331; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRAUN J, 1994, J NEUROSCI, V14, P554; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chance FS, 1998, J NEUROSCI, V18, P4785; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEAN AF, 1983, VISION RES, V23, P249, DOI 10.1016/0042-6989(83)90113-X; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; FINLAYSON PG, 1995, EXP BRAIN RES, V106, P145; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GARDNER JL, 2005, P INT SOC MAGN RES M, V13, P25; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MCKEEFRY DJ, 1997, BRAIN, V120, P2299; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2003, J NEUROSCI, V23, P3990; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1985, J NEUROPHYSIOL, V54, P668, DOI 10.1152/jn.1985.54.3.668; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	76	145	147	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					607	620		10.1016/j.neuron.2005.07.016	http://dx.doi.org/10.1016/j.neuron.2005.07.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102542	Bronze, Green Accepted			2022-12-24	WOS:000231411100016
J	Palmer, CL; Lim, W; Hastie, PGR; Toward, M; Korolchuk, VI; Burbidge, SA; Banting, G; Collingridge, GL; Isaac, JTR; Henley, JM				Palmer, CL; Lim, W; Hastie, PGR; Toward, M; Korolchuk, VI; Burbidge, SA; Banting, G; Collingridge, GL; Isaac, JTR; Henley, JM			Hippocalcin functions as a calcium sensor in hippocampal LTD	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; TYROSINE MOTIFS; 2-HYBRID SYSTEM; CLATHRIN; PROTEIN; ENDOCYTOSIS; BINDING; BRAIN	It is not fully understood how NMDAR-dependent LTD causes Ca2+-dependent endocytosis of AMPARs. Here we show that the neuronal Ca2+ sensor hippocalcin binds the beta 2-adaptin subunit of the AP2 adaptor complex and that along with GluR2 these coimmunoprecipitate in a Ca2+-sensitive manner. Infusion of a truncated mutant of hippocalcin (HIP2-72) that lacks the Ca2+ binding domains prevents synaptically evoked LTD but has no effect on LTR These data indicate that the AP2-hippocalcin complex acts as a Ca2+ sensor that couples NMDAR-dependent activation to regulated endocytosis of AMPARs during LTD.	Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; GlaxoSmithKline Inc, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; University of Bristol; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Henley, Jeremy M/A-2776-2009	Collingridge, Graham L/0000-0002-9572-5359; Henley, Jeremy/0000-0003-3589-8335; Banting, George/0000-0001-8249-1621; Korolchuk, Viktor/0000-0002-4071-592X	Medical Research Council [G9532377, G9629038] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER; MRC [G9532377, G9629038] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Cupers P, 1997, BIOCHEM BIOPH RES CO, V236, P661, DOI 10.1006/bbrc.1997.7033; GRAY EG, 1962, J ANAT, V96, P79; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hyun JK, 2000, MOL CELLS, V10, P669, DOI 10.1007/s100590000028; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; KOBAYASHI M, 1993, BIOCHEM BIOPH RES CO, V196, P1017, DOI 10.1006/bbrc.1993.2351; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mercer EA, 2000, EMBO J, V19, P3597, DOI 10.1093/emboj/19.14.3597; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nishimune A, 1996, TRENDS NEUROSCI, V19, P261, DOI 10.1016/S0166-2236(96)40003-0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Perestenko P, 2003, BIOCHEM SOC T, V31, P880, DOI 10.1042/bst0310880; SAITOH S, 1993, NEUROSCI LETT, V157, P107, DOI 10.1016/0304-3940(93)90654-4; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200	40	105	110	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					487	494		10.1016/j.neuron.2005.06.014	http://dx.doi.org/10.1016/j.neuron.2005.06.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102532	Bronze, Green Accepted			2022-12-24	WOS:000231411100006
J	Lai, HC; Grabe, M; Jan, YN; Jan, LY				Lai, HC; Grabe, M; Jan, YN; Jan, LY			The S4 voltage sensor packs against the pore domain in the KAT1 voltage-gated potassium channel	NEURON			English	Article							DEPENDENT K+ CHANNEL; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE SEGMENTS; FUNCTIONAL EXPRESSION; PACEMAKER CHANNELS; MOLECULAR-MOVEMENT; ESCHERICHIA-COLI; ELECTRIC-FIELD; GATING CHARGE	In voltage-gated ion channels, the S4 transmembrane segment responds to changes in membrane potential and controls channel opening. The local environment of S4 is still unknown, even regarding the basic question as to whether S4 is close to the pore domain. Relying on the ability of functional KAT1 channels to rescue potassium (K+) transport-deficient yeast, we have performed an unbiased mutagenesis screen aimed at determining whether S4 packs against S5 of the pore domain. Starting with semilethal mutations of surface-exposed S5 residues of the KAT1 pore domain, we have screened randomly mutagenized libraries of S4 or S1-S3 for second-site suppressors. Our study identifies two S4 residues that interact in a highly specific manner with two S5 residues in the middle of the membrane-spanning regions, supporting a model in which the S4 voltage sensor packs against the pore domain in the hyperpolarized, or "down," state of S4.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Sch Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu	Grabe, Michael/B-3705-2009	Lai, Helen/0000-0003-4334-0243	NIGMS NIH HHS [GM08284] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; ASCHROFT FM, 2000, ION CHANNELS DIS; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Brownlee C, 2002, CURR BIOL, V12, pR402, DOI 10.1016/S0960-9822(02)00886-2; CAO YW, 1995, J BIOL CHEM, V270, P17697, DOI 10.1074/jbc.270.30.17697; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; GRABE M, 2004, P NATL ACAD SCI USA, V102, P5020; Gulbis JM, 2004, CURR OPIN STRUC BIOL, V14, P440, DOI 10.1016/j.sbi.2004.06.008; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuruma A, 2000, AM J PHYSIOL-CELL PH, V279, pC1401, DOI 10.1152/ajpcell.2000.279.5.C1401; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Marten I, 1998, BIOPHYS J, V74, P2953, DOI 10.1016/S0006-3495(98)78002-6; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Mura CV, 2004, J MEMBRANE BIOL, V201, P157, DOI 10.1007/s00232-004-0713-8; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Ramon L, 2003, MOL MEMBR BIOL, V20, P19, DOI 10.1080/0968768021000057371; RASBAND WS, 1997, IMAGEJ COMPUTER PROG; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sands Z, 2005, CURR BIOL, V15, pR44, DOI 10.1016/j.cub.2004.12.050; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shieh CC, 2000, PHARMACOL REV, V52, P557; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zei PC, 1998, J GEN PHYSIOL, V112, P679, DOI 10.1085/jgp.112.6.679	75	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					395	406		10.1016/j.neuron.2005.06.019	http://dx.doi.org/10.1016/j.neuron.2005.06.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055063	Bronze			2022-12-24	WOS:000231051900010
J	Verstreken, P; Ly, CV; Venken, KJT; Koh, TW; Zhou, Y; Bellen, HJ				Verstreken, P; Ly, CV; Venken, KJT; Koh, TW; Zhou, Y; Bellen, HJ			Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions	NEURON			English	Article							MOTOR-NERVE TERMINALS; LIGHT-CHAIN KINASE; TRANSMITTER RELEASE; AXONAL-TRANSPORT; NEUROTRANSMITTER RELEASE; REPETITIVE STIMULATION; SYMPATHETIC NEURONS; INTRACELLULAR CA2+; MYOSIN-II; SYNAPSES	In a forward screen for genes affecting neurotransmission in Drosophila, we identified mutations in dynamin-related protein (drp1). DRP1 is required for proper cellular distribution of mitochondria, and in mutant neurons, mitochondria are largely absent from synapses, thus providing a genetic tool to assess the role of mitochondria at synapses. Although resting Ca2+ is elevated at drp1 NMJs, basal synaptic properties are barely affected. However, during intense stimulation, mutants fail to maintain normal neurotransmission. Surprisingly, FM1-43 labeling indicates normal exo- and endocytosis, but a specific inability to mobilize reserve pool vesicles, which is partially rescued by exogenous ATP. Using a variety of drugs, we provide evidence that reserve pool recruitment depends on mitochondrial ATP production downstream of PKA signaling and that mitochondrial ATP limits myosin-propelled mobilization of reserve pool vesicles. Our data suggest a specific role for mitochondria in regulating synaptic strength.	Baylor Coll Med, Dept Mol & Humal Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Humal Genet, 1 Baylor Pl, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Verstreken, Patrik/AAC-7591-2022; Venken, Koen/B-9909-2013; Koh, Tong-Wey/M-3774-2013	Verstreken, Patrik/0000-0002-5073-5393; Venken, Koen/0000-0003-0741-4698; Koh, Tong-Wey/0000-0001-9136-3189; Bellen, Hugo/0000-0001-5992-5989				AIUCHI T, 1985, BIOCHIM BIOPHYS ACTA, V843, P20, DOI 10.1016/0304-4165(85)90044-3; ALNAES E, 1975, J PHYSIOL-LONDON, V248, P285, DOI 10.1113/jphysiol.1975.sp010974; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; Billups B, 2002, J NEUROSCI, V22, P5840; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Budd SL, 1996, J NEUROCHEM, V67, P2282; Calupca MA, 2001, J PHYSIOL-LONDON, V532, P217, DOI 10.1111/j.1469-7793.2001.0217g.x; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; FRIEL DD, 1994, J NEUROSCI, V14, P4007; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hurd DD, 1996, GENETICS, V144, P1075; JENSEN JR, 1991, BRAIN RES, V551, P311, DOI 10.1016/0006-8993(91)90947-T; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kann O, 2003, J NEUROPHYSIOL, V90, P613, DOI 10.1152/jn.00042.2003; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, GENETICS, V138, P111; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; MAKISHIMA M, 1991, FEBS LETT, V287, P175, DOI 10.1016/0014-5793(91)80044-4; Mathews C.K., 1996, BIOCHEMISTRY; Medler K, 2002, J NEUROPHYSIOL, V87, P1426, DOI 10.1152/jn.00627.2001; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MOLGO J, 1988, NEUROSCIENCE, V24, P695, DOI 10.1016/0306-4522(88)90362-4; Mozhayeva MG, 2004, J NEUROSCI, V24, P1680, DOI 10.1523/JNEUROSCI.3801-03.2004; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rikhy R, 2003, GENETICS, V165, P1243; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Ryan TA, 1999, J NEUROSCI, V19, P1317; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SANYAL S, 2004, GENETICS, V24, P4518; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; WERTH JL, 1994, J NEUROSCI, V14, P348; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; ZENGEL JE, 1994, J GEN PHYSIOL, V104, P337, DOI 10.1085/jgp.104.2.337; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	73	597	605	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					365	378		10.1016/j.neuron.2005.06.018	http://dx.doi.org/10.1016/j.neuron.2005.06.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055061	Bronze			2022-12-24	WOS:000231051900008
J	Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF				Meyer-Lindenberg, A; Hariri, AR; Munoz, KE; Mervis, CB; Mattay, VS; Morris, CA; Berman, KF			Neural correlates of genetically abnormal social cognition in Williams syndrome	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; AMYGDALA RESPONSE; BEHAVIOR; STIMULI; ANXIETY	Williams-Beuren syndrome (WBS), caused by a microdeletion of approximately 21 genes on chromosome 7q11.23, is characterized by unique hypersociability combined with increased non-social anxiety. Using functional neuroimaging, we found reduced amygdala activation in individuals with WBS for threatening faces but increased activation for threatening scenes, relative to matched normal controls. Activation and interactions of prefrontal regions linked to amygdala, especially orbitofrontal cortex, were abnormal, suggesting a genetically controlled neural circuitry for regulating human social behavior.	NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Neuroimaging Core Facil, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,US Dept HHS, Bethesda, MD 20892 USA; Univ Louisville, Dept Psychol & Brain Sci, Neurodev Sci Lab, Louisville, KY 40292 USA; Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, US Dept HHS, Bethesda, MD 20892 USA.	andreasml@nih.gov	Hariri, Ahmad/D-5761-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002867, Z01MH002863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035102, NS35102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Dykens EM, 2003, DEV NEUROPSYCHOL, V23, P291, DOI 10.1207/S15326942DN231&2_13; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Klein-Tasman BP, 2003, DEV NEUROPSYCHOL, V23, P269, DOI 10.1207/S15326942DN231&2_12; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Wood JN, 2005, NEUROPSYCHOLOGIA, V43, P249, DOI 10.1016/j.neuropsychologia.2004.11.011	15	274	279	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					991	993		10.1038/nn1494	http://dx.doi.org/10.1038/nn1494			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007084				2022-12-24	WOS:000230760200009
J	McBride, SMJ; Choi, CH; Wang, Y; Liebelt, D; Braunstein, E; Ferreiro, D; Sehgal, A; Siwicki, KK; Dockendorff, TC; Nguyen, HT; McDonald, TV; Jongens, TA				McBride, SMJ; Choi, CH; Wang, Y; Liebelt, D; Braunstein, E; Ferreiro, D; Sehgal, A; Siwicki, KK; Dockendorff, TC; Nguyen, HT; McDonald, TV; Jongens, TA			Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; MENTAL-RETARDATION PROTEIN; LONG-TERM-MEMORY; CONDITIONED COURTSHIP; MELANOGASTER; MUTANTS; MALES; GENE; ANTAGONIST; ACTIVATION	Fragile X syndrome is a leading heritable cause of mental retardation that results from the loss of FMR1 gene function. A Drosophila model for Fragile X syndrome, based on the loss of dfmr1 activity, exhibits phenotypes that bear similarity to Fragile X-related symptoms. Herein, we demonstrate that treatment with metabotropic glutamate receptor (mGluR) antagonists or lithium can rescue courtship and mushroom body defects observed in these flies. Furthermore, we demonstrate that dfmr1 mutants display cognitive deficits in experience-dependent modification of courtship behavior, and treatment with mGluR antagonists or lithium restores these memory defects. These findings implicate enhanced mGluR signaling as the underlying cause of the cognitive, as well as some of the behavioral and neuronal, phenotypes observed in the Drosophila Fragile X model. They also raise the possibility that compounds having similar effects on metabotropic glutamate receptors may ameliorate cognitive and behavioral defects observed in Fragile X patients.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, Med Scientist Training Program, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Sect Mol Cardiol, Med Scientist Training Program, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Sect Mol Cardiol, Bronx, NY 10461 USA; Drexel Univ, Coll Med, Dept Pharmacol, MD PhD Program, Philadelphia, PA 19102 USA; Drexel Univ, Coll Med, Dept Physiol, MD PhD Program, Philadelphia, PA 19102 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; Miami Univ, Dept Zool, Oxford, OH 45056 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Drexel University; Drexel University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Swarthmore College; University System of Ohio; Miami University	McBride, SMJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, Med Scientist Training Program, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	smcbride@aecom.yu.edu; jongens@mail.med.upenn.edu						ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; Bakker CE, 2003, CYTOGENET GENOME RES, V100, P111, DOI 10.1159/000072845; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M, 1955, BEHAVIOUR, V8, P86, DOI DOI 10.1163/156853955X00184; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Cobb M, 1995, BEHAV PROCESS, V35, P35, DOI 10.1016/0376-6357(95)00052-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fisch GS, 1999, AM J MED GENET, V83, P257, DOI 10.1002/(SICI)1096-8628(19990402)83:4<257::AID-AJMG5>3.0.CO;2-U; GAILEY DA, 1984, GENETICS, V106, P613; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hagerman R.J., 2002, FRAGILE X SYNDROME D; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HEISENBERG M, 1980, DEV NEUROBIOLOGY DRO, P373; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pommier B, 2003, J NEUROCHEM, V85, P454, DOI 10.1046/j.1471-4159.2003.01690.x; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramaekers A, 2001, J COMP NEUROL, V438, P213, DOI 10.1002/cne.1310; Rasmussen K, 2004, NEUROPHARMACOLOGY, V46, P620, DOI 10.1016/j.neuropharm.2003.11.013; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sokal RR, 1995, BIOMETRY; Spooren WPJM, 2001, TRENDS PHARMACOL SCI, V22, P331, DOI 10.1016/S0165-6147(00)01694-1; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; VANSWINDEREN B, 1995, LEARN MEMORY, V2, P49, DOI 10.1101/lm.2.2.49; Villella A, 1996, GENETICS, V143, P331; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WrightTalamante C, 1996, AM J MED GENET, V64, P350, DOI 10.1002/(SICI)1096-8628(19960809)64:2<350::AID-AJMG23>3.0.CO;2-D; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	370	388	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					753	764		10.1016/j.neuron.2005.01.038	http://dx.doi.org/10.1016/j.neuron.2005.01.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748850	Bronze			2022-12-24	WOS:000227446700014
J	Slutsky, I; Sadeghpour, S; Li, B; Liu, GS				Slutsky, I; Sadeghpour, S; Li, B; Liu, GS			Enhancement of synaptic plasticity through chronically reduced Ca2+ flux during uncorrelated activity	NEURON			English	Article							NMDA RECEPTOR; NEUROTRANSMITTER RELEASE; CORTICAL PLASTICITY; HIPPOCAMPAL-NEURONS; CEREBROSPINAL-FLUID; VISUAL EXPERIENCE; ACTION-POTENTIALS; CRITICAL PERIOD; SYNAPSES; MAGNESIUM	The plasticity of synapses within neural circuits is regulated by activity, but the underlying mechanisms remain elusive. Using the dye FM1-43 to directly image presynaptic function, we found that large numbers of presynaptic terminals in hippocampal cultures have a low release probability. While these terminals were not readily modifiable, a transient but not permanent long-term reduction of network activity or Ca2+ influx could increase their modifiability. This modulation of plasticity was mediated by Ca2+ flux through NMDA and voltage-gated calcium channels and was lost within 48 hr. A more permanent enhancement of synaptic plasticity was achieved by selectively reducing the Ca2+ flux associated with uncorrelated activity via adjustment of the voltage-dependent Mg2+ block of the NMDAR. Upregulation of NR2B-containing NMDARs induced by this treatment is an important but not sole contributor to the enhancement of plasticity. Thus, quantity and quality of activity have differential effects on the intrinsic plasticity of neurons.	RIKEN, MIT, Ctr Neurosci, Cambridge, MA 02139 USA; Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN	Liu, GS (corresponding author), Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	liu@mit.edu		Slutsky, Inna/0000-0002-0700-2266	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037342] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58880] Funding Source: Medline; NINDS NIH HHS [NS37342] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P1826; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KAPAKI E, 1989, ACTA NEUROL SCAND, V79, P373, DOI 10.1111/j.1600-0404.1989.tb03803.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Raastad M, 2003, J PHYSIOL-LONDON, V548, P745, DOI 10.1113/jphysiol.2002.032706; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TIMNEY B, 1978, EXP BRAIN RES, V31, P547; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WOODBURY J, 1968, NEUROLOGY, V18, P700, DOI 10.1212/WNL.18.7.700; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	67	98	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					835	849		10.1016/j.neuron.2004.11.013	http://dx.doi.org/10.1016/j.neuron.2004.11.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572114	Bronze			2022-12-24	WOS:000225548400011
J	Preat, T				Preat, T			Diverse mechanisms to remember various odors	NEURON			English	Editorial Material							CONSOLIDATED MEMORY; DROSOPHILA; EXPRESSION; NEURONS		CNRS, Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France.			Preat, Thomas/0000-0001-9976-1763				BRAND AH, 1993, DEVELOPMENT, V118, P401; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5	9	0	0	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					404	405		10.1016/j.neuron.2004.10.022	http://dx.doi.org/10.1016/j.neuron.2004.10.022			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504321	Bronze			2022-12-24	WOS:000224771700003
J	Elia, LP; Yamamoto, M; Zang, KL; Reichardt, LF				Elia, Lisa P.; Yamamoto, Miya; Zang, Keling; Reichardt, Louis F.			p120 Catenin regulates dendritic spine and synapse development through Rho-family GTPases and cadherins	NEURON			English	Article							BETA-CATENIN; N-CADHERIN; TYROSINE PHOSPHORYLATION; CELL-ADHESION; DELTA-CATENIN; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; CONTACT FORMATION; NERVOUS-SYSTEM; NMDA RECEPTOR	Both the cadherin-catenin complex and Rho-family GTPases have been shown to regulate dendrite development. We show here a role for p120 catenin (p120ctn) in regulating spine and synapse formation in the developing mouse brain. p120catenin gene deletion in hippocampal pyramidal neurons in vivo resulted in reduced spine and synapse densities along dendrites. In addition, p120 catenin loss resulted in reduced cadherin levels and misregulation of Rho-family GTPases, with decreased Rac1 and increased RhoA activity. Analyses in vitro indicate that the reduced spine density reflects aberrant Rho-family GTPase signaling, whereas the effects on spine maturation appear to result from reduced cadherin levels and possibly aberrant Rho-family GTPase signaling. Thus, p120ctn acts as a signal coordinator between cadherins and Rho-family GTPases to regulate cytoskeletal changes required during spine and synapse development.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 1550 4th St, San Francisco, CA 94143 USA.	lfr@cgl.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-25, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Esser S, 1998, J CELL SCI, V111, P1853; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Gorski JA, 2002, J NEUROSCI, V22, P6309; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hering H, 2003, J NEUROSCI, V23, P11759; Ho C, 2000, J COMP NEUROL, V420, P261; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Orsulic S, 2000, J CELL SCI, V113, P1793; Ozawa M, 2001, J CELL SCI, V114, P503; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	71	160	163	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					43	56		10.1016/j.neuron.2006.05.018	http://dx.doi.org/10.1016/j.neuron.2006.05.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815331	Bronze, Green Accepted			2022-12-24	WOS:000239037700009
J	Greger, IH; Akamine, P; Khatri, L; Ziff, EB				Greger, Ingo H.; Akamine, Pearl; Khatri, Latika; Ziff, Edward B.			Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis	NEURON			English	Article							GLUTAMATE-OPERATED CHANNELS; LIGAND-BINDING CORE; AMINO-ACID-RESIDUES; KINETIC-PROPERTIES; ENDOPLASMIC-RETICULUM; RECOMBINANT AMPA; QUALITY-CONTROL; MESSENGER-RNAS; POINT MUTATION; DESENSITIZATION	The subunit composition determines AMPA receptor (AMPA-R) function and trafficking. Mechanisms underlying channel assembly are thus central to the efficacy and plasticity of glutamatergic synapses. We previously showed that RNA editing at the Q/R site of the GluR2 subunit contributes to the assembly of AMPAR heteromers by attenuating formation of GluR2 homotetramers. Here we report that this function of the Q/R site depends on subunit contacts between adjacent ligand binding domains (LBDs). Changes of LBD interface contacts alter GluR2 assembly properties, forward traffic, and expression at synapses. Interestingly, developmentally regulated RNA editing within the LBD (at the R/G site) produces analogous effects. Our data reveal that editing to glycine reduces the self-assembly competence of this critical subunit and slows GluR2 maturation in the endoplasmic reticulum (ER). Therefore, RNA editing sites, located at strategic subunit interfaces, shape AMPA-R assembly and trafficking in a developmentally regulated manner.	MRC, Lab Mol Biol, Neurobiol Div, Cambridge CB2 2QH, England; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	MRC Laboratory Molecular Biology; New York University	Greger, IH (corresponding author), MRC, Lab Mol Biol, Neurobiol Div, Cambridge CB2 2QH, England.	ig@mrc-lmb.cam.ac.uk		Ziff, Edward/0000-0001-7389-8649	MRC [MC_U105174197] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; Medical Research Council [MC_U105174197] Funding Source: Medline; NIA NIH HHS [AG13620] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Banke TG, 2001, J NEUROSCI, V21, P3052, DOI 10.1523/JNEUROSCI.21-09-03052.2001; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BASS MF, 2001, ANNU REV BIOCHEM, V71, P817; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fleck MW, 2003, J NEUROSCI, V23, P1219; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Gurevich I, 2002, J NEUROSCI, V22, P10529; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Norledge BV, 1996, NAT STRUCT BIOL, V3, P267, DOI 10.1038/nsb0396-267; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Paternain AV, 2003, J NEUROSCI, V23, P8641; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Sans N, 2003, J NEUROSCI, V23, P9367; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Singh J., 1992, ATLAS PROTEIN SIDE C; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	73	82	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					85	97		10.1016/j.neuron.2006.05.020	http://dx.doi.org/10.1016/j.neuron.2006.05.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815334	Bronze			2022-12-24	WOS:000239037700012
J	Perez-Garci, E; Gassmann, M; Bettler, B; Larkum, ME				Perez-Garci, E; Gassmann, M; Bettler, B; Larkum, ME			The GABA(B1b) isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons	NEURON			English	Article							RAT VISUAL-CORTEX; GABAERGIC NEURONS; IN-VIVO; SUBCELLULAR-LOCALIZATION; COINCIDENCE DETECTION; RECEPTOR SUBUNITS; ACTION-POTENTIALS; APICAL DENDRITES; CEREBRAL-CORTEX; MESSENGER-RNA	The apical tuft of layer 5 pyramidal neurons is innervated by a large number of inhibitory inputs with unknown functions. Here, we studied the functional consequences and underlying molecular mechanisms of apical inhibition on dendritic spike activity. Extracellular stimulation of layer 1, during blockade of glutamatergic transmission, inhibited the dendritic Ca2+ spike for up to 400 ms. Activation of metabotropic GABA(B) receptors was responsible for a gradual and long-lasting inhibitory effect, whereas GABA(A) receptors mediated a short-lasting (similar to 150 ms) inhibition. Our results suggest that the mechanism underlying the GABAB inhibition of Ca2+ spikes involves direct blockade of dendritic Ca2+ channels. By using knockout mice for the two predominant GABA(B1) isoforms, GABA(B1a). and GABA(B1b), we showed that postsynaptic inhibition of Ca2+ spikes is mediated by GABA(B1b), whereas presynaptic inhibition of GABA release is mediated by GABA(B1a). We conclude that the molecular subtypes of GABA(B) receptors play strategically different physiological roles in neocortical neurons.	Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland; Univ Basel, Pharmazentrum, Dept Clin Biol Sci, Inst Physiol, CH-4056 Basel, Switzerland	University of Bern; University of Basel	Perez-Garci, E (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.		bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207; Larkum, Matthew/0000-0001-9799-2656; Gassmann, Martin/0000-0001-6201-3032				AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BEULIEU C, 1992, CEREB CORTEX, V2, P295; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bischoff S, 1999, J COMP NEUROL, V412, P1; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; Chu ZG, 2003, J NEUROSCI, V23, P96; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Costa E, 2002, NEUROPHARMACOLOGY, V43, P925, DOI 10.1016/S0028-3908(02)00199-5; DEBLAS AL, 1988, J NEUROSCI, V8, P602; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Diamond ME, 1995, CEREBR CORT, V11, P189; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, J COMP NEUROL, V406, P346, DOI 10.1002/(SICI)1096-9861(19990412)406:3<346::AID-CNE4>3.0.CO;2-E; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HELMCHEN F, 2005, IMAGING NEUROSCIENCE, P253; Hestrin S, 1996, J NEUROSCI, V16, P5290; HOUSER CR, 1983, J NEUROCYTOL, V12, P617, DOI 10.1007/BF01181527; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Olson IR, 2001, BRAIN, V124, P1417, DOI 10.1093/brain/124.7.1417; Poorkhalkali N, 2000, ANAT EMBRYOL, V201, P1, DOI 10.1007/PL00008224; Princivalle AP, 2001, NEUROREPORT, V12, P591, DOI 10.1097/00001756-200103050-00032; Radnikow G, 2002, J NEUROSCI, V22, P6908; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schiller Y, 2004, J NEUROPHYSIOL, V92, P862, DOI 10.1152/jn.00972.2003; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; Shlosberg D, 2003, EUR J NEUROSCI, V18, P2751, DOI 10.1111/j.1460-9568.2003.03016.x; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; WONG RKS, 1979, SCIENCE, V204, P1228, DOI 10.1126/science.451569; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	74	194	202	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					603	616		10.1016/j.neuron.2006.04.019	http://dx.doi.org/10.1016/j.neuron.2006.04.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701210	Bronze			2022-12-24	WOS:000237875200011
J	Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL				Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL			Ghrelin controls hippocampal spine synapse density and memory performance	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS-ALTERNATION; GLUCOSE-CONCENTRATION; INTRASEPTAL MORPHINE; GROWTH-HORMONE; ACETYLCHOLINE OUTPUT; SPATIAL MEMORY; MEDIAL SEPTUM; BRAIN; ATTENUATION; INFUSIONS	The gut hormone and neuropeptide ghrelin affects energy balance and growth hormone release through hypothalamic action that involves synaptic plasticity in the melanocortin system. Ghrelin binding is also present in other brain areas, including the telencephalon, where its function remains elusive. Here we report that circulating ghrelin enters the hippocampus and binds to neurons of the hippocampal formation, where it promotes dendritic spine synapse formation and generation of long-term potentiation. These ghrelin-induced synaptic changes are paralleled by enhanced spatial learning and memory. Targeted disruption of the gene that encodes ghrelin resulted in decreased numbers of spine synapses in the CA1 region and impaired performance of mice in behavioral memory testing, both of which were rapidly reversed by ghrelin administration. Our observations reveal an endogenous function of ghrelin that links metabolic control with higher brain functions and suggest novel therapeutic strategies to enhance learning and memory processes.	Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT 06520 USA; VA Med Ctr, GRECC, St Louis, MO 63106 USA; St Louis Univ, Sch Med, Div Geriatr Med, Dept Internal Med, St Louis, MO 63103 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Rockefeller Univ, Howard Hughes Med Inst, Dept Mol Genet, New York, NY 10021 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Yale University; Geriatric Research Education & Clinical Center; Saint Louis University; University System of Ohio; University of Cincinnati; Yale University; Howard Hughes Medical Institute; Rockefeller University; Regeneron; Washington University (WUSTL); Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	morley, john e/F-9177-2011; Morley, John Edward/K-1570-2019; Silva, Ivaldo/E-4143-2012; Banks, William A/K-1330-2017; Horvath, Balazs/GQH-5692-2022; Tschoep, Matthias H/I-5443-2014; Xu, Lin/C-4662-2011	morley, john e/0000-0001-6444-2965; Silva, Ivaldo/0000-0002-2370-943X; Banks, William A/0000-0002-0496-3619; Horvath, Balazs/0000-0002-1566-6564; Tschoep, Matthias/0000-0002-4744-371X; Farr, Susan/0000-0002-0481-2570	NIAAA NIH HHS [AA12743] Funding Source: Medline; NIA NIH HHS [AG22880] Funding Source: Medline; NIDDK NIH HHS [DK61619, DK60711, DK70039, DK7386] Funding Source: Medline; NINDS NIH HHS [NS41725, NS40525] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386, R01DK070039, R01DK061619, R01DK060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040525, R01NS041725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012743] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BOSTOCK E, 1988, BEHAV NEUROSCI, V102, P643, DOI 10.1037/0735-7044.102.5.643; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Grove KL, 2005, J CLIN INVEST, V115, P3393, DOI 10.1172/JCI27211; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Horvath TL, 2003, CURR PHARM DESIGN, V9, P1383, DOI 10.2174/1381612033454748; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; McNay EC, 1998, J NEUROSCI, V18, P3853; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; RAGOZZINO ME, 1994, BRAIN RES, V655, P77, DOI 10.1016/0006-8993(94)91599-7; Ragozzino ME, 1995, BEHAV NEUROSCI, V109, P1074; RAGOZZINO ME, 1992, BRAIN RES, V597, P241, DOI 10.1016/0006-8993(92)91480-3; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Seyler DE, 2000, DRUG DEVELOP RES, V49, P260, DOI 10.1002/1098-2299(200004)49:4<260::AID-DDR5>3.0.CO;2-6; Talley CP, 1999, NEUROBIOL LEARN MEM, V71, P62, DOI 10.1006/nlme.1998.3861; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; WAN RQ, 1995, NEUROBIOL LEARN MEM, V63, P74, DOI 10.1006/nlme.1995.1007; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	42	645	675	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					381	388		10.1038/nn1656	http://dx.doi.org/10.1038/nn1656			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491079				2022-12-24	WOS:000235645600018
J	Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ				Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ			Altering expectancy dampens neural response to aversive taste in primary taste cortex	NATURE NEUROSCIENCE			English	Article; Proceedings Paper	34th Annual Meeting of the Society-for-Neuroscience	OCT 23-27, 2004	San Diego, CA	Soc Neurosci			FUNCTIONAL NEUROANATOMY; GUSTATORY CORTEX; INSULAR CORTEX; MACAQUE MONKEY; CONFIDENCE-INTERVALS; PLACEBO; PAIN; ACTIVATION; HUMANS; REPRESENTATION	The primary taste cortex consists of the insula and operculum. Previous work has indicated that neurons in the primary taste cortex respond solely to sensory input from taste receptors and lingual somatosensory receptors. Using functional magnetic resonance imaging, we show here that expectancy modulates these neural responses in humans. When subjects were led to believe that a highly aversive bitter taste would be less distasteful than it actually was, they reported it to be less aversive than when they had accurate information about the taste and, moreover, the primary taste cortex was less strongly activated. In addition, the activation of the right insula and operculum tracked online ratings of the aversiveness for each taste. Such expectancy-driven modulation of primary sensory cortex may affect perceptions of external events.	Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, Madison, WI 53705 USA; Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychol, Madison, WI 53705 USA; Princeton Univ, Dept Psychol, Ctr Study Brain, Princeton, NJ 08544 USA; Columbia Univ, Dept Psychol, New York, NY 10027 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Texas, Med Branch, Mind Brain Body & Hlth Initiat, Galveston, TX 77555 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Columbia University; Harvard University; University of Texas System; University of Texas Medical Branch Galveston	Nitschke, JB (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, 1500 Highland Ave, Madison, WI 53705 USA.	jnitschke@wisc.edu; rjdavids@wisc.edu	sarinopoulos, isidoros/B-5453-2010	Sarinopoulos, Issidoros/0000-0001-9879-5515; Short, Sarah/0000-0003-0985-999X; Davidson, Richard/0000-0002-8506-4964	NICHD NIH HHS [P30 HD03352] Funding Source: Medline; NIMH NIH HHS [T32-MH18931, K05-MH00875, K08-MH63984, MH43454, MH40747, P50-MH52354] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040747, K05MH000875, P50MH052354, K08MH063984, R37MH043454, R01MH043454, T32MH018931] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2000, J NEUROSCI, V20, P2683; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benedetti F, 1999, J NEUROSCI, V19, P3639; Bornstein W S, 1940, Yale J Biol Med, V12, P719; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Damasio A. R., 2003, LOOKING SPINOZA JOY; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mai JK, 2004, ATLAS HUMAN BRAIN; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Montgomery G, 1996, PSYCHOL SCI, V7, P174, DOI 10.1111/j.1467-9280.1996.tb00352.x; MOTTA G, 1959, Bull Sci Med (Bologna), V131, P480; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OGAWA H, 1994, NEUROSCI RES, V20, P1, DOI 10.1016/0168-0102(94)90017-5; Ostrowsky K, 2000, EPILEPSIA, V41, P681, DOI 10.1111/j.1528-1157.2000.tb00228.x; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Penfield W, 1954, EPILEPSY FUNCTIONAL; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; PFAFFMANN C, 1971, HDB SENSORY PHYSL, P75; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; ROLLS ET, 1988, J PHYSIOL-LONDON, V397, P1, DOI 10.1113/jphysiol.1988.sp016984; ROLLS ET, 1999, BRAIN EMOTION; SCOTT TR, 1986, J NEUROPHYSIOL, V56, P876, DOI 10.1152/jn.1986.56.3.876; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; SUDAKOV K, 1971, BRAIN RES, V28, P19, DOI 10.1016/0006-8993(71)90521-X; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanriover N, 2004, J NEUROSURG, V100, P891, DOI 10.3171/jns.2004.100.5.0891; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; YAXLEY S, 1988, PHYSIOL BEHAV, V42, P223, DOI 10.1016/0031-9384(88)90074-1; YAXLEY S, 1990, J NEUROPHYSIOL, V63, P689, DOI 10.1152/jn.1990.63.4.689; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	50	145	149	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					435	442		10.1038/nn1645	http://dx.doi.org/10.1038/nn1645			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	016UI	16462735				2022-12-24	WOS:000235645600024
J	He, W; Lam, TKT; Obici, S; Rossetti, L				He, W; Lam, TKT; Obici, S; Rossetti, L			Molecular disruption of hypothalamic nutrient sensing induces obesity	NATURE NEUROSCIENCE			English	Article							HEPATIC GLUCOSE-PRODUCTION; FOOD-INTAKE; MALONYL-COA; LEPTIN RECEPTOR; BODY-WEIGHT; INSULIN-RESISTANCE; FATTY-ACIDS; AMP-KINASE; RATS; GENE	The sensing of circulating nutrients within the mediobasal hypothalamus may be critical for energy homeostasis. To induce a sustained impairment in hypothalamic nutrient sensing, adeno-associated viruses ( AAV) expressing malonyl-coenzyme A decarboxylase ( MCD; an enzyme involved in the degradation of malonyl coenzyme A) were injected bilaterally into the mediobasal hypothalamus of rats. MCD overexpression led to decreased abundance of long-chain fatty acyl-coenzyme A in the mediobasal hypothalamus and blunted the hypothalamic responses to increased lipid availability. The enhanced expression of MCD within this hypothalamic region induced a rapid increase in food intake and progressive weight gain. Obesity was sustained for at least 4 months and occurred despite increased plasma concentrations of leptin and insulin. These findings indicate that nutritional modulation of the hypothalamic abundance of malonyl-coenzyme A is required to restrain food intake and that a primary impairment in this central nutrient-sensing pathway is sufficient to disrupt energy homeostasis and induce obesity.	Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Diabet Res, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Ctr Diabet Res, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HOSOKAWA Y, 1986, ANAL BIOCHEM, V153, P45, DOI 10.1016/0003-2697(86)90058-8; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	31	178	183	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					227	233		10.1038/nn1626	http://dx.doi.org/10.1038/nn1626			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415870				2022-12-24	WOS:000234990100018
J	Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ				Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ			An essential role for Delta FosB in the nucleus accumbens in morphine action	NATURE NEUROSCIENCE			English	Article							KAPPA-OPIOID RECEPTORS; CHRONIC COCAINE; WITHDRAWAL SYNDROME; OPIATE WITHDRAWAL; TRANSGENIC MICE; BRAIN; ADDICTION; SYSTEMS; REWARD; EXPRESSION	The transcription factor Delta FosB is induced in the nucleus accumbens ( NAc) and dorsal striatum by the repeated administration of drugs of abuse. Here, we investigated the role of DFosB in the NAc in behavioral responses to opiates. We achieved overexpression of DFosB by using a bitransgenic mouse line that inducibly expresses the protein in the NAc and dorsal striatum and by using viral-mediated gene transfer to specifically express the protein in the NAc. DFosB overexpression in the NAc increased the sensitivity of the mice to the rewarding effects of morphine and led to exacerbated physical dependence, but also reduced their sensitivity to the analgesic effects of morphine and led to faster development of analgesic tolerance. The opioid peptide dynorphin seemed to be one target through which DFosB produced this behavioral phenotype. Together, these experiments demonstrated that DFosB in the NAc, partly through the repression of dynorphin expression, mediates several major features of opiate addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Crete, Fac Med, Dept Basic Sci, Iraklion 71003, Crete, Greece; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Penn, Sch Med, Dept Anesthesia, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Crete; Virginia Commonwealth University; University of Pennsylvania	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kelz, Max/E-4054-2010; Kumar, Arvind/B-6094-2009; Zachariou, Venetia/L-2726-2016	Kelz, Max/0000-0002-2803-6078; Kumar, Arvind/0000-0003-2879-3826; DiLeone, Ralph/0000-0002-4770-2590				AKIL H, 1994, PROG BRAIN RES, V100, P81; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chefer VI, 2005, J NEUROSCI, V25, P5029, DOI 10.1523/JNEUROSCI.0854-05.2005; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; FUNADA M, 1993, NEUROPHARMACOLOGY, V32, P1315; GEAR RW, 1995, J NEUROSCI, V15, P3154; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; HARRIS GC, 1994, NATURE, V371, P155, DOI 10.1038/371155a0; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; MALDONADO R, 1992, J PHARMACOL EXP THER, V261, P669; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nye HE, 1996, MOL PHARMACOL, V49, P636; NYLANDER I, 1995, PSYCHOPHARMACOLOGY, V118, P391, DOI 10.1007/BF02245939; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pich EM, 1997, SCIENCE, V275, P83; Robinson TE, 2000, ADDICTION, V95, pS91; Schmidt BL, 2002, J NEUROSCI, V22, P6773; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Shippenberg TS, 1996, EUR J PHARMACOL, V299, P33, DOI 10.1016/0014-2999(95)00852-7; Shippenberg TS, 1998, EUR J PHARMACOL, V345, P27, DOI 10.1016/S0014-2999(97)01614-2; Shippenberg TS, 2001, ANN NY ACAD SCI, V937, P50; SUZUKI T, 1992, EUR J PHARMACOL, V213, P91, DOI 10.1016/0014-2999(92)90237-X; Svingos AL, 1999, J NEUROSCI, V19, P1804; Wang XM, 1999, MOL BRAIN RES, V66, P184, DOI 10.1016/S0169-328X(99)00021-2; Werme M, 2002, J NEUROSCI, V22, P8133; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; YUKHANANOV RY, 1993, NEUROPHARMACOLOGY, V32, P703, DOI 10.1016/0028-3908(93)90084-G; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	50	202	209	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					205	211		10.1038/nn1636	http://dx.doi.org/10.1038/nn1636			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415864				2022-12-24	WOS:000234990100015
J	de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R				de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R			Threshold behavior in the initiation of hippocampal population bursts	NEURON			English	Article							RECURRENT COLLATERAL SYNAPSES; SPONTANEOUS NETWORK ACTIVITY; EPILEPTIFORM BURSTS; IN-VITRO; FIRING PATTERNS; HIGH POTASSIUM; SPINAL-CORD/; RAT; NEURONS; SYNCHRONIZATION	Hippocampal population discharges such as sharp waves, epileptiform firing, and GDPs recur at long and variable intervals. The mechanisms for their precise timing are not well understood. Here, we show that population bursts in the disinhibited CA3 region are initiated at a threshold level of population firing after recovery from a previous event. Each population discharge follows an active buildup period when synaptic traffic and cell firing increase to threshold levels. Single-cell firing can advance burst onset by increasing population firing to suprathreshold values. Population synchrony is suppressed when threshold frequencies cannot be reached due to reduced cellular excitability or synaptic efficacy. Reducing synaptic strength reveals partially synchronous population bursts that are curtailed by GABA(B)-mediated conductances. Excitatory glutamatergic transmission and delayed GABA(B)-mediated signals have opposing feedback effects on CA3 cell firing and so determine threshold behavior for population synchrony.	Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France; Hosp Ramon y Cajal, E-28034 Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario Ramon y Cajal	de la Prida, LM (corresponding author), Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France.	liset.m.prida@hrc.es	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Cohen, Ivan/0000-0001-6046-5289; Miles, Richard/0000-0001-7303-0233	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agmon A, 2003, J NEUROSCI, V23, P3658; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Ankri N, 1999, J NEUROSCI METH, V91, P83, DOI 10.1016/S0165-0270(99)00078-3; Aradi I, 2004, J NEUROSCI, V24, P9681, DOI 10.1523/JNEUROSCI.2800-04.2004; AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; CALVIN WH, 1972, BRAIN RES, V39, P71, DOI 10.1016/0006-8993(72)90786-X; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; COLOM LV, 1994, J NEUROPHYSIOL, V71, P1574, DOI 10.1152/jn.1994.71.4.1574; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 1999, J NEUROPHYSIOL, V82, P202, DOI 10.1152/jn.1999.82.1.202; de la Prida LM, 2000, NEUROSCIENCE, V97, P227, DOI 10.1016/S0306-4522(00)00029-4; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Grzywacz NM, 2000, VISUAL NEUROSCI, V17, P229, DOI 10.1017/S0952523800172050; HABLITZ JJ, 1984, J NEUROPHYSIOL, V51, P1011, DOI 10.1152/jn.1984.51.5.1011; IVES AE, 1990, NEUROSCI LETT, V112, P239, DOI 10.1016/0304-3940(90)90210-Z; Jack J, 1983, ELECT CURRENT FLOW E; JEFFERYS JGR, 1994, CURR OPIN NEUROL, V7, P113, DOI 10.1097/00019052-199404000-00007; KNOWLES WD, 1987, NEUROSCIENCE, V21, P441, DOI 10.1016/0306-4522(87)90134-5; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; LEUNG LWS, 1992, HIPPOCAMPUS, V2, P93, DOI 10.1002/hipo.450020202; Levy R, 2000, J NEUROSCI, V20, P7766; MASUKAWA LM, 1982, BRAIN RES, V242, P341, DOI 10.1016/0006-8993(82)90320-1; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; TRAUB RD, 1990, J NEUROPHYSIOL, V64, P1009, DOI 10.1152/jn.1990.64.3.1009; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TRAUB RD, 1991, NEUROONAL NETWORKS H; Wenner P, 2001, J NEUROPHYSIOL, V86, P1481, DOI 10.1152/jn.2001.86.3.1481	51	133	135	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					131	142		10.1016/j.neuron.2005.10.034	http://dx.doi.org/10.1016/j.neuron.2005.10.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387645	Bronze, Green Submitted			2022-12-24	WOS:000236699300015
J	Koizumi, H; Tanaka, T; Gleeson, JG				Koizumi, H; Tanaka, T; Gleeson, JG			doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration	NEURON			English	Article							LISSENCEPHALY GENE; CALLOSAL AXONS; MOUSE; LIS1; EXPRESSION; MAP1B; MICE; TAU; CONNECTIONS; OUTGROWTH	The potential role of doublecortin (Dcx), encoding a microtubule-associated protein, in brain development has remained controversial. Humans with mutations show profound alterations in cortical lamination, whereas in mouse, RNAi-mediated knockdown but not germline knockout shows abnormal positioning of cortical neurons. Here, we report that the doublecortin-like kinase (Dclk) gene functions in a partially redundant pathway with Dcx in the formation of axonal projections across the midline and migration of cortical neurons. Dosage-dependent genetic effects were observed in both interhemispheric connectivity and migration of cortically and subcortically derived neurons. Surprisingly, RNAi-mediated knockdown of either gene results in similar migration defects. These results indicate the Dcx microtubule-associated protein family is required for proper neuronal migration and axonal wiring.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 93093 USA	University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 93093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS041537, NS47101, NS42749, NS41537] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, K02NS042749, P30NS047101] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Edelman AM, 2005, J BIOL CHEM, V280, P8531, DOI 10.1074/jbc.M411027200; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gotz M, 2003, NAT NEUROSCI, V6, P1245, DOI 10.1038/nn1203-1245; GREGORY WA, 1988, J NEUROSCI, V8, P1728; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hedin-Pereira C, 1999, CEREB CORTEX, V9, P50, DOI 10.1093/cercor/9.1.50; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Lin PT, 2000, J NEUROSCI, V20, P9152; Matsumoto N, 1999, GENOMICS, V56, P179, DOI 10.1006/geno.1998.5673; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NORRIS CR, 1991, J NEUROSCI, V11, P3481; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Omori Y, 1998, J HUM GENET, V43, P169, DOI 10.1007/s100380050063; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	51	194	202	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					55	66		10.1016/j.neuron.2005.10.040	http://dx.doi.org/10.1016/j.neuron.2005.10.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387639	Bronze			2022-12-24	WOS:000236699300009
J	Karpova, AY; Tervo, DGR; Gray, NW; Svoboda, K				Karpova, AY; Tervo, DGR; Gray, NW; Svoboda, K			Rapid and reversible chemical inactivation of synaptic transmission in genetically targeted neurons	NEURON			English	Article							GENE-EXPRESSION; IN-VIVO; DROSOPHILA; PROTEIN; DISRUPTION; RECEPTORS; CHANNEL; NEUROTRANSMISSION; SUPPRESSION; TRAFFICKING	Inducible and reversible silencing of selected neurons in vivo is critical to understanding the structure and dynamics of brain circuits. We have developed Molecules for Inactivation of Synaptic Transmission (MISTs) that can be genetically targeted to allow the reversible inactivation of neurotransmitter release. MISTs consist of modified presynaptic proteins that interfere with the synaptic vesicle cycle when crosslinked by small molecule "dimerizers." MISTs based on the vesicle proteins VAMP2/Synaptobrevin and Synaptophysin induced rapid (similar to 10 min) and reversible block of synaptic transmission in cultured neurons and brain slices. In transgenic mice expressing MISTs selectively in Purkinje neurons, administration of dimerizer reduced learning and performance of the rotarod behavior. MISTs allow for specific, inducible, and reversible lesions in neuronal circuits and may provide treatment of disorders associated with neuronal hyperactivity.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu		Gray, Noah/0000-0002-4672-7403				Abe K, 2003, INT REV NEUROBIOL, V55, P243, DOI 10.1016/S0074-7742(03)01011-0; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Clackson T, 1997, CURR OPIN CHEM BIOL, V1, P210, DOI 10.1016/S1367-5931(97)80012-9; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hallett Mark, 2004, Adv Neurol, V94, P1; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Hogarth Penelope, 2003, Curr Neurol Neurosci Rep, V3, P279, DOI 10.1007/s11910-003-0003-3; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Jin LQ, 2000, NAT GENET, V26, P64, DOI 10.1038/79194; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lalonde R, 1996, NEUROBIOL LEARN MEM, V65, P113, DOI 10.1006/nlme.1996.0013; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Mallet VO, 2002, NAT BIOTECHNOL, V20, P1234, DOI 10.1038/nbt762; Marek KW, 2003, CURR OPIN NEUROBIOL, V13, P607, DOI 10.1016/j.conb.2003.09.001; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rustay NR, 2003, BEHAV BRAIN RES, V141, P237, DOI 10.1016/S0166-4328(02)00376-5; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; White LJ, 2001, SOFTW TEST VERIF REL, V11, P1, DOI 10.1002/stvr.220; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	66	81	84	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					727	735		10.1016/j.neuron.2005.11.015	http://dx.doi.org/10.1016/j.neuron.2005.11.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337911	Bronze			2022-12-24	WOS:000233927300012
J	Mandiyan, VS; Coats, JK; Shah, NM				Mandiyan, VS; Coats, JK; Shah, NM			Deficits in sexual and aggressive behaviors in Cnga2 mutant mice	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; DISRUPTION; ODORANTS; DISTINCT; ANOSMIA	Odors detected by the vomeronasal organ or the main olfactory epithelium (MOE) trigger social behaviors in many animals. It is unknown whether MOE neurons detect cues that initiate mating or aggression. We demonstrate that mice lacking functional CNGA2 ( cyclic nucleotide - gated channel alpha 2), which is required for odor-evoked MOE signaling, fail to mate or fight, suggesting a broad and essential role for the MOE in regulating these behaviors.	Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, Box 2722, San Francisco, CA 94143 USA.	nms@itsa.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049488] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DEVOR M, 1973, BEHAV BIOL, V9, P31, DOI 10.1016/S0091-6773(73)80166-X; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	15	204	210	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1660	1662		10.1038/nn1589	http://dx.doi.org/10.1038/nn1589			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261133				2022-12-24	WOS:000233576200012
J	Adelsberger, H; Garaschuk, O; Konnerth, A				Adelsberger, H; Garaschuk, O; Konnerth, A			Cortical calcium waves in resting newborn mice	NATURE NEUROSCIENCE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; NETWORKS; DIFFERENTIATION; PLASTICITY; SPIKES; CORTEX	Using a new optical fiber - based approach, we demonstrate the presence of recurrent Ca2+ transients in cortical neurons of non-anesthetized newborn mice in vivo. These Ca2+ waves reflect the correlated activity of thousands of cells and were detected only in resting, but not in moving pups. Our results suggest that Ca2+-dependent cortical maturation occurs predominantly during the intermittent sleep-like resting periods that are characteristic for the first days of postnatal life.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.	konnerth@lrz.uni-muenchen.de	Garaschuk, Olga/G-5633-2015					Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; DASZUTA A, 1985, BRAIN RES, V354, P39; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GU XN, 1994, J NEUROSCI, V14, P6325; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; UYLINGS HBM, 1990, CEREBRAL CORTEX RAT, P36; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	15	187	196	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					988	990		10.1038/nn1502	http://dx.doi.org/10.1038/nn1502			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007081				2022-12-24	WOS:000230760200008
J	Morishita, W; Marie, H; Malenka, RC				Morishita, W; Marie, H; Malenka, RC			Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CALCIUM-DEPENDENT INACTIVATION; ALPHA-ACTININ; RECEPTORS; CALMODULIN; TRANSMISSION; BINDING; ENDOCYTOSIS; CHANNEL; DYNAMIN	Although long-term depression (LTD) of AMPA receptor - mediated postsynaptic currents (AMPAR EPSCs) has been extensively examined, little is known about the mechanisms responsible for LTD of NMDA receptor ( NMDAR)- mediated EPSCs. Here we show differences in the intracellular signaling cascades that mediate LTD of AMPAR EPSCs versus NMDAR EPSCs in rat hippocampus. Both forms of LTD were blocked by inhibitors of protein phosphatase 1, but only LTD of AMPAR EPSCs was affected by inhibition of calcineurin. Notably, in contrast to LTD of AMPAR EPSCs, LTD of NMDAR EPSCs was unaffected by endocytosis inhibitors. A role for calcium-dependent actin depolymerization in LTD of NMDAR EPSCs was supported by the findings that the actin stabilizer phalloidin and a cofilin inhibitory peptide each blocked LTD of NMDAR EPSCs but not AMPAR EPSCs. These results suggest that the same pattern of afferent activity elicits depression of AMPAR- and NMDAR-mediated synaptic responses by means of distinct triggering and expression mechanisms.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011	Marie, Hélène/0000-0003-2310-6097	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Kim CH, 1999, J NEUROSCI, V19, P4314; Kotecha SA, 2003, INT REV NEUROBIOL, V54, P53; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Li B, 2003, J NEUROSCI, V23, P11244; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Tovar KR, 2002, NEURON, V34, P253; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	141	148	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1043	1050		10.1038/nn1506	http://dx.doi.org/10.1038/nn1506			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025109				2022-12-24	WOS:000230760200016
J	Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P				Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P			Regulation of NMDA receptor trafficking by amyloid-beta	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; FAMILY TRANSCRIPTION FACTOR; TYROSINE PHOSPHATASE STEP; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; GLUTAMATE RECEPTORS	Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta dependent endocytosis of NMDA receptors required the alpha- 7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cornell University; Yale University; Yale University	Snyder, EM (corresponding author), McKinsey & Co Inc, 600 Campus Dr, Florham Pk, NJ 07932 USA.	ericmaltesnyder@gmail.com	Gouras, Gunnar/B-3021-2010; de Almeida, Cláudia Guimas/AAN-8935-2020	Gouras, Gunnar/0000-0002-5500-6325; de Almeida, Cláudia Guimas/0000-0001-9384-2896; Nairn, Angus/0000-0002-7075-0195; Choi, Eun Young/0000-0003-3226-1486	NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NIA NIH HHS [AG09464] Funding Source: Medline; PHS HHS [52711, 01527] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim JH, 2001, J NEUROSCI, V21, P1327; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Levy RB, 2002, J NEUROSCI, V22, P5001, DOI 10.1523/JNEUROSCI.22-12-05001.2002; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mammen AL, 1997, J NEUROSCI, V17, P7351; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; PERDAHL E, 1984, NEUROBEH TOXICOL TER, V6, P425; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stevens TR, 2003, J NEUROSCI, V23, P10093; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	40	1232	1302	0	128	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1051	1058		10.1038/nn1503	http://dx.doi.org/10.1038/nn1503			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025111				2022-12-24	WOS:000230760200017
J	Taketomi, T; Yoshiga, D; Taniguchi, K; Kobayashi, T; Nonami, A; Kato, R; Sasaki, M; Sasaki, A; Ishibashi, H; Moriyama, M; Nakamura, K; Nishimura, J; Yoshimura, A				Taketomi, T; Yoshiga, D; Taniguchi, K; Kobayashi, T; Nonami, A; Kato, R; Sasaki, M; Sasaki, A; Ishibashi, H; Moriyama, M; Nakamura, K; Nishimura, J; Yoshimura, A			Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia	NATURE NEUROSCIENCE			English	Article							TYROSINE KINASE; RET; ACTIVATION; RECEPTOR; GENE	We report here that loss of the Sprouty2 gene (also known as Spry2) in mice resulted in enteric nerve hyperplasia, which led to esophageal achalasia and intestinal pseudo-obstruction. Glial cell line-derived neurotrophic factor (GDNF) induced hyperactivation of ERK and Akt in enteric nerve cells. Anti-GDNF antibody administration corrected nerve hyperplasia in Sprouty2-deficient mice. We show Sprouty2 to be a negative regulator of GDNF for the neonatal development or survival of enteric nerve cells.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Fac Dent Sci, Div Oral & Maxillofacial Oncol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Fac Med, Dept Physiol, Higashi Ku, Fukuoka 8128582, Japan; Kurume Univ, Sch Med, Dept Anat, Kurume, Fukuoka 8300011, Japan; Kyushu Univ, Grad Sch Med Sci, Res Inst Angiocardiol, Div Mol Cardiol, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University; Kurume University; Kyushu University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013; YOSHIGA, Daigo/GZM-9352-2022	YOSHIGA, Daigo/0000-0001-9603-3138; Sasaki, Atsuo/0000-0003-2963-4501				Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; GHOSH P, 1994, AM J GASTROENTEROL, V89, P1880; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Ieiri S, 2001, BRIT J PHARMACOL, V133, P529, DOI 10.1038/sj.bjp.0704122; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; MUNAKATA K, 1985, J PEDIATR SURG, V20, P231, DOI 10.1016/S0022-3468(85)80109-3; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	11	107	112	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					855	857		10.1038/nn1485	http://dx.doi.org/10.1038/nn1485			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937482				2022-12-24	WOS:000230137100009
J	Fried, SI; Munch, TA; Werblin, FS				Fried, SI; Munch, TA; Werblin, FS			Directional selectivity is formed at multiple levels by laterally offset inhibition in the rabbit retina	NEURON			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RECEPTIVE-FIELDS; CHOLINERGIC NEURONS; BIPOLAR CELLS; ACETYLCHOLINE; RESPONSES; COMPUTATION; MECHANISMS; MORPHOLOGY	The excitatory and inhibitory inputs to directionally selective (DS) ganglion cells are themselves directionally selective. Directionality is achieved because excitation is reduced during null-direction movement along a GABAergic pathway. Inhibition is reduced during preferred-direction movement along a pathway that includes cholinergic synapses. Both excitation and inhibition are made directional by laterally offset inhibitory signals similar to the spatial offset of the direct inhibitory input to the DS cell dendrites. Thus, spatially offset lateral inhibition generates directionality at three different levels in the DS circuitry. We also found that for stimuli failing within the dendritic field, cholinergic input is delivered to the OFF but not the ON dendrites. Cholinergic pathways from outside the dendritic field reach both ON and OFF dendrites, but both of these pathways are normally inactivated by GABAergic synapses.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Werblin, FS (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 145 LSA, Berkeley, CA 94720 USA.	werblin@berkeley.edu	Fried, Shelley/S-7954-2016	Fried, Shelley/0000-0001-6456-8656; Munch, Thomas/0000-0002-8884-6961				Amthor FR, 1996, VISUAL NEUROSCI, V13, P303, DOI 10.1017/S0952523800007549; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; Barlow H, 1996, NETWORK-COMP NEURAL, V7, P251, DOI 10.1088/0954-898X/7/2/004; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Brown SP, 1999, J COMP NEUROL, V408, P97; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chiao CC, 2003, NAT NEUROSCI, V6, P1251, DOI 10.1038/nn1147; Chiao CC, 2002, J NEUROSCI, V22, P10509; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2001, CURR OPIN NEUROBIOL, V11, P415, DOI 10.1016/S0959-4388(00)00228-2; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Grzywacz NM, 1998, J PHYSIOL-LONDON, V512, P575, DOI 10.1111/j.1469-7793.1998.575be.x; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Reed BT, 2002, VISUAL NEUROSCI, V19, P427, DOI 10.1017/S0952523802194053; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920	41	96	96	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					117	127		10.1016/j.neuron.2005.02.007	http://dx.doi.org/10.1016/j.neuron.2005.02.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820698	Bronze			2022-12-24	WOS:000228228600013
J	Nguyen, QT; Kleinfeld, D				Nguyen, QT; Kleinfeld, D			Positive feedback in a brainstem tactile sensorimotor loop	NEURON			English	Article							FACIAL NUCLEUS; MEMBRANE-PROPERTIES; HYPOGLOSSAL NUCLEI; SYNAPTIC RESPONSES; RAT; NEURONS; VIBRISSAE; WHISKING; CONNECTIONS; MOTONEURONS	The trigeminal loop in the brainstem comprises the innermost level of sensorimotor feedback in the rat vibrissa system. Anatomy suggests that this loop relays tactile information from the vibrissae to the motoneurons that control vibrissa movement. We demonstrate, using in vitro and in vivo recordings, that the trigeminal loop consists of excitatory pathways from vibrissa sensory inputs to vibrissa motoneurons in the facial nucleus. We further show that the trigeminal loop implements a rapidly depressing reflex that provides positive sensory feedback to the vibrissa musculature during simulated whisking and contact. On the basis of these findings, we propose that the trigeminal loop provides an enhancement of vibrissa muscle tone upon contact during active touch.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59867] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; Ahrens KF, 2002, P NATL ACAD SCI USA, V99, P15176, DOI 10.1073/pnas.222547199; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; BROWN AWS, 1974, J PHYSIOL-LONDON, V238, P387, DOI 10.1113/jphysiol.1974.sp010531; Cabanes C, 2002, J NEUROPHYSIOL, V87, P2398, DOI 10.1152/jn.2002.87.5.2398; Cajal S. Ry, 1909, HIST SYSTEME NERVEUX; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; Dauvergne C, 2001, NEUROSCI LETT, V311, P109, DOI 10.1016/S0304-3940(01)02150-4; DORFL J, 1982, J ANAT, V135, P147; Dumitru D, 1995, ELECTRODIAGNOSTIC ME; ERZURUMLU RS, 1979, J COMP NEUROL, V188, P75, DOI 10.1002/cne.901880107; EVINGER C, 1993, EXP BRAIN RES, V92, P507; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Filipkowski RK, 2001, NEUROSCIENCE, V106, P679, DOI 10.1016/S0306-4522(01)00310-4; FRIAUF E, 1986, J COMP NEUROL, V253, P231, DOI 10.1002/cne.902530209; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Guido W, 2001, DEV BRAIN RES, V132, P97, DOI 10.1016/S0165-3806(01)00283-8; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Holstege Gert, 1995, P257; JACQUIN MF, 1990, SOMATOSENS MOT RES, V7, P399, DOI 10.3109/08990229009144716; Kis Z, 2004, NEUROSCI LETT, V358, P223, DOI 10.1016/j.neulet.2004.01.037; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Lo FS, 1999, J NEUROPHYSIOL, V82, P2765, DOI 10.1152/jn.1999.82.5.2765; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2004, J PHYSIOL-LONDON, V556, P203, DOI 10.1113/jphysiol.2003.060087; Onodera K, 2000, J PHYSIOL-LONDON, V524, P503, DOI 10.1111/j.1469-7793.2000.00503.x; Rice FL, 1997, J COMP NEUROL, V385, P149; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Schicatano EJ, 1997, J NEUROPHYSIOL, V77, P2842, DOI 10.1152/jn.1997.77.5.2842; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Voisin J, 2002, EXP BRAIN RES, V145, P251, DOI 10.1007/s00221-002-1118-5; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WINESKI LE, 1983, J ZOOL, V200, P261; Zerari-Mailly F, 2001, J COMP NEUROL, V429, P80, DOI 10.1002/1096-9861(20000101)429:1<80::AID-CNE7>3.0.CO;2-L; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	47	87	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					447	457		10.1016/j.neuron.2004.12.042	http://dx.doi.org/10.1016/j.neuron.2004.12.042			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694330	Bronze			2022-12-24	WOS:000226787700016
J	Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N				Zelano, C; Bensafi, M; Porter, J; Mainland, J; Johnson, B; Bremner, E; Telles, C; Khan, R; Sobel, N			Attentional modulation in human primary olfactory cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR PIRIFORM CORTEX; PRIMARY VISUAL-CORTEX; ORBITOFRONTAL CORTEX; FUNCTIONAL-HETEROGENEITY; SELECTIVE ATTENTION; SPATIAL ATTENTION; NEURONAL-ACTIVITY; CELL-ACTIVITY; BRAIN; FMRI	Central to the concept of attention is the fact that identical stimuli can be processed in different ways. In olfaction, attention may designate the identical flow of air through the nose as either respiration or olfactory exploration. Here we have used functional magnetic resonance imaging (fMRI) to probe this attentional mechanism in primary olfactory cortex (POC). We report a dissociation in POC that revealed attention-dependent and attention-independent subregions. Whereas a temporal subregion comprising temporal piriform cortex (PirT) responded equally across conditions, a frontal subregion comprising frontal piriform cortex (PirF) and the olfactory tubercle responded preferentially to attended sniffs as opposed to unattended sniffs. In addition, a task-specific anticipatory response occurred in the attention-dependent region only. This dissociation was consistent across two experimental designs: one focusing on sniffs of clean air, the other focusing on odor-laden sniffs. Our findings highlight the role of attention at the earliest cortical levels of olfactory processing.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Wheeler Brain Imaging Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelano, C (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	zelano@socrates.berkeley.edu; nsobel@socrates.berkeley.edu	Bensafi, Moustafa/H-6618-2017; Mainland, Joel/C-5171-2009	Bensafi, Moustafa/0000-0002-2991-3036; Mainland, Joel/0000-0002-5056-4598; Sobel, Noam/0000-0002-3232-9391	NIDCD NIH HHS [R01 DC005958] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005958] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRESSLER SL, 1987, BRAIN RES, V409, P294, DOI 10.1016/0006-8993(87)90714-1; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Effron B, 1993, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fontanini A, 2003, J NEUROSCI, V23, P7993; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Krauel K, 1998, CHEM SENSES, V23, P423, DOI 10.1093/chemse/23.4.423; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mai J.K., 1997, ATLAS HUMAN BRAIN; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; ODOHERTY J, 2000, NEUROREPORT, V11, P983; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2000, PERCEPT PSYCHOPHYS, V62, P1265, DOI 10.3758/BF03212128; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Wandell BA, 2003, NEUROL CLIN, V21, P417, DOI 10.1016/S0733-8619(03)00003-3; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson JL, 2002, MAGNET RESON MED, V48, P906, DOI 10.1002/mrm.10298; Yu YQ, 2004, J NEUROSCI, V24, P3060, DOI 10.1523/JNEUROSCI.4897-03.2004; Zinyuk LE, 2001, BEHAV BRAIN RES, V124, P29, DOI 10.1016/S0166-4328(01)00212-1	44	178	183	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					114	120		10.1038/nn1368	http://dx.doi.org/10.1038/nn1368			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608635				2022-12-24	WOS:000225967600024
J	Tarricone, C; Perrina, F; Monzani, S; Massimiliano, L; Kim, MH; Derewenda, ZS; Knapp, S; Tsai, LH; Musacchio, A				Tarricone, C; Perrina, F; Monzani, S; Massimiliano, L; Kim, MH; Derewenda, ZS; Knapp, S; Tsai, LH; Musacchio, A			Coupling PAF signaling to dynein regulation: Structure of LIS1 in complex with PAF-Acetylhydrolase	NEURON			English	Article							PLATELET-ACTIVATING-FACTOR; SUBCORTICAL BAND HETEROTOPIA; DIEKER LISSENCEPHALY GENE; PROTEIN BETA-SUBUNIT; CYTOPLASMIC DYNEIN; MISSENSE MUTATIONS; NEURONAL MIGRATION; CELLULAR FUNCTION; CRYSTAL-STRUCTURE; WD-REPEAT	Mutations in the LIS1 gene cause lissencephaly, a human neuronal migration disorder. LIS1 binds dynein and the dynein-associated proteins Nde1 (formerly known as NudE), Ndel1 (formerly known as NUDEL), and CLIP-170, as well as the catalytic a dimers of brain cytosolic platelet activating factor acetylhydrolase (PAF-AH). The mechanism coupling the two diverse regulatory pathways remains unknown. We report the structure of LIS1 in complex with the (alpha(2)/alpha(2) PAF-AH homodimer. One LIS1 homodimer binds symmetrically to one alpha(2)/alpha(2) homodimer via the highly conserved top faces of the LIS1 beta propellers. The same surface of LIS1 contains sites of mutations causing lissencephaly and overlaps with a putative dynein binding surface. Ndel1 competes with the alpha(2)/alpha(2) homodimer for LIS1, but the interaction is complex and requires both the N- and C-terminal domains of LIS1. Our data suggest that the LIS1 molecule undergoes major conformational rearrangement when switching from a complex with the acetylhydrolase to the one with Ndel1.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	IRCCS European Institute of Oncology (IEO); University of Virginia; University of Oxford; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Musacchio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	andrea.musacchio@ifom-ieo-campus.it	Knapp, Stefan/AAG-2347-2019; Massimiliano, Lucia/AAP-5179-2020	Knapp, Stefan/0000-0001-5995-6494; Massimiliano, Lucia/0000-0001-9128-4317; Musacchio, Andrea/0000-0003-2362-8784	Fondazione Telethon Funding Source: Custom; NINDS NIH HHS [NS36267] Funding Source: Medline; Telethon [GP0097Y01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036267] Funding Source: NIH RePORTER	Fondazione Telethon(Fondazione Telethon); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi T, 1997, NEUROSCI LETT, V235, P133, DOI 10.1016/S0304-3940(97)00742-8; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; BANKS JB, 1988, BIOCHIM BIOPHYS ACTA, V961, P48, DOI 10.1016/0005-2760(88)90129-4; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Caspi M, 2003, J BIOL CHEM, V278, P38740, DOI 10.1074/jbc.M301147200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gleeson Joseph G., 2000, Current Opinion in Neurology, V13, P121, DOI 10.1097/00019052-200004000-00002; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; HATTORI M, 1993, J BIOL CHEM, V268, P18748; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HAYASHI H, 1985, J BIOCHEM-TOKYO, V97, P1737, DOI 10.1093/oxfordjournals.jbchem.a135232; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kim MH, 2004, STRUCTURE, V12, P987, DOI 10.1016/j.str.2004.03.024; Kitagawa M, 2000, FEBS LETT, V479, P57, DOI 10.1016/S0014-5793(00)01856-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Leventer RJ, 2001, NEUROLOGY, V57, P416, DOI 10.1212/WNL.57.3.416; Liu Z, 1999, DEVELOPMENT, V126, P4477; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757; POLONSKY J, 1980, P NATL ACAD SCI-BIOL, V77, P7019, DOI 10.1073/pnas.77.12.7019; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sheffield PJ, 2001, PROTEIN ENG, V14, P513, DOI 10.1093/protein/14.7.513; Sheffield PJ, 2000, PROTEINS, V39, P1, DOI 10.1002/(SICI)1097-0134(20000401)39:1<1::AID-PROT1>3.0.CO;2-N; Sicca F, 2003, NEUROLOGY, V61, P1042, DOI 10.1212/WNL.61.8.1042; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tokuoka SM, 2003, EUR J NEUROSCI, V18, P563, DOI 10.1046/j.1460-9568.2003.02778.x; Torres FR, 2004, NEUROLOGY, V62, P799, DOI 10.1212/01.WNL.0000113725.46254.FD; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801	50	87	92	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					809	821		10.1016/S0896-6273(04)00751-2	http://dx.doi.org/10.1016/S0896-6273(04)00751-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572112	Bronze			2022-12-24	WOS:000225548400009
J	Zhou, L; Olivier, NB; Yao, H; Young, EC; Siegelbaum, SA				Zhou, L; Olivier, NB; Yao, H; Young, EC; Siegelbaum, SA			A conserved tripeptide in CNG and HCN channels regulates ligand gating by controlling C-terminal oligomerization	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; FUNCTIONAL EXPRESSION; OLFACTORY NEURONS; POTASSIUM CHANNEL; BINDING DOMAIN; SUBUNIT STOICHIOMETRY; MOLECULAR MECHANISM; ACTIVATED CHANNEL; CRYSTAL-STRUCTURE	Cyclic nucleotides directly enhance the opening of the tetrameric CNG and HCN channels, although the mechanism remains unclear. We examined why HCN and certain CNG subunits form functional homomeric channels, whereas other CNG subunits only function in heteromeric channels. The "defect" in the CNGA4 subunit that prevents its homomeric expression was localized to its C-linker, which connects the transmembrane domain to the binding domain and contains a tripeptide that decreases the efficacy of ligand gating. Remarkably, replacement of the homologous HCN tripeptide with the CNGA4 sequence transformed cAMP into an inverse agonist that inhibits HCN channel opening. Using analytical ultracentrifugation, we identified the structural basis for this gating switch: whereas cAMP normally enhances the assembly of HCN C-terminal domains into a tetrameric gating ring, inclusion of the CNGA4 tripeptide reversed this action so that cAMP now causes gating ring disassembly. Thus, ligand gating depends on the dynamic oligomerization of C-terminal binding domains.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu		Young, Edgar C./0000-0002-8453-088X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36658] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Bucossi G, 1997, BIOPHYS J, V72, P1165, DOI 10.1016/S0006-3495(97)78765-4; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Cheng KT, 2003, HISTOCHEM CELL BIOL, V120, P475, DOI 10.1007/s00418-003-0596-2; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Gerstner A, 2000, J NEUROSCI, V20, P1324; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Karpen JW, 1997, BIOPHYS J, V72, P986, DOI 10.1016/S0006-3495(97)78749-6; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KRAMER RH, 1994, NEURON, V12, P655, DOI 10.1016/0896-6273(94)90220-8; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scott SP, 2001, BIOCHEMISTRY-US, V40, P7464, DOI 10.1021/bi002804x; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Young EC, 2001, J GEN PHYSIOL, V118, P523, DOI 10.1085/jgp.118.5.523; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	51	48	48	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					823	834		10.1016/j.neuron.2004.11.012	http://dx.doi.org/10.1016/j.neuron.2004.11.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572113	Bronze			2022-12-24	WOS:000225548400010
J	Dorsey, SG; Renn, CL; Carim-Todd, L; Barrick, CA; Bambrick, L; Krueger, BK; Ward, CW; Tessarollo, L				Dorsey, Susan G.; Renn, Cynthia L.; Carim-Todd, Laura; Barrick, Colleen A.; Bambrick, Linda; Krueger, Bruce K.; Ward, Christopher W.; Tessarollo, Lino			In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model	NEURON			English	Article							MEDIATING BDNF MODULATION; NEUROTROPHIN RECEPTORS; HIPPOCAMPAL; SURVIVAL; MICE; EXPRESSION; PHOSPHORYLATION; ASTROCYTES; ROLES	Imbalances in neurotrophins or their high-affinity Trk receptors have long been reported in neurodegenerative diseases. However, a molecular link between these gene products and neuronal cell death has not been established. In the trisomy 16 (Ts16) mouse there is increased apoptosis in the cortex, and hippocampal neurons undergo accelerated cell death that cannot be rescued by administration of brain-derived neurotrophic factor (BDNF). Ts16 neurons have normal levels of the TrkB tyrosine kinase receptor but an upregulation of the TrkB.T1 truncated receptor isoform. Here we show that restoration of the physiological level of the TrkB.T1 receptor by gene targeting rescues Ts16 cortical cell and hippocampal neuronal death. Moreover, it corrects resting Ca2+ levels and restores BDNF-induced intracellular signaling mediated by full-length TrkB in Ts16 hippocampal neurons. These data provide a direct link between neuronal cell death and abnormalities in Trk neurotrophin receptor levels.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Neural Dev Grp, Frederick, MD 21702 USA; Univ Maryland, Sch Med, Sch Nursing, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dorsey, SG (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Neural Dev Grp, Frederick, MD 21702 USA.	sdorsey@son.umaryland.edu; tessarol@ncifcrf.gov		Renn, Cynthia/0000-0001-6764-9347	NATIONAL CANCER INSTITUTE [Z01BC010390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K22NR000174] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAMS NIH HHS [K01-AR02177] Funding Source: Medline; NINDS NIH HHS [R01NS40492] Funding Source: Medline; NINR NIH HHS [K22NR00174] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Alcantara S, 1997, J NEUROSCI, V17, P3623; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; BAMBRICK LL, 1995, P NATL ACAD SCI USA, V92, P9692, DOI 10.1073/pnas.92.21.9692; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blanquet PR, 2000, NEUROSCIENCE, V95, P705; Bonin A, 2000, METH MOL B, V158, P121; Chen KS, 1997, J NEUROSCI, V17, P7288; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Coyle J T, 1991, Res Publ Assoc Res Nerv Ment Dis, V69, P85; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Dorsey SG, 2002, J NEUROSCI, V22, P2571, DOI 10.1523/JNEUROSCI.22-07-02571.2002; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GEARHART JD, 1986, BRAIN RES BULL, V16, P789, DOI 10.1016/0361-9230(86)90075-4; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Haydar TF, 1996, J NEUROSCI, V16, P6175; Haydar TF, 2000, J NEUROSCI, V20, P4156; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; JACOBOWITZ DM, 1998, CHEMOARCHITECTONIC A; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; Muller W, 1997, NEUROSCI LETT, V223, P81, DOI 10.1016/S0304-3940(97)13406-1; Mutoh T, 2000, NEUROCHEM RES, V25, P239, DOI 10.1023/A:1007575504321; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Ohira K, 1999, DEV BRAIN RES, V112, P21, DOI 10.1016/S0165-3806(98)00151-5; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Schuchmann S, 1998, J NEUROSCI, V18, P7216; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tessarollo L, 2000, METH MOL B, V158, P47; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	49	87	89	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					21	28		10.1016/j.neuron.2006.06.009	http://dx.doi.org/10.1016/j.neuron.2006.06.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815329	Bronze			2022-12-24	WOS:000239037700007
J	Zou, YM				Zou, YM			Navigating the anterior-posterior axis with Wnts	NEURON			English	Editorial Material							HOX GENE-EXPRESSION; AXON GUIDANCE; COMMISSURAL AXONS; CELL-MIGRATION; SPINAL-CORD; C-ELEGANS; SYSTEM	Recent studies have begun to shed light on the molecular guidance cues controlling anterior-posterior axon guidance. Two recent studies in the current issue of Developmental Cell show that Wnts play critical roles in patterning processes and directing neuronal migration in C. elegans. Together with previous findings in vertebrates and flies, these new results establish conserved function of Wnts in A-P guidance.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dickson BJ, 2005, NAT NEUROSCI, V8, P1130, DOI 10.1038/nn0905-1130; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Harris J, 1996, DEVELOPMENT, V122, P3117; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Imondi R, 2003, SCIENCE, V302, P1903, DOI 10.1126/science.1092976; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maloof JN, 1999, DEVELOPMENT, V126, P37; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; PRASAD BC, 2006, IN PRESS DEVELOPMENT; Sato M, 2006, NAT NEUROSCI, V9, P67, DOI 10.1038/nn1604; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; Stoeckli ET, 2006, CURR OPIN NEUROBIOL, V16, P35, DOI 10.1016/j.conb.2006.01.008; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	18	19	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					787	789		10.1016/j.neuron.2006.03.004	http://dx.doi.org/10.1016/j.neuron.2006.03.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543126	Bronze			2022-12-24	WOS:000236227500006
J	Tanaka, M				Tanaka, M			Inactivation of the central thalamus delays self-timed saccades	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NEURONAL-ACTIVITY; PERIOD ACTIVITY; EYE-MOVEMENTS; MONKEY; MOTOR; REPRESENTATION; RESPONSES	The central thalamus transmits corollary discharge signals for eye movement control, but its role in eye movement generation remains uncertain. Inactivation of the paralaminar part of the ventrolateral thalamus delayed the initiation of contraversive saccades, particularly during a new memory-guided saccade task that required self-triggering of the movement. The results suggest that signals through the thalamus regulate the timing of self-initiated saccades.	Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Tanaka, M (corresponding author), Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan.	masaki@med.hokudai.ac.jp	Tanaka, Masaki/D-9199-2011	Tanaka, Masaki/0000-0002-6177-1314				HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McFarland NR, 2002, J NEUROSCI, V22, P8117; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; SCHLAGREY M, 1984, J NEUROPHYSIOL, V51, P1149, DOI 10.1152/jn.1984.51.6.1149; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tanaka M, 2005, J NEUROSCI, V25, P5866, DOI 10.1523/JNEUROSCI.0676-05.2005; Tanibuchi I, 2005, J NEUROPHYSIOL, V93, P614, DOI 10.1152/jn.00969.2003; van Donkelaar P, 2000, J NEUROPHYSIOL, V83, P2780, DOI 10.1152/jn.2000.83.5.2780; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Wyder MT, 2004, J NEUROPHYSIOL, V91, P2628, DOI 10.1152/jn.01221.2003; Wyder MT, 2003, J NEUROPHYSIOL, V90, P2029, DOI 10.1152/jn.00064.2003	15	36	37	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					20	22		10.1038/nn1617	http://dx.doi.org/10.1038/nn1617			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341209	Green Submitted			2022-12-24	WOS:000234288000011
J	Ryan, XZP; Alldritt, J; Svenningsson, P; Allen, PB; Wu, GY; Nairn, AC; Greengard, P				Ryan, XZP; Alldritt, J; Svenningsson, P; Allen, PB; Wu, GY; Nairn, AC; Greengard, P			The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ACTIN-BASED PLASTICITY; FILAMENT-BINDING PROTEIN; P70 S6 KINASE; SYNAPSE FORMATION; NMDA RECEPTOR; CELL-ADHESION; SMALL GTPASES; RAC; ACTIVATION	Neurabin and spinophilin are homologous protein phosphatase 1 and actin binding proteins that regulate dendritic spine function. A yeast two-hybrid analysis using the coiled-coil domain of neurabin revealed an interaction with Lfc, a Rho GEF. Lfc was highly expressed in brain, where it interacted with either neurabin or spinophilin. In neurons, Lfc was largely found in the shaft of dendrites in association with microtubules but translocated to spines upon neuronal stimulation. Moreover, expression of Lfc resulted in reduction in spine length and size. Both the translocation and the effect on spine morphology depended on the coiled-coil domain of Lfc. Coexpression of neurabin or spinophilin with Lfc resulted in their clustering together with F-actin, a process that depended on Rho activity. Thus, interaction between Lfc and neurabin/spinophilin selectively regulates Rho-dependent organization of F-actin in spines and is a link between the microtubule and F-actin cytoskeletons in dendrites.	Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Baylor College of Medicine; Rockefeller University; Yale University	Wu, GY (corresponding author), Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA.	gangyiw@bcm.tmc.edu; angus.nairn@yale.edu	Svenningsson, Per JL/K-5210-2014	Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R21DA017919] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044, P01 DA010044, DA17919] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen PB, 1999, BIOCHEM SOC T, V27, P543, DOI 10.1042/bst0270543; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blangy A, 2000, J CELL SCI, V113, P729; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buck KB, 2002, J NEUROSCI, V22, P9358; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Craig A. M, 1998, CULTURING NERVE CELL, P79; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Goslin K., 1998, CULTURING NERVE CELL, P339; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hering H, 2003, J NEUROSCI, V23, P11759; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Scott EK, 2003, J NEUROSCI, V23, P3118; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stephens DJ, 2000, BIOCHEM J, V345, P185, DOI 10.1042/0264-6021:3450185; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; WANG CM, 1994, STRUCT ENG MECH, V2, P369; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WHITEHEAD I, 1995, J BIOL CHEM, V270, P18388, DOI 10.1074/jbc.270.31.18388; Wittmann T, 2001, J CELL SCI, V114, P3795; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	77	112	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					85	100		10.1016/j.neuron.2005.05.013	http://dx.doi.org/10.1016/j.neuron.2005.05.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996550	Bronze			2022-12-24	WOS:000230464000010
J	Speidel, D; Bruederle, CE; Enk, C; Voets, T; Varoqueaux, F; Reim, K; Becherer, U; Fornal, F; Ruggieri, S; Holighaus, Y; Weihe, E; Bruns, D; Brose, N; Rettig, J				Speidel, D; Bruederle, CE; Enk, C; Voets, T; Varoqueaux, F; Reim, K; Becherer, U; Fornal, F; Ruggieri, S; Holighaus, Y; Weihe, E; Bruns, D; Brose, N; Rettig, J			CAPS1 regulates catecholamine loading of large dense-core vesicles	NEURON			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; VESICULAR MONOAMINE TRANSPORTER; CHROMAFFIN CELLS; ENDOCRINE-CELLS; PLASMA-MEMBRANE; SECRETION; EXOCYTOSIS; RELEASE; GENE; MECHANISMS	CAPS1 is thought to play an essential role in mediating exocytosis from large dense-core vesicles (LDCVs). We generated CAPS1-deficient (KO) mice and studied exocytosis in a model system for Ca2+- dependent LDCV secretion, the adrenal chromaffin cell. Adult heterozygous CAPS1 KO cells display a gene dosage-dependent decrease of CAPS1 expression and a concomitant reduction in the number of docked vesicles and secretion. Embryonic homozygous CAPS1 KO cells show a strong reduction in the frequency of amperometrically detectable release events of transmitter-filled vesicles, while the total number of fusing vesicles, as judged by capacitance recordings or total internal reflection microscopy, remains unchanged. We conclude that CAPS1 is required for an essential step in the uptake or storage of catecholamines in LDCVs.	Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Univ Saarland, Physiolog Inst, D-66421 Homburg, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Univ Pisa, Dept Human Morphol & Appl Biol, I-56126 Pisa, Italy; IRCCS Neuromed, Lab Neurobiol Movement Disorders, I-86077 Pozzilli, Isernia, Italy; Univ Marburg, Inst Anat & Zellbiol, Abt Mol Neurowissensch, D-35033 Marburg, Germany	Max Planck Society; Saarland University; Max Planck Society; University of Pisa; IRCCS Neuromed; Philipps University Marburg	Brose, N (corresponding author), Max Planck Inst Expt Med, Abt Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de; jrettig@uniklinik-saarland.de	Becherer, Ute/AGW-2576-2022; Voets, Thomas/AAD-4389-2019; Varoqueaux, Frederique/AAC-1834-2021; Becherer, Ute/F-6711-2010; Ruggieri, Stefano/G-7934-2011; Rettig, Jens/K-5103-2013; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Varoqueaux, Frederique/0000-0002-3614-3121; Becherer, Ute/0000-0001-6005-7517; Rettig, Jens/0000-0001-6160-3954; Voets, Thomas/0000-0001-5526-5821; FORNAI, FRANCESCO/0000-0002-3883-5084				Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; AVERY L, 1993, GENETICS, V134, P454; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; DELATORRE JC, 1980, J NEUROSCI METH, V3, P1, DOI 10.1016/0165-0270(80)90029-1; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Fornai F, 2003, J NEUROSCI, V23, P8955; Gong LW, 2003, J NEUROSCI, V23, P7917; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Henry JP, 1998, NEUROCHEM INT, V32, P227, DOI 10.1016/S0197-0186(97)00092-2; Iwasa K, 1999, J VET MED SCI, V61, P621, DOI 10.1292/jvms.61.621; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Markoglou N, 2001, J BIOCHEM BIOPH METH, V48, P61, DOI 10.1016/S0165-022X(00)00142-1; Moser T, 1997, J NEUROSCI, V17, P2314; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Pahner I, 2002, EUR J CELL BIOL, V81, P449, DOI 10.1078/0171-9335-00269; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Peaston RT, 2004, ANN CLIN BIOCHEM, V41, P17, DOI 10.1258/000456304322664663; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schonn JS, 2003, J NEUROCHEM, V84, P669, DOI 10.1046/j.1471-4159.2003.01561.x; SCHULDINER S, 1994, J NEUROCHEM, V62, P2067; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Tabares L, 2001, J BIOL CHEM, V276, P39974, DOI 10.1074/jbc.M106498200; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Wassenberg JJ, 2002, ANN NY ACAD SCI, V971, P201, DOI 10.1111/j.1749-6632.2002.tb04464.x; Weihe E, 2000, FASEB J, V14, P2435, DOI 10.1096/fj.00-0202rev; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730	48	87	91	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					75	88		10.1016/j.neuron.2005.02.019	http://dx.doi.org/10.1016/j.neuron.2005.02.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820695	Bronze, Green Published			2022-12-24	WOS:000228228600010
J	Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA				Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA			Corelease of dopamine and serotonin from striatal dopamine terminals	NEURON			English	Article							IN-VIVO MICRODIALYSIS; TRANSPORTER; RAT; RELEASE; MONOAMINE; NUCLEUS; MECHANISMS; FLUOXETINE; BEHAVIOR; NEURONS	The striatum receives rich dopaminergic and more moderate serotonergic innervation. After vesicular release, dopamine and serotonin (5-hydroxytryptamine, 5-HT) signaling is controlled by transporter-mediated reuptake. Dopamine is taken up by dopamine transporters (DATs), which are expressed at the highest density in the striatum. Although DATs also display a low affinity for 5-HT, that neurotransmitter is normally efficiently taken up by the 5-HT transporters. We found that when extracellular 5-HT is elevated by exogenous application or by using antidepressants (e.g., fluoxetine) to inhibit the 5-HT transporters, the extremely dense striatal DATs uptake 5-HT into dopamine terminals. Immunohistochemical results and measurements using fast cyclic voltammetry showed that elevated 5-HT is taken up by DATs into striatal dopamine terminals that subsequently release 5-HT and dopamine together. These results suggest that antidepressants that block serotonin transporters or other factors that elevate extracellular 5-HT alter the temporal and spatial relationship between dopamine and 5-HT signaling in the striatum.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu	Salas, Ramiro/A-9602-2015; De Biasi, Mariella/M-7646-2017	De Biasi, Mariella/0000-0002-0687-8872	NIDA NIH HHS [DA017173, DA09411] Funding Source: Medline; NIMH NIH HHS [MH67119] Funding Source: Medline; NINDS NIH HHS [R01 NS021229, NS048505, NS21229] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021229, R01NS021229, R01NS048505, R23NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017173, R01DA009411] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Bunin MA, 1998, J NEUROSCI, V18, P4854; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Cases O, 1998, J NEUROSCI, V18, P6914; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7; Descarries L, 2000, PROG BRAIN RES, V125, P27; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; FEUERSTEIN TJ, 1986, BRIT J PHARMACOL, V88, P677, DOI 10.1111/j.1476-5381.1986.tb10250.x; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Iravani MM, 1997, SYNAPSE, V25, P93; JACKSON BP, 1995, BRAIN RES, V674, P163, DOI 10.1016/0006-8993(95)00019-M; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Knobelman DA, 2000, J PHARMACOL EXP THER, V292, P1111; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Laasonen-Balk T, 1999, PSYCHOPHARMACOLOGY, V144, P282, DOI 10.1007/s002130051005; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McMahon LR, 2001, J NEUROSCI, V21, P7781, DOI 10.1523/JNEUROSCI.21-19-07781.2001; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; PRISTUPA ZB, 1994, MOL PHARMACOL, V45, P125; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sesack SR, 2002, HANDB EXP PHARM 1, P63; SHASKAN EG, 1970, J PHARMACOL EXP THER, V175, P404; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Smith TD, 2000, SYNAPSE, V38, P460, DOI 10.1002/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; VANBOCKSTAELE EJ, 1993, J COMP NEUROL, V334, P603, DOI 10.1002/cne.903340408; WILLNER P, 2002, HANDB EXP PHARM 2, V154, P387; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yelin Rodrigo, 2002, P313; Yuan J, 2002, J NEUROCHEM, V80, P960, DOI 10.1046/j.0022-3042.2002.00758.x; Zangen A, 2001, PSYCHOPHARMACOLOGY, V155, P434, DOI 10.1007/s002130100746; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	53	134	138	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					65	74		10.1016/j.neuron.2005.02.010	http://dx.doi.org/10.1016/j.neuron.2005.02.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820694	Bronze			2022-12-24	WOS:000228228600009
J	Lu, XF; Ashe, J				Lu, XF; Ashe, J			Anticipatory activity in primary motor cortex codes memorized movement sequences	NEURON			English	Article							CONTEXT-RECALL TASK; CORTICAL ACTIVITY; MULTIPLE MOVEMENTS; ARM MOVEMENTS; SINGLE-CELL; TEMPORAL ORGANIZATION; SEQUENTIAL MOVEMENT; NEURONAL-ACTIVITY; FINGER MOVEMENT; PREMOTOR CORTEX	Movement sequences, defined both by the component movements and by the serial order in which they are produced, are fundamental building blocks of motor behavior. The serial order of sequence production is strongly encoded in medial motor areas. It is not known to what extent sequences are further elaborated or encoded in primary motor cortex. Here, we describe cells in the primary motor cortex of the monkey that show anticipatory activity exclusively related to a specific memorized sequence of upcoming movements. In addition, the injection of muscimol, a GABA agonist, into motor cortex resulted in an increase in the error rate during sequence production, without concomitant effects on nonsequenced motor performance. Our results challenge the role of medial motor areas in the control of well-practiced movement sequences and suggest that motor cortex contains a complete apparatus for the planning and production of this complex behavior.	Vet Adm Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ashe, J (corresponding author), Vet Adm Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA.	ashe@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042278] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42278] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; ASHE J, 1993, EXP BRAIN RES, V95, P118; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hatsopoulos NG, 2003, EXP BRAIN RES, V149, P478, DOI 10.1007/s00221-003-1385-9; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705; James W., 1890, PRINCIPLES PSYCHOL; KARNI A, 1995, NATURE, V377, P155; Kettner RE, 1996, EXP BRAIN RES, V112, P347, DOI 10.1007/BF00227941; Lashley KS., 1951, PROBLEM SERIAL ORDER, V21; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; LURITO JT, 1991, EXP BRAIN RES, V87, P562; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PELLIZZER G, 1995, SCIENCE, V269, P702, DOI 10.1126/science.7624802; Schlag JD, 2002, NEURON, V34, P177, DOI 10.1016/S0896-6273(02)00668-2; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Taira M, 1996, EXP BRAIN RES, V109, P367; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462	37	91	94	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					967	973		10.1016/j.neuron.2005.01.036	http://dx.doi.org/10.1016/j.neuron.2005.01.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797556	Bronze			2022-12-24	WOS:000228031300016
J	Grant, KA; Raible, DW; Piotrowski, T				Grant, KA; Raible, DW; Piotrowski, T			Regulation of latent sensory hair cell precursors by glia in the zebrafish lateral line	NEURON			English	Article							NEURAL-CREST; POSTEMBRYONIC DEVELOPMENT; CAGED FLUORESCEIN; NERVOUS-SYSTEM; SCHWANN-CELL; DANIO-RERIO; FATE; NEUROGENIN1; MUTATIONS; MIGRATION	The lateral line is a placodally derived mechanosensory organ in anamniotes that detects the movement of water. In zebrafish embryos, a migrating primordium deposits seven to nine clusters of sensory hair cells, or neuromasts, at intervals along the trunk. Post-embryonically, neuromasts continue to be added. We show that some secondary neuromasts arise from a pool of latent precursors that are deposited by the primordium between primary neuromasts. Interneuromast cells lie adjacent to the lateral line nerve and associated glia. These cells remain quiescent while they are juxtaposed with the glia; however, when they move away from the nerve they increase proliferation and form neuromasts. If glia are manually removed or genetically ablated by mutations in cis/sox10, hypersensitive (hps), or rowgain (rog), neuromasts precociously differentiate. Transplantation of wt glia into mutants rescues the appropriate temporal differentiation of interneuromast cells. Our studies reveal a role for glia in regulating sensory hair cell precursors.	NICHD, NIH, LMG, Bethesda, MD 20892 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Cell & Mol Biol Program, Seattle, WA 98195 USA; Univ Utah, Dept Anat & Neurobiol, Salt Lake City, UT 84132 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah	Raible, DW (corresponding author), NICHD, NIH, LMG, Bethesda, MD 20892 USA.	draible@u.washington.edu; piotrowski@neuro.utah.edu		Raible, David/0000-0002-5342-5841	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005987] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007183, 5 T32 HD07183-25] Funding Source: Medline; NIDCD NIH HHS [DC005987] Funding Source: Medline; NINDS NIH HHS [NS35833] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Blader P, 1997, DEVELOPMENT, V124, P4557; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; Cooper KL, 2003, DEV BIOL, V253, P200, DOI 10.1016/S0012-1606(02)00018-0; Cornell RA, 2002, DEVELOPMENT, V129, P2639; DUTTON K, 2001, DEVELOPMENT, V128, P2809; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Gompel N, 2001, DEVELOPMENT, V128, P387; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; HAECKEL E, 1875, JENA Z NATURWISS, V9, P401; HALL BK, 1990, CLEFT PALATE J, V27, P95, DOI 10.1597/1545-1569(1990)027<0095:EIICB>2.3.CO;2; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kos R, 2001, DEVELOPMENT, V128, P1467; Kozlowski DJ, 2000, METH MOL B, V135, P349; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Ledent V, 2002, DEVELOPMENT, V129, P597; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; NORTHCUTT RG, 1994, J COMP NEUROL, V340, P480, DOI 10.1002/cne.903400404; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Pichon F, 2004, EVOL DEV, V6, P187, DOI 10.1111/j.1525-142X.2004.04024.x; Piotrowski T, 1996, BRAIN BEHAV EVOLUT, V47, P55, DOI 10.1159/000113229; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; PLATT JB, 1896, Q J MICROSC SCI, V38, P485; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Raible DW, 1996, DEVELOPMENT, V122, P501; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Sahly I, 1999, DEV GENES EVOL, V209, P399, DOI 10.1007/s004270050270; Sapede D, 2002, DEVELOPMENT, V129, P605; Schulze F., 1861, ARCH ANAT PHYSL, V3, P759; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stone LS, 1935, P SOC EXP BIOL MED, V33, P80; Stone LS, 1922, J EXP ZOOL, V35, P421; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WINKLBAUER R, 1989, PROG NEUROBIOL, V32, P181, DOI 10.1016/0301-0082(89)90016-6; WOO K, 1995, DEVELOPMENT, V121, P2595	56	95	98	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					69	80		10.1016/j.neuron.2004.12.020	http://dx.doi.org/10.1016/j.neuron.2004.12.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629703	Bronze			2022-12-24	WOS:000226217100010
J	Kettunen, P; Kyriakatos, A; Hallen, K; El Manira, A				Kettunen, P; Kyriakatos, A; Hallen, K; El Manira, A			Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network	NEURON			English	Article							ENDOGENOUS CANNABINOIDS; FICTIVE LOCOMOTION; RETROGRADE INHIBITION; PATTERN GENERATION; MOTOR-NEURONS; CORD INVITRO; LAMPREY; RECEPTORS; ACTIVATION; HIPPOCAMPUS	Endocannabinoids act as retrograde signals to modulate synaptic transmission. Little is known, however, about their significance in integrated network activity underlying motor behavior. We have examined the physiological effects of endocannabinoids in a neuronal network underlying locomotor behavior using the isolated lamprey spinal cord. Our results show that endocannabinoids are released during locomotor activity and participate in setting the baseline burst rate. They are released in response to mGluR1 activation and act as retrograde messengers. This conditional release of endocannabinoids can transform motoneurons and crossing interneurons into modulatory neurons by enabling them to regulate their inhibitory synaptic inputs and thus contribute to the modulation of the locomotor burst frequency. These results provide evidence that endocannabinoid retrograde signaling occurs within the locomotor network and contributes to motor pattern generation and regulation in the spinal cord.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden	Karolinska Institutet	El Manira, A (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden.	abdel.elmanira@neuro.ki.se	Kettunen, Petronella/AAF-7606-2019	Kettunen, Petronella/0000-0002-2510-3423; El Manira, Abdel/0000-0001-5920-9384				Alford S, 2003, NEUROSCIENTIST, V9, P217, DOI 10.1177/1073858403009003014; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Buchanan JT, 2001, PROG NEUROBIOL, V63, P441, DOI 10.1016/S0301-0082(00)00050-2; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Clarac F, 2004, PROG BRAIN RES, V143, P57, DOI 10.1016/S0079-6123(03)43006-9; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; COHEN AH, 1984, BRAIN RES, V293, P164, DOI 10.1016/0006-8993(84)91464-1; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Dale N, 1996, NATURE, V383, P259, DOI 10.1038/383259a0; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; El Manira A, 2002, BRAIN RES REV, V40, P9, DOI 10.1016/S0165-0173(02)00184-4; ElManira A, 1997, J NEUROPHYSIOL, V78, P1334; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Kettunen P, 2003, J NEUROPHYSIOL, V90, P2341, DOI 10.1152/jn.01132.2002; Kettunen P, 2002, J NEUROSCI, V22, P1868, DOI 10.1523/JNEUROSCI.22-05-01868.2002; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kim J, 2002, J NEUROSCI, V22, P10182; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Krieger P, 1996, J NEUROPHYSIOL, V76, P3834, DOI 10.1152/jn.1996.76.6.3834; Krieger P, 2000, J NEUROSCI, V20, P5382, DOI 10.1523/JNEUROSCI.20-14-05382.2000; Krieger P, 1998, EUR J NEUROSCI, V10, P3333, DOI 10.1046/j.1460-9568.1998.00337.x; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; MANGAN PS, 1994, J COMP PHYSIOL A, V175, P709, DOI 10.1007/BF00191843; MCPHERSON DR, 1994, J COMP PHYSIOL A, V175, P311; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts A, 1995, J PHYSIOL-PARIS, V89, P241, DOI 10.1016/0928-4257(96)83640-0; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	55	58	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					95	104		10.1016/j.neuron.2004.12.022	http://dx.doi.org/10.1016/j.neuron.2004.12.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629705	Bronze			2022-12-24	WOS:000226217100012
J	Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D				Peters, HC; Hu, H; Pongs, O; Storm, JF; Isbrandt, D			Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; K+ CHANNEL; FREQUENCY PREFERENCES; NEONATAL CONVULSIONS; THETA-OSCILLATIONS; MAMMALIAN-CELLS; KCNQ2 SUBUNITS; WORKING-MEMORY	In humans, mutations in the KCNQ2 or KCNQ3 potassium-channel genes are associated with an inherited epilepsy syndrome. We have studied the contribution of KCNQ/M-channels to the control of neuronal excitability by using transgenic mice that conditionally express dominant-negative KCNQ2 subunits in brain. We show that suppression of the neuronal M current in mice is associated with spontaneous seizures, behavioral hyperactivity and morphological changes in the hippocampus. Restriction of transgene expression to defined developmental periods revealed that M-channel activity is critical to the development of normal hippocampal morphology during the first postnatal weeks. Suppression of the M current after this critical period resulted in mice with signs of increased neuronal excitability and deficits in hippocampus-dependent spatial memory. M-current-deficient hippocampal CA1 pyramidal neurons showed increased excitability, reduced spike-frequency adaptation, attenuated medium afterhyperpolarization and reduced intrinsic subthreshold theta resonance. M channels are thus critical determinants of cellular and neuronal network excitability, postnatal brain development and cognitive performance.	Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, D-20246 Hamburg, Germany; Univ Oslo, Dept Physiol, Inst Basic Med Sci, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oslo; University of Oslo	Storm, JF (corresponding author), Zentrum Mol Neurobiol Hamburg, Inst Neurale Signalverarbeitung, Martinistr 52, D-20246 Hamburg, Germany.	j.f.storm@medisin.uio.no; isbrandt@uni-hamburg.de		Hu, Hua/0000-0001-8187-4735; Isbrandt, Dirk/0000-0002-4720-1016				Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; Dedek K, 2001, P NATL ACAD SCI USA, V98, P12272, DOI 10.1073/pnas.211431298; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hadley JK, 2003, J NEUROSCI, V23, P5012; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; Lechner SG, 2003, J PHYSIOL-LONDON, V553, P789, DOI 10.1113/jphysiol.2003.052449; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MALENKA RC, 1986, J NEUROSCI, V6, P475; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; SCHRETER RK, 1996, PSYCHIAT PRACTICE MA, V2, P3; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; WILLIAMSON A, 1990, J NEUROPHYSIOL, V63, P72, DOI 10.1152/jn.1990.63.1.72; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118	50	304	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					51	60		10.1038/nn1375	http://dx.doi.org/10.1038/nn1375			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608631				2022-12-24	WOS:000225967600015
J	Surmeier, DJ; Spruston, N				Surmeier, DJ; Spruston, N			Peering into the dendritic machinery of striatal medium spiny neurons	NEURON			English	Editorial Material							NMDA RECEPTORS; CALCIUM; ACTIVATION; CURRENTS; INFLUX		Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Surmeier, DJ (corresponding author), Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA.			Spruston, Nelson/0000-0003-3118-1636				Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chen Q, 1998, NEUROSCIENCE, V83, P749, DOI 10.1016/S0306-4522(97)00452-1; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Kerr JND, 2004, J NEUROSCI, V24, P877, DOI 10.1523/JNEUROSCI.4475-03.2004; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; WILSON CJ, 1994, MICROSC RES TECHNIQ, V29, P368, DOI 10.1002/jemt.1070290507; Wilson CJ, 1996, J NEUROSCI, V16, P2397	13	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					401	402		10.1016/j.neuron.2004.10.021	http://dx.doi.org/10.1016/j.neuron.2004.10.021			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504319	Bronze			2022-12-24	WOS:000224771700001
J	Mi, RF; Sia, GM; Rosen, K; Tang, XP; Moghekar, A; Black, JL; McEnery, M; Huganir, RL; O'Brien, RJ				Mi, RF; Sia, GM; Rosen, K; Tang, XP; Moghekar, A; Black, JL; McEnery, M; Huganir, RL; O'Brien, RJ			AMPA receptor-dependent clustering of synaptic NMDA receptors is mediated by stargazin and NR2A/B in spinal neurons and hippocampal interneurons	NEURON			English	Article							POSTSYNAPTICALLY SILENT SYNAPSES; EXCITATORY SYNAPSES; GLUTAMATERGIC SYNAPSES; DENDRITIC SPINES; SUBUNIT GENE; PLASTICITY; PROTEIN; EXPRESSION; LOCALIZATION; MECHANISMS	Under standard conditions, cultured ventral spinal neurons cluster AMPA- but not NMDA-type glutamate receptors at excitatory synapses on their dendritic shafts in spite of abundant expression of the ubiquitous NMDA receptor subunit NRII. We demonstrate here that the NMDA receptor subunits NR2A and NR2B are not routinely expressed in cultured spinal neurons and that transfection with NR2A or NR2B reconstitutes the synaptic targeting of NMDA receptors and confers on exogenous application of the immediate early gene product Narp the ability to cluster both AMPA and NMDA receptors. The use of dominant-negative mutants of GluR2 further showed that the synaptic targeting of NMDA receptors is dependent on the presence of synaptic AMPA receptors and that synaptic AMPA and NMDA receptors are linked by Stargazin and a MAGUK protein. This system of AMPA receptor-dependent synaptic NMDA receptor localization was preserved in hippocampal interneurons but reversed in hippocampal pyramidal neurons.	Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Tufts Univ, Sch Med, Dept Neurol, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA; Mayo Clin & Mayo Grad Sch Med, Dept Psychiat & Psychol, Rochester, MN 55905 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; St. Elizabeth's Medical Center; Tufts University; Mayo Clinic; Case Western Reserve University	O'Brien, RJ (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA.	robrien@jhmi.edu		Sia, Gek Ming/0000-0001-9333-0065	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037694] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS037694] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi SY, 2004, J NEUROCHEM, V88, P708, DOI 10.1046/j.1471-4159.2003.02187.x; Cutforth T, 2002, TRENDS NEUROSCI, V25, P332, DOI 10.1016/S0166-2236(02)02187-2; Desai A, 2002, J BIOL CHEM, V277, P46374, DOI 10.1074/jbc.M203032200; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KALB RG, 1992, P NATL ACAD SCI USA, V89, P8502, DOI 10.1073/pnas.89.18.8502; KONNERTH A, 1990, PFLUG ARCH EUR J PHY, V417, P285, DOI 10.1007/BF00370994; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Mammen AL, 1997, J NEUROSCI, V17, P7351; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; Mi RF, 2002, J NEUROSCI, V22, P7606; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Rao A, 1998, J NEUROSCI, V18, P1217; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sasner M, 1996, J BIOL CHEM, V271, P21316, DOI 10.1074/jbc.271.35.21316; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tao YX, 2003, J NEUROSCI, V23, P6703; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; ZISKINDCONHAIM L, 1990, J NEUROSCI, V10, P125	51	31	34	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					335	349		10.1016/j.neuron.2004.09.029	http://dx.doi.org/10.1016/j.neuron.2004.09.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473971	Bronze			2022-12-24	WOS:000224635800015
J	Shalin, SC; Hernandez, CM; Dougherty, MK; Morrison, DK; Sweatt, JD				Shalin, Sara C.; Hernandez, Caterina M.; Dougherty, Michele K.; Morrison, Deborah K.; Sweatt, J. David			Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; DENDRITIC K+ CHANNELS; ERK MAP KINASE; AREA CA1; PRESYNAPTIC PLASTICITY; DORSAL HIPPOCAMPUS; CONTEXTUAL FEAR; ERK/MAP KINASE; NMDA RECEPTOR	The ERK/MAP kinase cascade is important for long-term memory formation and synaptic plasticity, with a myriad of upstream signals converging upon ERK activation. Despite this convergence of signaling, neurons routinely activate appropriate biological responses to different stimuli. Scaffolding proteins represent a mechanism to achieve compartmentalization of signaling and the appropriate targeting of ERK-dependent processes. We report that kinase suppressor of Ras (KSR1) functions biochemically in the hippocampus to scaffold the components of the ERK cascade, specifically regulating the cascade when a membrane fraction of ERK is activated via a PKC-dependent pathway but not via a cAMP/PKA-dependent pathway. Specificity of KSR1-dependent signaling also extends to specific downstream targets of ERK. Behaviorally and physiologically, we found that the absence of KSR1 leads to deficits in associative learning and theta burst stimulation-induced LTP. Our report provides novel insight into the endogenous scaffolding role of KSR1 in controlling kinase activation within the nervous system.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; NCI, Lab Prot Dynam & Signaling, Ft Detrick, MD 21702 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sweatt, JD (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Pl, Houston, TX 77030 USA.	dsweatt@nrc.uab.edu		Sweatt, J. David/0000-0003-3567-485X	NATIONAL CANCER INSTITUTE [Z01BC010329, ZIABC010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014, F31MH071014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013546, P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [F31MH071014, MH57014] Funding Source: Medline; NINDS NIH HHS [NS37444, NS13546] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Blum S, 1999, J NEUROSCI, V19, P3535; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ohmachi M, 2002, CURR BIOL, V12, P427, DOI 10.1016/S0960-9822(02)00690-5; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schafe GE, 2000, J NEUROSCI, V20, P8177; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2004, J BIOL CHEM, V279, P26210, DOI 10.1074/jbc.M401323200; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	51	74	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					765	779		10.1016/j.neuron.2006.04.029	http://dx.doi.org/10.1016/j.neuron.2006.04.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731514	Bronze			2022-12-24	WOS:000238165000011
J	Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A				Bandell, M; Dubin, AE; Petrus, MJ; Orth, A; Mathur, J; Hwang, SW; Patapoutian, A			High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNELS; ION-CHANNEL; MOLECULAR MECHANISM; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; CRYSTAL-STRUCTURE; HCN CHANNELS; K+ CHANNEL; COLD; TRPA1	Menthol is a cooling compound derived from mint leaves and is extensively used as a flavoring chemical. Menthol activates transient receptor potential melastatin 8 (TRPM8), an ion channel also activated by cold, voltage and phosphatidylinositol-4,5-bisphosphate (PIP2). Here we investigated the mechanism by which menthol activates mouse TRPM8. Using a new high-throughput approach, we screened a random mutant library consisting of similar to 14,000 individual TRPM8 mutants for clones that are affected in their response to menthol while retaining channel function. We identified determinants of menthol sensitivity in two regions: putative transmembrane segment 2 (S2) and the C-terminal TRP domain. Analysis of these mutants indicated that activation by menthol involves a gating mechanism distinct and separable from gating by cold, voltage or PIP2. Notably, TRP domain mutations mainly attenuated menthol efficacy, suggesting that this domain influences events downstream of initial binding. In contrast, S2 mutations strongly shifted the concentration dependence of menthol activation, raising the possibility that S2 influences menthol binding.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480	PHS HHS [MS046303] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taylor J. R., 1982, INTRO ERROR ANAL STU; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; YU FH, 2004, SCI STKE; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012	39	195	200	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					493	500		10.1038/nn1665	http://dx.doi.org/10.1038/nn1665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520735				2022-12-24	WOS:000236310700016
J	Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U				Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U			Silencing of EphA3 through a cis interaction with ephrinA5	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASES; GANGLION-CELL AXONS; LIPID RAFTS; MOLECULAR GRADIENTS; VISUAL-SYSTEM; A LIGANDS; GUIDANCE; ADHESION; GROWTH; MAP	EphAs and ephrinAs are expressed in multiple areas of the developing brain in overlapping countergradients, notably in the retina and tectum. Here they are involved in targeting retinal axons to their correct topographic position in the tectum. We have used truncated versions of EphA3, single-amino acid point mutants of ephrinA5 and fluorescence resonance energy transfer technology to uncover a cis interaction between EphA3 and ephrinA5 that is independent of the established ligand-binding domain of EphA3. This cis interaction abolishes the induction of tyrosine phosphorylation of EphA3 and results in a loss of sensitivity of retinal axons to ephrinAs in trans. Our data suggest that formation of this complex transforms the uniform expression of EphAs in the nasal part of the retina into a gradient of functional EphAs and has a key role in controlling retinotectal mapping.	Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, London SE1 1UL, England; Univ London Kings Coll, Randall Div Cell & Mol Biophys, London SE1 1UL, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London	Drescher, U (corresponding author), Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	uwe.drescher@kcl.ac.uk	Heintzmann, Rainer/AAY-4849-2020; Heintzmann, Rainer/I-5667-2012; Drescher, Uwe/C-5438-2009	Heintzmann, Rainer/0000-0002-4950-1936; Ng, Tony/0000-0003-3894-5619; Drescher, Uwe/0000-0001-9725-7643	Medical Research Council [G0100152] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G9900989B] Funding Source: researchfish; MRC [G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Goodhill GJ, 2004, NEURAL COMPUT, V16, P2221, DOI 10.1162/0899766041941934; Gu CK, 2005, ONCOGENE, V24, P4243, DOI 10.1038/sj.onc.1208584; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Niclou SP, 2000, J NEUROSCI, V20, P4962; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sobieszczuk DF, 1999, CURR BIOL, V9, pR469, DOI 10.1016/S0960-9822(99)80296-6; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	50	142	146	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					322	330		10.1038/nn1655	http://dx.doi.org/10.1038/nn1655			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491080				2022-12-24	WOS:000235645600011
J	Wehr, M; Zador, AM				Wehr, M; Zador, AM			Synaptic mechanisms of forward suppression in rat auditory cortex	NEURON			English	Article							SHORT-TERM PLASTICITY; PRIMARY VISUAL-CORTEX; DIRECTION SELECTIVITY; CORTICAL-NEURONS; INHIBITION; SYNAPSES; DEPRESSION; REPRESENTATION; ORIENTATION; POTENTIALS	In the auditory cortex, brief sounds elicit a powerful suppression of responsiveness that can persist for hundreds of milliseconds. This forward suppression (sometimes also called forward masking) has usually been attributed to synaptic (GABAergic) inhibition. Here we have used whole-cell recordings in vivo to assess the role of synaptic inhibition in forward suppression in auditory cortex. We measured the excitatory and inhibitory synaptic conductances elicited by pairs of brief sounds presented at intervals from tens to hundreds of milliseconds. We find that inhibitory conductances rarely last longer than 50-100 ms, whereas spike responses and synaptic inputs remain suppressed for hundreds of milliseconds. We conclude that postsynaptic inhibition contributes to forward suppression for only the first 50-100 ms after a stimulus and that intracortical contributions to long-lasting suppression must involve other mechanisms, such as synaptic depression.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; [Anonymous], [No title captured]; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carandini M, 2002, J NEUROSCI, V22, P10053; CastroAlamancos MA, 1997, REV NEUROSCIENCE, V8, P95; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Denham SL, 2001, NATO SCI S A LIF SCI, V312, P281; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; EGGERMONT JJ, 1995, J NEUROPHYSIOL, V73, P227, DOI 10.1152/jn.1995.73.1.227; Eggermont JJ, 1999, J NEUROSCI, V19, P2780; FERSTER D, 1986, J NEUROSCI, V6, P1284; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; METHERATE R, 1994, J PHYSIOL-LONDON, V481, P331, DOI 10.1113/jphysiol.1994.sp020443; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore B. C. J., 1995, HEARING; NICOLL RA, 1975, NATURE, V258, P625, DOI 10.1038/258625a0; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Talbot MJ, 1996, J NEUROPHYSIOL, V76, P2120, DOI 10.1152/jn.1996.76.3.2120; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Varela JA, 1999, J NEUROSCI, V19, P4293; Varela JA, 1997, J NEUROSCI, V17, P7926; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	45	312	318	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					437	445		10.1016/j.neuron.2005.06.009	http://dx.doi.org/10.1016/j.neuron.2005.06.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055066	Bronze			2022-12-24	WOS:000231051900013
J	Martinez-Trujillo, JC				Martinez-Trujillo, JC			Noncommutativity of eye rotations and the half-angle rule	NEURON			English	Editorial Material							NEURAL-CONTROL; PULLEYS; SYSTEM	In order to produce kinematically efficient behavior when dealing with the noncommutativity of rotations, the oculomotor system has developed strategies such as the half-angle rule. In this issue of Neuron, Ghasia and Angelaki demonstrate that during smooth pursuit eye movements the half-angle rule is implemented by the mechanical properties of the eye plant.	McGill Univ, Dept Physiol, Aerosp Med Res Unit, Montreal, PQ H3G 1Y6, Canada	McGill University	Martinez-Trujillo, JC (corresponding author), McGill Univ, Dept Physiol, Aerosp Med Res Unit, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Martinez-Trujillo, Julio C/M-2146-2015	Martinez-Trujillo, Julio C/0000-0003-3338-578X				Crawford JD, 2003, CURR OPIN NEUROBIOL, V13, P655, DOI 10.1016/j.conb.2003.10.009; CRAWFORD JD, 1994, J NEUROSCI, V14, P6911; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Ghasia FF, 2005, NEURON, V47, P281, DOI 10.1016/j.neuron.2005.05.031; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2179; Misslisch H, 2001, J NEUROPHYSIOL, V86, P1877, DOI 10.1152/jn.2001.86.4.1877; Quaia Christian, 2003, Strabismus, V11, P17, DOI 10.1076/stra.11.1.17.14088; SCHNABOLK C, 1994, J NEUROPHYSIOL, V71, P623, DOI 10.1152/jn.1994.71.2.623; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; Tweed DB, 1999, NATURE, V399, P261, DOI 10.1038/20441; Wong AMF, 2004, SURV OPHTHALMOL, V49, P563, DOI 10.1016/j.survophthal.2004.08.002	11	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					171	173		10.1016/j.neuron.2005.07.003	http://dx.doi.org/10.1016/j.neuron.2005.07.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039558	Bronze			2022-12-24	WOS:000230693900003
J	Inanobe, A; Furukawa, H; Gouaux, E				Inanobe, A; Furukawa, H; Gouaux, E			Mechanism of partial agonist action at the NR1 subunit of NMDA receptors	NEURON			English	Article							LIGAND-BINDING CORE; IONOTROPIC GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; ION-CHANNEL; 1-AMINOCYCLOBUTANE-1-CARBOXYLATE ACBC; TETRAMERIC STRUCTURE; GLYCINE; GLUR2; ACTIVATION	Partial agonists produce submaximal activation of ligand-gated ion channels. To address the question of partial agonist action at the NR1 subunit of the NMDA receptor, we performed crystallographic and electrophysiological studies with 1-aminocyclopropane-1-carboxylic acid (ACPC), 1-aminocyclobutane-l-carboxylic acid (ACBC), and 1-aminocyclopentane-1-carboxylic acid (cycloleucine), three compounds with incrementally larger carbocyclic rings. Whereas ACPC and ACBC partially activate the NMDA receptor by 80% and 42%, respectively, their cocrystal structures of the NR1 ligand binding core show the same degree of domain closure as found in the complex with glycine, a full agonist, illustrating that the NR1 subunit provides a new paradigm for partial agonist action that is distinct from that of the evolutionarily related GluR2, AMPA-sensitive receptor. Cycloleucine behaves as an antagonist and stabilizes an open-cleft conformation. The NR1-cycloleucine complex forms a dimer that is similar to the GluR2 dimer, thereby suggesting a conserved mode of subunit-subunit interaction in AMPA and NMDA receptors.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baron BM, 1996, J PHARMACOL EXP THER, V279, P62; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Danysz W, 1998, PHARMACOL REV, V50, P597; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOOD WF, 1989, EUR J PHARMACOL, V161, P281, DOI 10.1016/0014-2999(89)90861-3; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2003, BIOCHEMISTRY-US, V42, P5201, DOI 10.1021/bi020632t; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kalbaugh TL, 2004, MOL PHARMACOL, V66, P209, DOI 10.1124/mol.66.2.209; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laube B, 1998, J NEUROSCI, V18, P2954; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NADLER V, 1988, EUR J PHARMACOL, V157, P115, DOI 10.1016/0014-2999(88)90478-5; Nahum-Levy R, 1999, MOL PHARMACOL, V56, P1207, DOI 10.1124/mol.56.6.1207; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; WATSON GB, 1989, EUR J PHARMACOL, V167, P291, DOI 10.1016/0014-2999(89)90590-6; WATSON GB, 1990, NEUROPHARMACOLOGY, V29, P727, DOI 10.1016/0028-3908(90)90125-B; Zhang M, 2004, ACTA CRYSTALLOGR D, V60, P985, DOI 10.1107/S0907444904003786	59	155	159	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					71	84		10.1016/j.neuron.2005.05.022	http://dx.doi.org/10.1016/j.neuron.2005.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996549	Bronze			2022-12-24	WOS:000230464000009
J	Hatton, CJ; Paoletti, P				Hatton, CJ; Paoletti, P			Modulation of triheteromeric NMDA receptors by N-terminal domain Ligands	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; MOLECULAR CHARACTERIZATION; DEVELOPMENTAL-CHANGES; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURES; ZINC INHIBITION; BINDING DOMAIN; NR2A SUBUNIT; ACTIVATION	NMDA receptors (NMDARs) are heteromeric assemblies of NR1 and NR2(A-D) subunits with properties heavily influenced by the type of NF12 subunit incorporated. While NMDARs with only one type of NR2 subunit have been extensively characterized, little is known about receptors containing two different NR2 subunits, despite compelling evidence that such triheteromeric receptors exist in vivo. We used a point-mutation approach that allows isolation of recombinant triheteromeric NMDARs possessing two different NF12 N-terminal domains (NTDs). We show that in receptors associating the NR2A-NTD (sensing nanomolar Zn) and the NR2B-NTD (sensing ifenprodil), each NTD binding site retains selective high affinity for its ingand. However, each ligand produces only partial inhibition, and maximal inhibition requires occupancy of both NR2-NTDs by their respective ligands. Similarly, NR1/2A/2C receptors are inhibited by zinc with high potency but low efficacy. Therefore, interactions between homologous N-terminal domains determine the unique pharmacological properties of triheteromeric NIVIDARs.	Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Paoletti, P (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Anson LC, 1998, J NEUROSCI, V18, P581; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Brickley SG, 2003, J NEUROSCI, V23, P4958; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chazot PL, 1997, J NEUROCHEM, V69, P2138; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DIDIER M, 1995, NEUROREPORT, V6, P2255, DOI 10.1097/00001756-199511000-00036; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Laube B, 1998, J NEUROSCI, V18, P2954; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Martell A. E., 1982, CRITICAL STABILITY C, V5; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Neugebauer R, 2003, BIOCHEM BIOPH RES CO, V305, P476, DOI 10.1016/S0006-291X(03)00768-X; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Sundstrom E, 1997, EXP NEUROL, V148, P407, DOI 10.1006/exnr.1997.6691; Tovar KR, 1999, J NEUROSCI, V19, P4180; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x	54	190	198	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					261	274		10.1016/j.neuron.2005.03.005	http://dx.doi.org/10.1016/j.neuron.2005.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848804	Green Submitted, Bronze			2022-12-24	WOS:000228674800012
J	Brandish, PE; Su, M; Holder, DJ; Hodor, P; Szumiloski, J; Kleinhanz, RR; Forbes, JE; McWhorter, ME; Duenwald, SJ; Parrish, ML; Na, S; Liu, Y; Phillips, RL; Renger, JJ; Sankaranarayanan, S; Simon, AJ; Scolnick, EM				Brandish, PE; Su, M; Holder, DJ; Hodor, P; Szumiloski, J; Kleinhanz, RR; Forbes, JE; McWhorter, ME; Duenwald, SJ; Parrish, ML; Na, S; Liu, Y; Phillips, RL; Renger, JJ; Sankaranarayanan, S; Simon, AJ; Scolnick, EM			Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex	NEURON			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; BIPOLAR MOOD DISORDER; TRANSCRIPTION FACTOR; MESSENGER-RNA; BRAIN; TRIAL; PRAMIPEXOLE; LOCUS	Lithium inhibits inositol monophosphatase at therapeutically effective concentrations, and it has been hypothesized that depletion of brain inositol levels is an important chemical alteration for lithium's therapeutic efficacy in bipolar disorder. We have employed adult rat cortical slices as a model to investigate the gene regulatory consequences of inositol depletion effected by lithium using cytidine diphosphoryl-diacylglycerol as a functionally relevant biochemical marker to define treatment conditions. Genes coding for the neuropeptide hormone pituitary adenylate cyclase activating polypeptide (PACAP) and the enzyme that processes PACAP's precursor to the mature form, peptidylglycine alpha-amidating monooxygenase, were upregulated by inositol depletion. Previous work has shown that PACAP can increase tyrosine hydroxylase (TH) activity and dopamine release, and we found that the gene for GTP cyclohydrolase, which effectively regulates TH through synthesis of tetrahydrobiopterin, was also upregulated by inositol depletion. We propose that modulation of brain PACAP signaling might represent a new opportunity in the treatment of bipolar disorder.	Merck & Co Inc, West Point, PA 19486 USA; Rosetta Inpharmat LLC, Seattle, WA 98011 USA	Merck & Company; Merck & Company	Brandish, PE (corresponding author), Merck & Co Inc, West Point, PA 19486 USA.	philip_brandish@merck.com						ALLISON JH, 1971, NATURE-NEW BIOL, V233, P267, DOI 10.1038/newbio233267a0; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderson ST, 1998, BRAIN RES, V790, P343, DOI 10.1016/S0006-8993(98)00176-0; ATACK JR, 1993, BRIT J PHARMACOL, V110, P809, DOI 10.1111/j.1476-5381.1993.tb13884.x; ATACK JR, 1992, J NEUROCHEM, V59, P1946, DOI 10.1111/j.1471-4159.1992.tb11031.x; BANKER G, 1998, CULTURING NERVE CELL; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Bonde C, 2002, NEUROSCI LETT, V327, P49, DOI 10.1016/S0304-3940(02)00382-8; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392; Chen G, 1998, J NEUROCHEM, V70, P1768; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dinan TG, 2002, BRIT MED J, V324, P989, DOI 10.1136/bmj.324.7344.989; GODFREY PP, 1989, BIOCHEM J, V258, P621, DOI 10.1042/bj2580621; Goldberg JF, 2004, AM J PSYCHIAT, V161, P564, DOI 10.1176/appi.ajp.161.3.564; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Gray SL, 2002, ENDOCRINOLOGY, V143, P3946, DOI 10.1210/en.2002-220401; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Hyland K, 2003, ANN NEUROL, V54, pS46, DOI 10.1002/ana.10695; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kawaguchi C, 2003, BIOCHEM BIOPH RES CO, V310, P169, DOI 10.1016/j.bbrc.2003.09.004; Kristensen BW, 2003, BRAIN RES, V964, P264, DOI 10.1016/S0006-8993(02)04080-5; Lenox RH, 2002, AM J MED GENET, V114, P391, DOI 10.1002/ajmg.10360; LENOX RH, 1998, TXB PSYCHOPHARMACOLO; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lubrich B, 1997, MOL PSYCHIATR, V2, P407, DOI 10.1038/sj.mp.4000267; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McInnes LA, 2001, P NATL ACAD SCI USA, V98, P11485, DOI 10.1073/pnas.191519098; MIKKELSEN JD, 1994, NEUROSCI LETT, V171, P121, DOI 10.1016/0304-3940(94)90620-3; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Moser A, 1999, NEUROPEPTIDES, V33, P492, DOI 10.1054/npep.1999.0768; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Pinhiero J.C., 2000, MIXED EFFECTS MODELS; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; SCHULLER HJ, 1995, FEBS LETT, V370, P149, DOI 10.1016/0014-5793(95)00818-T; Searle S., 1992, VARIANCE COMPONENTS; SHANNON K, 2000, Patent No. 6132997; SHERMAN WR, 1986, FASEB J, V45, P2639; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; SMYTH GK, 2004, STAT APPL GENETICS M, V3; STUBBS EB, 1993, J NEUROCHEM, V60, P1292, DOI 10.1111/j.1471-4159.1993.tb03289.x; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wang L, 2001, J NEUROCHEM, V79, P816, DOI 10.1046/j.1471-4159.2001.00631.x; WEISSMAN MM, 1988, PSYCHOL MED, V18, P141, DOI 10.1017/S0033291700001975; WELSH DK, 1990, BIOL PSYCHIAT, V28, P117, DOI 10.1016/0006-3223(90)90629-G; Wilhelmi E, 2002, ATLA-ALTERN LAB ANIM, V30, P275, DOI 10.1177/026119290203000304; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013	55	76	79	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					861	872		10.1016/j.neuron.2005.02.006	http://dx.doi.org/10.1016/j.neuron.2005.02.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797548	Bronze			2022-12-24	WOS:000228031300008
J	Arlotta, P; Molyneaux, BJ; Chen, J; Inoue, J; Kominami, R; Macklis, JD				Arlotta, P; Molyneaux, BJ; Chen, J; Inoue, J; Kominami, R; Macklis, JD			Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo	NEURON			English	Article							ZINC-FINGER GENE; TRANSCRIPTIONAL REPRESSION; THALAMOCORTICAL AXONS; SUBCORTICAL TARGETS; BINDING PROTEIN-4; MOLECULAR-CLONING; SUBPLATE NEURONS; DEFICIENT MICE; COUP-TFI; EXPRESSION	Within the vertebrate nervous system, the presence of many different lineages of neurons and glia complicates the molecular characterization of single neuronal populations. In order to elucidate molecular mechanisms underlying the specification and development of corticospinal motor neurons (CSMN), we purified CSMN at distinct stages of development in vivo and compared their gene expression to two other pure populations of cortical projection neurons: callosal projection neurons and corticotectal projection neurons. We found genes that are potentially instructive for CSMN development, as well as genes that are excluded from CSMN and are restricted to other populations of neurons, even within the same cortical layer. Loss-of-function experiments in null mutant mice for Ctip2 (also known as Bcl1 1b), one of the newly characterized genes, demonstrate that it plays a critical role in the development of CSMN axonal projections to the spinal cord in vivo, confirming that we identified central genetic determinants of the CSMN population.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518122, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Niigata University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu	INOUE, Jun/O-7352-2016; Chen, Jinhui/A-7138-2009	INOUE, Jun/0000-0003-4145-3754; Chen, Jinhui/0000-0002-6864-7121; Molyneaux, Bradley/0000-0002-3377-1229				Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bayer S.A., 1991, NEOCORTICAL DEV; Becker T, 2002, MECH DEVELOP, V117, P75, DOI 10.1016/S0925-4773(02)00178-8; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; CAJAL SRY, 1928, RECUERDOS MI VIDA; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Coonan JR, 2001, J COMP NEUROL, V436, P248; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Fujimori KE, 2000, J COMP NEUROL, V417, P275, DOI 10.1002/(SICI)1096-9861(20000214)417:3<275::AID-CNE2>3.0.CO;2-7; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Huang ZY, 2003, MOL CELL BIOL, V23, P566, DOI 10.1128/MCB.23.2.566-578.2003; Inoue J, 2004, J OCUL PHARMACOL TH, V20, P1, DOI 10.1089/108076804772745419; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES EG, 1982, PROG BRAIN RES, V57, P361, DOI 10.1016/S0079-6123(08)64137-0; Kamme F, 2003, J NEUROSCI, V23, P3607; Kolle G, 2000, MECH DEVELOP, V90, P181, DOI 10.1016/S0925-4773(99)00248-8; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Liu Q, 2000, J NEUROSCI, V20, P7682; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Mori JI, 2002, ENDOCRINOLOGY, V143, P1538, DOI 10.1210/en.143.4.1538; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Olson MF, 2003, CURR BIOL, V13, pR360, DOI 10.1016/S0960-9822(03)00277-X; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Rolf B, 2002, J NEUROSCI, V22, P8357; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; SARIS CJM, 1987, J BIOL CHEM, V262, P10663; Segovia L, 1997, Mol Vis, V3, P9; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; STENVERS KL, 1994, J COMP NEUROL, V339, P91, DOI 10.1002/cne.903390109; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	57	778	789	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					207	221		10.1016/j.neuron.2004.12.036	http://dx.doi.org/10.1016/j.neuron.2004.12.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664173	Bronze			2022-12-24	WOS:000226451500008
J	Sgaier, SK; Millet, S; Villanueva, MP; Berenshteyn, F; Song, C; Joyner, AL				Sgaier, SK; Millet, S; Villanueva, MP; Berenshteyn, F; Song, C; Joyner, AL			Morphogenetic and cellular movements that shape the mouse cerebellum: Insights from genetic fate mapping	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; MID-HINDBRAIN; RHOMBIC LIP; EXPRESSION; CELLS; PROGENITORS; TAMOXIFEN; REPLACEMENT; MIGRATION; PATTERNS	We used the cerebellum as a model to study the morphogenetic and cellular processes underlying the formation of elaborate brain structures from a simple neural tube, using an inducible genetic fate mapping approach in mouse. We demonstrate how a 90 rotation between embryonic days 9 and 12 converts the rostral-caudal axis of dorsal rhombomere 1 into the medial-lateral axis of the wing-like bilateral cerebellar primordium. With the appropriate use of promoters, we marked specific medial-lateral domains of the cerebellar primordium and derived a positional fate map of the murine cerebellum. We show that the adult medial cerebellum is produced by expansion, rather than fusion, of the thin medial primordium. Furthermore, ventricular-derived cells maintain their original medial-lateral coordinates into the adult, whereas rhombic lip-derived granule cells undergo lateral to medial posterior transverse migrations during foliation. Thus, we show that progressive changes in the axes of the cerebellum underlie its genesis.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; GenOway SA, F-69007 Lyon, France	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu		Song, Christian/0000-0003-3807-3398				Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Altman J, 1997, DEV CEREBELLAR SYSTE; Bai CB, 2002, DEVELOPMENT, V129, P4753; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamre KM, 1997, DEVELOPMENT, V124, P4201; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hanks MC, 1998, DEVELOPMENT, V125, P4521; Helms AW, 1998, DEVELOPMENT, V125, P919; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Lin JC, 1999, DEV BIOL, V211, P177, DOI 10.1006/dbio.1999.9316; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; Mathis L, 1997, DEVELOPMENT, V124, P4089; Matise MP, 2000, PRACT APPROACH SER, V212, P101; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Millet S, 1996, DEVELOPMENT, V122, P3785; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; OTERO RA, 1993, J COMP NEUROL, V333, P597, DOI 10.1002/cne.903330411; Papaioannou V, 2000, PRACT APPROACH SER, V212, P133; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rosario CM, 1997, DEVELOPMENT, V124, P4213; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	42	129	130	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					27	40		10.1016/S0896-6273(04)00802-5	http://dx.doi.org/10.1016/S0896-6273(04)00802-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629700	Bronze			2022-12-24	WOS:000226217100007
J	Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ				Rotshtein, P; Henson, RNA; Treves, A; Driver, J; Dolan, RJ			Morphing Marilyn into Maggie dissociates physical and identity face representations in the brain	NATURE NEUROSCIENCE			English	Article							FAMOUS FACES; PERCEPTION; RECOGNITION; FMRI; RESPONSES; NEURONS; ACCOUNT; AREA; ACTIVATION; EXPRESSION	How the brain represents different aspects of faces remains controversial. Here we presented subjects with stimuli drawn from morph continua between pairs of famous faces. In the paired presentations, a second face could be identical to the first, could share perceived identity but differ physically (30% along the morph continuum), or could differ physically by the same distance along the continuum (30%) but in the other direction. We show that, behaviorally, subjects are more likely to classify face pairs in the third paired presentation as different and that this effect is more pronounced for subjects who are more familiar with the faces. In functional magnetic resonance imaging (fMRI), inferior occipital gyrus (IOG) shows sensitivity to physical rather than to identity changes, whereas right fusiform gyrus (FFG) shows sensitivity to identity rather than to physical changes. Bilateral anterior temporal regions show sensitivity to identity change that varies with the subjects' pre-experimental familiarity with the faces. These findings provide neurobiological support for a hierarchical model of face perception.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England; UCL, Dept Psychol, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3BG, England; SISSA, Program Neurosci, I-34013 Trieste, Italy	University of London; University College London; University of London; University College London; University of London; University College London; International School for Advanced Studies (SISSA)	Rotshtein, P (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London, England.	p.rotshtein@fil.ion.ucl.ac.uk	Henson, Richard/H-8822-2019; Driver, Jon/A-4779-2010; Treves, Alessandro/B-2318-2009	Henson, Richard/0000-0002-0712-2639; Dolan, Ray/0000-0001-9356-761X; TREVES, Alessandro/0000-0001-7246-5673; Rotshtein, Pia/0000-0002-0301-9511				Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Harnad S., 1987, CATEGORICAL PERCEPTI, P29; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Josephs O., 2000, NEUROIMAGE, V11, pS543; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mundel T, 2003, J CLIN NEUROPHYSIOL, V20, P102, DOI 10.1097/00004691-200304000-00003; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; PENNY W, 2003, HUMAN BRAIN FUNCTION, V2, P851; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Rajah MN, 1999, COGNITIVE BRAIN RES, V8, P259, DOI 10.1016/S0926-6410(99)00030-0; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	50	413	417	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					107	113		10.1038/nn1370	http://dx.doi.org/10.1038/nn1370			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592463	Green Published			2022-12-24	WOS:000225967600023
J	Menon, KP; Sanyal, S; Habara, Y; Sanchez, R; Wharton, RP; Ramaswami, M; Zinn, K				Menon, KP; Sanyal, S; Habara, Y; Sanchez, R; Wharton, RP; Ramaswami, M; Zinn, K			The translational repressor Pumilio regulates presynaptic morphology and controls postsynaptic accumulation of translation factor elF-4E	NEURON			English	Article							CYTOPLASMIC POLYADENYLATION ELEMENT; DROSOPHILA NEUROMUSCULAR-JUNCTION; HUNCHBACK MESSENGER-RNA; GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; BINDING PROTEIN; AXON GUIDANCE; STEM-CELLS; NANOS; EXPRESSION	Translational repression by Drosophila Pumilio (Pum) protein controls posterior patterning during embryonic development. Here, we show that Pum is an important mediator of synaptic growth and plasticity at the neuromuscular junction (NMJ). Pum is localized to the postsynaptic side of the NMJ in third instar larvae and is also expressed in larval neurons. Neuronal Pum regulates synaptic growth. In its absence, NMJ boutons are larger and fewer in number, while Pum overexpression increases bouton number and decreases bourton size. Postsynaptic Pum negatively regulates expression of the translation factor elF-4E at the NMJ, and Pum binds selectively to the 3'UTR of elF-4E mRNA. The GluRlla glutamate receptor is upregulated in pum mutants. These results, together with genetic epistasis studies, suggest that postsynaptic Pum modulates synaptic function via direct control of elF-4E expression.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85716 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85716 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	California Institute of Technology; University of Arizona; University of Arizona; Duke University; Howard Hughes Medical Institute	Zinn, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu		Ramaswami, Mani/0000-0001-7631-0468; Sanyal, Subhabrata/0000-0003-2590-2732	NCI NIH HHS [T32 CA09213] Funding Source: Medline; NIDA NIH HHS [DA15495, DA15383] Funding Source: Medline; NINDS NIH HHS [R01 NS043416, R37 NS028182, R01 NS028182-15, R01 NS028182, R01 NS43416, R01 NS043416-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182, R01NS043416, R37NS028182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015383, R01DA015495] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; Forbes A, 1998, DEVELOPMENT, V125, P679; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Menon KP, 1998, DEVELOPMENT, V125, P4121; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Parisi M, 1999, GENETICS, V153, P235; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rorth P, 1998, DEVELOPMENT, V125, P1049; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schweers BA, 2002, GENETICS, V161, P1177; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; STERN M, 1990, GENETICS, V124, P133; STERN M, 1989, J NEUROGENET, V5, P215, DOI 10.3109/01677068909066209; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Stimson DT, 1998, J NEUROSCI, V18, P9638; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	38	119	122	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					663	676		10.1016/j.neuron.2004.10.028	http://dx.doi.org/10.1016/j.neuron.2004.10.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541314	Bronze			2022-12-24	WOS:000225338100012
J	Jordan, H; Fallah, M; Stoner, GR				Jordan, H; Fallah, M; Stoner, GR			Adaptation of gender derived from biological motion	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL SYSTEM; NEURONS; PERCEPTION	Human observers adapted to complex biological motions that distinguish males from females: viewing the gait of one gender biased judgments of subsequent gaits toward the opposite gender. This adaptation was not simply due to local features of the stimuli but instead relied upon the global motion of the figures. These results suggest the existence of neurons selective for gender and demonstrate that gender-from-motion judgments are not fixed but depend upon recent viewing history.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Jordan, H (corresponding author), York Univ, Ctr Vis Res, 4500 Keele St, N York, ON M3J 1P3, Canada.	Jordan@cvr.yorku.ca	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	NATIONAL EYE INSTITUTE [R01EY012872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NEI NIH HHS [2R01EY12872-05] Funding Source: Medline; NIMH NIH HHS [5T32MH020002-05] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420	15	41	41	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					738	739		10.1038/nn1710	http://dx.doi.org/10.1038/nn1710			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715080				2022-12-24	WOS:000237895200012
J	Wang, XH; Lou, NH; Xu, QW; Tian, GF; Peng, WG; Han, XN; Kang, J; Takano, T; Nedergaard, M				Wang, Xiaohai; Lou, Nanhong; Xu, Qiwu; Tian, Guo-Feng; Peng, Wei Guo; Han, Xiaoning; Kang, Jian; Takano, Takahiro; Nedergaard, Maiken			Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RAT BARREL CORTEX; NEURONAL-ACTIVITY; CALCIUM WAVES; SYNAPTIC-TRANSMISSION; GLUTAMATE; RECEPTORS; BRAIN; SITU; OSCILLATIONS	Although astrocytes are the most abundant cell type in the brain, evidence for their activation during physiological sensory activity is lacking. Here we show that whisker stimulation evokes increases in astrocytic cytosolic calcium (Ca2+) within the barrel cortex of adult mice. Increases in astrocytic Ca2+ were a function of the frequency of stimulation, occurred within several seconds and were inhibited by metabotropic glutamate receptor antagonists. To distinguish between synaptic input and output, local synaptic activity in cortical layer 2 was silenced by iontophoresis of AMPA and NMDA receptor antagonists. The antagonists did not reduce astrocytic Ca2+ responses despite a marked reduction in excitatory postsynaptic currents in response to whisker stimulation. These findings indicate that astrocytes respond to synaptic input, by means of spillover or ectopic release of glutamate, and that increases in astrocytic Ca2+ occur independently of postsynaptic excitatory activity.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	University of Rochester; New York Medical College	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Nedergaard@URMC.Rochester.edu		Takano, Takahiro/0000-0002-6235-6673; Wang, Xiaohai/0000-0001-5814-4072	NINDS NIH HHS [NS38073, NS30007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030007, R01NS038073, R01NS030007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, J NEUROSCI, V18, P6822; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina M., 2005, NEUROGLIA, P229; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DUFFY S, 1995, J NEUROSCI, V15, P5535; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 1999, Adv Neurol, V79, P565; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; NILSSON M, 1991, DEV BRAIN RES, V63, P33, DOI 10.1016/0165-3806(91)90064-P; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; PORTER T, 1995, IEEE MULTIMEDIA, V2, P101; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Venance L, 1997, J NEUROSCI, V17, P1981; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	50	487	501	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					816	823		10.1038/nn1703	http://dx.doi.org/10.1038/nn1703			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699507				2022-12-24	WOS:000237895200022
J	Kerr, MA; Belluscio, L				Kerr, MA; Belluscio, L			Olfactory experience accelerates glomerular refinement in the mammalian olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT RECEPTORS; CREB	Primary olfactory sensory neurons (OSNs) impart both molecular and functional organization to the olfactory bulb. Because OSNs can be selectively activated by odorants in vivo, we sought to determine whether odorant experience alters the cellular dynamics of specific OSNs or their axonal projections. Using mice, we found that odorant stimulation associated with behavioral conditioning influenced OSN wiring by accelerating glomerular refinement independent of OSN number; furthermore, this wiring was strongly associated with olfactory learning.	NINDS, Dev Neural Plast Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Belluscio, L (corresponding author), NINDS, Dev Neural Plast Unit, NIH, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003002, ZIANS003002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; COOPERSMITH R, 1986, DEV BRAIN RES, V27, P191, DOI 10.1016/0165-3806(86)90245-2; COOPERSMITH R, 1986, DEV BRAIN RES, V24, P271, DOI 10.1016/0165-3806(86)90195-1; GUENTHER E, 1948, ESSENTIAL OILS, V3; JOHNSON BA, 1995, BRAIN RES, V699, P192, DOI 10.1016/0006-8993(95)00896-X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Yuan Q, 2000, LEARN MEMORY, V7, P413, DOI 10.1101/lm.35900; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	15	66	67	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					484	486		10.1038/nn1673	http://dx.doi.org/10.1038/nn1673			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547509				2022-12-24	WOS:000236310700013
J	Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS				Wang, Y; Markram, H; Goodman, PH; Berger, TK; Ma, JY; Goldman-Rakic, PS			Heterogeneity in the pyramidal network of the medial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SHORT-TERM PLASTICITY; IN-VITRO; PERSISTENT ACTIVITY; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; WORKING-MEMORY; VISUAL-CORTEX; RAT NEOCORTEX; PAIRED-PULSE; FRONTAL-LOBE	The prefrontal cortex is specially adapted to generate persistent activity that outlasts stimuli and is resistant to distractors, presumed to be the basis of working memory. The pyramidal network that supports this activity is unknown. Multineuron patch-clamp recordings in the ferret medial prefrontal cortex showed a heterogeneity of synapses interconnecting distinct subnetworks of different pyramidal cells. One subnetwork was similar to the pyramidal network commonly found in primary sensory areas, consisting of accommodating pyramidal cells interconnected with depressing synapses. The other subnetwork contained complex pyramidal cells with dual apical dendrites displaying nonaccommodating discharge patterns; these cells were hyper-reciprocally connected with facilitating synapses displaying pronounced synaptic augmentation and post-tetanic potentiation. These cellular, synaptic and network properties could amplify recurrent interactions between pyramidal neurons and support persistent activity in the prefrontal cortex.	Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA; Ecole Polytech Fed Lausanne, Brain & Mind Inst, CH-1015 Lausanne, Switzerland; Univ Nevada, Dept Internal Med, Reno, NV 89557 USA; Univ Nevada, Biomed Engn Program, Reno, NV 89557 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	St. Elizabeth's Medical Center; Tufts University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University	Wang, Y (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Div Neurol Res, Boston, MA 02135 USA.	yun.wang@tufts.edu						Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Douglas RJ, 1996, J NEUROCYTOL, V25, P893, DOI 10.1007/BF02284849; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; McCormick DA, 2001, NAT NEUROSCI, V4, P113, DOI 10.1038/83917; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WEST DC, CEREB CORTEX, V16, P200; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	307	308	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					534	542		10.1038/nn1670	http://dx.doi.org/10.1038/nn1670			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547512				2022-12-24	WOS:000236310700021
J	Darcy, KJ; Staras, K; Collinson, LM; Goda, Y				Darcy, KJ; Staras, K; Collinson, LM; Goda, Y			Constitutive sharing of recycling synaptic vesicles between presynaptic boutons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; RELEASE; PLASTICITY; TRANSPORT; VISUALIZATION; TRANSMITTER; ENDOCYTOSIS; GLUTAMATE; MEMBRANE; TURNOVER	The synaptic vesicle cycle is vital for sustained neurotransmitter release. It has been assumed that functional synaptic vesicles are replenished autonomously at individual presynaptic terminals. Here we tested this assumption by using FM dyes in combination with fluorescence recovery after photobleaching and correlative light and electron microscopy in cultured rat hippocampal neurons. After photobleaching, synapses acquired recently recycled FM dye-labeled vesicles originating from nonphotobleached synapses by a process requiring dynamic actin turnover. The imported vesicles entered the functional pool at their host synapses, as revealed by the exocytic release of the dye upon stimulation. FM1-43 photoconversion and ultrastructural analysis confirmed the incorporation of imported vesicles into the presynaptic terminal, where they mixed with the native vesicle pools. Our results demonstrate that synaptic vesicle recycling is not confined to individual presynaptic terminals as is widely believed; rather, a substantial proportion of recycling vesicles are shared constitutively between boutons.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, Electron Microscopy Facil, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Dept Pharmacol, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Goda, Y (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	y.goda@ucl.ac.uk	Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Collinson, Lucy/0000-0003-0260-613X; Staras, Kevin/0000-0003-4141-339X	Medical Research Council [MC_U122669937] Funding Source: Medline; MRC [MC_U122669937] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hiruma H, 2003, J NEUROSCI, V23, P8967; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; STINCHCOMBE JC, 1995, J CELL BIOL, V131, P1387, DOI 10.1083/jcb.131.6.1387; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	158	161	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					315	321		10.1038/nn1640	http://dx.doi.org/10.1038/nn1640			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462738				2022-12-24	WOS:000235645600010
J	Ryu, JB; Liu, LD; Wong, TP; Wu, DC; Burette, A; Weinberg, R; Wang, YT; Sheng, M				Ryu, JB; Liu, LD; Wong, TP; Wu, DC; Burette, A; Weinberg, R; Wang, YT; Sheng, M			A critical role for myosin IIB in dendritic spine morphology and synaptic function	NEURON			English	Article							HEAVY-CHAIN GENE; LIGHT-CHAIN; ACTIN; EXPRESSION; PLASTICITY; DYNAMICS; BLEBBISTATIN; INHIBITOR; RECEPTORS; MOTILITY	Dendritic spines show rapid motility and plastic morphology, which may mediate information storage in the brain. It is presently believed that polymerization/ depolymerization of actin is the primary determinant of spine motility and morphogenesis. Here, we show that myosin IIB, a molecular motor that binds and contracts actin filaments, is essential for normal spine morphology and dynamics and represents a distinct biophysical pathway to control spine size and shape. Myosin IIB is enriched in the postsynaptic density (PSD) of neurons. Pharmacologic or genetic inhibition of myosin IIB alters protrusive motility of spines, destabilizes their classical mushroom-head morphology, and impairs excitatory synaptic transmission. Thus, the structure and function of spines is regulated by an actin-based motor in addition to the polymerization state of actin.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, RIKEN,Nueorsci Res Ctr, Cambridge, MA 02139 USA; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, RIKEN,Nueorsci Res Ctr, Cambridge, MA 02139 USA.	msheng@mit.edu	Wu, Dong Chuan/O-3909-2015; Wang, Yu Tian/A-4729-2008; Weinberg, Richard/AAC-1898-2020; Wang, Yu Tian/J-8255-2015	Sheng, Morgan/0000-0002-8703-5366; Liu, Lidong/0000-0002-7026-690X; Weinberg, Richard/0000-0001-9689-7278; Wong, Tak Pan/0000-0001-8611-4911; WU, DONG CHUAN/0000-0002-9539-5935				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Dailey ME, 1996, J NEUROSCI, V16, P2983; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUZUKI H, 1978, J BIOCHEM, V84, P1529, DOI 10.1093/oxfordjournals.jbchem.a132278; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	129	131	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					175	182		10.1016/j.neuron.2005.12.017	http://dx.doi.org/10.1016/j.neuron.2005.12.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423692	Bronze, Green Submitted			2022-12-24	WOS:000234979900005
J	Prado, J; Clavagnier, S; Otzenberger, H; Scheiber, C; Kennedy, H; Perenin, MT				Prado, J; Clavagnier, S; Otzenberger, H; Scheiber, C; Kennedy, H; Perenin, MT			Two cortical systems for reaching in central and peripheral vision	NEURON			English	Article							EYE-HAND COORDINATION; POSTERIOR PARIETAL CORTEX; OPTIC ATAXIA; HUMAN INTRAPARIETAL; FUNCTIONAL-ANATOMY; VISUAL SPACE; MOVEMENTS; GAZE; TARGET; AREA	Parietal lesions in humans can produce a specific disruption of visually guided hand movement, termed optic ataxia. The fact that the deficit mainly occurs in peripheral vision suggests that reaching in foveal and extrafoveal vision rely on two different neural substrates. In the present study, we have directly tested this hypothesis by event-related fMRI in healthy subjects. Brain activity was measured when participants reached toward central or peripheral visual targets. Our results confirm the existence of two systems, differently modulated by the two conditions. Reaching in central vision involved a restricted network including the medial intraparietal sulcus (mIPS) and the caudal part of the dorsal premotor cortex (PMd). Reaching in peripheral vision activated in addition the parietooccipital junction (POJ) and a more rostral part of PMd. These results show that reaching to the peripheral visual field engages a more extensive cortical network than reaching to the central visual field.	INSERM, U371, Dept Cognit Neurosci, F-69675 Bron, France; Univ Lyon 1, Inst Federatif Neurosci IFR19, F-69675 Bron, France; CNRS, UMR 7004, Lab Neuroimagerie In Vivo, F-67085 Strasbourg, France; Univ Strasbourg, Fac Med, F-67085 Strasbourg, France; CNRS, UMR 5015, Inst Cognit Sci, F-69675 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS)	Prado, J (corresponding author), INSERM, U371, Dept Cognit Neurosci, F-69675 Bron, France.	jprado@isc.cnrs.fr; clavagnier@lyon.inserm.fr; perenin@lyon.inserm.fr	Kennedy, Henry/B-9636-2013; Prado, Jérôme/D-5581-2013; Scheiber, Christian/O-3259-2017	Kennedy, Henry/0000-0002-2796-7663; Prado, Jérôme/0000-0003-3548-5610; Clavagnier, Simon/0000-0002-1425-4584				Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Blouin J, 2002, EXP BRAIN RES, V144, P281, DOI 10.1007/s00221-002-1029-5; BLOUIN J, 1995, NEUROSCI LETT, V183, P187, DOI 10.1016/0304-3940(94)11147-B; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Carey DP, 2002, PROG BRAIN RES, V140, P311; Carey DP, 1997, CORTEX, V33, P639, DOI 10.1016/S0010-9452(08)70722-6; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Dechent P, 2003, EUR J NEUROSCI, V17, P2201, DOI 10.1046/j.1460-9568.2003.02645.x; DEGRAAF JB, 1995, NEUROREPORT, V6, P1733, DOI 10.1097/00001756-199509000-00007; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FISK JD, 1985, EXP BRAIN RES, V60, P159; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Hoffmann A, 2000, MAGNET RESON MED, V44, P791, DOI 10.1002/1522-2594(200011)44:5<791::AID-MRM17>3.0.CO;2-2; Inoue K, 1998, J NEUROPHYSIOL, V79, P117, DOI 10.1152/jn.1998.79.1.117; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kawashima R, 1996, NEUROREPORT, V7, P1253, DOI 10.1097/00001756-199605170-00006; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Matelli M, 1998, J COMP NEUROL, V402, P327; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; Neggers SFW, 1999, EXP BRAIN RES, V125, P97, DOI 10.1007/s002210050663; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Sailer U, 2000, EXP BRAIN RES, V134, P163, DOI 10.1007/s002210000457; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Donkelaar P, 2000, J NEUROPHYSIOL, V84, P1677, DOI 10.1152/jn.2000.84.3.1677; van Donkelaar P, 2000, EXP BRAIN RES, V133, P414, DOI 10.1007/s002210000422; van Donkelaar P, 2005, J MOTOR BEHAV, V37, P157, DOI 10.3200/JMBR.37.2.157-163; vanDonkelaar P, 1997, NEUROREPORT, V8, P2139, DOI 10.1097/00001756-199707070-00010; VERCHER JL, 1994, EXP BRAIN RES, V99, P507	55	242	245	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					849	858		10.1016/j.neuron.2005.10.010	http://dx.doi.org/10.1016/j.neuron.2005.10.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337921	Bronze			2022-12-24	WOS:000233927300022
J	Buchsbaum, BR; Olsen, RK; Koch, P; Berman, KF				Buchsbaum, BR; Olsen, RK; Koch, P; Berman, KF			Human dorsal and ventral auditory streams subserve rehearsal-based and echoic processes during verbal working memory	NEURON			English	Article							SHORT-TERM-MEMORY; PRECATEGORICAL ACOUSTIC STORAGE; POSITRON-EMISSION-TOMOGRAPHY; SUPERIOR TEMPORAL GYRUS; EVENT-RELATED FMRI; SPEECH-PERCEPTION; FUNCTIONAL NEUROANATOMY; SELECTIVE IMPAIRMENT; EPISODIC RETRIEVAL; EXECUTIVE CONTROL	To hear a sequence of words and repeat them requires sensory-motor processing and something more-temporary storage. We investigated neural mechanisms of verbal memory by using fMRI and a task designed to tease apart perceptually based ("echoic") memory from phonological-articulatory memory. Sets of two- or three-word pairs were presented bimodally, followed by a cue indicating from which modality (auditory or visual) items were to be retrieved and rehearsed over a delay. Although delay-period activation in the planum temporale (PT) was insensible to the source modality and showed sustained delay-period activity, the superior temporal gyrus (STG) activated more vigorously when the retrieved items had arrived to the auditory modality and showed transient delay-period activity. Functional connectivity analysis revealed two topographically distinct fronto-temporal circuits, with STG coactivating more strongly with ventrolateral prefrontal cortex and PT coactivating more strongly with dorsolateral prefrontal cortex. These argue for separate contributions of ventral and dorsal auditory streams in verbal working memory.	NIMH, Sect Integrat Neuroimaging, Clin Brain Disorders Branch,Dept Hlth & Human Ser, NIH,Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Buchsbaum, BR (corresponding author), NIMH, Sect Integrat Neuroimaging, Clin Brain Disorders Branch,Dept Hlth & Human Ser, NIH,Intramural Res Program, Bethesda, MD 20892 USA.	buchsbab@intra.nimh.nih.gov		Olsen, Rosanna/0000-0002-2918-4152	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley A., 2007, WORKING MEMORY THOUG; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BROADBENT DE, 1956, Q J EXP PSYCHOL, V8, P145, DOI 10.1080/17470215608416814; Buchsbaum BR, 2005, NEUROIMAGE, V24, P444, DOI 10.1016/j.neuroimage.2004.08.025; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; CROWDER RG, 1969, PERCEPT PSYCHOPHYS, V5, P365, DOI 10.3758/BF03210660; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fiez JA, 1996, J NEUROSCI, V16, P808; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRANKISH C, 1989, J EXP PSYCHOL LEARN, V15, P469, DOI 10.1037/0278-7393.15.3.469; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jonides J, 1998, J NEUROSCI, V18, P5026; Kraus N, 2005, TRENDS NEUROSCI, V28, P176, DOI 10.1016/j.tins.2005.02.003; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Loader C., 1999, LOCAL REGRESSION LIK; LU ZL, 1992, BRAIN RES, V572, P236, DOI 10.1016/0006-8993(92)90475-O; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Martin N, 2002, APHASIOLOGY, V16, P107, DOI 10.1080/02687040143000447; Milner A. D., 1995, VISUAL BRAIN ACTION; Mustovic H, 2003, NEUROIMAGE, V20, P429, DOI 10.1016/S1053-8119(03)00293-3; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Pinheiro J, 2001, MIXED EFFECTS MODELS; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Postle BR, 2003, CORTEX, V39, P927, DOI 10.1016/S0010-9452(08)70871-2; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Ramsay J.O., 1997, FUNCTIONAL DATA ANAL; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2003, NEUROIMAGE, V20, P173, DOI 10.1016/S1053-8119(03)00218-0; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; SHIFFRIN RM, 1969, PSYCHOL REV, V76, P179, DOI 10.1037/h0027277; Stevens AA, 2004, COGNITIVE BRAIN RES, V18, P162, DOI 10.1016/j.cogbrainres.2003.10.008; Takayama Y, 2004, EUR NEUROL, V51, P115, DOI 10.1159/000076792; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; WATKINS MJ, 1973, J EXP PSYCHOL, V99, P226, DOI 10.1037/h0034651; WATKINS OC, 1980, J EXP PSYCHOL GEN, V109, P251, DOI 10.1037/0096-3445.109.3.251; WENICKE C, 1874, WERNICKES WORKS APHA, P91; Wilson M, 2001, PSYCHOL BULL, V127, P543, DOI 10.1037/0033-2909.127.4.543; Winkler I, 2005, EXP PSYCHOL, V52, P3, DOI 10.1027/1618-3169.52.1.3; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83	63	198	199	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					687	697		10.1016/j.neuron.2005.09.029	http://dx.doi.org/10.1016/j.neuron.2005.09.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301183	Bronze			2022-12-24	WOS:000233677300020
J	Beffert, U; Weeber, EJ; Durudas, A; Qiu, SF; Masiulis, I; Sweatt, JD; Li, WP; Adelmann, G; Frotscher, M; Hammer, RE; Herz, J				Beffert, U; Weeber, EJ; Durudas, A; Qiu, SF; Masiulis, I; Sweatt, JD; Li, WP; Adelmann, G; Frotscher, M; Hammer, RE; Herz, J			Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2	NEURON			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; CA3 NMDA RECEPTORS; TYROSINE PHOSPHORYLATION; BRAIN-DEVELOPMENT; BINDING DOMAIN; VLDL RECEPTOR; DISABLED 1; MOUSE; EXPRESSION	Apolipoprotein E receptor 2 (Apoer2), a member of the LDL receptor gene family, and its ligand Reelin control neuronal migration during brain development. Apoer2 is also essential for induction of long-term potentiation (LTP) in the adult brain. Here we show that Apoer2 is present in the postsynaptic densities of excitatory synapses where it forms a functional complex with NMDA receptors. Reelin signaling through Apoer2 markedly enhances LTP through a mechanism that requires the presence of amino acids encoded by an exon in the intracellular domain of Apoer2. This exon is alternatively spliced in an activity-dependent manner and is required for Reelin-induced tyrosine phosphorylation of NMDA receptor subunits. Mice constitutively lacking the exon perform poorly in learning and memory tasks. Thus, alternative splicing of Apoer2, a novel component of the NMDA receptor complex, controls the modulation of NMDA receptor activity, synaptic neurotransmission, and memory by Reelin.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ Freiburg, Zentrum Neurowissensch, Inst Anat & Zellbiol, D-79104 Freiburg, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Baylor College of Medicine; University of Freiburg	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	Weeber, Edwin J/A-5396-2012	Hammer, Robert E./0000-0001-5487-7551; Sweatt, J. David/0000-0003-3567-485X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762, HL20948, HL63762] Funding Source: Medline; NIMH NIH HHS [MH57014] Funding Source: Medline; NINDS NIH HHS [NS43408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Black D L, 2003, Prog Mol Subcell Biol, V31, P187; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Drakew A, 1998, NEUROSCIENCE, V82, P1079; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Pesold C, 1999, P NATL ACAD SCI USA, V96, P3217, DOI 10.1073/pnas.96.6.3217; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	42	353	376	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					567	579		10.1016/j.neuron.2005.07.007	http://dx.doi.org/10.1016/j.neuron.2005.07.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102539	Bronze			2022-12-24	WOS:000231411100013
J	Koekkoek, SKE; Yamaguchi, K; Milojkovic, BA; Dortland, BR; Ruigrok, TJH; Maex, R; De Graaf, W; Smit, AE; VanderWerf, F; Bakker, CE; Willemsen, R; Ikeda, T; Kakizawa, S; Onodera, K; Nelson, DL; Mientjes, E; Joosten, M; De Schutter, E; Oostra, BA; Ito, M; De Zeeuw, CI				Koekkoek, SKE; Yamaguchi, K; Milojkovic, BA; Dortland, BR; Ruigrok, TJH; Maex, R; De Graaf, W; Smit, AE; VanderWerf, F; Bakker, CE; Willemsen, R; Ikeda, T; Kakizawa, S; Onodera, K; Nelson, DL; Mientjes, E; Joosten, M; De Schutter, E; Oostra, BA; Ito, M; De Zeeuw, CI			Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; DENDRITIC SPINE; SYNAPSE ELIMINATION; CGG REPEAT; EXPRESSION; MOUSE; MICE; CORTEX; MODEL	Absence of functional FMRP causes Fragile X syndrome. Abnormalities in synaptic processes in the cerebral cortex and hippocampus contribute to cognitive deficits in Fragile X patients. So far, the potential roles of cerebellar deficits have not been investigated. Here, we demonstrate that both global and Purkinje cell-specific knockouts of Fmr1 show deficits in classical delay eyeblink conditioning in that the percentage of conditioned responses as well as their peak amplitude and peak velocity are reduced. Purkinje cells of these mice show elongated spines and enhanced LTD induction at the parallel fiber synapses that innervate these spines. Moreover, Fragile X patients display the same cerebellar deficits in eyeblink conditioning as the mutant mice. These data indicate that a lack of FMRP leads to cerebellar deficits at both the cellular and behavioral levels and raise the possibility that cerebellar dysfunctions can contribute to motor learning deficits in Fragile X patients.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Inst Clin Genet, NL-3000 DR Rotterdam, Netherlands; RIKEN, Lab Memory & Learning, Brain Sc Inst, Wako, Saitama 3510198, Japan; RIKEN, Lab Behav Genet, Brain Sc Inst, Wako, Saitama 3510198, Japan; Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; RIKEN; RIKEN; University of Antwerp; Baylor College of Medicine	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	De Schutter, Erik/G-8460-2011; Maex, Reinoud/GSN-0965-2022	De Schutter, Erik/0000-0001-8618-5138; Maex, Reinoud/0000-0002-5543-8902	NICHD NIH HHS [5 R01 HD38038] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cesa R, 2003, J NEUROSCI, V23, P2363; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; De Zeeuw CI, 2004, SCIENCE, V304; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gruart A, 1997, PROG BRAIN RES, V114, P511; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Haasdijk ED, 2002, NEUROSCI LETT, V335, P29, DOI 10.1016/S0304-3940(02)01159-X; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; LEINER HC, 1993, TRENDS NEUROSCI, V16, P444, DOI 10.1016/0166-2236(93)90072-T; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Miyata M, 1999, NEURON, V22, P763, DOI 10.1016/S0896-6273(00)80735-7; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Strata P, 2000, TRENDS NEUROSCI, V23, P198, DOI 10.1016/S0166-2236(00)01571-X; Teune TM, 2000, PROG BRAIN RES, V124, P141; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; VANPELT J, 1992, B MATH BIOL, V54, P759, DOI 10.1016/S0092-8240(05)80142-9; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vokaer M, 2002, NEUROLOGY, V58, P967, DOI 10.1212/WNL.58.6.967; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	65	353	363	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					339	352		10.1016/j.neuron.2005.07.005	http://dx.doi.org/10.1016/j.neuron.2005.07.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055059	Green Published, Bronze			2022-12-24	WOS:000231051900006
J	Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS				Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS			Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; MOLECULAR PHYSIOLOGY; SUPRAOPTIC NEURONS; ASTROCYTES; GLUTAMATE; HYPOTHALAMUS; VASOPRESSIN	Glial cells actively participate in synaptic transmission. They clear molecules from the synaptic cleft, receive signals from neurons and, in turn, release molecules that can modulate signaling between neuronal elements. Whether glial-derived transmitters can contribute to enduring changes in postsynaptic efficacy, however, remains to be established. In rat hypothalamic paraventricular nucleus, we demonstrate an increase in the amplitude of miniature excitatory postsynaptic currents in response to norepinephrine that requires the release of ATP from glial cells. The increase in quantal efficacy, which likely results from an insertion of AMPA receptors, is secondary to the activation of P2X7 receptors, an increase in postsynaptic calcium and the activation of phosphatidylinositol 3-kinase. The gliotransmitter ATP, therefore, contributes directly to the regulation of postsynaptic efficacy at glutamatergic synapses in the CNS.	Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 5E5, Canada	University of Calgary; University of Calgary; University of Saskatchewan	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jsbains@ucalgary.ca		Fisher, Thomas/0000-0003-3890-2774; Bains, Jaideep/0000-0002-3634-6463				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Armstrong JN, 2002, J NEUROSCI, V22, P5938; ARMSTRONG WE, 1986, BRAIN RES, V365, P192, DOI 10.1016/0006-8993(86)90739-0; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bekar LK, 2005, J NEUROPHYSIOL, V93, P1699, DOI 10.1152/jn.00850.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Daftary SS, 1998, J NEUROSCI, V18, P10619; DAY TA, 1993, BRAIN RES, V607, P341, DOI 10.1016/0006-8993(93)91528-Z; Di S, 2003, J NEUROSCI, V23, P4850; DUFFY S, 1995, J NEUROSCI, V15, P5535; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kapoor JR, 2000, J NEUROSCI, V20, P8868; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kombian SB, 2000, J NEUROPHYSIOL, V83, P2542, DOI 10.1152/jn.2000.83.5.2542; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; RANDLE JCR, 1986, AM J PHYSIOL, V251, pR569, DOI 10.1152/ajpregu.1986.251.3.R569; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanna PP, 2002, J NEUROSCI, V22, P3359; SAWYER CH, 1980, FED PROC, V39, P2889; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shibuya I, 1999, J PHYSIOL-LONDON, V514, P351, DOI 10.1111/j.1469-7793.1999.351ae.x; Shigetomi E, 2004, J NEUROSCI, V24, P3125, DOI 10.1523/JNEUROSCI.0090-04.2004; Stern JE, 1999, J NEUROSCI, V19, P3367; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; TWEEDLE CD, 1987, NEUROSCIENCE, V20, P241, DOI 10.1016/0306-4522(87)90016-9; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zucker RS, 2003, NEURON, V38, P845, DOI 10.1016/S0896-6273(03)00363-5	50	247	257	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1078	1086		10.1038/nn1498	http://dx.doi.org/10.1038/nn1498			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995701				2022-12-24	WOS:000230760200020
J	Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M				Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M			Neuronal fate determinants of adult olfactory bulb neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; SUBVENTRICULAR ZONE; MOUSE FOREBRAIN; MAMMALIAN BRAIN; MIGRATION; PAX6; SPECIFICATION; OLIG2; PROGENITORS	Adult neurogenesis in mammals is restricted to two small regions, including the olfactory bulb, where GABAergic and dopaminergic interneurons are newly generated throughout the entire lifespan. However, the mechanisms directing them towards a specific neuronal phenotype are not yet understood. Here, we demonstrate the dual role of the transcription factor Pax6 in generating neuronal progenitors and also in directing them towards a dopaminergic periglomerular phenotype in adult mice. We present further evidence that dopaminergic periglomerular neurons originate in a distinct niche, the rostral migratory stream, and are fewer derived from precursors in the zone lining the ventricle. This regionalization of the adult precursor cells is further supported by the restricted expression of the transcription factor Olig2, which specifies transit-amplifying precursor fate and opposes the neurogenic role of Pax6. Together, these data explain both extrinsic and intrinsic mechanisms controlling neuronal identity in adult neurogenesis.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; Inst Pasteur, CNRS, Unite Rech Associee 2182, Lab Percept & Memory, F-75724 Paris, France; Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany; Sackler Fac Med, Dept Human Genet & Mol Med, IL-69987 Tel Aviv, Israel; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Munich; Tel Aviv University; Sackler Faculty of Medicine; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	pmlledo@pasteur.fr; magdalena.goetz@gsf.de	Messier, Claude/A-2322-2008; de Chevigny, Antoine/M-7477-2016	Messier, Claude/0000-0002-4791-1763; Gotz, Magdalena/0000-0003-1551-9203; de Chevigny, Antoine/0000-0002-7413-0591; Saghatelyan, Armen/0000-0003-4962-0465				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Beech RD, 2004, J COMP NEUROL, V475, P128, DOI 10.1002/cne.20179; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	41	467	488	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					865	872		10.1038/nn1479	http://dx.doi.org/10.1038/nn1479			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951811				2022-12-24	WOS:000230137100013
J	Sun, Y; Goderie, SK; Temple, S				Sun, Y; Goderie, SK; Temple, S			Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EPIDERMAL-GROWTH-FACTOR; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; DEVELOPING TELENCEPHALON; NEUROEPITHELIAL CELLS; CORTICAL NEUROGENESIS; SUBVENTRICULAR ZONE; ENDOCYTIC PROTEIN; BINDING-PROTEIN	It has been debated whether asymmetric distribution of cell surface receptors during mitosis could generate asymmetric cell divisions by yielding daughters with different environmental responsiveness and, thus, different fates. We have found that in mouse embryonic forebrain ventricular and subventricular zones, the EGFR can distribute asymmetrically during mitosis in vivo and in vitro. This occurs during divisions yielding two Nestin(+) progenitor cells, via an actindependent mechanism. The resulting sibling progenitor cells respond differently to EGFR ligand in terms of migration and proliferation. Moreover, they express different phenotypic markers: the EGFR(high) daughter usually has radial glial/astrocytic markers, while its EGFR(low) sister lacks them, indicating fate divergence. Lineage trees of cultured cortical glioblasts reveal repeated EGFR asymmetric distribution, and asymmetric divisions underlie formation of oligodendrocytes and astrocytes in clones. These data suggest that asymmetric EGFR distribution contributes to forebrain development by creating progenitors with different proliferative, migratory, and differentiation responses to ligand.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Temple, S (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	temples@mail.amc.edu			NINDS NIH HHS [R37NS033529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Bulgheresi S, 2001, J CELL SCI, V114, P3655; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Caric D, 2001, DEVELOPMENT, V128, P4203; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.0.CO;2-G; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu Y, 2004, GLIA, V45, P67, DOI 10.1002/glia.10303; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mai JK, 1998, EUR J NEUROSCI, V10, P746, DOI 10.1046/j.1460-9568.1998.00029.x; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Maric D, 2003, J NEUROSCI, V23, P240; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; NAUBENSAK W, 2004, P NATL ACAD SCI USA, V101, P3196; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RIEDER CL, 1985, J HISTOCHEM CYTOCHEM, V33, P165, DOI 10.1177/33.2.3881520; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schools GP, 2003, J NEUROSCI RES, V73, P765, DOI 10.1002/jnr.10680; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shibata T, 1997, J NEUROSCI, V17, P9212; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SPANA EP, 1995, DEVELOPMENT, V121, P3489; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Walsh C, 1995, CIBA F SYMP, V193, P21; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	57	162	166	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					873	886		10.1016/j.neuron.2005.01.045	http://dx.doi.org/10.1016/j.neuron.2005.01.045			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797549	Bronze			2022-12-24	WOS:000228031300009
J	Tao, HW; Poo, MM				Tao, HW; Poo, MM			Activity-dependent matching of excitatory and inhibitory inputs during refinement of visual receptive fields	NEURON			English	Article							DEVELOPING RETINOTECTAL SYNAPSES; PRIMARY AUDITORY-CORTEX; DIRECTION SELECTIVITY; CRITICAL-PERIOD; MAP FORMATION; NEURONS; ORIENTATION; PLASTICITY; XENOPUS; GABA	The receptive field (RF) of single visual neurons undergoes progressive refinement during development. It remains largely unknown how the excitatory and inhibitory inputs on single developing neurons are refined in a coordinated manner to allow the formation of functionally correct circuits. Using whole-cell voltage-clamp recording from Xenopus tectal neurons, we found that RFs determined by excitatory and inhibitory inputs in more mature tectal neurons are spatially matched, with each spot stimulus evoking balanced synaptic excitation and inhibition. This emerges during development through a gradual reduction in the RF size and a transition from disparate to matched topography of excitatory and inhibitory inputs to the tectal neurons. Altering normal spiking activity of tectal neurons by either blocking or elevating GABAA receptor activity significantly impeded the developmental reduction and topographic matching of RFs. Thus, appropriate inhibitory activity is essential for the coordinated refinement of excitatory and inhibitory connections.	Univ Calif Berkeley, Dept Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Tao, Huizhong W/HDM-9767-2022		NEI NIH HHS [EY015019, EY36999] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY015019] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; [Anonymous], [No title captured]; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BENARI Y, 2004, NAT REV NEUROSCI, V9, P728; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren CD, 2001, J NEUROSCI, V21, P8270; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAZAR G, 1973, J ANAT, V116, P347; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MUELLER AL, 1984, J NEUROSCI, V4, P860; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; PRINCE DA, 1984, ANN NEUROL, V16, pS59, DOI 10.1002/ana.410160710; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHMIDT JT, 1991, ANN NY ACAD SCI, V627, P385; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	52	113	114	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					829	836		10.1016/j.neuron.2005.01.046	http://dx.doi.org/10.1016/j.neuron.2005.01.046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797545	Bronze			2022-12-24	WOS:000228031300005
J	Tomita, S; Stein, V; Stocker, TJ; Nicoll, RA; Bredt, DS				Tomita, S; Stein, V; Stocker, TJ; Nicoll, RA; Bredt, DS			Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; CHANNEL GAMMA-SUBUNIT; EXCITATORY SYNAPSES; KINASE-II; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; GLUR1 SUBUNIT; MUTANT MOUSE	Synaptic plasticity involves protein phosphorylation cascades that alter the density of AMPA-type glutamate receptors at excitatory synapses; however, the crucial phosphorylated substrates remain uncertain. Here, we show that the AMPA receptor-associated protein stargazin is quantitatively phosphorylated and that stargazin phosphorylation promotes synaptic trafficking of AMPA receptors. Synaptic NMDA receptor activity can induce both stargazin phosphorylation, via activation of CaMKII and PKC, and stargazin dephosphorylation, by activation of PP1 downstream of PP2B. At hippocampal synapses, long-term potentiation and long-term depression require stargazin phosphorylation and dephosphorylation, respectively. These results establish stargazin as a critical substrate in the bidirectional control of synaptic strength, which is thought to underlie aspects of learning and memory.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	bredt@itsa.ucsf.edu	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928				Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GILL GN, 1990, MOL REPROD DEV, V27, P46, DOI 10.1002/mrd.1080270110; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche WK, 1996, NEURON, V16, P1179; Rousset M, 2001, J PHYSIOL-LONDON, V532, P583, DOI 10.1111/j.1469-7793.2001.0583e.x; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	55	246	256	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					269	277		10.1016/j.neuron.2005.01.009	http://dx.doi.org/10.1016/j.neuron.2005.01.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664178	Bronze			2022-12-24	WOS:000226451500013
J	Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG				Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG			Hair cells require phosphatidylinositol 4,5-bisphosphate for mechanical transduction and adaptation	NEURON			English	Article							MYOSIN-I-BETA; BULLFROGS SACCULUS; MEMBRANE-PROTEINS; BINDING; PHOSPHOINOSITIDES; STEREOCILIA; MOTOR; PHOSPHATASE; CALMODULIN; DOMAINS	After opening in response to mechanical stimuli, hair cell transduction channels adapt with fast and slow mechanisms that each depend on Call. We demonstrate here that transduction and adaptation require phosphatidylinositol 4,5-bisphosphate (PIP2) for normal kinetics. PlP(2) has a striking distribution in hair cells, being excluded from the basal region of hair bundles and apical surfaces of frog saccular hair cells. Localization of a phosphatidylinositol lipid phosphatase, Ptprq, to these PlP(2)-free domains suggests that Ptprq maintains low PIP2 levels there. Depletion of PIP2 by inhibition of phosphatidylinositol 4-kinase or sequestration by aminoglycosides reduces the rates of fast and slow adaptation. PIP2 and other anionic phospholipids bind directly to the 10 domains of myosin-1c, the motor that mediates slow adaptation, permitting a strong interaction with membranes and likely regulating the motor's activity. PlP2 depletion also causes a loss in transduction current. PlP2 therefore plays an essential role in hair cell adaptation and transduction.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	Oregon Health & Science University; Oregon Health & Science University; University of Sussex	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gillespp@ohsu.edu		Hirono, Moritoshi/0000-0001-6068-1045; Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC004571] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30 DC005983, R01 DC004571, R01 DC002387] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; AUGERT G, 1989, J BIOL CHEM, V264, P2574; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; CHOQUETTE D, 1984, BIOCHEM BIOPH RES CO, V125, P908, DOI 10.1016/0006-291X(84)91369-X; COCHET C, 1986, BIOCHEM J, V237, P25, DOI 10.1042/bj2370025; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; HILGEMANN DW, 2001, SCI STKE; Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; SCHAEFER T, 1994, ANN NY ACAD SCI, V710, P356, DOI 10.1111/j.1749-6632.1994.tb26642.x; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; TACHIBANA M, 1984, HISTOCHEMISTRY, V81, P157, DOI 10.1007/BF00490110; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Thomas CL, 1999, BIOCHEM SOC T, V27, P648, DOI 10.1042/bst0270648; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; WANG BM, 1984, BIOCHEM PHARMACOL, V33, P3257, DOI 10.1016/0006-2952(84)90087-X; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	54	135	139	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					309	320		10.1016/j.neuron.2004.09.020	http://dx.doi.org/10.1016/j.neuron.2004.09.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473969	Bronze			2022-12-24	WOS:000224635800013
J	Morris, RGM; Inglis, J; Ainge, JA; Olverman, HJ; Tulloch, J; Dudai, Y; Kelly, PAT				Morris, Richard G. M.; Inglis, Jennifer; Ainge, James A.; Olverman, Henry J.; Tulloch, Jane; Dudai, Yadin; Kelly, Paul A. T.			Memory reconsolidation: Sensitivity of spatial memory to inhibition of protein synthesis in dorsal hippocampus during encoding and retrieval	NEURON			English	Article							TASTE-AVERSION; CONSOLIDATION; EXTINCTION; TRACE; NEUROBIOLOGY; INFORMATION; MECHANISMS; REMINDER; REQUIRE	Reconsolidation is a putative neuronal process in which the retrieval of a previously consolidated memory returns it to a labile state that is once again subject to stabilization. This study explored the idea that reconsolidation occurs in spatial memory when animals retrieve memory under circumstances in which new memory encoding is likely to occur. Control studies confirmed that intrahippocampal infusions of anisomycin inhibited protein synthesis locally and that the spatial training protocols we used are subject to overnight protein synthesis-dependent consolidation. We then compared the impact of anisomycin in two conditions: when memory retrieval occurred in a reference memory task after performance had reached asymptote over several days; and after a comparable extent of training of a delayed matching-to-place task in which new memory encoding was required each day. Sensitivity to intrahippocampal anisomycin was observed only in the protocol involving new memory encoding at the time of retrieval.	Univ Edinburgh, Labs Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Cerebral Neuropharmacol Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	University of Edinburgh; University of Edinburgh; Weizmann Institute of Science	Morris, RGM (corresponding author), Univ Edinburgh, Labs Cognit Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Ainge, James A/D-5831-2012; Morris, Richard G M/C-9982-2013; Kelly, Paul AT/A-1663-2008	Ainge, James A/0000-0002-0007-1533; MORRIS, Richard G M/0000-0001-8661-1520	MRC [G9200370] Funding Source: UKRI; Medical Research Council [G9200370] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; de Hoz L, 2005, EUR J NEUROSCI, V22, P745, DOI 10.1111/j.1460-9568.2005.04255.x; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nader K, 2005, TRENDS NEUROSCI, V28, P346, DOI 10.1016/j.tins.2005.04.011; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PANAKHOVA E, 1984, INT J PSYCHOPHYSIOL, V2, P5, DOI 10.1016/0167-8760(84)90066-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rodriguez-Ortiz CJ, 2005, LEARN MEMORY, V12, P533, DOI 10.1101/lm.94505; Runyan JD, 2005, HIPPOCAMPUS, V15, P333, DOI 10.1002/hipo.20055; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SMITH CB, 1991, NEUROCHEM RES, V16, P1037, DOI 10.1007/BF00965848; Spooner R I, 1994, Learn Mem, V1, P203; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293; von Hertzen LSJ, 2005, J NEUROSCI, V25, P1935, DOI 10.1523/JNEUROSCI.4707-04.2005	46	258	261	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					479	489		10.1016/j.neuron.2006.04.012	http://dx.doi.org/10.1016/j.neuron.2006.04.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	045FA	16675401	Bronze			2022-12-24	WOS:000237726800016
J	Sherman, DL; Tait, S; Melrose, S; Johnson, R; Zonta, B; Court, FA; Macklin, WB; Meek, S; Smith, AJH; Cottrell, DF; Brophy, PJ				Sherman, DL; Tait, S; Melrose, S; Johnson, R; Zonta, B; Court, FA; Macklin, WB; Meek, S; Smith, AJH; Cottrell, DF; Brophy, PJ			Neurofascins are required to establish axonal domains for saltatory conduction	NEURON			English	Article							CELL-ADHESION MOLECULES; MYELINATED AXONS; ANKYRIN-G; INITIAL SEGMENTS; PROTEIN CASPR; NR-CAM; RANVIER; NODES; PERIAXIN; DIFFERENTIATION	Voltage-gated sodium channels are concentrated in myelinated nerves at the nodes of Ranvier flanked by paranodal axoglial junctions. Establishment of these essential nodal and paranodal domains is determined by myelin-forming glia, but the mechanisms are not clear. Here, we show that two isoforms of Neurofascin, Nfasc155 in glia and Nfasc186 in neurons, are required for the assembly of these specialized domains. In Neurofascin-null mice, neither paranodal adhesion junctions nor nodal complexes are formed. Transgenic expression of Nfasc155 in the myelinating glia of Nfasc(-/-) nerves rescues the axoglial adhesion complex by recruiting the axonal proteins Caspr and Contactin to the paranodes. However, in the absence of Nfasc186, sodium channels remain diffusely distributed along the axon. Our study shows that the two major Neurofascins play essential roles in assembling the nodal and paranodal domains of myelinated axons; therefore, they are essential for the transition to saltatory conduction in developing vertebrate nerves.	Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Univ Edinburgh, Inst Stem Cell Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh; Cleveland Clinic Foundation; University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland.	peter.brophy@ed.ac.uk	Court, Felipe/C-5911-2015	Court, Felipe/0000-0002-1384-2552; Court, Felipe/0000-0002-9394-7601	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025304] Funding Source: NIH RePORTER; Medical Research Council [G0301172, G0000221] Funding Source: Medline; Multiple Sclerosis Society [669] Funding Source: Medline; NINDS NIH HHS [R01 NS025304] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000221, G0301172] Funding Source: UKRI	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society(National Multiple Sclerosis Society); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Custer AW, 2003, J NEUROSCI, V23, P10032; DAVIDSON JM, 1993, J CELL BIOCHEM, P109; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Lambert S, 1997, J NEUROSCI, V17, P7025; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Ranvier LA, 1875, TRAITE TECHNIQUE HIS; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443	32	253	269	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					737	742		10.1016/j.neuron.2005.10.019	http://dx.doi.org/10.1016/j.neuron.2005.10.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337912	Bronze			2022-12-24	WOS:000233927300013
J	Zigman, M; Cayouette, M; Charalambous, C; Schleiffer, A; Hoeller, O; Dunican, D; McCudden, CR; Firnberg, N; Barres, BA; Siderovski, DP; Knoblich, JA				Zigman, M; Cayouette, M; Charalambous, C; Schleiffer, A; Hoeller, O; Dunican, D; McCudden, CR; Firnberg, N; Barres, BA; Siderovski, DP; Knoblich, JA			Mammalian inscuteable regulates spindle orientation and cell fate in the developing retina	NEURON			English	Article							DROSOPHILA NEUROBLASTS; ASYMMETRIC LOCALIZATION; DIVISION; PROTEIN; NEUROGENESIS; PINS; DIFFERENTIATION; IDENTIFICATION; INHERITANCE; VERTEBRATES	During mammalian neurogenesis, progenitor cells can divide with the mitotic spindle oriented parallel or perpendicular to the surface of the neuroepithelium. Perpendicular divisions are more likely to be asymmetric and generate one progenitor and one neuronal precursor. Whether the orientation of the mitotic spindle actually determines their asymmetric outcome is unclear. Here, we characterize a mammalian homolog of Inscuteable (mlnsc), a key regulator of spindle orientation in Drosophila. mlnsc is expressed temporally and spatially in a manner that suggests a role in orienting the mitotic spindle in the developing nervous system. Using retroviral RNAi in rat retinal explants, we show that downregulation of mlnsc inhibits vertical divisions. This results in enhanced proliferation, consistent with a higher frequency of symmetric divisions generating two proliferating cells. Our results suggest that the orientation of neural progenitor divisions is important for cell fate specification in the retina and determines their symmetric or asymmetric outcome.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Med Univ Vienna, A-1090 Vienna, Austria; MRC, Cambridge CB2 2QH, England; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of North Carolina; University of North Carolina Chapel Hill	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Siderovski, David Peter/AAA-9603-2019; Knoblich, Juergen A/C-2974-2015; Dunican, Dara/A-1208-2010; Zigman, Mihaela/E-9430-2014	Siderovski, David Peter/0000-0002-0688-8210; Knoblich, Juergen A/0000-0002-6751-3404; Dunican, Dara/0000-0001-6563-8089; McCudden, Christopher/0000-0002-4172-4641; Schleiffer, Alexander/0000-0001-6251-2747; Zigman, Mihaela/0000-0001-8306-1922; Cayouette, Michel/0000-0003-4655-9048	NATIONAL EYE INSTITUTE [R01EY011310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, R01GM062338] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11310] Funding Source: Medline; NIGMS NIH HHS [R01 GM062338, P01 GM065533] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DAVIDSON EH, 1991, DEVELOPMENT, V113, P1; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Irion U, 2004, CURR BIOL, V14, P138, DOI 10.1016/j.cub.2004.01.002; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Katoh M, 2003, INT J MOL MED, V11, P111; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; MARTIN AH, 1967, NATURE, V216, P1133, DOI 10.1038/2161133a0; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	32	103	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					539	545		10.1016/j.neuron.2005.09.030	http://dx.doi.org/10.1016/j.neuron.2005.09.030			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301171	Green Published, Bronze			2022-12-24	WOS:000233677300008
J	Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA				Brewer, AA; Liu, JJ; Wade, AR; Wandell, BA			Visual field maps and stimulus selectivity in human ventral occipital cortex	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; HUMAN OBJECT AREAS; HUMAN COLOR-CENTER; FUNCTIONAL MRI; ORGANIZATION; BRAIN; TOPOGRAPHY; PERCEPTION; FMRI	Human visual cortex is organized into distinct visual field maps whose locations and properties provide important information about visual computations. There are two conflicting models of the organization and computational role of ventral occipital visual field maps. We report new functional MRI measurements that test these models. We also present the first coordinated measurements of visual field maps and stimulus responsivity to color, objects and faces in ventral occipital cortex. These measurements support a model that includes a hemifield map, hV4, adjacent to the central field representation of ventral V3. In addition, the measurements demonstrate a cluster of visual field maps in ventral occipital cortex ( VO cluster) anterior to hV4. We describe the organization and stimulus responsivity of two new hemifield maps, VO-1 and VO-2, within this cluster. The maps and stimulus responsivity support a general organization of visual cortex based on clusters of maps that serve distinct computational functions.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Stanford University; Stanford University; The Smith-Kettlewell Eye Research Institute	Brewer, AA (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	alyssa.brewer@stanford.edu	Wade, Alex/B-5473-2010	Wade, Alexander Robert/0000-0003-4871-2747; Brewer, Alyssa/0000-0001-8820-1525; Liu, Junjie/0000-0001-5820-4266	NEI NIH HHS [R01 EY03164] Funding Source: Medline; NINDS NIH HHS [F30 NS044759, 5 F30 NS44759] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIZER JS, 1991, J NEUROSCI, V11, P168; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRAINARD DH, 1995, HDB OPTICAL SOC, V1; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Ejima Y, 2003, NEUROREPORT, V14, P1579, DOI 10.1097/00001756-200308260-00008; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Levy I, 2004, HUM BRAIN MAPP, V22, P15, DOI 10.1002/hbm.20010; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; MEADOWS JC, 1974, BRAIN, V97, P615, DOI 10.1093/brain/97.1.615; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Van Essen DC, 2003, VISUAL NEUROSCIENCES, V1, P507; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wandell B.A., 1995, FDN VISION; Wandell BA, 2002, P IEEE, V90, P5, DOI 10.1109/5.982401; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1999, PHILOS T R SOC B, V354, P1371, DOI 10.1098/rstb.1999.0485; Zeki S, 1998, NAT NEUROSCI, V1, P335, DOI 10.1038/1537	50	303	304	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1102	1109		10.1038/nn1507	http://dx.doi.org/10.1038/nn1507			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025108				2022-12-24	WOS:000230760200023
J	Rashid, T; Upton, AL; Blentic, A; Ciossek, T; Knoll, B; Thompson, ID; Drescher, U				Rashid, T; Upton, AL; Blentic, A; Ciossek, T; Knoll, B; Thompson, ID; Drescher, U			Opposing gradients of ephrin-As and EphA7 in the superior colliculus are essential for topographic mapping in the mammalian visual system	NEURON			English	Article							CONTROL AXON GROWTH; TYROSINE PHOSPHORYLATION; RETINOTECTAL MAP; FAMILY RECEPTORS; LIGANDS; EXPRESSION; GUIDANCE; KINASE; ARBORIZATION; ORGANIZATION	During development of the retinocollicular projection in mouse, retinal axons initially overshoot their future termination zones (TZs) in the superior colliculus (SC). The formation of TZs is initiated by interstitial branching at topographically appropriate positions. Ephrin-As are expressed in a decreasing posterior-to-anterior gradient in the SC, and they suppress branching posterior to future TZs. Here we investigate the role of an EphA7 gradient in the SC, which has the reverse orientation to the ephrin-A gradient. We find that in EphA7 mutant mice the retinocollicular map is disrupted, with nasal and temporal axons forming additional or extended TZs, respectively. In vitro, retinal axons are repelled from growing on EphA7-containing stripes. Our data support the idea that EphA7 is involved in suppressing branching anterior to future TZs. These findings suggest that opposing ephrin-A and EphA gradients are required for the proper development of the retinocollicular projection.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	University of London; King's College London; University of Oxford; Max Planck Society	Drescher, U (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	uwe.drescher@kcl.ac.uk	Thompson, Ian D/C-5785-2009; Drescher, Uwe/C-5438-2009	Drescher, Uwe/0000-0001-9725-7643	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brennan C, 1997, DEVELOPMENT, V124, P655; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CIOSSEK T, 1995, ONCOGENE, V10, P97; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FUJISAWA H, 1981, BRAIN RES, V206, P27, DOI 10.1016/0006-8993(81)90098-6; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; GIERER A, 1988, BIOL CYBERN, V59, P13, DOI 10.1007/BF00336886; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Goodhill GJ, 2000, NEURON, V25, P501, DOI 10.1016/S0896-6273(00)81051-X; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 1999, NEURON, V22, P636, DOI 10.1016/S0896-6273(00)80718-7; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1987, DEVELOPMENT, V101, P909; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	60	125	127	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					57	69		10.1016/j.neuron.2005.05.030	http://dx.doi.org/10.1016/j.neuron.2005.05.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996548	Bronze			2022-12-24	WOS:000230464000008
J	Puchalla, JL; Schneidman, E; Harris, RA; Berry, MJ				Puchalla, JL; Schneidman, E; Harris, RA; Berry, MJ			Redundancy in the population code of the retina	NEURON			English	Article							GANGLION-CELLS; NATURAL IMAGES; MAMMALIAN RETINA; CAT RETINA; FUNCTIONAL ARCHITECTURE; VISUAL INFORMATION; RECEPTIVE-FIELDS; CORTICAL-NEURONS; RABBIT RETINA; SPIKE TRAINS	We have explored the manner in which the population of retinal ganglion cells collectively represent the visual world. Ganglion cells in the salamander were recorded simultaneously with a multielectrode array during stimulation with both artificial and natural visual stimuli, and the mutual information that single cells and pairs of cells conveyed about the stimulus was estimated. We found significant redundancy between cells spaced as far as 500 mu m apart. When we used standard methods for defining functional types, only ON-type and OFF-type cells emerged as truly independent information channels. Although the average redundancy between nearby cell pairs was moderate, each ganglion cell shared information with many neighbors, so that visual information was represented 10-fold within the ganglion cell population. This high degree of retinal redundancy suggests that design principles beyond coding efficiency may be important at the population level.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Berry, MJ (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	berry@princeton.edu		schneidman, elad/0000-0001-8653-9848	NEI NIH HHS [R01 EY14196] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balasubramanian V, 2002, NETWORK-COMP NEURAL, V13, P531, DOI 10.1088/0954-898X/13/4/306; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Gat I., 1999, ADV NEURAL INFORM P, V11, P465; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P249, DOI 10.1113/jphysiol.2004.063503; Pang JJ, 2002, J NEUROSCI, V22, P4693, DOI 10.1523/JNEUROSCI.22-11-04693.2002; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Schneidman E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Sterling P, 1998, SYNAPTIC ORG BRAIN; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; van Hateren JH, 2002, J NEUROSCI, V22, P9945; VANEY DI, 1994, J NEUROSCI, V14, P6301; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000	56	154	154	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					493	504		10.1016/j.neuron.2005.03.026	http://dx.doi.org/10.1016/j.neuron.2005.03.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882648	Bronze			2022-12-24	WOS:000229011400020
J	Palanca, BJA; DeAngelis, GC				Palanca, BJA; DeAngelis, GC			Does neuronal synchrony underlie visual feature grouping?	NEURON			English	Article							TEMPORAL CORRELATION HYPOTHESIS; CROSS-CORRELATION ANALYSIS; CLASSICAL RECEPTIVE-FIELD; MONKEY STRIATE CORTEX; BINDING PROBLEM; AREA MT; OSCILLATORY RESPONSES; FEATURE INTEGRATION; MACAQUE MONKEY; CORTICAL AREAS	Previous research suggests that synchronous neural activity underlies perceptual grouping of visual image features. The generality of this mechanism is unclear, however, as previous studies have focused on pairs of neurons with overlapping or collinear receptive fields. By sampling more broadly and employing stimuli that contain partially occluded objects, we have conducted a more incisive test of the binding by synchrony hypothesis in area MT. We find that synchrony in spiking activity shows little dependence on feature grouping, whereas gamma band synchrony in field potentials can be significantly stronger when features are grouped. However, these changes in gamma band synchrony are small relative to the variability of synchrony across recording sites and do not provide a robust population signal for feature grouping. Moreover, these effects are reduced when stimulus differences nearby the receptive fields are eliminated using partial occlusion. Our findings suggest that synchrony does not constitute a general mechanism of visual feature binding.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	gregd@cabernet.wusti.edu	Palanca, Ben Julian/AAW-4006-2021	Palanca, Ben Julian/0000-0001-7535-5701; DeAngelis, Gregory/0000-0002-1635-1273	NATIONAL EYE INSTITUTE [R01EY013644] Funding Source: NIH RePORTER; NEI NIH HHS [EY-013644] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bretzner F, 2001, EUR J NEUROSCI, V14, P1539, DOI 10.1046/j.0953-816x.2001.01776.x; Bretzner F, 2000, NEUROREPORT, V11, P1313, DOI 10.1097/00001756-200004270-00033; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brosch M, 1997, CEREB CORTEX, V7, P70, DOI 10.1093/cercor/7.1.70; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; Frien A, 2000, EUR J NEUROSCI, V12, P1466, DOI 10.1046/j.1460-9568.2000.00026.x; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Ghose GM, 1999, NEURON, V24, P79, DOI 10.1016/S0896-6273(00)80823-5; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Golledge HDR, 2003, NEUROREPORT, V14, P1045, DOI 10.1097/00001756-200305230-00028; Golledge HDR, 1996, CURR BIOL, V6, P1092, DOI 10.1016/S0960-9822(02)70675-1; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Halliday D.M., 1999, TIME FREQUENCY DOMAI, P503, DOI DOI 10.1007/978-3-642-58552-4_18; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; KISVARDAY ZF, 1993, J COMP NEUROL, V327, P398, DOI 10.1002/cne.903270307; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SINGER W, 1997, COGNITIVE NEUROSCIEN, P91; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TSO DY, 1986, J NEUROSCI, V6, P1160; Uka T, 2003, J NEUROSCI, V23, P3515; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X; Woelbern T, 2002, NEUROREPORT, V13, P1881, DOI 10.1097/00001756-200210280-00010; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1	65	82	83	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					333	346		10.1016/j.neuron.2005.03.002	http://dx.doi.org/10.1016/j.neuron.2005.03.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848810	Bronze			2022-12-24	WOS:000228674800018
J	Medina, JF; Carey, MR; Lisberger, SG				Medina, JF; Carey, MR; Lisberger, SG			The representation of time for motor learning	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; HUMAN SMOOTH-PURSUIT; PURKINJE-CELL ACTIVITY; VESTIBULOOCULAR REFLEX; ADAPTIVE-CHANGES; DECISION-MAKING; NEURONS; MONKEY; RESPONSES; FLOCCULUS	We have identified factors that control precise motor timing by studying learning in smooth pursuit eye movements. Monkeys tracked a target that moved horizontally for a fixed time interval before changing direction through the addition of a vertical component of motion. After repeated presentations of the same target trajectory, infrequent probe trials of purely horizontal target motion evoked a vertical eye movement around the time when the change in target direction would have occurred. The pursuit system timed the vertical eye movement by keeping track of the duration of horizontal target motion and by measuring the distance the target traveled before changing direction, but not by learning the position in space where the target changed direction. We conclude that high temporal precision in motor output relies on multiple signals whose contributions to timing vary according to task requirements.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Intergrat Neurosci, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Medina, JF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Medina, Javier/0000-0001-8708-5315; Carey, Megan/0000-0002-4499-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOMAN DK, 1992, VISION RES, V32, P675, DOI 10.1016/0042-6989(92)90184-K; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chou IH, 2004, J NEUROSCI, V24, P4124, DOI 10.1523/JNEUROSCI.0172-04.2004; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Fukushima K, 1996, NEUROSCI RES, V25, P391; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Heinen SJ, 1997, VISUAL NEUROSCI, V14, P853, DOI 10.1017/S0952523800011597; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kahlon M, 1996, J NEUROSCI, V16, P7270; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Karniel A, 2003, BIOL CYBERN, V89, P10, DOI 10.1007/s00422-003-0397-7; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; Martin TA, 2001, J NEUROPHYSIOL, V85, P2298, DOI 10.1152/jn.2001.85.5.2298; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; MIALL RC, 1992, NATO ASI SERIES D, P215; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Raymond JL, 1998, J NEUROSCI, V18, P9112; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; SAKATA H, 1983, J NEUROPHYSIOL, V49, P1364, DOI 10.1152/jn.1983.49.6.1364; SCHNEIDERMAN N, 1964, J COMP PHYSIOL PSYCH, V57, P188, DOI 10.1037/h0043419; Schoner G, 2002, BRAIN COGNITION, V48, P31, DOI 10.1006/brcg.2001.1302; SCHWARTZ JD, 1994, VISUAL NEUROSCI, V11, P411, DOI 10.1017/S0952523800002352; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; VANDENBERG AV, 1988, EXP BRAIN RES, V72, P95, DOI 10.1007/BF00248504; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATERSTON JA, 1992, BRAIN, V115, P1343, DOI 10.1093/brain/115.5.1343; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Wright BA, 1997, J NEUROSCI, V17, P3956	58	66	68	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					157	167		10.1016/j.neuron.2004.12.017	http://dx.doi.org/10.1016/j.neuron.2004.12.017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629710	Bronze			2022-12-24	WOS:000226217100017
J	Corl, AB; Rodan, AR; Heberlein, U				Corl, AB; Rodan, AR; Heberlein, U			Insulin signaling in the nervous system regulates ethanol intoxication in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							PHENOTYPES; RECEPTOR; GROWTH; CELL; SENSITIVITY; HOMOLOG; SIZE	The insulin signaling pathway regulates multiple physiological processes, including energy metabolism, organismal growth, aging and reproduction. Here we show that genetic manipulations in Drosophila melanogaster that impair the function of insulin-producing cells or of the insulin-receptor signaling pathway in the nervous system lead to increased sensitivity to the intoxicating effects of ethanol. These findings suggest a previously unknown role for this highly conserved pathway in regulating the behavioral responses to an addictive drug.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Heberlein, U (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	ulrike@itsa.ucsf.edu		Rodan, Aylin/0000-0001-9202-2378	NIAAA NIH HHS [AA10035, AA13105] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013105, R01AA010035] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Figlewicz Dianne P, 2003, Semin Clin Neuropsychiatry, V8, P82, DOI 10.1053/scnp.2003.50012; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	14	72	73	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					18	19		10.1038/nn1363	http://dx.doi.org/10.1038/nn1363			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592467				2022-12-24	WOS:000225967600008
J	Glickfeld, LL; Scanziani, M				Glickfeld, Lindsey L.; Scanziani, Massimo			Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells	NATURE NEUROSCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; HIPPOCAMPAL PYRAMIDAL CELLS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; NETWORK OSCILLATIONS; FEEDFORWARD INHIBITION; DENDRITIC INHIBITION; GAMMA OSCILLATIONS; GABA RELEASE; IN-VITRO	Cannabinoids are powerful modulators of inhibition, yet the precise spike timing of cannabinoid receptor (CB1R)-expressing inhibitory neurons in relation to other neurons in the circuit is poorly understood. Here we found that the spike timing of CB1R-expressing basket cells, a major target for cannabinoids in the rat hippocampus, was distinct from the other main group of basket cells, the CB1R-negative. Despite receiving the same afferent inputs, the synaptic and biophysical properties of the two cell types were tuned to detect different features of activity. CB1R-negative basket cells responded reliably and immediately to subtle and repetitive excitation. In contrast, CB1R-positive basket cells responded later and did not follow repetitive activity, but were better suited to integrate the consecutive excitation of independent afferents. This temporal separation in the activity of the two basket cell types generated distinct epochs of somatic inhibition that were differentially affected by endocannabinoids.	Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Div Biol, Grad Program Neurosci, La Jolla, CA 92093 USA.	massimo@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401, R01MH070058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007315] Funding Source: NIH RePORTER; NIDA NIH HHS [T32 DA007315, 5T32DA007315] Funding Source: Medline; NIMH NIH HHS [MH71401, R01 MH070058, MH70058, R01 MH071401] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; ANDERSEN P, 1973, EXP BRAIN RES, V17, P152; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fukuda T, 1996, NEUROSCI RES, V26, P181, DOI 10.1016/S0168-0102(96)01102-9; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Katona I, 1999, J NEUROSCI, V19, P4544; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Matyas F, 2004, EUR J NEUROSCI, V19, P1243, DOI 10.1111/j.1460-9568.2004.03225.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morales M, 2002, HIPPOCAMPUS, V12, P756, DOI 10.1002/hipo.10025; Nicoll RA, 2004, SCI AM, V291, P68, DOI 10.1038/scientificamerican1204-68; PITLER TA, 1994, NEURON, V13, P1447; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; SIK A, 1995, J NEUROSCI, V15, P6651; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Wierenga CJ, 2003, NEUROSCIENCE, V118, P1129, DOI 10.1016/S0306-4522(03)00060-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	42	166	167	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					807	815		10.1038/nn1688	http://dx.doi.org/10.1038/nn1688			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648849	Green Accepted			2022-12-24	WOS:000237895200021
J	Inoue, E; Mochida, S; Takagi, H; Higa, S; Deguchi-Tawarada, M; Takao-Rikitsu, E; Inoue, M; Yao, I; Takeuchi, K; Kitajima, I; Setou, M; Ohtsuka, T; Takai, Y				Inoue, E; Mochida, S; Takagi, H; Higa, S; Deguchi-Tawarada, M; Takao-Rikitsu, E; Inoue, M; Yao, I; Takeuchi, K; Kitajima, I; Setou, M; Ohtsuka, T; Takai, Y			SAD: A presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release	NEURON			English	Article							PROTEIN-INTERACTION SITE; FUNCTIONAL INTERACTION; SYNAPSES; FAMILY; RIM1-ALPHA; BASSOON; RIM1; CAST; DEPRESSION; MUNC13-1	A serine/threonine kinase SAD-1 in C. elegans regulates synapse development. We report here the isolation and characterization of mammalian orthologs of SAD-1, named SAD-A and SAD-B, which are specifically expressed in the brain. SAD-B is associated with synaptic vesicles and, like the active zone proteins CAST and Bassoon, is tightly associated with the presynaptic cytomatrix in nerve terminals. A short conserved region (SCR) in the COOH-terminus is required for the synaptic localization of SAD-B. Overexpression of SAD-B in cultured rat hippocampal neurons significantly increases the frequency of miniature excitatory postsynaptic current but not its amplitude. Introduction of SCR into presynaptic superior cervical ganglion neurons in culture significantly inhibits evoked synaptic transmission. Moreover, SCR decreases the size of the readily releasable pool measured by applying hypertonic sucrose. Furthermore, SAD-B phosphorylates the active zone protein RIM1 but not Munc13-1. These results suggest that mammalian SAD kinase presynaptically regulates neurotransmitter release.	KAN Res Inst, Kyoto 6008815, Japan; Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; Mitsubishi Kagaku Inst Life Sci, Setou Grp, Lab Mol Gerontol, Machida, Tokyo 1948511, Japan; Toyama Univ, Fac Med, Grad Sch Med, Dept Clin & Mol Pathol, Toyama 9300194, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan; Natl Inst Physiol Sci, Lab Nanostruct Physiol, Okazaki, Aichi 4448787, Japan; Osaka Univ, Grad Sch Med, Fac Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan	KAN Research Institute; Tokyo Medical University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Toyama; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University	Ohtsuka, T (corresponding author), KAN Res Inst, Kyoto 6008815, Japan.	tohtsuka@med.u-toyama.ac.jp	Takeuchi, Kosei/AAV-3577-2021	Takeuchi, Kosei/0000-0001-6397-2243				Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Deguchi-Tawarada M, 2006, J COMP NEUROL, V495, P480, DOI 10.1002/cne.20893; Deguchi-Tawarada M, 2004, GENES CELLS, V9, P15, DOI 10.1111/j.1356-9597.2004.00697.x; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hennou S, 2003, EUR J NEUROSCI, V18, P811, DOI 10.1046/j.1460-9568.2003.02812.x; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; KISTNER U, 1993, J BIOL CHEM, V268, P4580; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MIZOGUCHI A, 1989, MOL BRAIN RES, V5, P31, DOI 10.1016/0169-328X(89)90015-6; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 1998, P NATL ACAD SCI USA, V95, P14523, DOI 10.1073/pnas.95.24.14523; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	48	85	94	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					261	275		10.1016/j.neuron.2006.03.018	http://dx.doi.org/10.1016/j.neuron.2006.03.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630837	Bronze			2022-12-24	WOS:000237176700013
J	Ko, JW; Kim, SH; Chung, HS; Kim, K; Han, KH; Kim, H; Jun, HJ; Kaang, BK; Kim, EJ				Ko, JW; Kim, SH; Chung, HS; Kim, K; Han, KH; Kim, H; Jun, HJ; Kaang, BK; Kim, EJ			SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses	NEURON			English	Article							INHIBITORY SYNAPSES; LIPRIN-ALPHA; PROTEIN; FAMILY; NEUROLIGIN; PSD-95; BINDING; ASSOCIATION; RECEPTORS; DOMAIN	Synaptic cell adhesion molecules (CAMs) are known to play key roles in various aspects of synaptic structures and functions, including early differentiation, maintenance, and plasticity. We herein report the identification of a family of cell adhesion-like molecules termed SALM that interacts with the abundant postsynaptic density (PSD) protein PSD-95. SALM2, a SALM isoform, distributes to excitatory, but not inhibitory, synaptic sites. Overexpression of SALM2 increases the number of excitatory synapses and dendritic spines. Mislocalized expression of SALM2 disrupts excitatory synapses and dendritic spines. Bead-induced direct aggregation of SALM2 results in coclustering of PSD-95 and other postsynaptic proteins, including GKAP and AMPA receptors. Knockdown of SALM2 by RNA interference reduces the number of excitatory synapses and dendritic spines and the frequency, but not amplitude, of miniature excitatory postsynaptic currents. These results suggest that SALM2 is an important regulator of the differentiation of excitatory synapses.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Univ, Dept Anat, Seoul 136705, South Korea; Korea Univ, Div Brain Korea 21 Biomed Sci, Coll Med, Seoul 136705, South Korea; Seoul Natl Univ, Coll Nat Sci, Natl Res Lab, Inst Mol Biol & Genet,Sch Biol Sci, Seoul 151742, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Kim, EJ (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea.	kime@kaist.ac.kr	Han, Kihoon/AAE-8919-2019; Kim, Eunjoon/C-1566-2011; Chun, Heejung/B-3454-2014; Kim, Karam/K-1412-2018	Han, Kihoon/0000-0002-5925-2152; Chun, Heejung/0000-0002-6451-1542; Kim, Karam/0000-0002-1886-5163; Kim, Hyun/0000-0002-7210-5798				Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Mok H, 2002, J NEUROSCI, V22, P5253; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi SH, 2004, P NATL ACAD SCI USA, V101, P13346, DOI 10.1073/pnas.0405371101; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	58	118	144	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					233	245		10.1016/j.neuron.2006.04.005	http://dx.doi.org/10.1016/j.neuron.2006.04.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630835	Bronze			2022-12-24	WOS:000237176700011
J	Lien, CC; Mu, YL; Vargas-Caballero, M; Poo, MM				Lien, CC; Mu, YL; Vargas-Caballero, M; Poo, MM			Visual stimuli-induced LTD of GABAergic synapses mediated by presynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DEVELOPING RETINOTECTAL SYNAPSES; XENOPUS-LAEVIS; GABA RELEASE; SYNAPTIC MODIFICATION; TRANSMITTER RELEASE; CORRELATED ACTIVITY; RAT HIPPOCAMPUS; PLASTICITY; NEURONS	Local GABA (c-aminobutyric acid) circuits contribute to sensory experience-dependent refinement of neuronal connections in the developing nervous system, but whether GABAergic synapses themselves can be rapidly modified by sensory stimuli is largely unknown. Here we report that repetitive light stimuli or theta burst stimulation (TBS) of the optic nerve in the developing Xenopus retinotectal system induces long-term potentiation (LTP) of glutamatergic inputs but long-term depression (LTD) of GABAergic inputs to the same tectal neuron. The LTD is due to a reduction in presynaptic GABA release and requires activation of presynaptic NMDA (N-methyl-D-aspartate) receptors (NMDARs) and coincident high-level GABAergic activity. Thus, the presynaptic NMDAR may function as a coincidence detector for adjacent glutamatergic and GABAergic activities, leading to coordinated synaptic modification by sensory experience.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Lien, Cheng-Chang/AAO-6249-2020	Lien, Cheng-Chang/0000-0002-6692-9942; Vargas-Caballero, Mariana/0000-0003-2326-4001	NEI NIH HHS [EY014949] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brody DL, 2000, J NEUROSCI, V20, P2480; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cottone E, 2003, J COMP NEUROL, V464, P487, DOI 10.1002/cne.10808; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Ferster D, 2004, SCIENCE, V303, P1619, DOI 10.1126/science.1096224; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glaum SR, 1996, J NEUROPHYSIOL, V76, P30, DOI 10.1152/jn.1996.76.1.30; Glitsch M, 1999, J NEUROSCI, V19, P511; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; RYBICKA KK, 1994, EUR J NEUROSCI, V6, P1567, DOI 10.1111/j.1460-9568.1994.tb00547.x; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Tzingounis AV, 2004, NAT NEUROSCI, V7, P419, DOI 10.1038/nn0504-419; Udin SB, 1999, PROG NEUROBIOL, V59, P81, DOI 10.1016/S0301-0082(98)00096-3; Unni VK, 2004, J NEUROSCI, V24, P9612, DOI 10.1523/JNEUROSCI.5583-03.2004; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	50	79	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					372	380		10.1038/nn1649	http://dx.doi.org/10.1038/nn1649			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474391				2022-12-24	WOS:000235645600017
J	Meliza, CD; Dan, Y				Meliza, CD; Dan, Y			Receptive-field modification in rat visual cortex induced by paired visual stimulation and single-cell spiking	NEURON			English	Article							PRESYNAPTIC NEURONAL EXCITABILITY; DEPENDENT SYNAPTIC PLASTICITY; HIPPOCAMPAL SLICE CULTURES; MONOCULAR DEPRIVATION; CORTICAL PLASTICITY; PYRAMIDAL CELLS; STRIATE CORTEX; SPINY STELLATE; CONNECTIONS; SPECIFICITY	Experience-dependent plasticity of visual cortical receptive fields (RFs) involves synaptic modifications in the underlying neural circuits, but the site and mechanism of these modifications remain to be elucidated. Using in vivo whole-cell recordings, we show that pairing visual stimulation at a given retinal location with spiking of a single neuron in developing rat visual cortex induces rapid RF modifications. The time course of the response to the visual stimulus at the paired RF location is altered, with an enhancement of the response preceding the spike time and a reduction following the spike. Such bidirectional modification is consistent with spike timing-dependent plasticity. Response modification also occurs at nearby locations, the direction and magnitude of which are correlated with the change at the paired location. In addition, changes at unpaired locations show a negative correlation with the initial strength of the response, which may facilitate rapid modification of the spatial RF profile.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X; Meliza, C Daniel/0000-0002-9395-4369	NATIONAL EYE INSTITUTE [R01EY015180] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015180] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Fregnac Y, 1999, J NEUROBIOL, V41, P69; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Hebb Donald O., 1949, ORG BEHAV; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li CY, 2004, NEURON, V41, P257, DOI 10.1016/S0896-6273(03)00847-X; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McLean J, 1998, VISUAL NEUROSCI, V15, P177, DOI 10.1017/S0952523898151143; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zilles Karl, 1995, P649	40	87	88	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					183	189		10.1016/j.neuron.2005.12.009	http://dx.doi.org/10.1016/j.neuron.2005.12.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423693	Bronze			2022-12-24	WOS:000234979900006
J	Tu, DC; Zhang, DY; Demas, J; Slutsky, EB; Provencio, I; Holy, TE; Van Gelder, RN				Tu, DC; Zhang, DY; Demas, J; Slutsky, EB; Provencio, I; Holy, TE; Van Gelder, RN			Physiologic diversity and development of intrinsically photosensitive retinal ganglion cells	NEURON			English	Article							PHOTOPIGMENT MELANOPSIN; NON-CONE; NON-ROD; EXPRESSION; RESPONSES; PHOTORECEPTION; NETWORK; OPSIN; UNITS; MICE	Intrinsically photosensitive retinal ganglion cells (ipRGCs) mediate numerous nonvisual phenomena, including entrainment of the circadian clock to light-dark cycles, pupillary light responsiveness, and light-regulated hormone release. We have applied multielectrode array recording to characterize murine ipRGCs. We find that all ipRGC photosensitivity is melanopsin dependent. At least three populations of ipRGCs are present in the postnatal day 8 (P8) murine retina: slow onset, sensitive, fast off (type 1); slow onset, insensitive, slow off (type 11); and rapid onset, sensitive, very slow off (type 111). Recordings from adult rd/rd retinas reveal cells comparable to postnatal types 11 and 111. Recordings from early postnatal retinas demonstrate intrinsic light responses from PO. Early light responses are transient and insensitive but by P6 show increased photosensitivity and persistence. These results demonstrate that ipRGCs are the first light-sensitive cells in the retina and suggest previously unappreciated diversity in this cell population.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Uniformed Serv Univ Hlth Sci, Circadian Res Ctr, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Genet, Bethesda, MD 20814 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; University of Virginia	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	vangelder@vision.wustl.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Provencio, Ignacio/0000-0003-1175-920X; Demas, Jay/0000-0001-7678-1905	NATIONAL EYE INSTITUTE [T32EY013360, R01EY014988] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY13360, R01-EY14988] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Fahrenkrug J, 2004, NEUROREPORT, V15, P781, DOI 10.1097/00001756-200404090-00008; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hu EH, 2003, J NEUROSCI, V23, P6768; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; LEARD LE, 1994, NEUROREPORT, V5, P2683, DOI 10.1097/00001756-199412000-00069; Llamosas MM, 2000, DEV BRAIN RES, V120, P1, DOI 10.1016/S0165-3806(99)00175-3; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 2002, ASS RES VIS OPTH FOR; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Silverman B.W, 1986, DENSITY ESTIMATION; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; WEAVER DR, 1995, MOL BRAIN RES, V33, P136, DOI 10.1016/0169-328X(95)00117-B; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	45	177	183	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					987	999		10.1016/j.neuron.2005.09.031	http://dx.doi.org/10.1016/j.neuron.2005.09.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364902	Bronze			2022-12-24	WOS:000234301700014
J	Fischer, A; Sananbenesi, F; Pang, PT; Lu, B; Tsai, LH				Fischer, A; Sananbenesi, F; Pang, PT; Lu, B; Tsai, LH			Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory	NEURON			English	Article							CDK5 ACTIVATOR P35; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; DENDRITIC SPINES; CONDITIONED FEAR; KINASE-ACTIVITY; NMDA RECEPTORS; HUMAN BRAIN; NEURODEGENERATION	While deregulation of cyclin-dependent kinase 5 (Cdk5) has been implicated in neurodegenerative diseases, its precise role in synaptic plasticity and memory remains elusive. Proteolytic cleavage of p35, a regulatory subunit of Cdk5, by calpain results in the generation of the truncated p25 protein, which causes hyperactivation of Cdk5. Using region-specific and inducible transgenic mice, we show that transiently increased p25 expression in the hippocampus enhanced long-term potentiation (LTP) and facilitated hippocampus-dependent memory. Moreover, p25 expression increased the number of dendritic spines and synapses. Importantly, enhanced memory achieved by a transient expression of p25 followed by its repression did not cause neurodegeneration. In contrast, prolonged p25 production caused severe cognitive deficits, which were accompanied by synaptic and neuronal loss and impaired LTP. Our data suggest a role for p25 in synaptic plasticity, synaptogenesis, learning, and memory and provide a model whereby deregulation of a plasticity factor can contribute to neurodegeneration.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; NIMH, Gene Cognit & Psychosis Program, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759; Fischer, Andre/0000-0001-8546-1161	Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [NS051874] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Arendt T, 2004, INT J DEV NEUROSCI, V22, P507, DOI 10.1016/j.ijdevneu.2004.07.007; Armstrong DM, 2003, CELL MOL NEUROBIOL, V23, P491, DOI 10.1023/A:1025063811290; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; COTMAN CW, 1988, ADV NEUROL, V47, P12; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Howell D, 2002, STAT METHODS PSYCHOL; KAPLAN MS, 1988, ARCH PHYS MED REHAB, V69, P984; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rademakers R, 2005, NEUROBIOL AGING, V26, P1145, DOI 10.1016/j.neurobiolaging.2004.10.003; RAMONMOLINIER E, 1970, CONT RES METHODS NEU; Richardson JC, 2003, NEUROSCIENCE, V122, P213, DOI 10.1016/S0306-4522(03)00389-0; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheff S, 2003, NEUROCHEM RES, V28, P1625, DOI 10.1023/A:1026048619220; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Weishaupt JH, 2003, MOL CELL NEUROSCI, V24, P489, DOI 10.1016/S1044-7431(03)00221-5; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146	58	215	240	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					825	838		10.1016/j.neuron.2005.10.033	http://dx.doi.org/10.1016/j.neuron.2005.10.033			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337919	Bronze			2022-12-24	WOS:000233927300020
J	Khalilov, I; Le van Quyen, M; Gozlan, H; Ben-Ari, Y				Khalilov, I; Le van Quyen, M; Gozlan, H; Ben-Ari, Y			Epileptogenic actions of GABA and fast oscillations in the developing hippocampus	NEURON			English	Article							GAMMA-FREQUENCY OSCILLATIONS; ICTAL EPILEPTIFORM ACTIVITY; SEIZURE-LIKE ACTIVITY; NETWORK OSCILLATIONS; EXCITATORY ACTIONS; GAP-JUNCTIONS; FAST RIPPLES; INTERNEURONS; RAT; MECHANISMS	GABA excites immature neurons and inhibits adult ones, but whether this contributes to seizures in the developing brain is not known. We now report that in the developing, but not the adult, hippocampus, seizures beget seizures only if GABAergic synapses are functional. In the immature hippocampus, seizures generated with functional GABAergic synapses include fast oscillations that are required to transform a naive network to an epileptic one: blocking GABA receptors prevents the long-lasting sequels of seizures. In contrast, in adult neurons, full blockade of GABA(A) receptors generates epileptogenic high-frequency seizures. Therefore, purely glutamatergic seizures are not epileptogenic in the developing hippocampus. We suggest that the density of glutamatergic synapses is not sufficient for epileptogenesis in immature neurons; excitatory GABAergic synapses are required for that purpose. We suggest that the synergistic actions of GABA and NMDA receptors trigger the cascades involved in epileptogenesis in the developing hippocampus.	INSERM, U29 Marseille, INMED, F-13273 Marseille, France; Hop La Pitie Salpetriere, CNRS,UPR 640, Neurodynam Grp, Cognit Neurosci & Brain Imaging Lab LENA, F-75651 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ben-Ari, Y (corresponding author), INSERM, U29 Marseille, INMED, 163 Route Luminy, F-13273 Marseille, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480				Avoli M, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P293; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Borck C, 1999, J NEUROPHYSIOL, V82, P2130, DOI 10.1152/jn.1999.82.5.2130; Bracci E, 1999, J NEUROSCI, V19, P8104; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dzhala VI, 2004, J NEUROSCI, V24, P8896, DOI 10.1523/JNEUROSCI.3112-04.2004; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; FISHER RS, 1992, J CLIN NEUROPHYSIOL, V9, P441; Fujiwara-Tsukamoto Y, 2003, NEUROSCIENCE, V119, P265, DOI 10.1016/S0306-4522(03)00102-7; Fukuda T, 2000, J NEUROSCI, V20, P1519; Gao XB, 1998, J NEUROPHYSIOL, V79, P716, DOI 10.1152/jn.1998.79.2.716; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GOWERS WR, 2001, EPILEPSY OTHER CHRON; Gozlan H, 2003, CEREB CORTEX, V13, P684, DOI 10.1093/cercor/13.6.684; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; HOLMES GL, 1984, ARCH NEUROL-CHICAGO, V41, P853, DOI 10.1001/archneur.1984.04050190059014; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Isomura Y, 2003, J NEUROPHYSIOL, V90, P2752, DOI 10.1152/jn.00142.2003; Karnup S, 2001, J PHYSIOL-LONDON, V532, P713, DOI 10.1111/j.1469-7793.2001.0713e.x; Khalilov I, 1999, EUR J NEUROSCI, V11, P3468, DOI 10.1046/j.1460-9568.1999.00768.x; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 1999, J NEUROPHYSIOL, V81, P921, DOI 10.1152/jn.1999.81.2.921; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Kohling R, 2000, J NEUROSCI, V20, P6820, DOI 10.1523/JNEUROSCI.20-18-06820.2000; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Quilichini PP, 2002, EUR J NEUROSCI, V16, P850, DOI 10.1046/j.1460-9568.2002.02143.x; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Ruusuvuori E, 2004, J NEUROSCI, V24, P2699, DOI 10.1523/JNEUROSCI.5176-03.2004; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Velazquez JLP, 1999, EUR J NEUROSCI, V11, P4110, DOI 10.1046/j.1460-9568.1999.00837.x; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149	62	121	144	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					787	796		10.1016/j.neuron.2005.09.026	http://dx.doi.org/10.1016/j.neuron.2005.09.026			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337916	Bronze			2022-12-24	WOS:000233927300017
J	Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J				Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J			K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons	NATURE NEUROSCIENCE			English	Article							SENSITIVE POTASSIUM CHANNELS; PARKINSONS-DISEASE; MOUSE MODEL; UNCOUPLING PROTEIN-2; SUBSTANTIA-NIGRA; GENE-EXPRESSION; PROTECTIVE ROLE; DEFICIENT MICE; MECHANISMS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	The selective degeneration of dopaminergic (DA) midbrain neurons in the substantia nigra (SN) is a hallmark of Parkinson disease. DA neurons in the neighboring ventral tegmental area (VTA) are significantly less affected. The mechanisms for this differential vulnerability of DA neurons are unknown. We identified selective activation of ATP-sensitive potassium (K-ATP) channels as a potential mechanism. We show that in response to parkinsonism-inducing toxins, electrophysiological activity of SN DA neurons, but not VTA DA neurons, is lost owing to activation of K-ATP channels. This selective K-ATP channel activation is controlled by differences in mitochondrial uncoupling between SN and VTA DA neurons. Genetic inactivation of the K-ATP channel pore-forming subunit Kir6.2 resulted in a selective rescue of SN but not VTA DA neurons in two mechanistically distinct mouse models of dopaminergic degeneration, the neurotoxicological 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine ( MPTP) model and the mutant weaver mouse. Thus, K-ATP channel activation has an unexpected role in promoting death of DA neurons in chronic disease.	Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England; Univ Grad Sch Med, Kobe, Hyogo 6500017, Japan	Philipps University Marburg; University of Oxford; University of Oxford	Liss, B (corresponding author), Univ Marburg, Dept Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	birgit.liss@staff.uni-marburg.de	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Roeper, Jochen/0000-0003-2145-8742; liss, Birgit/0000-0002-6733-9207				ALBURGES ME, 1993, SYNAPSE, V14, P314, DOI 10.1002/syn.890140409; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; Avshalumov MV, 2005, J NEUROSCI, V25, P4222, DOI 10.1523/JNEUROSCI.4701-04.2005; Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Hernandez-Sanchez C, 2001, P NATL ACAD SCI USA, V98, P3549, DOI 10.1073/pnas.051012898; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; JIANG C, 1994, J NEUROSCI, V14, P5590; Keuker JIH, 2001, BRAIN RES PROTOC, V7, P211, DOI 10.1016/S1385-299X(01)00064-2; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liss B, 2001, MOL MEMBR BIOL, V18, P117; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 2004, TRENDS NEUROSCI, V27, P475, DOI 10.1016/j.tins.2004.06.007; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; MERCURI NB, 1994, J NEUROPHYSIOL, V71, P1165, DOI 10.1152/jn.1994.71.3.1165; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; MORATALLA R, 1992, P NATL ACAD SCI USA, V89, P3859, DOI 10.1073/pnas.89.9.3859; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schapira AHV, 2001, ADV NEUROL, V86, P155; Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	49	219	233	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1742	1751		10.1038/nn1570	http://dx.doi.org/10.1038/nn1570			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299504				2022-12-24	WOS:000233576200024
J	Lieberam, I; Agalliu, D; Nagasawa, T; Ericson, J; Jessell, TM				Lieberam, I; Agalliu, D; Nagasawa, T; Ericson, J; Jessell, TM			A Cxcl12-Cxcr4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons	NEURON			English	Article							LIM HOMEOBOX GENES; SPINAL-CORD; NEURON DIFFERENTIATION; ODORANT RECEPTORS; BRANCHIAL ARCHES; GUIDES AXONS; MICE LACKING; EXIT POINTS; GROWTH CONE; GUIDANCE	Motor neurons, alone among neurons in the vertebrate CNS, extend axons out of the neural tube to innervate peripheral targets. Two classes of motor neurons, termed vMNs and dMNs, extend axons out of the neural tube via ventral and dorsal exit points, respectively, in accord with their homeodomain transcription factor repertoire. Downstream of these transcriptional codes, the cell surface receptors that shape initial motor axon trajectories have not been identified. We show here that the chemokine receptor Cxcr4 is expressed on the axons of vMNs as they follow their ventral trajectory, whereas its ligand, Cxcl12, is expressed by mesenchymal cells surrounding the ventral neural tube. Genetic studies reveal that Cxcl12-Cxcr4 signaling directs the ventral trajectory of spinal vMNs. In its absence, these neurons adopt a dMN-like trajectory, despite preservation of their vMN transcriptional identity. Thus, the status of Cxcr4 signaling helps to determine the initial axonal trajectory of mammalian motor neurons.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Kyoto 6068507, Japan; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Kyoto University; Karolinska Institutet	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	tmj1@columbia.edu	Lieberam, Ivo/C-5324-2009	Ericson, Johan/0000-0002-8019-7127; Lieberam, Ivo/0000-0003-3539-3054; Nagasawa, Takashi/0000-0002-1085-0960				Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7; Caton A, 2000, DEVELOPMENT, V127, P1751; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jacob J, 2000, MOL CELL NEUROSCI, V16, P14, DOI 10.1006/mcne.2000.0855; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; LEBER SM, 1995, J NEUROSCI, V15, P1236; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MOODY SA, 1983, J COMP NEUROL, V213, P327, DOI 10.1002/cne.902130308; Naeem A, 2002, J NEUROBIOL, V51, P101, DOI 10.1002/neu.10048; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Tran PB, 2003, J COMP NEUROL, V457, P1, DOI 10.1002/cne.10546; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Zhang LQ, 2000, ANAT EMBRYOL, V201, P235, DOI 10.1007/s004290050314; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	128	130	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					667	679		10.1016/j.neuron.2005.08.011	http://dx.doi.org/10.1016/j.neuron.2005.08.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129397	Bronze			2022-12-24	WOS:000231782700009
J	Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL				Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL			XTRPC1-dependent chemotropic guidance of neuronal growth cones	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; INTRACELLULAR CALCIUM; COMMISSURAL AXONS; TRP CHANNELS; MYELIN; REGENERATION; NETRINS; NOGO; CNS; ACTIVATION	Calcium arising through release from intracellular stores and from influx across the plasma membrane is essential for signalling by specific guidance cues and by factors that inhibit axon regeneration. The mediators of calcium influx in these cases are largely unknown. Transient receptor potential channels (TRPCs) belong to a superfamily of Ca2+-permeable, receptor-operated channels that have important roles in sensing and responding to changes in the local environment. Here we report that XTRPC1, a Xenopus homolog of mammalian TRPC1, is required for proper growth cone turning responses of Xenopus spinal neurons to microscopic gradients of netrin-1, brain-derived neurotrophic factor and myelin-associated glycoprotein, but not to semaphorin 3A. Furthermore, XTRPC1 is required for midline guidance of axons of commissural interneurons in the developing Xenopus spinal cord. Thus, members of the TRPC family may serve as a key mediator for the Ca2+ influx that regulates axon guidance during development and inhibits axon regeneration in adulthood.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	gming1@bs.jhmi.edu	Sailor, Kurt/GSO-2237-2022; Bootman, Martin/AAB-3330-2019; Goh, Eyleen/A-8006-2013; Ming, Guo-li/J-7880-2013; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Bootman, Martin/0000-0002-6447-3451; Sailor, Kurt Andrew/0000-0002-9574-6838; Roderick, Hywel/0000-0001-7065-3523; Ming, Guo-li/0000-0002-2517-6075; Goh, Eyleen/0000-0002-8244-6959	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R37NS047344, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C116, BBS/E/B/00001116] Funding Source: Medline; NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NICHD NIH HHS [R01 HD069184] Funding Source: Medline; NINDS NIH HHS [R01 NS047344, R01 NS048271, R56 NS047344, R37 NS047344] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; GORDON XW, 2005, NATURE, V434, P898; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Phelps PE, 1999, J COMP NEUROL, V409, P285; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; ROBERTS A, 1988, DEVELOPMENT, V103, P447; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	139	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					730	735		10.1038/nn1459	http://dx.doi.org/10.1038/nn1459			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880110	Green Accepted, Green Published			2022-12-24	WOS:000229345300012
J	Itri, JN; Michel, S; Vansteensel, MJ; Meijer, JH; Colwell, CS				Itri, JN; Michel, S; Vansteensel, MJ; Meijer, JH; Colwell, CS			Fast delayed rectifier potassium current is required for circadian neural activity	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS NEURONS; GATED K+ CHANNELS; MEMBRANE-PROPERTIES; GENE-EXPRESSION; SCN NEURONS; PACEMAKER; MOUSE; MECHANISMS; RHYTHMS; CAMP	In mammals, the precise circadian timing of many biological processes depends on the generation of oscillations in neural activity of pacemaker cells in the suprachiasmatic nucleus (SCN). The ionic mechanisms that underlie these rhythms are largely unknown. Using the mouse brain slice preparation, we show that the magnitude of fast delayed rectifier (FDR) potassium currents has a diurnal rhythm that peaks during the day. Notably, this rhythm continues in constant darkness, providing the first demonstration of the circadian regulation of an intrinsic voltage-gated current in mammalian cells. Blocking this current prevented the daily rhythm in firing rate in SCN neurons. Kv3.1b and Kv3.2 potassium channels were widely distributed within the SCN, with higher expression during the day. We conclude that the FDR is necessary for the circadian modulation of electrical activity in SCN neurons and represents an important part of the ionic basis for the generation of rhythmic output.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2300 RC Leiden, Netherlands	University of California System; University of California Los Angeles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ccolwell@mednet.ucla.edu	Vansteensel, Mariska/K-8015-2019; Colwell, Chris/AAM-6111-2020	Vansteensel, Mariska/0000-0002-9252-5116; Colwell, Christopher/0000-0002-1059-184X	NHLBI NIH HHS [HL64582, R01 HL064582] Funding Source: Medline; NIMH NIH HHS [F30 MH068087, MH68087] Funding Source: Medline; NINDS NIH HHS [R01 NS043169, NS043169] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH068087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; BOUSKILA Y, 1995, J PHYSIOL-LONDON, V488, P339, DOI 10.1113/jphysiol.1995.sp020970; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; de Jeu M, 2002, J NEUROPHYSIOL, V88, P869, DOI 10.1152/jn.2002.88.2.869; deJeu MTG, 1997, BRAIN RES, V767, P72, DOI 10.1016/S0006-8993(97)00632-X; Gan L, 1998, J NEUROBIOL, V37, P69, DOI 10.1002/(SICI)1097-4695(199810)37:1<69::AID-NEU6>3.0.CO;2-6; Gillette MU, 1997, CURR OPIN NEUROBIOL, V7, P797, DOI 10.1016/S0959-4388(97)80138-9; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Kononenko NI, 2004, J NEUROPHYSIOL, V91, P710, DOI 10.1152/jn.00770.2003; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Martina M, 1998, J NEUROSCI, V18, P8111; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Michel S, 2002, J NEUROPHYSIOL, V88, P817, DOI 10.1152/jn.2002.88.2.817; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Schaap J, 2003, CHRONOBIOL INT, V20, P171, DOI 10.1081/CBI-120019311; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; Teshima K, 2003, NEUROSCIENCE, V120, P65, DOI 10.1016/S0306-4522(03)00270-7; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	40	99	100	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					650	656		10.1038/nn1448	http://dx.doi.org/10.1038/nn1448			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852012	Green Accepted			2022-12-24	WOS:000228895100026
J	Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP				Ngo-Anh, TJ; Bloodgood, BL; Lin, M; Sabatini, BL; Maylie, J; Adelman, JP			SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; SYNAPTIC PLASTICITY; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; TIME COURSE; AREA CA1; CA2+	Small-conductance Ca2+-activated K+ channels (SK channels) influence the induction of synaptic plasticity at hippocampal CA3-CA1 synapses. We find that in mice, SK channels are localized to dendritic spines, and their activity reduces the amplitude of evoked synaptic potentials in an NMDA receptor (NMDAR)-dependent manner. Using combined two-photon laser scanning microscopy and two-photon laser uncaging of glutamate, we show that SK channels regulate NMDAR-dependent Ca2+ influx within individual spines. SK channels are tightly coupled to synaptically activated Ca2+ sources, and their activity reduces the amplitude of NMDAR-dependent Ca2+ transients. These effects are mediated by a feedback loop within the spine head; during an excitatory postsynaptic potential (EPSP), Ca2+ influx opens SK channels that provide a local shunting current to reduce the EPSP and promote rapid Mg2+ block of the NMDAR. Thus, blocking SK channels facilitates the induction of long-term potentiation by enhancing NMDAR-dependent Ca2+ signals within dendritic spines.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	adelman@ohsu.edu		Bloodgood, Brenda/0000-0002-4797-9119				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Goslin K., 1998, CULTURING NERVE CELL, P339; HABERMANN E, 1984, PHARMACOL THERAPEUT, V25, P255, DOI 10.1016/0163-7258(84)90046-9; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hirschberg B, 1999, BIOPHYS J, V77, P1905, DOI 10.1016/S0006-3495(99)77032-3; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LORENZON NM, 1992, J NEUROPHYSIOL, V67, P350, DOI 10.1152/jn.1992.67.2.350; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Naraghi M, 1997, J NEUROSCI, V17, P6961; Paul K, 2003, NEUROSCI LETT, V348, P180, DOI 10.1016/S0304-3940(03)00747-X; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; ZORUMSKI CF, 1989, NEUROSCI LETT, V99, P293, DOI 10.1016/0304-3940(89)90462-X	43	348	354	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					642	649		10.1038/nn1449	http://dx.doi.org/10.1038/nn1449			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852011				2022-12-24	WOS:000228895100025
J	Liu, TS; Pestilli, F; Carrasco, M				Liu, TS; Pestilli, F; Carrasco, M			Transient attention enhances perceptual performance and fMRI response in human visual cortex	NEURON			English	Article							SELECTIVE ATTENTION; CONTRAST SENSITIVITY; REFLEXIVE ATTENTION; NEURAL MECHANISMS; CORTICAL AREAS; BRAIN ACTIVITY; STRIATE; MODULATION; COMPONENTS; MT	When a visual stimulus suddenly appears, it captures attention, producing a transient improvement of performance on basic visual tasks. We investigate the effect of transient attention on stimulus representations in early visual areas using rapid event-related fMRI. Participants discriminated the orientation of one of two gratings preceded or followed by a non-predictive peripheral cue. Compared to control conditions, precueing the target location improved performance and produced a larger fMRI response in corresponding retinotopic areas. This enhancement progressively increased from striate to extrastriate areas. Control conditions indicated that the enhanced fMRI response was not due to sensory summation of cue and target signals. Thus, an uninformative precue increases both perceptual performance and the concomitant stimulus-evoked activity in early visual areas. These results provide evidence regarding the retinotopically specific neural correlate for the effects of transient attention on early vision.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu	Pestilli, Franco/J-5236-2012; Liu, Taosheng/K-9148-2013	Pestilli, Franco/0000-0002-2469-0494; Liu, Taosheng/0000-0002-9768-0393	NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016200] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GOBEL J, 2005, IN PRESS PSYCHOL SCI; Handy TC, 2003, NAT NEUROSCI, V6, P421, DOI 10.1038/nn1031; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1999, PERCEPT PSYCHOPHYS, V61, P1424, DOI 10.3758/BF03206191; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; NACHMIAS J, 1967, J OPT SOC AM, V57, P421, DOI 10.1364/JOSA.57.000421; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Noesselt T, 2002, NEURON, V35, P575, DOI 10.1016/S0896-6273(02)00781-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PESTILLI F, 2005, IN PRESS VISION RES; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SERENCES JT, 2005, IN PRESS PSYCHOL SCI; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; WANDELL BA, 2005, IN PRESS PHILOS T B; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	60	142	144	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					469	477		10.1016/j.neuron.2004.12.039	http://dx.doi.org/10.1016/j.neuron.2004.12.039			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694332	Green Accepted, Bronze			2022-12-24	WOS:000226787700018
J	Tombola, F; Pathak, MM; Isacoff, EY				Tombola, F; Pathak, MM; Isacoff, EY			Voltage-sensing arginines in a potassium channel permeate and occlude cation-selective pores	NEURON			English	Article							SHAKER K+ CHANNEL; CHARGE MOVEMENT; MOLECULAR-BASIS; GATING CHARGE; S4 SEGMENT; TRANSMEMBRANE SEGMENTS; SENSOR; INACTIVATION; MODELS; DOMAIN	Voltage-gated ion channels sense voltage by shuttling arginine residues located in the S4 segment across the membrane electric field. The molecular pathway for this arginine permeation is not understood, nor is the filtering mechanism that permits passage of charged arginines but excludes solution ions. We find that substituting the first S4 arginine with smaller amino acids opens a high-conductance pathway for solution cations in the Shaker K+ channel at rest. The cationic current does not flow through the central K+ pore and is influenced by mutation of a conserved residue in S2, suggesting that it flows through a protein pathway within the voltage-sensing domain. The current can be carried by guanidinium ions, suggesting that this is the pathway for transmembrane arginine permeation. We propose that when S4 moves it ratchets between conformations in which one arginine after another occupies and occludes to ions the narrowest part of this pathway.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	eisacoff@socrates.berkeley.edu	Tombola, Francesco/C-7311-2011; Tombola, Francesco/ABA-6002-2020; isacoff, ehud/AAP-1459-2020	Tombola, Francesco/0000-0002-9315-0352; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS35549, R01 NS035549-08] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Goldstein SAN, 1996, NEURON, V16, P717, DOI 10.1016/S0896-6273(00)80092-6; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lecar H, 2003, BIOPHYS J, V85, P2854, DOI 10.1016/S0006-3495(03)74708-0; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	39	212	216	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					379	388		10.1016/j.neuron.2004.12.047	http://dx.doi.org/10.1016/j.neuron.2004.12.047			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694325	Bronze			2022-12-24	WOS:000226787700011
J	Mazzoni, EO; Desplan, C; Blau, J				Mazzoni, EO; Desplan, C; Blau, J			Circadian pacemaker neurons transmit and modulate visual information to control a rapid behavioral response	NEURON			English	Article							DROSOPHILA-MELANOGASTER; CHOLINE-ACETYLTRANSFERASE; GENETIC-ANALYSIS; NERVOUS-SYSTEM; CLOCK NEURONS; OPTIC-NERVE; PERIOD GENE; EXPRESSION; RHYTHMS; CRYPTOCHROME	Circadian pacemaker neurons contain a molecular clock that oscillates with a period of similar to24 hr, controlling circadian rhythms of behavior. Pacemaker neurons respond to visual system inputs for clock resetting, but, unlike other neurons, have not been reported to transmit rapid signals to their targets. Here we show that pacemaker neurons are required to mediate a rapid behavior. The Drosophila larval visual system, Bolwig's organ (BO), projects to larval pacemaker neurons to entrain their clock. BO also mediates larval photophobic behavior. We found that ablation or electrical silencing of larval pacemaker neurons abolished light avoidance. Thus, circadian pacemaker neurons receive input from BO not only to reset the clock but also to transmit rapid photophobic signals. Furthermore, as clock gene mutations also affect photophobicity, the pacemaker neurons modulate the sensitivity of larvae to light, generating a circadian rhythm in visual sensitivity.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	justin.blau@nyu.edu		mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER; NEI NIH HHS [EY013010] Funding Source: Medline; NIGMS NIH HHS [GM063911] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; BARLOW RB, 1977, SCIENCE, V197, P86, DOI 10.1126/science.867057; BATTELLE BA, 2002, CELL, V15, P345; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5; Dettman RW, 2001, GENETICS, V158, P253; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; Han DD, 2000, DEVELOPMENT, V127, P573; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J BIOL RHYTHM, V15, P13, DOI 10.1177/074873040001500103; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Malpel S, 2004, J BIOL RHYTHM, V19, P10, DOI 10.1177/0748730403260621; Malpel S, 2002, DEVELOPMENT, V129, P1443; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Ousley A, 1998, GENETICS, V148, P815; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Tosini G, 2002, CELL TISSUE RES, V309, P119, DOI 10.1007/s00441-002-0578-z; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; YASUYAMA K, 1995, CELL TISSUE RES, V282, P193, DOI 10.1007/BF00319111	41	119	122	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					293	300		10.1016/j.neuron.2004.12.038	http://dx.doi.org/10.1016/j.neuron.2004.12.038			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664180	Bronze			2022-12-24	WOS:000226451500015
J	Humeau, Y; Herry, C; Kemp, N; Shaban, H; Fourcaudot, E; Bissiere, S; Luthi, A				Humeau, Y; Herry, C; Kemp, N; Shaban, H; Fourcaudot, E; Bissiere, S; Luthi, A			Dendritic spine heterogeneity determines afferent-specific Hebbian plasticity in the amygdala	NEURON			English	Article							LONG-TERM POTENTIATION; GATED CALCIUM-CHANNELS; LATERAL AMYGDALA; ELECTROPHYSIOLOGICAL PROPERTIES; ASSOCIATIVE PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL INPUTS; NMDA RECEPTORS; FEAR MEMORY; NEURONS	Functional compartmentalization of dendrites is thought to underlie afferent-specific integration of neural activity in laminar brain structures. Here we show that in the lateral nucleus of the amygdala (LA), an area lacking apparent laminar organization, thalamic and cortical afferents converge on the same dendrites, contacting neighboring but morphologically and functionally distinct spine types. Large spines contacted by thalamic afferents exhibited larger Ca2+ transients during action potential backpropagation than did small spines contacted by cortical afferents. Accordingly, induction of Hebbian plasticity, dependent on postsynaptic spikes, was restricted to thalamic afferents. This synapse-specific effect involved activation of R-type voltage-dependent Ca2+ channels preferentially located at thalamic inputs. These results indicate that afferent-specific mechanisms of postsynaptic, associative Hebbian plasticity in LA projection neurons depend on local, spine-specific morphological and molecular properties, rather than global differences between dendritic compartments.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; CNRS, UPR2356, F-67084 Strasbourg, France; Univ Basel, Bioctr, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel	Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	shaban, Hamdy/C-1939-2014; Herry, Cyril/AAP-9902-2020; Shaban, Hamdy/ABD-5617-2021	shaban, Hamdy/0000-0003-3760-6113; Herry, Cyril/0000-0003-2973-0843; Shaban, Hamdy/0000-0003-3760-6113				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cain CK, 2002, J NEUROSCI, V22, P9113; CARLSEN J, 1988, BRAIN RES, V441, P377, DOI 10.1016/0006-8993(88)91418-7; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Farb CR, 1999, SYNAPSE, V33, P218, DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AID-SYN6>3.0.CO;2-1; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heinbockel T, 2000, J NEUROSCI, V20; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Mainen Z. F., 1999, DENDRITES, P310; Majewska A, 2000, J NEUROSCI, V20, P1722; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Normann C, 2000, J NEUROSCI, V20, P8290, DOI 10.1523/JNEUROSCI.20-22-08290.2000; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Smith Y, 2000, J COMP NEUROL, V416, P496; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Wilson SM, 2000, J NEUROSCI, V20, P8566; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	63	110	112	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					119	131		10.1016/j.neuron.2004.12.019	http://dx.doi.org/10.1016/j.neuron.2004.12.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629707	Bronze			2022-12-24	WOS:000226217100014
J	Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH				Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH			Natural oligomers of the amyloid-protein specifically disrupt cognitive function	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; MEMORY DEFICITS; TRANSGENIC MICE; NEURONAL LOSS; MOUSE MODEL; BRAIN; PLAQUES; DEPOSITS	A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia. Here we provide the first direct experimental evidence that a defined molecular species of the amyloid-protein interferes with cognitive function. Soluble oligomeric forms of amyloid-beta, including trimers and dimers, were both necessary and sufficient to disrupt learned behavior in a manner that was rapid, potent and transient; they produced impaired cognitive function without inducing permanent neurological deficits. Although beta-amyloidosis has long been hypothesized to affect cognition, the abnormally folded protein species associated with this or any other neurodegenerative disease has not previously been isolated, defined biochemically and then specifically characterized with regard to its effects on cognitive function. The biochemical isolation of discrete amyloid-moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.	Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Coll Dublin, Conway Inst Biomed & Biomol Res, Lab Neurodegenerat Res, Dublin 4, Ireland; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University College Dublin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ashe, KH (corresponding author), Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA.	hsiao005@umn.edu						Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CLEARY J, 1995, BRAIN RES, V682, P69, DOI 10.1016/0006-8993(95)00323-I; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dudai Y., 2002, MEMORY KEYWORDS CONC; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Johnson D, 1997, EDN, V42, P94; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mishima K, 2000, JPN J PHARMACOL, V84, P163, DOI 10.1254/jjp.84.163; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Hare E, 1999, BRAIN RES, V815, P1, DOI 10.1016/S0006-8993(98)01002-6; OHare E, 1996, BEHAV PHARMACOL, V7, P742; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pederson ES, 2001, REGUL PEPTIDES, V102, P147, DOI 10.1016/S0167-0115(01)00312-3; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Sweeney WA, 1997, NEUROBIOL LEARN MEM, V68, P97, DOI 10.1006/nlme.1997.3770; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Weldon DT, 1996, PHARMACOL BIOCHEM BE, V54, P753, DOI 10.1016/0091-3057(96)00014-7; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	46	1409	1499	1	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					79	84		10.1038/nn1372	http://dx.doi.org/10.1038/nn1372			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608634				2022-12-24	WOS:000225967600019
J	Corlett, PR; Aitken, MRF; Dickinson, A; Shanks, DR; Honey, GD; Honey, RAE; Robbins, TW; Bullmore, ET; Fletcher, PC				Corlett, PR; Aitken, MRF; Dickinson, A; Shanks, DR; Honey, GD; Honey, RAE; Robbins, TW; Bullmore, ET; Fletcher, PC			Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning	NEURON			English	Article							WITHIN-COMPOUND ASSOCIATIONS; FALSE DISCOVERY RATE; CONTINGENCY JUDGMENT; FRONTAL-CORTEX; RESPONSES	Associative learning theory assumes that prediction error is a driving force in learning. A competing view, probabilistic contrast (PC) theory, is that learning and prediction error are unrelated. We tested a learning phenomenon that has proved troublesome for associative theory-retrospective revaluation-to evaluate these two models. We previously showed that activation in right lateral prefrontal cortex (PFC) provides a reliable signature for the presence of prediction error. Thus, if the associative view is correct, retrospective revaluation should be accompanied by right lateral PFC activation. PC theory would be supported by the absence of this activation. Right PFC and ventral striatal activation occurred during retrospective revaluation, supporting the associative account. Activations appeared to reflect the degree of revaluation, predicting later brain responses to revalued cues. Our results support a modified associative account of retrospective revaluation and demonstrate the potential of functional neuroimaging as a tool for evaluating competing learning models.	Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Psychiat,Brain Mapping Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; UCL, Dept Psychol, London WC1E 6BT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London	Fletcher, PC (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Psychiat,Brain Mapping Unit, Cambridge CB2 2QQ, England.	pcf22@cam.ac.uk	Shanks, David/A-1510-2015; Bullmore, Ed/C-1706-2012; Robbins, Trevor W/A-7551-2008; Fletcher, Paul/F-5380-2011	Shanks, David/0000-0002-4600-6323; Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Robbins, Trevor/0000-0003-0642-5977; Aitken Deakin, Michael/0000-0001-9763-8999; Corlett, Philip/0000-0002-5368-1992	Medical Research Council [G9439390, G0001237] Funding Source: Medline; Wellcome Trust [064351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AITKEN MR, 2004, IN PRESS LEARN BEHAV; Aitken MRF, 2001, Q J EXP PSYCHOL-B, V54, P27, DOI 10.1080/02724990042000029; ALLAN LG, 1993, PSYCHOL BULL, V114, P435, DOI 10.1037/0033-2909.114.3.435; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; CHENG PW, 1992, PSYCHOL REV, V99, P83; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Denniston JC, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P65; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; DICKINSON A, 1996, J EXP PSYCHOL B, V37, P397; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Larkin MJW, 1998, J EXP PSYCHOL LEARN, V24, P1331, DOI 10.1037/0278-7393.24.6.1331; Macho S, 2002, J EXP PSYCHOL LEARN, V28, P1171, DOI 10.1037//0278-7393.28.6.1171; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Melchers KG, 2004, Q J EXP PSYCHOL-B, V57, P25, DOI 10.1080/02724990344000042; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PRICE PC, 1995, J EXP PSYCHOL LEARN, V21, P1639, DOI 10.1037/0278-7393.21.6.1639; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SHANKS DR, 1985, Q J EXP PSYCHOL-B, V37, P1, DOI 10.1080/14640748508402082; Talairach J, 1988, CO PLANAR STEREOTAXI; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; VANHAMME LJ, 1994, LEARN MOTIV, V25, P127, DOI 10.1006/lmot.1994.1008; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Zink CF, 2003, J NEUROSCI, V23, P8092	32	122	124	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 2	2004	44	5					877	888		10.1016/j.neuron.2004.11.022	http://dx.doi.org/10.1016/j.neuron.2004.11.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572117	Bronze			2022-12-24	WOS:000225548400014
J	Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S				Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S			Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation	NEURON			English	Article							HIGH-FREQUENCY STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; BASAL GANGLIA; NEURONAL-ACTIVITY; DOPAMINE; OSCILLATIONS; INHIBITION	A concept in Parkinson's disease postulates that motor cortex may pattern abnormal rhythmic activities in the basal ganglia, underlying the genesis of observed motor symptoms. We conducted a preclinical study of electrical interference in the primary motor cortex using a chronic MPTP primate model in which dopamine depletion was progressive and regularly documented using F-18-DOPA positron tomography. High-frequency motor cortex stimulation significantly reduced akinesia and bradykinesia. This behavioral benefit was associated with an increased metabolic activity in the supplementary motor area as assessed with 18-F-deoxyglucose PET, a normalization of mean firing rate in the internal globus pallidus (GPi) and the subthalamic nucleus (STN), and a reduction of synchronized oscillatory neuronal activities in these two structures. Motor cortex stimulation is a simple and safe procedure to modulate subthalamo-pallido-cortical loop and alleviate parkinsonian symptoms without requiring deep brain stereotactic surgery.	Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Isotop Imaging Biochem & Pharmacol Unit, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Imagene Program, F-91401 Orsay, France; Univ Paris 12, UPVM U 421, INSERM, F-94010 Creteil, France; Univ Paris 12, Serv Physiol, F-94010 Creteil, France; Univ Paris 12, Serv Neurol, F-94010 Creteil, France; Univ Paris 12, Serv Neurochirurg, Hop Henri Mondor, AP HP, F-94010 Creteil, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Palfi, S (corresponding author), Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France.	stephane.palfi@hmn.ap-hop-paris.fr	Oshino, Satoru/AAS-1647-2020; Dollé, Frédéric/R-5756-2017; Jarraya, Bechir/R-6023-2019; Peschanski, Marc/N-5769-2017	Jarraya, Bechir/0000-0003-0878-763X; Remy, Philippe/0000-0003-2150-2563; Drouot, Xavier/0000-0002-3940-4825; Oshino, Satoru/0000-0002-4248-2322				Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bezard Erwan, 2001, FASEB Journal, V15, P1092; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Escola L, 2003, BRAIN, V126, P95, DOI 10.1093/brain/awg004; Fukuda M, 2001, ANN NEUROL, V49, P155, DOI 10.1002/1531-8249(20010201)49:2<155::AID-ANA35>3.0.CO;2-9; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; GRAFTON ST, 1995, ANN NEUROL, V37, P776, DOI 10.1002/ana.410370611; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Hashimoto T, 2002, J NEUROSCI METH, V113, P181, DOI 10.1016/S0165-0270(01)00491-5; Heimer G, 2002, J NEUROSCI, V22, P7850; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Krack P, 1998, BRAIN, V121, P451, DOI 10.1093/brain/121.3.451; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wichmann T, 1999, NATURE, V400, P621, DOI 10.1038/23148	34	132	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					769	778		10.1016/j.neuron.2004.11.023	http://dx.doi.org/10.1016/j.neuron.2004.11.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572109	Bronze			2022-12-24	WOS:000225548400006
J	Enomoto, H; Hughes, I; Golden, J; Baloh, RH; Yonemura, S; Heuckeroth, RO; Johnson, EM; Milbrandt, J				Enomoto, H; Hughes, I; Golden, J; Baloh, RH; Yonemura, S; Heuckeroth, RO; Johnson, EM; Milbrandt, J			GFR alpha 1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration	NEURON			English	Article							GDNF FAMILY LIGANDS; MOTOR-NEURON POOLS; NEUROTROPHIC FACTOR; MICE LACKING; RECEPTOR COMPONENTS; PERIPHERAL-NERVE; SURVIVAL FACTOR; OLFACTORY-BULB; ENTERIC NEURON; AXONAL GROWTH	The GDNF family ligands signal through a receptor complex composed of a ligand binding subunit, GFRalpha, and a signaling subunit, the RET tyrosine kinase. GFRalphas are expressed not only in RET-expressing cells, but also in cells lacking RET. A body of evidence suggests that RET-independent GFRalphas are important for (1) modulation of RET signaling in a non-cell-autonomous fashion (trans-signaling) and (2) regulation of NCAM function. To address the physiological significance of these roles, we generated mice specifically lacking RET-independent GFRalpha1. These mice exhibited no deficits in regions where trans-signaling has been implicated in vitro, including enteric neurons, motor neurons, kidney, and regenerating nerves. Furthermore, no abnormalities were found in the olfactory bulb, which requires proper NCAM function for its formation and is putatively a site of GDNF-GFRalpha-NCAM signaling. Thus RET-independent GFRalpha1 is dispensable for organogenesis and nerve regeneration in vivo, indicating that trans-signaling and GFRalpha-dependent NCAM signaling play a minor role physiologically.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); RIKEN; RIKEN	Enomoto, H (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	enomoto@cdb.riken.jp; jeff@pathology.wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689; Golden, Judith/0000-0002-5168-8525; Heuckeroth, Robert/0000-0002-3282-1765	NIA NIH HHS [AG01373, AG13729] Funding Source: Medline; NIDDK NIH HHS [R01 DK57038, R01 DK64592] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057038, R01DK064592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Ehrenfels CW, 1999, DEV GENET, V24, P263, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<263::AID-DVG9>3.0.CO;2-D; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hoke A, 2003, J NEUROSCI, V23, P561; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mikaels-Edman A, 2003, DEV DYNAM, V227, P27, DOI 10.1002/dvdy.10280; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Rossi J, 2000, EUR J NEUROSCI, V12, P3944, DOI 10.1046/j.1460-9568.2000.00292.x; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Sagot Y, 1998, J NEUROSCI, V18, P1132; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Worley DS, 2000, DEVELOPMENT, V127, P4383; Yu T, 1998, J NEUROSCI, V18, P4684	50	56	59	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					623	636		10.1016/j.neuron.2004.10.032	http://dx.doi.org/10.1016/j.neuron.2004.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541311	Bronze			2022-12-24	WOS:000225338100009
J	Voglmaier, SM; Kam, K; Yang, H; Fortin, DL; Hua, ZL; Nicoll, RA; Edwards, RH				Voglmaier, Susan M.; Kam, Kaiwen; Yang, Hua; Fortin, Doris L.; Hua, Zhaolin; Nicoll, Roger A.; Edwards, Robert H.			Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTER; KISS-AND-RUN; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; C2B DOMAIN; ENDOPHILIN; MEMBRANE; CLATHRIN; SYNAPSES; ADAPTER	Synaptic vesicles have been proposed to form through two mechanisms: one directly from the plasma membrane involving clathrin-dependent endocytosis and the adaptor protein AP2, and the other from an endosomal intermediate mediated by the adaptor AP3. However, the relative role of these two mechanisms in synaptic vesicle recycling has remained unclear. We now find that vesicular glutamate transporter VGLUT1 interacts directly with endophilin, a component of the clathrin-dependent endocytic machinery. In the absence of its interaction with endophilin, VGLUT1 recycles more slowly during prolonged, high-frequency stimulation. Inhibition of the AP3 pathway with brefeldin A rescues the rate of recycling, suggesting a competition between AP2 and -3 pathways, with endophilin recruiting VGLUT1 toward the faster AP2 pathway. After stimulation, however, inhibition of the AP3 pathway prevents the full recovery of VGLUT1 by endocytosis, implicating the AP3 pathway specifically in compensatory endocytosis.	UCSF, Sch Med, Dept Neurol & Physiol, San Francisco, CA 94143 USA; UCSF, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Cell Biol, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Neurosci, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Biomed Sci, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), UCSF, Sch Med, Dept Neurol & Physiol, 600 16th St, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu		Hua, Zhaolin/0000-0001-9242-1387; Fortin, Doris/0000-0002-2729-7890	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482, K08MH071626] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH071626] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; DEGOIS S, 2006, IN PRESS CELL MOL NE; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakatsu F, 2004, J CELL BIOL, V167, P293, DOI 10.1083/jcb.200405032; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Paillart C, 2003, J NEUROSCI, V23, P4092; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Seong E, 2005, MOL BIOL CELL, V16, P128, DOI 10.1091/mbc.E04-10-0892; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	76	281	287	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					71	84		10.1016/j.neuron.2006.05.027	http://dx.doi.org/10.1016/j.neuron.2006.05.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815333	Bronze			2022-12-24	WOS:000239037700011
J	Choi, WY; Guitton, D				Choi, Woo Young; Guitton, Daniel			Responses of collicular fixation neurons to gaze shift perturbations in head-unrestrained monkey reveal gaze feedback control	NEURON			English	Article							STEM OMNIPAUSE NEURONS; SUPERIOR COLLICULUS; TECTORETICULOSPINAL SYSTEM; VESTIBULOOCULAR REFLEX; FREE CAT; EYE; SACCADES; CELLS; COORDINATION; STIMULATION	A prominent hypothesis in motor control is that endpoint errors are minimized because motor commands are updated in real time via internal feedback loops. We investigated in monkey whether orienting saccadic gaze shifts made in the dark with coordinated eye-head movements are controlled by feedback. We recorded from superior colliculus fixation neurons (SCFNs) that fired tonically during fixation and were silent during gaze shifts. When we briefly (<= 700 ms) interrupted gaze shifts by transiently braking head movements, SCFNs fired steadily during brake-induced gaze immobility, and their mean frequency was inversely related to the remaining distance between current gaze position and the target. After head release, a corrective gaze saccade brought gaze on the unseen goal, and SCFN firing frequency peaked. The results support gaze feedback control and show that the SC is part of a network that encodes, during orientation, the distance between eye and target, irrespective of gaze trajectory characteristics.	Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Guitton, D (corresponding author), Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	daniel.guitton@mcgill.ca						Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2003, NAT NEUROSCI, V6, P404, DOI 10.1038/nn1027; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; Coimbra AJF, 2000, J NEUROPHYSIOL, V83, P1103, DOI 10.1152/jn.2000.83.2.1103; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Freedman EG, 2001, BIOL CYBERN, V84, P453, DOI 10.1007/PL00007989; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GALIANA HL, 1992, ANN NY ACAD SCI, V656, P452; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Guitton D, 2004, METH NE FRO NEUROSCI, P241; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; GUITTON D, 1984, J NEUROPHYSIOL, V52, P1030, DOI 10.1152/jn.1984.52.6.1030; Keller EL, 2004, METH NE FRO NEUROSCI, P277; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; Lefevre P, 1998, NEURAL NETWORKS, V11, P1175, DOI 10.1016/S0893-6080(98)00071-9; Matsuo S, 2004, J NEUROSCI, V24, P2760, DOI 10.1523/JNEUROSCI.5120-03.2004; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; PELISSON D, 1995, EXP BRAIN RES, V106, P196; Phillips JO, 1999, J NEUROPHYSIOL, V81, P1284, DOI 10.1152/jn.1999.81.3.1284; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Roy JE, 1998, NAT NEUROSCI, V1, P404, DOI 10.1038/1619; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; Sparks DL, 2004, METH NE FRO NEUROSCI, P303; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; Takahashi M, 2005, J NEUROPHYSIOL, V94, P1707, DOI 10.1152/jn.00347.2005; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; Waitzman DM, 2002, ANN NY ACAD SCI, V956, P111, DOI 10.1111/j.1749-6632.2002.tb02813.x; WAITZMAN DM, 1991, J NEUROPHYSIOL, V66, P1716, DOI 10.1152/jn.1991.66.5.1716; Yoshida K, 2001, J NEUROPHYSIOL, V85, P2639, DOI 10.1152/jn.2001.85.6.2639	45	31	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					491	505		10.1016/j.neuron.2006.03.032	http://dx.doi.org/10.1016/j.neuron.2006.03.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675402	Bronze			2022-12-24	WOS:000237726800017
J	Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ				Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ			Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC-FACTOR; HISTONE ACETYLATION; SOCIAL STRESS; LONG-TERM; RAT HIPPOCAMPUS; GENE-EXPRESSION; MESSENGER-RNA; BRAIN; BDNF; MEMORY	To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; McLean Hosp 202 MRC, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Yan, Shuo/B-8381-2009; Winwood, Peter/A-6363-2008	Kumar, Arvind/0000-0003-2879-3826; Renthal, William/0000-0003-0206-2101				Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoshino M, 2003, J NEUROCHEM, V87, P257, DOI 10.1046/j.1471-4159.2003.01991.x; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Huang YF, 2002, J NEUROSCI, V22, P8422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; Miczek KA, 2004, NEUROSCI BIOBEHAV R, V27, P787, DOI 10.1016/j.neubiorev.2003.11.005; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2003, J NEUROSCI, V23, P10841; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286	50	1296	1369	0	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					519	525		10.1038/nn1659	http://dx.doi.org/10.1038/nn1659			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501568				2022-12-24	WOS:000236310700019
J	Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A				Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A			Serum response factor controls neuronal circuit assembly in the hippocampus	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCIUM INFLUX; MICE LACKING; RHO-GTPASES; EPHRIN-AS; SRF; ACTIVATION; DYNAMICS; FAMILY	Higher organisms rely on multiple modes of memory storage using the hippocampal network, which is built by precisely orchestrated mechanisms of axonal outgrowth, guidance and synaptic targeting. We demonstrate essential roles of the transcription factor serum response factor ( SRF), a sensor of cytoskeletal actin dynamics, in all these processes. Conditional deletion of the mouse Srf gene reduced neurite outgrowth and abolished mossy fiber segregation, resulting in ectopic fiber growth inside the pyramidal layer. SRF-deficient mossy fibers aberrantly targeted CA3 somata for synapse formation. Axon guidance assays showed that SRF was a key mediator of ephrin-A and semaphorin guidance cues; in SRF-deficient neurons, these resulted in the formation of F-actin-microtubule rings rather than complete growth cone collapse. Dominant-negative variants of the SRF cofactor megakaryocytic acute leukemia ( MAL) severely impeded neurite outgrowth and guidance. These data highlight essential links between SRF-mediated transcription and axon guidance and circuit formation in the hippocampus.	Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, D-72076 Tubingen, Germany; Univ Freiburg, Inst Anat & Zellbiol, D-79104 Freiburg, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	Eberhard Karls University of Tubingen; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Nordheim, A (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, Morgenstelle 15, D-72076 Tubingen, Germany.	alfred.nordheim@uni-tuebingen.de		Kretz, Oliver/0000-0003-1152-5956				Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brownlee H, 2000, J COMP NEUROL, V425, P315, DOI 10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen B, 2001, SPECTROSC SPECT ANAL, V21, P263; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Goetze B, 2004, J NEUROBIOL, V60, P517, DOI 10.1002/neu.20073; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; LIPP HP, 1988, J NEUROSCI, V8, P1905; LIPP HP, 1989, EXPERIENTIA, V45, P845, DOI 10.1007/BF01954059; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599	50	128	131	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					195	204		10.1038/nn1627	http://dx.doi.org/10.1038/nn1627			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415869				2022-12-24	WOS:000234990100014
J	Harata, NC; Choi, S; Pyle, JL; Aravanis, AM; Tsien, RW				Harata, NC; Choi, S; Pyle, JL; Aravanis, AM; Tsien, RW			Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; NERVE-TERMINALS; EXOCYTOSIS; MEMBRANE; RELEASE; FUSION; TRANSMISSION; TRANSMITTER; NEURONS	The kinetics of exo-endocytotic recycling could restrict information transfer at central synapses if neurotransmission were entirely reliant on classical full-collapse fusion. Nonclassical fusion retrieval by kiss-and-run would be kinetically advantageous but remains controversial. We used a hydrophilic quencher, bromophenol blue (BPB), to help detect nonclassical events. Upon stimulation, extracellular BPB entered synaptic vesicles and quenched FM1-43 fluorescence, indicating retention of FM dye beyond first fusion. BPB also quenched fluorescence of VAMP (synaptobrevin-2)-EGFP, thus indicating the timing of first fusion of vesicles in the total recycling pool. Comparison with FM dye destaining revealed that kiss-and-run strongly prevailed over full-collapse fusion at low frequency, giving way to a near-even balance at high frequency. Quickening of kiss-and-run vesicle reuse was also observed at higher frequency in the average single vesicle fluorescence response. Kiss-and-run and reuse could enable hippocampal nerve terminals to conserve scarce vesicular resources when responding to widely varying input patterns.	Stanford Univ, Sch Med, Stanford, CA 94305 USA; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Stanford University; Seoul National University (SNU)	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Harata, N. Charles/0000-0003-3287-4549	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64070] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Aravanis AM, 2003, NEUROPHARMACOLOGY, V45, P797, DOI 10.1016/S0028-3908(03)00310-1; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1989, Q J EXP PHYSIOL CMS, V74, P1051, DOI 10.1113/expphysiol.1989.sp003333; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	47	128	133	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					243	256		10.1016/j.neuron.2005.12.018	http://dx.doi.org/10.1016/j.neuron.2005.12.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423698	Bronze			2022-12-24	WOS:000234979900011
J	Arumugam, H; Liu, XH; Colombo, PJ; Corriveau, RA; Belousov, AB				Arumugam, H; Liu, XH; Colombo, PJ; Corriveau, RA; Belousov, AB			NMDA receptors regulate developmental gap junction uncoupling via CREB signaling	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMUS IN-VITRO; RAT-BRAIN; ELECTRICAL SYNAPSES; NERVOUS-SYSTEM; CONNEXIN EXPRESSION; MAMMALIAN BRAIN; VISUAL-CORTEX; MESSENGER-RNA; RETINAL WAVES; SPINAL-CORD	Signaling through gap junctions ( electrical synapses) is important in the development of the mammalian central nervous system. Abundant between neurons during postnatal development, gap junction coupling subsequently decreases and remains low in the adult, confined to specific subsets of neurons. Here we report that developmental uncoupling of gap junctions in the rat hypothalamus in vivo and in vitro is associated with a decrease in connexin 36 (Cx36) protein expression. Both developmental gap junction uncoupling and Cx36 downregulation are prevented by the blockade of NMDA glutamate receptors, action potentials and the calcium - cyclic AMP response element binding protein ( CREB), and are accelerated by CREB overexpression. Developmental gap junction uncoupling and Cx36 downregulation are not affected by blockade of non-NMDA glutamate receptors, and do not occur in hypothalamic neurons from NMDA receptor subunit 1 (NMDAR1) knockout mice. These results demonstrate that NMDA receptor activity contributes to the developmental uncoupling of gap junctions via CREB-dependent downregulation of Cx36.	Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Belousov, AB (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	belousov@tulane.edu		Liu, Xinhuai/0000-0002-4096-6913	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015088] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015088-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aberg ND, 1999, DEV BRAIN RES, V115, P97, DOI 10.1016/S0165-3806(99)00052-8; ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; Bani-Yaghoub M, 1999, DEV GENET, V24, P69, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<69::AID-DVG8>3.0.CO;2-M; Becker DL, 1999, EXP NEUROL, V156, P326, DOI 10.1006/exnr.1999.7027; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Belousov AB, 2002, J NEUROPHYSIOL, V88, P1352, DOI 10.1152/jn.2002.88.3.1352; Belousov AB, 1997, J PHYSIOL-LONDON, V499, P747, DOI 10.1113/jphysiol.1997.sp021966; Belousov AB, 2001, J NEUROSCI, V21, P2015, DOI 10.1523/JNEUROSCI.21-06-02015.2001; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; FACCHINETTI F, 1993, DEV BRAIN RES, V74, P219, DOI 10.1016/0165-3806(93)90007-W; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Greenberg ME, 2001, SYNAPSES, P357; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hatton GI, 1998, CELL BIOL INT, V22, P765, DOI 10.1006/cbir.1998.0386; Kandler K, 1998, DEV NEUROSCI-BASEL, V20, P59, DOI 10.1159/000017299; Kandler K, 1998, J NEUROSCI, V18, P1419; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Mentis GZ, 2002, J PHYSIOL-LONDON, V544, P757, DOI 10.1113/jphysiol.2002.028159; MEYER T, 1991, CELL, V64, P675, DOI 10.1016/0092-8674(91)90496-L; Milner LD, 1999, J NEUROSCI, V19, P3007; Naus CCG, 1998, CELL BIOL INT, V22, P751, DOI 10.1006/cbir.1998.0391; PEINADO A, 1993, CEREB CORTEX, V3, P488, DOI 10.1093/cercor/3.5.488; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Personius K, 2001, CELL COMMUN ADHES, V8, P329, DOI 10.3109/15419060109080748; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Srinivas M, 1999, J NEUROSCI, V19, P9848; Strata F, 1997, J NEUROSCI, V17, P1435; Sugiura N, 2001, J BIOL CHEM, V276, P14257, DOI 10.1074/jbc.M100011200; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; XIA Z, 1996, REGULATORY PROPERTIE, P105	50	77	79	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1720	1726		10.1038/nn1588	http://dx.doi.org/10.1038/nn1588			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299502				2022-12-24	WOS:000233576200021
J	Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW				Brenner, R; Chen, QH; Vilaythong, A; Toney, GM; Noebels, JL; Aldrich, RW			BK channel beta 4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; SPIKE FREQUENCY ADAPTATION; RAT LATERAL AMYGDALA; LARGE-CONDUCTANCE; GRANULE CELLS; PYRAMIDAL CELLS; MOSSY CELLS; NEURONS; INHIBITION	Synaptic inhibition within the hippocampus dentate gyrus serves a 'low-pass filtering' function that protects against hyperexcitability that leads to temporal lobe seizures. Here we demonstrate that calcium-activated potassium (BK) channel accessory beta 4 subunits serve as key regulators of intrinsic firing properties that contribute to the low-pass filtering function of dentate granule cells. Notably, a critical b4 subunit function is to preclude BK channels from contributing to membrane repolarization and thereby broaden action potentials. Longer-duration action potentials secondarily recruit SK channels, leading to greater spike frequency adaptation and reduced firing rates. In contrast, granule cells from beta 4 knockout mice show a gain-of-function for BK channels that sharpens action potentials and supports higher firing rates. Consistent with breakdown of the dentate filter, beta 4 knockouts show distinctive seizures emanating from the temporal cortex, demonstrating a unique nonsynaptic mechanism for gate control of hippocampal synchronization leading to temporal lobe epilepsy.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Howard Hughes Medical Institute; Stanford University	Brenner, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu; raldrich@leland.stanford.edu		Brenner, Robert/0000-0002-1036-8031; Noebels, Jeffrey/0000-0002-2887-0839	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071645] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS29709] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; Blank T, 2004, CNS NEUROL DISORD-DR, V3, P161, DOI 10.2174/1568007043337472; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Coulter DA, 2000, EPILEPSIA, V41, pS96, DOI 10.1111/j.1528-1157.2000.tb01565.x; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Engel J, 1999, BIOPHYS J, V76, P1310, DOI 10.1016/S0006-3495(99)77293-0; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; Greffrath W, 2004, J NEUROENDOCRINOL, V16, P577, DOI 10.1111/j.1365-2826.2004.01204.x; Ha TS, 2004, BIOPHYS J, V86, P2871, DOI 10.1016/S0006-3495(04)74339-8; HEINEMANN U, 1992, EPILEPSY RES, P273; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Juhng KN, 1999, EPILEPSY RES, V34, P177, DOI 10.1016/S0920-1211(98)00111-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Lau D, 2000, J NEUROSCI, V20, P9071; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MODY I, 1992, EPILEPSY RES, P159; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; MOTT DD, 1993, J NEUROPHYSIOL, V69, P674, DOI 10.1152/jn.1993.69.3.674; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2004, TOXICON, V43, P933, DOI 10.1016/j.toxicon.2003.12.009; Strassle BW, 2005, J COMP NEUROL, V484, P144, DOI 10.1002/cne.20443; Swensen AM, 2003, J NEUROSCI, V23, P9650; Teshima K, 2003, NEUROSCIENCE, V120, P65, DOI 10.1016/S0306-4522(03)00270-7; Tian LJ, 1998, J BIOL CHEM, V273, P13531, DOI 10.1074/jbc.273.22.13531; WANG G, 1992, PFLUG ARCH EUR J PHY, V421, P558, DOI 10.1007/BF00375051; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Williamson PD, 1997, EPILEPSY COMPREHENSI, P557; Yen JC, 1999, J BIOMED SCI, V6, P418, DOI 10.1159/000025417	49	277	286	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1752	1759		10.1038/nn1573	http://dx.doi.org/10.1038/nn1573			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261134				2022-12-24	WOS:000233576200025
J	Kamke, MR; Brown, M; Irvine, DRF				Kamke, MR; Brown, M; Irvine, DRF			Basal forebrain cholinergic input is not essential for lesion-induced plasticity in mature auditory cortex	NEURON			English	Article							PARTIAL COCHLEAR LESIONS; CORTICAL PLASTICITY; ADULT CATS; NUCLEUS BASALIS; CORTICOFUGAL MODULATION; TONOTOPIC ORGANIZATION; FREQUENCY ORGANIZATION; SOMATOSENSORY CORTEX; INFERIOR COLLICULUS; SYSTEM	The putative role of the basal forebrain cholinergic system in mediating lesion-induced plasticity in topographic cortical representations was investigated. Cholinergic immunolesions were combined with unilateral restricted cochlear lesions in adult cats, demonstrating the consequence of cholinergic depletion on lesion-induced plasticity in primary auditory cortex (AI). Immunolesions almost eliminated the cholinergic input to AI, while cochlear lesions produced broad high-frequency hearing losses. The results demonstrate that the near elimination of cholinergic input does not disrupt reorganization of the tonotopic representation of the lesioned (contralateral) cochlea in AI and does not affect the normal representation of the unlesioned (ipsilateral) cochlea. It is concluded that cholinergic basal forebrain input to AI is not essential for the occurrence of lesion-induced plasticity in AI.	Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia	Monash University	Kamke, MR (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia.	Marc.Kamke@med.monash.edu.au	Irvine, Dexter R/F-7474-2011; Kamke, Marc/J-4059-2014	Kamke, Marc/0000-0003-0248-9682; Irvine, Dexter/0000-0002-4397-947X				Avendano C, 1996, J CHEM NEUROANAT, V11, P113, DOI 10.1016/0891-0618(96)00132-9; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Berman AL, 1982, THALAMUS BASAL TELEN; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALFORD MB, 1993, NEUROSCIENCE, V55, P953, DOI 10.1016/0306-4522(93)90310-C; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dupont E, 2002, BRAIN RES, V926, P51, DOI 10.1016/S0006-8993(01)03293-0; Edeline JM, 2003, EXP BRAIN RES, V153, P554, DOI 10.1007/s00221-003-1608-0; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas J. H., 2001, MUTABLE BRAIN, P165; KAAS JH, 2000, NEW COGNITIVE NEUROS, P223; Kakigi A, 2000, AUDIOLOGY, V39, P153; Kamke MR, 2005, HEARING RES, V206, P89, DOI 10.1016/j.heares.2004.12.014; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 2000, NEUROSCI RES, V38, P19, DOI 10.1016/S0168-0102(00)00151-6; Mercado E, 2001, NEUROREPORT, V12, P2283, DOI 10.1097/00001756-200107200-00047; Rajan R, 1998, J COMP NEUROL, V399, P35; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; Rajan R, 1996, AUDITORY SYSTEM PLASTICITY AND REGENERATION, P224; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; SCHWABER MK, 1993, AM J OTOL, V14, P252; Snyder RL, 2002, J NEUROPHYSIOL, V87, P434, DOI 10.1152/jn.00937.2000; STICHEL CC, 1987, J COMP NEUROL, V258, P91, DOI 10.1002/cne.902580107; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; TAGO H, 1986, J HISTOCHEM CYTOCHEM, V34, P1431, DOI 10.1177/34.11.2430009; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wiley RG, 1997, ANN NY ACAD SCI, V835, P20, DOI 10.1111/j.1749-6632.1997.tb48615.x; WILLIAMSON BP, 1993, NLGI SPOKESMAN, V57, P329; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Yan J, 2005, EUR J NEUROSCI, V21, P563, DOI 10.1111/j.1460-9568.2005.03878.x	44	33	35	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					675	686		10.1016/j.neuron.2005.09.014	http://dx.doi.org/10.1016/j.neuron.2005.09.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301182	Bronze			2022-12-24	WOS:000233677300019
J	Torii, M; Levitt, P				Torii, M; Levitt, P			Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism	NEURON			English	Article							EMBRYONIC MOUSE-BRAIN; SOMATOSENSORY CORTEX; MUTANT MICE; THALAMIC INNERVATION; GENE-EXPRESSION; CEREBRAL-CORTEX; VISUAL-CORTEX; AREA IDENTITY; LAMINAR FATE; PROJECTIONS	Molecular mechanisms generating the topographic organization of corticothalamic (CT) circuits, which comprise more than three-quarters of the synaptic inputs onto sensory relay neurons, and their interdependence with thalamocortical (TC) axon development are unknown. Using in utero electroporation-mediated gene transfer, we show that EphA7-mediated signaling on neocortical axons controls the within-nucleus topography of CT projections in the thalamus. Notably, CT axons that misexpress EphA7 do not shift the relative positioning of their pathway within the subcortical telencephalon (ST), indicating that they do not depend upon EphA7/ephrin-A signaling in the ST for establishing this topography. Moreover, misexpression of cortical EphA7 results in disrupted topography of CT projections, but unchanged inter- and intra-areal topography of TC projections. Our results support a model in which EphA/ephrin-A signaling controls independently the precision with which CT and TC projections develop, yet is essential for establishing their topographic reciprocity.	Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA.	pat.levitt@vanderbilt.edu			NICHD NIH HHS [P30HD15052] Funding Source: Medline; NIMH NIH HHS [MH45507] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045507, R01MH045507] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams NC, 1997, EUR J NEUROSCI, V9, P204, DOI 10.1111/j.1460-9568.1997.tb01391.x; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Alloway KD, 2003, BRAIN RES, V968, P54, DOI 10.1016/S0006-8993(02)04265-8; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CARVELL GE, 1987, J COMP NEUROL, V265, P409, DOI 10.1002/cne.902650309; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Frassoni C, 1995, DEV BRAIN RES, V90, P111, DOI 10.1016/0165-3806(96)83491-2; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Janis LS, 1999, J NEUROSCI, V19, P4962; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Korematsu K, 1997, DEV DYNAM, V208, P178, DOI 10.1002/(SICI)1097-0177(199702)208:2<178::AID-AJA5>3.0.CO;2-F; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Lozsadi DA, 1996, EUR J NEUROSCI, V8, P2416, DOI 10.1111/j.1460-9568.1996.tb01205.x; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Mui SH, 2002, DEVELOPMENT, V129, P797; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOTHIAS F, 1988, BRAIN RES, V447, P169, DOI 10.1016/0006-8993(88)90980-8; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1999, J NEUROSCI, V19, P10357; Temereanca S, 2004, NEURON, V41, P639, DOI 10.1016/S0896-6273(04)00046-7; Torii MA, 1999, DEVELOPMENT, V126, P443; Uziel D, 2002, J NEUROSCI, V22, P9352; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	62	76	78	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					563	575		10.1016/j.neuron.2005.09.021	http://dx.doi.org/10.1016/j.neuron.2005.09.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301174	Bronze			2022-12-24	WOS:000233677300011
J	Liu, SQJ; Cull-Candy, SG				Liu, SQJ; Cull-Candy, SG			Subunit interaction with PICK and GRIP controls Ca2+ permeability of AMPARs at cerebellar synapses	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR CHANNELS; DOMAIN-CONTAINING PROTEINS; LONG-TERM DEPRESSION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; FOREBRAIN ISCHEMIA; C-TERMINUS; GLUR-B; EXPRESSION; NSF	At many excitatory central synapses, activity produces a lasting change in the synaptic response by modifying postsynaptic AMPA receptors (AMPARs). Although much is known about proteins involved in the trafficking of Ca2+-impermeable (GluR2-containing) AMPARs, little is known about protein partners that regulate subunit trafficking and plasticity of Ca2+-permeable (GluR2-lacking) AMPARs. At cerebellar parallel fiber - stellate cell synapses, activity triggers a novel type of plasticity: Ca2+ influx through GluR2-lacking synaptic AMPARs drives incorporation of GluR2-containing AMPARs, generating rapid, lasting changes in excitatory postsynaptic current properties. Here we examine how glutamate receptor interacting protein ( GRIP, also known as AMPAR binding protein or ABP) and protein interacting with C-kinase-1 ( PICK) regulate subunit trafficking and plasticity. We find that repetitive synaptic activity triggers loss of synaptic GluR2-lacking AMPARs by selectively disrupting their interaction with GRIP and that PICK drives activity-dependent delivery of GluR2-containing receptors. This dynamic regulation of AMPARs provides a feedback mechanism for controlling Ca2+ permeability of synaptic receptors.	UCL, Dept Pharmacol, London WC1E 6BT, England; Penn State Univ, Dept Biol, State Coll, PA 16801 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Liu, SQJ (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	sjl16@psu.edu; s.cull-candy@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1997, J NEUROSCI, V17, P9393; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	50	132	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					768	775		10.1038/nn1468	http://dx.doi.org/10.1038/nn1468			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895086				2022-12-24	WOS:000229345300017
J	Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD				Ramanan, N; Shen, Y; Sarsfield, S; Lemberger, T; Schutz, G; Linden, DJ; Ginty, DD			SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability	NATURE NEUROSCIENCE			English	Article							SERUM RESPONSE FACTOR; NMDA RECEPTOR ACTIVATION; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENES; C-FOS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; CRE RECOMBINASE; NERVOUS-SYSTEM	Synaptic activity-dependent gene expression is critical for certain forms of neuronal plasticity and survival in the mammalian nervous system, yet the mechanisms by which coordinated regulation of activity-induced genes supports neuronal function is unclear. Here, we show that deletion of serum response factor (SRF) in specific neuronal populations in adult mice results in profound deficits in activity-dependent immediate early gene expression, but components of upstream signaling pathways and cyclic AMP - response element binding protein ( CREB)- dependent transactivation remain intact. Moreover, SRF-deficient CA1 pyramidal neurons show attenuation of long-term synaptic potentiation, a model for neuronal information storage. Furthermore, in contrast to the massive neurodegeneration seen in adult mice lacking CREB family members, SRF-deficient adult neurons show normal morphologies and basal excitatory synaptic transmission. These findings indicate that the transcriptional events underlying neuronal survival and plasticity are dissociable and that SRF plays a prominent role in use-dependent modification of synaptic strength in the adult brain.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,Preclin Teaching Bldg Room 1015, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Sarsfield, Sarah/Y-5113-2019; RAMANAN, NARENDRAKUMAR/L-7487-2018; Lemberger, Thomas/A-7301-2008	Lemberger, Thomas/0000-0002-2499-4025				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Balschun D, 2003, J NEUROSCI, V23, P6304; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Gass P, 1998, LEARN MEMORY, V5, P274; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Treisman R, 1990, Semin Cancer Biol, V1, P47; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	46	169	169	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					759	767		10.1038/nn1462	http://dx.doi.org/10.1038/nn1462			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880109				2022-12-24	WOS:000229345300016
J	Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J				Da Silva, JS; Hasegawa, T; Miyagi, T; Dotti, CG; Abad-Rodriguez, J			Asymmetric membrane ganglioside sialidase activity specifies axonal fate	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; CULTURED HIPPOCAMPAL-NEURONS; GM1 GANGLIOSIDE; CELL POLARITY; ACTIN FLOW; RHOA; 3-KINASE; GTPASES; RAC1; CONE	Axon specification triggers the polarization of neurons and requires the localized destabilization of filamentous actin. Here we show that plasma membrane ganglioside sialidase (PMGS) asymmetrically accumulates at the tip of one neurite of the unpolarized rat neuron, inducing actin instability. Suppressing PMGS activity blocks axonal generation, whereas stimulating it accelerates the formation of a single (not several) axon. PMGS induces axon specification by enhancing TrkA activity locally, which triggers phosphatidylinositol-3-kinase (PI3K)- and Rac1-dependent inhibition of RhoA signaling and the consequent actin depolymerization in one neurite only. Thus, spatial restriction of an actin-regulating molecular machinery, in this case a membrane enzymatic activity, before polarization is enough to determine axonal fate.	Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy; Miyagi Prefectural Canc Ctr, Div Biochem, Natori, Miyagi 9811293, Japan; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	University of Turin; Universite Catholique Louvain	Abad-Rodriguez, J (corresponding author), Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy.	carlos.dotti@unito.it; jose.abad@unito.it	Abad-Rodríguez, José/L-8274-2014; Dotti, Carlos G/I-5533-2015; Hasegawa, Takafumi/I-6668-2017	Abad-Rodríguez, José/0000-0002-0350-500X; Dotti, Carlos G/0000-0003-4052-1719; 				Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Banker G., 1991, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Da Silva JS, 2004, MOL CELL NEUROSCI, V27, P1, DOI 10.1016/j.men.2004.03.008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Duchemin AM, 1998, ANN NY ACAD SCI, V845, P406, DOI 10.1111/j.1749-6632.1998.tb09696.x; Hasegawa T, 2000, J BIOL CHEM, V275, P14778; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kalka D, 2001, BIOCHEM BIOPH RES CO, V283, P989, DOI 10.1006/bbrc.2001.4864; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1997, J CELL SCI, V110, P2417; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; RABIN SJ, 1995, J NEUROCHEM, V65, P347; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P371; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	183	187	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					606	615		10.1038/nn1442	http://dx.doi.org/10.1038/nn1442			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834419				2022-12-24	WOS:000228895100021
J	Hubbard, EM; Arman, AC; Ramachandran, VS; Boynton, GM				Hubbard, EM; Arman, AC; Ramachandran, VS; Boynton, GM			Individual differences among grapheme-color synesthetes: Brain-behavior correlations	NEURON			English	Article							PERCEPTION; SYNAESTHESIA; FORM; NUMBER; CORTEX; SPECIALIZATION; RETINOTOPY; ACTIVATION; SIMILARITY; RESOLUTION	Grapheme-color synesthetes experience specific colors associated with specific number or letter characters. To determine the neural locus of this condition, we compared behavioral and fMR1 responses in six grapheme-color synesthetes to control subjects. In our behavioral experiments, we found that a subject's synesthetic experience can aid in texture segregation (experiment 1) and reduce the effects of crowding (experiment 2). For synesthetes, graphemes produced larger fMR1 responses in color-selective area human V4 than for control subjects (experiment 3). Importantly, we found a correlation within subjects between the behavioral and fMR1 results; subjects with better performance on the behavioral experiments showed larger fMR1 responses in early retinotopic visual areas (V1, V2, V3, and hV4). These results suggest that grapheme-color synesthesia is the result of crossactivation between grapheme-selective and colorselective brain areas. The correlation between the behavioral and fMR1 results suggests that graphemecolor synesthetes may constitute a heterogeneous group.	Salk Inst Biol Studies, Syst Neurobiol Lab B, La Jolla, CA 92037 USA; Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Hubbard, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab B, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edhubbard@gmail.com	Hubbard, Edward/N-2931-2019; Hubbard, Edward/C-1770-2012	Hubbard, Edward/0000-0002-2701-415X; 	NATIONAL EYE INSTITUTE [R01EY012925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH063585, R01MH060474] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12925] Funding Source: Medline; NIMH NIH HHS [R01 MH 60474, F31 MH63585, F31 MH063585] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aleman A, 2001, NEUROREPORT, V12, P2827, DOI 10.1097/00001756-200109170-00015; Armel KC, 1999, NEUROCASE, V5, P293, DOI 10.1093/neucas/5.4.293; Baron-Cohen S., 1997, SYNAESTHESIA CLASSIC; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; Barrett NA, 2001, HUM BRAIN MAPP, V13, P213, DOI 10.1002/hbm.1034.abs; BECK J, 1966, PERCEPT PSYCHOPHYS, V1, P300, DOI 10.3758/BF03215792; Blake R., 2005, SYNESTHESIA PERSPECT, P47; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BOYNTON RM, 1968, SCIENCE, V161, P366, DOI 10.1126/science.161.3839.366; BOYNTON RM, 1988, ANNU REV PSYCHOL, V39, P69, DOI 10.1146/annurev.ps.39.020188.000441; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; CHURCHLAND PS, 2002, BRAIN WISIE STUDIES; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crick F., 1994, ASTONISHING HYPOTHES; Cytowic R. E., 2002, SYNAESTHESIA UNION S; DAY S, 2005, SYNESTHESIA PERSPECT, P11; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Galton F., 1983, INQUIRY HUMAN FACULT; Gray JA, 2002, J CONSCIOUSNESS STUD, V9, P5; GRAY JA, 1997, POSSIBLE IMPLICATION, P173; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Hubbard EM, 2003, J CONSCIOUSNESS STUD, V10, P77; HUBBARD EM, 2005, IN PRESS CORTEX; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; KENNEDY H, 1997, SYNAESTHESIA CLASSIC, P243; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Laeng B, 2004, PSYCHOL SCI, V15, P277, DOI 10.1111/j.0956-7976.2004.00666.x; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rich AN, 2002, NAT REV NEUROSCI, V3, P43, DOI 10.1038/nrn702; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Robertson LC, 2005, SYNESTHESIA PERSPECT; Rodman HR, 1997, CEREBR CORT, V12, P639; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SAGIV N, 2003, J COGNITIVE NEUROS S, V15, P153; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; SMILEK D, 2002, PSYCHE, V8, P475; SMILEK D, 2005, SYNESTHESIA PERSPECT, P74; Treisman A., 2005, SYNESTHESIA PERSPECT, P239; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wagar BM, 2002, BRAIN COGNITION, V48, P606, DOI 10.1006/brcg.2001.1426; Weiss PH, 2001, CORTEX, V37, P750, DOI 10.1016/S0010-9452(08)70631-2; WOLFE JM, 1992, VISION RES, V32, P757, DOI 10.1016/0042-6989(92)90190-T; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669	72	242	245	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					975	985		10.1016/j.neuron.2005.02.008	http://dx.doi.org/10.1016/j.neuron.2005.02.008			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911UO	15797557	Bronze			2022-12-24	WOS:000228031300017
J	Bagley, EE; Gerke, MB; Vaughan, CW; Hack, SP; Christie, MJ				Bagley, EE; Gerke, MB; Vaughan, CW; Hack, SP; Christie, MJ			GABA transporter currents activated by protein kinase a excite midbrain neurons during opioid withdrawal	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; PERIAQUEDUCTAL GRAY NEURONS; ROSTRAL VENTROMEDIAL MEDULLA; LOCUS-COERULEUS NEURONS; IN-VITRO; OPIATE WITHDRAWAL; ADENYLYL-CYCLASE; GLUTAMATE TRANSPORTERS; POTASSIUM CONDUCTANCE; MORPHINE-WITHDRAWAL	Adaptations in neurons of the midbrain periaqueductal gray (PAG) induced by chronic morphine treatment mediate expression of many signs of opioid withdrawal. The abnormally elevated action potential rate of opioid-sensitive PAG neurons is a likely cellular mechanism for withdrawal expression. We report here that opioid withdrawal in vitro induced an opioid-sensitive cation current that was mediated by the GABA transporter-1 (GAT-1) and required activation of protein kinase A (PKA) for its expression. Inhibition of GAT-1 or PKA also prevented withdrawal-induced hyperexcitation of PAG neurons. Our findings indicate that GAT-1 currents can directly increase the action potential rates of neurons and that GAT-1 may be a target for therapy to alleviate opioid-withdrawal symptoms.	Univ Sydney, Pain Management Res Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney	Bagley, EE (corresponding author), Univ Sydney, Pain Management Res Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia.	bagleye@med.usyd.edu.au	Christie, MacDonald J/F-4724-2013	Christie, MacDonald J/0000-0002-0622-609X; Vaughan, Christopher/0000-0003-4314-7689; Bagley, Elena/0000-0002-3167-0707	NIDA NIH HHS [DA 12926-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012926] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; BARABAN SC, 1995, BRAIN RES, V676, P245, DOI 10.1016/0006-8993(95)00097-A; Barakat L, 2002, J NEUROPHYSIOL, V88, P1407, DOI 10.1152/jn.2002.88.3.1407; Barbaresi P, 2001, J COMP NEUROL, V429, P337, DOI 10.1002/1096-9861(20000108)429:2<337::AID-CNE12>3.0.CO;2-Z; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; Bellchambers CE, 1998, NEUROSCIENCE, V83, P517, DOI 10.1016/S0306-4522(97)00399-0; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; CAMMACK JN, 1993, J PHYSIOL-LONDON, V472, P81, DOI 10.1113/jphysiol.1993.sp019938; Chieng B, 1996, J NEUROSCI, V16, P7128; CHIENG B, 1994, BRIT J PHARMACOL, V113, P121, DOI 10.1111/j.1476-5381.1994.tb16183.x; COLLIER HOJ, 1974, NATURE, V248, P24, DOI 10.1038/248024a0; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; FEDYNYSHYN JP, 1989, FEBS LETT, V253, P23, DOI 10.1016/0014-5793(89)80921-4; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hack SP, 2003, NEUROPHARMACOLOGY, V45, P575, DOI 10.1016/S0028-3908(03)00205-3; Haghparast A, 1998, BRAIN RES, V814, P71, DOI 10.1016/S0006-8993(98)01029-4; Himmelsbach CK, 1943, FED PROC, V2, P201; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; INGRAM SL, 1994, NEURON, V13, P179, DOI 10.1016/0896-6273(94)90468-5; Ingram SL, 1998, J NEUROSCI, V18, P10269; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ivanov A, 2001, J NEUROPHYSIOL, V85, P2388, DOI 10.1152/jn.2001.85.6.2388; Kalyuzhny AE, 1998, J COMP NEUROL, V392, P528; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MALCHOW RP, 1990, P NATL ACAD SCI USA, V87, P8945, DOI 10.1073/pnas.87.22.8945; MALDONADO R, 1995, N-S ARCH PHARMACOL, V352, P565; Mao JR, 2002, J NEUROSCI, V22, P8312; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; NORTH RA, 1985, J PHYSIOL-LONDON, V364, P265, DOI 10.1113/jphysiol.1985.sp015743; Osborne PB, 1996, J PHYSIOL-LONDON, V490, P383, DOI 10.1113/jphysiol.1996.sp021152; Ozawa T, 2001, BRAIN RES, V905, P254, DOI 10.1016/S0006-8993(01)02536-7; Punch LJ, 1997, J NEUROSCI, V17, P8520; Quick MW, 2002, P NATL ACAD SCI USA, V99, P5686, DOI 10.1073/pnas.082712899; Risso S, 1996, J PHYSIOL-LONDON, V490, P691, DOI 10.1113/jphysiol.1996.sp021178; Schoffelmeer ANM, 2000, J NEUROSCI, V20, P3496, DOI 10.1523/JNEUROSCI.20-09-03496.2000; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; STINUS L, 1990, NEUROSCIENCE, V37, P767, DOI 10.1016/0306-4522(90)90106-E; SUZDAK PD, 1992, EUR J PHARMACOL, V224, P189, DOI 10.1016/0014-2999(92)90804-D; Svoboda KR, 1998, J NEUROSCI, V18, P7084; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; VAUGHAN CW, 2003, BRIT J PHARMACOL, V139, P392; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299	54	60	60	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 3	2005	45	3					433	445		10.1016/j.neuron.2004.12.049	http://dx.doi.org/10.1016/j.neuron.2004.12.049			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694329	Bronze			2022-12-24	WOS:000226787700015
J	Shao, ZH; Browning, JL; Lee, XH; Scott, ML; Shulga-Morskaya, S; Allaire, N; Thill, G; Levesque, M; Sah, D; McCoy, JM; Murray, B; Jung, V; Pepinsky, RB; Mi, S				Shao, ZH; Browning, JL; Lee, XH; Scott, ML; Shulga-Morskaya, S; Allaire, N; Thill, G; Levesque, M; Sah, D; McCoy, JM; Murray, B; Jung, V; Pepinsky, RB; Mi, S			TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration	NEURON			English	Article							CELL-DEATH; SUPERFAMILY; TNFRSF19; EDAR; MICE; CNS	Myelin-associated inhibitory factors (MAIFs) are inhibitors of CNS axonal regeneration following injury. The Nogo receptor complex, composed of the Nogo66 receptor 1 (NgR1), neurotrophin p75 receptor (p75), and LINGO-1, represses axon regeneration upon binding to these myelin components. The limited expression of p75 to certain types of neurons and its temporal expression during development prompted speculation that other receptors are involved in the NgR1 complex. Here, we show that an orphan receptor in the TNF family called TAJ, broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors. In vitro exogenously added TAJ reversed neurite outgrowth caused by MAIFs. Neurons from Taj-deficient mice were more resistant to the suppressive action of the myelin inhibitors. Given the limited expression of p75, the discovery of TAJ function is an important step for understanding the regulation of axonal regeneration.	Biogen Inc, Dept Discovery Biol, Cambridge, MA 02142 USA	Biogen	Mi, S (corresponding author), Biogen Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com		Browning, Jeffrey/0000-0001-9168-5233				BROWNING JL, 1995, J IMMUNOL, V154, P33; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; Copray S, 2004, J NEUROIMMUNOL, V148, P41, DOI 10.1016/j.jneuroim.2003.11.008; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Hisaoka T, 2003, DEV BRAIN RES, V143, P105, DOI 10.1016/S0165-3806(03)00101-9; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994	19	319	355	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					353	359		10.1016/j.neuron.2004.12.050	http://dx.doi.org/10.1016/j.neuron.2004.12.050			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694322	Bronze			2022-12-24	WOS:000226787700008
J	Wang, HG; Lu, FM; Jin, L; Udo, H; Kandel, ER; de Vente, J; Walter, U; Lohmann, SM; Hawkins, RD; Antonova, I				Wang, HG; Lu, FM; Jin, L; Udo, H; Kandel, ER; de Vente, J; Walter, U; Lohmann, SM; Hawkins, RD; Antonova, I			Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; ELEMENT-DEPENDENT TRANSCRIPTION; LATE-PHASE LTP; TERM POTENTIATION; GUANYLYL CYCLASE; DENDRITIC SPINE; NMDA RECEPTOR; SMOOTH-MUSCLE; CGMP; KINASE	Recent results suggest that long-lasting potentiation at hippocampal synapses involves the rapid formation of clusters or puncta of presynaptic as well as postsynaptic proteins, both of which are blocked by antagonists of NMDA receptors and an inhibitor of actin polymerization. We have investigated whether the increase in puncta involves retrograde signaling through the NO-cGMP-cGK pathway and also examined the possible roles of two classes of molecules that regulate the actin cytoskeleton: Ena/VASP proteins and Rho GTPases. Our results suggest that NO, cGMP, cGK, actin, and Rho GTPases including RhoA play important roles in the potentiation and act directly in both the presynaptic and postsynaptic neurons, where they contribute to the increase in puncta of synaptic proteins. cGK phosphorylates synaptic VASP during the potentiation, whereas Rho GTPases act both in parallel and upstream of cGMP, in part by maintaining the synaptic localization of soluble guanylyl cyclase.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; Kavli Inst Brain Sci, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Limburg, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Hasselt University; Maastricht University; University of Wurzburg	Hawkins, RD (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	rdh1@columbia.edu	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50733] Funding Source: Medline; NINDS NIH HHS [NS45108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Blackshaw S, 2003, NEUROSCIENCE, V119, P979, DOI 10.1016/S0306-4522(03)00217-3; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Burette A, 2002, J NEUROSCI, V22, P8961; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; DEVENTE J, 1988, BRAIN RES, V446, P387, DOI 10.1016/0006-8993(88)90900-6; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; Hawkins RD, 1996, NEURON, V16, P465, DOI 10.1016/S0896-6273(00)80064-1; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hindley S, 1997, J NEUROSCI RES, V47, P427; Kim CH, 1999, J NEUROSCI, V19, P4314; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kleppisch T, 1999, J NEUROSCI, V19, P48, DOI 10.1523/JNEUROSCI.19-01-00048.1999; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Leamey CA, 2001, J NEUROSCI, V21, P3871, DOI 10.1523/JNEUROSCI.21-11-03871.2001; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lu YF, 2002, J NEUROPHYSIOL, V88, P1270, DOI 10.1152/jn.2002.88.3.1270; Lu YF, 1999, J NEUROSCI, V19, P10250; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; MONTFORT P, 2002, J NEUROSCI, V22, P10116; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; POPOV S, 1992, J NEUROSCI, V12, P77; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schmidt H, 2002, J CELL BIOL, V159, P489, DOI 10.1083/jcb.200207058; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Son H, 1998, LEARN MEMORY, V5, P231; Stanton PK, 2003, J NEUROSCI, V23, P5936; Tanaka J, 1997, GLIA, V19, P286; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WENDLAND B, 1994, P NATL ACAD SCI USA, V91, P2151, DOI 10.1073/pnas.91.6.2151; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	80	167	172	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					389	403		10.1016/j.neuron.2005.01.011	http://dx.doi.org/10.1016/j.neuron.2005.01.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694326	Bronze			2022-12-24	WOS:000226787700012
J	Abraham, NM; Spors, H; Carleton, A; Margrie, TW; Kuner, T; Schaefer, AT				Abraham, NM; Spors, H; Carleton, A; Margrie, TW; Kuner, T; Schaefer, AT			Maintaining accuracy at the expense of speed: Stimulus similarity defines odor discrimination time in mice	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; LATERAL INHIBITION; GLOMERULAR LAYER; REPRESENTATIONS; RAT; DYNAMICS; NEURONS; SYSTEM; ORGANIZATION; INCREASES	Odor discrimination times and their dependence on stimulus similarity were evaluated to test temporal and spatial models of odor representation in mice. In a go/ no-go operant conditioning paradigm, discrimination accuracy and time were determined for simple monomolecular odors and binary mixtures of odors. Mice discriminated simple odors with an accuracy exceeding 95%. Binary mixtures evoking highly overlapping spatiotemporal patterns of activity in the olfactory bulb were discriminated equally well. However, while discriminating simple odors in less than 200 ms, mice required 70-100 ms more time to discriminate highly similar binary mixtures. We conclude that odor discrimination in mice is fast and stimulus dependent. Thus, the underlying neuronal mechanisms act on a fast timescale, requiring only a brief epoch of odor-specific spatiotemporal representations to achieve rapid discrimination of dissimilar odors. The fine discrimination of highly similar stimuli, however, requires temporal integration of activity, suggesting a tradeoff between accuracy and speed.	Heidelberger Akad Wissensch, WIN Grp Olfact Dynam, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Schaefer, AT (corresponding author), Heidelberger Akad Wissensch, WIN Grp Olfact Dynam, Jahnstr 29, D-69120 Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de	Abraham, Nixon/R-8381-2016; Carleton, Alan/C-9721-2010	Abraham, Nixon/0000-0001-8523-716X; Carleton, Alan/0000-0001-5633-9159; Schaefer, Andreas/0000-0002-4677-8788; Spors, Hartwig/0000-0003-3153-9001				ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; BEIDLER LM, 1953, J NEUROPHYSIOL, V16, P595, DOI 10.1152/jn.1953.16.6.595; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FREEMAN WJ, 1981, PERSPECT BIOL MED, V24, P561; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HALPERN BP, 1971, SCIENCE, V171, P1256, DOI 10.1126/science.171.3977.1256; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1996, J NEUROSCI, V16, P3837; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Linster C, 2002, J NEUROSCI, V22, P6842; Luce R. D., 1986, RESPONSE TIMES; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Meister M, 2001, J NEUROSCI, V21, P1351; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Rabinovich M., 2001, PHYS REV LETT, V87; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROSPARS JP, 1994, NETWORK-COMP NEURAL, V5, P121, DOI 10.1088/0954-898X/5/2/001; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Slotnick B.M., 1990, COMP PERCEPT, V1, P155; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; TAYLOR DA, 1976, PSYCHOL BULL, V83, P161, DOI 10.1037/0033-2909.83.2.161; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VONHELMHOLTZ H, 1850, MITTH PHYS GESELLSCH, P1; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	52	276	277	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					865	876		10.1016/j.neuron.2004.11.017	http://dx.doi.org/10.1016/j.neuron.2004.11.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572116	Bronze			2022-12-24	WOS:000225548400013
J	Zhou, Q; Homma, KJ; Poo, MM				Zhou, Q; Homma, KJ; Poo, MM			Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses	NEURON			English	Article							AREA CA1; RAT HIPPOCAMPUS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; MOLECULAR LAYER; KNOCKOUT MICE; POTENTIATION; DENSITY; CORTEX	Activity-induced modification of neuronal connections is essential for the development of the nervous system and may also underlie learning and memory functions of mature brain. Previous studies have shown an increase in dendritic spine density and/or enlargement of spines after the induction of long-term potentiation (LTP). Using two-photon time-lapse imaging of dendritic spines in acute hippocampal slices from neonatal rats, we found that the induction of long-term depression (LTD) by low-frequency stimulation is accompanied by a marked shrinkage of spines, which can be reversed by subsequent high-frequency stimulation that induces LTP. The spine shrinkage requires activation of NMDA receptors and calcineurin, similar to that for LTD. However, spine shrinkage is mediated by cofilin, but not by protein phosphatase 1 (PP1), which is essential for LTD, suggesting that different downstream pathways are involved in spine shrinkage and LTD. This activity-induced spine shrinkage may contribute to activity-dependent elimination of synaptic connections.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Will Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Will Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999, R01NS037831] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37831, NS36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Dailey ME, 1996, J NEUROSCI, V16, P2983; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; DESMOND NL, 1986, J COMP NEUROL, V253, P476, DOI 10.1002/cne.902530405; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Jacobs B, 1997, J COMP NEUROL, V386, P661; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Malley A, 2000, NEUROSCIENCE, V99, P229, DOI 10.1016/S0306-4522(00)00182-2; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sorra KE, 1998, J NEUROSCI, V18, P658; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; UEMURA E, 1980, EXP NEUROL, V69, P164, DOI 10.1016/0014-4886(80)90151-X; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITE EL, 1997, MOTOR RES, V14, P34; WISE SP, 1979, NEUROSCIENCE, V4, P1275, DOI 10.1016/0306-4522(79)90157-X; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	53	750	771	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					749	757		10.1016/j.neuron.2004.11.011	http://dx.doi.org/10.1016/j.neuron.2004.11.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572107	Bronze			2022-12-24	WOS:000225548400004
J	Zimprich, A; Biskup, S; Leitner, P; Lichtner, P; Farrer, M; Lincoln, S; Kachergus, J; Hulihan, M; Uitti, RJ; Calne, DB; Stoessl, AJ; Pfeiffer, RF; Patenge, N; Carbajal, IC; Vieregge, P; Asmus, F; Muller-Myhsok, B; Dickson, DW; Meitinger, T; Strom, TM; Wszolek, ZK; Gasser, T				Zimprich, A; Biskup, S; Leitner, P; Lichtner, P; Farrer, M; Lincoln, S; Kachergus, J; Hulihan, M; Uitti, RJ; Calne, DB; Stoessl, AJ; Pfeiffer, RF; Patenge, N; Carbajal, IC; Vieregge, P; Asmus, F; Muller-Myhsok, B; Dickson, DW; Meitinger, T; Strom, TM; Wszolek, ZK; Gasser, T			Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology	NEURON			English	Article							ALPHA-SYNUCLEIN; TAU-SYNUCLEIN; DISEASE; LOCUS; GENE; PROTEIN; DEGENERATION; LINKAGE; REPEAT; MAPS	We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.	GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38103 USA; Klinikum Lemgo, Dept Neurol, D-32657 Lemgo, Germany; Max Planck Inst Psychiat, Computat Genet Grp, D-80804 Munich, Germany; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Medical University of Vienna; Mayo Clinic; Mayo Clinic; University of British Columbia; University of Tennessee System; University of Tennessee Health Science Center; Max Planck Society; Technical University of Munich	Meitinger, T (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany.	meitinger@gsf.de; wszolek.zbigniew@mayo.edu; thomas.gasser@med.uni-tuebingen.de	Wszolek, Zbigniew K./AAB-1431-2019; Gasser, Thomas/GNH-5293-2022; Zimprich, Alexander/A-5232-2017; Stoessl, A Jon/J-9661-2015; Carballo-Carbajal, Iria/F-5312-2016; Müller-Myhsok, Bertram/A-3289-2013; Meitinger, Thomas/O-1318-2015	Gasser, Thomas/0000-0002-1069-1146; Zimprich, Alexander/0000-0002-1668-5177; Stoessl, A Jon/0000-0002-9778-7246; Carballo-Carbajal, Iria/0000-0002-4403-8006; Dickson, Dennis W/0000-0001-7189-7917; Meitinger, Thomas/0000-0002-8838-8403; Farrer, Matthew/0000-0003-1159-5321	NINDS NIH HHS [P50-NS40256-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvanitakis Z, 2001, CURR OPIN NEUROL, V14, P491, DOI 10.1097/00019052-200108000-00010; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Dickson DW, 1999, J NEUROL, V246, P6; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GHETTI B, 2003, NEURODEGENERATION MO, P86; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	31	2108	2177	2	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					601	607		10.1016/j.neuron.2004.11.005	http://dx.doi.org/10.1016/j.neuron.2004.11.005			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541309	Bronze			2022-12-24	WOS:000225338100007
J	Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K				Yasuda, R; Harvey, CD; Zhong, HN; Sobczyk, A; van Aelst, L; Svoboda, K			Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNELS; BINDING DOMAIN; ACTION-POTENTIALS; GROWTH-FACTOR; PROTEIN; FRET; LOCALIZATION; DEPENDENCE; EXCHANGE; VARIANT	To understand the biochemical signals regulated by neural activity, it is necessary to measure protein-protein interactions and enzymatic activity in neuronal microcompartments such as axons, dendrites and their spines. We combined two-photon excitation laser scanning with fluorescence lifetime imaging to measure fluorescence resonance energy transfer at high resolutions in brain slices. We also developed sensitive fluorescent protein-based sensors for the activation of the small GTPase protein Ras with slow ( FRas) and fast ( FRas-F) kinetics. Using FRas-F, we found in CA1 hippocampal neurons that trains of back-propagating action potentials rapidly and reversibly activated Ras in dendrites and spines. The relationship between firing rate and Ras activation was highly nonlinear ( Hill coefficient similar to 5). This steep dependence was caused by a highly cooperative interaction between calcium ions ( Ca2+) and Ras activators. The Ras pathway therefore functions as a supersensitive threshold detector for neural activity and Ca2+ concentration.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Zhong, Haining/0000-0002-7109-4724; Yasuda, Ryohei/0000-0001-6263-9297				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Davis AJ, 1996, J BIOL CHEM, V271, P24333, DOI 10.1074/jbc.271.40.24333; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MCALLISTER AK, 2000, SCI STKE, pPL1; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PISTON DW, 1992, TIME RESOLVED LASER, V3, P379; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SHANER NC, 2004, NAT BIOTECHNOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	196	202	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					283	291		10.1038/nn1635	http://dx.doi.org/10.1038/nn1635			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16429133				2022-12-24	WOS:000234990100025
J	Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX				Aragona, BJ; Liu, Y; Yu, YJ; Curtis, JT; Detwiler, JM; Insel, TR; Wang, ZX			Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds	NATURE NEUROSCIENCE			English	Article							FEMALE PRAIRIE VOLES; COCAINE-SEEKING BEHAVIOR; MICROTUS-OCHROGASTER; PARTNER PREFERENCES; SOCIAL-ORGANIZATION; MOLECULAR-MECHANISMS; DRUG-ADDICTION; D-2 RECEPTORS; MALE-RATS; VASOPRESSIN	The involvement of dopamine within the nucleus accumbens in the formation and maintenance of pair bonds was assessed in a series of experiments using the monogamous prairie vole. We show that dopamine transmission that promotes pair bond formation occurs within the rostral shell of the nucleus accumbens, but not in its core or caudal shell. Within this specific brain region, D1- and D2-like receptor activation produced opposite effects: D1-like activation prevented pair bond formation, whereas D2-like activation facilitated it. After extended cohabitation with a female, male voles showed behavior indicative of pair bond maintenance-namely, selective aggression towards unfamiliar females. These voles also showed a significant upregulation in nucleus accumbens D1- like receptors, and blockade of these receptors abolished selective aggression. Thus, neuroplastic reorganization of the nucleus accumbens dopamine system is responsible for the enduring nature of monogamous pair bonding. Finally, we show that this system may also contribute to species-specific social organization.	Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; NIMH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Aragona, BJ (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	aragona@unc.edu	Curtis, J. Thomas/J-4193-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD040722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066734, F31MH067396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019627] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-40722] Funding Source: Medline; NIDA NIH HHS [DA-19627] Funding Source: Medline; NIMH NIH HHS [MH-67396, MH-58616, MH-66734] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; DEWSBURY DA, 1988, NEBR SYM MOTIV, V35, P1; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Eyny YS, 2003, J NEUROSCI, V23, P1584; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 1997, J NEUROSCI, V17, P8580; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2002, J NEUROSCI, V22, P3306; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Panksepp J, 2002, ADDICTION, V97, P459, DOI 10.1046/j.1360-0443.2002.00025.x; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pizzuto T, 1998, BEHAV PROCESS, V43, P79, DOI 10.1016/S0376-6357(97)00091-0; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schuiling GA, 2003, J PSYCHOSOM OBST GYN, V24, P55, DOI 10.3109/01674820309042802; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Wang ZX, 1997, J COMP NEUROL, V378, P535; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	50	323	333	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					133	139		10.1038/nn1613	http://dx.doi.org/10.1038/nn1613			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327783				2022-12-24	WOS:000234288000027
J	Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M				Hofer, SB; Mrsic-Flogel, TD; Bonhoeffer, T; Hubener, M			Prior experience enhances plasticity in adult visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; DEPENDENT PLASTICITY; AUDITORY-SYSTEM; MOUSE; RECOVERY; CATS; ADAPTATION; RESPONSES	The brain has a remarkable capacity to adapt to alterations in its sensory environment, which is normally much more pronounced in juvenile animals. Here we show that in adult mice, the ability to adapt to changes can be improved profoundly if the mouse has already experienced a similar change in its sensory environment earlier in life. Using the standard model for sensory plasticity in mouse visual cortex-ocular dominance (OD) plasticity-we found that a transient shift in OD, induced by monocular deprivation (MD) earlier in life, renders the adult visual cortex highly susceptible to subsequent MD many weeks later. Irrespective of whether the first MD was experienced during the critical period (around postnatal day 28) or in adulthood, OD shifts induced by a second MD were faster, more persistent and specific to repeated deprivation of the same eye. The capacity for plasticity in the mammalian cortex can therefore be conditioned by past experience.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X				Antonini A, 1999, J NEUROSCI, V19, P4388; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MCGONIGLE BO, 1978, NATURE, V272, P364, DOI 10.1038/272364a0; MITCHELL DE, 1977, J COMP NEUROL, V176, P53, DOI 10.1002/cne.901760104; MUIR DW, 1973, SCIENCE, V180, P420, DOI 10.1126/science.180.4084.420; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yang YP, 2005, NAT NEUROSCI, V8, P791, DOI 10.1038/nn1464	32	167	171	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					127	132		10.1038/nn1610	http://dx.doi.org/10.1038/nn1610			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327785				2022-12-24	WOS:000234288000026
J	Egner, T; Hirsch, J				Egner, T; Hirsch, J			Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN VISUAL-CORTEX; SELECTIVE ATTENTION; NEURAL MECHANISMS; SIMON TASK; AREAS; FMRI; INTEGRATION; PERCEPTION; MODULATION	A prominent model of how the brain regulates attention proposes that the anterior cingulate cortex monitors the occurrence of conflict between incompatible response tendencies and signals this information to a cognitive control system in dorsolateral prefrontal cortex. Cognitive control is thought to resolve conflict through the attentional biasing of perceptual processing, emphasizing task-relevant stimulus information. It is not known, however, whether conflict resolution is mediated by amplifying neural representations of task-relevant information, inhibiting representations of task-irrelevant information, or both. Here we manipulated trial-by-trial levels of conflict and control during a Stroop task using face stimuli, while recording hemodynamic responses from human visual cortex specialized for face processing. We show that, in response to high conflict, cognitive control mechanisms enhance performance by transiently amplifying cortical responses to task-relevant information rather than by inhibiting responses to task-irrelevant information. These results implicate attentional target-feature amplification as the primary mechanism for conflict resolution through cognitive control.	Columbia Univ, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA	Columbia University	Egner, T (corresponding author), Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Box 108,710 W 168th St, New York, NY 10032 USA.	te2111@columbia.edu	Egner, Tobias/A-5237-2009; Egner, Tobias/AAD-5864-2022	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cho IH, 2002, WA SCI TECHNOL, V2, P299, DOI 10.2166/ws.2002.0035; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ., 2004, HUMAN BRAIN FUNCTION, P971, DOI DOI 10.1016/B978-012264841-0/50050-0; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NIEUWENHUIS S, IN PRESS MEM COGNIT; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; SUMMERFIELD C, 2005, CEREB CORTEX    0713; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003	44	773	784	3	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1784	1790		10.1038/nn1594	http://dx.doi.org/10.1038/nn1594			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	988FC	16286928				2022-12-24	WOS:000233576200029
J	Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL				Tavazoie, SF; Alvarez, VA; Ridenour, DA; Kwiatkowski, DJ; Sabatini, BL			Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM DEPRESSION; DENDRITIC SPINE MORPHOGENESIS; LHERMITTE-DUCLOS-DISEASE; CELL-GROWTH; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; PRODUCT TUBERIN; ACTIN DYNAMICS; KNOCKOUT MICE	Mutations in the TSC1 or TSC2 tumor suppressor genes lead to tuberous sclerosis complex (TSC), a dominant hamartomatous disorder that often presents with mental retardation, epilepsy and autism. The etiology of these neurological symptoms is unclear and the function of the TSC pathway in neurons is unknown. We found that in post-mitotic, hippocampal pyramidal neurons of mice and rats, loss of Tsc1 or Tsc2 triggered enlargement of somas and dendritic spines and altered the properties of glutamatergic synapses. Furthermore, loss of a single copy of the Tsc1 gene was sufficient to perturb dendritic spine structure. Morphological changes required regulation of the actin-depolymerization factor cofilin at a conserved LIM-kinase phosphorylation site, the phosphorylation of which was increased by loss of Tsc2. Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675	NINDS NIH HHS [5T32 NS07484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; CARTER AG, 2004, NEURON; Chang HI, 1996, BIOCHEM BIOPH RES CO, V223, P324, DOI 10.1006/bbrc.1996.0893; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hengstschlager M, 2003, BIOCHEM BIOPH RES CO, V312, P676, DOI 10.1016/j.bbrc.2003.10.170; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramesh V, 2003, BIOCHEM SOC T, V31, P579, DOI 10.1042/bst0310579; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SHEPHERD CW, 1995, AM J NEURORADIOL, V16, P149; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	363	376	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1727	1734		10.1038/nn1566	http://dx.doi.org/10.1038/nn1566			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286931				2022-12-24	WOS:000233576200022
J	Porter, J; Anand, T; Johnson, B; Khan, RM; Sobel, N				Porter, J; Anand, T; Johnson, B; Khan, RM; Sobel, N			Brain mechanisms for extracting spatial information from smell	NEURON			English	Article							HUMAN OLFACTORY CORTEX; FALSE DISCOVERY RATE; TRIGEMINAL NERVE; ODORS; ACTIVATION; FMRI; NOSTRIL; RAT; DISCRIMINATION; LOCALIZATION	Forty years ago, von Bekesy demonstrated that the spatial source of an odorant is determined by comparing input across nostrils, but it is unknown how this comparison is effected in the brain. To address this, we delivered odorants to the left or right of the nose, and contrasted olfactory left versus right localization with olfactory identification during brain imaging. We found nostril-specific responses in primary olfactory cortex that were predictive of the accuracy of left versus right localization, thus providing a neural substrate for the behavior described by von Bdkdsy. Additionally, left versus right localization preferentially engaged a portion of the superior temporal gyrus previously implicated in visual and auditory localization, suggesting that localization information extracted from smell was then processed in a convergent brain system for spatial representation of multisensory inputs.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Porter, J (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	jessiep@calmail.berkeley.edu; nsobel@socrates.berkeley.edu		Sobel, Noam/0000-0002-3232-9391	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006915] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006915-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACKERMAN D, 1990, NATURAL HIST SENSESS; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bensafi M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P259; BOJSENMOLLER F, 1975, J COMP NEUROL, V159, P245, DOI 10.1002/cne.901590206; BOUVET JF, 1987, NEUROSCI LETT, V77, P181, DOI 10.1016/0304-3940(87)90583-0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, 1995, NEUROL DIS, V32, P821; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Gottfried JA, 2002, J NEUROSCI, V22, P10819; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mai J.K., 1997, ATLAS HUMAN BRAIN; Marchini J, 2004, NEUROIMAGE, V22, P1203, DOI 10.1016/j.neuroimage.2004.03.030; Masago Ryoko, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P7, DOI 10.2114/jpa.20.7; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEGUS SV, 1958, COMP ANATOMY PHYSL N; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Price J.L., 1987, P179; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; PRINCIPATO JJ, 1970, ARCHIV OTOLARYNGOL, V91, P71; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Sabri M, 2005, NEUROIMAGE, V25, P969, DOI 10.1016/j.neuroimage.2004.12.033; Savic I, 2000, CHEM SENSES, V25, P517, DOI 10.1093/chemse/25.5.517; Savic I, 2000, NEUROREPORT, V11, P2861, DOI 10.1097/00001756-200009110-00007; Savic I, 2002, HUM BRAIN MAPP, V17, P17, DOI 10.1002/hbm.10045; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; SCHNEIDER RA, 1967, PHYSIOL BEHAV, V2, P305, DOI 10.1016/0031-9384(67)90084-4; Settles GS, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P323; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Sobel N, 1999, NATURE, V402, P35, DOI 10.1038/46944; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2001, Q J EXP PSYCHOL-A, V54, P775, DOI 10.1080/02724980042000480; STODDART DM, 1979, EXPERIENTIA, V35, P1456, DOI 10.1007/BF01962780; STONE H, 1970, BRAIN RES, V21, P138, DOI 10.1016/0006-8993(70)90030-2; STONE H, 1968, EXP NEUROL, V21, P11, DOI 10.1016/0014-4886(68)90029-0; THESEN A, 1993, J EXP BIOL, V180, P247; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368	70	115	116	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					581	592		10.1016/j.neuron.2005.06.028	http://dx.doi.org/10.1016/j.neuron.2005.06.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102540	Bronze			2022-12-24	WOS:000231411100014
J	Turney, SG; Bridgman, PC				Turney, SG; Bridgman, PC			Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity	NATURE NEUROSCIENCE			English	Article							CYTOSKELETAL DYNAMICS; GUIDANCE; MOTILITY; INTEGRINS; INHIBITOR	Guidance cues and signal transduction mechanisms acting at the nerve growth cone are fairly well understood, but the intracellular mechanisms operating to change the direction of axon outgrowth remain unknown. We now show that growth cones integrate myosin II - dependent contraction for rapid, coordinated turning at borders of laminin stripes in response to signals from laminin-activated integrin receptors; in the absence of myosin II activity, outgrowth continues across the borders.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bridgman, PC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	bridgmap@pcg.wustl.edu			NINDS NIH HHS [NS26150] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026150] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bridgman PC, 2003, METHOD CELL BIOL, V71, P353, DOI 10.1016/S0091-679X(03)01017-3; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Nakamoto T, 2004, CURR BIOL, V14, pR121, DOI 10.1016/j.cub.2004.01.020; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Schmucker D, 2003, NEURON, V40, P4, DOI 10.1016/S0896-6273(03)00603-2; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U	15	93	96	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					717	719		10.1038/nn1466	http://dx.doi.org/10.1038/nn1466			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880105				2022-12-24	WOS:000229345300009
J	Brambilla, D; Chapman, D; Greene, R				Brambilla, D; Chapman, D; Greene, R			Adenosine mediation of presynaptic feedback inhibition of glutamate release	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SYNAPSES; EXTRACELLULAR ADENOSINE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; PYRAMIDAL CELLS; NMDA RECEPTORS; NEURONS; POOL; ACTIVATION	Conditions of increased metabolic demand relative to metabolite availability are associated with increased extracellular adenosine in CNS tissue. Synaptic activation of postsynaptic NIVIDA receptors on neurons of the cholinergic brainstern arousal center can increase sufficient extracellular adenosine to act on presynaptic All adenosine receptors (AlADRs) of glutamate terminals, reducing release from the readily releasable pool. The time course of the adenosine response to an increase in glutamate release is slow (tau > 10 min), consistent with the role of adenosine as a fatigue factor that inhibits the activity of cholinergic arousal centers to reduce arousal.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Greene, R (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robertw.greene@utsouthwestern.edu	Shin, Jung Hoon/C-9566-2012; Brambilla, Dario/F-3126-2012	Brambilla, Dario/0000-0002-4838-482X	NIMH NIH HHS [5 R01 MH067777-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067777] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arrigoni E, 2001, J NEUROSCI, V21, P1076, DOI 10.1523/JNEUROSCI.21-03-01076.2001; Biber K, 1997, J NEUROSCI, V17, P4956; CRAIG CG, 1993, J NEUROCHEM, V60, P1073, DOI 10.1111/j.1471-4159.1993.tb03256.x; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; GOODMAN RR, 1983, SCIENCE, V220, P967, DOI 10.1126/science.6302841; GREENE RW, 1991, PROG NEUROBIOL, V36, P329, DOI 10.1016/0301-0082(91)90005-L; HAAS HL, 1984, PFLUG ARCH EUR J PHY, V402, P244, DOI 10.1007/BF00585506; Harvey J, 1997, J NEUROSCI, V17, P5271; Hausser M, 1997, J NEUROSCI, V17, P7606; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huston JP, 1996, NEUROSCIENCE, V73, P99, DOI 10.1016/0306-4522(96)00021-8; LUEBKE JI, 1993, J NEUROPHYSIOL, V70, P2128, DOI 10.1152/jn.1993.70.5.2128; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MCILWAIN H, 1986, J NEUROBIOL, V17, P39, DOI 10.1002/neu.480170105; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; POLI A, 1991, J NEUROCHEM, V57, P298, DOI 10.1111/j.1471-4159.1991.tb02128.x; Porkka-Heiskanen T, 2000, NEUROSCIENCE, V99, P507, DOI 10.1016/S0306-4522(00)00220-7; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Portas CM, 1997, NEUROSCIENCE, V79, P225, DOI 10.1016/S0306-4522(96)00640-9; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAINNIE DG, 1994, SCIENCE, V263, P689, DOI 10.1126/science.8303279; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; RIVKEES SA, 1995, BRAIN RES, V677, P193, DOI 10.1016/0006-8993(95)00062-U; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; Silinsky EM, 2004, J PHYSIOL-LONDON, V558, P389, DOI 10.1113/jphysiol.2004.061457; STERIADE M, 1990, J NEUROSCI, V10, P2541; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; WHITE TD, 1993, DRUG DEVELOP RES, V28, P406, DOI 10.1002/ddr.430280340; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; ZIMMERMANN H, 1995, ADENOSINE AND ADENINE NUCLEOTIDES: FROM MOLECULAR BIOLOGY TO INTEGRATIVE PHYSIOLOGY, P179	42	50	56	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					275	283		10.1016/j.neuron.2005.03.016	http://dx.doi.org/10.1016/j.neuron.2005.03.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848805	Bronze			2022-12-24	WOS:000228674800013
J	Cowan, CW; Shao, YR; Sahin, M; Shamah, SM; Lin, MZ; Greer, PL; Gao, S; Griffith, EC; Brugge, JS; Greenberg, ME				Cowan, CW; Shao, YR; Sahin, M; Shamah, SM; Lin, MZ; Greer, PL; Gao, S; Griffith, EC; Brugge, JS; Greenberg, ME			Vav family GEFs link activated Ephs to endocytosis and axon guidance	NEURON			English	Article							RECEPTOR TYROSINE KINASE; NUCLEOTIDE EXCHANGE FACTOR; GROWTH CONE COLLAPSE; GANGLION-CELL AXONS; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ACTIVATION; LIGAND ACTIVATION; GDP/GTP EXCHANGE; PHOSPHORYLATION; PROTEINS	Ephrin signaling through Eph receptor tyrosine kinases can promote attraction or repulsion of axonal growth cones during development. However, the mechanisms that determine whether Eph signaling promotes attraction or repulsion are not known. We show here that the Rho family GEF Vav2 plays a key role in this process. We find that, during axon guidance, ephrin binding to Ephs triggers Vav-dependent endocytosis of the ligand-receptor complex, thus converting an initially adhesive interaction into a repulsive event. In the absence of Vav proteins, ephrin-Eph endocytosis is blocked, leading to defects in growth cone collapse in vitro and significant defects in the ipsilateral retinogeniculate projections in vivo. These findings suggest an important role for Vav family GEFs as regulators of ligand-receptor endocytosis and determinants of repulsive signaling during axon guidance.	Harvard Univ, Sch Med, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu	Cowan, Christopher W/I-2497-2014; SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Lin, Michael/0000-0002-0492-1961; Griffith, Eric/0000-0003-0428-3215	NHLBI NIH HHS [HL059561] Funding Source: Medline; NICHD NIH HHS [HD18655, K08 HD01384] Funding Source: Medline; NINDS NIH HHS [NS43855, R01 NS045500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAVIS A, 1994, SCIENCE, V264, P839, DOI 10.1126/science.8171338; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Ellis C, 1996, ONCOGENE, V12, P1727; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; STRITTMATTER RG, 2000, J CELL BIOL, V149, P411; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tamas P, 2001, CELL SIGNAL, V13, P475, DOI 10.1016/S0898-6568(01)00172-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walkenhorst J, 2000, MOL CELL NEUROSCI, V16, P365, DOI 10.1006/mcne.2000.0878; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	66	185	190	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					205	217		10.1016/j.neuron.2005.03.019	http://dx.doi.org/10.1016/j.neuron.2005.03.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848800	Bronze			2022-12-24	WOS:000228674800008
J	Juttner, R; More, MI; Das, D; Babich, A; Meier, J; Henning, M; Erdmann, B; Muller, EC; Otto, A; Grantyn, R; Rathjen, FG				Juttner, R; More, MI; Das, D; Babich, A; Meier, J; Henning, M; Erdmann, B; Muller, EC; Otto, A; Grantyn, R; Rathjen, FG			Impaired synapse function during postnatal development in the absence of CALEB, an EGF-like protein processed by neuronal activity	NEURON			English	Article							CLASS-I MHC; AMPA RECEPTORS; NEUROGLYCAN-C; CHONDROITIN SULFATE; TENASCIN-C; PLASTICITY; EXPRESSION; RELEASE; FAMILY; MEMBER	In an attempt to characterize the molecular components by which electric activity influences the development of synapses, we searched for cell surface proteins modulated by calcium influx and glutamate receptor activity. Here, we report that neuronal depolarization facilitates the conversion of CALEB, which results in a truncated transmembrane form with an exposed EGF domain. To characterize the role of CALEB in synapse development, synaptic features were investigated in slices of the colliculus superior from CALEBdeficient mice. In the absence of CALEB, the number of synapses and their morphological characteristics remained unchanged. However, in CALEB-deficient mice, synapses displayed higher paired-pulse ratios, less depression during prolonged repetitive activation, a lower rate of spontaneous postsynaptic currents, and a lower release probability at early but not mature postnatal stages. Our findings indicate that CALEB provides a molecular basis for maintaining normal release probability at early developmental stages.	Max Delbruck Cent, D-13092 Berlin, Germany; Humboldt Univ Med Sch, Charite, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rathjen, FG (corresponding author), Max Delbruck Cent, Robert Rossle Str 10, D-13092 Berlin, Germany.	rathjen@mdc-berlin.de	Jüttner, Rene/G-4327-2011; Das, Debashish/ABB-4272-2020	Jüttner, Rene/0000-0003-3565-0698; Das, Debashish/0000-0002-9171-656X; More, Margret/0000-0002-3672-521X; Meier, Jochen/0000-0001-5574-3336				Aono S, 2000, J BIOL CHEM, V275, P337, DOI 10.1074/jbc.275.1.337; Aono S, 2004, J BIOL CHEM, V279, P46536, DOI 10.1074/jbc.M403263200; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Dumoulin A, 1999, J CELL SCI, V112, P811; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Grantyn R, 2004, METH NE FRO NEUROSCI, P173; Han B, 1999, J BIOL CHEM, V274, P26407, DOI 10.1074/jbc.274.37.26407; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ishizaki H, 2000, P NATL ACAD SCI USA, V97, P11587, DOI 10.1073/pnas.97.21.11587; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Juttner R, 2001, EUR J NEUROSCI, V13, P2088, DOI 10.1046/j.0953-816x.2001.01587.x; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kinugasa Y, 2004, BIOCHEM BIOPH RES CO, V321, P1045, DOI 10.1016/j.bbrc.2004.07.066; Kirischuk S, 2005, J PHYSIOL-LONDON, V563, P795, DOI 10.1113/jphysiol.2004.081216; Kirov SA, 1999, J NEUROSCI, V19, P2876; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; Meier J, 2004, J PHYSIOL-LONDON, V559, P355, DOI 10.1113/jphysiol.2004.066233; Meier J, 2003, MOL CELL NEUROSCI, V23, P600, DOI 10.1016/S1044-7431(03)00079-4; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schumacher S, 2003, J NEUROCHEM, V87, P1213, DOI 10.1046/j.1471-4159.2003.02112.x; Schumacher S, 2001, J BIOL CHEM, V276, P7337, DOI 10.1074/jbc.M007234200; Schumacher S, 1997, J CELL BIOL, V136, P895, DOI 10.1083/jcb.136.4.895; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Tsui CC, 1996, J NEUROSCI, V16, P2463; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yasuda Y, 1998, NEUROSCI RES, V32, P313, DOI 10.1016/S0168-0102(98)00098-4	58	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					233	245		10.1016/j.neuron.2005.02.027	http://dx.doi.org/10.1016/j.neuron.2005.02.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848802	Bronze			2022-12-24	WOS:000228674800010
J	Saddoris, MP; Gallagher, M; Schoenbaum, G				Saddoris, MP; Gallagher, M; Schoenbaum, G			Rapid associative encoding in basolateral amygdala depends on connections with orbitofrontal cortex	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; AUDITORY SECONDARY REINFORCEMENT; FRONTAL-CORTEX; RHESUS-MONKEYS; CONDITIONED REINFORCEMENT; LIMBIC CONNECTIONS; NEURONAL-ACTIVITY; ALERT MONKEY; LESIONS; DISCRIMINATION	Certain goal-directed behaviors depend upon interactions between basolateral amygdala (ABL) and orbitofrontal cortex (OFC). Here we describe neurophysiological evidence of this cooperative function. We recorded from ABL in intact and OFC-lesioned rats during learning of odor discrimination problems and reversals. During learning, rats with ipsilateral OFC lesions exhibited a marked decline in the proportion of ABL neurons that fired differentially during cue sampling both before and after reversal and in the proportion of neurons that reversed odor preference when the odor-outcome associations were reversed. This decline appeared to reflect a loss of rapid flexibility in cue selectivity that characterized activity in intact rats. In addition, lesioned rats had fewer neurons that fired in anticipation of the predicted outcome during a delay period after responding but before outcome delivery. These findings support a role for OFC in facilitating the encoding of information about expected outcomes in ABL.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Saddoris, MP (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, 3400 N Charles St,25 Ames Hall, Baltimore, MD 21218 USA.	saddoris@jhu.edu; schoenbg@schoenbaumlab.org						ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BAXER MG, 2000, AMYGDALA FUNCTIONAL, P545; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1999, J NEUROSCI, V19, P5473; Blundell P, 2001, J NEUROSCI, V21, P9018, DOI 10.1523/JNEUROSCI.21-22-09018.2001; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gallagher M, 1999, ANN NY ACAD SCI, V877, P397, DOI 10.1111/j.1749-6632.1999.tb09279.x; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hatfield T, 1996, J NEUROSCI, V16, P5256; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; Malkova L, 1997, J NEUROSCI, V17, P6011; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; MCDANNALD MA, 2005, IN PRESS J NEUROSCI; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pears A, 2003, J NEUROSCI, V23, P11189; Pears A, 2001, BRAIN COGNITION, V47, P44; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; TRAPOLD MA, 1970, LEARN MOTIV, V1, P129, DOI 10.1016/0023-9690(70)90079-2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009	52	174	178	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					321	331		10.1016/j.neuron.2005.02.018	http://dx.doi.org/10.1016/j.neuron.2005.02.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848809	Bronze			2022-12-24	WOS:000228674800017
J	Grieco, TM; Malhotra, JD; Chen, C; Isom, LL; Raman, IM				Grieco, TM; Malhotra, JD; Chen, C; Isom, LL; Raman, IM			Open-channel block by the cytoplasmic tail of sodium channel beta 4 as a mechanism for resurgent sodium current	NEURON			English	Article							AUXILIARY SUBUNIT; PURKINJE NEURONS; FUNCTIONAL EXPRESSION; INACTIVATION; VOLTAGE; MODULATION; MICE; RESTORATION; ACTIVATION; CONTACTIN	Voltage-gated sodium channels with "resurgent" kinetics are specialized for high-frequency firing. The alpha subunits interact with a blocking protein that binds open channels upon depolarization and unbinds upon repolarization, producing resurgent sodium current. By limiting classical inactivation, the cycle of block and unblock shortens refractory periods. To characterize the blocker in Purkinje neurons, we briefly exposed inside-out patches to substrate-specific proteases. Trypsin and chymotrypsin each removed resurgent current, consistent with established roles for positively charged and hydrophobic/aromatic groups in blocking sodium channels. In Purkinje cells, the only known sodium channel-associated subunit that has a cytoplasmic sequence with several positive charges and clustered hydrophobic/aromatic residues is beta4 (KKLITFILKKT REK; beta4(154-167)). After enzymatic removal of block, beta4(154-167) fully reconstituted resurgent current, whereas scrambled or point-mutated peptides were ineffective. In CA3 pyramidal neurons, which lack beta4 and endogenous block, beta4(154-167) generated resurgent current. Thus, 134 may be the endogenous open-channel blocker responsible for resurgent kinetics.	Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan	Raman, IM (corresponding author), Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA.	i-raman@northwestern.edu		Isom, Lori/0000-0002-9479-6729; Grieco-Calub, Tina M./0000-0001-8699-5990	NIMH NIH HHS [MH59980] Funding Source: Medline; NINDS NIH HHS [F31 NS045483, NS39395] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS045483, R01NS039395] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afshari FS, 2004, J NEUROPHYSIOL, V92, P2831, DOI 10.1152/jn.00261.2004; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; CAHALAN MD, 1979, BIOPHYS J, V27, P57, DOI 10.1016/S0006-3495(79)85202-9; Cantrell AR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0003.1999; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Eaholtz G, 1999, J GEN PHYSIOL, V113, P279, DOI 10.1085/jgp.113.2.279; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Grieco TM, 2004, J NEUROSCI, V24, P35, DOI 10.1523/JNEUROSCI.3807-03.2004; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; KELLENBERGER S, 1909, J GEN PHYSIOL, V109, P589; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; OLEARY ME, 1994, J GEN PHYSIOL, V104, P507, DOI 10.1085/jgp.104.3.507; PAN F, 1999, J NEUROSCI, V17, P4517; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Smith MR, 1998, J NEUROSCI, V18, P6093; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WANG GK, 1993, MOL PHARMACOL, V44, P667; YEH JZ, 1977, J GEN PHYSIOL, V69, P293, DOI 10.1085/jgp.69.3.293; Yu FH, 2003, J NEUROSCI, V23, P7577; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAMPONI GW, 1994, BIOPHYS J, V67, P1040, DOI 10.1016/S0006-3495(94)80569-7	45	179	182	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					233	244		10.1016/j.neuron.2004.12.035	http://dx.doi.org/10.1016/j.neuron.2004.12.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664175	Bronze			2022-12-24	WOS:000226451500010
J	Armstrong, KM; Fitzgerald, JK; Moore, T				Armstrong, Katherine M.; Fitzgerald, Jamie K.; Moore, Tirin			Changes in visual receptive fields with microstimulation of frontal cortex	NEURON			English	Article							COVERT SPATIAL ATTENTION; EYE-MOVEMENTS; SUPERIOR COLLICULUS; SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; MACAQUE; V4; RESPONSES; ORGANIZATION	The influence of attention on visual cortical neurons has been described in terms of its effect on the structure of receptive fields (RFs), where multiple stimuli compete to drive neural responses and ultimately behavior. We stimulated the frontal eye field (FEF) of passively fixating monkeys and produced changes in V4 responses similar to known effects of voluntary attention. Subthreshold FEF stimulation enhanced visual responses at particular locations within the RF and altered the interaction between pairs of RF stimuli to favor those aligned with the activated FEF site. Thus, we could influence which stimulus drove the responses of individual V4 neurons. These results suggest that spatial signals involved in saccade preparation are used to covertly select among multiple stimuli appearing within the RFs of visual cortical neurons.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Moore, T (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	tirin@stanford.edu			NEI NIH HHS [EY14924] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARBAS H, 1981, J COMP NEUROL, V200, P407, DOI 10.1002/cne.902000309; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DETZ EE, 1971, SCINECE, V174, P431; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GATTASS R, 1988, J NEUROSCI, V8, P1831; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Nowak LG, 1997, CEREBR CORT, V12, P205; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; WELCH K, 1958, BRAIN, V81, P341, DOI 10.1093/brain/81.3.341; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	42	167	169	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					791	798		10.1016/j.neuron.2006.05.010	http://dx.doi.org/10.1016/j.neuron.2006.05.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731516	Bronze			2022-12-24	WOS:000238165000013
J	Manookin, MB; Demb, JB				Manookin, Michael B.; Demb, Jonathan B.			Presynaptic mechanism for slow contrast adaptation in mammalian retinal ganglion cells	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LATERAL GENICULATE-NUCLEUS; VISUAL CORTICAL-NEURONS; BIPOLAR CELLS; TEMPORAL CONTRAST; PYRAMIDAL NEURONS; MACAQUE MONKEYS; RIBBON SYNAPSE; PRIMATE RETINA; CAT	Visual neurons, from retina to cortex, adapt slowly to stimulus contrast. Following a switch from high to low contrast, a neuron rapidly decreases its responsiveness and recovers over 5-20 s. Cortical adaptation arises from an intrinsic cellular mechanism: a sodium-dependent potassium conductance that causes prolonged hyperpolarization. Spiking can drive this mechanism, raising the possibility that the same mechanism exists in retinal ganglion cells. We found that adaptation in ganglion cells corresponds to a slowly recovering after hyperpolarization (AHP), but, unlike in cortical cells, this AHP is not primarily driven by an intrinsic cellular property: spiking was not sufficient to generate adaptation. Adaptation was strongest following spatial stimuli tuned to presynaptic bipolar cells rather than the ganglion cell; it was driven by a reduced excitatory conductance, and it persisted while blocking GABA and glycine receptors, K-(Ca) channels or mGluRs. Thus, slow adaptation arises from reduced glutamate release from presynaptic (nonspiking) bipolar cells.	Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Demb, JB (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA.	jdemb@umich.edu		Manookin, Michael/0000-0001-8116-7619; Demb, Jonathan/0000-0003-2227-9041	NATIONAL EYE INSTITUTE [T32EY013934, P30EY007003, R01EY014454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005341] Funding Source: NIH RePORTER; NEI NIH HHS [EY07003, T32 EY013934, T32-EY13934, EY14454] Funding Source: Medline; NIDCD NIH HHS [T32 DC005341, T32-DC005341] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Awatramani GB, 2001, J NEUROSCI, V21, P741, DOI 10.1523/JNEUROSCI.21-02-00741.2001; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Baccus SA, 2004, NEURON, V42, P5, DOI 10.1016/S0896-6273(04)00187-4; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Calkins D.J., 1999, COLOR VISION GENES P, P163; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cohen E D, 2001, Prog Brain Res, V131, P215; Cohen ED, 2000, J NEUROPHYSIOL, V83, P3217, DOI 10.1152/jn.2000.83.6.3217; Colbert CM, 1997, J NEUROSCI, V17, P6512; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; KIER CK, 1995, J NEUROSCI, V15, P7673; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; LLINAS R, 1988, J NEUROPHYSIOL, V60, P869, DOI 10.1152/jn.1988.60.3.869; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PAIMER MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRY VH, 1984, NEUROSCIENCE, V12, P1101, DOI 10.1016/0306-4522(84)90006-X; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; SAKAI HM, 1995, J GEN PHYSIOL, V105, P815, DOI 10.1085/jgp.105.6.815; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; TROY JB, 1993, EXP BRAIN RES, V93, P383; VIDYASAGAR TR, 1990, NEUROSCIENCE, V36, P175, DOI 10.1016/0306-4522(90)90360-G; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	59	87	90	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					453	464		10.1016/j.neuron.2006.03.039	http://dx.doi.org/10.1016/j.neuron.2006.03.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675399	Bronze			2022-12-24	WOS:000237726800014
J	Kittler, JT				Kittler, JT			Censoring the editor transient forebrain ischemia	NEURON			English	Editorial Material							CELL-DEATH; NEURONAL DEATH; AMPA RECEPTORS; CHANNELS; MECHANISMS; BLOCKADE; BRAIN	A molecular explanation for why some neurons are more vulnerable than others to ischemic injury has long remained elusive. In this issue of Neuron, Peng et al. propose that CREB-dependent downregulation of the RNA editing enzyme ADAR2, resulting in defective Q/R editing of AMPA receptor GluR2 subunits and increased availability of calcium and zinc-permeable death-promoting AMPA receptors, underlies the vulnerability of some neuronal populations to ischemia.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Kittler, JT (corresponding author), UCL, Dept Physiol, London WC1E 6BT, England.		Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010	Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456	MRC [G120/972] Funding Source: UKRI; Medical Research Council [G120/972] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	16	2	2	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 2	2006	49	5					646	648		10.1016/j.neuron.2006.02.013	http://dx.doi.org/10.1016/j.neuron.2006.02.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504939	Bronze			2022-12-24	WOS:000236070600004
J	Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M				Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M			Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELLS; PROTECTIVE AUTOIMMUNITY; SYNAPTIC PLASTICITY; NEUROPROTECTIVE AUTOIMMUNITY; THERAPEUTIC VACCINATION; ENRICHED ENVIRONMENT; NEUROTROPHIC FACTOR; GRANULE CELLS; BRAIN	Neurogenesis is known to take place in the adult brain. This work identifies T lymphocytes and microglia as being important to the maintenance of hippocampal neurogenesis and spatial learning abilities in adulthood. Hippocampal neurogenesis induced by an enriched environment was associated with the recruitment of T cells and the activation of microglia. In immune-deficient mice, hippocampal neurogenesis was markedly impaired and could not be enhanced by environmental enrichment, but was restored and boosted by T cells recognizing a specific CNS antigen. CNS-specific T cells were also found to be required for spatial learning and memory and for the expression of brain-derived neurotrophic factor in the dentate gyrus, implying that a common immune-associated mechanism underlies different aspects of hippocampal plasticity and cell renewal in the adult brain.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Minist Hlth, Mental Hlth Ctr,Anxiety & Stress Res Unit, IL-84105 Beer Sheva, Israel	Weizmann Institute of Science; Ben Gurion University	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	jkipnis@unmc.edu; michal.schwartz@weizmann.ac.il	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Butovsky, Oleg/0000-0003-0186-8867				Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; BUTOVSKY O, 2005, MOL CELL NEUROSCI; Butovsky Oleg, 2001, FASEB Journal, V15, P1065; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; COHEN H, IN PRESS J NEUROBIOL; Diesing Thomas S, 2002, AIDS Read, V12, P358; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Gaillard RC, 1998, ANN NY ACAD SCI, V840, P480, DOI 10.1111/j.1749-6632.1998.tb09586.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Muhallab S, 2002, SCAND J IMMUNOL, V55, P264, DOI 10.1046/j.0300-9475.2002.01038.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schwartz M, 2002, TRENDS IMMUNOL, V23, P530, DOI 10.1016/S1471-4906(02)02322-0; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wekerle H, 2005, P NATL ACAD SCI USA, V102, P3, DOI 10.1073/pnas.0408495101; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	48	843	879	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					268	275		10.1038/nn1629	http://dx.doi.org/10.1038/nn1629			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415867				2022-12-24	WOS:000234990100023
J	Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H				Toyofuku, T; Yoshida, J; Sugimoto, T; Zhang, H; Kumanogoh, A; Hori, M; Kikutani, H			FARP2 triggers signals for Sema3A-mediated axonal repulsion	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE COLLAPSE; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RECEPTOR PLEXIN-B1; CELL-ADHESION; FERM DOMAIN; RHO-GTPASES; FAMILY; BETA-1-INTEGRIN; MORPHOGENESIS	Sema3A, a prototypical semaphorin, acts as a chemorepellent or a chemoattractant for axons by activating a receptor complex comprising neuropilin-1 as the ligand-binding subunit and plexin-A1 as the signal-transducing subunit. How the signals downstream of plexin-A1 are triggered upon Sema3A stimulation, however, is unknown. Here we show that, in the presence of neuropilin-1, the FERM domain - containing guanine nucleotide exchange factor (GEF) FARP2 associates directly with plexin-A1. Sema3A binding to neuropilin-1 induces the dissociation of FARP2 from plexin-A1, resulting in activation of FARP2' s Rac GEF activity, Rnd1 recruitment to plexin-A1, and downregulation of R-Ras. Simultaneously, the FERM domain of FARP2 sequesters phosphatidylinositol phosphate kinase type I isoform PIPKI gamma 661 from talin, thereby inhibiting its kinase activity. These activities are required for Sema3A-mediated repulsion of outgrowing axons and suppression of neuronal adhesion. We therefore conclude that FARP2 is a key molecule involved in the response of neuronal growth cones to class-3 semaphorins.	Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Saitama 3326612, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Toyofuku, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	toyofuku@medone.med.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009					Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grabham PW, 2000, J CELL SCI, V113, P3003; Jin Z, 1997, J NEUROSCI, V17, P6256; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Koyano Y, 1997, BIOCHEM BIOPH RES CO, V241, P369, DOI 10.1006/bbrc.1997.7826; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kubo T, 2002, J NEUROSCI, V22, P8504; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77	43	171	184	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1712	1719		10.1038/nn1596	http://dx.doi.org/10.1038/nn1596			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286926				2022-12-24	WOS:000233576200020
J	Beck, DM; Kastner, S				Beck, DM; Kastner, S			Stimulus context modulates competition in human extrastriate cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; AREA V4; MACAQUE; SEARCH; V1; SEGREGATION	When multiple stimuli appear simultaneously in the visual field, they are not processed independently, but rather interact in a mutually suppressive way, suggesting that they compete for neural representation in visual cortex. The biased competition model of selective attention predicts that the competition can be influenced by both top-down and bottom-up mechanisms. Directed attention has been shown to bias competition in favor of the attended stimulus in extrastriate cortex. Here, we show that suppressive interactions among multiple stimuli are eliminated in extrastriate cortex when they are presented in the context of pop-out displays, in which a single item differs from the others, but not in heterogeneous displays, in which all items differ from each other. The pop-out effects seemed to originate in early visual cortex and were independent of attentional top-down control, suggesting that stimulus context may provide a powerful influence on neural competition in human visual cortex.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University; Princeton University	Beck, DM (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	dbeck@princeton.edu	Beck, Diane M/F-7536-2010	Beck, Diane M/0000-0001-9802-5828; Kastner, Sabine/0000-0002-9742-965X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043, P50MH062196] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH062196, P50 MH-62196, R01 MH064043, R01 MH-64043] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BANKS WP, 1976, PERCEPT PSYCHOPHYS, V19, P361, DOI 10.3758/BF03204244; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; BUNDESEN C, 1983, PERCEPT PSYCHOPHYS, V33, P487, DOI 10.3758/BF03202901; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kahneman D., 1981, PERCEPTUAL ORG, P181; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 1999, VISUAL NEUROSCI, V16, P587, DOI 10.1017/S095252389916317X; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Neisser U., 1967, COGNITIVE PSYCHOL; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1993, VISION RES, V33, P1937, DOI 10.1016/0042-6989(93)90020-W; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	49	137	140	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1110	1116		10.1038/nn1501	http://dx.doi.org/10.1038/nn1501			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007082	Green Accepted			2022-12-24	WOS:000230760200024
J	Franks, KM; Isaacson, JS				Franks, KM; Isaacson, JS			Synapse-specific downregulation of NMDA receptors by early experience: A critical period for plasticity of sensory input to olfactory cortex	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; PIRIFORM CORTEX; SILENT SYNAPSES; THALAMOCORTICAL SYNAPSES; POSTNATAL-DEVELOPMENT; AMPA RECEPTORS; BARREL CORTEX; MEMORY; TRANSMISSION	Olfaction is required at birth for survival; however, little is known about the maturation of olfactory cortical circuits. Here we show that in vivo sensory experience mediates the development of excitatory transmission in pyramidal neurons of rat olfactory cortex. We find a postnatal critical period during which there is an experience-dependent increase in the contribution of AMPARs versus NMDARs to transmission at primary sensory synapses but not associational inputs. The shift in receptors underlying transmission is mediated by a strong activity-dependent downregulation of NMDARs and modest increase in AMPARs. Sensory activity leads to a loss of "silent" NMDAR-only synapses and an increase in threshold for inducing long-term plasticity. These results indicate the importance of early olfactory experience in the establishment of cortical circuits and could reflect mechanisms governing early olfactory "imprinting."	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	jisaacson@ucsd.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04682] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Best AR, 2003, BRAIN RES, V961, P81, DOI 10.1016/S0006-8993(02)03847-7; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Erisir A, 2003, J NEUROSCI, V23, P5208; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fiske BK, 2001, J COMP NEUROL, V431, P311; Groc L, 2002, J NEUROSCI, V22, P5552; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JUNG MW, 1990, SYNAPSE, V6, P279, DOI 10.1002/syn.890060307; KANTER ED, 1993, J NEUROSCI, V13, P2477, DOI 10.1523/JNEUROSCI.13-06-02477.1993; KANTER ED, 1990, BRAIN RES, V525, P175, DOI 10.1016/0006-8993(90)91337-G; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LEON M, 1992, ANNU REV PSYCHOL, V43, P377; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Mower GD, 2003, MOL BRAIN RES, V119, P19, DOI 10.1016/j.molbrainres.2003.08.007; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Patil MM, 1998, J NEUROPHYSIOL, V80, P2467, DOI 10.1152/jn.1998.80.5.2467; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; Rumpel S, 2004, J NEUROPHYSIOL, V91, P1097, DOI 10.1152/jn.00443.2003; Rumpel S, 1998, J NEUROSCI, V18, P8863; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2000, BRAIN RES, V853, P317, DOI 10.1016/S0006-8993(99)02287-8; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	62	106	107	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					101	114		10.1016/j.neuron.2005.05.024	http://dx.doi.org/10.1016/j.neuron.2005.05.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996551	Bronze			2022-12-24	WOS:000230464000011
J	Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O				Huang, ZL; Qu, WM; Eguchi, N; Chen, JF; Schwarzschild, MA; Fredholm, BB; Urade, Y; Hayaishi, O			Adenosine A2(A), but not A(1), receptors mediate the arousal effect of caffeine	NATURE NEUROSCIENCE			English	Article							HOMEOSTATIC REGULATION; SLEEP; RATS	Caffeine, a component of tea, coffee and cola, induces wakefulness. It binds to adenosine A(1) and A(2A) receptors as an antagonist, but the receptor subtype mediating caffeine-induced wakefulness remains unclear. Here we report that caffeine at 5, 10 and 15 mg kg(-1) increased wakefulness in both wild-type mice and A(1) receptor knockout mice, but not in A(2A) receptor knockout mice. Thus, caffeine-induced wakefulness depends on adenosine A(2A) receptors.	Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Massachusetts Gen Hosp, Mol Neurobiol Lab, Boston, MA 02129 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Boston University; Harvard University; Massachusetts General Hospital; Karolinska Institutet	Hayaishi, O (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan.	hayaishi@obi.or.jp		Chen, Jiang-Fan/0000-0002-0446-3956; Huang, Zhi-Li/0000-0001-9359-1150				Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; El Yacoubi M, 2003, NEUROPHARMACOLOGY, V45, P977, DOI 10.1016/S0028-3908(03)00254-5; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Hayaishi O, 2004, ARCH ITAL BIOL, V142, P533; Hong ZY, 2005, J NEUROCHEM, V92, P1542, DOI 10.1111/j.1471-4159.2004.02991.x; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Porkka-Heiskanen T, 2002, SLEEP MED REV, V6, P321, DOI 10.1053/smrv.2001.0201; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; RAINNIE DG, 1994, SCIENCE, V263, P689, DOI 10.1126/science.8303279; Satoh S, 1996, P NATL ACAD SCI USA, V93, P5980, DOI 10.1073/pnas.93.12.5980; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Stenberg D, 2003, J SLEEP RES, V12, P283, DOI 10.1046/j.0962-1105.2003.00367.x	15	390	422	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					858	859		10.1038/nn1491	http://dx.doi.org/10.1038/nn1491			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965471				2022-12-24	WOS:000230137100010
J	Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV				Revest, JM; Di Blasi, F; Kitchener, P; Rouge-Pont, F; Desmedt, A; Turiault, M; Tronche, F; Piazza, PV			The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids	NATURE NEUROSCIENCE			English	Article							EARLY GENE ZIF268; RECOGNITION MEMORY; NERVOUS-SYSTEM; KINASE CASCADE; SPATIAL MEMORY; FEAR MEMORY; DNA-BINDING; RECEPTOR; EXPRESSION; HIPPOCAMPUS	Many of the behavioral consequences of stress are mediated by the activation of the glucocorticoid receptor by stress-induced high levels of glucocorticoid hormones. To explore the molecular mechanisms of these effects, we combined in vivo and in vitro approaches. We analyzed mice carrying a brain-specific mutation (GR(NesCre)) in the glucocorticoid receptor gene (GR, also called Nr3c1) and cell lines that either express endogenous glucocorticoid receptor or carry a constitutively active form of the receptor (Delta GR) that can be transiently induced. In the hippocampus of the mutant mice after stress, as well as in the cell lines, activation of glucocorticoid receptors greatly increased the expression and enzymatic activity of proteins in the MAPK signaling pathway and led to an increase in the levels of both Egr-1 mRNA and protein. In parallel, inhibition of the MAPK pathway within the hippocampus abolished the increase in contextual fear conditioning induced by glucocorticoids. The present results provide a molecular mechanism for the stress-related effects of glucocorticoids on fear memories.	Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, F-33077 Bordeaux, France; Cognit Neurosci Lab, CNRS, UMR5106, F-33405 Talence, France; Coll France, Inst Biol, CNRS, FRE2401, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Piazza, PV (corresponding author), Univ Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportement, INSERM,U588, Domaine Carreire,146 Rue Leo Saignat, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	TRONCHE, François/F-3895-2011	Desmedt, aline/0000-0002-1179-7161; Di Blasi, Francesco/0000-0001-8085-7538				Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blum S, 1999, J NEUROSCI, V19, P3535; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; de Kloet E Ronald, 2003, Endocr Regul, V37, P51; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Desmedt A, 1998, J NEUROSCI, V18, P480; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUNDER JW, 1992, J STEROID BIOCHEM, V43, P389, DOI 10.1016/0960-0760(92)90074-S; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jouvert P, 2002, NEUROMOL MED, V1, P137, DOI 10.1385/NMM:1:2:137; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Lee JE, 1996, ONCOGENE, V12, P1669; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Marais R, 1996, CANCER SURV, V27, P101; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MORATALLA R, 1992, J NEUROSCI, V12, P2609; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; STORM SM, 1990, ONCOGENE, V5, P345; STRAWHECKER JM, 1989, ONCOGENE, V4, P1317; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Widen C, 2000, J BIOL CHEM, V275, P39296, DOI 10.1074/jbc.M006943200; Yuryev A, 1998, Cell Res, V8, P81	50	175	181	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					664	672		10.1038/nn1441	http://dx.doi.org/10.1038/nn1441			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834420				2022-12-24	WOS:000228895100028
J	Park, JB; Yiu, G; Kaneko, S; Wang, J; Chang, JF; He, ZG				Park, JB; Yiu, G; Kaneko, S; Wang, J; Chang, JF; He, ZG			A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; OPTIC-NERVE REGENERATION; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; NEUROTROPHIN RECEPTOR; SIGNALING PATHWAY; AXON REGENERATION; SENSORY NEURONS; GLYCOPROTEIN; EXPRESSION	A major obstacle for successful axon regeneration in the adult central nervous system (CNS) arises from inhibitory molecules in CNS myelin, which signal through a common receptor complex on neurons consisting of the ligand-binding Nogo-66 receptor (NgR) and two transmembrane coreceptors, p75 and LINGO-1. However, p75 expression is only detectable in sub-populations of mature neurons, raising the question of how these inhibitory signals are transduced in neurons lacking p75. In this study, we demonstrate that TROY (also known as TAJ), a TNF receptor family member selectively expressed in the adult nervous system, can form a functional receptor complex with NgR and LINGO-1 to mediate cellular responses to myelin inhibitors. Also, both overexpressing a dominant-negative TROY or presence of a soluble TROY protein can efficiently block neuronal response to myelin inhibitors. Our results implicate TROY in mediating myelin inhibition, offering new insights into the molecular mechanisms of regeneration failure in the adult nervous system.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	He, ZG (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Yiu, Glenn/AAF-2858-2020	Yiu, Glenn/0000-0003-3061-3310				Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Niederost B, 2002, J NEUROSCI, V22, P10368; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; RENNO T, 1995, J IMMUNOL, V154, P944; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006	42	319	360	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					345	351		10.1016/j.neuron.2004.12.040	http://dx.doi.org/10.1016/j.neuron.2004.12.040			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694321	Bronze			2022-12-24	WOS:000226787700007
J	Hashimotodani, Y; Ohno-Shosaku, T; Tsubokawa, H; Ogata, H; Emoto, K; Maejima, T; Araishi, K; Shin, HS; Kano, M				Hashimotodani, Y; Ohno-Shosaku, T; Tsubokawa, H; Ogata, H; Emoto, K; Maejima, T; Araishi, K; Shin, HS; Kano, M			Phospholipase C beta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal	NEURON			English	Article							DEPOLARIZED POSTSYNAPTIC NEURONS; LIVER PLASMA-MEMBRANES; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; INOSITOL 1,4,5-TRISPHOSPHATE; RECEPTOR REGULATION; CALCIUM; ACTIVATION; RELEASE; CELLS	Endocannabinoids mediate retrograde signal and modulate transmission efficacy at various central synapses. Although endocannabinoid release is induced by either depolarization or activation of G(q/11)-coupled receptors, it is markedly enhanced by the coincidence of depolarization and receptor activation. Here we report that this coincidence is detected by phospholipase Cbeta1 (PLCbeta1) in hippocampal neurons. By measuring cannabinoid-sensitive synaptic currents, we found that the receptor-driven endocannabinoid release was dependent on physiological levels of intracellular Call concentration ([Ca2+]i), and markedly enhanced by depolarization-induced [Call]i elevation. Furthermore, we measured PLC activity in intact neurons by using exogenous TRPC6 channel as a biosensor for the PLC product diacylglycerol and found that the receptor-driven PLC activation exhibited similar [Calli dependence to that of endocannabinoid release. Neither endocannabinoid release nor PLC activation was induced by receptor activation in PLCbeta1 knockout mice. We therefore conclude that PLCbeta1 serves as a coincidence detector through its Call dependency for endocannabinoid release in hippocampal neurons.	Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Tohoku Univ, Grad Sch Informat Sci, Lab Life Fluctuomat, Sendai, Miyagi 9808579, Japan; Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Kobe Univ, Grad Sch Med, Div Cell Biol, Kobe, Hyogo 6500017, Japan; Korea Inst Sci & Technol, Ctr Calcium & Learning, Natl Creat Res Initit, Seoul 136791, South Korea	Kanazawa University; Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kobe University; Korea Institute of Science & Technology (KIST)	Kano, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan.	mkano@med.kanazawa-u.ac.jp	Ohno-Shosaku, Takako/C-3250-2015; Ogata, Hidenori/GXN-3776-2022; Hashimotodani, Yuki/W-4690-2018	Ogata, Hidenori/0000-0001-8932-9731; Hashimotodani, Yuki/0000-0001-6723-2736; Kano, Masanobu/0000-0002-0725-3292				Alger BE, 2002, PROG NEUROBIOL, V68, P247; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; CREPEL V, 1994, J NEUROPHYSIOL, V72, P1561, DOI 10.1152/jn.1994.72.4.1561; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DELRIO E, 1994, J NEUROCHEM, V63, P535; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FISHER SK, 1989, MOL PHARMACOL, V35, P195; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Gee CE, 2003, J PHYSIOL-LONDON, V546, P655, DOI 10.1113/jphysiol.2002.032961; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Irving AJ, 1998, J PHYSIOL-LONDON, V511, P747, DOI 10.1111/j.1469-7793.1998.747bg.x; Kano M, 2002, MOL PSYCHIATR, V7, P234, DOI 10.1038/sj.mp.4000999; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim J, 2002, J NEUROSCI, V22, P10182; KONNERTH A, 1996, COINCEDENCE DETECTIO; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Masgrau R, 2001, EUR J NEUROSCI, V13, P248, DOI 10.1046/j.0953-816X.2000.01384.x; Masgrau R, 2000, J NEUROCHEM, V74, P818, DOI 10.1046/j.1471-4159.2000.740818.x; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Nakahara N, 2000, REFR SCI T, V2000, P1; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; UHING RJ, 1986, J BIOL CHEM, V261, P2140; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; J NEUROSCI, V20, P8365	73	240	249	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					257	268		10.1016/j.neuron.2005.01.004	http://dx.doi.org/10.1016/j.neuron.2005.01.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664177	Bronze, Green Submitted			2022-12-24	WOS:000226451500012
J	Linkenhoker, BA; von der Ohe, CG; Knudsen, EI				Linkenhoker, BA; von der Ohe, CG; Knudsen, EI			Anatomical traces of juvenile learning in the auditory system of adult barn owls	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; SPACE MAP; OPTIC TECTUM; VISUAL CALIBRATION; NEURAL REPRESENTATION; INFERIOR COLLICULUS; LOCALIZATION; MIDBRAIN; TIME; SITE	Early experience plays a powerful role in shaping adult neural circuitry and behavior. In barn owls, early experience markedly influences sound localization. Juvenile owls that learn new, abnormal associations between auditory cues and locations in visual space as a result of abnormal visual experience can readapt to the same abnormal experience in adulthood, when plasticity is otherwise limited. Here we show that abnormal anatomical projections acquired during early abnormal sensory experience persist long after normal experience has been restored. These persistent projections are perfectly situated to provide a physical framework for subsequent readaptation in adulthood to the abnormal sensory conditions experienced in early life. Our results show that anatomical changes that support strong learned neural connections early in life can persist even after they are no longer functionally expressed. This maintenance of silenced neural circuitry that was once adaptive may represent an important mechanism by which the brain preserves a record of early experience.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Sci Bldg, Stanford, CA 94305 USA.	eknudsen@stanford.edu						Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hyde PS, 2002, NATURE, V415, P73, DOI 10.1038/415073a; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; Kuhl PK, 1998, DAHLEM WORK, P53; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; OLSEN JF, 1989, J NEUROSCI, V9, P2591; SOMOGYI P, 1982, J NEUROCYTOL, V11, P779, DOI 10.1007/BF01153519; Spitz R, 1946, PSYCHOANALYTIC STUDY, V2; TAKAHASHI TT, 1987, J NEUROSCI, V7, P1843; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	20	61	62	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					93	98		10.1038/nn1367	http://dx.doi.org/10.1038/nn1367			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608636				2022-12-24	WOS:000225967600021
J	Feng, YY; Walsh, CA				Feng, YY; Walsh, CA			Mitotic spindle regulation by Nde1 controls cerebral cortical size	NEURON			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; CELL-DIVISION; ASYMMETRIC DISTRIBUTION; LISSENCEPHALY GENE; TUMOR-SUPPRESSOR; PRECURSOR CELLS; PROTEIN; LIS1	Ablation of the LIS1-interacting protein Nde1 (formerly mNudE) in mouse produces a small brain (microcephaly), with the most dramatic reduction affecting the cerebral cortex. While cortical lamination is mostly preserved, the mutant cortex has fewer neurons and very thin superficial cortical layers (II to IV). BrdU birthdating revealed retarded and modestly disorganized neuronal migration; however, more dramatic defects on mitotic progression, mitotic orientation, and mitotic chromosome localization in cortical progenitors were observed in Nde1 mutant embryos. The small cerebral cortex seems to reflect both reduced progenitor cell division and altered neuronal cell fates. In vitro analysis demonstrated that Nde1 is essential for centrosome duplication and mitotic spindle assembly. Our data show that mitotic spindle function and orientation are essential for normal development of mammalian cerebral cortex.	Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Howard Hughes Med I, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Howard Hughes Med I, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	NICHD NIH HHS [P30HD18655] Funding Source: Medline; NIMH NIH HHS [K01MH065338] Funding Source: Medline; NINDS NIH HHS [P01 NS40043, R01 NS032457] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH065338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043, R01NS032457] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; BARKOVICH AJ, 1991, ANN NEUROL, V30, P139, DOI 10.1002/ana.410300204; Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOE CQ, 1995, NEURON, V15, P991, DOI 10.1016/0896-6273(95)90088-8; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; NIETO M, 2004, IN PRESS J COMP NEUR; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RAKIC P, 1988, PROG BRAIN RES, V73, P15; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shen Q, 2002, DEVELOPMENT, V129, P4843; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sweeney KJ, 2001, MECH DEVELOP, V101, P21, DOI 10.1016/S0925-4773(00)00543-8; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	57	273	282	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					279	293		10.1016/j.neuron.2004.09.023	http://dx.doi.org/10.1016/j.neuron.2004.09.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473967	Bronze			2022-12-24	WOS:000224635800011
J	Schneider, VA; Granato, M				Schneider, Valerie A.; Granato, Michael			The myotomal diwanka (lh3) glycosyltransferase and type XVIII collagen are critical for motor growth cone migration	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; LYSYL HYDROXYLASE ISOFORMS; PERIPHERAL NERVOUS-SYSTEM; MIDLINE AXON GUIDANCE; EXTRACELLULAR-MATRIX; IV COLLAGEN; LYSYL-HYDROXYLASE-3 LH3; EMBRYONIC ZEBRAFISH; FLOOR PLATE; NC1 DOMAIN	The initial migration of motor growth cones from the spinal cord into the periphery requires extrinsic cues, yet their identities are largely unknown. In zebrafish diwanka mutants, motor growth cones are motile but fail to pioneer into the periphery. Here, we report on the positional cloning of diwanka and show that it encodes LH3, a myotomally expressed multifunctional enzyme with lysyl hydroxylase and glycosyltransferase domains. Cloning, expression analysis, and ubiquitous overexpression of other LH family members reveals that only diwanka (lh3) possesses a critical role in growth cone migration. We show that this unique role depends critically on the LH3 glycosyltransferase domain, and provide compelling evidence that diwanka (W) acts through myotomal type XVIII collagen, a ligand for neural-receptor protein tyrosine phosphatases that guide motor axons. Together, our results provide the first genetic evidence that glycosyltransferase modifications of the ECM playa critical role during vertebrate motor axon migration.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu		Schneider, Valerie/0000-0002-3442-1888	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037975-10, R01 HD037975, R01 HD037975-09] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Allan DW, 1998, J COMP NEUROL, V391, P275, DOI 10.1002/(SICI)1096-9861(19980216)391:3<275::AID-CNE1>3.0.CO;2-Z; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Bernhardt RR, 1998, DEV DYNAM, V213, P334, DOI 10.1002/(SICI)1097-0177(199811)213:3<334::AID-AJA9>3.0.CO;2-4; Bhatt RS, 2000, GENE DEV, V14, P2216, DOI 10.1101/gad.821600; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cerda J, 2002, DEV DYNAM, V224, P200, DOI 10.1002/dvdy.10101; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Ensslen-Craig SE, 2004, DEV BIOL, V275, P12, DOI 10.1016/j.ydbio.2004.08.009; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; GREENSPOON S, 1995, J NEUROSCI, V15, P5956; Haftek Z, 2003, GENE EXPR PATTERNS, V3, P351, DOI 10.1016/S1567-133X(03)00027-9; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Iglesias M, 1996, NEUROSCI LETT, V207, P81, DOI 10.1016/0304-3940(96)12506-4; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Krull CE, 2000, BRAIN RES BULL, V53, P479, DOI 10.1016/S0361-9230(00)00381-6; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P308, DOI 10.1016/0012-1606(90)90300-8; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sajnani-Perez G, 2003, MOL CELL NEUROSCI, V22, P37, DOI 10.1016/S1044-7431(02)00026-X; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Schneider VA, 2003, DEV BIOL, V263, P1, DOI 10.1016/S0012-1606(03)00329-4; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Suokas M, 2003, BIOCHEM J, V370, P913, DOI 10.1042/BJ20021533; Tai MH, 2002, J NEUROCYTOL, V31, P743, DOI 10.1023/A:1025756015281; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2000, DNA CELL BIOL, V19, P71, DOI 10.1089/104454900314582; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	65	71	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					683	695		10.1016/j.neuron.2006.04.024	http://dx.doi.org/10.1016/j.neuron.2006.04.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731508	Bronze			2022-12-24	WOS:000238165000005
J	Soler-Llavina, GJ; Sabatini, BL				Soler-Llavina, Gilberto J.; Sabatini, Bernardo L.			Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells	NATURE NEUROSCIENCE			English	Article							BOVINE CHROMAFFIN CELLS; CALCIUM-PERMEABLE AMPA; DENDRITIC SPINES; HIPPOCAMPAL INTERNEURONS; PURKINJE-CELLS; RETROGRADE INHIBITION; ENDOGENOUS CANNABINOIDS; EXCITATORY SYNAPSES; CA2+; RECEPTORS	Here we demonstrate that cerebellar stellate cells diffusionally isolate synaptically evoked signals in dendrites and are capable of input-specific synaptic plasticity. Sustained activity of parallel fibers induces a form of long-term depression that requires opening of calcium (Ca21)-permeable AMPA-type glutamate receptors (CP-AMPARs) and signaling through class 1 metabotropic glutamate receptors (mGluR1) and CB1 receptors. This depression is induced by postsynaptic increases in Ca2+ concentration ([Ca2+]) and is limited to activated synapses. To understand how synapse-specific plasticity is induced by diffusible second messengers in aspiny dendrites, we examined diffusion of Ca2+ and small molecules within stellate cell dendrites. Activation of a single parallel fiber opened CP-AMPARs, generating long-lived Ca2+ transients that were confined to submicron dendritic stretches. The diffusion of Ca2+ was severely retarded due to interactions with parvalbumin and a general restriction of small molecule mobility. Thus stellate cell dendrites spatially restrict signaling cascades that lead from CP-AMPAR activation to endocannabinoid production and trigger the selective regulation of active synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049655, R01NS046579] Funding Source: NIH RePORTER; NINDS NIH HHS [1 F31 NS049655-01, R01 NS046579] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; HOU TT, 1991, J PHYSIOL-LONDON, V441, P285, DOI 10.1113/jphysiol.1991.sp018752; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; PALAY SL, 1974, STELLATE CELL, P216; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; POPOV S, 1992, J NEUROSCI, V12, P77; Rancillac A, 2005, J NEUROSCI RES, V80, P414, DOI 10.1002/jnr.20473; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rozsa B, 2004, J NEUROSCI, V24, P661, DOI 10.1523/JNEUROSCI.3906-03.2004; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Xia P, 1998, BIOPHYS J, V74, P3302, DOI 10.1016/S0006-3495(98)78037-3; YASUDA R, 2004, SCI STKE, pP15; ZADOR A, 1994, J NEUROSCI, V14, P4705; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	50	123	127	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					798	806		10.1038/nn1698	http://dx.doi.org/10.1038/nn1698			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680164				2022-12-24	WOS:000237895200020
J	Vigot, R; Barbieri, S; Brauner-Osborne, H; Turecek, R; Shigemoto, R; Zhang, YP; Lujan, R; Jacobson, LH; Biermann, B; Fritschy, JM; Vacher, CM; Muller, M; Sansig, G; Guetg, N; Cryan, JF; Kaupmann, K; Gassmann, M; Oertner, TG; Bettler, B				Vigot, Rejan; Barbieri, Samuel; Brauner-Osborne, Hans; Turecek, Rostislav; Shigemoto, Ryuichi; Zhang, Yan-Ping; Lujan, Rafael; Jacobson, Laura H.; Biermann, Barbara; Fritschy, Jean-Marc; Vacher, Claire-Marie; Mueller, Matthias; Sansig, Gilles; Guetg, Nicole; Cryan, John F.; Kaupmann, Klemens; Gassmann, Martin; Oertner, Thomas G.; Bettler, Bernhard			Differential compartmentalization and distinct functions of GABA(B) receptor variants	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PYRAMIDAL CELLS; SILENT SYNAPSES; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; INHIBITORY SYNAPSES; GLUTAMATE RELEASE; K+ CHANNELS; CA1 REGION; PROTEIN	GABA(B) receptors are the G protein-coupled receptors for the main inhibitory neurotransmitter in the brain, gamma-aminobutyric acid (GABA). Molecular diversity in the GABA(B) system arises from the GABA(B1a) and GABA(B1b) subunit isoforms that solely differ in their ectodomains by a pair of sushi repeats that is unique to GABA(B1a). Using a combined genetic, physiological, and morphological approach, we now demonstrate that GABA(B1) isoforms localize to distinct synaptic sites and convey separate functions in vivo. At hippocampal CA3-to-CA1 synapses, GABA(B1a) assembles heteroreceptors inhibiting glutamate release, while predominantly GABA(B1b) mediates postsynaptic inhibition. Electron microscopy reveals a synaptic distribution of GABA(B1) isoforms that agrees with the observed functional differences. Transfected CA3 neurons selectively express GABA(B1a) in distal axons, suggesting that the sushi repeats, a conserved protein interaction motif, specify heteroreceptor localization. The constitutive absence of GABA(B1a) but not GABA(B1b) results in impaired synaptic plasticity and hippocampus-dependent memory, emphasizing molecular differences in synaptic GABA(B) functions.	Univ Basel, Inst Physiol, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland; Danish Univ Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark; Acad Sci Czech Republ, Inst Expt Med, Prague 14220, Czech Republic; Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, CRIB, Albacete 02006, Spain; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Basel; University of Copenhagen; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Friedrich Miescher Institute for Biomedical Research; Universidad de Castilla-La Mancha; Novartis; University of Zurich	Bettler, B (corresponding author), Univ Basel, Inst Physiol, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch	Bräuner-Osborne, Hans/D-7260-2011; Jacobson, Laura/A-3363-2013; Turecek, Rostislav/H-2706-2014; Cryan, John F./A-6950-2013; jacobson, laura/AAI-7429-2021; Turecek, Rostislav/AAL-3523-2020; bettler, bernhard/AAO-8018-2020; Shigemoto, Ryuichi/E-3628-2013; Oertner, Thomas/F-2214-2010; Lujan, Rafael/G-2555-2015	Bräuner-Osborne, Hans/0000-0001-9495-7388; Cryan, John F./0000-0001-5887-2723; jacobson, laura/0000-0003-2910-8659; Turecek, Rostislav/0000-0003-4978-7556; Shigemoto, Ryuichi/0000-0001-8761-9444; Oertner, Thomas/0000-0002-2312-7528; Bettler, Bernhard/0000-0003-0842-8207; Gassmann, Martin/0000-0001-6201-3032; Lujan Miras, Rafael/0000-0003-2001-9545; Kaupmann, Klemens/0000-0001-8903-2508; Vacher, Claire-Marie/0000-0002-2966-8149; Zhang, Yan-Ping/0000-0001-7602-4453; Fritschy, Jean-Marc/0000-0002-8552-3702	NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH069062] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARNES CA, 1994, J NEUROSCI, V14, P5793; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Bonanno G, 1997, BRIT J PHARMACOL, V120, P60, DOI 10.1038/sj.bjp.0700852; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Cunningham MD, 1996, BRAIN RES, V720, P220, DOI 10.1016/0006-8993(96)00120-5; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; GEMIGNANI A, 1994, MOL PHARMACOL, V46, P558; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Martin SC, 2001, GENE, V278, P63, DOI 10.1016/S0378-1119(01)00678-3; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Pozza MF, 1999, BRIT J PHARMACOL, V127, P211, DOI 10.1038/sj.bjp.0702498; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	61	240	255	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					589	601		10.1016/j.neuron.2006.04.014	http://dx.doi.org/10.1016/j.neuron.2006.04.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701209	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000237875200010
J	Lauri, SE; Vesikansa, A; Segerstale, M; Collingridge, GL; Isaac, JTR; Taira, T				Lauri, Sari E.; Vesikansa, Aino; Segerstale, Mikael; Collingridge, Graham L.; Isaac, John T. R.; Taira, Tomi			Functional maturation of CA1 synapses involves activity-dependent loss of tonic kainate receptor-mediated inhibition of glutamate release	NEURON			English	Article							MOSSY FIBER SYNAPSES; LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; SILENT SYNAPSES; AREA CA1; METABOTROPIC FUNCTION; AMPA; ACTIVATION; PLASTICITY	Early in development, excitatory synapses transmit with low efficacy, one mechanism for which is a low probability of transmitter release (Pr). However, little is known about the developmental mechanisms that control activity-dependent maturation of the presynaptic release. Here, we show that during early development, transmission at CA3-CA1 synapses is regulated by a high-affinity, G protein-dependent kainate receptor (KAR), which is endogenously activated by ambient glutamate. By tonically depressing glutamate release, this mechanism sets the dynamic properties of neonatal inputs to favor transmission during high frequency bursts of activity, typical for developing neuronal networks. In response to induction of LTP, the tonic activation of KAR is rapidly down regulated, causing an increase in Pr and profoundly changing the dynamic properties of transmission. Early development of the glutamatergic connectivity thus involves an activity-dependent loss of presynaptic KAR function producing maturation in the mode of excitatory transmission from CA3 to CA1.	Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Bio & Environm Sci, FIN-00014 Helsinki, Finland; Univ Bristol, Sch Med, MRC, Ctr Synapt Plast,Dept Anat, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Helsinki; University of Helsinki; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Taira, T (corresponding author), Univ Helsinki, Ctr Neurosci, POB 65 Viikinkaari 1, FIN-00014 Helsinki, Finland.	tomi.taira@helsinki.fi	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Lauri, Sari/AAD-6417-2021	Collingridge, Graham L/0000-0002-9572-5359; Lauri, Sari/0000-0002-5895-1357	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BAHN S, 1994, J NEUROSCI, V14, P5525; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clarke VRJ, 2002, NEUROPHARMACOLOGY, V42, P889, DOI 10.1016/S0028-3908(02)00039-4; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hanse E, 2001, J PHYSIOL-LONDON, V537, P141, DOI 10.1111/j.1469-7793.2001.0141k.x; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lahtinen H, 2002, J NEUROPHYSIOL, V88, P1469, DOI 10.1152/jn.2002.88.3.1469; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; LAURI SE, 2005, IN PRESS J NEUROSCI; LAURI SE, 2004, MOL NEUROPHARMACOLOG, P27; Lee CJ, 2001, J NEUROSCI, V21, P4572, DOI 10.1523/JNEUROSCI.21-13-04572.2001; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maggi L, 2004, J PHYSIOL-LONDON, V559, P863, DOI 10.1113/jphysiol.2004.067041; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rozas JL, 2003, NEURON, V39, P543, DOI 10.1016/S0896-6273(03)00436-7; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Safiulina VF, 2005, J NEUROPHYSIOL, V94, P2797, DOI 10.1152/jn.00445.2005; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sykova E, 2000, PROG BRAIN RES, V125, P155; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Wasling P, 2004, J NEUROPHYSIOL, V92, P2714, DOI 10.1152/jn.00464.2004; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	59	101	103	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					415	429		10.1016/j.neuron.2006.03.020	http://dx.doi.org/10.1016/j.neuron.2006.03.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675396	Bronze			2022-12-24	WOS:000237726800011
J	Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM				Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM			Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia	NATURE NEUROSCIENCE			English	Article							EFFLUX	The blood-brain barrier possesses active transporters carrying brain-permeable xenobiotics back into the blood against concentration gradients. We demonstrate that multidrug resistance transporter (Mdr)-1 is upregulated on capillary endothelium after focal cerebral ischemia; moreover, Mdr-1 deactivation by pharmacological inhibition or genetic knockout preferably enhances the accumulation and efficacy of two neuroprotectants known as Mdr-1 substrates in the ischemic brain. We predict that Mdr-1 inhibition may greatly facilitate neuroprotective therapies.	Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Clin Chem, CH-8091 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hermann, DM (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	dirk.hermann@usz.ch	Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M/AAP-5538-2020; Kilic, Ertugrul/W-4563-2018; Hermann, Dirk M./AAT-3652-2021	Kilic, Ertugrul/0000-0001-6494-8923; Hermann, Dirk M./0000-0003-0198-3152; Bassetti, Claudio/0000-0002-4535-0245				Comerford KM, 2002, CANCER RES, V62, P3387; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Sisodiya SM, 2001, LANCET, V357, P42, DOI 10.1016/S0140-6736(00)03573-X; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Yulug B, 2004, BRAIN RES, V996, P76, DOI 10.1016/j.brainres.2003.10.012	11	126	133	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					487	488		10.1038/nn1676	http://dx.doi.org/10.1038/nn1676			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16565717				2022-12-24	WOS:000236310700014
J	Sawamura, H; Orban, GA; Vogels, R				Sawamura, H; Orban, GA; Vogels, R			Selectivity of neuronal adaptation does not match response selectivity: A single-cell study of the fMRI adaptation paradigm	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; TERM MOTION ADAPTATION; MACAQUE AREA MT; INFEROTEMPORAL CORTEX; RECOGNITION MEMORY; RECEPTIVE-FIELDS; VISUAL-MOTION; OBJECT SHAPE; ANTERIOR; REPRESENTATION	fMRI-based adaptation paradigms (fMR-A) have been used to infer neuronal stimulus selectivities in humans. Inferring neuronal selectivities from fMR-A, however, requires an understanding of the relationship between the stimulus selectivity of neuronal adaptation and responses. We studied this relationship by recording single cells in macaque inferior temporal (IT)cortex, an area that shows fMRI adaptation. Repetition of identical object images reduced the responsiveness of single IT neurons. Presentation of an image to which the neuron was unresponsive did not alter the response to a subsequent image that activated the neuron. Successive presentation of two different images to which the neuron responded similarly produced adaptation, but less so than the repeated presentation of an image. The neuronal adaptation at the single-cell level showed a greater degree of stimulus selectivity than the responses. This complicates the interpretation of fMR-A paradigms when inferring neuronal selectivity.	Catholic Univ Louvain, Sch Med, Lab Neuro Psychofysiol, B-3000 Louvain, Belgium	Universite Catholique Louvain	Vogels, R (corresponding author), Catholic Univ Louvain, Sch Med, Lab Neuro Psychofysiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.be		Orban, Guy/0000-0002-8179-9584				Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2003, J NEUROSCI, V23, P8781; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; FAHY FL, 1993, EXP BRAIN RES, V96, P457; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1967, J NEUROPHYSIOL, V30, P833, DOI 10.1152/jn.1967.30.4.833; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P370, DOI 10.1152/jn.2002.88.1.370; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; RICHES IP, 1991, J NEUROSCI, V11, P1763; Ringo JL, 1996, BEHAV BRAIN RES, V76, P191, DOI 10.1016/0166-4328(95)00197-2; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P3120; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6	57	249	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					307	318		10.1016/j.neuron.2005.11.028	http://dx.doi.org/10.1016/j.neuron.2005.11.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423703	Bronze			2022-12-24	WOS:000234979900016
J	Small, DM; Gerber, JC; Mak, YE; Hummel, T				Small, DM; Gerber, JC; Mak, YE; Hummel, T			Differential neural responses evoked by orthonasal versus retronasal odorant perception in humans	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; HUMAN AMYGDALA; SPATIOTEMPORAL ANALYSIS; GUSTATORY STIMULATION; EMOTIONAL RESPONSES; REWARD; TASTE; BRAIN; ACTIVATION	Odors perceived through the mouth (retronasally) as flavor are referred to the oral cavity, whereas odors perceived through the nose (orthonasally) are referred to the external world. We delivered vaporized odorants via the orthonasal and retronasal routes and measured brain response with fMRI. Comparison of retronasal versus orthonasal delivery produced preferential activity in the mouth area at the base of the central sulcus, possibly reflecting olfactory referral to the mouth, associated with retronasal olfaction. Routes of delivery produced differential activation in the insula/operculum, thalamus, hippocampus, amygdala, and caudolateral orbitofrontal cortex in orthonasal > retronasal and in the perigenual cingulate and medial orbitofrontal cortex in retronasal > orthonasal in response to chocolate, but not lavender, butanol, or farnesol, so that an interaction of route and odorant may be inferred. These findings demonstrate differential neural recruitment depending upon the route of odorant administration and suggest that its effect is influenced by whether an odorant represents a food.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Dept Surg, Sch Med, New Haven, CT 06510 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Univ Dresden, Sch Med, Dept Neuroradiol, D-10307 Dresden, Germany; Univ Dresden, Sch Med, Smell & Taste Clin, D-10307 Dresden, Germany; Univ Dresden, Sch Med, Dept Otorhinolaryngol, D-10307 Dresden, Germany	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Small, DM (corresponding author), John B Pierce Fdn Lab, 290 Congress Ave, New Haven, CT 06519 USA.	dsmall@jbpierce.org	Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700; Small, Dana/0000-0001-7363-1100	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006169] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC006169-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Balleine BW, 2000, J NEUROSCI, V20, P8954; Baxter MG, 2000, J NEUROSCI, V20, P4311; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Boling W, 2002, J NEUROSURG, V97, P388, DOI 10.3171/jns.2002.97.2.0388; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Chiavaras MM, 2000, J COMP NEUROL, V422, P35; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Frey S, 1999, EUR J NEUROSCI, V11, P2985, DOI 10.1046/j.1460-9568.1999.00738.x; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Heilmann S, 2004, BEHAV NEUROSCI, V118, P412, DOI 10.1037/0735-7044.118.2.412; HEILMANN S, 2001, CHEM SENSES, V26, P1086; Holland PC, 2002, PHYSIOL BEHAV, V76, P117, DOI 10.1016/S0031-9384(02)00688-1; HUMMEL T, 2005, IN PRESS FLAVOR FRAG; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; KOBAL G, 1981, ELECTROPHYSIOLOGISCH, P18; Kobayakawa T, 1996, NEUROSCI LETT, V212, P155, DOI 10.1016/0304-3940(96)12798-1; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Morris JS, 2001, J NEUROSCI, V21, P5304, DOI 10.1523/JNEUROSCI.21-14-05304.2001; MOZELL MM, 1969, ARCH OTOLARYNGOL, V90, P367; MOZELL MM, 1966, J GEN PHYSIOL, V50, P25, DOI 10.1085/jgp.50.1.25; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; MURPHY C, 1977, SENS PROCESS, V1, P204; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Pardo JV, 1997, NEUROSCI LETT, V234, P23, DOI 10.1016/S0304-3940(97)00650-2; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Royet JP, 2000, J NEUROSCI, V20, P7752; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; VOIROL E, 1986, LEBENSM WISS TECHNOL, V19, P316; WHITE NM, 1989, NEUROSCI BIOBEHAV R, V13, P181, DOI 10.1016/S0149-7634(89)80028-4; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	88	273	280	4	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					593	605		10.1016/j.neuron.2005.07.022	http://dx.doi.org/10.1016/j.neuron.2005.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102541	Bronze			2022-12-24	WOS:000231411100015
J	Sandberg, M; Kallstrom, M; Muhr, J				Sandberg, M; Kallstrom, M; Muhr, J			Sox21 promotes the progression of vertebrate neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURONAL DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MAMMALIAN-CELLS; NERVOUS-SYSTEM; STEM-CELLS; EXPRESSION; IDENTITY; PROTEIN; GENES; LOOP	The generation of neurons constitutes the foundation of nervous system development, yet the mechanisms underlying neurogenesis are not well established. The HMG-box transcription factors Sox1, Sox2 and Sox3 ( Sox1 - 3) have previously been shown to suppress neurogenesis by maintaining neural cells in an undifferentiated state. Here we report that another HMG-box protein, Sox21, has the opposite activity and promotes neuronal differentiation. Using genetic studies in the chick embryo, we found that Sox21 mediates this function by counteracting the activity of Sox1 - 3. Accordingly, the balance of Sox21 and Sox1 - 3 activities determines whether neural cells remain as progenitors or commit to differentiation. Proneural basic helix-loop-helix proteins are essential for the establishment of neuronal fates. We now show that proneural proteins promote neurogenesis by upregulating Sox21 expression. These data establish a key role for Sox21 in the progression of neuronal differentiation and indicate that an important role of proneural proteins is their capacity to upregulate the expression of Sox21.	Karolinska Inst, Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research	Muhr, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Box 240, SE-17177 Stockholm, Sweden.	jonas.muhr@licr.ki.se		Sandberg, Magnus/0000-0003-0809-0656				Bae SK, 2000, DEVELOPMENT, V127, P2933; Beranger F, 2000, J BIOL CHEM, V275, P16103, DOI 10.1074/jbc.275.21.16103; Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohba H, 2004, NEUROSCI LETT, V358, P157, DOI 10.1016/j.neulet.2004.01.026; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Smith ST, 1996, DEVELOPMENT, V122, P3141; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090	39	153	158	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					995	1001		10.1038/nn1493	http://dx.doi.org/10.1038/nn1493			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995704				2022-12-24	WOS:000230760200010
J	Morrone, MC; Ross, J; Burr, D				Morrone, MC; Ross, J; Burr, D			Saccadic eye movements cause compression of time as well as space	NATURE NEUROSCIENCE			English	Article							VISUAL-PERCEPTION; VOLUNTARY ACTION; PARIETAL CORTEX; REPRESENTATION; ATTENTION; DURATION; LOCALIZATION; SUPPRESSION; INTEGRATION; AWARENESS	There is now considerable evidence that space is compressed when stimuli are flashed shortly before or after the onset of a saccadic eye movement. Here we report that short intervals of time between two successive perisaccadic visual (but not auditory) stimuli are also underestimated, indicating a compression of perceived time. We were even more surprised that in a critical interval before saccades, perceived temporal order is consistently reversed. The very similar time courses of spatial and temporal compression suggest that both are mediated by a common neural mechanism, probably related to the predictive shifts that occur in receptive fields of many visual areas at the time of saccades.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University; University of Western Australia; University of Florence	Burr, D (corresponding author), CNR, Ist Neurosci, Via Moruzzi 1, I-56100 Pisa, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Burr DC, 1996, VISION RES, V36, P2069, DOI 10.1016/0042-6989(95)00282-0; Carpenter R. H. S., 1988, MOVEMENT EYES; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Enns JT, 1999, J GEN PSYCHOL, V126, P355, DOI 10.1080/00221309909595371; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LIBET B, 1979, BRAIN, V102, P193, DOI 10.1093/brain/102.1.193; MATIN L, 1972, HDB SENSORY PHYSIOLO, V7, P331; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Morrone MC, 1997, J NEUROSCI, V17, P7941; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Park J, 2003, VISION RES, V43, P1667, DOI 10.1016/S0042-6989(03)00217-7; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; RIDDER WH, 1993, VISION RES, V33, P1795, DOI 10.1016/0042-6989(93)90170-2; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; ROSS J, 1972, 4 U W AUSTR DEP PSYC; Santoro L, 2002, VISION RES, V42, P1361, DOI 10.1016/S0042-6989(02)00056-1; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	40	292	296	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					950	954		10.1038/nn1488	http://dx.doi.org/10.1038/nn1488			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965472				2022-12-24	WOS:000230137100023
J	Goto, Y; Grace, AA				Goto, Y; Grace, AA			Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior	NATURE NEUROSCIENCE			English	Article							SCHIZOPHRENIA; RECEPTOR; RAT; BINDING; SYSTEM; PATHOPHYSIOLOGY; HIPPOCAMPAL; PERFORMANCE; HYPOTHESIS; STRIATUM	Goal-directed behavior is believed to involve interactions of prefrontal cortical and limbic inputs in the nucleus accumbens (NAcc), and their modulation by mesolimbic dopamine (DA) seems to be of primary importance in NAcc function. Using in vivo electrophysiological recordings simultaneously with DA system manipulation in rats, we show that tonic and phasic DA release selectively modulates hippocampal and prefrontal cortical inputs through D1 and D2 receptors, respectively. In addition, we also found that D1 activation and D2 inactivation in the NAcc produced behaviorally selective effects ( learning versus set shifting of response strategy) that correspond to specific afferents. These results suggest that the dynamics of DA release regulate the balance between limbic and cortical drive through activation and inactivation of DA receptor subtypes in the accumbens, and this regulates goal-directed behavior.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat & Psychol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goto, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	goto@bns.pitt.edu		Grace, Anthony/0000-0003-1864-5504	NIMH NIH HHS [MH57440] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440, R01MH057440] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albertin SV, 2000, BEHAV BRAIN RES, V117, P173, DOI 10.1016/S0166-4328(00)00303-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Charara A, 2003, NEUROPSYCHOPHARMACOL, V28, P1412, DOI 10.1038/sj.npp.1300220; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CREESE I, 1983, ANNU REV NEUROSCI, V6, P43, DOI 10.1146/annurev.ne.06.030183.000355; Csernansky JG, 1998, SCHIZOPHRENIA BULL, V24, P231, DOI 10.1093/oxfordjournals.schbul.a033323; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Floresco SB, 1997, J NEUROSCI, V17, P1880; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 1999, PSYCHOBIOLOGY, V27, P277; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Grunder G, 2003, ARCH GEN PSYCHIAT, V60, P974, DOI 10.1001/archpsyc.60.10.974; HALL H, 1985, EUR J PHARMACOL, V111, P191, DOI 10.1016/0014-2999(85)90756-3; Humeau Y, 2002, J NEUROSCI, V22, P7968; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Phillips PEM, 2004, NAT NEUROSCI, V7, P199, DOI 10.1038/nn0304-199a; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; VOORN P, 1986, J COMP NEUROL, V251, P84, DOI 10.1002/cne.902510106; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495	34	434	440	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					805	812		10.1038/nn1471	http://dx.doi.org/10.1038/nn1471			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908948				2022-12-24	WOS:000229345300022
J	Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ				Lee, A; Kessler, JD; Read, TA; Kaiser, C; Corbeil, D; Huttner, WB; Johnson, JE; Wechsler-Reya, RJ			Isolation of neural stem cells from the postnatal cerebellum	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; BRAIN-TUMORS; MOUSE CEREBELLUM; PRECURSOR CELLS; SONIC HEDGEHOG; WHITE-MATTER; IN-VITRO; CNS; NEURONS	The cerebellum is critical for motor coordination and cognitive function and is the target of transformation in medulloblastoma, the most common malignant brain tumor in children. Although the development of granule cells, the most abundant neurons in the cerebellum, has been studied in detail, the origins of other cerebellar neurons and glia remain poorly understood. Here we show that the murine postnatal cerebellum contains multipotent neural stem cells (NSCs). These cells can be prospectively isolated based on their expression of the NSC marker prominin-1 (CD133) and their lack of markers of neuronal and glial lineages (lin(-)). Purified prominin(+)lin(-) cells form self-renewing neurospheres and can differentiate into astrocytes, oligodendrocytes and neurons in vitro. Moreover, they can generate each of these lineages after transplantation into the cerebellum. Identification of cerebellar stem cells has important implications for the understanding of cerebellar development and the origins of medulloblastoma.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	Duke University; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wechsler-Reya, RJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	rw.reya@duke.edu	Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Johnson, Jane/F-8881-2010; Corbeil, Denis/A-6519-2010; Huttner, Wieland B./P-4080-2018	Corbeil, Denis/0000-0003-1181-3659; Read, Tracy-Ann/0000-0002-5436-1296; /0000-0002-8605-2746; Hartman, Jessica/0000-0003-1578-3389	NIMH NIH HHS [R01 MH067916, R01 MH067916-05, R01 MH067916-01A1, 1R01MH067916-01, R01 MH067916-03, R01 MH067916-04] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067916] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altman J, 1997, DEV CEREBELLAR SYSTE; AOKI E, 1986, NEUROSCI LETT, V68, P267, DOI 10.1016/0304-3940(86)90500-8; ARUGA J, 1994, J NEUROCHEM, V63, P1880; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cheng YH, 2001, J NEUROBIOL, V46, P220, DOI 10.1002/1097-4695(20010215)46:3<220::AID-NEU1004>3.0.CO;2-P; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; GAO WQ, 1994, DEVELOPMENT, V120, P1059; Geisert EE, 1996, J NEUROSCI, V16, P5478; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HAEGEL H, 1993, J CELL BIOL, V122, P1067, DOI 10.1083/jcb.122.5.1067; HALLONET MER, 1990, DEVELOPMENT, V108, P19; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Imura T, 2003, J NEUROSCI, V23, P2824; KATSETOS CD, 1995, ARCH PATHOL LAB MED, V119, P734; Kern JK, 2002, MED HYPOTHESES, V59, P255, DOI 10.1016/S0306-9877(02)00212-8; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MARTIN P, 1995, SCHIZOPHRENIA BULL, V21, P241, DOI 10.1093/schbul/21.2.241; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG RN, 1989, NEUROL CLIN, V7, P25, DOI 10.1016/S0733-8619(18)30826-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Shetty AK, 1998, J NEUROBIOL, V35, P395, DOI 10.1002/(SICI)1097-4695(19980615)35:4<395::AID-NEU7>3.0.CO;2-U; SIMMONS ML, 1992, J NEUROSCI RES, V31, P646, DOI 10.1002/jnr.490310408; Singh SK, 2003, CANCER RES, V63, P5821; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TUCKER RP, 1988, J NEUROSCI, V8, P4503; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	50	374	399	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					723	729		10.1038/nn1473	http://dx.doi.org/10.1038/nn1473			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908947	Green Accepted			2022-12-24	WOS:000229345300011
J	Chacron, MJ; Maler, L; Bastian, J				Chacron, MJ; Maler, L; Bastian, J			Electroreceptor neuron dynamics shape information transmission	NATURE NEUROSCIENCE			English	Article							ELECTRIC FISH; APTERONOTUS-ALBIFRONS; RECEPTIVE-FIELDS; SENSORY NEURONS; STRIATE CORTEX; BRAIN; ADAPTATION; MODULATION; STIMULI; MONKEY	The gymnotiform weakly electric fish Apteronotus leptorhynchus can capture prey using electrosensory cues that are dominated by low temporal frequencies. However, conventional tuning curves predict poor electroreceptor afferent responses to low-frequency stimuli. We compared conventional tuning curves with information tuning curves and found that the latter predicted substantially improved responses to these behaviorally relevant stimuli. Analysis of receptor afferent baseline activity showed that negative correlations reduced low-frequency noise levels, thereby increasing information transmission. Multiunit recordings from receptor afferents showed that this increased information transmission could persist at the population level. Finally, we verified that this increased low-frequency information is preserved in the spike trains of central neurons that receive receptor afferent input. Our results demonstrate that conventional tuning curves can be misleading when certain noise reduction strategies are used by the nervous system.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Oklahoma System; University of Oklahoma - Norman; University of Ottawa	Chacron, MJ (corresponding author), Univ Oklahoma, Dept Zool, 730 Van Vleet Oval, Norman, OK 73019 USA.	mauricejchacron@yahoo.ca		Chacron, Maurice/0000-0002-3032-452X	Canadian Institutes of Health Research [71094-1] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Bennett M.V.L., 1986, P157; Berry MJ, 1998, J NEUROSCI, V18, P2200; Bialek W., 1996, SPIKES EXPLORING NEU; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARR CE, 1990, J NEUROSCI, V10, P3227; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Cook EP, 2004, J NEUROSCI, V24, P7964, DOI 10.1523/JNEUROSCI.5102-03.2004; Dayan P, 2001, THEORETICAL NEUROSCI, P45; DEBOER E, 1968, IEEE T BIOMED ENG, V15, P159; EGGERMONT JJ, 1990, HEARING RES, V43, P181, DOI 10.1016/0378-5955(90)90227-G; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Gabbiani F., 1998, METHODS NEURONAL MOD, P313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Holden AV, 2004, NATURE, V428, P382, DOI 10.1038/428382a; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KLEMM WR, 1981, INT J NEUROSCI, V14, P15, DOI 10.3109/00207458108985812; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; Lebedev MA, 1996, EXP BRAIN RES, V111, P313; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; LOWEN SB, 1992, J ACOUST SOC AM, V92, P803, DOI 10.1121/1.403950; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nelson ME, 1997, J COMP PHYSIOL A, V181, P532, DOI 10.1007/s003590050137; Norsworthy S. R., 1996, DELTA SIGMA DATA CON; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; RISKEN H, 1996, FOKKERPLANCK EQUATIO, P43003; SHIN JH, 1993, INT J ELECTRON, V74, P359, DOI 10.1080/00207219308925840; Shin JH, 2001, NEURAL NETWORKS, V14, P907, DOI 10.1016/S0893-6080(01)00077-6; SHUMWAY CA, 1989, J NEUROSCI, V9, P4388; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P187, DOI 10.1196/annals.1298.020; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WANG XJ, 1995, HDB BRAIN THEORY NEU, P686; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323	45	97	97	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					673	678		10.1038/nn1433	http://dx.doi.org/10.1038/nn1433			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15806098	Green Accepted			2022-12-24	WOS:000228895100029
J	Long, MA; Jutras, MJ; Connors, BW; Burwell, RD				Long, MA; Jutras, MJ; Connors, BW; Burwell, RD			Electrical synapses coordinate activity in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; NEURONAL-ACTIVITY; GAP-JUNCTIONS; SYNCHRONIZATION; TRANSMISSION; NETWORKS; TETRODOTOXIN; INTERNEURONS; CHANNELS	In the suprachiasmatic nucleus (SCN), the master circadian pacemaker, neurons show circadian variations in firing frequency. There is also considerable synchrony of spiking across SCN neurons on a scale of milliseconds, but the mechanisms are poorly understood. Using paired whole-cell recordings, we have found that many neurons in the rat SCN communicate via electrical synapses. Spontaneous spiking was often synchronized in pairs of electrically coupled neurons, and the degree of this synchrony could be predicted from the magnitude of coupling. In wild-type mice, as in rats, the SCN contained electrical synapses, but electrical synapses were absent in connexin36-knockout mice. The knockout mice also showed dampened circadian activity rhythms and a delayed onset of activity during transition to constant darkness. We suggest that electrical synapses in the SCN help to synchronize its spiking activity, and that such synchrony is necessary for normal circadian behavior.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Dept Psychol, Providence, RI 02912 USA	Brown University; Brown University	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	bwc@brown.edu	Connors, Barry/AAX-1975-2020; Burwell, Rebecca D/E-4970-2011	Connors, Barry/0000-0002-3739-3157; Burwell, Rebecca/0000-0002-2063-9616	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12500] Funding Source: Medline; NIMH NIH HHS [MH60284] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; Brandstaetter R, 2004, P NATL ACAD SCI USA, V101, P5699, DOI 10.1073/pnas.0401378101; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; Chu ZG, 2003, J NEUROSCI, V23, P96; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Long MA, 2002, J NEUROSCI, V22, P10898; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; Shinohara K, 2001, NEUROSCI LETT, V309, P37, DOI 10.1016/S0304-3940(01)02022-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Srinivas M, 1999, J NEUROSCI, V19, P9848; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; VANDENPOL AN, 1986, NEUROSCIENCE, V17, P643, DOI 10.1016/0306-4522(86)90037-0; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	154	158	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					61	66		10.1038/nn1361	http://dx.doi.org/10.1038/nn1361			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15580271				2022-12-24	WOS:000225967600016
J	Williams, SE; Grumet, M; Colman, DR; Henkemeyer, M; Mason, CA; Sakurai, T				Williams, Scott E.; Grumet, Martin; Colman, David R.; Henkemeyer, Mark; Mason, Carol A.; Sakurai, Takeshi			A role for Nr-CAM in the patterning of binocular visual pathways	NEURON			English	Article							CELL-ADHESION MOLECULES; RETINAL AXON DIVERGENCE; GROWTH CONE BEHAVIOR; OPTIC CHIASM; NEURITE OUTGROWTH; VENTRAL MIDLINE; GANGLION-CELLS; MOUSE EMBRYOS; GUIDANCE; NEURONS	Retinal ganglion cell (RGC) axons diverge within the optic chiasm to project to opposite sides of the brain. In mouse, contralateral RGCs are distributed throughout the retina, whereas ipsilateral RGCs are restricted to the ventrotemporal crescent (VTC). While repulsive guidance mechanisms play a major role in the formation of the ipsilateral projection, little is known about the contribution of growth-promoting interactions to the formation of binocular visual projections. Here, we show that the cell adhesion molecule Nr-CAM is expressed by RGCs that project contralaterally and is critical for the guidance of late-born RGCs within the VTC. Blocking Nr-CAM function causes an increase in the size of the ipsilateral projection and reduces neurite outgrowth on chiasm cells in an age- and region-specific manner. Finally, we demonstrate that EphB1/ephrin-B2-mediated repulsion and Nr-CAM-mediated attraction comprise distinct molecular programs that each contributes to the proper formation of binocular visual pathways.	Mt Sinai Sch Med, Dept Pharmacol & Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biol Chem, New York, NY 10029 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Rutgers State University New Brunswick; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Psychiat, New York, NY 10029 USA.	takeshi.sakurai@mssm.edu	grumet, martin/ABC-6462-2020	Williams, Scott/0000-0001-9975-7334; Henkemeyer, Mark/0000-0002-7525-1061	NEI NIH HHS [R01 EY012736, EY012736, R01 EY015290, T32 EY013933] Funding Source: Medline; NINDS NIH HHS [NS040560] Funding Source: Medline; CSR NIH HHS [RG3217-A-8] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012736, R01EY015290, T32EY013933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040560] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKER GE, 1993, J COMP NEUROL, V330, P95, DOI 10.1002/cne.903300108; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BRUMMENDORF T, 1995, PROTEIN PROFILE, V2, P963; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; CHAN SO, 1993, J NEUROSCI, V13, P5277, DOI 10.1523/JNEUROSCI.13-12-05277.1993; Chan SO, 1999, J COMP NEUROL, V406, P251, DOI 10.1002/(SICI)1096-9861(19990405)406:2<251::AID-CNE8>3.0.CO;2-E; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; Deiner MS, 1999, J NEUROSCI, V19, P9900; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; Lambot MA, 2005, J NEUROSCI, V25, P7232, DOI 10.1523/JNEUROSCI.0802-05.2005; Lin L, 2005, DEV BRAIN RES, V158, P1, DOI 10.1016/j.devbrainres.2005.05.001; Lin L, 2003, EUR J NEUROSCI, V17, P2299, DOI 10.1046/j.1460-9568.2003.02686.x; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Lustig M, 2001, J COMP NEUROL, V434, P13, DOI 10.1002/cne.1161; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Pratt T, 2004, DEVELOPMENT, V131, P3773, DOI 10.1242/dev.01246; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; REESE BE, 1992, J COMP NEUROL, V324, P336, DOI 10.1002/cne.903240304; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	53	70	70	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					535	547		10.1016/j.neuron.2006.03.037	http://dx.doi.org/10.1016/j.neuron.2006.03.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701205	Bronze			2022-12-24	WOS:000237875200006
J	Stegmuller, J; Konishi, Y; Huynh, MA; Yuan, ZQ; DiBacco, S; Bonni, A				Stegmuller, Judith; Konishi, Yoshiyuki; Huynh, Mai Anh; Yuan, Zengqiang; DiBacco, Sara; Bonni, Azad			Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN	NEURON			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANSFORMING-GROWTH-FACTOR; SKI ONCOPROTEIN; SMAD PROTEINS; CO-REPRESSOR; GUIDANCE; RECEPTOR; DESTRUCTION; DEGRADATION; TRANSPORT	Axonal growth is fundamental to the establishment of neuronal connectivity in the brain. However, the cell-intrinsic mechanisms that govern axonal morphogenesis remain to be elucidated. The ubiquitin ligase Cdh1-anaphase-promoting complex (Cdh1-APC) suppresses the growth of axons in postmitotic neurons. Here, we report that Cdh1-APC operates in the nucleus to inhibit axonal growth. We also identify the transcriptional corepressor SnoN as a key target of neuronal Cdh1-APC that promotes axonal growth. Cdh1 forms a physical complex with SnoN and stimulates the ubiquitin-dependent proteasomal degradation of SnoN in neurons. Knockdown of SnoN in neurons significantly reduces axonal growth and suppresses Cdh1 RNAi enhancement of axonal growth. In addition, SnoN knockdown in vivo suggests an essential function for SnoN in the development of granule neuron parallel fibers in the cerebellar cortex. These findings define Cdh1-APC and SnoN as components of a cell-intrinsic pathway that orchestrates axonal morphogenesis in a transcription-dependent manner in the mammalian brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02116 USA	Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02116 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017	Yuan, Zengqiang/0000-0001-5739-2867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bayer, 1997, RELATION ITS EVOLUTI; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Reed JA, 2001, CANCER RES, V61, P8074; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Shalizi A, 2003, J NEUROSCI, V23, P7326; Stegmuller J, 2005, TRENDS NEUROSCI, V28, P596, DOI 10.1016/j.tins.2005.09.003; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang SW, 2002, DEVELOPMENT, V129, P467; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhang F, 2003, CANCER RES, V63, P5005	43	135	146	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					389	400		10.1016/j.neuron.2006.03.034	http://dx.doi.org/10.1016/j.neuron.2006.03.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675394	Bronze			2022-12-24	WOS:000237726800009
J	Zheng, JJ; Lee, S; Zhou, ZJ				Zheng, JJ; Lee, S; Zhou, ZJ			A transient network of intrinsically bursting starburst cells underlies the generation of retinal waves	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; RETINOTOPIC MAP REFINEMENT; RAT HIPPOCAMPAL-NEURONS; AMACRINE CELLS; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; RABBIT RETINA; MICE LACKING; AFTER-HYPERPOLARIZATIONS; SUPERIOR COLLICULUS	Pharmacologically isolated starburst amacrine cells (SACs) in perinatal rabbit retinas spontaneously generated semiperiodic calcium spikes and long-lasting after-hyperpolarizations (AHPs), mediated by calcium-activated, cyclic AMP-sensitive potassium currents. These AHPs, rather than a depletion of neurotransmitters (as was previously believed), produced the refractory period of spontaneous retinal waves and set the upper limit of the wave frequency. Each SAC received inputs from roughly 10-30 neighboring SACs during a wave. These inputs synchronized and reshaped the intrinsic bursts to produce network oscillations at a rhythm different from that of individual SACs. With maturation, the semiperiodic bursts in SACs disappeared, owing to reduced intrinsic excitability and increased network inhibition. Thus, retinal waves are generated by a transient and specific network of cell-autonomous oscillators synchronized by reciprocally excitatory connections.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NATIONAL EYE INSTITUTE [R01EY010894] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY10894] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Bansal A, 2000, J NEUROSCI, V20, P7672; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 1999, J NEUROSCI, V19, P3657; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SCHWINDT PC, 1992, NEUROSCIENCE, V47, P571, DOI 10.1016/0306-4522(92)90166-Y; Shah MM, 2001, BRIT J PHARMACOL, V132, P889, DOI 10.1038/sj.bjp.0703895; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Velumian AA, 1999, J PHYSIOL-LONDON, V517, P201, DOI 10.1111/j.1469-7793.1999.0201z.x; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou Z J, 2001, Prog Brain Res, V131, P599; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	44	94	94	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					363	371		10.1038/nn1644	http://dx.doi.org/10.1038/nn1644			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462736				2022-12-24	WOS:000235645600016
J	Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA				Aoyama, K; Suh, SW; Hamby, AM; Liu, JL; Chan, WY; Chen, YM; Swanson, RA			Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse	NATURE NEUROSCIENCE			English	Article							GLUTAMATE TRANSPORTER EAAC1; CULTURED HIPPOCAMPAL-NEURONS; AMINO-ACID TRANSPORTER; NITRIC-OXIDE; DICARBOXYLIC AMINOACIDURIA; INTRACELLULAR GLUTATHIONE; CORTICAL-NEURONS; OXIDATIVE STRESS; CYSTEINE UPTAKE; IN-VITRO	Uptake of the neurotransmitter glutamate is effected primarily by transporters expressed on astrocytes, and downregulation of these transporters leads to seizures and neuronal death. Neurons also express a glutamate transporter, termed excitatory amino acid carrier-1 (EAAC1), but the physiological function of this transporter remains uncertain. Here we report that genetically EAAC1-null (Slc1a1(-/-)) mice have reduced neuronal glutathione levels and, with aging, develop brain atrophy and behavioral changes. EAAC1 can also rapidly transport cysteine, an obligate precursor for neuronal glutathione synthesis. Neurons in the hippocampal slices of EAAC1(-/-) mice were found to have reduced glutathione content, increased oxidant levels and increased susceptibility to oxidant injury. These changes were reversed by treating the EAAC1(-/-) mice with N-acetylcysteine, a membrane-permeable cysteine precursor. These findings suggest that EAAC1 is the primary route for neuronal cysteine uptake and that EAAC1 deficiency thereby leads to impaired neuronal glutathione metabolism, oxidative stress and age-dependent neurodegeneration.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Swanson, RA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ray@itsa.ucsf.edu	Liu, Jialing/A-8627-2012	Liu, Jialing/0000-0003-4420-4382; Aoyama, Koji/0000-0003-4752-9262; Swanson, Raymond/0000-0002-3664-5359				AOYAMA K, 2005, J CEREB BLOOD FLOW M, V25, P258; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Avshalumov MV, 2002, J NEUROPHYSIOL, V87, P2896, DOI 10.1152/jn.2002.87.6.2896; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Dringen R, 2001, J NEUROSCI RES, V66, P1003, DOI 10.1002/jnr.10042; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Grover LM, 1999, J NEUROPHYSIOL, V81, P2814, DOI 10.1152/jn.1999.81.6.2814; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Lantz RC, 2001, TOXICOL SCI, V60, P348, DOI 10.1093/toxsci/60.2.348; Mazor D, 1996, EUR J HAEMATOL, V57, P241; MEISTER A, 1986, J AM COLL NUTR, V5, P137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parsons JL, 2000, MUTAGENESIS, V15, P311, DOI 10.1093/mutage/15.4.311; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sato H, 2002, J NEUROSCI, V22, P8028; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3; Shashidharan P, 1997, BRAIN RES, V773, P139, DOI 10.1016/S0006-8993(97)00921-9; SMITH CP, 1994, GENOMICS, V20, P335, DOI 10.1006/geno.1994.1183; Suh SW, 2003, J NEUROSCI, V23, P10681; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Umansky V, 2000, J CELL BIOCHEM, V78, P578, DOI 10.1002/1097-4644(20000915)78:4<578::AID-JCB7>3.0.CO;2-A; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yang YX, 2004, J NEUROCHEM, V88, P1361, DOI 10.1046/j.1471-4159.2003.02279.x; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	50	361	377	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					119	126		10.1038/nn1609	http://dx.doi.org/10.1038/nn1609			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311588				2022-12-24	WOS:000234288000025
J	Hayden, BY; Gallant, JL				Hayden, BY; Gallant, JL			Time course of attention reveals different mechanisms for spatial and feature-based attention in area V4	NEURON			English	Article							VISUAL-ATTENTION; STRIATE CORTEX; EYE-MOVEMENTS; RESPONSES; NEURONS; SEARCH; COLOR; SELECTION; LOCATION; VISION	Attention can facilitate visual processing, emphasizing specific locations and highlighting stimuli containing specific features. To dissociate the mechanisms of spatial and feature-based attention, we compared the time course of visually evoked responses under different attention conditions. We recorded from single neurons in area V4 during a delayed match-to-sample task that controlled both spatial and feature-based attention. Neuronal responses increased when spatial attention was directed toward the receptive field and were modulated by the identity of the target of feature-based attention. Modulation by spatial attention was weaker during the early portion of the visual response and stronger during the later portion of the response. In contrast, modulation by feature-based attention was relatively constant throughout the response. It appears that stimulus onset transients disrupt spatial attention, but not feature attention. We conclude that spatial attention reflects a combination of stimulus-driven and goal-driven processes, while feature-based attention is purely goal driven.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Gallant, Jack L/C-4426-2011; Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281	NATIONAL EYE INSTITUTE [R01EY012241] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012241] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEAN AF, 1982, EXP BRAIN RES, V45, P456, DOI 10.1007/BF01208607; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DeValois R.L., 1990, SPATIAL VISION, V14; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; GATTASS R, 1990, BRAZ J MED BIOL RES, V23, P375; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamy D, 2001, EUR J COGN PSYCHOL, V13, P305, DOI 10.1080/09541440042000016; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2178; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Shih SI, 1996, J EXP PSYCHOL HUMAN, V22, P758, DOI 10.1037/0096-1523.22.3.758; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TSAL Y, 1993, J EXP PSYCHOL HUMAN, V19, P131, DOI 10.1037/0096-1523.19.1.131; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002	33	99	101	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					637	643		10.1016/j.neuron.2005.07.020	http://dx.doi.org/10.1016/j.neuron.2005.07.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129394	Bronze			2022-12-24	WOS:000231782700006
J	Frank, MJ; Woroch, BS; Curran, T				Frank, MJ; Woroch, BS; Curran, T			Error-related negativity predicts reinforcement learning and conflict biases	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; REWARD PREDICTION; AVERAGE REFERENCE; DOPAMINE RELEASE; BRAIN POTENTIALS; NEURAL SYSTEM; BASAL GANGLIA; PERSONALITY; SEROTONIN	The error-related negativity (ERN) is an electrophysiological marker thought to reflect changes in dopamine when participants make errors in cognitive tasks. Our computational model further predicts that larger ERNs should be associated with better learning to avoid maladaptive responses. Here we show that participants who avoided negative events had larger ERNs than those who were biased to learn more from positive outcomes. We also tested for effects of response conflict on ERN magnitude. While there was no overall effect of conflict, positive learners had larger ERNs when having to choose among two good options (win/win decisions) compared with two bad options (lose/lose decisions), whereas negative learners exhibited the opposite pattern. These results demonstrate that the ERN predicts the degree to which participants are biased to learn more from their mistakes than their correct choices and clarify the extent to which it indexes decision conflict.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Frank, MJ (corresponding author), Univ Colorado, Dept Psychol, 345 UCB, Boulder, CO 80309 USA.	frankmj@psych.colorado.edu	Frank, Michael J/B-2979-2008		NIMH NIH HHS [MH64812-01, MH069597-01] Funding Source: Medline; PHS HHS [N00014-03-1-0428] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597, R01MH064812] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrams KY, 2004, PSYCHIAT CLIN NEUROS, V58, P240, DOI 10.1111/j.1440-1819.2004.01226.x; Bates AT, 2004, J PSYCHIATR RES, V38, P347, DOI 10.1016/j.jpsychires.2003.11.002; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; EBLEN F, 1995, J NEUROSCI, V15, P5999; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fallgatter AJ, 2004, NEUROPSYCHOPHARMACOL, V29, P1506, DOI 10.1038/sj.npp.1300409; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; HACJAK G, 2004, BRAIN COGNITION, V56, P189; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI 10.1037//0096-3445.129.1.43; McGowan S, 2004, ARCH GEN PSYCHIAT, V61, P134, DOI 10.1001/archpsyc.61.2.134; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; OREILLY RC, 2005, IN PRESS NEURAL COMP; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PICTON TW, 1995, HDB NEUROPSYCHOLOGY, V10, P373; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Ventura R, 2004, J NEUROCHEM, V89, P494, DOI 10.1111/j.1471-4159.2004.02342.x; Wu Q, 2002, J NEUROSCI, V22, P6272; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	47	314	321	0	48	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 18	2005	47	4					495	501		10.1016/j.neuron.2005.06.020	http://dx.doi.org/10.1016/j.neuron.2005.06.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102533	Bronze			2022-12-24	WOS:000231411100007
J	Cavodeassi, F; Carreira-Barbosa, F; Young, RM; Concha, ML; Allende, ML; Houart, C; Tada, M; Wilson, SW				Cavodeassi, F; Carreira-Barbosa, F; Young, RM; Concha, ML; Allende, ML; Houart, C; Tada, M; Wilson, SW			Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway	NEURON			English	Article							CONVERGENT EXTENSION MOVEMENTS; SIGNALING PATHWAY; BETA-CATENIN; MOLECULAR-MECHANISM; NEGATIVE REGULATOR; PRECHORDAL PLATE; XENOPUS; EXPRESSION; GENES; MORPHOGENESIS	During regional patterning of the anterior neural plate a medially positioned domain of cells is specified to adopt retinal identity. These eye field cells remain coherent as they undergo morphogenetic events distinct from other prospective forebrain domains. We show that two branches of the Wnt signaling pathway coordinate cell fate determination with cell behavior during eye field formation. Wnt/beta-catenin signaling antagonizes eye specification through the activity of Wnt8b and Fz8a. In contrast, Wnt-11 and Fz5 promote eye field development, at least in part, through local antagonism of Wnt/beta-catenin signaling. Additionally, Wnt11 regulates the behavior of eye field cells, promoting their cohesion. Together, these results allow us to postulate a model in which Wnt11 and Fz5 signaling promotes early eye development through the coordinated antagonism of signals that suppress retinal identity and promotion of coherence of eye field cells.	UCL, Dept Anat, London 6BT WC1, England; Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Neurociencias Integradas,Programa Anat & Biol, Santiago, Chile; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 9RT, England	University of London; University College London; Universidad de Chile; Universidad de Chile; University of London; King's College London	Wilson, SW (corresponding author), UCL, Dept Anat, Gower St, London 6BT WC1, England.	s.wilson@ucl.ac.uk	Houart, Corinne/B-5128-2009; Wilson, Stephen W/B-9404-2008; Cavodeassi, Florencia/K-4400-2014; Cavodeassi, Florencia/AAW-4688-2020; Zebrafish, UCL/A-3125-2009; Concha, Miguel/I-2551-2013; Young, Rodrigo M/A-9512-2016; Allende, Miguel L/C-5167-2008; Tada, Masazumi/A-1431-2009; Young, Rodrigo/AAM-9392-2020	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Cavodeassi, Florencia/0000-0003-4609-6258; Cavodeassi, Florencia/0000-0003-4609-6258; Concha, Miguel/0000-0003-3353-9398; Young, Rodrigo M/0000-0001-5765-197X; Allende, Miguel L/0000-0002-2783-2152; Young, Rodrigo/0000-0001-5765-197X	Wellcome Trust [074376] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barth KA, 1999, DEVELOPMENT, V126, P4977; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Chuang JC, 2002, BIOESSAYS, V24, P519, DOI 10.1002/bies.10097; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hammerschmidt M, 2003, DEV DYNAM, V227, P128, DOI 10.1002/dvdy.10281; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim SH, 1998, MECH DEVELOP, V78, P193, DOI 10.1016/S0925-4773(98)00137-3; Kim SH, 2002, DEVELOPMENT, V129, P4443; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; MOON RT, 1993, DEV S, V120, P85; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tada M, 2000, DEVELOPMENT, V127, P2227; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WOO K, 1995, DEVELOPMENT, V121, P2595; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8	58	150	154	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					43	56		10.1016/j.neuron.2005.05.026	http://dx.doi.org/10.1016/j.neuron.2005.05.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996547	Green Accepted, Bronze			2022-12-24	WOS:000230464000007
J	Lamsa, K; Heeroma, JH; Kullmann, DM				Lamsa, K; Heeroma, JH; Kullmann, DM			Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; DENDRITIC SPINES; CA1 NEURONS; CELL; FORM; EXCITABILITY; MECHANISMS	Cortical information processing requires a delicate balance of excitatory and inhibitory signaling. How is this balance preserved during hippocampal memory encoding, which involves NMDA receptor-dependent long term potentiation (LTP)? This form of LTP occurs at synapses between pyramidal neurons but has not been detected in feed-forward inhibitory interneurons. We show that paired pre- and postsynaptic activity evokes pathway-specific LTP in half of rat stratum radiatum interneurons if cytoplasmic integrity is preserved. LTP occurs in aspiny feed-forward interneurons and propagates to pyramidal neurons as an enhancement of disynaptic inhibition. We also show that when LTP is restricted to synapses on pyramidal neurons, the temporal fidelity of synaptic integration and action potential generation in pyramidal cells is compromised. However, when LTP also occurs at synapses on feed-forward interneurons, temporal fidelity is preserved. We propose that Hebbian LTP at synapses driving disynaptic inhibition is necessary to maintain information processing without degradation during memory encoding.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Heeroma, Joost/AFI-8727-2022; Heeroma, Joost/C-1749-2008; Lamsa, Karri/T-2025-2019; Kullmann, Dimitri M/A-3162-2009; Heeroma, Joost/AAF-4310-2022	Kullmann, Dimitri M/0000-0001-6696-3545; Lamsa, Karri/0000-0002-4609-1337				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christie BR, 2000, HIPPOCAMPUS, V10, P673, DOI 10.1002/1098-1063(2000)10:6<673::AID-HIPO1005>3.0.CO;2-O; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gulyas AI, 1998, EUR J NEUROSCI, V10, P3813, DOI 10.1046/j.1460-9568.1998.00402.x; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hebb Donald O., 1949, ORG BEHAV; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sourdet V, 2003, J NEUROSCI, V23, P10238; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	42	129	131	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					916	924		10.1038/nn1486	http://dx.doi.org/10.1038/nn1486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937481				2022-12-24	WOS:000230137100019
J	Udo, H; Jin, I; Kim, JH; Li, HL; Youn, T; Hawkins, RD; Kandel, ER; Bailey, CH				Udo, H; Jin, I; Kim, JH; Li, HL; Youn, T; Hawkins, RD; Kandel, ER; Bailey, CH			Serotonin-induced regulation of the actin network for learning-related synaptic growth requires Cdc42, N-WASP, and PAK in Aplysia sensory neurons	NEURON			English	Article							LONG-TERM FACILITATION; STRUCTURAL-CHANGES; RHO GTPASES; DEPOLYMERIZING PROTEIN; P21-ACTIVATED KINASE; MEMORY; RAC; PLASTICITY; SYNAPSES; TARGET	Application of Clostridium difficile toxin B, an inhibitor of the Rho family of GTPases, at the Aplysia sensory to motor neuron synapse blocks long-term facilitation and the associated growth of new sensory neuron varicosities induced by repeated pulses of serotonin (5-HT). We have isolated cDNAs encoding Aplysia Rho, Rac, and Cdc42 and found that Rho and Rac had no effect but that overexpression in sensory neurons of a dominant-negative mutant of ApCdc42 or the CRIB domains of its downstream effectors PAK and N-WASP selectively reduces the long-term changes in synaptic strength and structure. FRET analysis indicates that 5-HT activates ApCdc42 in a subset of varicosities contacting the postsynaptic motor neuron and that this activation is dependent on the PI3K and PLC signaling pathways. The 5-HT-induced activation of ApCdc42 initiates reorganization of the presynaptic actin network leading to the outgrowth of filopodia, some of which are morphological precursors for the learning-related formation of new sensory neuron varicosities.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Pohang Univ Sci & Technol, Dept Life Sci, Kyungbuk 790784, South Korea	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Kyushu University; Pohang University of Science & Technology (POSTECH)	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA.	erk5@columbia.edu	Li, Hsiu-Ling/C-3567-2011		NIMH NIH HHS [MH37134, MH26212] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212, R01MH037134] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KUKAZAWA Y, 2003, NEURON, V38, P447; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RAYPORT SG, 1986, J NEUROSCI, V6, P759; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	54	84	86	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					887	901		10.1016/j.neuron.2005.01.044	http://dx.doi.org/10.1016/j.neuron.2005.01.044			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797550	Bronze			2022-12-24	WOS:000228031300010
J	Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T				Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T			Bidirectional activity-dependent morphological plasticity in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; AREA CA1; STIMULATION; DEPRESSION; EXPERIENCE; INDUCTION; SYNAPSES; LTP	Dendritic spines on pyramidal neurons receive the vast majority of excitatory input and are considered electrobiochemical processing units, integrating and compartmentalizing synaptic input. Following synaptic plasticity, spines can undergo morphological plasticity, which possibly forms the structural basis for long-term changes in neuronal circuitry. Here, we demonstrate that spines on CA1 pyramidal neurons from organotypic slice cultures show bidirectional activity-dependent morphological plasticity. Using two-photon time-lapse microscopy, we observed that low-frequency stimulation induced NMDA receptor-dependent spine retractions, whereas theta burst stimulation led to the formation of new spines. Moreover, without stimulation the number of spine retractions was on the same order of magnitude as the stimulus-induced spine gain or loss. Finally, we found that the ability of neurons to eliminate spines in an activity-dependent manner decreased with developmental age. Taken together, our data show that hippocampal neurons can undergo bidirectional morphological plasticity; spines are formed and eliminated in an activity-dependent way.	Max Planck Inst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Am Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Cambridge, Sidney/GYQ-5764-2022; Bonhoeffer, Tobias/B-9481-2009; Nägerl, Valentin/AAD-2575-2022	Bonhoeffer, Tobias/0000-0001-7897-6634; Nägerl, Valentin/0000-0001-6831-9008				BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Cooper L. N., 1973, P NOBEL S COLLECTIVE, P252; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PALM G, 1982, CYBERNETICS SYSTEM R; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	22	430	440	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					759	767		10.1016/j.neuron.2004.11.016	http://dx.doi.org/10.1016/j.neuron.2004.11.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572108	Bronze			2022-12-24	WOS:000225548400005
J	Leitges, M; Kovac, J; Plomann, M; Linden, DJ				Leitges, M; Kovac, J; Plomann, M; Linden, DJ			A unique PDZ ligand in PKC alpha confers induction of cerebellar long-term synaptic depression	NEURON			English	Article							PROTEIN-KINASE-C; PURKINJE-CELLS; CELLULAR-DISTRIBUTION; EXPRESSION; GLUR2; PHOSPHORYLATION; MULTIPLE; FAMILY; PICK1; LTD	Induction of cerebellar long-term depression (LTD) requires a postsynaptic cascade involving activation of mGluR1 and protein kinase C (PKC). Our understanding of this process has been limited by the fact that PKC is a large family of molecules, many isoforms of which are expressed in the relevant postsynaptic compartment, the cerebellar Purkinje cell. Here, we report that LTD is absent in Purkinje cells in which the alpha isoform of PKC has been reduced by targeted RNA interference or in cells derived from PKCalpha null mice. In both of these cases, LTD could be rescued by expression of PKCalpha but not other PKC isoforms. The special role of PKCa in cerebellar LTD is likely to derive from its unique PDZ ligand (OSAV). When this motif is mutated, PKCalpha no longer supports LTD. Conversely, when this PDZ ligand is inserted in a nonpermissive isoform, PKCgamma, it confers the capacity for LTD induction.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Max Planck Inst Expt Endokrinol, D-30625 Hannover, Germany; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany	Johns Hopkins University; Max Planck Society; University of Cologne	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, R01MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bareggi R, 1996, BIOL CELL, V87, P55, DOI 10.1016/S0248-4900(97)89837-1; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Bear MF, 2001, SYNAPSES, P455; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Garcia MM, 1997, J COMP NEUROL, V385, P26; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hirono M, 2001, J BIOL CHEM, V276, P45236, DOI 10.1074/jbc.M105413200; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Nishizuka Y, 2001, ALCOHOL CLIN EXP RES, V25, p3S, DOI 10.1111/j.1530-0277.2001.tb02367.x; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SHIMOHAMA S, 1990, J CHEM NEUROANAT, V3, P367; Shutoh F, 2003, EUR J NEUROSCI, V18, P134, DOI 10.1046/j.1460-9568.2003.02717.x; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	34	95	98	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					585	594		10.1016/j.neuron.2004.10.024	http://dx.doi.org/10.1016/j.neuron.2004.10.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541307	Bronze			2022-12-24	WOS:000225338100005
J	Smith, KM; Ohkubo, Y; Maragnoli, ME; Rasin, MR; Schwartz, ML; Sestan, N; Vaccarino, FM				Smith, Karen Mueller; Ohkubo, Yasushi; Maragnoli, Maria Elisabetta; Rasin, Mladen-Roko; Schwartz, Michael L.; Sestan, Nenad; Vaccarino, Flora M.			Midline radial glia translocation and corpus callosum formation require FGF signaling	NATURE NEUROSCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; ABNORMAL-DEVELOPMENT; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; CELLS; GENERATION; EXPRESSION; NEOCORTEX; AXONS; CRE	Midline astroglia in the cerebral cortex develop earlier than other astrocytes through mechanisms that are still unknown. We show that radial glia in dorsomedial cortex retract their apical endfeet at midneurogenesis and translocate to the overlaying pia, forming the indusium griseum. These cells require the fibroblast growth factor receptor 1 (Fgfr1) gene for their precocious somal translocation to the dorsal midline, as demonstrated by inactivating the Fgfr1 gene in radial glial cells and by RNAi knockdown of Fgfr1 in vivo. Dysfunctional astroglial migration underlies the callosal dysgenesis in conditional Fgfr1 knockout mice, suggesting that precise targeting of astroglia to the cortex has unexpected roles in axon guidance. FGF signaling is sufficient to induce somal translocation of radial glial cells throughout the cortex; furthermore, the targeting of astroglia to dorsolateral cortex requires FGFr2 signaling after neurogenesis. Hence, FGFs have an important role in the transition from radial glia to astrocytes by stimulating somal translocation of radial glial cells.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA.	flora.vaccarino@yale.edu		Vaccarino, Flora/0000-0003-2167-981X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067715, T32MH018268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035476, R01NS054273] Funding Source: NIH RePORTER; NICHD NIH HHS [HD045481] Funding Source: Medline; NIMH NIH HHS [MH067715, 5T32-MH18268] Funding Source: Medline; NINDS NIH HHS [NS054273, NS35476] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cheng YH, 2002, EUR J NEUROSCI, V15, P3, DOI 10.1046/j.0953-816x.2001.01832.x; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gregg C, 2003, J NEUROSCI, V23, P11587; Hasegawa H, 2004, J NEUROSCI, V24, P8711, DOI 10.1523/JNEUROSCI.3070-04.2004; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minowada G, 1999, DEVELOPMENT, V126, P4465; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Morrow T, 2001, DEVELOPMENT, V128, P3585; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Ornitz DM, 2001, GENOME BIOL, V2; OZAKI HS, 1992, J COMP NEUROL, V323, P81, DOI 10.1002/cne.903230107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Raballo R, 2000, J NEUROSCI, V20, P5012; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schmid RS, 2006, GLIA, V53, P345, DOI 10.1002/glia.20274; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shin DM, 2004, J NEUROSCI, V24, P2247, DOI 10.1523/JNEUROSCI.5285-03.2004; Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2003, J NEUROSCI, V23, P203; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SILVER J, 1983, SCIENCE, V220, P1067, DOI 10.1126/science.6844928; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Webber CA, 2003, DEV BIOL, V263, P24, DOI 10.1016/S0012-1606(03)00435-4; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	106	107	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					787	797		10.1038/nn1705	http://dx.doi.org/10.1038/nn1705			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715082				2022-12-24	WOS:000237895200019
J	Steinert, JR; Kuromi, H; Hellwig, A; Knirr, M; Wyatt, AW; Kidokoro, Y; Schuster, CM				Steinert, Joern R.; Kuromi, Hiroshi; Hellwig, Andrea; Knirr, Matthias; Wyatt, Amanda W.; Kidokoro, Yoshiaki; Schuster, Christoph M.			Experience-dependent formation and recruitment of large vesicles from reserve pool	NEURON			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; QUANTAL SIZE; SYNAPTIC VESICLES; DROSOPHILA MUTANT; DISTINCT POOLS; MESSENGER-RNA; RELEASE; GABA; EXPRESSION; SYNAPSES	The sizes and contents of transmitter-filled vesicles have been shown to vary depending on experimental manipulations resulting in altered quantal sizes. However, whether such a presynaptic regulation of quantal size can be induced under physiological conditions as a potential alternative mechanism to alter the strength of synaptic transmission is unknown. Here we show that presynaptic vesicles of glutamatergic synapses of Drosophila neuromuscular junctions increase in size as a result of high natural crawling activities of larvae, leading to larger quantal sizes and enhanced evoked synaptic transmission. We further show that these larger vesicles are formed during a period of enhanced replenishment of the reserve pool of vesicles, from which they are recruited via a PKA- and actin-dependent mechanism. Our results demonstrate that natural behavior can induce the formation, recruitment, and release of larger vesicles in an experience-dependent manner and hence provide evidence for an additional mechanism of synaptic potentiation.	Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, D-69120 Heidelberg, Germany; Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Ruprecht Karls University Heidelberg; Gunma University	Schuster, CM (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, D-69120 Heidelberg, Germany.	christoph.schuster@urz.uni-heidelberg.de	Steinert, Joern R/AAI-2742-2020; Steinert, Joern/A-6678-2008; Steinert, Joern/ABB-4561-2020	Steinert, Joern R/0000-0003-1640-0845; Steinert, Joern/0000-0003-1640-0845; 	MRC [MC_U132681855] Funding Source: UKRI; Medical Research Council [MC_U132681855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Engel D, 2000, EPILEPSY RES, V40, P99, DOI 10.1016/S0920-1211(00)00112-1; Esclapez M, 1999, J COMP NEUROL, V412, P488; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; FELDBLUM S, 1990, NEURON, V5, P361, DOI 10.1016/0896-6273(90)90172-C; Frazer A, 1999, INT J NEUROPSYCHOPH, V2, P305, DOI 10.1017/S1461145799001625; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; Gierdalski M, 1999, MOL BRAIN RES, V71, P111, DOI 10.1016/S0169-328X(99)00153-9; Gong LW, 2003, J NEUROSCI, V23, P7917; GRAM L, 1988, EPILEPSY RES, V2, P87, DOI 10.1016/0920-1211(88)90024-1; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; IKEDA K, 1988, J PHYSIOL-LONDON, V406, P215, DOI 10.1113/jphysiol.1988.sp017377; Johnston TH, 2006, CURR OPIN INVEST DR, V7, P25; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LOSCHER W, 1989, EUR J PHARMACOL, V163, P1, DOI 10.1016/0014-2999(89)90389-0; LUPA MT, 1988, BRAIN RES, V461, P118, DOI 10.1016/0006-8993(88)90730-5; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pothos EN, 2002, BEHAV BRAIN RES, V130, P203, DOI 10.1016/S0166-4328(01)00419-3; Pothos EN, 2002, J PHYSIOL-LONDON, V542, P453, DOI 10.1113/jphysiol.2002.018630; Pothos EN, 2000, J NEUROSCI, V20, P7297; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; SEARL T, 1990, NEUROSCIENCE, V35, P145, DOI 10.1016/0306-4522(90)90129-R; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; VANDERKLOOT W, 1985, EXPERIENTIA, V41, P47; VANDERKLOOT W, 1986, BRAIN RES, V376, P378, DOI 10.1016/0006-8993(86)90203-9; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	57	38	40	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					723	733		10.1016/j.neuron.2006.04.025	http://dx.doi.org/10.1016/j.neuron.2006.04.025			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731511	Bronze			2022-12-24	WOS:000238165000008
J	Farago, AF; Awatramani, RB; Dymecki, SM				Farago, AF; Awatramani, RB; Dymecki, SM			Assembly of the brainstem cochlear nuclear complex is revealed by intersectional and subtractive genetic fate maps	NEURON			English	Article							QUAIL-CHICK CHIMERAS; RHOMBIC-LIP; AUDITORY-SYSTEM; EXPRESSION PATTERN; MEDULLA-OBLONGATA; MOUSE; MICE; CEREBELLUM; HINDBRAIN; MIGRATION	The cochlear nuclear complex (CN) is the entry point for central auditory processing. Although constituent neurons have been studied physiologically, their embryological origins and molecular profiles remain obscure. Applying intersectional and subtractive genetic fate mapping approaches, we show that this complex develops modularly from genetically separable progenitor populations arrayed as rostrocaudal microdomains within and outside the hindbrain (lower) rhombic lip (LRL). The dorsal CN subdivision, structurally and topographically similar to the cerebellum, arises from microdomains unexpectedly caudal and noncontiguous to cerebellar primordium; ventral CN subdivisions arise from more rostral LRL. Magnocellular regions receive contributions from LRL and coaxial non-lip progenitors; contrastingly, ensheathing granule cells derive principally from LRL. Also LRL-derived and molecularly similar to CN granule cells are precerebellar mossy fiber neurons; surprisingly, these ostensibly intertwined populations have separable origins and adjacent but segregated migratory streams. Together, these findings provide new platforms for investigating the development and evolution of auditory and cerebellar systems.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD051936, P01 HD036379] Funding Source: Medline; NIDDK NIH HHS [R21 DK618021, R01 DK067826] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; PHS HHS [T32 GMO7753-26] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN J, 1980, J COMP NEUROL, V194, P877, DOI 10.1002/cne.901940410; ALTMAN J, 1996, RELATION ITS EVOULTI; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; BERREBI AS, 1990, J NEUROCYTOL, V19, P643, DOI 10.1007/BF01188033; BOORD RL, 1963, J COMP NEUROL, V120, P463, DOI 10.1002/cne.901200305; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Cant NB, 1992, MAMMALIAN AUDITORY P, P66; Carr CE, 2002, BRAIN BEHAV EVOLUT, V59, P294, DOI 10.1159/000063565; Chai Y, 2000, DEVELOPMENT, V127, P1671; Clark JA, 1997, BRAIN BEHAV EVOLUT, V50, P198, DOI 10.1159/000113334; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Cramer KS, 2000, DEV BIOL, V224, P138, DOI 10.1006/dbio.2000.9779; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Eddison M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-14; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HIS W, 1891, MAT PHYS KI, V29, P1; Ivanova A, 1998, DEV NEUROSCI-BASEL, V20, P495, DOI 10.1159/000017350; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; Jiang W, 1998, BIOTECHNIQUES, V24, P349; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARTIN MR, 1981, J COMP NEUROL, V197, P169, DOI 10.1002/cne.901970113; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; RYUGO DK, 1985, J COMP NEUROL, V242, P381, DOI 10.1002/cne.902420307; Ryugo DK, 2003, BRAIN RES BULL, V60, P435, DOI 10.1016/S0361-9230(03)00049-2; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TABERPIERCE E, 1967, J COMP NEUROL, V131, P27; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; TAN K, 1991, ANAT EMBRYOL, V183, P321; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 1996, DEVELOPMENT, V122, P2143; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	54	173	174	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					205	218		10.1016/j.neuron.2006.03.014	http://dx.doi.org/10.1016/j.neuron.2006.03.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630833	Bronze			2022-12-24	WOS:000237176700009
J	Losonczy, A; Magee, JC				Losonczy, A; Magee, JC			Integrative properties of radial oblique Dendrites in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; VOLTAGE ATTENUATION; RAT HIPPOCAMPUS; BASAL DENDRITES; SPINE-NECK; SPIKES; INITIATION; MECHANISM; SUMMATION; CHANNELS	Although radial oblique dendrites are a major synaptic input site in CA1 pyramidal neurons, little is known about their integrative properties. We have used multisite two-photon glutamate uncaging to deliver different spatiotemporal input patterns to single branches while simultaneously recording the uncaging-evoked excitatory postsynaptic potentials and local Ca2+ signals. Asynchronous input patterns sum linearly in spite of the spatial clustering and produce Ca2+ signals that are mediated by NMDA receptors (NMDARs). Appropriately timed and sized input patterns (similar to 20 inputs within similar to 6 ms) produce a supralinear summation due to the initiation of a dendritic spike. The Ca2+ signals associated with synchronous input were larger and mediated by influx through both NMDARs and voltage-gated Ca2+ channels (VGCCs). The oblique spike is a fast Na+ spike whose duration is shaped by the coincident activation of NMDAR, VGCCs, and transient K+ currents. Our results suggest that individual branches can function as single integrative compartments.	Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Losonczy, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA.	aloson@lsuhsc.edu			NINDS NIH HHS [NS39458, R01 NS035865-08, R01 NS035865] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039458, R01NS035865] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Majewska A, 2000, J NEUROSCI, V20, P1722; Marchetti C, 2003, MOL BRAIN RES, V117, P139, DOI 10.1016/S0169-328X(03)00293-6; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Stuart G, 1998, J NEUROSCI, V18, P3501; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	39	400	406	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					291	307		10.1016/j.neuron.2006.03.016	http://dx.doi.org/10.1016/j.neuron.2006.03.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630839	Bronze			2022-12-24	WOS:000237176700015
J	Adler, CE; Fetter, RD; Bargmann, CI				Adler, CE; Fetter, RD; Bargmann, CI			UNC-6/Netrin induces neuronal asymmetry and defines the site of axon formation	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; NETRIN RECEPTOR; EXPRESSION PATTERNS; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; COLORECTAL-CANCER; CELL-MIGRATION; PI 3-KINASE	UNC-6/Netrin and its receptor UNC-40/DCC are conserved regulators of growth cone guidance. By directly observing developing neurons in vivo, we show that UNC-6 and UNC-40 also function during axon formation to initiate, maintain and orient asymmetric neuronal growth. The immature HSN neuron of Caenorhabditis elegans breaks spherical symmetry to extend a leading edge toward ventral UNC-6. In unc-6 and unc-40 mutants, leading edge formation fails, the cell remains symmetrical until late in development and the axon that eventually forms is misguided. Thus netrin has two activities: one that breaks neuronal symmetry and one that guides the future axon. As the axon forms, UNC-6, UNC-40 and the lipid modulators AGE-1/phosphoinositide 3-kinase (PI3K) and DAF-18/PTEN drive the actin-regulatory pleckstrin homology (PH) domain protein MIG-10/lamellipodin ventrally in HSN to promote asymmetric growth. The coupling of a directional netrin cue to sustained asymmetric growth via PI3K signaling is reminiscent of polarization in chemotaxing cells.	Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	NIGMS NIH HHS [F32 GM084661, F32 GM084661-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084661] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; BRENNER S, 1974, GENETICS, V77, P71; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Manser J, 1997, DEV BIOL, V184, P150, DOI 10.1006/dbio.1997.8516; Mello C, 1995, METHOD CELL BIOL, V48, P451; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321	47	205	217	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					511	518		10.1038/nn1666	http://dx.doi.org/10.1038/nn1666			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520734	Green Accepted			2022-12-24	WOS:000236310700018
J	Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK				Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK			Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RESONANCE-IMAGING SIGNAL; RAT SOMATOSENSORY CORTEX; HUMAN-BRAIN; SENSORY STIMULATION; OXYGEN-CONSUMPTION; HEMODYNAMIC-RESPONSE; INTRINSIC SIGNALS; ACTIVATION; FMRI	Most functional brain imaging studies use task-induced hemodynamic responses to infer underlying changes in neuronal activity. In addition to increases in cerebral blood flow and blood oxygenation level-dependent (BOLD) signals, sustained negative responses are pervasive in functional imaging. The origin of negative responses and their relationship to neural activity remain poorly understood. Through simultaneous functional magnetic resonance imaging and electrophysiological recording, we demonstrate a negative BOLD response (NBR) beyond the stimulated regions of visual cortex, associated with local decreases in neuronal activity below spontaneous activity, detected 7.15 +/- 3.14 mm away from the closest positively responding region in V1. Trial-by-trial amplitude fluctuations revealed tight coupling between the NBR and neuronal activity decreases. The NBR was associated with comparable decreases in local field potentials and multiunit activity. Our findings indicate that a significant component of the NBR originates in neuronal activity decreases.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Shmuel, Amir/G-8690-2013; Logothetis, Nikos/U-9282-2019					Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer AA, 2002, J NEUROSCI, V22, P10416; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pfeuffer J, 2004, MAGN RESON IMAGING, V22, P1343, DOI 10.1016/j.mri.2004.10.004; RAICHLE ME, 1983, J NUCL MED, V24, P790; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013	50	679	686	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					569	577		10.1038/nn1675	http://dx.doi.org/10.1038/nn1675			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547508				2022-12-24	WOS:000236310700025
J	Duebel, J; Haverkamp, S; Schleich, W; Feng, GP; Augustine, GJ; Kuner, T; Euler, T				Duebel, J; Haverkamp, S; Schleich, W; Feng, GP; Augustine, GJ; Kuner, T; Euler, T			Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor clomeleon	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; GABA-INDUCED CURRENTS; RECEPTIVE-FIELD; INTRACELLULAR CHLORIDE; MAMMALIAN RETINA; HORIZONTAL CELLS; AMACRINE CELLS; MOUSE RETINA; HIPPOCAMPAL-NEURONS; TIGER SALAMANDER	A somatodendritic gradient of Cl- concentration ([Cl-](i)) has been postulated to generate GABA-evoked responses of different polarity in retinal bipolar cells, hyperpolarizing in OFF cells with low dendritic [Cl-](i), and depolarizing in ON cells with high dendritic [Cl-](i). As glutamate released by the photoreceptors depolarizes OFF cells and hyperpolarizes ON cells, the bipolars' antagonistic receptive field (RF) could be computed by simply integrating glutamatergic inputs from the RF center and GABAergic inputs from horizontal cells in the RF surround. Using ratiometric two-photon imaging of Clomeleon, a Cl- indicator transgenically expressed in ON bipolar cells, we found that dendritic [Cl-](i) exceeds somatic [Cl-](i) by up to 20 mM and that GABA application can lead to Cl- efflux (depolarization) in these dendrites. Blockers of Cl- transporters reduced the somatodendritic [Cl-](i) gradient. Hence, our results support the idea that ON bipolar cells employ a somatodendritic [Cl-](i) gradient to invert GABAergic horizontal cell input.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; Max Planck Inst Brain Res, Dept Neuroanat, D-60528 Frankfurt, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Max Planck Society; Max Planck Society; Max Planck Society; Duke University	Kuner, T (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.	thomas.kuner@mpimf-heidelberg.mpg.de; teuler@mpimf-heidelberg.mpg.de	Augustine, George James/J-9228-2013; Feng, Guoping/Y-2827-2019	Euler, Thomas/0000-0002-4567-6966; Duebel, Jens/0000-0002-9906-5597	NIMH NIH HHS [MH073166] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073166] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKAIKE N, 1994, JPN J PHYSIOL, V44, pS113; Amos BJ, 1996, EXP PHYSIOL, V81, P261, DOI 10.1113/expphysiol.1996.sp003930; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Ballanyi Klaus, 1998, P291; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BERGLUND K, 2004, IMAGING NEUROSCIENCE; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Dallwig R, 1999, PFLUG ARCH EUR J PHY, V437, P289, DOI 10.1007/s004240050782; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Enz R, 1996, J NEUROSCI, V16, P4479; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GREFERATH U, 1994, CELL TISSUE RES, V276, P295, DOI 10.1007/s004410050092; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; HARE WA, 1990, J PHYSIOL-LONDON, V421, P223, DOI 10.1113/jphysiol.1990.sp017942; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Haugh-Scheidt L, 1998, EXP EYE RES, V66, P449, DOI 10.1006/exer.1997.0441; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kamermans M, 2004, CURR OPIN NEUROBIOL, V14, P531, DOI 10.1016/j.conb.2004.08.016; KANEKO A, 1973, J PHYSIOL-LONDON, V235, P133, DOI 10.1113/jphysiol.1973.sp010381; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Luckermann M, 1997, J NEUROPHYSIOL, V77, P1844, DOI 10.1152/jn.1997.77.4.1844; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; MILLER RF, 1983, VISION RES, V23, P399, DOI 10.1016/0042-6989(83)90087-1; MILLER RF, 1976, J GEN PHYSIOL, V67, P639, DOI 10.1085/jgp.67.6.639; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Protti DA, 1998, J NEUROSCI, V18, P3715; Satoh H, 2001, NEUROSCI LETT, V310, P161, DOI 10.1016/S0304-3940(01)02120-6; Schwartz EA, 2002, PHYSIOL REV, V82, P875, DOI 10.1152/physrev.00010.2002; STONE S, 1991, VISUAL NEUROSCI, V7, P363, DOI 10.1017/S0952523800004855; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TOYODA J, 1982, J GEN PHYSIOL, V79, P131, DOI 10.1085/jgp.79.1.131; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; Vardi N, 2000, J NEUROSCI, V20, P7657; Wachter RM, 1997, BIOCHEMISTRY-US, V36, P9759, DOI 10.1021/bi970563w; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; YAMASHITA M, 1991, VISUAL NEUROSCI, V6, P399, DOI 10.1017/S0952523800006635; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310	61	129	133	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					81	94		10.1016/j.neuron.2005.10.035	http://dx.doi.org/10.1016/j.neuron.2005.10.035			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387641	Bronze			2022-12-24	WOS:000236699300011
J	O'Neill, J; Senior, T; Csicsvari, J				O'Neill, J; Senior, T; Csicsvari, J			Place-selective firing of CA1 pyramidal cells during sharp wave/ripple network patterns in exploratory behavior	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; WAVE-RIPPLE COMPLEXES; INTACT HIPPOCAMPUS; RAT HIPPOCAMPUS; NEURONS; EXPERIENCE; OSCILLATIONS; MEMORY; SLEEP; MECHANISMS	We observed sharp wave/ripples (SWR) during exploration within brief (< 2.4 s) interruptions of or during theta oscillations. CA1 network responses of SWRs occurring during exploration (eSWR) and SWRs detected in waking immobility or sleep were similar. However, neuronal activity during eSWR was location dependent, and eSWR-related firing was stronger inside the place field than outside. The eSPW-related firing increase was stronger than the baseline increase inside compared to outside, suggesting a "supralinear" summation of eSWR and place-selective inputs. Pairs of cells with similar place fields and/or correlated firing during exploration showed stronger coactivation during eSWRs and subsequent sleep-SWRs. Sequential activation of place cells was not required for the reactivation of waking co-firing patterns; cell pairs with symmetrical cross-correlations still showed reactivated waking co-firing patterns during sleep-SWRs. We suggest that place-selective firing during eSWRs facilitates initial associations between cells with similar place fields that enable place-related ensemble patterns to recur during subsequent sleep-SWRs.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jozsef.csicsvari@pharm.ox.ac.uk			MRC [MC_U138169944] Funding Source: UKRI; Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BENARDO LS, 1993, NEUROSCIENCE, V53, P11, DOI 10.1016/0306-4522(93)90280-S; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; DUTAR P, 1988, J NEUROSCI, V8, P4214; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HOUNSGAARD J, 1978, EXP NEUROL, V62, P787, DOI 10.1016/0014-4886(78)90284-4; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jarosiewicz B, 2004, J NEUROSCI, V24, P5070, DOI 10.1523/JNEUROSCI.5650-03.2004; Kamondi A, 1998, J NEUROSCI, V18, P3919; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LEUNG LS, 1979, J NEUROPHYSIOL, V42, P1571, DOI 10.1152/jn.1979.42.6.1571; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Nimmrich V, 2005, J PHYSIOL-LONDON, V563, P663, DOI 10.1113/jphysiol.2004.079558; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P532, DOI 10.1016/0013-4694(88)90165-4; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Traub RD, 2000, J NEUROSCI, V20, P2086; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; YLINEN A, 1995, J NEUROSCI, V15, P30; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	61	187	189	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					143	155		10.1016/j.neuron.2005.10.037	http://dx.doi.org/10.1016/j.neuron.2005.10.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387646	Bronze			2022-12-24	WOS:000236699300016
J	McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M				McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M			Odorant representations are modulated by intra- but not interglomerular presynaptic inhibition of olfactory sensory neurons	NEURON			English	Article							EXTERNAL TUFTED CELLS; BULB GLOMERULI; SYNAPTIC-TRANSMISSION; FUNCTIONAL-ORGANIZATION; RECIPROCAL SYNAPSES; NERVE-TERMINALS; INPUT; RAT; EXPRESSION; RELEASE	Input to the central nervous system from olfactory sensory neurons (OSNs) is modulated presynaptically. We investigated the functional organization of this inhibition and its role in odor coding by imaging neurotransmitter release from OSNs in slices and in vivo in mice expressing synaptopHluorin, an optical indicator of vesicle exocytosis. Release from OSNs was strongly suppressed by heterosynaptic, intraglomerular inhibition. In contrast, inhibitory connections between glomeruli mediated only weak lateral inhibition of OSN inputs in slices and did not do so in response to odorant stimulation in vivo. Blocking presynaptic inhibition in vivo increased the amplitude of odorant-evoked input to glomeruli but had little effect on spatial patterns of glomerular input. Thus, intraglomerular inhibition limits the strength of olfactory input to the CNS, whereas interglomerular inhibition plays little or no role. This organization allows for control of input sensitivity while maintaining the spatial maps of glomerular activity thought to encode odorant identity.	Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	McGann, JP (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	mcgann@bu.edu		Gainey, Melanie/0000-0002-4782-9647; Pirez, Nicolas/0000-0002-0463-0080	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006441, F32DC007258, R03DC004938] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC6441, F32 DC007258, DC4938, DC7258] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Cho JY, 1996, J COMP NEUROL, V369, P264; Duchamp-Viret P, 2000, NEUROSCIENCE, V97, P771, DOI 10.1016/S0306-4522(00)00055-5; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GETCHELL TV, 1975, J PHYSIOL-LONDON, V251, P523, DOI 10.1113/jphysiol.1975.sp011106; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Keller A, 1998, J NEUROSCI, V18, P2602; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohliger-Frerking P, 2003, J NEUROSCI, V23, P4809; PINCHING AJ, 1971, J CELL SCI, V9, P379; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Toida K, 2000, NEUROSCIENCE, V101, P11, DOI 10.1016/S0306-4522(00)00356-0; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VUCINIC D, 2005, IN PRESS J NEUROPHYS, V30; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	40	137	139	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					1039	1053		10.1016/j.neuron.2005.10.031	http://dx.doi.org/10.1016/j.neuron.2005.10.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364906	Bronze			2022-12-24	WOS:000234301700018
J	Cang, JH; Renteria, RC; Kaneko, M; Liu, XR; Copenhagen, DR; Stryker, MP				Cang, JH; Renteria, RC; Kaneko, M; Liu, XR; Copenhagen, DR; Stryker, MP			Development of precise maps in visual cortex requires patterned spontaneous activity in the retina	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; OCULAR DOMINANCE COLUMNS; EYE-SPECIFIC SEGREGATION; MICE LACKING; BETA-2 SUBUNIT; GANGLION-CELLS; SUPERIOR COLLICULUS; NEURONAL-ACTIVITY; MAMMALIAN RETINA	The visual cortex is organized into retinotopic maps that preserve an orderly representation of the visual world, achieved by topographically precise inputs from the lateral geniculate nucleus. We show here that geniculocortical mapping is imprecise when the waves of spontaneous activity in the retina during the first postnatal week are disrupted genetically. This anatomical mapping defect is present by postnatal day 8 and has functional consequences, as revealed by optical imaging and microelectrode recording in adults. Pharmacological disruption of these retinal waves during the first week phenocopies the mapping defect, confirming both the site and the timing of the disruption in neural activity responsible for the defect. Analysis shows that the geniculocortical miswiring is not a trivial or necessary consequence of the retinogeniculate defect. Our findings demonstrate that disrupting early spontaneous activity in the eye alters thalamic connections to the cortex.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831; Renteria, Rene/0000-0002-4490-0735	NEI NIH HHS [R37 EY002874-24S1, R37 EY002874] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bansal A, 2000, J NEUROSCI, V20, P7672; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Demas J, 2003, J NEUROSCI, V23, P2851; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FOX K, 1992, J NEUROSCI, V12, P1826; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; GUILLERY RW, 1979, J COMP NEUROL, V185, P623, DOI 10.1002/cne.901850404; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huang K, 1985, Brain Res, V352, P213; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; KAAS JH, 1973, BRAIN RES, V59, P61, DOI 10.1016/0006-8993(73)90253-9; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Krug K, 1998, J NEUROSCI, V18, P5766; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Xu W, 1999, J NEUROSCI, V19, P9298; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zoli M, 1998, J NEUROSCI, V18, P4461	50	219	220	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					797	809		10.1016/j.neuron.2005.09.015	http://dx.doi.org/10.1016/j.neuron.2005.09.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337917	Green Accepted, Bronze			2022-12-24	WOS:000233927300018
J	Li, HY; Waites, CL; Staal, RG; Dobryy, Y; Park, J; Sulzer, DL; Edwards, RH				Li, HY; Waites, CL; Staal, RG; Dobryy, Y; Park, J; Sulzer, DL; Edwards, RH			Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines	NEURON			English	Article							SYNAPTIC-LIKE MICROVESICLES; TERMINAL DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; DENSE CORE VESICLES; NERVE GROWTH-FACTOR; SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; MEMBRANE-PROTEIN; TIME-COURSE	The release of monoamine neurotransmitters from cell bodies and dendrites has an important role in behavior, but the mechanism (vesicular or nonvesicular) has remained unclear. Because the location of vesicular monoamine transporter 2 (VMAT2) defines the secretory vesicles capable of monoamine release, we have studied its trafficking to assess the potential for monoamine release by exocytosis. In neuroendocrine PC12 cells, VMAT2 localizes exclusively to large dense-core vesicles (LDCVs), and we now show that cytoplasmic signals target VMAT2 directly to LDCVs within the biosynthetic pathway. In neurons, VMAT2 localizes to a population of vesicles that we now find undergo regulated exocytosis in dendrites. Although hippocampal neurons do not express typical LDCV proteins, transfected chromogranins A, B, and brain-derived neurotrophic factor (BDNF) colocalize with VMAT2. VMAT2 thus defines a population of secretory vesicles that mediate the activity-dependent somato-dendritic release of multiple retrograde signals involved in synaptic function, growth, and plasticity.	Univ Calif San Francisco, Sch Med, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Grad Program Cell Biol, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Grad Program Neurosci, 600 16th St, San Francisco, CA 94143 USA.	edwards@itsa.ucsf.edu		Staal, Roland/0000-0002-2857-2241	NIDA NIH HHS [DA10154] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adell A, 1998, BRIT J PHARMACOL, V125, P1361, DOI 10.1038/sj.bjp.0702206; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bergquist F, 2003, BRAIN RES, V973, P81, DOI 10.1016/S0006-8993(03)02555-1; Bergquist F, 2002, BRAIN RES, V950, P245, DOI 10.1016/S0006-8993(02)03047-0; Blagoveshchenskaya AD, 1999, J CELL BIOL, V145, P1419, DOI 10.1083/jcb.145.7.1419; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FISCHERCOLBRIE R, 1993, J NEUROCHEM, V60, P2312, DOI 10.1111/j.1471-4159.1993.tb03520.x; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HURTLEY SM, 1993, J CELL SCI, V106, P649; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; Modderman PW, 1998, BIOCHEM J, V336, P153, DOI 10.1042/bj3360153; Mowla SJ, 1999, J NEUROSCI, V19, P2069; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; PETER D, 1995, J NEUROSCI, V15, P6179; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; SULZER D, 1995, J NEUROSCI, V15, P4102; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; Travis ER, 1998, ANNU REV BIOPH BIOM, V27, P77, DOI 10.1146/annurev.biophys.27.1.77; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wasmeier C, 2005, TRAFFIC, V6, P474, DOI 10.1111/j.1600-0854.2005.00292.x; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	61	62	64	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					619	633		10.1016/j.neuron.2005.09.033	http://dx.doi.org/10.1016/j.neuron.2005.09.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301178	Bronze			2022-12-24	WOS:000233677300015
J	Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A				Bielle, F; Griveau, A; Narboux-Neme, N; Vigneau, S; Sigrist, M; Arber, S; Wassef, M; Pierani, A			Multiple origins of Cajal-Retzius cells at the borders of the developing pallium	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA EXPRESSION; SPINAL-CORD; GANGLIONIC EMINENCE; NEURONAL MIGRATION; MARGINAL ZONE; HIPPOCAMPAL CONNECTIONS; MAMMALIAN TELENCEPHALON; HOMEOBOX GENE; MOUSE	Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin(+) Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin(+) neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin(+) cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.	Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France; Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute	Pierani, A (corresponding author), Ecole Normale Super, CNRS, UMR 8542, 46 Rue Ulm, F-75005 Paris, France.	pierani@biologie.ens.fr	Pierani, Alessandra/O-6136-2017; Vigneau, Sébastien/B-2842-2008	Pierani, Alessandra/0000-0002-4872-4791; Vigneau, Sebastien/0000-0002-9091-2067; Narboux-Neme, Nicolas/0000-0002-3791-7459; Bielle, Franck/0000-0001-6564-6388; Arber, Silvia/0000-0002-6261-250X				Aboitiz F, 2002, BRAZ J MED BIOL RES, V35, P1455, DOI 10.1590/S0100-879X2002001200006; Alcantara S, 1998, J NEUROSCI, V18, P7779; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Borrell V, 1999, J NEUROSCI, V19, P1345; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; LU SW, 1994, MECH DEVELOP, V47, P187, DOI 10.1016/0925-4773(94)90089-2; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 1998, J COMP NEUROL, V397, P493; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Yun K, 2001, DEVELOPMENT, V128, P193; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	48	325	332	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1002	1012		10.1038/nn1511	http://dx.doi.org/10.1038/nn1511			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16041369				2022-12-24	WOS:000230760200011
J	Mileykovskiy, BY; Kiyashchenko, LI; Siegel, JM				Mileykovskiy, BY; Kiyashchenko, LI; Siegel, JM			Behavioral correlates of activity in identified hypocretin/orexin neurons	NEURON			English	Article							DORSAL RAPHE NUCLEUS; FREELY MOVING CATS; HYPOTHALAMIC AROUSAL SYSTEM; MEDIAL PREFRONTAL CORTEX; POWER SPECTRAL-ANALYSIS; SLEEP-WAKING DISCHARGE; VENTRAL TEGMENTAL AREA; OREXIN NEURONS; LOCUS-COERULEUS; RETICULAR-FORMATION	Micropipette recording with juxtacellular Neurobiotin ejection, linked micropipette-microwire recording, and antidromic and orthodromic activation from the ventral tegmental area and locus coeruleus were used to identify hypocretin (Hcrt) cells in anesthetized rats and develop criteria for identification of these cells in unanesthetized, unrestrained animals. We found that Hcrt cells have broad action potentials with elongated later positive deflections that distinguish them from adjacent antidromically identified cells. They are relatively inactive in quiet waking but are transiently activated during sensory stimulation. Hcrt cells are silent in slow wave sleep and tonic periods of REM sleep, with occasional burst discharge in phasic REM. Hcrt cells discharge in active waking and have moderate and approximately equal levels of activity during grooming and eating and maximal activity during exploratory behavior. Our findings suggest that these cells are activated during emotional and sensorimotor conditions similar to those that trigger cataplexy in narcoleptic animals.	Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles Healthcare Syst Sepul, North Hills, CA 91343 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Mileykovskiy, BY (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA.	bmileyko@ucla.edu; jsiegel@ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH071350, R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH064109, MH071350, MH064109, R03 MH071350] Funding Source: Medline; NINDS NIH HHS [R37 NS014610, R01 NS014610, NS14610] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acuna-Goycolea C, 2004, J NEUROSCI, V24, P3013, DOI 10.1523/JNEUROSCI.5416-03.2004; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Baker TL, 1985, BRAIN MECH SLEEP, P199; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; BEYER C, 1971, BRAIN RES, V29, P213, DOI 10.1016/0006-8993(71)90029-1; Borland LM, 2004, J NEUROCHEM, V91, P220, DOI 10.1111/j.1471-4159.2004.02708.x; Brown RE, 2002, J NEUROSCI, V22, P8850; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; CESPUGLIO R, 1992, J SLEEP RES, V1, P150, DOI 10.1111/j.1365-2869.1992.tb00030.x; CESPUGLIO R, 1990, EXP BRAIN RES, V80, P121; CHANG AYW, 1995, SYNAPSE, V21, P149, DOI 10.1002/syn.890210208; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Eggermann E, 2003, J NEUROSCI, V23, P1557; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Espana RA, 2003, NEUROSCIENCE, V121, P201, DOI 10.1016/S0306-4522(03)00334-8; Espana RA, 2001, NEUROSCIENCE, V106, P699, DOI 10.1016/S0306-4522(01)00319-0; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fadel J, 2002, J NEUROSCI, V22, P6742; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; FINDLAY ALR, 1969, J PHYSIOL-LONDON, V201, P237, DOI 10.1113/jphysiol.1969.sp008753; Fornal CA, 1996, BRAIN RES, V716, P123, DOI 10.1016/0006-8993(96)00006-6; Fu LY, 2004, J NEUROSCI, V24, P8741, DOI 10.1523/JNEUROSCI.2268-04.2004; GLOTZBACH SF, 1987, BRAIN RES, V419, P279, DOI 10.1016/0006-8993(87)90594-4; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Horvath TL, 1999, J COMP NEUROL, V415, P145; HOUDOUIN F, 1991, BRAIN RES, V565, P48, DOI 10.1016/0006-8993(91)91735-J; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Izumi T, 1968, Seishin Shinkeigaku Zasshi, V70, P493; JACOBS BL, 1991, J CLIN PSYCHIAT, V52, P17; John J, 2004, NEURON, V42, P619, DOI 10.1016/S0896-6273(04)00247-8; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Korotkova TM, 2003, J NEUROSCI, V23, P7; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lambe EK, 2003, NEURON, V40, P139, DOI 10.1016/S0896-6273(03)00598-1; LEE M, 2004, DISCHARGE IDENTIFIED; LEVITT DR, 1975, P NATL ACAD SCI USA, V72, P2819, DOI 10.1073/pnas.72.7.2819; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu RJ, 2002, J NEUROSCI, V22, P9453; LUOH HF, 1994, SYNAPSE, V16, P29, DOI 10.1002/syn.890160104; Mathe JM, 1999, NEUROPHARMACOLOGY, V38, P121, DOI 10.1016/S0028-3908(98)00163-4; MITLER MM, 1976, J AM VET MED ASSOC, V168, P1036; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; PARMEGGIANI PL, 1987, BRAIN RES, V415, P79, DOI 10.1016/0006-8993(87)90270-8; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; PORTAS CM, 1994, BRAIN RES, V648, P306, DOI 10.1016/0006-8993(94)91132-0; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; SIEGEL JM, 1978, SCIENCE, V199, P207; SIEGEL JM, 1979, BRAIN RES REV, V1, P69, DOI 10.1016/0165-0173(79)90017-1; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Siegel JM, 2000, SCI AM, V282, P76, DOI 10.1038/scientificamerican0100-76; Sinnamon HM, 1997, BEHAV BRAIN RES, V89, P289, DOI 10.1016/S0166-4328(97)00089-2; Soffin EM, 2002, NEUROPHARMACOLOGY, V42, P127, DOI 10.1016/S0028-3908(01)00156-3; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; Torterolo P, 2004, SLEEP, V27, P5; Torterolo P, 2003, SLEEP, V26, P25; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; VALENSTEIN ES, 1971, J PSYCHIATR RES, V8, P335, DOI 10.1016/0022-3956(71)90029-X; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; VANNIMERCIER G, 1984, CR ACAD SCI III-VIE, V298, P195; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; YOSHIDA K, 2004, AFFERENTS OREXIN NEU	83	617	633	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					787	798		10.1016/j.neuron.2005.04.035	http://dx.doi.org/10.1016/j.neuron.2005.04.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924864	Bronze, Green Accepted			2022-12-24	WOS:000229689800012
J	Yang, YP; Fischer, QS; Zhang, Y; Baumgartel, K; Mansuy, IM; Daw, NW				Yang, YP; Fischer, QS; Zhang, Y; Baumgartel, K; Mansuy, IM; Daw, NW			Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; LONG-TERM DEPRESSION; PROTEIN-KINASE-A; EXTRACELLULAR-MATRIX; ADENYLYL-CYCLASE; BINDING PROTEIN; PHOSPHATASE; RECEPTORS; INDUCTION; ADULT	Numerous protein kinases have been implicated in visual cortex plasticity, but the role of serine/threonine protein phosphatases has not yet been established. Calcineurin, the only known Ca2+/calmodulin-activated protein phosphatase in the brain, has been identified as a molecular constraint on synaptic plasticity in the hippocampus and on memory. Using transgenic mice overexpressing calcineurin inducibly in forebrain neurons, we now provide evidence that calcineurin is also involved in ocular dominance plasticity. A transient increase in calcineurin activity is found to prevent the shift of responsiveness in the visual cortex following monocular deprivation, and this effect is reversible. These results imply that the balance between protein kinases and phosphatases is critical for visual cortex plasticity.	Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Univ Connecticut, Dept Chem Engn, Storrs, CT 06269 USA; Univ Zurich, Fac Med, Brain Res Inst, Dept Biol,Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	Yale University; University of Connecticut; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Yang, YP (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 333 Cedar St, New Haven, CT 06520 USA.	yuyang@aecom.yu.edu	Mansuy, Isabelle M/N-3042-2015; Yang, Yupeng/G-5107-2018	Mansuy, Isabelle M/0000-0001-7785-5371; Yang, Yupeng/0000-0002-9473-9994; Fischer, Quentin/0000-0002-7803-1179	NATIONAL EYE INSTITUTE [R01EY000053] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY00053] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antoni FA, 1998, J NEUROSCI, V18, P9650; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Daw N, 2004, VISION RES, V44, P3377, DOI 10.1016/j.visres.2004.09.004; Daw NW, 1999, J NEUROPHYSIOL, V81, P204, DOI 10.1152/jn.1999.81.1.204; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fansa H, 2000, RESTOR NEUROL NEUROS, V16, P77; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; FUNAUCHI M, 1994, NEUROSCI RES, V19, P269, DOI 10.1016/0168-0102(94)90039-6; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gordon JA, 1996, J NEUROSCI, V16, P3274; GOTO S, 1993, NEUROSCI LETT, V149, P189, DOI 10.1016/0304-3940(93)90768-G; GOTO S, 1994, NEUROSCIENCE, V62, P695, DOI 10.1016/0306-4522(94)90470-7; GOTO S, 1993, EXP BRAIN RES, V96, P377; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hensch TK, 1998, J NEUROSCI, V18, P2108; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Iwai Y, 2003, J NEUROSCI, V23, P6695; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; POLLI JW, 1991, DEV BRAIN RES, V63, P105, DOI 10.1016/0165-3806(91)90071-P; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Robertson A, 2002, GENE, V282, P65, DOI 10.1016/S0378-1119(01)00793-4; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TORII N, 1995, NEUROSCI LETT, V185, P1, DOI 10.1016/0304-3940(94)11210-A; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	34	36	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					791	796		10.1038/nn1464	http://dx.doi.org/10.1038/nn1464			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880107				2022-12-24	WOS:000229345300020
J	Kamitani, Y; Tong, F				Kamitani, Y; Tong, F			Decoding the visual and subjective contents of the human brain	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; MONKEY STRIATE CORTEX; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE FIELDS; MOTION; AREAS; REPRESENTATIONS; SPECTROSCOPY; ORGANIZATION	The potential for human neuroimaging to read out the detailed contents of a person's mental state has yet to be fully explored. We investigated whether the perception of edge orientation, a fundamental visual feature, can be decoded from human brain activity measured with functional magnetic resonance imaging (fMRI). Using statistical algorithms to classify brain states, we found that ensemble fMRI signals in early visual areas could reliably predict on individual trials which of eight stimulus orientations the subject was seeing. Moreover, when subjects had to attend to one of two overlapping orthogonal gratings, feature-based attention strongly biased ensemble activity toward the attended orientation. These results demonstrate that fMRI activity patterns in early visual areas, including primary visual cortex (V1), contain detailed orientation information that can reliably predict subjective perception. Our approach provides a framework for the readout of fine-tuned representations in the human brain and their subjective contents.	ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto 6190288, Japan; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Kamitani, Y (corresponding author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	kmtn@atr.jp	Patanaik, Amiya/G-4336-2010		NEI NIH HHS [R01-EY14202, R01 EY014202] Funding Source: Medline; NIMH NIH HHS [P50 MH062196, P50-MH62196] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BAUER R, 1989, EXP BRAIN RES, V76, P503, DOI 10.1007/BF00248906; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KAHNEMAN D, 1970, PERCEPT PSYCHOPHYS, V8, P161, DOI 10.3758/BF03210195; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Koch Christof, 2004, QUEST CONSCIOUSNESS; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MINSKY LM, 1987, PERCEPTRONS EXPANDED; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; Vapnik V., 1998, STAT LEARNING THEORY; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wilson H. R., 1990, VISUAL PERCEPTION NE, P231, DOI DOI 10.1016/B978-0-12-657675-7.50016-8; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; ZEKI S, 1991, J NEUROSCI, V11, P641	40	1212	1234	7	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					679	685		10.1038/nn1444	http://dx.doi.org/10.1038/nn1444			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852014	Green Accepted			2022-12-24	WOS:000228895100030
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			Direction selectivity of excitation and inhibition in simple cells of the cat primary visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; STRIATE CORTEX; ORIENTATION SELECTIVITY; SYNAPTIC POTENTIALS; RECEPTIVE-FIELDS; CORTICAL-NEURONS; QUADRATURE SUBUNITS; CONTRAST INVARIANCE; LINEAR MECHANISMS	Direction selectivity in simple cells of primary visual cortex, defined from their spike responses, cannot be predicted using linear models. It has been suggested that the shunting inhibition evoked by visual stimulation is responsible for the nonlinear component of direction selectivity. Cortical inhibition would suppress a neuron's firing when stimuli move in the nonpreferred direction, but would allow responses to stimuli in the preferred direction. Models of direction selectivity based solely on input from the lateral geniculate nucleus, however, propose that the nonlinear response is caused by spike threshold. By extracting excitatory and inhibitory components of synaptic inputs from intracellular records obtained in vivo, we demonstrate that excitation and inhibition are tuned for the same direction, but differ in relative timing. Further, membrane potential responses combine in a linear fashion. Spike threshold, however, quantitatively accounts for the nonlinear component of direction selectivity, amplifying the direction selectivity of spike output relative to that of synaptic inputs.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Priebe, NJ (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	nico@northwestern.edu			NEI NIH HHS [EY-014499, EY-04726] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY014499, R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Baker CL, 2001, VISUAL NEUROSCI, V18, P465, DOI 10.1017/S0952523801183136; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Contreras D, 2003, J NEUROSCI, V23, P6936; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Emerson RC, 1997, VISUAL NEUROSCI, V14, P373, DOI 10.1017/S0952523800011494; Emerson RC, 1997, VISUAL NEUROSCI, V14, P357, DOI 10.1017/S0952523800011482; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GRZYWACZ NM, 1987, SYNAPSE, V1, P417, DOI 10.1002/syn.890010506; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rall W, 1964, NEURAL THEORY MODELI, P73; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Rieke F., 1997, SPIKES EXPLORING NEU; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; SAUL AB, 1995, VISUAL NEUROSCI, V12, P191, DOI 10.1017/S0952523800007872; Sokal R. R., 2012, BIOMETRY; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Troyer TW, 1998, J NEUROSCI, V18, P5908; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	49	188	190	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					133	145		10.1016/j.neuron.2004.12.024	http://dx.doi.org/10.1016/j.neuron.2004.12.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629708	Bronze			2022-12-24	WOS:000226217100015
J	Doi, M; Yujnovsky, I; Hirayama, J; Malerba, M; Tirotta, E; Sassone-Corsi, P; Borrelli, E				Doi, Masao; Yujnovsky, Irene; Hirayama, Jun; Malerba, Monica; Tirotta, Emanuele; Sassone-Corsi, Paolo; Borrelli, Emiliana			Impaired light masking in dopamine D2 receptor-null mice	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK	Disruption of overt circadian rhythms can occur without influencing the endogenous pacemaker, the so-called 'masking' effect classically elicited by light. As the physiological pathways involved in light masking remain elusive, we analyzed mice lacking the dopamine D2 receptor. Although circadian rhythmicity was normal, D2R-null mice showed a markedly deficient light masking response, indicating that D2R-mediated signaling is an essential component of the neuronal pathways leading to light masking of circadian rhythms.	Kobe Univ, Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA	Kobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Irvine; University of California System; University of California Irvine	Borrelli, E (corresponding author), Kobe Univ, Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, 7-5-1 Kusonoki Cho, Kobe, Hyogo 6500017, Japan.	paolosc@igbmc.u-strasbg.fr; eb@igbmc.u-strasbg.fr	Doi, Masao/J-9267-2019; Jansen, Heiko T./A-5770-2008; Sassone-Corsi, Paolo/H-6182-2011; Borrelli, Emiliana/M-8994-2018	Doi, Masao/0000-0001-6264-9217; Jansen, Heiko T./0000-0003-0178-396X; Hirayama, Jun/0000-0002-8485-3320				BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; CAHILL GM, 1991, J NEUROSCI, V11, P2959; Cermakian N, 2002, CURR OPIN NEUROBIOL, V12, P359, DOI 10.1016/S0959-4388(02)00347-1; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Steenhard BM, 2000, J NEUROSCI, V20, P8572; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	15	60	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					732	734		10.1038/nn1711	http://dx.doi.org/10.1038/nn1711			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715079				2022-12-24	WOS:000237895200010
J	Nicholson, DA; Trana, R; Katz, Y; Kath, WL; Spruston, N; Geinisman, Y				Nicholson, Daniel A.; Trana, Rachel; Katz, Yael; Kath, William L.; Spruston, Nelson; Geinisman, Yuri			Distance-dependent differences in synapse number and AMPA receptor expression in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NMDA RECEPTORS; POSTSYNAPTIC DENSITY; STRATUM-RADIATUM; RAT HIPPOCAMPUS; SPIKES; CELLS; LOCATION; RELEASE	The ability of synapses throughout the dendritic tree to influence neuronal output is crucial for information processing in the brain. Synaptic potentials attenuate dramatically, however, as they propagate along dendrites toward the soma. To examine whether excitatory axospinous synapses on CA1 pyramidal neurons compensate for their distance from the soma to counteract such dendritic filtering, we evaluated axospinous synapse number and receptor expression in three progressively distal regions: proximal and distal stratum radiatum (SR), and stratum lacunosum-moleculare (SLM). We found that the proportion of perforated synapses increases as a function of distance from the soma and that their AMPAR, but not NMDAR, expression is highest in distal SR and lowest in SLM. Computational models of pyramidal neurons derived from these results suggest that they arise from the compartment-specific use of conductance scaling in SR and dendritic spikes in SLM to minimize the influence of distance on synaptic efficacy.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Geinisman, Y (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	yurig@northwestern.edu	Kath, William/B-6771-2009	Kath, William/0000-0003-3867-4783; Nicholson, Dan/0000-0002-1963-0569; Spruston, Nelson/0000-0003-3118-1636	NIA NIH HHS [AG20506, AG17139] Funding Source: Medline; NINDS NIH HHS [NS35180, NS46064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180, R01NS046064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017139, R01AG017139, T32AG020506] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMARAL DG, 1995, RAT NERVOUS SYSTEM, P91; Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Geinisman Y, 2004, NEUROBIOL AGING, V25, P407, DOI 10.1016/j.neurobiolaging.2003.12.001; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; PETERS A, 1969, Z ZELLFORSCH MIK ANA, V100, P487, DOI 10.1007/BF00344370; Petralia RS, 1999, METH MOL B, V128, P73; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Racca C, 2000, J NEUROSCI, V20, P2512; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; RALL W, 1977, HDB PHYSL NERVOUS SY, P3; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SMITH MA, 2003, J PHYSL, V528, P245; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	59	139	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					431	442		10.1016/j.neuron.2006.03.022	http://dx.doi.org/10.1016/j.neuron.2006.03.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675397	Bronze			2022-12-24	WOS:000237726800012
J	Shen, WH; Wu, B; Zhang, ZJ; Dou, Y; Rao, ZR; Chen, YR; Duan, SM				Shen, Wanhua; Wu, Be; Zhang, Zhijun; Dou, Ying; Rao, Zhi-ren; Chen, Yi-ren; Duan, Shumin			Activity-induced rapid synaptic maturation mediated by presynaptic Cdc42 signaling	NEURON			English	Article							LONG-TERM-POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; BRAIN MYOSIN-V; NEUROTROPHIC FACTOR; ACTIN CYTOSKELETON; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; RHO GTPASES; PLASTICITY	Maturation of presynaptic transmitter secretion machinery is a critical step in synaptogenesis. Here we report that a brief train of presynaptic action potentials rapidly converts early nonfunctional contacts between cultured hippocampal neurons into functional synapses by enhancing presynaptic glutamate release. The enhanced release was confirmed by a marked increase in the number of depolarization-induced FM4-64 puncta in the presynaptic axon. This rapid presynaptic maturation can be abolished by treatments that interfered with presynaptic BDNF and Cdc42 signaling or actin polymerization. Activation of Cdc42 by applying BDNF or bradykinin mimicked the effect of electrical activity in promoting synaptic maturation. Furthermore, activity-induced increase in presynaptic actin polymerization, as revealed by increased concentration of actin-YFP at axon boutons, was abolished by inhibiting BDNF and Cdc42 signaling. Thus, rapid presynaptic maturation induced by neuronal activity is mediated by presynaptic activation of the Cdc42 signaling pathway.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; Nantong Univ, Neurosci Res Inst, Nantong, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Air Force Military Medical University; Nantong University	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Wu, Bei/F-6659-2012; Shen, Wanhua/B-5554-2011	Shen, Wanhua/0000-0002-5178-9561				Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Berninger B, 1999, LEARN MEMORY, V6, P232; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Doussau F, 2000, J BIOL CHEM, V275, P7764, DOI 10.1074/jbc.275.11.7764; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Evans LL, 1998, J CELL SCI, V111, P2055; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Humeau Y, 2002, J NEUROSCI, V22, P7968; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Udo H, 2005, NEURON, V45, P887, DOI 10.1016/j.neuron.2005.01.044; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	57	99	105	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					401	414		10.1016/j.neuron.2006.03.017	http://dx.doi.org/10.1016/j.neuron.2006.03.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675395	Bronze			2022-12-24	WOS:000237726800010
J	Dhillon, H; Zigman, JM; Ye, CP; Lee, CE; McGovern, RA; Tang, VS; Kenny, CD; Christiansen, LM; White, RD; Edelstein, EA; Coppari, R; Balthasar, N; Cowley, MA; Chua, S; Elmquist, JK; Lowelll, BB				Dhillon, H; Zigman, JM; Ye, CP; Lee, CE; McGovern, RA; Tang, VS; Kenny, CD; Christiansen, LM; White, RD; Edelstein, EA; Coppari, R; Balthasar, N; Cowley, MA; Chua, S; Elmquist, JK; Lowelll, BB			Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; ARCUATE NUCLEUS; POMC NEURONS; OBESITY; BRAIN; HYPOTHALAMUS; EXPRESSION	Leptin, an adipocyte-derived hormone, acts directly on the brain to control food intake and energy expenditure. An important question is the identity of first-order neurons initiating leptin's anti-obesity effects. A widely held view is that most, if not all, of leptin's effects are mediated by neurons located in the arcuate nucleus of the hypothalamus. However, leptin receptors (LEPRs) are expressed in other sites as well, including the ventromedial hypothalamus (VMH). The possible role of leptin acting in "nonarcuate" sites has largely been ignored. In the present study, we show that leptin depolarizes and increases the firing rate of steroidogenic factor-1 (SF1)-positive neurons in the VMH. We also show, by generating mice that lack LEPRs on SF1-positive neurons, that leptin action at this site plays an important role in reducing body weight and, of note, in resisting diet-induced obesity. These results reveal a critical role for leptin action on VMH neurons.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Program Neurosci, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Oregon Hlth & Sci Univ, Oregon Reg Primate Res Ctr, Div Neurosci, Portland, OR 97006 USA; Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Oregon Health & Science University; Oregon National Primate Research Center; Yeshiva University; Yeshiva University	Elmquist, JK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu; blowell@bidmc.harvard.edu	Coppari, Roberto/B-4799-2014; Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; COPPARI, Roberto/0000-0003-1288-6948; Zigman, Jeffrey/0000-0003-3477-1295	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053301, P01DK056116, T32DK007516, F32DK064564, R37DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK53301-07S2, 5T32DK07516, DK53301, 1F32DK64564-01, P01 DK56116] Funding Source: Medline; NIMH NIH HHS [MH61583] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dellovade TL, 2000, J COMP NEUROL, V423, P579, DOI 10.1002/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 2000, FRONT HORM RES, V26, P21; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Seeley RJ, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1111/j.1651-2227.1999.tb14352.x; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	54	573	578	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					191	203		10.1016/j.neuron.2005.12.021	http://dx.doi.org/10.1016/j.neuron.2005.12.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423694	Bronze			2022-12-24	WOS:000234979900007
J	Adesnik, H; Nicoll, RA; England, PM				Adesnik, H; Nicoll, RA; England, PM			Photoinactivation of native AMPA receptors reveals their real-time trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; BINDING; REDISTRIBUTION; DEGRADATION; EXPRESSION; PLASTICITY; ANTIBODY; GLUR2; CELLS	AMPA receptors mediate the majority of the fast excitatory transmission in the central nervous system. Much evidence suggests that the fast trafficking of AMPA receptors into and out of the postsynaptic membrane underlies changes in synaptic strength thought to be necessary for higher cognitive functions such as learning and memory. Despite the abundance of research conducted in this area, a direct, real-time functional assay that measures the trafficking of native AMPA receptors has been lacking. Toward this aim, we use a photoreactive, irreversible antagonist of AMPA receptors, ANQX, to rapidly silence surface AMPA receptors and investigate directly the trafficking of native AMPA receptors in real time. We find that the most dynamic movement of AMPA receptors occurs by lateral movement across the surface of neurons. Fast cycling of surface AMPA receptors with receptors from internal stores does occur but exclusively at extra-synaptic somatic sites. The cycling of synaptic AMPA receptors only occurs on a much longer timescale with complete exchange requiring at least 16 hr. This cycling is not dependent on protein synthesis or action potential driven network activity. These data suggest a revised model of AMPA receptor trafficking wherein a large internal store of AMPA receptors exchanges rapidly with extrasynaptic somatic AMPA receptors, and these newly inserted AMPA receptors then travel laterally along dendrites to reside stably at synapses.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; england@picasso.ucsf.edu						Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bouron A, 1997, FEBS LETT, V404, P221, DOI 10.1016/S0014-5793(97)00135-X; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chambers JJ, 2004, J AM CHEM SOC, V126, P13886, DOI 10.1021/ja048331p; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GRUNFELD C, 1984, P NATL ACAD SCI-BIOL, V81, P2508, DOI 10.1073/pnas.81.8.2508; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KLECKNER NW, 1989, MOL PHARMACOL, V36, P430; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WEISSMAN AM, 1986, J CELL BIOL, V102, P951, DOI 10.1083/jcb.102.3.951; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	35	173	183	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					977	985		10.1016/j.neuron.2005.11.030	http://dx.doi.org/10.1016/j.neuron.2005.11.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364901	Bronze			2022-12-24	WOS:000234301700013
J	Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA				Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA			Ephrin-As guide the formation of functional maps in the visual cortex	NEURON			English	Article							THALAMOCORTICAL PROJECTIONS; GENE-TRANSFER; MULTIPLE ROLES; CORTICAL AREAS; RECEPTORS; NEOCORTEX; SPECIFICATION; EMX2; MECHANISMS; GUIDANCE	Ephrin-As and their receptors, EphAs, are expressed in the developing cortex where they may act to organize thalamic inputs. Here, we map the visual cortex (V1) in mice deficient for ephrin-A2, -A3, and -A5 functionally, using intrinsic signal optical imaging and microelectrode recording, and structurally, by anatomical tracing of thalamocortical projections. V1 is shifted medially, rotated, and compressed and its internal organization is degraded. Expressing ephrin-A5 ectopically by in utero electroporation in the lateral cortex shifts the map of V1 medially, and expression within V1 disrupts its internal organization. These findings indicate that interactions between gradients of EphA/ephrin-A in the cortex guide map formation, but that factors other than redundant ephrin-As are responsible for the remnant map. Together with earlier work on the retinogeniculate map, the current findings show that the same molecular interactions may operate at successive stages of the visual pathway to organize maps.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu; feldheim@biology.ucsc.edu		Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [EY02874, R01 EY014689, R37 EY002874, R01 EY002874, EY014689, R37 EY002874-24S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874, R01EY014689, R01EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Molnar Z, 1998, J NEUROSCI, V18, P5723; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Uziel D, 2002, J NEUROSCI, V22, P9352; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	137	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					577	589		10.1016/j.neuron.2005.10.026	http://dx.doi.org/10.1016/j.neuron.2005.10.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301175	Bronze, Green Accepted			2022-12-24	WOS:000233677300012
J	Egea, J; Nissen, UV; Dufour, A; Sahin, M; Greer, P; Kullander, K; Mrsic-Flogel, TD; Greenberg, ME; Kiehn, O; Vanderhaeghen, P; Klein, R				Egea, J; Nissen, UV; Dufour, A; Sahin, M; Greer, P; Kullander, K; Mrsic-Flogel, TD; Greenberg, ME; Kiehn, O; Vanderhaeghen, P; Klein, R			Regulation of EphA4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function	NEURON			English	Article							CENTRAL PATTERN GENERATORS; NEONATAL-RAT; SPINAL-CORD; THALAMOCORTICAL PROJECTIONS; TYROSINE KINASES; ACTIVATION; DOMAIN; MECHANISMS; ATTACHMENT; EPHRIN-B3	Signaling by receptor tyrosine kinases (RTKs) is mediated by their intrinsic kinase activity. Typically, kinase-activating mutations result in ligand-independent signaling and gain-of-function phenotypes. Like other RTKs, Ephs require kinase activity to signal, but signaling by Ephs in vitro also requires clustering by their membrane bound ephrin ligands. The relative importance of Eph kinase activity and clustering for in vivo functions is unknown. We find that knockin mice expressing a mutant form of EphA4 (EphA4(EE)), whose kinase is constitutively activated in the absence of ephrinB ligands, are deficient in the development of thalamocortical projections and some aspects of central pattern generator rhythmicity. Surprisingly, other functions of EphA4 were regulated normally by EphA4(EE), including midline axon guidance, hindlimb locomotion, in vitro growth cone collapse, and phosphorylation of ephexin1. These results suggest that signaling of Eph RTKs follows a multistep process of induced kinase activity and higher-order clustering different from RTKs responding to soluble ligands.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Brussels, Inst Rech Interdisciplinaires Biol Humaine & Mol, B-1070 Brussels, Belgium; Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp, Boston, MA 02115 USA; Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden	Max Planck Society; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; Uppsala University	Klein, R (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	rklein@neuro.mpg.de	kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019; Egea, Joaquim/AAT-1984-2021; SAHIN, MUSTAFA/I-8653-2019; Egea, Joaquim/A-7501-2010; Klein, Ruediger/C-6147-2008; Kiehn, Ole/C-4679-2008	SAHIN, MUSTAFA/0000-0001-7044-2953; Klein, Ruediger/0000-0002-3109-0163; Mrsic-Flogel, Tom/0000-0002-8947-408X; Vanderhaeghen, Pierre/0000-0001-7899-5720; Egea Navarro, Joaquim/0000-0002-1164-8377; Kiehn, Ole/0000-0002-5954-469X; Kullander, Klas/0000-0001-6418-5460	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045500] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardelli A, 1998, P NATL ACAD SCI USA, V95, P14379, DOI 10.1073/pnas.95.24.14379; BECKER N, 1995, FEBS LETT, V368, P353, DOI 10.1016/0014-5793(95)00652-P; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Chen LI, 1997, J CELL BIOL, V137, P619, DOI 10.1083/jcb.137.3.619; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; Cowan CA, 2004, DEV BIOL, V271, P263, DOI 10.1016/j.ydbio.2004.03.026; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kremer E, 1997, J NEUROPHYSIOL, V77, P1155, DOI 10.1152/jn.1997.77.3.1155; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	41	99	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					515	528		10.1016/j.neuron.2005.06.029	http://dx.doi.org/10.1016/j.neuron.2005.06.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102535	Bronze			2022-12-24	WOS:000231411100009
J	Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR				Cobos, I; Calcagnotto, ME; Vilaythong, AJ; Thwin, MT; Noebels, JL; Baraban, SC; Rubenstein, JLR			Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC NEURONS; DIVERSITY-SERIES; ADULT-MOUSE; CORTICAL INTERNEURONS; HOMEOBOX GENES; VISUAL-CORTEX; IN-VITRO; RAT; FOREBRAIN	Dlx homeodomain transcription factors are essential during embryonic development for the production of forebrain GABAergic interneurons. Here we show that Dlx1 is also required for regulating the functional longevity of cortical and hippocampal interneurons in the adult brain. We demonstrate preferential Dlx1 expression in a subset of cortical and hippocampal interneurons which, in postnatal Dlx1 mutants, show a time-dependent reduction in number. This reduction preferentially affects calretinin(+) ( bipolar cells) and somatostatin(+) subtypes ( for example, bitufted cells), whereas parvalbumin(+) subpopulations ( basket cells and chandelier cells) seem to be unaffected. Cell transplantation analysis demonstrates that interneuron loss reflects cell-autonomous functions of Dlx1. The decrease in the number of interneurons was associated with a reduction of GABA-mediated inhibitory postsynaptic current in neocortex and hippocampus in vitro and cortical dysrhythmia in vivo. Dlx1 mutant mice show generalized electrographic seizures and histological evidence of seizure-induced reorganization, linking the Dlx1 mutation to delayed-onset epilepsy associated with interneuron loss.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol Surg, Epilepsy Res Lab, San Francisco, CA 94143 USA; Baylor Coll Med, Dept Neurol, Dev Neurogenet Lab, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine	Cobos, I (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA.	icobos@itsa.ucsf.edu; jlrr@itsa.ucsf.edu	calcagnotto, maria elisa/B-1645-2013; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020	calcagnotto, maria elisa/0000-0001-8196-0596; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Noebels, Jeffrey/0000-0002-2887-0839; Baraban, Scott/0000-0003-1975-9781; Cobos, Inma/0000-0002-2043-1890	NICHD NIH HHS [HD24064] Funding Source: Medline; NIMH NIH HHS [R01 MH49428, K05 MH065670] Funding Source: Medline; NINDS NIH HHS [NS 29709, R01 NS40272] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, K05MH065670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040272, R01NS029709] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cobos I, 2005, J COMP NEUROL, V483, P292, DOI 10.1002/cne.20405; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2002, J COMP NEUROL, V443, P1, DOI 10.1002/cne.1425; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kobayashi M, 2003, J NEUROSCI, V23, P2440; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sussel L, 1999, DEVELOPMENT, V126, P3359; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yun K, 2002, DEVELOPMENT, V129, P5029	49	381	390	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1059	1068		10.1038/nn1499	http://dx.doi.org/10.1038/nn1499			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007083				2022-12-24	WOS:000230760200018
J	Bae, BI; Xu, H; Igarashi, S; Fujimuro, M; Agrawal, N; Taya, Y; Hayward, SD; Moran, TH; Montell, C; Ross, CA; Snyder, SH; Sawa, A				Bae, BI; Xu, H; Igarashi, S; Fujimuro, M; Agrawal, N; Taya, Y; Hayward, SD; Moran, TH; Montell, C; Ross, CA; Snyder, SH; Sawa, A			p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; N-TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE PATHOGENESIS; TRANSCRIPTIONAL ACTIVATOR; NUCLEAR-LOCALIZATION; PREPULSE INHIBITION; STRIATAL CELLS	We present evidence for a specific role of p53 in the mitochondria-associated cellular dysfunction and behavioral abnormalities of Huntington's disease (HD). Mutant huntingtin (mHtt) with expanded polyglutamine (polyQ) binds to p53 and upregulates levels of nuclear p53 as well as p53 transcriptional activity in neuronal cultures. The augmentation is specific, as it occurs with mHtt but not mutant ataxin-1 with expanded polyQ. p53 levels are also increased in the brains of mHtt transgenic (mHtt-Tg) mice and HD patients. Perturbation of p53 by pifithrin-alpha, RNA interference, or genetic deletion prevents mitochondrial membrane depolarization and cytotoxicity in HD cells, as well as the decreased respiratory complex IV activity of mHtt-Tg mice. Genetic deletion of p53 suppresses neurodegeneration in mHtt-Tg flies and neurobehavioral abnormalities of mHtt-Tg mice. Our findings suggest that p53 links nuclear and mitochondrial pathologies characteristic of HD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Natl Canc Ctr, Res Inst, Radiobiol Div, Tokyo 1040045, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Cancer Center - Japan	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	asawa1@jhmi.edu	Xu, Hong/H-9997-2016; Ross, Christopher A/H-8395-2013; Fujimuro, Masahiro/AAC-4727-2020; Montell, Craig/AAH-3357-2021	Xu, Hong/0000-0003-1049-1184; Montell, Craig/0000-0001-5637-1482; Fujimuro, Masahiro/0000-0002-5165-0789; BAE, BYOUNG-IL/0000-0002-9958-678X	NEI NIH HHS [EY08117] Funding Source: Medline; NIDA NIH HHS [DA-00266, DA-00074] Funding Source: Medline; NIMH NIH HHS [MH-069853] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BEAL MF, 1993, J NEUROSCI, V13, P4181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Grunewald T, 1999, ANN NY ACAD SCI, V893, P203, DOI 10.1111/j.1749-6632.1999.tb07827.x; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hebb MO, 1999, J COMP NEUROL, V410, P99, DOI 10.1002/(SICI)1096-9861(19990719)410:1<99::AID-CNE9>3.0.CO;2-E; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan J, 1997, J NEUROSCI, V17, P1397; Kazemi-Esfarjani P, 2002, HUM MOL GENET, V11, P2657, DOI 10.1093/hmg/11.21.2657; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuntz C, 2000, EXP NEUROL, V165, P184, DOI 10.1006/exnr.2000.7464; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandir AS, 2002, J NEUROCHEM, V83, P186, DOI 10.1046/j.1471-4159.2002.01144.x; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; MIYASHITA T, 1995, CELL, V80, P293; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Morrison RS, 1996, J NEUROSCI, V16, P1337; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sawa A, 2001, J MOL MED, V79, P375, DOI 10.1007/s001090100223; Schapira AHV, 1997, ANN NEUROL, V41, P141, DOI 10.1002/ana.410410203; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shahbazian MD, 2001, NEUROBIOL DIS, V8, P974, DOI 10.1006/nbdi.2001.0444; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	72	379	391	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 7	2005	47	1					29	41		10.1016/j.neuron.2005.06.005	http://dx.doi.org/10.1016/j.neuron.2005.06.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996546	Bronze			2022-12-24	WOS:000230464000006
J	Avenanti, A; Bueti, D; Galati, G; Aglioti, SM				Avenanti, A; Bueti, D; Galati, G; Aglioti, SM			Transcranial magnetic stimulation highlights the sensorimotor side of empathy for pain	NATURE NEUROSCIENCE			English	Article							HUMAN MOTOR CORTEX; PHANTOM-LIMB PAIN; COIL ORIENTATION; NEURAL SYSTEMS; MODULATION; IMITATION; ACTIVATION; MECHANISMS; PREMOTOR; BRAIN	Pain is intimately linked with action systems that are involved in observational learning and imitation. Motor responses to one's own pain allow freezing or escape reactions and ultimately survival. Here we show that similar motor responses occur as a result of observation of painful events in others. We used transcranial magnetic stimulation to record changes in corticospinal motor representations of hand muscles of individuals observing needles penetrating hands or feet of a human model or noncorporeal objects. We found a reduction in amplitude of motor-evoked potentials that was specific to the muscle that subjects observed being pricked. This inhibition correlated with the observer's subjective rating of the sensory qualities of the pain attributed to the model and with sensory, but not emotional, state or trait empathy measures. The empathic inference about the sensory qualities of others' pain and their automatic embodiment in the observer's motor system may be crucial for the social learning of reactions to pain.	Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Univ G DAnnunzio, Dipartimento Sci Clin & Bioimmagini, I-66010 Chieti, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Via Marsi 78, I-00185 Rome, Italy.	salvatoremaria.aglioti@uniroma1.it	Avenanti, Alessio/K-5250-2012; Aglioti, Salvatore M/E-9829-2012; Galati, Gaspare/F-3277-2011; Bueti, Domenica/E-7627-2014	Avenanti, Alessio/0000-0003-1139-9996; Galati, Gaspare/0000-0002-0640-4247; Bueti, Domenica/0000-0001-6660-7241; Aglioti, Salvatore Maria/0000-0001-8175-7563				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Bonino S., 1998, EMPATIA PROCESSI CON; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Davis M., 1996, EMPATHY SOCIAL PSYCH; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; EISEN A, 1987, CAN J NEUROL SCI, V14, P501, DOI 10.1017/S0317167100037999; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; KIMURA J, 1993, ELECTRODIAGNOSIS DIS; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MAIANI G, 1985, PAIN, V22, P399, DOI 10.1016/0304-3959(85)90045-4; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Saitoh Y, 1999, LANCET, V353, P212, DOI 10.1016/S0140-6736(05)77223-8; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Urban PP, 2004, MUSCLE NERVE, V29, P663, DOI 10.1002/mus.20011; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Wittgenstein Ludwig, 1958, PHILOS INVESTIGATION	50	425	435	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					955	960		10.1038/nn1481	http://dx.doi.org/10.1038/nn1481			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937484				2022-12-24	WOS:000230137100024
J	Haynes, JD; Driver, J; Rees, G				Haynes, JD; Driver, J; Rees, G			Visibility reflects dynamic changes of effective connectivity between V1 and fusiform cortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; HUMAN OCCIPITAL CORTEX; STRIATE CORTEX; HUMAN BRAIN; METACONTRAST MASKING; BACKWARD-MASKING; FEEDBACK CONNECTIONS; COGNITIVE-PROCESSES; DISTINCT MODES; MONKEY	Identifying the neural basis of visibility is central to understanding conscious visual perception. Visibility of basic features such as brightness is often thought to reflect activity in just early visual cortex. But here we show under metacontrast masking that fMRI activity in stimulus-driven areas of early visual cortex did not reflect parametric changes in the visibility of a brightness stimulus. The psychometric visibility function was instead correlated with activity in later visual regions plus parieto-frontal areas, and surprisingly, in representations of the unstimulated stimulus surround for primary visual cortex. Critically, decreased stimulus visibility was associated with a regionally-specific decoupling between early visual cortex and higher visual areas. This provides evidence that dynamic changes in effective connectivity can closely reflect visual perception.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; UCL, Neurol Inst, London WC1N 3BG, England; Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany	University of London; University College London; University of London; University College London; University of London; University College London; Otto von Guericke University	Haynes, JD (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008; Driver, Jon/A-4779-2010	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007; 	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BRIDGEMAN B, 1975, VISION RES, V15, P91, DOI 10.1016/0042-6989(75)90065-6; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Francis G, 2000, PSYCHOL REV, V107, P768, DOI 10.1037/0033-295X.107.4.768; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Green MF, 2005, J COGNITIVE NEUROSCI, V17, P13, DOI 10.1162/0898929052880011; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2003, J NEUROPHYSIOL, V89, P2655, DOI 10.1152/jn.00820.2002; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik SL, 1999, P NATL ACAD SCI USA, V96, P15208, DOI 10.1073/pnas.96.26.15208; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; RAMACHANDRAN VS, 1995, NATURE, V373, P66, DOI 10.1038/373066a0; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; ROCKLAND KS, 1994, VISUAL NEUROSCI, V11, P579, DOI 10.1017/S0952523800002480; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; VAUGHAN HG, 1968, SCIENCE, V160, P207, DOI 10.1126/science.160.3824.207; vonderHeydt R, 1997, INVEST OPHTH VIS SCI, V38, P2146; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	57	137	142	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					811	821		10.1016/j.neuron.2005.05.012	http://dx.doi.org/10.1016/j.neuron.2005.05.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924866	Bronze			2022-12-24	WOS:000229689800014
J	Dreier, L; Burbea, M; Kaplan, JM				Dreier, L; Burbea, M; Kaplan, JM			LIN-23-mediated degradation of beta-catenin regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C elegans	NEURON			English	Article							UBIQUITIN LIGASE COMPLEX; I-KAPPA-B; HOX GENE LIN-39; CAENORHABDITIS-ELEGANS; ALPHA UBIQUITINATION; WINGLESS SIGNAL; SYNAPTIC GROWTH; CELL-ADHESION; WNT PATHWAY; PROTEIN	Ubiquitin-mediated protein degradation has been proposed to play an important role in regulating synaptic transmission. Here we show that LIN-23, the substrate binding subunit of a Skp1/Cullin/F Box (SCF) ubiquitin ligase, regulates the abundance of the glutamate receptor GLR-1 in the ventral nerve cord of C. elegans. Mutants lacking lin-23 had an increased abundance of GLR-1 in the ventral cord. The increase of GLR-1 was not caused by changes in the ubiquitination of GLR-1. Instead, SCFLIN-23 regulates GLR-1 through the P-catenin homolog BAR-1 and the TCF/Lef transcription factor homolog POP-1. We hypothesize that LIN-23-mediated degradation of BAR-1 P-catenin regulates the transcription of Wnt target genes, which in turn alter postsynaptic properties.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Kaplan, JM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NINDS NIH HHS [F32 NS41705, NS32196] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032196, F32NS041705, R01NS032196] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Herman MA, 2001, DEVELOPMENT, V128, P581; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maloof JN, 1999, DEVELOPMENT, V126, P37; Maloof JN, 1998, DEVELOPMENT, V125, P181; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	79	76	84	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					51	64		10.1016/j.neuron.2004.12.058	http://dx.doi.org/10.1016/j.neuron.2004.12.058			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820693	Bronze			2022-12-24	WOS:000228228600008
J	DeVries, SH; Li, W; Saszik, S				DeVries, Steven H.; Li, Wei; Saszik, Shannon			Parallel processing in two transmitter microenvironments at the cone photoreceptor synapse	NEURON			English	Article							GLUTAMATE-RECEPTOR SUBUNITS; GROUND-SQUIRREL RETINA; BIPOLAR CELLS; AMPA RECEPTORS; KAINATE RECEPTORS; MULTIVESICULAR RELEASE; ELECTRON-MICROSCOPY; PLEXIFORM LAYER; GANGLION-CELLS; PRIMATE RETINA	A cone photoreceptor releases glutamate at ribbons located atop narrow membrane invaginations that empty onto a terminal base. The unique shape of the cone terminal suggests that there are two transmitter microenvironments: within invaginations, where concentrations are high and exposures are brief; and at the base, where concentrations are low and exposure is smoothed by diffusion. Using multicell voltage-clamp recording, we show that different subtypes of Off bipolar cells sample transmitter in two microenvironments. The dendrites of an AMPA receptor-containing cell insert into invaginations and sense rapid fluctuations in glutamate concentration that can lead to transient responses. The dendrites of kainate receptor-containing cells make basal contacts and respond to a smoothed flow of glutamate that produces sustained responses. Signaling at the cone to Off bipolar cell synapse illustrates how transmitter spillover and synapse architecture can combine to produce distinct signals in postsynaptic neurons.	Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	DeVries, SH (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	s-devries@northwestern.edu		Li, Wei/0000-0002-2897-649X	NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Cadetti L, 2005, J PHYSIOL-LONDON, V569, P773, DOI 10.1113/jphysiol.2005.096545; Calkins DJ, 1996, VISION RES, V36, P3373, DOI 10.1016/0042-6989(95)00333-9; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Colquhoun David, 1995, P589; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; DVORAK CA, 1980, NATURE, V283, P860, DOI 10.1038/283860a0; ELIASOF S, 1993, J NEUROSCI, V13, P402; FAIN GL, 1977, NATURE, V265, P181, DOI 10.1038/265181a0; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; Frerking M, 2002, J NEUROSCI, V22, P7434; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Hopkins JM, 1997, J NEUROCYTOL, V26, P313, DOI 10.1023/A:1018504718282; HOPKINS JM, 1992, VISUAL NEUROSCI, V8, P379, DOI 10.1017/S0952523800005125; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; KOLB H, 1970, PHILOS T R SOC B, V258, P261, DOI 10.1098/rstb.1970.0036; LASANSKY A, 1973, PHILOS T ROY SOC B, V265, P471, DOI 10.1098/rstb.1973.0033; Lerma J, 1999, HANDB EXP PHARM, V141, P275; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; NELSON R, 1983, VISION RES, V23, P1183, DOI 10.1016/0042-6989(83)90032-9; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Pourcho RG, 2002, J COMP NEUROL, V454, P341, DOI 10.1002/cne.10457; Qin P, 1999, VISUAL NEUROSCI, V16, P169, DOI 10.1017/S0952523899161121; Qin P, 2001, BRAIN RES, V890, P211, DOI 10.1016/S0006-8993(00)03162-0; RAO MR, 1995, NEURON, V14, P561; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; WEST RW, 1975, J COMP NEUROL, V159, P439, DOI 10.1002/cne.901590402; Zenisek D, 2003, J NEUROSCI, V23, P2538	62	125	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					735	748		10.1016/j.neuron.2006.04.034	http://dx.doi.org/10.1016/j.neuron.2006.04.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731512	Bronze			2022-12-24	WOS:000238165000009
J	Dosenbach, NUF; Visscher, KM; Palmer, ED; Miezin, FM; Wenger, KK; Kang, HSC; Burgund, ED; Grimes, AL; Schlaggar, BL; Petersen, SE				Dosenbach, Nico U. F.; Visscher, Kristina M.; Palmer, Erica D.; Miezin, Francis M.; Wenger, Kristin K.; Kang, Hyunseon C.; Burgund, E. Darcy; Grimes, Ansley L.; Schlaggar, Bradley L.; Petersen, Steven E.			A core system for the implementation of task sets	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; BLOOD-FLOW CHANGES; PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN ACTIVITY; VISUAL TASKS; CONFLICT; ATTENTION; FMRI; TRANSIENT	When performing tasks, humans are thought to adopt task sets that configure moment-to-moment data processing. Recently developed mixed blocked/eventrelated designs allow task set-related signals to be extracted in fMRI experiments, including activity related to cues that signal the beginning of a task block, "set-maintenance" activity sustained for the duration of a task block, and event-related signals for different trial types. Data were conjointly analyzed from mixed design experiments using ten different tasks and 183 subjects. Dorsal anterior cingulate cortex/medial superior frontal cortex (dACC/msFC) and bilateral anterior insula/frontal operculum (al/fO) showed reliable start-cue and sustained activations across all or nearly all tasks. These regions also carried the most reliable error-related signals in a subset of tasks, suggesting that the regions form a "core" task-set system. Prefrontal regions commonly related to task control carried task-set signals in a smaller subset of tasks and lacked convergence across signal types.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurobiol & Anat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; San Diego State Univ, Dept Psychol, San Diego, CA 92120 USA; Rice Univ, Dept Psychol, Houston, TX 77251 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brandeis University; California State University System; San Diego State University; Rice University	Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	ndosenbach@wustl.edu; sep@npg.wustl.edu	Petersen, Steve/ABF-1368-2020; Schlaggar, Bradley/AAZ-4153-2020	Visscher, Kristina/0000-0003-0737-4024; Kang, Hyunseon/0000-0001-5313-3526	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041255, R01NS046424] Funding Source: NIH RePORTER; NINDS NIH HHS [NS46424, NS41255, R21 NS041255, R01 NS046424] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARRIS RW, 1953, NEUROLOGY, V3, P44, DOI 10.1212/WNL.3.1.44; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; BROADBENT DE, 1982, ACTA PSYCHOL, V50, P253, DOI 10.1016/0001-6918(82)90043-9; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donaldson DI, 2004, TRENDS NEUROSCI, V27, P442, DOI 10.1016/j.tins.2004.06.001; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Konishi S, 2005, P NATL ACAD SCI USA, V102, P12584, DOI 10.1073/pnas.0500585102; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Luria A. R., 2012, HIGHER CORTICAL FUNC; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manes F, 1999, J NERV MENT DIS, V187, P707, DOI 10.1097/00005053-199912000-00001; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Posner M., 1975, INFORM PROCESSING CO; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wenger KK, 2004, NEUROIMAGE, V22, P975, DOI 10.1016/j.neuroimage.2004.02.028; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	81	1230	1241	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					799	812		10.1016/j.neuron.2006.04.031	http://dx.doi.org/10.1016/j.neuron.2006.04.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	051MK	16731517	Bronze, Green Accepted			2022-12-24	WOS:000238165000014
J	Kwan, KY; Allchorne, AJ; Vollrath, MA; Christensen, AP; Zhang, DS; Woolf, CJ; Corey, DP				Kwan, KY; Allchorne, AJ; Vollrath, MA; Christensen, AP; Zhang, DS; Woolf, CJ; Corey, DP			TRPA1 contributes to cold, mechanical, and chemical Nociception but is not essential for hair-cell transduction	NEURON			English	Article							PRIMARY SENSORY NEURONS; SPARED NERVE INJURY; ION-CHANNEL TRPA1; NEUROPATHIC PAIN; THERMOTRP CHANNELS; SEX-DIFFERENCES; TRK RECEPTORS; GROWTH-FACTOR; TIP LINKS; RAT	TRPA1, a member of the transient receptor potential (TRP) family of ion channels, is expressed by dorsal root ganglion neurons and by cells of the inner ear, where it has proposed roles in sensing sound, painful cold, and irritating chemicals. To test the in vivo roles of TRPA1, we generated a mouse in which the essential exons required for proper function of the Trpa1 gene were deleted. Knockout mice display behavioral deficits in response to mustard oil, to cold (similar to 0 degrees C), and to punctate mechanical stimuli. These mice have a normal startle reflex to loud noise, a normal sense of balance, a normal auditory brainstem response, and normal transduction currents in vestibular hair cells. TRPA1 is apparently not essential for hair-cell transduction but contributes to the transduction of mechanical, cold, and chemical stimuli in nociceptor sensory neurons.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Neural Plast Res Grp, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School	Kwan, KY (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	kelvin_kwan@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Kwan, Kelvin/0000-0002-8617-5543; Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R37NS039518, R01NS039518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00304] Funding Source: Medline; NINDS NIH HHS [NS-039518, NS-038253] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allchorne AJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-36; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CARLTON SM, 1994, PAIN, V56, P155, DOI 10.1016/0304-3959(94)90090-6; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Fillingim RB, 2000, NEUROSCI BIOBEHAV R, V24, P485, DOI 10.1016/S0149-7634(00)00017-8; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; HANDWERKER HO, 1991, J PHYSIOL-LONDON, V435, P229, DOI 10.1113/jphysiol.1991.sp018507; Hu J, 2006, PAIN, V120, P3, DOI 10.1016/j.pain.2005.11.002; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Meyers JR, 2003, J NEUROSCI, V23, P4054; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suter MR, 2003, ANESTHESIOLOGY, V99, P1402, DOI 10.1097/00000542-200312000-00025; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	939	984	0	69	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 20	2006	50	2					277	289		10.1016/j.neuron.2006.03.042	http://dx.doi.org/10.1016/j.neuron.2006.03.042			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630838	Bronze			2022-12-24	WOS:000237176700014
J	Fiumelli, H; Cancedda, L; Poo, MM				Fiumelli, H; Cancedda, L; Poo, MM			Modulation of GABAergic transmission by activity via postsynaptic Ca2+-dependent regulation of KCC2 function	NEURON			English	Article							K-CL COTRANSPORTER; EXCITATORY ACTIONS; DEPENDENT DEPRESSION; CA2+ OSCILLATIONS; RAT HIPPOCAMPUS; DOWN-REGULATION; GABA RESPONSES; SYNAPSES; EXPRESSION; POTENTIATION	Activity-induced modification of GABAergic transmission contributes to the plasticity of neural circuits. In the present work we found that prolonged postsynaptic spiking of hippocampal neurons led to a shift in the reversal potential of GABA-induced Cl- currents (E-Cl) toward positive levels in a duration- and frequency-dependent manner. This effect was abolished by blocking cytosolic Ca2+ elevation and mimicked by releasing Ca2+, from internal stores. Activity- and Ca2+-induced Eel shifts were larger in mature neurons, which express the K-Cl cotransporter KCC2 at high levels, and inhibition of KCC2 occluded the shifts. Overexpression of KCC2 in young cultured neurons, which express lower levels of KCC2 and have a more positive Eel, resulted in hyperpolarized Eel similar to that of mature cells. Importantly, these young KCC2-expressing neurons became responsive to neuronal spiking and Ca2+ elevation by showing positive Eel shifts. Thus, repetitive postsynaptic spiking reduces the inhibitory action of GABA through a Ca2+-dependent downregulation of KCC2 function.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Cancedda, Laura/0000-0003-0566-057X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1981, NEUROSCIENCE, V6, P2445, DOI 10.1016/0306-4522(81)90091-9; Chudotvorova I, 2005, J PHYSIOL-LONDON, V566, P671, DOI 10.1113/jphysiol.2005.089821; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LING DSF, 1995, BRAIN RES, V670, P142, DOI 10.1016/0006-8993(94)01298-V; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Owens DF, 1996, J NEUROSCI, V16, P6414; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Taketo M, 2004, BRAIN RES, V1016, P229, DOI 10.1016/j.brainres.2004.05.008; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wan JJ, 1999, SCIENCE, V285, P1725, DOI 10.1126/science.285.5434.1725; Wang J, 2003, J NEUROSCI, V23, P826; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Zucchi R, 1997, PHARMACOL REV, V49, P1	38	165	171	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					773	786		10.1016/j.neuron.2005.10.025	http://dx.doi.org/10.1016/j.neuron.2005.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337915	Bronze			2022-12-24	WOS:000233927300016
J	Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T				Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T			Synaptic background activity controls spike transfer from thalamus to cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RELAY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; NEOCORTICAL NEURONS; VISUAL INFORMATION; PYRAMIDAL NEURONS; SENSORY INPUT; IN-VIVO; CAT; CELLS	Characterizing the responsiveness of thalamic neurons is crucial to understanding the flow of sensory information. Typically, thalamocortical neurons possess two distinct firing modes. At depolarized membrane potentials, thalamic cells fire single action potentials and faithfully relay synaptic inputs to the cortex. At hyperpolarized potentials, the activation of T-type calcium channels promotes burst firing, and the transfer is less accurate. Our results suggest that this duality no longer holds if synaptic background activity is taken into account. By injecting stochastic conductances into guinea-pig thalamocortical neurons in slices, we show that the transfer function of these neurons is strongly influenced by conductance noise. The combination of synaptic noise with intrinsic properties gives a global responsiveness that is more linear, mixing single-spike and burst responses at all membrane potentials. Because in thalamic neurons, background synaptic input originates mainly from cortex, these results support a determinant role of corticothalamic feedback during sensory information processing.	CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France; Univ Bordeaux 2, INSERM 358, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bal, T (corresponding author), CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France.	jakob.wolfart@unklinik-freiburg.de; thierry.bal@iaf.cnrs-gif.fr	Wolfart, Jakob/F-1698-2011	Wolfart, Jakob/0000-0003-0594-2112; Destexhe, Alain/0000-0001-7405-0455				Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 2002, PHILOS T ROY SOC B, V357, P1649, DOI 10.1098/rstb.2002.1154; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; KOCH C, 1987, NEUROSCIENCE, V23, P399, DOI 10.1016/0306-4522(87)90064-9; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Leresche N, 2004, J NEUROSCI, V24, P5592, DOI 10.1523/JNEUROSCI.1038-04.2004; Lewis JE, 1999, J COMP PHYSIOL A, V185, P373, DOI 10.1007/s003590050397; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Shu YS, 2003, J NEUROSCI, V23, P10388; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434; Steriade M, 1997, THALAMUS, VI; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; TROY JB, 1992, VISUAL NEUROSCI, V9, P535, DOI 10.1017/S0952523800001784; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	49	126	129	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1760	1767		10.1038/nn1591	http://dx.doi.org/10.1038/nn1591			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261132				2022-12-24	WOS:000233576200026
J	Choi, SY; Borghuis, B; Rea, R; Levitan, ES; Sterling, P; Kramer, RH				Choi, SY; Borghuis, B; Rea, R; Levitan, ES; Sterling, P; Kramer, RH			Encoding light intensity by the cone photoreceptor synapse	NEURON			English	Article							TIGER SALAMANDER RETINA; HIPPOCAMPAL SYNAPSES; BIPOLAR CELLS; VERTEBRATE PHOTORECEPTORS; RIBBON SYNAPSE; GANGLION-CELLS; OUTPUT SYNAPSE; VESICLES; TRANSMISSION; SENSITIVITY	How cone synapses encode light intensity determines the precision of information transmission at the first synapse on the visual pathway. Although it is known that cone photoreceptors hyperpolarize to light over 4-5 log units of intensity, the relationship between light intensity and transmitter release at the cone synapse has not been determined. Here, we use two-photon microscopy to visualize release of the synaptic vesicle dye FM1-43 from cone terminals in the intact lizard retina, in response to different stimulus light intensities. We then employ electron microscopy to translate these measurements into vesicle release rates. We find that from darkness to bright light, release decreases from 49 to similar to 2 vesicles per 200 ms; therefore, cones compress their 10,000-fold operating range for phototransduction into a 25-fold range for synaptic vesicle release. Tonic release encodes ten distinguishable intensity levels, skewed to most finely represent bright light, assuming release obeys Poisson statistics.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kramer, RH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu			NEI NIH HHS [EY00828, EY015514] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000828, R01EY015514] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; ATTWELL D, 1982, J PHYSIOL-LONDON, V328, P259, DOI 10.1113/jphysiol.1982.sp014263; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Berntson A, 2003, VISUAL NEUROSCI, V20, P621, DOI 10.1017/S0952523803206040; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; DEMARCO PJ, 1994, VISUAL NEUROSCI, V11, P491, DOI 10.1017/S0952523800002418; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HAYHOE MM, 1992, VISION RES, V32, P323, DOI 10.1016/0042-6989(92)90142-6; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PATEL AS, 1968, J OPT SOC AM, V58, P696, DOI 10.1364/JOSA.58.000696; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Purves D, 2004, PSYCHOL REV, V111, P142, DOI 10.1037/0033-295X.111.1.142; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Rodieck R.W., 1998, 1 STEPS SEEING; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; WU SM, 1994, ANNU REV PHYSIOL, V56, P141; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	44	53	54	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					555	562		10.1016/j.neuron.2005.09.011	http://dx.doi.org/10.1016/j.neuron.2005.09.011			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301173	Bronze			2022-12-24	WOS:000233677300010
J	Koob, GF; Le Moal, M				Koob, GF; Le Moal, M			Plasticity of reward neurocircuitry and the 'dark side' of drug addiction	NATURE NEUROSCIENCE			English	Editorial Material							DYSREGULATION; ALLOSTASIS; WITHDRAWAL; STRESS; DEPENDENCE; BEHAVIOR; ETHANOL; RELAPSE; SEEKING; BRAIN	Drug seeking is associated with activation of reward neural circuitry. Here we argue that drug addiction also involves a 'dark side'-a decrease in the function of normal reward-related neurocircuitry and persistent recruitment of anti-reward systems. Understanding the neuroplasticity of the dark side of this circuitry is the key to understanding vulnerability to addiction.	Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Univ Bordeaux 2, Lab Physiopathol Comportements, INSERM, U588, F-33076 Bordeaux, France	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Koob, GF (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	gkoob@scripps.edu	LE MOAL, Michel/B-5125-2008					Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Le Moal Michel, 1995, P283; MARTIN WR, 1968, ADDICT STATES, P206; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; See RE, 2003, ANN NY ACAD SCI, V985, P294; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shippenberg TS, 2002, NEUROPSYCHOPHARMACOL, P1381; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; World Health Organization, 1992, INT STAT CLASS DIS R	22	644	657	2	65	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1442	1444		10.1038/nn1105-1442	http://dx.doi.org/10.1038/nn1105-1442			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251985				2022-12-24	WOS:000232966600013
J	Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL				Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL			Neuregulin-1 type III determines the ensheathment fate of axons	NEURON			English	Article							SCHWANN-CELL MYELINATION; NEURON-DERIVED FACTOR; SIGNAL-REGULATED KINASE; PERIPHERAL-NERVE; PLASMA-MEMBRANE; PI 3-KINASE; EXPRESSION; RECEPTOR; GROWTH; HEREGULIN	The signals that determine whether axons are ensheathed or myelinated by Schwann cells have long been elusive. We now report that threshold levels of neuregulin-1 (NRG1) type III on axons determine their ensheathment fate. Ensheathed axons express low levels whereas myelinated fibers express high levels of NRG1 type III. Sensory neurons from NRG1 type III deficient mice are poorly ensheathed and fail to myelinate; lentiviral-mediated expression of NRG1 type III rescues these defects. Expression also converts the normally unmyelinated axons of sympathetic neurons to myelination. Nerve fibers of mice haploinsufficient for NRG1 type III are disproportionately unmyelinated, aberrantly ensheathed, and hypomyelinated, with reduced conduction velocities. Type III is the sole NRG1 isoform retained at the axon surface and activates PI 3-kinase, which is required for Schwann cell myelination. These results indicate that levels of NRG1 type III, independent of axon diameter, provide a key instructive signal that determines the ensheathment fate of axons.	NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA; NYU, Sch Med, Rusk Inst, New York, NY 10016 USA; CUNY Hunter Coll, Sch Hlth Sci, New York, NY 10010 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; New York University; New York University; New York University; New York University; City University of New York (CUNY) System; Hunter College (CUNY); University of Rochester; University of Rochester; Wayne State University; Wayne State University; Emory University; Columbia University	Salzer, JL (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	salzer@saturn.med.nyu.edu	Role, LW/Q-7371-2018; Taveggia, Carla/AAN-4784-2020; Messier, Claude/A-2322-2008	Role, LW/0000-0001-5851-212X; Messier, Claude/0000-0002-4791-1763; Salzer, James/0000-0001-9126-7197; Petrylak, Ashley/0000-0003-2972-7054; Chao, Moses/0000-0002-6969-3744	NINDS NIH HHS [R01 NS029071-17, R01 NS026001, R01 NS029071-13S1, NS29071, R01 NS029071-15, R01 NS017965, NS17965, R01 NS037475, NS051282, R01 NS029071, R01 NS029071-16, NS037475, NS26001, R01 NS051282, R01 NS029071-14, R01 NS029071-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051282, R01NS017965, R01NS037475, R01NS026001, R01NS029071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; AGUAYO AJ, 1976, J NEUROCYTOL, V5, P565, DOI 10.1007/BF01175570; Auger KR, 2000, BIOCHEM BIOPH RES CO, V272, P822, DOI 10.1006/bbrc.2000.2806; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BRUNDEN KR, 1992, J NEUROSCI RES, V32, P507, DOI 10.1002/jnr.490320406; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cabedo H, 2002, J BIOL CHEM, V277, P19905, DOI 10.1074/jbc.M201587200; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; ESTRIDGE M, 1978, J CELL BIOL, V79, P138, DOI 10.1083/jcb.79.1.138; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Frenzel KE, 2001, J NEUROCHEM, V77, P1; FRIEDE RL, 1972, J COMP NEUROL, V144, P233, DOI 10.1002/cne.901440207; FRIEDE RL, 1967, J COMP NEUROL, V130, P223, DOI 10.1002/cne.901300304; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HILLARP NA, 1946, ACTA ANAT, V2, P17; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Hoke A, 2003, J NEUROSCI, V23, P561; JESSEN KR, 2003, MYELIN BIOL DISORDER, P329; Langley JN, 1903, J PHYSL, V30, P439; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Murphy P, 1996, DEVELOPMENT, V122, P2847; MURRAY MA, 1968, ANAT REC, V161, P337; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; OBREMSKI VJ, 1993, J NEUROCYTOL, V22, P102, DOI 10.1007/BF01181574; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Peters A., 1991, FINE STRUCTURE NERVO; Rosenbluth J, 2003, GLIA, V41, P318, DOI 10.1002/glia.10179; ROUFA D, 1986, J NEUROSCI, V6, P790; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Schroering A, 1998, J BIOL CHEM, V273, P30643, DOI 10.1074/jbc.273.46.30643; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIMPSON SA, 1945, J ANAT, V79, P48; SMITH KJ, 1982, J NEUROL SCI, V55, P231, DOI 10.1016/0022-510X(82)90103-4; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Spencer PS, 1978, PHYSL PATHOBIOLOGY A, P389; Vabnick I, 1999, J NEUROSCI, V19, P747; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	65	537	556	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					681	694		10.1016/j.neuron.2005.08.017	http://dx.doi.org/10.1016/j.neuron.2005.08.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129398	Green Accepted, Bronze			2022-12-24	WOS:000231782700010
J	Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I				Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I			Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety	NATURE NEUROSCIENCE			English	Article							DELTA-SUBUNIT; NEUROACTIVE STEROIDS; ESTROUS-CYCLE; ANTICONVULSANT ACTIVITY; WITHDRAWAL PROPERTIES; LUTEAL-PHASE; PROGESTERONE; ETHANOL; MODEL; NEUROSTEROIDS	Disturbances of neuronal excitability changes during the ovarian cycle may elevate seizure frequency in women with catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD). The mechanisms underlying these changes are unknown, but they could result from the effects of fluctuations in progesterone-derived neurosteroids on the brain. Neurosteroids and some anxiolytics share an important site of action: tonic inhibition mediated by delta subunit - containing GABA(A) receptors (delta GABA(A)Rs). Here we demonstrate periodic alterations in specific GABA(A)R subunits during the estrous cycle in mice, causing cyclic changes of tonic inhibition in hippocampal neurons. In late diestrus (high-progesterone phase), enhanced expression of delta GABA(A)Rs increases tonic inhibition, and a reduced neuronal excitability is reflected by diminished seizure susceptibility and anxiety. Eliminating cycling of delta GABA(A)Rs by antisense RNA treatment or gene knockout prevents the lowering of excitability during diestrus. Our findings are consistent with possible deficiencies in regulatory mechanisms controlling normal cycling of delta GABA(A)Rs in individuals with catamenial epilepsy or PMDD.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	mody@ucla.edu		Stell, Brandon/0000-0003-1287-9211; Maguire, Jamie/0000-0002-4085-8605	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002808, T32NS007449, R01NS030549, R37NS030549] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30549, T32 NS07449, NS02808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agmo A, 1997, PSYCHOPHARMACOLOGY, V129, P372, DOI 10.1007/s002130050203; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Broadbent J, 1999, PSYCHOPHARMACOLOGY, V141, P197, DOI 10.1007/s002130050825; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Gulinello M, 2002, NEUROPHARMACOLOGY, V43, P701, DOI 10.1016/S0028-3908(02)00171-5; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog AG, 1999, NEUROLOGY, V52, P1917, DOI 10.1212/WNL.52.9.1917-a; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Jones A, 1997, J NEUROSCI, V17, P1350; Lancel M, 2001, AM J PHYSIOL-ENDOC M, V281, pE130, DOI 10.1152/ajpendo.2001.281.1.E130; MARTIN JV, 1995, LIFE SCI, V57, P1903, DOI 10.1016/0024-3205(95)02177-K; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Molina-Hernandez M, 2001, NEUROPSYCHOBIOLOGY, V43, P29, DOI 10.1159/000054862; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nyberg S, 2004, PSYCHONEUROENDOCRINO, V29, P767, DOI 10.1016/S0306-4530(03)00121-5; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Reddy DS, 2001, EPILEPSIA, V42, P328, DOI 10.1046/j.1528-1157.2001.10100.x; Reddy DS, 1999, PHARMACOL BIOCHEM BE, V62, P53, DOI 10.1016/S0091-3057(98)00126-9; Reddy DS, 2004, J PHARMACOL EXP THER, V310, P230, DOI 10.1124/jpet.104.065268; Reddy DS, 2001, EPILEPSIA, V42, P337, DOI 10.1046/j.1528-1157.2001.10200.x; Rogawski MA, 2003, ANN NEUROL, V53, P288, DOI 10.1002/ana.10534; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Shuman Sevie, 2003, Epilepsia, V44, P292; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Smith SS, 2004, ALCOHOL, V33, P41, DOI 10.1016/j.alcohol.2004.04.003; Smith SS, 2002, STEROIDS, V67, P519, DOI 10.1016/S0039-128X(01)00170-2; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	48	457	465	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					797	804		10.1038/nn1469	http://dx.doi.org/10.1038/nn1469			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895085				2022-12-24	WOS:000229345300021
J	Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB				Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB			LINGO-1 negatively regulates myelination by oligodendrocytes	NATURE NEUROSCIENCE			English	Article							RECEPTOR FAMILY-MEMBER; FYN TYROSINE KINASE; MORPHOLOGICAL-DIFFERENTIATION; SHEATH THICKNESS; NERVOUS-SYSTEM; SCHWANN-CELLS; ACTIVATION; EXPRESSION; NEUREGULIN; MOLECULES	The control of myelination by oligodendrocytes in the CNS is poorly understood. Here we show that LINGO-1 is an important negative regulator of this critical process. LINGO-1 is expressed in oligodendrocytes. Attenuation of its function by dominant-negative LINGO-1, LINGO-1 RNA-mediated interference (RNAi) or soluble human LINGO-1 (LINGO-1-Fc) leads to differentiation and increased myelination competence. Attenuation of LINGO-1 results in downregulation of RhoA activity, which has been implicated in oligodendrocyte differentiation. Conversely, overexpression of LINGO-1 leads to activation of RhoA and inhibition of oligodendrocyte differentiation and myelination. Treatment of oligodendrocyte and neuron cocultures with LINGO-1-Fc resulted in highly developed myelinated axons that have internodes and well-defined nodes of Ranvier. The contribution of LINGO-1 to myelination was verified in vivo through the analysis of LINGO-1 knockout mice. The ability to recapitulate CNS myelination in vitro using LINGO-1 antagonists and the in vivo effects seen in the LINGO-1 knockout indicate that LINGO-1 signaling may be critical for CNS myelination.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Biogen; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard Medical School; Cleveland Clinic Foundation	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Bhat RV, 1996, GLIA, V17, P169; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; FRIEDE RL, 1986, EXP NEUROL, V92, P234, DOI 10.1016/0014-4886(86)90137-8; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kiewe P, 2003, LEUKEMIA LYMPHOMA, V44, P1815, DOI 10.1080/1042819031000116625; KOLODNY EH, 1993, CURR OPIN NEUROL NEU, V6, P379; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Li C, 1998, J NEUROSCI RES, V51, P210, DOI 10.1002/(SICI)1097-4547(19980115)51:2<210::AID-JNR9>3.0.CO;2-G; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Partadiredja G, 2003, J NEUROCYTOL, V32, P1165, DOI 10.1023/B:NEUR.0000021910.65920.41; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salvati S, 2000, DEV NEUROSCI-BASEL, V22, P481, DOI 10.1159/000017479; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Villagra NT, 2004, NEUROBIOL DIS, V16, P158, DOI 10.1016/j.nbd.2004.02.005; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	33	471	517	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					745	751		10.1038/nn1460	http://dx.doi.org/10.1038/nn1460			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895088				2022-12-24	WOS:000229345300014
J	Faber, ESL; Delaney, AJ; Sah, P				Faber, ESL; Delaney, AJ; Sah, P			SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; ACTIVATED POTASSIUM CURRENTS; NMDA-RECEPTOR ACTIVATION; DENDRITIC SPINES; LESIONED MICE; HAIR-CELLS; IN-VITRO; CALCIUM	At glutamatergic synapses, calcium influx through NMDA receptors (NMDARs) is required for long-term potentiation (LTP); this is a proposed cellular mechanism underlying memory and learning. Here we show that in lateral amygdala pyramidal neurons, SK channels are also activated by calcium influx through synaptically activated NMDARs, resulting in depression of the synaptic potential. Thus, blockade of SK channels by apamin potentiates fast glutamatergic synaptic potentials. This potentiation is blocked by the NMDAR antagonist AP5 (D(-)-2-amino-5-phosphono-valeric acid) or by buffering cytosolic calcium with BAPTA. Blockade of SK channels greatly enhances LTP of cortical inputs to lateral amygdala pyramidal neurons. These results show that NMDARs and SK channels are colocalized at glutamatergic synapses in the lateral amygdala. Calcium influx through NMDARs activates SK channels and shunts the resultant excitatory postsynaptic potential. These results demonstrate a new role for SK channels as postsynaptic regulators of synaptic efficacy.	Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Sah, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	pankaj.sah@uq.edu.au	Delaney, Andrew/H-4238-2018; Sah, Pankaj/C-8175-2009	Delaney, Andrew/0000-0001-8972-4870; Sah, Pankaj/0000-0001-5063-1589; Faber, Luli/0000-0001-9015-9805				Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; BELCADIABBASSI W, 1995, NEUROREPORT, V6, P1293, DOI 10.1097/00001756-199506090-00016; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cangiano L, 2002, J NEUROPHYSIOL, V88, P289, DOI 10.1152/jn.2002.88.1.289; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Ikonen S, 1999, EUR J PHARMACOL, V382, P151, DOI 10.1016/S0014-2999(99)00616-0; Ikonen S, 1998, EUR J PHARMACOL, V347, P13, DOI 10.1016/S0014-2999(98)00075-2; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Power JM, 2002, J NEUROSCI, V22, P3454; ROMEY G, 1984, J PHYSIOL-PARIS, V79, P259; Roncarati R, 2001, NEUROSCIENCE, V104, P253, DOI 10.1016/S0306-4522(01)00066-5; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sah P, 1996, J NEUROSCI, V16, P4537; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2002, J NEUROSCI, V22, P9698; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; van der Staay FJ, 1999, NEUROSCI BIOBEHAV R, V23, P1087, DOI 10.1016/S0149-7634(99)00043-3; Villalobos C, 2004, J NEUROSCI, V24, P3537, DOI 10.1523/JNEUROSCI.0380-04.2004; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yamada SI, 2004, J NEUROPHYSIOL, V91, P2322, DOI 10.1152/jn.01049.2003; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	45	189	192	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					635	641		10.1038/nn1450	http://dx.doi.org/10.1038/nn1450			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852010				2022-12-24	WOS:000228895100024
J	Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Kohn, PD; Kolachana, B; Kippenhan, S; McInerney-Leo, A; Nussbaum, R; Weinberger, DR; Berman, KF			Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; MESSENGER-RNA; SCHIZOPHRENIA; EXPRESSION; SYSTEMS; CORTEX; MEMORY	Using multimodal neuroimaging in humans, we demonstrate specific interactions between prefrontal activity and midbrain dopaminergic synthesis. A common V(108/158)M substitution in the gene for catecholamine-O-methyltransferase (COMT), an important enzyme regulating prefrontal dopamine turnover, predicted reduced dopamine synthesis in midbrain and qualitatively affected the interaction with prefrontal cortex. These data implicate a dopaminergic tuning mechanism in prefrontal cortex and suggest a systems-level mechanism for cognitive and neuropsychiatric associations with COMT.	NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyer-Lindenberg, A (corresponding author), NIMH, Sect Integrat Neuroimaging, NIH, Dept Hlth & Human Serv, 9000 Rockville Pike, Bethesda, MD 20892 USA.	andreasml@nih.gov	McInerney-Leo, Aideen M/D-8302-2016; McInerney-Leo, Aideen M/E-1788-2018; Meyer-Lindenberg, Andreas/H-1076-2011	McInerney-Leo, Aideen M/0000-0002-0059-5732; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002716, Z01MH002867, Z01MH002716, ZIAMH002717, Z01MH002717] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akil M, 2003, J NEUROSCI, V23, P2008; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MEADORWOODRUFF JH, 1994, P NATL ACAD SCI USA, V91, P8297, DOI 10.1073/pnas.91.17.8297; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	15	341	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					594	596		10.1038/nn1438	http://dx.doi.org/10.1038/nn1438			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15821730				2022-12-24	WOS:000228895100019
J	Tolias, AS; Keliris, GA; Smirnakis, SM; Logothetis, NK				Tolias, AS; Keliris, GA; Smirnakis, SM; Logothetis, NK			Neurons in macaque area V4 acquire directional tuning after adaptation to motion stimuli	NATURE NEUROSCIENCE			English	Article							VISUAL AREA; SELECTIVE ATTENTION; RHESUS-MONKEY; MT; CONNECTIONS; LESIONS; CORTEX	Neurons in area V4 of the macaque are generally not selective for direction of motion, as judged from their response to directional stimuli presented after a baseline condition devoid of movement. We used motion adaptation to investigate whether stimulation history influences direction-of-motion selectivity. We found that classically nondirectional V4 neurons develop direction-of-motion selectivity after adaptation, an observation that underscores the dynamic nature of functional cortical architecture.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Max Planck Society; Harvard University; Massachusetts General Hospital	Tolias, AS (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	andreas.tolias@tuebingen.mpg.de	Keliris, Georgios A/B-6692-2008; Logothetis, Nikos/U-9282-2019	Keliris, Georgios A/0000-0001-6732-1261; 				Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	15	104	104	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					591	593		10.1038/nn1446	http://dx.doi.org/10.1038/nn1446			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834417				2022-12-24	WOS:000228895100018
J	Moradi, F; Koch, C; Shimojo, S				Moradi, F; Koch, C; Shimojo, S			Face adaptation depends on seeing the face	NEURON			English	Article							ORIENTATION-SELECTIVE ADAPTATION; BINOCULAR-RIVALRY SUPPRESSION; MOTION-INDUCED BLINDNESS; FACIAL EXPRESSIONS; VISUAL AWARENESS; ATTENTION; DISCRIMINATION; PERCEPTION; IMAGERY; OBJECTS	Retinal input that is suppressed from visual awareness can nevertheless produce measurable aftereffects, revealing neural processes that do not directly result in a conscious percept. We here report that the face identity-specific aftereffect requires a visible face; it is effectively cancelled by binocular suppression or by inattentional blindness of the inducing face. Conversely, the same suppression does not interfere with the orientation-specific aftereffect. Thus, the competition between incompatible or interfering visual inputs to reach awareness is resolved before those aspects of information that are exploited in face identification are processed. We also found that the face aftereffect remained intact when the visual distracters in the inattention experiment were replaced with auditory distracters. Thus, cross-modal or cognitive interference that does not affect the visibility of the face does not interfere with the face aftereffect. We conclude that adaptation to face identity depends on seeing the face.	CALTECH, Pasadena, CA 91125 USA; NTT Corp, Commun Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Moradi, F (corresponding author), CALTECH, Pasadena, CA 91125 USA.	farshadm@caltech.edu		Koch, Christof/0000-0001-6482-8067				AGHDAEE SM, 2004, IN PRES PERCEPTION; Arnell KM, 2002, PSYCHON B REV, V9, P497, DOI 10.3758/BF03196305; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLANZ V, 1999, 1999 S INT 3D GRAPH, P187; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; de Gelder B, 2000, BRAIN COGNITION, V44, P425, DOI 10.1006/brcg.1999.1203; DEHAAN EHF, 1992, CORTEX, V28, P77, DOI 10.1016/S0010-9452(13)80167-0; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Mack A., 1998, INATTENTIONAL BLINDN; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Paller KA, 2003, NEURON, V38, P507, DOI 10.1016/S0896-6273(03)00198-3; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; WHITE KD, 1978, VISION RES, V18, P1201, DOI 10.1016/0042-6989(78)90105-0; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3	35	129	132	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					169	175		10.1016/j.neuron.2004.12.018	http://dx.doi.org/10.1016/j.neuron.2004.12.018			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629711	Bronze			2022-12-24	WOS:000226217100018
J	Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H				Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H			Odorant receptor heterodimerization in the olfactory system of Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							DIMERIZATION; EXPRESSION; ANTENNA; MAP	Despite increasing knowledge about dimerization of G-protein-coupled receptors, nothing is known about dimerization in the largest subfamily, odorant receptors. Using a combination of biochemical and electrophysiological approaches, we demonstrate here that odorant receptors can dimerize. DOR83b, an odorant receptor that is ubiquitously expressed in olfactory neurons from Drosophila melanogaster and highly conserved among insect species, forms heterodimeric complexes with other odorant-receptor proteins, which strongly increases their functionality.	Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; Ruhr Univ Bochum, AG Sinnesphysiol, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Neuhaus, EM (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.	eva.neuhaus@rub.de	Dooley, Ruth/A-5480-2010; Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Elmore T, 2003, J NEUROSCI, V23, P9906; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998	15	241	265	2	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					15	17		10.1038/nn1371	http://dx.doi.org/10.1038/nn1371			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592462				2022-12-24	WOS:000225967600007
J	Zugaro, MB; Monconduit, LC; Buzsaki, G				Zugaro, MB; Monconduit, LC; Buzsaki, G			Spike phase precession persists after transient intrahippocampal perturbation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; PLACE CELLS; THETA OSCILLATIONS; MEMORY SEQUENCES; RAT HIPPOCAMPUS; TEMPORAL CODE; SPATIAL MAP; EXPERIENCE; DYNAMICS; MODEL	Oscillatory spike timing in the hippocampus is regarded as a temporal coding mechanism for space, but the underlying mechanisms are poorly understood. To contrast the predictions of the different models of phase precession, we transiently turned off neuronal discharges for up to 250 ms and reset the phase of theta oscillations by stimulating the commissural pathway in rats. After recovery from silence, phase precession continued. The phase of spikes for the first theta cycle after the perturbation was more advanced than the phase of spikes for the last theta cycle just before the perturbation. These findings indicate that phase advancement that emerges within hippocampal circuitry may be updated at the beginning of each theta cycle by extrahippocampal inputs.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	monconduit, lenaic/GYV-2004-2022	monconduit, lenaic/0000-0001-8856-3809; Zugaro, Michael/0000-0002-6199-2635; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH054671] Funding Source: Medline; NINDS NIH HHS [R01 NS034994, R01 NS043157] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Booth V, 2001, J NEUROPHYSIOL, V85, P2432, DOI 10.1152/jn.2001.85.6.2432; Bose A, 2001, HIPPOCAMPUS, V11, P204, DOI 10.1002/hipo.1038; Bose A, 2000, J COMPUT NEUROSCI, V9, P5, DOI 10.1023/A:1008976210366; BUZSAKI G, 1990, PROG BRAIN RES, V83, P257; BUZSAKI G, 1981, EXP BRAIN RES, V43, P429; BUZSAKI G, 1981, BRAIN RES, V225, P235, DOI 10.1016/0006-8993(81)90833-7; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DEADWYLER SA, 1975, EXP NEUROL, V49, P35, DOI 10.1016/0014-4886(75)90194-6; DOUGLAS RM, 1983, J COMP NEUROL, V219, P285, DOI 10.1002/cne.902190304; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Friedman HS, 1998, J NEUROSCI METH, V83, P185, DOI 10.1016/S0165-0270(98)00075-2; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magee JC, 2003, TRENDS NEUROSCI, V26, P14, DOI 10.1016/S0166-2236(02)00012-7; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sato N, 2003, NEURAL COMPUT, V15, P2379, DOI 10.1162/089976603322362400; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Yamaguchi Y, 2003, BIOL CYBERN, V89, P1, DOI 10.1007/s00422-003-0415-9	40	68	70	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					67	71		10.1038/nn1369	http://dx.doi.org/10.1038/nn1369			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592464	Green Accepted			2022-12-24	WOS:000225967600017
J	Anggono, V; Smillie, KJ; Graham, ME; Valova, VA; Cousin, MA; Robinson, PJ				Anggono, Victor; Smillie, Karen J.; Graham, Mark E.; Valova, Valentina A.; Cousin, Michael A.; Robinson, Phillip J.			Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis	NATURE NEUROSCIENCE			English	Article							ACTIN-BINDING PROTEIN; PROLINE-RICH DOMAIN; NERVE-TERMINALS; MEDIATED ENDOCYTOSIS; GTPASE DYNAMIN; SH3 DOMAIN; CYTOSKELETON; AMPHIPHYSIN-1; ENDOPHILIN; CELLS	Dynamin I is dephosphorylated at Ser-774 and Ser-778 during synaptic vesicle endocytosis (SVE) in nerve terminals. Phosphorylation was proposed to regulate the assembly of an endocytic protein complex with amphiphysin or endophilin. Instead, we found it recruits syndapin I for SVE and does not control amphiphysin or endophilin binding in rat synaptosomes. After depolarization, syndapin showed a calcineurin-mediated interaction with dynamin. A peptide mimicking the phosphorylation sites disrupted the dynamin-syndapin complex, not the dynamin-endophilin complex, arrested SVE and produced glutamate release fatigue after repetitive stimulation. Pseudophosphorylation of Ser-774 or Ser-778 inhibited syndapin binding without affecting amphiphysin recruitment. Site mutagenesis to alanine arrested SVE in cultured neurons. The effects of the sites were additive for syndapin I binding and SVE. Thus syndapin I is a central component of the endocytic protein complex for SVE via stimulus-dependent recruitment to dynamin I and has a key role in synaptic transmission.	Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; Univ Edinburgh, Membrane Biol Grp, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; University of Edinburgh	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	phrobins@mail.usyd.edu.au	Robinson, Phillip J/G-4008-2011; Anggono, Victor/J-2750-2013; Graham, Mark E/A-6480-2014	Robinson, Phillip J/0000-0002-7878-0313; Anggono, Victor/0000-0002-4062-4884; Graham, Mark E/0000-0002-7290-1217; Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470	Wellcome Trust [GR070569, 070569] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tibbs GR, 1996, J NEUROCHEM, V67, P389; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455	40	165	174	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					752	760		10.1038/nn1695	http://dx.doi.org/10.1038/nn1695			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648848	Green Accepted			2022-12-24	WOS:000237895200015
J	DeBruyne, JP; Noton, E; Lambert, CM; Maywood, ES; Weaver, DR; Reppert, SM				DeBruyne, Jason P.; Noton, Elizabeth; Lambert, Christopher M.; Maywood, Elizabeth S.; Weaver, David R.; Reppert, Steven M.			A clock shock: Mouse CLOCK is not required for circadian oscillator function	NEURON			English	Article							GENE-EXPRESSION; MUTANT MICE; CRE RECOMBINASE; TRANSCRIPTION; COMPONENT; DNA; MUTAGENESIS; MECHANISM; PACEMAKER; PROTEINS	The circadian clock mechanism in the mouse is composed of interlocking transcriptional feedback loops. Two transcription factors, CLOCK and BMAL1, are believed to be essential components of the circadian clock. We have used the Cre-LoxP system to generate whole-animal knockouts of CLOCK and evaluated the resultant circadian phenotypes. Surprisingly, CLOCK-deficient mice continue to express robust circadian rhythms in locomotor activity, although they do have altered responses to light. At the molecular and biochemical levels, clock gene mRNA and protein levels in both the master clock in the suprachiasmatic nuclei and a peripheral clock in the liver show alterations in the CLOCK-deficient animals, although the molecular feedback loops continue to function. Our data challenge a central feature of the current mammalian circadian clock model regarding the necessity of CLOCK:BMAL1 heterodimers for clock function.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Weaver, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	david.weaver@umassmed.edu		DeBruyne, Jason/0000-0001-9803-9568; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051458, R01NS047141] Funding Source: NIH RePORTER; MRC [MC_U105170643] Funding Source: UKRI; Medical Research Council [MC_U105170643] Funding Source: Medline; NIDDK NIH HHS [DK32520] Funding Source: Medline; NIGMS NIH HHS [F32 GM074277] Funding Source: Medline; NINDS NIH HHS [R21 NS051458, RR01NS047141] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; ALBUIN A, 1996, MOL CELL BIOL, V16, P1851; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings M.H., 1999, J NEUROSCI, V11, P1; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Ochi M, 2003, NEUROSCI LETT, V347, P163, DOI 10.1016/S0304-3940(03)00688-8; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Onishi H, 2002, J NEUROSCI RES, V68, P551, DOI 10.1002/jnr.10226; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Redlin U, 2005, J COMP PHYSIOL A, V191, P51, DOI 10.1007/s00359-004-0570-z; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SAUER B, 1987, P NATL ACAD SCI USA, V84, P9108, DOI 10.1073/pnas.84.24.9108; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	55	323	328	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					465	477		10.1016/j.neuron.2006.03.041	http://dx.doi.org/10.1016/j.neuron.2006.03.041			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675400	Bronze			2022-12-24	WOS:000237726800015
J	Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD				Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD			Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; NECROSIS-FACTOR-ALPHA; ZINC-FINGER PROTEIN; CELL-DEATH; P75-MEDIATED DEATH; NOGO RECEPTOR; IN-VITRO	The p75 neurotrophin receptor regulates neuronal survival, promoting it in some contexts yet activating apoptosis in others. The mechanism by which the receptor elicits these differential effects is poorly understood. Here, we demonstrate that p75 is cleaved by gamma-secretase in sympathetic neurons, specifically in response to proapoptotic ligands. This cleavage resulted in ubiquitination and subsequent nuclear translocation of NRIF, a DNA binding protein essential for p75-mediated apoptosis. Inhibition of gamma-secretase or expression of a mutant p75 resistant to this protease prevented receptor proteolysis, blocked NRIF nuclear entry, and prevented apoptosis. In contrast, overexpression of the p75 ICD resulted in NRIF nuclear accumulation and apoptosis. The receptor proteolysis and NRIF nuclear localization were also observed in vivo during naturally occurring cell death in the superior cervical ganglia. These results indicate that p75-mediated apoptosis requires gamma-secretase dependent release of its ICD, which facilitates nuclear translocation of NRIF.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; McGill Univ, Inst Neurol, Montreal, PQ H3A 2B4, Canada; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; New York University; New York University; McGill University; Cornell University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu		Zampieri, Niccolo/0000-0002-2228-9453; Chao, Moses/0000-0002-6969-3744	NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072, NS38220, NS30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R01NS038220] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barde YA, 2004, P NATL ACAD SCI USA, V101, P5703, DOI 10.1073/pnas.0401374101; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Berezovska O, 2000, ANN NY ACAD SCI, V920, P223; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1996, NATURE, V383, P166; Frankowski H, 2002, NEUROMOL MED, V1, P153; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	68	140	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					219	232		10.1016/j.neuron.2006.03.011	http://dx.doi.org/10.1016/j.neuron.2006.03.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630834	Bronze			2022-12-24	WOS:000237176700010
J	Rosenbaum, EE; Hardie, RC; Colley, NJ				Rosenbaum, EE; Hardie, RC; Colley, NJ			Calnexin is essential for rhodopsin maturation, Ca2+ regulation, and photoreceptor cell survival	NEURON			English	Article							CYCLOPHILIN HOMOLOG NINAA; DROSOPHILA-MELANOGASTER; VISUAL TRANSDUCTION; QUALITY-CONTROL; IN-VIVO; ENDOPLASMIC-RETICULUM; RETINAL DEGENERATION; MOLECULAR CHAPERONE; PROTEIN; GENE	In sensory neurons, successful maturation of signaling molecules and regulation of Ca2+ are essential for cell function and survival. Here, we demonstrate a multifunctional role for calnexin as both a molecular chaperone uniquely required for rhodopsin maturation and a regulator of Ca2+ that enters photoreceptor cells during light stimulation. Mutations in Drosophila calnexin lead to severe defects in rhodopsin (Rh1) expression, whereas other photoreceptor cell proteins are expressed normally. Mutations in calnexin also impair the ability of photoreceptor cells to control cytosolic Ca2+ levels following activation of the light-sensitive TRP channels. Finally, mutations in calnexin lead to retinal degeneration that is enhanced by light, suggesting that calnexin's function as a Ca2+ buffer is important for photoreceptor cell survival. Our results illustrate a critical role for calnexin in Rh1 maturation and Ca2+ regulation and provide genetic evidence that defects in calnexin lead to retinal degeneration.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA; Univ Wisconsin, Dept Genet, Madison, WI 53792 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Colley, NJ (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA.	njcolley@wisc.edu		Hardie, Roger/0000-0001-5531-3264	Biotechnology and Biological Sciences Research Council [BB/D007585/1] Funding Source: Medline; NEI NIH HHS [R01 EY008768-12, R01 EY008768-18, R01 EY008768-12S1, R01 EY008768-11, R01 EY008768-13S1, R01 EY008768-10A1, R01 EY008768-17S1, R01 EY008768-17, R01 EY008768-13, R01 EY008768-15S1, R01 EY008768-16S1, EY08768, R01 EY008768-14A1, P30 EY016665, R01 EY008768-09, R01 EY008768, R01 EY008768-16, R01 EY008768-15, R01 EY008768-09S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY016665, R29EY008768, R01EY008768] Funding Source: NIH RePORTER; BBSRC [BB/D007585/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BAUMANN O, 1994, CELL TISSUE RES, V275, P225, DOI 10.1007/BF00319420; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Christodoulou S, 1997, GENE, V191, P143, DOI 10.1016/S0378-1119(97)00025-5; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellgaard L., 2003, CALRETICULIN, P19, DOI [10.1007/978-1-4419-9258-1_3, DOI 10.1007/978-1-4419-9258-1_3]; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Franceschini N., 1972, INFORMATION PROCESSI, P75; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Georgiev P, 2005, J CELL SCI, V118, P1373, DOI 10.1242/jcs.01712; Hardie RC, 1996, J NEUROSCI, V16, P2924; Hardie RC, 1996, CELL CALCIUM, V20, P315, DOI 10.1016/S0143-4160(96)90037-8; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; Haug-Collet K, 1999, J CELL BIOL, V147, P659, DOI 10.1083/jcb.147.3.659; Hong CS, 1996, GENETICS, V142, P879; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MONTELL C, 1987, J NEUROSCI, V7, P1558; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, P NATL ACAD SCI USA, V97, P8578, DOI 10.1073/pnas.97.15.8578; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PADINJAT R, 2000, MOL CELL NEUROSCI, V15, P429; Pak WL, 2003, RECEPTOR CHANNEL, V9, P149, DOI 10.1080/10606820308242; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Postma M, 1999, BIOPHYS J, V77, P1811, DOI 10.1016/S0006-3495(99)77026-8; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Sung CH, 2000, INT REV CYTOL, V195, P215; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200	57	84	86	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					229	241		10.1016/j.neuron.2005.12.011	http://dx.doi.org/10.1016/j.neuron.2005.12.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423697	Green Accepted, Bronze			2022-12-24	WOS:000234979900010
J	Vervaeke, K; Hu, H; Graham, LJ; Storm, JF				Vervaeke, K; Hu, H; Graham, LJ; Storm, JF			Contrasting effects of the persistent Na+ current on neuronal excitability and spike timing	NEURON			English	Article							ACTION-POTENTIAL GENERATION; SODIUM CURRENT; PYRAMIDAL NEURONS; AFTER-HYPERPOLARIZATION; SMALL-CONDUCTANCE; K+ CHANNELS; RAT; AMPLIFICATION; PRECISION; EPSPS	The persistent Na+ current, /(NaP), is known to amplify subthreshold oscillations and synaptic potentials, but its impact on action potential generation remains enigmatic. Using computational modeling, whole-cell recording, and dynamic clamp of CA1 hippocampal pyramidal cells in brain slices, we examined how /(NaP) changes the transduction of excitatory current into action potentials. Model simulations predicted that /(NaP) increases afterhyperpolarizations, and, although it increases excitability by reducing rheobase, /(NaP) also reduces the gain in discharge frequency in response to depolarizing current (0 gain). These predictions were experimentally confirmed by using dynamic clamp, thus circumventing the longstanding problem that /(NaP) cannot be selectively blocked. Furthermore, we found that /(NaP) increased firing regularity in response to sustained depolarization, although it decreased spike time precision in response to single evoked EPSPs. Finally, model simulations demonstrated that /(NaP) increased the relative refractory period and decreased interspike-interval variability under conditions resembling an active network in vivo.	Univ Oslo, Dept Physiol, Inst Bascal Med, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Paris 05, Lab Neurophys & Physiol, CNRS UMR 8119, UFR Biomed, F-75006 Paris, France	University of Oslo; University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Storm, JF (corresponding author), Univ Oslo, Dept Physiol, Inst Bascal Med, PB 1103 Blindern, N-0317 Oslo, Norway.	jstorm@medisin.uio.no		Hu, Hua/0000-0001-8187-4735				ALZHEIMER C, 1993, J NEUROSCI, V13, P660; Andreasen M, 1999, J PHYSIOL-LONDON, V519, P85, DOI 10.1111/j.1469-7793.1999.0085o.x; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berry MJ, 1998, J NEUROSCI, V18, P2200; BORGGRAHAM L, 1999, CEREBRAL CORTEX, V12; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FRENCH CR, 1985, NEUROSCI LETT, V56, P289, DOI 10.1016/0304-3940(85)90257-5; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Graham LJ, 2004, SURF HIPPO NEURON SI; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Hallworth NE, 2003, J NEUROSCI, V23, P7525; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; HOTSON JR, 1979, J NEUROPHYSIOL, V42, P889, DOI 10.1152/jn.1979.42.3.889; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Kay AR, 1998, J NEUROPHYSIOL, V80, P1167, DOI 10.1152/jn.1998.80.3.1167; Koch Christof, 1999, P1; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; Lien CC, 2003, J NEUROSCI, V23, P2058; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; Sah P, 1996, J NEUROSCI, V16, P4537; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1990, PROG BRAIN RES, V83, P161; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001	54	114	116	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					257	270		10.1016/j.neuron.2005.12.022	http://dx.doi.org/10.1016/j.neuron.2005.12.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423699	Bronze			2022-12-24	WOS:000234979900012
J	Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW				Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW			ORL1 receptor-mediated internalization of N-type calcium channels	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; INTRATHECALLY ADMINISTERED NOCICEPTIN; ROOT GANGLION NEURONS; MU-OPIOID RECEPTORS; RAT SPINAL-CORD; ORPHANIN-FQ; MORPHINE-TOLERANCE; CA2+ CHANNELS; PERIPHERAL INFLAMMATION; NEUROPATHIC PAIN	The inhibition of N-type calcium channels by opioid receptor like receptor 1 (ORL1) is a key mechanism for controlling the transmission of nociceptive signals. We recently reported that signaling complexes consisting of ORL1 receptors and N-type channels mediate a tonic inhibition of calcium entry. Here we show that prolonged (similar to 30 min) exposure of ORL1 receptors to their agonist nociceptin triggers an internalization of these signaling complexes into vesicular compartments. This effect is dependent on protein kinase C activation, occurs selectively for N-type channels and cannot be observed with mu-opioid or angiotensin receptors. In expression systems and in rat dorsal root ganglion neurons, the nociceptin-mediated internalization of the channels is accompanied by a significant downregulation of calcium entry, which parallels the selective removal of N-type calcium channels from the plasma membrane. This may provide a new means for long-term regulation of calcium entry in the pain pathway.	Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; John P Robarts Res Inst, Cell Biol Res Grp, London, ON N6A 5K8, Canada; Univ UMI, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France; Univ UMII, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France	University of Calgary; Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Khosravani, Houman/X-2391-2019; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Dubel, Stefan/0000-0001-8811-7390; Zamponi, Gerald W./0000-0002-0644-9066				Abdulla FA, 1997, J NEUROSCI, V17, P8721; Abdulla FA, 1998, J NEUROSCI, V18, P9685; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Andoh T, 1997, NEUROREPORT, V8, P2793, DOI 10.1097/00001756-199708180-00028; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Becker JAJ, 1999, J BIOL CHEM, V274, P27513, DOI 10.1074/jbc.274.39.27513; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Borgland SL, 2001, J PHYSIOL-LONDON, V536, P35, DOI 10.1111/j.1469-7793.2001.t01-1-00035.x; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Connor M, 1998, J PHYSIOL-LONDON, V509, P47, DOI 10.1111/j.1469-7793.1998.047bo.x; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; DE WM, 1997, NATURE, V385, P446; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Hao JX, 1997, NEUROSCI LETT, V223, P49, DOI 10.1016/S0304-3940(97)13401-2; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; IKEDA SR, 1996, NATURE, V380, P258; Jhamandas KH, 1998, CAN J PHYSIOL PHARM, V76, P314, DOI 10.1139/cjpp-76-3-314; Jia YP, 1998, NEUROSCI LETT, V250, P21, DOI 10.1016/S0304-3940(98)00430-3; Knoflach F, 1996, J NEUROSCI, V16, P6657; Larsson KP, 2000, NEUROSCI LETT, V296, P121, DOI 10.1016/S0304-3940(00)01640-2; Lutfy K, 2003, J NEUROSCI, V23, P10331; Mandyam CD, 2002, J PHARMACOL EXP THER, V302, P502, DOI 10.1124/jpet.102.033159; Mills RH, 2004, J NEUROSCI, V24, P947, DOI 10.1523/JNEUROSCI.1366-03.2004; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Neal CR, 1999, J COMP NEUROL, V406, P503; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; Scott RH, 1997, NEUROPHARMACOLOGY, V36, P195, DOI 10.1016/S0028-3908(97)83783-5; Spampinato S, 2002, CELL MOL LIFE SCI, V59, P2172, DOI 10.1007/s000180200016; Spampinato S, 2001, NEUROREPORT, V12, P3159, DOI 10.1097/00001756-200110080-00035; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Sutton KG, 2002, BRIT J PHARMACOL, V135, P257, DOI 10.1038/sj.bjp.0704439; Toth PT, 1996, J NEUROSCI, V16, P4617; Ueda H, 2000, J NEUROSCI, V20, P7640; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wick M J, 1994, Brain Res Mol Brain Res, V27, P37; Yamamoto T, 1997, NEUROSCI LETT, V224, P107, DOI 10.1016/S0304-3940(97)13475-9; Yamamoto T, 1997, NEUROSCIENCE, V81, P249, DOI 10.1016/S0306-4522(97)00166-8; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848	49	127	135	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					31	40		10.1038/nn1605	http://dx.doi.org/10.1038/nn1605			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311589				2022-12-24	WOS:000234288000015
J	Tolias, AS; Sultan, F; Augath, M; Oeltermann, A; Tehovnik, EJ; Schiller, PH; Logothetis, NK				Tolias, AS; Sultan, F; Augath, M; Oeltermann, A; Tehovnik, EJ; Schiller, PH; Logothetis, NK			Mapping cortical activity elicited with electrical microstimulation using fMRI in the macaque	NEURON			English	Article							PYRAMIDAL TRACT CELLS; PRIMARY VISUAL-CORTEX; SUPERIOR TEMPORAL SULCUS; SACCADIC EYE-MOVEMENTS; STRIATE CORTEX; RHESUS-MONKEY; FRONTAL-CORTEX; INTRACORTICAL MICROSTIMULATION; INTRINSIC CONNECTIONS; AXONAL PROJECTIONS	Over the last two centuries, electrical microstimulation has been used to demonstrate causal links between neural activity and specific behaviors and cognitive functions. However, to establish these links it is imperative to characterize the cortical activity patterns that are elicited by stimulation locally around the electrode and in other functionally connected areas. We have developed a technique to record brain activity using the blood oxygen level dependent (BOLD) signal while applying electrical microstimulation to the primate brain. We find that the spread of activity around the electrode tip in macaque area V1 was larger than expected from calculations based on passive spread of current and therefore may reflect functional spread by way of horizontal connections. Consistent with this functional transynaptic spread we also obtained activation in expected projection sites in extrastriate visual areas, demonstrating the utility of our technique in uncovering in vivo functional connectivity maps.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Massachusetts Institute of Technology (MIT)	Tolias, AS (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	andreas.tolias@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		NATIONAL EYE INSTITUTE [R01EY014884] Funding Source: NIH RePORTER; NEI NIH HHS [EY014884] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGNEW WF, 1986, EXP NEUROL, V92, P162, DOI 10.1016/0014-4886(86)90132-9; [Anonymous], 1901, ARCH ITAL BIOL; ASANUMA H, 1976, EXP BRAIN RES, V26, P443; ASANUMA H, 1973, EXP BRAIN RES, V16, P507, DOI 10.1007/BF00234477; Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; Bartlett JR, 2005, J NEUROPHYSIOL, V94, P3430, DOI 10.1152/jn.00406.2005; BEEBE X, 1988, IEEE T BIO-MED ENG, V35, P494, DOI 10.1109/10.2122; BLASDEL GG, 1985, J NEUROSCI, V5, P3350; Brecht M, 2004, J NEUROPHYSIOL, V92, P424, DOI 10.1152/jn.00639.2003; Brewer AA, 2002, J NEUROSCI, V22, P10416; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DOBELLE WH, 1974, J PHYSIOL-LONDON, V243, P553, DOI 10.1113/jphysiol.1974.sp010766; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DOTY RW, 1981, ELECT STIMULATION RE, P71; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; FISKEN RA, 1973, BRAIN RES, V53, P208, DOI 10.1016/0006-8993(73)90782-8; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; FRITSCH G, 1870, CEREB CORTEX, P73; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HENTALL ID, 1984, J NEUROPHYSIOL, V51, P968, DOI 10.1152/jn.1984.51.5.968; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P597, DOI 10.1113/jphysiol.1972.sp009817; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P637, DOI 10.1113/jphysiol.1975.sp011035; LI CL, 1976, EXP NEUROL, V50, P67, DOI 10.1016/0014-4886(76)90236-3; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MCILWAIN JT, 1982, J NEUROPHYSIOL, V47, P167, DOI 10.1152/jn.1982.47.2.167; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Nowak LG, 1997, CEREBR CORT, V12, P205; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; Peters A, 1996, J COMP NEUROL, V365, P232; PETERS A, 1991, J COMP NEUROL, V306, P1, DOI 10.1002/cne.903060102; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; ROBERTS WJ, 1973, ACTA PHYSIOL SCAND, V89, P384, DOI 10.1111/j.1748-1716.1973.tb05533.x; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; RONNER SF, 1981, CLIN NEUROPHYSIOL, V52, P375; Rushton D. N., 1978, Frontiers in Visual Science, P574; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schafer E., 1888, BRAIN, V11, P1; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SCHILLER PH, 1979, BRAIN RES, V179, P162, DOI 10.1016/0006-8993(79)90500-6; SCLOSSER MJ, 1999, NEUROSURG FOCUS, V6, P1; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SIBLEY GNA, 1984, J PHYSIOL-LONDON, V354, P431, DOI 10.1113/jphysiol.1984.sp015386; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; Tehovnik EJ, 2005, J NEUROPHYSIOL, V93, P1, DOI 10.1152/jn.00736.2004; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; WOOSLEY CN, 1952, RES PUBL ASS NERV ME, V30, P328; YEOMANS J, 1995, BEHAV BRAIN RES, V67, P121, DOI 10.1016/0166-4328(94)00149-A; Yeomans J. S., 1990, PRINCIPLES BRAIN STI; YEOMANS JS, 1988, BRAIN RES REV, V13, P235, DOI 10.1016/0165-0173(88)90008-2; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	78	196	198	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					901	911		10.1016/j.neuron.2005.11.034	http://dx.doi.org/10.1016/j.neuron.2005.11.034			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364895	Bronze, Green Published			2022-12-24	WOS:000234301700007
J	Jacobs, WB; Govoni, G; Ho, D; Atwal, JK; Barnabe-Heider, F; Keyes, WM; Mills, AA; Miller, FD; Kaplan, DR				Jacobs, WB; Govoni, G; Ho, D; Atwal, JK; Barnabe-Heider, F; Keyes, WM; Mills, AA; Miller, FD; Kaplan, DR			P63 is an essential proapoptotic protein during neural development	NEURON			English	Article							CYTOCHROME-C RELEASE; PROMOTES NEURONAL SURVIVAL; PROGRAMMED CELL-DEATH; P53 FAMILY; P53-DEPENDENT APOPTOSIS; SYMPATHETIC NEURONS; TUMOR-SUPPRESSOR; NERVOUS-SYSTEM; P73; BAX	The p53 family member p63 is required for nonneural development, but has no known role in the nervous system. Here, we define an essential proapoptotic role for p63 during naturally occurring neuronal death. Sympathetic neurons express full-length TAp63 during the developmental death period, and TAp63 levels increase following NGF withdrawal. Overexpression of TAp63 causes neuronal apoptosis in the presence of NGF, while cultured p63(-/-) neurons are resistant to apoptosis following NGF withdrawal. TAp63 is also essential in vivo, since embryonic p63(-/-) mice display a deficit in naturally occurring sympathetic neuron death. While both TAp63 and p53 induce similar apoptotic signaling proteins and require BAX expression and function for their effects, TAp63 induces neuronal death in the absence of p53, but p53 requires coincident p63 expression for its proapoptotic actions. Thus, p63 is essential for developmental neuronal death, likely functioning both on its own, and as an obligate proapoptotic partner for p53.	Univ Toronto, Hosp Sick Children, Canc Res Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dev Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Div Neurosurg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; McGill University; Cold Spring Harbor Laboratory	Kaplan, DR (corresponding author), Univ Toronto, Hosp Sick Children, Canc Res Program, Toronto, ON M5G 1X8, Canada.	dkaplan@sickkids.ca		Govoni, Gregory/0000-0002-4664-0834; Keyes, William M./0000-0002-8917-2268				Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kirkland RA, 2002, J NEUROSCI, V22, P6480; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MIYASHITA T, 1995, CELL, V80, P293; Moll UM, 2004, MOL CANCER RES, V2, P371; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Vogel KS, 1998, MOL CELL NEUROSCI, V11, P19, DOI 10.1006/mcne.1998.0670; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	48	93	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					743	756		10.1016/j.neuron.2005.10.027	http://dx.doi.org/10.1016/j.neuron.2005.10.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337913	Bronze			2022-12-24	WOS:000233927300014
J	Knaut, H; Blader, P; Strahle, U; Schier, AF				Knaut, H; Blader, P; Strahle, U; Schier, AF			Assembly of trigeminal sensory ganglia by chemokine signaling	NEURON			English	Article							GERM-CELL MIGRATION; LATERAL-LINE SYSTEM; NEURAL CREST; ZEBRAFISH EMBRYO; GENE-EXPRESSION; CRANIAL GANGLIA; RECEPTOR CXCR4; NEURONS; NEUROGENIN1; CADHERIN	Sensory neurons with related functions form ganglia, but how these precisely positioned clusters are assembled has been unclear. Here, we use the zebrafish trigeminal sensory ganglion as a model to address this question. We find that some trigeminal sensory neurons are born at the position where the ganglion is assembled, whereas others are born at a distance and have to migrate against opposing morphogenetic movements to reach the site of ganglion assembly. Loss of Cxcr4b-mediated chemokine signaling results in the formation of mispositioned ganglia. Conversely, ectopic sources of the chemokine SDF1a can attract sensory neurons. Transplantation experiments reveal that neuron-neuron interaction and the adhesion molecules E- and N-Cadherin also contribute to ganglion assembly. These results indicate that ganglion formation depends on the interplay of birthplace, chemokine attraction, cell-cell interaction, and cadherin-mediated adhesion.	NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ Toulouse 3, Ctr Dev Biol, F-31062 Toulouse, France; Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76021 Karlsruhe, Germany	New York University; New York University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Helmholtz Association; Karlsruhe Institute of Technology	Knaut, H (corresponding author), NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	knaut@saturn.med.nyu.edu; schier@saturn.med.nyu.edu	Straehle, Uwe/K-7054-2013	Schier, Alexander Franz/0000-0001-7645-5325; Blader, Patrick/0000-0003-3299-6108; Knaut, Holger/0000-0002-8399-8720				Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Artinger KB, 1999, DEVELOPMENT, V126, P3969; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Cornell RA, 2002, DEVELOPMENT, V129, P2639; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; DAVIES AM, 1988, DEVELOPMENT, V103, P175; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Halloran MC, 2000, DEVELOPMENT, V127, P1953; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Holley SA, 2000, GENE DEV, V14, P1678; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kerstetter AE, 2004, DEV DYNAM, V230, P137, DOI 10.1002/dvdy.20021; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein RS, 2001, DEVELOPMENT, V128, P1971; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lele Z, 2002, DEVELOPMENT, V129, P3281; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu Q, 2003, GENE EXPR PATTERNS, V3, P653, DOI 10.1016/S1567-133X(03)00109-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Norton WHJ, 2000, MECH DEVELOP, V99, P149, DOI 10.1016/S0925-4773(00)00472-X; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Ramon y Cajal S, 1894, P R SOC LOND, V55, P444, DOI DOI 10.1098/RSPL.1894.0063; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Romer AS., 1986, VERTEBRATE BODY; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Schimel D, 2003, ECOL APPL, V13, P1, DOI 10.1890/1051-0761(2003)013[0001:E]2.0.CO;2; Schlosser G, 2000, J COMP NEUROL, V418, P121; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; WILSON SW, 1991, DEVELOPMENT, V112, P723; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	64	70	73	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					653	666		10.1016/j.neuron.2005.07.014	http://dx.doi.org/10.1016/j.neuron.2005.07.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129396	Bronze			2022-12-24	WOS:000231782700008
J	Ishikane, H; Gangi, M; Honda, S; Tachibana, M				Ishikane, H; Gangi, M; Honda, S; Tachibana, M			Synchronized retinal oscillations encode essential information for escape behavior in frogs	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LONG-RANGE SYNCHRONIZATION; LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; NEURONAL RESPONSES; NEURAL ASSEMBLIES; GABA RECEPTORS; INHIBITION; INTEGRATION; MODULATION	Synchronized oscillatory activity is generated among visual neurons in a manner that depends on certain key features of visual stimulation. Although this activity may be important for perceptual integration, its functional significance has yet to be explained. Here we find a very strong correlation between synchronized oscillatory activity in a class of frog retinal ganglion cells ( dimming detectors) and a well-known escape response, as shown by behavioral tests and multi-electrode recordings from isolated retinas. Escape behavior elicited by an expanding dark spot was suppressed and potentiated by intraocular injection of GABA(A) receptor and GABA(C) receptor antagonists, respectively. Changes in escape behavior correlated with antagonist-evoked changes in synchronized oscillatory activity but not with changes in the discharge rate of dimming detectors. These antagonists did not affect the expanding dark spot - induced responses in retinal ganglion cells other than dimming detectors. Thus, synchronized oscillations in the retina are likely to encode escape-related information in frogs.	Univ Tokyo, Dept Psychol, Grad Sch Human & Sociol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Tachibana, M (corresponding author), Univ Tokyo, Dept Psychol, Grad Sch Human & Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	Ltmasao@L.u-tokyo.ac.jp	Ishikane, Hiroshi/AAX-8462-2021	Ishikane, Hiroshi/0000-0003-1316-2255				Arai I, 2004, J NEUROPHYSIOL, V92, P715, DOI 10.1152/jn.00159.2004; BACKSTROM AC, 1978, MED BIOL, V56, P72; BONAVENTURE N, 1986, EUR J PHARMACOL, V121, P327, DOI 10.1016/0014-2999(86)90253-0; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Du JL, 2000, J NEUROPHYSIOL, V84, P666, DOI 10.1152/jn.2000.84.2.666; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grusser O J, 1972, Bibl Ophthalmol, V82, P260; Grusser O.-J, 1976, P297; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; King JG, 1999, BRAIN RES, V841, P20, DOI 10.1016/S0006-8993(99)01764-3; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Molotchnikoff S, 1996, BRAIN RES, V731, P91, DOI 10.1016/0006-8993(96)00468-4; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Vitanova L, 2001, VISION RES, V41, P691, DOI 10.1016/S0042-6989(00)00294-7; WALDECK RF, 1995, BRAIN BEHAV EVOLUT, V46, P84, DOI 10.1159/000113261; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Watanabe S, 2000, J NEUROPHYSIOL, V84, P1826, DOI 10.1152/jn.2000.84.4.1826; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	46	88	93	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1087	1095		10.1038/nn1497	http://dx.doi.org/10.1038/nn1497			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995702				2022-12-24	WOS:000230760200021
J	Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB				Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB			ATP mediates rapid microglial response to local brain injury in vivo	NATURE NEUROSCIENCE			English	Article							ASTROCYTES; CELLS; ACTIVATION; RELEASE; PROTEIN; EXPRESSION; MOTILITY	Parenchymal microglia are the principal immune cells of the brain. Time-lapse two-photon imaging of GFP-labeled microglia demonstrates that the fine termini of microglial processes are highly dynamic in the intact mouse cortex. Upon traumatic brain injury, microglial processes rapidly and autonomously converge on the site of injury without cell body movement, establishing a potential barrier between the healthy and injured tissue. This rapid chemotactic response can be mimicked by local injection of ATP and can be inhibited by the ATP-hydrolyzing enzyme apyrase or by blockers of G protein - coupled purinergic receptors and connexin channels, which are highly expressed in astrocytes. The baseline motility of microglial processes is also reduced significantly in the presence of apyrase and connexin channel inhibitors. Thus, extracellular ATP regulates microglial branch dynamics in the intact brain, and its release from the damaged tissue and surrounding astrocytes mediates a rapid microglial response towards injury.	NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Davalos, Dimitrios/G-8627-2011; Jung, Steffen/K-1409-2012; Grutzendler, Jaime/F-3691-2010; Dustin, Michael/AAM-4611-2020	Davalos, Dimitrios/0000-0001-9038-6688; Jung, Steffen/0000-0003-4290-5716; Zuo, Yi/0000-0001-9020-0003; Yang, Guang/0000-0002-5739-9126; Dustin, Michael/0000-0003-4983-6389				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; SMITH SJ, 1990, SYMP MED H, V23, P49; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	40	2522	2599	7	256	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					752	758		10.1038/nn1472	http://dx.doi.org/10.1038/nn1472			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895084				2022-12-24	WOS:000229345300015
J	Hoebeek, FE; Stahl, JS; van Alphen, AM; Schonewille, M; Luo, C; Rutteman, M; van den Maagdenberg, AMJM; Molenaar, R; Goossens, HHLM; Frens, MA; De Zeeuw, CI				Hoebeek, FE; Stahl, JS; van Alphen, AM; Schonewille, M; Luo, C; Rutteman, M; van den Maagdenberg, AMJM; Molenaar, R; Goossens, HHLM; Frens, MA; De Zeeuw, CI			Increased noise level of Purkinje cell activities minimizes impact of their modulation during sensorimotor control	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; COMPLEX SPIKE ACTIVITY; CALCIUM-CHANNEL; P-TYPE; INTRINSIC EXCITABILITY; SYNAPTIC-TRANSMISSION; CEREBELLAR-ATAXIA; ALPHA(1A) SUBUNIT; NUCLEUS NEURONS; CA2+ CHANNELS	While firing rate is well established as a relevant parameter for encoding information exchanged between neurons, the significance of other parameters is more conjectural. Here, we show that regularity of neuronal spike activities affects sensorimotor processing in tottering mutants, which suffer from a mutation in P/Q-type voltage-gated calcium channels. While the modulation amplitude of the simple spike firing rate of their floccular Purkinje cells during optokinetic stimulation is indistinguishable from that of wild-types, the regularity of their firing is markedly disrupted. The gain and phase values of tottering's compensatory eye movements are indistinguishable from those of flocculectomized wild-types or from totterings with the flocculus treated with P/Q-type calcium channel blockers. Moreover, normal eye movements can be evoked in tottering when the flocculus is electrically stimulated with regular spike trains mimicking the firing pattern of normal simple spikes. This study demonstrates the importance of regularity of firing in Purkinje cells for neuronal information processing.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2333 AL Leiden, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6500 HB Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Case Western Reserve University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Hoebeek, FE (corresponding author), Erasmus MC, Dept Neurosci, Dr Molenwaterpl 50,POB 1738, NL-3000 DR Rotterdam, Netherlands.	f.hoebeek@erasmusmc.nl; c.dezeeuw@erasmusmc.nl	Schonewille, Martijn/E-6170-2013; Goossens, Jeroen/D-7311-2010	Goossens, Jeroen/0000-0001-5522-3437				Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Baloh RW, 1997, ANN NEUROL, V41, P8, DOI 10.1002/ana.410410105; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Buttner N, 1998, ARCH NEUROL-CHICAGO, V55, P1353, DOI 10.1001/archneur.55.10.1353; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Chacron MJ, 2003, NETWORK-COMP NEURAL, V14, P803, DOI 10.1088/0954-898X/14/4/010; Craig PJ, 1998, J COMP NEUROL, V397, P251; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 2004, SPR HDB AUD, P375; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; DEZEEUW CI, 1995, J NEUROPHYSIOL, V74, P2051, DOI 10.1152/jn.1995.74.5.2051; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; GRAF W, 1988, J NEUROPHYSIOL, V60, P2091, DOI 10.1152/jn.1988.60.6.2091; GREEN MC, 1962, J HERED, V53, P233, DOI 10.1093/oxfordjournals.jhered.a107180; HAMO H, 2003, NEUROLOGY, V61, P1748; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; JAARSMA D, 1992, HIPPOCAMPUS, V2, P143, DOI 10.1002/hipo.450020206; Knight YE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0002.2002; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; Leenders AGM, 2002, EUR J NEUROSCI, V15, P13, DOI 10.1046/j.0953-816x.2001.01839.x; Li ZZ, 1999, J NEUROPHYSIOL, V82, P188, DOI 10.1152/jn.1999.82.1.188; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Qian J, 2001, J NEUROSCI, V21, P3721, DOI 10.1523/JNEUROSCI.21-11-03721.2001; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rieke F., 1997, SPIKES EXPLORING NEU; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; SATO Y, 1993, J NEUROPHYSIOL, V69, P1082, DOI 10.1152/jn.1993.69.4.1082; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; SHIELDS KG, IN PRESS NEUROSCIENC; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1383, DOI 10.1152/jn.1995.73.4.1383; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Steinmetz PN, 2001, BIOSYSTEMS, V62, P87, DOI 10.1016/S0303-2647(01)00139-3; Tiesinga PHE, 2002, NEURAL COMPUT, V14, P1629, DOI 10.1162/08997660260028647; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; VANDERSTEEN J, 1994, J NEUROPHYSIOL, V72, P31, DOI 10.1152/jn.1994.72.1.31; VANDERSTEEN J, 1995, VISION RES, V35, P3459, DOI 10.1016/0042-6989(95)00138-5; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WYLIE DR, 1995, J NEUROSCI, V15, P2875; Zee D S, 1983, Neurol Clin, V1, P909; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhou YD, 2003, J PHYSIOL-LONDON, V547, P497, DOI 10.1113/jphysiol.2002.033415; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	66	117	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					953	965		10.1016/j.neuron.2005.02.012	http://dx.doi.org/10.1016/j.neuron.2005.02.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797555	Bronze			2022-12-24	WOS:000228031300015
J	Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Sotnikova, TD; Burch, LH; Williams, RB; Schwartz, DA; Krishnan, KRR; Caron, MG				Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Sotnikova, TD; Burch, LH; Williams, RB; Schwartz, DA; Krishnan, KRR; Caron, MG			Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression	NEURON			English	Article							SEROTONIN; GENE; EXPRESSION; POLYMORPHISM; DISORDERS; TRAITS; MODELS; SYSTEM; LOCUS; TPH1	Dysregulation of central serotonin neurotransmission has been widely suspected as an important contributor to major depression. Here, we identify a (G1463A) single nucleotide polymorphism (SNP) in the rate-limiting enzyme of neuronal serotonin synthesis, human tryptophan hydroxylase-2 (hTPH2). The functional SNP in hTPH2 replaces the highly conserved Arg441 with His, which results in similar to80% loss of function in serotonin production when hTPH2 is expressed in PC12 cells. Strikingly, SNP analysis in a cohort of 87 patients with unipolar major depression revealed that nine patients carried the mutant (1463A) allele, while among 219 controls, three subjects carried this mutation. In addition, this functional SNP was not found in a cohort of 60 bipolar disorder patients. Identification of a loss-of-function mutation in hTPH2 suggests that defect in brain serotonin synthesis may represent an important risk factor for unipolar major depression.	Duke Univ, Med Ctr, Dept Cell Biol, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA.	caron002@mc.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011; Sotnikova, Tatyana D/T-9992-2017	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; 	NCRR NIH HHS [M01RR30] Funding Source: Medline; NHLBI NIH HHS [P01HL36587] Funding Source: Medline; NIMH NIH HHS [MH60451, K05MH79482] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Arango V, 2003, J PSYCHIATR RES, V37, P375, DOI 10.1016/S0022-3956(03)00048-7; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, P37; Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Bosworth HB, 2002, AM J GERIAT PSYCHIAT, V10, P551, DOI 10.1176/appi.ajgp.10.5.551; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Jiang GCT, 2000, J MOL BIOL, V302, P1005, DOI 10.1006/jmbi.2000.4097; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Malhotra AK, 2004, AM J PSYCHIAT, V161, P780, DOI 10.1176/appi.ajp.161.5.780; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Murphy DL, 2003, GENES BRAIN BEHAV, V2, P350, DOI 10.1046/j.1601-1848.2003.00049.x; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Pey AL, 2003, HUM MUTAT, V21, P370, DOI 10.1002/humu.10198; Quist JF, 2001, J AM ACAD CHILD PSY, V40, P253, DOI 10.1097/00004583-200102000-00022; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; YANG XJ, 1994, P NATL ACAD SCI USA, V91, P6659, DOI 10.1073/pnas.91.14.6659; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	35	360	387	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					11	16		10.1016/j.neuron.2004.12.014	http://dx.doi.org/10.1016/j.neuron.2004.12.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629698	Bronze			2022-12-24	WOS:000226217100005
J	Torborg, CL; Hansen, KA; Feller, MB				Torborg, CL; Hansen, KA; Feller, MB			High frequency, synchronized bursting drives eye-specific segregation of retinogeniculate projections	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; RETINAL WAVES; MAMMALIAN RETINA; BETA-2 SUBUNIT; MICE LACKING; FUNCTIONAL-DEVELOPMENT; CORRELATED ACTIVITY; GANGLION-CELLS; MOUSE RETINA	Blockade of retinal waves prevents the segregation of retinogeniculate afferents into eye-specific layers in the visual thalamus. However, the key features of retinal waves that drive this refinement are controversial. Some manipulations of retinal waves lead to normal eye-specific segregation but others do not. By comparing retinal spiking patterns in several mutant mice with differing levels of eye-specific segregation, we show that the presence of high-frequency bursts synchronized across neighboring retinal ganglion cells correlates with robust eye-specific segregation and that the presence of high levels of asynchronous spikes does not inhibit this segregation. These findings provide a possible resolution to previously described discrepancies regarding the role of retinal waves in retinogeniculate segregation.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Feller, MB (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfeller@ucsd.edu			NATIONAL EYE INSTITUTE [R01EY013528] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013528] Funding Source: Medline; NINDS NIH HHS [NS13528-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bansal A, 2000, J NEUROSCI, V20, P7672; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Buhl DL, 2003, J NEUROSCI, V23, P1013; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Demas J, 2003, J NEUROSCI, V23, P2851; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Long MA, 2002, J NEUROSCI, V22, P10898; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sohl G, 2000, BRAIN RES REV, V32, P138, DOI 10.1016/S0165-0173(99)00074-0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Zoli M, 1998, J NEUROSCI, V18, P4461	36	121	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					72	78		10.1038/nn1376	http://dx.doi.org/10.1038/nn1376			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608630	Green Accepted			2022-12-24	WOS:000225967600018
J	Makris, N; Gasic, GP; Seidman, LJ; Goldstein, JM; Gastfriend, DR; Elman, I; Albaugh, MD; Hodge, SM; Ziegler, DA; Sheahan, FS; Caviness, VS; Tsuang, MT; Kennedy, DN; Hyman, SE; Rosen, BR; Breiter, HC				Makris, N; Gasic, GP; Seidman, LJ; Goldstein, JM; Gastfriend, DR; Elman, I; Albaugh, MD; Hodge, SM; Ziegler, DA; Sheahan, FS; Caviness, VS; Tsuang, MT; Kennedy, DN; Hyman, SE; Rosen, BR; Breiter, HC			Decreased absolute amygdala volume in cocaine addicts	NEURON			English	Review							LEFT-RIGHT ASYMMETRY; ADULT HUMAN BRAIN; HIPPOCAMPAL VOLUME; WHITE-MATTER; VULNERABILITY INDICATOR; NUCLEUS-ACCUMBENS; TEMPORAL-LOBE; RISK-FACTORS; MRI; SCHIZOPHRENIA	The amygdala is instrumental to a set of brain processes that lead to cocaine consumption, including those that mediate reward and drug craving. This study examined the volumes of the amygdala and hippocampus in cocaine-addicted subjects and matched healthy controls and determined that the amygdala but not the hippocampus was significantly reduced in volume. The right-left amygdala asymmetry in control subjects was absent in the cocaine addicts. Topological analysis of amygdala isosurfaces (population averages) revealed that the isosurface of the cocaine-dependent group undercut the anterior and superior surfaces of the control group, implicating a difference in the corticomedial and basolateral nuclei. In cocaine addicts, amygdala volume did not correlate with any measure of cocaine use. The amygdala symmetry coefficient did correlate with baseline but not cocaine-primed craving. These findings argue for a condition that predisposes the individual to cocaine dependence by affecting the amygdala, or a primary event early in the course of cocaine use.	Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Collaborat, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Ctr Morphometr Anal Dept Neurol, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02120 USA; Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02120 USA; McLean Hosp, Belmont, MA 02478 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Calif San Diego, Inst Behav Genom, Dept Psychiat, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Div Addict, Cambridge, MA 02138 USA; Harvard Univ, Off Provost, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard University	Breiter, HC (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Collaborat, Boston, MA 02129 USA.	hbreiter@partners.org	Albaugh, Matthew/ABB-5839-2020; Ziegler, David/L-5717-2019; Albaugh, Matthew D/R-4349-2016; Kennedy, David N/H-3627-2012; Elman, Igor/O-2884-2017	Albaugh, Matthew/0000-0002-5971-6658; Elman, Igor/0000-0002-1345-2677	NIDA NIH HHS [DA14118, DA00265, DA09467] Funding Source: Medline; NIMH NIH HHS [MH435518, MH00976, MH63951, MH46318, MH56956] Funding Source: Medline; NINDS NIH HHS [NS34189] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000976, R01MH063951, R01MH056956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014118] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; AITKEN J, 1991, NATURE, V353, P306, DOI 10.1038/353306a0; Almasy L, 2001, AM J MED GENET, V105, P42, DOI 10.1002/1096-8628(20010108)105:1<42::AID-AJMG1055>3.3.CO;2-0; AMARAL D G, 1992, P1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Breiter HC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1043; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 1998, P INT SOC MAGN RESON, V1, P499; BREITER HC, 2004, IN PRESS COMPLEX SYS; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Dworkin S I, 1988, NIDA Res Monogr, V88, P185; Elman I, 2001, AM J DRUG ALCOHOL AB, V27, P193, DOI 10.1081/ADA-100103705; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FLEISS JL, 1977, AM J PUBLIC HEALTH, V67, P1188, DOI 10.2105/AJPH.67.12.1188; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; FRAZIER JA, 2004, IN PRESS AM J PSYCHI; GALABURDA AM, 1990, NEUROPSYCHOLOGIA, V28, P529, DOI 10.1016/0028-3932(90)90032-J; GALLOWAY J, 1990, NATURE, V346, P223, DOI 10.1038/346223a0; GAWIN FH, 1988, NEW ENGL J MED, V318, P1173, DOI 10.1056/NEJM198805053181806; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hyatt BA, 1998, CELL, V93, P37, DOI 10.1016/S0092-8674(00)81144-7; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jenike MA, 1996, ARCH GEN PSYCHIAT, V53, P625; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kennedy DN, 1999, NEUROLOGY, V53, P1260, DOI 10.1212/WNL.53.6.1260; KENNEDY DN, 1989, IEEE T MED IMAGING, V8, P1, DOI 10.1109/42.20356; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KOOB GF, 1992, RES P ARNMD, V70, P79; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; KORNETSKY C, 1981, BRAIN RES, V209, P496, DOI 10.1016/0006-8993(81)90177-3; KRISHNAN KRR, 1991, J NEUROPSYCH CLIN N, V3, P387; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Mai J.K., 1997, ATLAS HUMAN BRAIN; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Meredith GE, 2000, J NEUROSCI, V20, P7798; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Mountcastle VB, 1962, INTERHEMISPHER RELAT, P87; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; PETTIT HO, 1991, BRAIN RES, V539, P94, DOI 10.1016/0006-8993(91)90690-W; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Reich T, 1999, AM J HUM GENET, V65, P599, DOI 10.1086/302561; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 2001, SYNAPSE, V17, P8491; Roubertoux PL, 2003, GENETICS, V163, P1023; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; See RE, 2003, NEUROSCIENCE, V117, P477, DOI 10.1016/S0306-4522(02)00665-6; Seidman LJ, 1999, BIOL PSYCHIAT, V46, P941, DOI 10.1016/S0006-3223(99)00075-X; Seidman LJ, 2003, SCHIZOPHRENIA BULL, V29, P803, DOI 10.1093/oxfordjournals.schbul.a007048; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Self DW, 1998, J NEUROSCI, V18, P1848; STEIN EA, 1992, J PHARMACOL EXP THER, V262, P327; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Tsuang MT, 2001, HARVARD REV PSYCHIAT, V9, P267, DOI 10.1093/hrp/9.6.267; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; VINCENT KR, 1984, J CLIN PSYCHOL, V40, P400, DOI 10.1002/1097-4679(198403)40:2<400::AID-JCLP2270400202>3.0.CO;2-I; Volkow ND, 1999, AM J PSYCHIAT, V156, P19, DOI 10.1176/ajp.156.1.19; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; WISE RA, 1982, BEHAV BRAIN SCI, V5, P39, DOI 10.1017/S0140525X00010372; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	101	125	131	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					729	740		10.1016/j.neuron.2004.10.027	http://dx.doi.org/10.1016/j.neuron.2004.10.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541319	Bronze			2022-12-24	WOS:000225338100017
J	Cai, X; Liang, CW; Muralidharan, S; Kao, JPY; Tang, CM; Thompson, SM				Cai, X; Liang, CW; Muralidharan, S; Kao, JPY; Tang, CM; Thompson, SM			Unique roles of SK and Kv4.2 potassium channels in dendritic integration	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; RAT-BRAIN; SYNAPTIC EXCITATION; BASAL DENDRITES; CA2+ CHANNELS; CELLS; TRANSIENT; HIPPOCAMPUS	Focal activation of glutamate receptors in distal dendrites of hippocampal pyramidal cells triggers voltage-dependent Ca2+ channel-mediated plateau potentials that are confined to the stimulated dendrite. We examined the role of dendritic K+ conductances in determining the amplitude, duration, and spatial compartmentalization of plateau potentials. Manipulations that blocked SK-type Ca2+-activated K+ channels, including apamin and BAPTA dialysis, increased the duration of plateau potentials without affecting their amplitude or compartmentalization. Manipulations that blocked Kv4.2 A-type K+ channels, including a dominant-negative Kv4.2 construct and 4-aminopyridine, increased the amplitude of plateau potentials by allowing them to recruit neighboring dendrites. Prolongation of plateau potentials or block of Kv4.2 channels at branch points facilitated the ability of dendritic excitation to trigger fast action potentials. SK channels thus underlie repolarization of dendritic plateau potentials, whereas Kv4.2 channels confine these potentials to single dendritic branches, and both act in concert to regulate synaptic integration.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; Univ Maryland, Neurol Serv, Baltimore VA Med Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015	Kao, Joseph/0000-0002-8875-2180				Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Finlayson K, 2001, NEUROPHARMACOLOGY, V41, P341, DOI 10.1016/S0028-3908(01)00067-3; Frick A, 2003, J NEUROSCI, V23, P3243; GAHWILER BH, 1998, CULTURING NERVE CELL, P379; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hosseini R, 2001, J PHYSIOL-LONDON, V535, P323, DOI 10.1111/j.1469-7793.2001.00323.x; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lancaster B, 2001, J PHYSIOL-LONDON, V536, P809, DOI 10.1111/j.1469-7793.2001.00809.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MADISON DV, 1987, J NEUROSCI, V7, P733; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; MCALLISTER AK, 2000, BIOLISTIC TRANSFECTI; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Milojkovic BA, 2004, J PHYSIOL-LONDON, V558, P193, DOI 10.1113/jphysiol.2004.061416; Poolos NP, 1999, J NEUROSCI, V19, P5205; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Ro S, 2001, AM J PHYSIOL-GASTR L, V281, pG964, DOI 10.1152/ajpgi.2001.281.4.G964; RUTECKI PA, 1987, J NEUROPHYSIOL, V57, P1911, DOI 10.1152/jn.1987.57.6.1911; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2002, J NEUROSCI, V22, P9698; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	50	217	223	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					351	364		10.1016/j.neuron.2004.09.026	http://dx.doi.org/10.1016/j.neuron.2004.09.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473972	Bronze			2022-12-24	WOS:000224635800016
J	Collins, CA; Wairkar, YP; Johnson, SL; DiAntonio, A				Collins, Catherine A.; Wairkar, Yogesh P.; Johnson, Sylvia L.; DiAntonio, Aaron			Highwire restrains synaptic growth by attenuating a MAP kinase signal	NEURON			English	Article							ZIPPER-BEARING KINASE; ACTIVATED PROTEIN-KINASE; MOLECULAR-CLONING; II RECEPTOR; DROSOPHILA; GENE; EXPRESSION; IDENTIFICATION; ORTHOLOG; RPM-1	Highwire is an extremely large, evolutionarily conserved E3 ubiquitin ligase that negatively regulates synaptic growth at the Drosophila NMJ. Highwire has been proposed to restrain synaptic growth by downregulating a synaptogenic signal. Here we identify such a downstream signaling pathway. A screen for suppressors of the highwire synaptic overgrowth phenotype yielded mutations in wallenda, a MAP kinase kinase kinase (MAPKKK) homologous to vertebrate DLK and LZK. wallenda is both necessary for highwire synaptic overgrowth and sufficient to promote synaptic overgrowth, and synaptic levels of Wallenda protein are controlled by Highwire and ubiquitin hydrolases. highwire synaptic overgrowth requires the MAP kinase JNK and the transcription factor Fos. These results suggest that Highwire controls structural plasticity of the synapse by regulating gene expression through a MAP kinase signaling pathway. In addition to controlling synaptic growth, Highwire promotes synaptic function through a separate pathway that does not require wallenda.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	dianton@molecool.wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Collins, Catherine/0000-0002-1608-6692	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453, R01NS043171] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051453, R01 NS043171] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chen B, 1998, GENETICS, V149, P157; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HARRISON SD, 1995, GENETICS, V139, P1701; Hirai S, 2005, GENE EXPR PATTERNS, V5, P517, DOI 10.1016/j.modgep.2004.12.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; KULKARNI SJ, 1994, MOL GEN GENET, V243, P555, DOI 10.1007/BF00284204; LAINE A, 2005, SCI STKE; Le Guyader S, 2005, DEV BIOL, V277, P378, DOI 10.1016/j.ydbio.2004.09.029; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; PIERARD E, 2004, RES DATA CTR INFORMA, V1, P23; Riese J, 1997, DEVELOPMENT, V124, P3353; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Robitaille H, 2005, J BIOL CHEM, V280, P12732, DOI 10.1074/jbc.M411619200; Rorth P, 1998, DEVELOPMENT, V125, P1049; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; SchultzEhrenburg U, 1996, PHLEBOLOGY, V11, P17; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weber U, 2000, DEVELOPMENT, V127, P3619; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; YAO KM, 1994, J NEUROCHEM, V63, P41; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	52	244	251	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					57	69		10.1016/j.neuron.2006.05.026	http://dx.doi.org/10.1016/j.neuron.2006.05.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815332	Bronze			2022-12-24	WOS:000239037700010
J	Liston, C; Matalon, S; Hare, TA; Davidson, MC; Casey, BJ				Liston, Conor; Matalon, Shanna; Hare, Todd A.; Davidson, Matthew C.; Casey, B. J.			Anterior cingulate and posterior parietal cortices are sensitive to dissociable forms of conflict in a task-switching paradigm	NEURON			English	Article							COGNITIVE CONTROL MECHANISMS; MEDIAL FRONTAL-CORTEX; PREFRONTAL CORTEX; ATTENTIONAL SET; FUNCTIONAL-ANATOMY; RESPONSE CONFLICT; RHESUS-MONKEY; FMRI; PERFORMANCE; COMPUTATIONS	The conflict-monitoring hypothesis posits that anterior cingulate cortex (ACC) monitors conflict in information processing and recruits dorsolateral prefrontal cortex (DLPFC) to resolve competition as needed. We used fMRI to test this prediction directly in the context of a task-switching paradigm, in which subjects responded to the color or the motion of a visual stimulus. Conflict was indexed in terms of the product of activities in areas specialized for color or motion processing on a trial-by-trial basis. Here, we report that ACC and posterior parietal cortex (PPC) were sensitive to distinct forms of conflict, at the level of the response and the stimulus representation, respectively. Activity in PPC preceded increased activity in DLPFC and predicted enhanced behavioral performance on subsequent trials. These findings suggest that ACC and PPC may act in concert to detect dissociable forms of conflict and signal to DLPFC the need for increased control.	Cornell Univ, Weill Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	Cornell University	Liston, C (corresponding author), Cornell Univ, Weill Med Coll, Sackler Inst Dev Psychobiol, 1300 York Ave,Box 40, New York, NY 10021 USA.	col2004@med.cornell.edu	Hare, Todd A/E-7091-2017; , Conor Liston/GQH-8931-2022; Hare, Todd/AAE-8574-2019	Hare, Todd A/0000-0002-0260-2772; Hare, Todd/0000-0002-0260-2772	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063255, P50MH062196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015882] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA15882] Funding Source: Medline; NIGMS NIH HHS [GM 07739] Funding Source: Medline; NIMH NIH HHS [R01 MH63255, P01 MH62196] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CAMPBELL FW, 1981, VISION RES, V21, P713, DOI 10.1016/0042-6989(81)90080-8; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; COHEN JD, 1992, PSYCHOL REV, V99, P47; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Durston S, 2002, NEUROIMAGE, V16, P449, DOI 10.1006/nimg.2002.1074; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Glover GH, 2004, MAGN RESON MED, V51, P863, DOI 10.1002/mrm.20016; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; MENT XL, 1992, PSYCHOL BULL, V111, P172; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	52	181	183	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					643	653		10.1016/j.neuron.2006.04.015	http://dx.doi.org/10.1016/j.neuron.2006.04.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701213	Bronze			2022-12-24	WOS:000237875200014
J	Fonseca, R; Nagerl, UV; Bonhoeffer, T				Fonseca, R; Nagerl, UV; Bonhoeffer, T			Neuronal activity determines the protein synthesis dependence of long-term potentiation	NATURE NEUROSCIENCE			English	Article							MEMORY; RECONSOLIDATION; PHOSPHORYLATION; REACTIVATION; HIPPOCAMPUS; RETRIEVAL; REGION; FORMS; SHOCK; LTP	Long-term potentiation (LTP) is generally divided into two phases, early (E-) and late (L-) LTP, of which only L-LTP is thought to depend on protein synthesis. Here we report that E-LTP can also be dependent on protein synthesis at higher levels of synaptic activation. Moreover, we show that the requirement for protein synthesis during L-LTP extends beyond the early induction phase and that it depends on synaptic stimulation. This suggests that the level of neuronal activity is a crucial determinant for the role of protein synthesis in E- and L-LTP.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Fonseca, Rosalina/I-1715-2012; Fonseca, Rosalina/AAS-1117-2020; Nägerl, Valentin/AAD-2575-2022; Bonhoeffer, Tobias/B-9481-2009	Fonseca, Rosalina/0000-0003-0884-6441; Nägerl, Valentin/0000-0001-6831-9008; Bonhoeffer, Tobias/0000-0001-7897-6634				Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; SPRINGER AD, 1972, SCIENCE, V177, P628, DOI 10.1126/science.177.4049.628; STANTON PK, 1984, J NEUROSCI, V4, P3080; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214	15	105	110	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					478	480		10.1038/nn1667	http://dx.doi.org/10.1038/nn1667			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531998				2022-12-24	WOS:000236310700011
J	Lamprecht, R; Farb, CR; Rodrigues, SM; LeDoux, JE				Lamprecht, R; Farb, CR; Rodrigues, SM; LeDoux, JE			Fear conditioning drives profilin into amygdala dendritic spines	NATURE NEUROSCIENCE			English	Article							MEMORY; SYNAPSES	Changes in spine morphology may underlie memory formation, but the molecular mechanisms that subserve such alterations are poorly understood. Here we show that fear conditioning in rats leads to the movement of profilin, an actin polymerization-regulatory protein, into dendritic spines in the lateral amygdala and that these spines undergo enlargements in their postsynaptic densities (PSDs). A greater proportion of profilin-containing spines with enlarged PSDs could contribute to the enhancement of associatively induced synaptic responses in the lateral amygdala following fear learning.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	Lamprecht, R (corresponding author), Univ Haifa, Fac Sci & Sci Educ, Dept Neurobiol & Ethol, IL-31905 Haifa, Israel.	rlamp@research.haifa.ac.il			NIMH NIH HHS [MH58911, MH067048, MH38774, MH46516] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038774, K05MH067048, R01MH046516, R37MH038774, P50MH058911] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; MILLHOUSE OE, 1983, NEUROSCIENCE, V10, P1269, DOI 10.1016/0306-4522(83)90112-4; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003	13	81	82	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					481	483		10.1038/nn1672	http://dx.doi.org/10.1038/nn1672			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547510				2022-12-24	WOS:000236310700012
J	Murray, SO; Boyaci, H; Kersten, D				Murray, SO; Boyaci, H; Kersten, D			The representation of perceived angular size in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							MOON ILLUSION; SPATIAL SUMMATION; RECEPTIVE-FIELDS; FUNCTIONAL MRI; DISTANCE; MODULATION; RETINOTOPY; PERCEPTION; VISION; SYSTEM	Two objects that project the same visual angle on the retina can appear to occupy very different proportions of the visual field if they are perceived to be at different distances. What happens to the retinotopic map in primary visual cortex (V1) during the perception of these size illusions? Here we show, using functional magnetic resonance imaging (fMRI), that the retinotopic representation of an object changes in accordance with its perceived angular size. A distant object that appears to occupy a larger portion of the visual field activates a larger area in V1 than an object of equal angular size that is perceived to be closer and smaller. These results demonstrate that the retinal size of an object and the depth information in a scene are combined early in the human visual system.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Murray, SO (corresponding author), Univ Washington, Dept Psychol, Box 351525, Seattle, WA 98195 USA.	somurray@u.washington.edu	Boyaci, Huseyin/ABI-5769-2020	Boyaci, Huseyin/0000-0003-3168-0654	NEI NIH HHS [F32 EY015342, R01 EY-015261] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY015342, R01EY015261] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FOLEY JM, 1972, VISION RES, V12, P323, DOI 10.1016/0042-6989(72)90121-6; GILINSKY A S, 1955, Am J Psychol, V68, P173; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JENKIN N, 1959, AM J PSYCHOL, V72, P68, DOI 10.2307/1420212; Joynson RB, 1949, Q J EXP PSYCHOL, V1, P119; KAUFMAN L, 1962, SCIENCE, V136, P953, DOI 10.1126/science.136.3520.953; Kaufman L, 2000, P NATL ACAD SCI USA, V97, P500, DOI 10.1073/pnas.97.1.500; KERSTEN D, 1984, VISION RES, V24, P1977, DOI 10.1016/0042-6989(84)90033-6; KING WL, 1962, SCIENCE, V135, P1125, DOI 10.1126/science.135.3509.1125; LARSON GW, 1996, RENDERING RADIANCE A; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; MARG E, 1970, EXPERIENTIA, V26, P270, DOI 10.1007/BF01900088; MCCREADY D, 1985, PERCEPT PSYCHOPHYS, V37, P323, DOI 10.3758/BF03211355; ONO H, 1966, AM J PSYCHOL, V79, P234, DOI 10.2307/1421129; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; RICHARDS W, 1968, KYBERNETIK, V4, P146, DOI 10.1007/BF00288548; RICHARDS W, 1967, NEUROPSYCHOLOGIA, V5, P63, DOI 10.1016/0028-3932(67)90051-6; ROCK I, 1962, SCIENCE, V136, P1023, DOI 10.1126/science.136.3521.1023; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839	27	277	282	7	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					429	434		10.1038/nn1641	http://dx.doi.org/10.1038/nn1641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462737				2022-12-24	WOS:000235645600023
J	Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K				Walter, JT; Alvina, K; Womack, MD; Chevez, C; Khodakhah, K			Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; CALCIUM-CHANNEL; MUTANT MICE; SYNAPTIC-TRANSMISSION; ELECTRICAL-ACTIVITY; CENTRAL NEURONS; CURRENTS; PATTERNS; OUTPUT	Episodic ataxia type-2 (EA2) is caused by mutations in P/Q-type voltage-gated calcium channels that are expressed at high densities in cerebellar Purkinje cells. Because P/Q channels support neurotransmitter release at many synapses, it is believed that ataxia is caused by impaired synaptic transmission. Here we show that in ataxic P/Q channel mutant mice, the precision of Purkinje cell pacemaking is lost such that there is a significant degradation of the synaptic information encoded in their activity. The irregular pacemaking is caused by reduced activation of calcium-activated potassium (K-Ca) channels and was reversed by pharmacologically increasing their activity with 1-ethyl-2-benzimidazolinone (EBIO). Moreover, chronic in vivo perfusion of EBIO into the cerebellum of ataxic mice significantly improved motor performance. Our data support the hypothesis that the precision of intrinsic pacemaking in Purkinje cells is essential for motor coordination and suggest that K-Ca channels may constitute a potential therapeutic target in EA2.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 506 Kennedy Ctr,1410 Pelham Pkwy S, Bronx, NY 10461 USA.	Kkhodakh@aecom.yu.edu		Alvina, Karina/0000-0002-8369-0953	NINDS NIH HHS [R01 NS050808] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Dove LS, 1998, J NEUROSCI, V18, P7687; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; GRIGGS RC, 1995, ANN NEUROL, V37, P285, DOI 10.1002/ana.410370302; Harno H, 2004, J NEUROL, V251, P232, DOI 10.1007/s00415-004-0299-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Ito M, 1984, CEREBELLUM NEURAL CO; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaunisto MA, 2004, NEUROGENETICS, V5, P69, DOI 10.1007/s10048-003-0161-0; Khavandgar S, 2005, J PHYSIOL-LONDON, V569, P545, DOI 10.1113/jphysiol.2005.098053; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; STONE TW, 1993, PHARMACOL REV, V45, P309; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Swensen AM, 2003, J NEUROSCI, V23, P9650; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Tricarico D, 2000, ANN NEUROL, V48, P304, DOI 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Weisz CJC, 2005, J NEUROSCI, V25, P4141, DOI 10.1523/JNEUROSCI.0098-05.2005; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643	50	301	309	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					389	397		10.1038/nn1648	http://dx.doi.org/10.1038/nn1648			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474392				2022-12-24	WOS:000235645600019
J	Takeda, M; Naya, Y; Fujimichi, R; Takeuchi, D; Miyashita, Y				Takeda, M; Naya, Y; Fujimichi, R; Takeuchi, D; Miyashita, Y			Active maintenance of associative mnemonic signal in monkey inferior temporal cortex	NEURON			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INFEROTEMPORAL CORTEX; PREFRONTAL CORTEX; PERIRHINAL CORTEX; STIMULUS ASSOCIATION; PERSISTENT ACTIVITY; NEURONAL-ACTIVITY; PRIMATE; MACAQUE	We investigated the contribution of the inferior temporal (IT) cortical neurons to the active maintenance of internal representations. The activity of single neurons in the IT cortex was recorded while the monkeys performed a sequential-type associative memory task in which distractor stimuli interrupted the delay epoch between the cue and target (paired-associate) stimuli. For each neuron, information about each stimulus conveyed by the delay activity was estimated as a coefficient of multiple regression analysis. We found that target information derived from long-term memory (LTM) persisted despite the distractors. By contrast, cue information derived from the visual system was attenuated and frequently replaced by distractor information. These results suggest that LTM-derived information required for upcoming behavior is actively maintained in the IT neurons, whereas visually derived information tends to be updated irrespective of behavioral relevance.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637; Takeda, Masaki/0000-0002-2235-1624				Amit DJ, 2003, CEREB CORTEX, V13, P1139, DOI 10.1093/cercor/bhg103; Anderson J.R., 1995, COGNITIVE PSYCHOL IT, V4th; Buckley MJ, 1997, J NEUROPHYSIOL, V77, P587, DOI 10.1152/jn.1997.77.2.587; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Fuster JM, 1995, MEMORY CEREBRAL CORT; Grunewald A, 2002, J NEUROSCI, V22, P6195; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Jha Amishi P., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P517, DOI 10.3758/CABN.4.4.517; Law JR, 2005, J NEUROSCI, V25, P5720, DOI 10.1523/JNEUROSCI.4935-04.2005; Littell RC, 2002, SAS LINEAR MODELS; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Postle BR, 2003, CORTEX, V39, P927, DOI 10.1016/S0010-9452(08)70871-2; Rainer G, 1999, J NEUROSCI, V19, P5493; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Ranganath C, 2004, J NEUROSCI, V24, P3917, DOI 10.1523/JNEUROSCI.5053-03.2004; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Rolls ET, 2002, COMPUTATIONAL NEUROS; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; Zar JH, 1999, BIOSTATISTICAL ANAL	49	43	43	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					839	848		10.1016/j.neuron.2005.09.028	http://dx.doi.org/10.1016/j.neuron.2005.09.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337920	Bronze			2022-12-24	WOS:000233927300021
J	Jia, SP; He, DZZ				Jia, SP; He, DZZ			Motility-associated hair-bundle motion in mammalian outer hair cells	NATURE NEUROSCIENCE			English	Article							GUINEA-PIG COCHLEA; BASILAR-MEMBRANE; MECHANOELECTRICAL TRANSDUCTION; RECEPTOR POTENTIALS; GERBIL HEMICOCHLEA; SOMATIC MOTILITY; ADAPTATION; MOVEMENTS; ORGAN; CORTI	Mammalian hearing owes its remarkable sensitivity and frequency selectivity to a local mechanical feedback process within the cochlea. Cochlear outer hair cells (OHCs) function as the key elements in the feedback loop in which the fast somatic motility of OHCs is thought to be the source of cochlear amplification. An alternative view is that amplification arises from active hair-bundle movement, similar to that seen in nonmammalian hair cells. We measured voltage-evoked hair-bundle motions in the gerbil cochlea to determine if such movements were also present in mammalian OHCs. The OHCs showed bundle movement with peak responses of up to 830 nm. The movement was insensitive to manipulations that would normally block mechanotransduction in the stereocilia, and it was absent in neonatal OHCs and prestin-knockout OHCs. These findings suggest that the bundle movement originated in somatic motility and that somatic motility has a central role in cochlear amplification in mammals.	Creighton Univ, Sch Med, Dept Biomed Sci, Hair Cell Biophys Lab, Omaha, NE 68175 USA	Creighton University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Hair Cell Biophys Lab, 2500 Calif Plaza, Omaha, NE 68175 USA.	hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [R01 DC004696, R21 DC 006039, R21 DC006039, R01 DC 006496] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006039, R01DC004696] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; Benser ME, 1996, J NEUROSCI, V16, P5629; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; De Boer E., 1996, COCHLEA, P8, DOI [10.1007/978-1-4612-0757-3_5, DOI 10.1007/978-1-4612-0757-3_5]; EVANS BN, 1993, P NATL ACAD SCI USA, V90, P8347, DOI 10.1073/pnas.90.18.8347; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; He DZZ, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P181, DOI 10.1142/9789812704931_0024; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; He DZZ, 1997, J NEUROSCI, V17, P3634; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KOSSL M, 1992, J NEUROSCI, V12, P1575; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1995, PFLUG ARCH EUR J PHY, V430, P745, DOI 10.1007/BF00386170; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; MCMULLEN TA, 1985, HEARING RES, V17, P127, DOI 10.1016/0378-5955(85)90016-4; Murugasu E, 1996, J NEUROSCI, V16, P325; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; REUTER G, 1992, HEARING RES, V60, P236, DOI 10.1016/0378-5955(92)90025-I; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Richter CP, 1998, J NEUROPHYSIOL, V79, P2255, DOI 10.1152/jn.1998.79.5.2255; RUSCH A, 1990, HEARING RES, V48, P247, DOI 10.1016/0378-5955(90)90065-W; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; Spector AA, 2003, J ACOUST SOC AM, V113, P453, DOI 10.1121/1.1526493; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Weitzel EK, 2003, J ACOUST SOC AM, V114, P1462, DOI 10.1121/1.1596172; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	56	60	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1028	1034		10.1038/nn1509	http://dx.doi.org/10.1038/nn1509			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16041370				2022-12-24	WOS:000230760200014
J	Marcaggi, P; Attwell, D				Marcaggi, P; Attwell, D			Endocannabinoid signaling depends on the spatial pattern of synapse activation	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; PARALLEL FIBER SYNAPSES; LONG-TERM DEPRESSION; RETROGRADE INHIBITION; ENDOGENOUS CANNABINOIDS; CURRENTS; TRANSPORTERS; RELEASE	The brain's endocannabinoid retrograde messenger system decreases presynaptic transmitter release, but its physiological function is uncertain. We show that endocannabinoid signaling is absent when spatially dispersed synapses are activated on rodent cerebellar Purkinje cells but that it reduces presynaptic glutamate release when nearby synapses are active. This switching of signaling according to the spatial pattern of activity is controlled by postsynaptic type I metabotropic glutamate receptors, which are activated disproportionately when glutamate spillover between synapses produces synaptic crosstalk. When spatially distributed synapses are activated, endocannabinoid inhibition of transmitter release can be rescued by inhibiting glutamate uptake to increase glutamate spillover. Endocannabinoid signaling initiated by type I metabotropic glutamate receptors is a homeostatic mechanism that detects synaptic crosstalk and downregulates glutamate release in order to promote synaptic independence.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Marcaggi, P (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	P.Marcaggi@ucl.ac.uk	Marcaggi, Païkan/GYU-1658-2022; Attwell, David/ABE-6750-2020; Marcaggi, Païkan/P-5855-2016	Marcaggi, Païkan/0000-0003-3575-8340	Wellcome Trust [017948, 075232] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Coutinho V, 2004, EUR J NEUROSCI, V20, P740, DOI 10.1111/j.1460-9568.2004.03533.x; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Levenes C, 2001, J PHYSIOL-LONDON, V537, P125, DOI 10.1111/j.1469-7793.2001.0125k.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Neale SA, 2001, NEUROPHARMACOLOGY, V41, P42, DOI 10.1016/S0028-3908(01)00046-6; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	25	88	89	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					776	781		10.1038/nn1458	http://dx.doi.org/10.1038/nn1458			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15864304	Green Accepted			2022-12-24	WOS:000229345300018
J	Aktas, O; Smorodchenko, A; Brocke, S; Infante-Duarte, C; Topphoff, US; Vogt, J; Prozorovski, T; Meier, S; Osmanova, V; Pohl, E; Bechmann, I; Nitsch, R; Zipp, F				Aktas, O; Smorodchenko, A; Brocke, S; Infante-Duarte, C; Topphoff, US; Vogt, J; Prozorovski, T; Meier, S; Osmanova, V; Pohl, E; Bechmann, I; Nitsch, R; Zipp, F			Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL	NEURON			English	Article							APOPTOSIS-INDUCING LIGAND; HUMAN T-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; EFFECTOR-CELLS; AXONAL DAMAGE; HUMAN BRAIN; RECEPTOR; ENCEPHALOMYELITIS; EXPRESSION	Here, we provide evidence for a detrimental role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in neural death in T cell-induced experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Clinical severity and neuronal apoptosis in brainstem motor areas were substantially reduced upon brain-specific blockade of TRAIL after induction of EAE through adoptive transfer of encephalitogenic T cells. Furthermore, TRAIL-deficient myelin-specific lymphocytes showed reduced encephalitogenicity when transferred to wildtype mice. Conversely, intracerebral delivery of TRAIL to animals with EAE increased clinical deficits, while naive mice were not susceptible to TRAIL. Using organotypic slice cultures as a model for living brain tissue, we found that neurons were susceptible to TRAIL-mediated injury induced by encephalitogenic T cells. Thus, in addition to its known immunoregulatory effects, the death ligand TRAIL contributes to neural damage in the inflamed brain.	Humboldt Univ, Charite, Neurosci Res Ctr, Inst Neuroimmunol, D-10098 Berlin, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91120 Jerusalem, Israel; Humboldt Univ, Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-10098 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zipp, F (corresponding author), Humboldt Univ, Charite, Neurosci Res Ctr, Inst Neuroimmunol, Clara Zetkin Str 94, D-10098 Berlin, Germany.	frauke.zipp@charite.de	Vogt, Johannes/O-4289-2019; Nitsch, Robert/AAI-9129-2021; Smorodchenko, Alina/ABB-2411-2020; Zipp, Frauke/C-9968-2015; Smorodchenko, Alina/AAU-2854-2020; Smorodchenko, Alina/D-1880-2010; Pohl, Elena E./A-4025-2009; Aktas, Orhan/B-7623-2009; Vogt, Johannes/K-2278-2015	Zipp, Frauke/0000-0002-1231-1928; Pohl, Elena E./0000-0002-0604-5950; Aktas, Orhan/0000-0002-2020-9210; Infante Duarte, Carmen/0000-0003-3005-351X; Vogt, Johannes/0000-0003-2439-8247; Smorodchenko, Alina/0000-0003-1415-1531				Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Brocke Stefan, 1996, Methods (Orlando), V9, P458, DOI 10.1006/meth.1996.0053; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Dorr J, 2002, J NEUROIMMUNOL, V122, P117, DOI 10.1016/S0165-5728(01)00450-7; Dorr J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0001.2002; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; FORD AL, 1995, J IMMUNOL, V154, P4309; Gimsa U, 2000, BRAIN PATHOL, V10, P365; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; LERANTH C, 1994, J NEUROSCI, V14, P4079; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Miura Y, 2003, P NATL ACAD SCI USA, V100, P2777, DOI 10.1073/pnas.2628048100; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Okuda Y, 1998, J NEUROIMMUNOL, V81, P201, DOI 10.1016/S0165-5728(97)00180-X; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Qin JZ, 2001, NAT MED, V7, P385, DOI 10.1038/86401; Reijneveld JC, 1999, J NEURO-ONCOL, V42, P137, DOI 10.1023/A:1006237917632; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; SAEKI Y, 1992, P NATL ACAD SCI USA, V89, P6157, DOI 10.1073/pnas.89.13.6157; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wendling U, 2000, CELL DEATH DIFFER, V7, P637, DOI 10.1038/sj.cdd.4400692; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; Zamai L, 2000, BLOOD, V95, P3716; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zheng SJ, 2004, J CLIN INVEST, V113, P58, DOI 10.1172/JCI200419255; Zipp F, 1999, IMMUNOL TODAY, V20, P550, DOI 10.1016/S0167-5699(99)01545-5	63	174	183	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					421	432		10.1016/j.neuron.2005.03.018	http://dx.doi.org/10.1016/j.neuron.2005.03.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882642	Bronze, Green Accepted			2022-12-24	WOS:000229011400014
J	Bokor, H; Frere, SGA; Eyre, MD; Slezia, A; Ulbert, I; Luthi, A; Acsady, L				Bokor, H; Frere, SGA; Eyre, MD; Slezia, A; Ulbert, I; Luthi, A; Acsady, L			Selective GABAergic control of higher-order thalamic relays	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; ANTERIOR PRETECTAL NUCLEUS; ELECTRON-MICROSCOPIC ANALYSIS; GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC ACID; CENTRAL-NERVOUS-SYSTEM; RETICULAR NUCLEUS; ZONA INCERTA; SYNAPTIC INPUT; A-LAMINAE	GABAergic signaling is central to the function of the thalamus and has been traditionally attributed primarily to the nucleus reticularis thalami (nRT). Here we present a GABAergic pathway, distinct from the nRT, that exerts a powerful inhibitory effect selectively in higher-order thalamic relays of the rat. Axons originating in the anterior pretectal nucleus (APT) innervated the proximal dendrites of relay cells via large GABAergic terminals with multiple release sites. Stimulation of the APT in an in vitro slice preparation revealed a GABA(A) receptor-mediated, monosynaptic IPSC in relay cells. Activation of presumed single APT fibers induced rebound burst firing in relay cells. Different APT neurons recorded in vivo displayed fast bursting, tonic, or rhythmic firing. Our data suggest that selective extrareticular GABAergic control of relay cell activity will result in effective, state-dependent gating of thalamocortical information transfer in higher-order but not in first-order relays.	Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary; Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland; Hungarian Acad Sci, Inst Psychol, H-1068 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Basel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Acsady, L (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.	acsady@koki.hu	Ulbert, Istvan/F-2213-2010; Acsady, Laszlo/C-7773-2014; Luthi, Anita/ABE-1411-2021	Acsady, Laszlo/0000-0002-0679-2980; Luthi, Anita/0000-0002-4954-4143; Eyre, Mark/0000-0001-9102-2894; Slezia, Andrea/0000-0002-4528-3169	Wellcome Trust [067573] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; Bartho P, 2002, EUR J NEUROSCI, V16, P999, DOI 10.1046/j.1460-9568.2002.02157.x; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; BERMAN N, 1977, J COMP NEUROL, V174, P227, DOI 10.1002/cne.901740204; CADUSSEAU J, 1991, NEUROSCI RES, V12, P83, DOI 10.1016/0168-0102(91)90102-5; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304; CUCCHIARO JB, 1993, J COMP NEUROL, V334, P618, DOI 10.1002/cne.903340409; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; FOSTER GA, 1989, NEUROSCIENCE, V29, P685, DOI 10.1016/0306-4522(89)90141-3; GRAHAM J, 1981, NEUROSCI LETT, V26, P209, DOI 10.1016/0304-3940(81)90134-8; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517; Huguenard JR, 1998, J SLEEP RES, V7, P24, DOI 10.1046/j.1365-2869.7.s1.5.x; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; JOURDAIN A, 1989, BRAIN RES, V505, P55, DOI 10.1016/0006-8993(89)90115-7; Kenigfest NB, 2000, J COMP NEUROL, V426, P31, DOI 10.1002/1096-9861(20001009)426:1<31::AID-CNE3>3.0.CO;2-S; Kim U, 1998, J NEUROSCI, V18, P9500; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203; LLINAS R, 1997, COHERENT OSCILLATION, P501; LUBKE J, 1993, J COMP NEUROL, V329, P458, DOI 10.1002/cne.903290404; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; May PJ, 1997, NEUROSCIENCE, V77, P1091, DOI 10.1016/S0306-4522(96)00535-0; MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; ROBERTSON RT, 1983, EXP BRAIN RES, V51, P157; Schiff ND, 2002, NEUROL RES, V24, P116, DOI 10.1179/016164102101199576; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P240, DOI 10.1177/33.3.2579123; Steriade M, 2004, NEURON, V41, P493, DOI 10.1016/S0896-6273(04)00076-5; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; TERENZI MG, 1995, BRAIN RES, V701, P183, DOI 10.1016/0006-8993(95)01001-8; Trageser JC, 2004, J NEUROSCI, V24, P8911, DOI 10.1523/JNEUROSCI.3218-04.2004; Veinante P, 1999, J NEUROSCI, V19, P5085; Vidnyanszky Z, 1996, EXP BRAIN RES, V109, P63; Wang ST, 2002, NEUROSCI LETT, V323, P141, DOI 10.1016/S0304-3940(01)02533-2; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	57	102	104	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					929	940		10.1016/j.neuron.2005.01.048	http://dx.doi.org/10.1016/j.neuron.2005.01.048			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797553	Bronze			2022-12-24	WOS:000228031300013
J	Wang, T; Xu, H; Oberwinkler, J; Gu, YC; Hardie, RC; Montell, C				Wang, T; Xu, H; Oberwinkler, J; Gu, YC; Hardie, RC; Montell, C			Light activation, adaptation, and cell survival functions of the Na+/Ca2(+) exchanger CaIX	NEURON			English	Article							DROSOPHILA-NINAC KINASE; RETINAL DEGENERATION; MOLECULAR CHARACTERIZATION; CALMODULIN REGULATION; VISUAL TRANSDUCTION; NA+-CA2+ EXCHANGER; DOMAIN PROTEIN; CALCIUM INFLUX; PDZ PROTEIN; TRP GENE	In sensory neurons, Ca2+ entry is crucial for both activation and subsequent attenuation of signaling. Influx of Ca2+ is counterbalanced by Ca2+ extrusion, and Na+/Ca2+ exchange is the primary mode for rapid Ca2+ removal during and after sensory stimulation. However, the consequences on sensory signaling resulting from mutations in Na+/Ca2+ exchangers have not been described. Here, we report that mutations in the Drosophila Na+/Ca2+ exchanger calk have a profound effect on activity-dependent survival of photoreceptor cells. Loss of CalX activity resulted in a transient response to light, a dramatic decrease in signal amplification, and unusually rapid adaptation. Conversely, overexpression of CalX had reciprocal effects and greatly suppressed the retinal degeneration caused by constitutive activity of the TRP channel. These results illustrate the critical role of Ca2+ for proper signaling and provide genetic evidence that Ca2+ overload is responsible for a form of retinal degeneration resulting from defects in the TRIP channel.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	Johns Hopkins University; University of Cambridge; Saarland University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Xu, Hong/H-9997-2016; Montell, Craig/AAH-3357-2021	Xu, Hong/0000-0003-1049-1184; Montell, Craig/0000-0001-5637-1482; gu, yuchun/0000-0002-7558-0447; Wang, Tao/0000-0002-2395-3483; Oberwinkler, Johannes/0000-0002-8541-3626; Xu, Hong/0000-0002-1423-1809; Hardie, Roger/0000-0001-5531-3264	NEI NIH HHS [EY08117, EY10852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852, R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Arnon A, 1997, P NATL ACAD SCI USA, V94, P5894, DOI 10.1073/pnas.94.11.5894; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Haug-Collet K, 1999, J CELL BIOL, V147, P659, DOI 10.1083/jcb.147.3.659; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; MATSUMOTO E, 1988, CELL TISSUE RES, V252, P293; MINKE B, 1984, VISION RES, V24, P109, DOI 10.1016/0042-6989(84)90095-6; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, P NATL ACAD SCI USA, V97, P8578, DOI 10.1073/pnas.97.15.8578; OBERWINKLER J, 2000, THESIS U GRONINGEN G; ODAY PM, 1991, ANN NY ACAD SCI, V639, P285, DOI 10.1111/j.1749-6632.1991.tb17317.x; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pak WL, 2003, RECEPTOR CHANNEL, V9, P149, DOI 10.1080/10606820308242; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Ruknudin A, 1997, AM J PHYSIOL-CELL PH, V273, pC257, DOI 10.1152/ajpcell.1997.273.1.C257; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Winkfein RJ, 2004, CELL CALCIUM, V36, P147, DOI 10.1016/j.ceca.2004.01.021; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000	59	98	98	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					367	378		10.1016/j.neuron.2004.12.046	http://dx.doi.org/10.1016/j.neuron.2004.12.046			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694324	Bronze			2022-12-24	WOS:000226787700010
J	Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC				Rosso, SB; Sussman, D; Wynshaw-Boris, A; Salinas, PC			Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; N-TERMINAL KINASE; SMALL GTPASES RAC; RHO-GTPASES; VERTEBRATE GASTRULATION; NEURONAL MORPHOGENESIS; TRANSDUCTION PATHWAY; ACTIN CYTOSKELETON; PYRAMIDAL NEURONS; BETA-CATENIN	Dendritic arborization is required for proper neuronal connectivity. Rho GTPases have been implicated in the regulation of dendrite development. However, the signaling pathways that impinge on these molecular switches remain poorly understood. Here we show that Wnt7b, which is expressed in the mouse hippocampus, increases dendritic branching in cultured hippocampal neurons. This effect is mimicked by the expression of Dishevelled (Dvl) and is blocked by Sfrp1, a secreted Wnt antagonist. Consistent with these findings, hippocampal neurons from mice lacking Dvl1 show reduced dendritic arborization. Activation of the canonical Wnt-Gsk3beta pathway does not affect dendritic development. In contrast, Wnt7b and Dvl activate Rac and JNK in hippocampal neurons. Dominant-negative Rac, dominant-negative JNK or inhibition of JNK blocks Dvl-mediated dendritic growth. These findings demonstrate a new function for the non-canonical Wnt pathway in dendrite development and identify Dvl as a regulator of Rho GTPases and JNK during dendritic morphogenesis.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Salinas, PC (corresponding author), UCL, Dept Anat & Dev Biol, Rockefeller Bldg,Univ St, London WC1E 6BT, England.	p.salinas@ucl.ac.uk		Salinas, Patricia C./0000-0002-5748-083X	NINDS NIH HHS [R01 NS073159] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Coffey ET, 2000, J NEUROSCI, V20, P7602; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paglini G, 1998, J NEUROSCI, V18, P9858; Penton A, 2002, GENETICS, V161, P747; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	50	372	379	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					34	42		10.1038/nn1374	http://dx.doi.org/10.1038/nn1374			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608632				2022-12-24	WOS:000225967600013
J	Dorris, MC; Glimcher, PW				Dorris, MC; Glimcher, PW			Activity in posterior parietal cortex is correlated with the relative subjective desirability of action	NEURON			English	Article							PERCEPTUAL DECISION; AREA LIP; REPRESENTATION; RESPONSES; SELECTION; NEURONS; SPACE; CELLS	Behavioral studies suggest that making a decision involves representing the overall desirability of all available actions and then selecting that action that is most desirable. Physiological studies have proposed that neurons in the parietal cortex play a role in selecting movements for execution. To test the hypothesis that these parietal neurons encode the subjective desirability of making particular movements, we exploited Nash's game theoretic equilibrium, during which the subjective desirability of multiple actions should be equal for human players. Behavior measured during a strategic game suggests that monkeys' choices, like those of humans, are guided by subjective desirability. Under these conditions, activity in the parietal cortex was correlated with the relative subjective desirability of actions irrespective of the specific combination of reward magnitude, reward probability, and response probability associated with each action. These observations may help place many recent findings regarding the posterior parietal cortex into a common conceptual framework.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu		Glimcher, Paul/0000-0001-7872-3856				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Barlow H. B., 1961, P331; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Basso MA, 1998, J NEUROSCI, V18, P7519; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer C, 2003, BEHAV GAME THEORY; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Fudenberg D., 1994, GAME THEORY; Glimcher PW, 2003, BRADFORD BOOKS, P1; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; GLIMCHER PW, 2004, IN PRESS COGNITIVE N; GLIMCHER PW, 2005, IN PRESS ANN REV PSY, V56; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HERRNSTEIN RJ, 1964, J EXP ANAL BEHAV, V7, P179, DOI 10.1901/jeab.1964.7-179; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Kagel JH, 1995, HDB EXPT EC; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KREBS JR, 1996, BEHAV ECOLOGY; Kreps D. M, 1990, COURSE MICROECONOMIC; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Platt M.L., 2003, OCULOMOTOR SYSTEM NE, P1; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559	44	311	314	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					365	378		10.1016/j.neuron.2004.09.009	http://dx.doi.org/10.1016/j.neuron.2004.09.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473973	Bronze			2022-12-24	WOS:000224635800017
J	Kosolapov, A; Tu, LW; Wang, J; Deutsch, C				Kosolapov, A; Tu, LW; Wang, J; Deutsch, C			Structure acquisition of the T1 domain of Kv1.3 during biogenesis	NEURON			English	Article							GATED K+ CHANNELS; SHAKER POTASSIUM CHANNEL; LARGE RIBOSOMAL-SUBUNIT; BETA-SUBUNIT; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; SECRETORY PROTEINS; MEMBRANE; PEPTIDE; PORE	The T1 recognition domains of voltage-gated K+ (Kv) channel subunits form tetramers and acquire tertiary structure while still attached to their individual ribosomes. Here we ask when and in which compartment secondary and tertiary structures are acquired. We answer this question using biogenic intermediates and recently developed folding and accessibility assays to evaluate the status of the nascent Kv peptide both inside and outside of the ribosome. A compact structure (likely helical) that corresponds to a region of helicity in the mature structure is already manifest in the nascent protein within the ribosomal tunnel. The T1 domain acquires tertiary structure only after emerging from the ribosomal exit tunnel and complete synthesis of the T1-S1 linker. These measurements of ion channel folding within the ribosomal tunnel and its exit port bear on basic principles of protein folding and pave the way for understanding the molecular basis of protein misfolding, a fundamental cause of channelopathies.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	cjd@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052302] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-07027] Funding Source: Medline; NIGMS NIH HHS [GM 52302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agmon I, 2003, EUR J BIOCHEM, V270, P2543, DOI 10.1046/j.1432-1033.2003.03634.x; Ashcroft FM, 2000, ION CHANNELS DIS; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Bezrukov SM, 1996, MACROMOLECULES, V29, P8517, DOI 10.1021/ma960841j; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P171; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gilbert RJC, 2004, MOL CELL, V14, P57, DOI 10.1016/S1097-2765(04)00163-7; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SHEN NV, 1993, NEURON, V11, P67; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	41	49	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					295	307		10.1016/j.neuron.2004.09.011	http://dx.doi.org/10.1016/j.neuron.2004.09.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473968	Bronze			2022-12-24	WOS:000224635800012
J	Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P				Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P			Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; MOTOR-NEURON DISEASE; MUTANT SUPEROXIDE-DISMUTASE; UBIQUITIN-PROTEASOME SYSTEM; TRANSGENIC MOUSE MODEL; LINKED SOD1 MUTANTS; ALZHEIMERS-DISEASE; MUSCLE-FIBERS; ALS MICE	Neurodegenerative diseases can have long preclinical phases and insidious progression patterns, but the mechanisms of disease progression are poorly understood. Because quantitative accounts of neuronal circuitry affected by disease have been lacking, it has remained unclear whether disease progression reflects processes of stochastic loss or temporally defined selective vulnerabilities of distinct synapses or axons. Here we derive a quantitative topographic map of muscle innervation in the hindlimb. We show that in two mouse models of motoneuron disease (G93A SOD1 and G85R SOD1), axons of fast-fatiguable motoneurons are affected synchronously, long before symptoms appear. Fast-fatigue-resistant motoneuron axons are affected at symptom-onset, whereas axons of slow motoneurons are resistant. Axonal vulnerability leads to synaptic vesicle stalling and accumulation of BC12a1-a, an anti-apoptotic protein. It is alleviated by ciliary neurotrophic factor and triggers proteasome-dependent pruning of peripheral axon branches. Thus, motoneuron disease involves predictable, selective vulnerability patterns by physiological subtypes of axons, episodes of abrupt pruning in the target region and compensation by resistant axons.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Santos, Alexsandro/HCI-9028-2022	Saxena, Smita/0000-0003-4574-4591				Al-Chalabi A, 2003, ANN NEUROL, V54, P130, DOI 10.1002/ana.10638; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Burke RE, 1994, MYOLOGY, P464; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; DELIO DA, 1992, J NEUROL SCI, V109, P30, DOI 10.1016/0022-510X(92)90090-8; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LARSSON L, 1995, J NEUROL SCI, V132, P182, DOI 10.1016/0022-510X(95)00138-R; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Peterson WM, 2000, J NEUROSCI, V20, P4081; PINTER MJ, 1995, J NEUROSCI, V15, P3447; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Sagot Y, 1998, J NEUROSCI, V18, P1132; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Shaw PJ, 2000, J NEUROL, V247, P17; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	50	455	468	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					408	419		10.1038/nn1653	http://dx.doi.org/10.1038/nn1653			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474388				2022-12-24	WOS:000235645600021
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Dynamic shape synthesis in posterior inferotemporal cortex	NEURON			English	Article							VISUAL-CORTEX; AREA MT; MACAQUE; NEURONS; REPRESENTATION; RESPONSES; FEATURES; FACE; RECOGNITION; SELECTIVITY	How does the brain synthesize low-level neural signals for simple shape parts into coherent representations of complete objects? Here, we present evidence for a dynamic process of object part integration in macaque posterior inferotemporal cortex (IT). Immediately after stimulus onset, neural responses carried information about individual object parts (simple contour fragments) only. Subsequently, information about specific multipart configurations emerged, building gradually over the course of similar to 60 ms, producing a sparser and more explicit representation of object shape. We show that this gradual transformation can be explained by a recurrent network process that effectively compares parts signals across neurons to generate inferences about multipart shape configurations.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						Arguin M, 2000, VISION RES, V40, P3099, DOI 10.1016/S0042-6989(00)00155-3; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Dayan P., 2001, THEORETICAL NEUROSCI; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Movshon A, 1985, PATTERN RECOGN, V54, P117; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pugh MC, 2000, J COMPUT NEUROSCI, V8, P143, DOI 10.1023/A:1008921231855; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	38	132	132	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					17	24		10.1016/j.neuron.2005.11.026	http://dx.doi.org/10.1016/j.neuron.2005.11.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387636	Bronze			2022-12-24	WOS:000236699300006
J	Sato, M; Umetsu, D; Murakami, S; Yasugi, T; Tabata, T				Sato, M; Umetsu, D; Murakami, S; Yasugi, T; Tabata, T			DWnt4 regulates the dorsoventral specificity of retinal projections in the Drosophila melanogaster visual system	NATURE NEUROSCIENCE			English	Article							AXON GUIDANCE; WINGLESS; WNT; EYE; MORPHOGENESIS; KINASE; GENES; PROTEINS; RECEPTOR; BRAIN	In Drosophila melanogaster, the axons of retinal photoreceptor cells extend to the first optic ganglion, the lamina, forming a topographic representation. Here we show that DWnt4, a secreted protein of the Wnt family, is the ventral cue for the lamina. In DWnt4 mutants, ventral retinal axons misprojected to the dorsal lamina. DWnt4 was normally expressed in the ventral half of the developing lamina and DWnt4 protein was detected along ventral retinal axons. Dfrizzled2 and dishevelled, respectively, encode a receptor and a signaling molecule required for Wnt signaling. Mutations in both genes caused DWnt4-like defects, and both genes were autonomously required in the retina, suggesting a direct role of DWnt4 in retinal axon guidance. In contrast, iroquois homeobox genes are the dorsal cues for the retina. Dorsal axons accumulated DWnt4 and misprojected to the ventral lamina in iroquois mutants; the phenotype was suppressed in iroquois Dfrizzled2 mutants, suggesting that iroquois may attenuate the competence of Dfrizzled2 to respond to DWnt4.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Morphogenesis, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Tabata, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Morphogenesis, Bunkyo Ku, Tokyo 1130032, Japan.	ttabata@iam.u-tokyo.ac.jp	Yasugi, Tetsuo/N-4913-2015	Sato, Makoto/0000-0002-7763-0751				Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Chen CM, 1999, DEVELOPMENT, V126, P5441; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; GRABA Y, 1995, DEVELOPMENT, V121, P209; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; KUNES S, 1993, J NEUROSCI, V13, P752; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Oh SW, 2003, GENETICS, V163, P195; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pai LM, 1997, DEVELOPMENT, V124, P2255; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Stowers RS, 1999, GENETICS, V152, P1631; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	41	68	74	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					67	75		10.1038/nn1604	http://dx.doi.org/10.1038/nn1604			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369482				2022-12-24	WOS:000234288000019
J	Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP				Urushitani, M; Sik, A; Sakurai, T; Nukina, N; Takahashi, R; Julien, JP			Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOLECULAR-WEIGHT COMPLEXES; B-LIKE IMMUNOREACTIVITY; BRAIN MICROGLIAL CELLS; MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; TRANSGENIC MICE; FAMILIAL ALS; SPINAL-CORD; MOUSE MODEL	Here we report that chromogranins, components of neurosecretory vesicles, interact with mutant forms of superoxide dismutase (SOD1) that are linked to amyotrophic lateral sclerosis (ALS), but not with wild-type SOD1. This interaction was confirmed by yeast two-hybrid screen and by co-immunoprecipitation assays using either lysates from Neuro2a cells coexpressing chromogranins and SOD1 mutants or lysates from spinal cord of ALS mice. Confocal and immunoelectron microscopy revealed a partial colocalization of mutant SOD1 with chromogranins in spinal cord of ALS mice. Mutant SOD1 was also found in immuno-isolated trans-Golgi network and in microsome preparations, suggesting that it can be secreted. Indeed we report evidence that chromogranins may act as chaperone-like proteins to promote secretion of SOD1 mutants. From these results, and our finding that extracellular mutant SOD1 can trigger microgliosis and neuronal death, we propose a new ALS pathogenic model based on the toxicity of secreted SOD1 mutants.	Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada; Univ Laval Robert Giffard, Dept Psychiat, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Laval University; Laval University; RIKEN	Julien, JP (corresponding author), Univ Laval, Ctr Rech, CHU Laval, Dept Anat & Physiol, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	jean-pierre.julien@crchul.ulaval.ca	Nukina, Nobuyuki/GPP-6265-2022	Urushitani, Makoto/0000-0003-2773-9836				BOOJ S, 1989, NEUROSCIENCE, V30, P479, DOI 10.1016/0306-4522(89)90267-4; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Ciesielski-Treska J, 1998, J BIOL CHEM, V273, P14339, DOI 10.1074/jbc.273.23.14339; Ciesielski-Treska J, 2001, J BIOL CHEM, V276, P13113, DOI 10.1074/jbc.M009711200; Cimini V, 2002, HISTOCHEM CELL BIOL, V118, P163, DOI 10.1007/s00418-002-0429-8; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kato A, 2000, BRAIN RES, V852, P444, DOI 10.1016/S0006-8993(99)02229-5; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Li JY, 1999, EUR J NEUROSCI, V11, P528, DOI 10.1046/j.1460-9568.1999.00456.x; LI JY, 1992, J NEUROBIOL, V23, P1094, DOI 10.1002/neu.480230813; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Marksteiner J, 2000, ACTA NEUROPATHOL, V100, P205, DOI 10.1007/s004010000239; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Parkin ET, 1999, J NEUROCHEM, V72, P1534, DOI 10.1046/j.1471-4159.1999.721534.x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; SCHIFFER D, 1995, J NEUROL SCI, V129, P68, DOI 10.1016/0022-510X(95)00068-D; SHARPLESS N, 1992, VIROLOGY, V191, P813, DOI 10.1016/0042-6822(92)90257-P; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; Stieber A, 2004, J NEUROL SCI, V219, P45, DOI 10.1016/j.jns.2003.12.004; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 1996, NEUROSCIENCE, V72, P377, DOI 10.1016/0306-4522(96)83172-1; Taylor DL, 2003, J NEUROSCI, V23, P2150; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	47	318	342	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					108	118		10.1038/nn1603	http://dx.doi.org/10.1038/nn1603			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369483				2022-12-24	WOS:000234288000024
J	Voss, M; Ingram, JN; Haggard, P; Wolpert, DM				Voss, M; Ingram, JN; Haggard, P; Wolpert, DM			Sensorimotor attenuation by central motor command signals in the absence of movement	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; VOLUNTARY MOVEMENT; HUMAN BRAIN; STIMULATION; PERCEPTION; SUPPRESSION; DELAY; TIME	Voluntary actions typically produce suppression of afferent sensation from the moving body part. We used transcranial magnetic stimulation to delay the output of motor commands from the motor cortex during voluntary movement. We show attenuation of sensation during this delay, in the absence of movement. We conclude that sensory suppression mainly relies on central signals related to the preparation for movement and that these signals are upstream of primary motor cortex.	Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; Dept Psychol, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Voss, M (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	martin.voss@charite.de	Haggard, Patrick/A-5081-2010	Wolpert, Daniel/0000-0003-2011-2790; Voss, Martin/0000-0002-5221-4647; Haggard, Patrick/0000-0001-7798-793X	Wellcome Trust [077730] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; PALMER E, 1994, J PHYSIOL-LONDON, V481, P509, DOI 10.1113/jphysiol.1994.sp020459; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P230, DOI 10.1016/0168-5597(94)90045-0; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; SEYAL M, 1992, ELECTROEN CLIN NEURO, V85, P397, DOI 10.1016/0168-5597(92)90053-E; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464; Wasaka T, 2003, NEUROIMAGE, V20, P1830, DOI 10.1016/S1053-8119(03)00442-7; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Ziemann U, 1997, BRAIN RES, V744, P32, DOI 10.1016/S0006-8993(96)01062-1	15	150	150	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					26	27		10.1038/nn1592	http://dx.doi.org/10.1038/nn1592			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311591	Green Accepted			2022-12-24	WOS:000234288000013
J	Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA				Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA			Adenosine and ATP link P-CO2 to cortical excitability via pH	NEURON			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICE; CENTRAL-NERVOUS-SYSTEM; CA3 NETWORK ACTIVITY; METHYL-D-ASPARTATE; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; EPILEPTIFORM ACTIVITY; SEROTONERGIC NEURONS; CARBON-DIOXIDE	In addition to affecting respiration and vascular tone, deviations from normal CO2 alter pH, consciousness, and seizure propensity. Outside the brainstem, however, the mechanisms by which CO2 levels modify neuronal function are unknown. In the hippocampal slice preparation, increasing CO2, and thus decreasing pH, increased the extracellular concentration of the endogenous neuromodulator adenosine and inhibited excitatory synaptic transmission. These effects involve adenosine A(1) and ATP receptors and depend on decreased extracellular pH. In contrast, decreasing CO2 levels reduced extracellular adenosine concentration and increased neuronal excitability via adenosine A, receptors, ATP receptors, and ecto-ATPase. Based on these studies, we propose that CO2-induced changes in neuronal function arise from a pH-dependent modulation of adenosine and ATP levels. These findings demonstrate a mechanism for the bidirectional effects Of CO2 on neuronal excitability in the forebrain.	Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Dundee, Div Pathol & Neurosci, Inst Neurosci, Ninewells Hosp, Dundee DD1 9SY, Scotland; Trinity Coll, Program Neurosci, Hartford, CT 06106 USA; Trinity Coll, Dept Psychol, Hartford, CT 06106 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Dundee; Trinity College; Trinity College	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Program Neurosci, 4200 E 9th Ave, Denver, CO 80262 USA.	kevin.staley@uchsc.edu	Frenguelli, Bruno/C-5007-2015	Frenguelli, Bruno/0000-0001-7214-3172; Dulla, Chris/0000-0002-6560-6535	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029173] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029173-13, R01 NS029173, R01 NS029173-10, R01 NS029173-12, R01 NS029173-11, R01 NS029173-09A1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ACHENBACHNG J, 1994, J CLIN NEUROPHYSIOL, V11, P220, DOI 10.1097/00004691-199403000-00007; ADAMS DJ, 1981, NEUROLOGY, V31, P1175, DOI 10.1212/WNL.31.9.1175; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Almeida T, 2003, NEUROSCIENCE, V122, P111, DOI 10.1016/S0306-4522(03)00523-2; ARAM JA, 1987, NEUROSCI LETT, V83, P345, DOI 10.1016/0304-3940(87)90112-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BALESTRINO M, 1988, J PHYSIOL-LONDON, V396, P247, DOI 10.1113/jphysiol.1988.sp016961; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Boison D, 2002, EPILEPSIA, V43, P788, DOI 10.1046/j.1528-1157.2002.33001.x; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Capps R T, 1968, Clin Anesth, V3, P122; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cunha RA, 1998, J NEUROSCI, V18, P1987; Dale N, 1998, J PHYSIOL-LONDON, V511, P265, DOI 10.1111/j.1469-7793.1998.265bi.x; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Datto C, 2002, J ECT, V18, P118, DOI 10.1097/00124509-200209000-00002; Drakulich DA, 2004, EUR J PHARMACOL, V485, P137, DOI 10.1016/j.ejphar.2003.11.056; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FUJIWARA N, 1992, BRAIN RES, V572, P335, DOI 10.1016/0006-8993(92)90496-V; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; GU JG, 1995, J NEUROCHEM, V64, P2105; Guaranha MSB, 2005, EPILEPSIA, V46, P69, DOI 10.1111/j.0013-9580.2005.11104.x; Huguenard J R, 1999, Adv Neurol, V79, P991; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Khakh BS, 2003, J NEUROSCI, V23, P7426; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Lee J, 1996, BRAIN RES, V706, P210, DOI 10.1016/0006-8993(95)01214-1; MACVICAR BA, 1982, BRAIN RES, V242, P341; Malva JO, 2003, NEUROCHEM RES, V28, P1501, DOI 10.1023/A:1025618324593; Masino SA, 1999, J NEUROSCI, V19, P1932; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MILEY CE, 1977, ARCH NEUROL-CHICAGO, V34, P371, DOI 10.1001/archneur.1977.00500180065014; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; NAGY AK, 1986, J NEUROCHEM, V47, P976; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Pankratov Y, 1999, PROG BRAIN RES, V120, P237; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; Thummler S, 2000, J NEUROPHYSIOL, V83, P1787, DOI 10.1152/jn.2000.83.4.1787; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wirrell EC, 1996, EPILEPSIA, V37, P459, DOI 10.1111/j.1528-1157.1996.tb00592.x; Yoshioka K, 2002, FEBS LETT, V531, P299, DOI 10.1016/S0014-5793(02)03540-8; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; ZIGANSHIN AU, 1994, DRUG DEVELOP RES, V32, P134, DOI 10.1002/ddr.430320303; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	67	132	136	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1011	1023		10.1016/j.neuron.2005.11.009	http://dx.doi.org/10.1016/j.neuron.2005.11.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364904	Green Accepted, Bronze			2022-12-24	WOS:000234301700016
J	Marowsky, A; Yanagawa, Y; Obata, K; Vogt, KE				Marowsky, A; Yanagawa, Y; Obata, K; Vogt, KE			A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function	NEURON			English	Article							ANTAGONIST SCH 23390; GREEN FLUORESCENT PROTEIN; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; POTENTIATED STARTLE; LATERAL AMYGDALA; CONDITIONED FEAR; ACOUSTIC STARTLE; RAT AMYGDALA; IN-VIVO	The amygdala is under inhibitory control from the cortex through the activation of local GABAergic interneurons. This inhibition is greatly diminished during heightened emotional states due to dopamine release. However, dopamine excites most amygdala interneurons, suggesting that this dopaminergic gate may be mediated by an unknown subpopulation of interneurons. We hypothesized that this gate is mediated by paracapsular intercalated cells, a subset of interneurons that are innervated by both cortical and mesolimbic dopaminergic afferents. Using transgenic mice that express GFP in GABAergic interneurons, we show that paracapsular cells form a network surrounding the basolateral complex of the amygdala. We found that they provide feedforward inhibition into the basolateral and the central amygdala. Dopamine hyperpolarized paracapsular cells through D1 receptors and substantially suppressed their excitability, resulting in a disinhibition of the basolateral and central nuclei. Suppression of the paracapsular system by dopamine provides a compelling neural mechanism for the increased affective behavior observed during stress or other hyperdopaminergic states.	Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Japan; RIKEN, Brain Sci Inst, Neuronal Circuit Mechanisms Res Grp, Wako, Saitama 35101, Japan	University of Zurich; Gunma University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN	Vogt, KE (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	kvogt@pharma.unizh.ch		Vogt, Kaspar/0000-0002-0859-876X				Alheid George F., 1995, P495; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Asan E, 1998, Adv Anat Embryol Cell Biol, V142, P1; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Borowski TB, 1998, BEHAV NEUROSCI, V112, P952, DOI 10.1037/0735-7044.112.4.952; Collins DR, 1999, EUR J NEUROSCI, V11, P3441, DOI 10.1046/j.1460-9568.1999.00763.x; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; de la Mora MP, 2005, NEUROSCI LETT, V377, P101, DOI 10.1016/j.neulet.2004.11.079; Freedman LJ, 2000, J COMP NEUROL, V421, P172; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Inoue T, 2000, PHARMACOL BIOCHEM BE, V66, P573, DOI 10.1016/S0091-3057(00)00254-9; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; KRONER S, 2004, J NEUROPHYSIOL, V843, P1; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEGALLASALLE G, 1978, BRAIN RES, V155, P397, DOI 10.1016/0006-8993(78)91037-5; Leonard SK, 2003, SYNAPSE, V50, P320, DOI 10.1002/syn.10272; Loretan K, 2004, NEUROPHARMACOLOGY, V47, P631, DOI 10.1016/j.neuropharm.2004.07.015; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; Meloni EG, 1999, PSYCHOPHARMACOLOGY, V144, P373, DOI 10.1007/s002130051020; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Nicola SM, 1996, J NEUROSCI, V16, P1591; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2000, J NEUROSCI, V20, P9034; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Smith Y, 2000, J COMP NEUROL, V416, P496; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taylor SF, 2002, SCHIZOPHR RES, V58, P159, DOI 10.1016/S0920-9964(01)00403-0; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Yokoyama M, 2005, NEUROSCI LETT, V379, P37, DOI 10.1016/j.neulet.2004.12.047; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	60	231	242	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1025	1037		10.1016/j.neuron.2005.10.029	http://dx.doi.org/10.1016/j.neuron.2005.10.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364905	Bronze			2022-12-24	WOS:000234301700017
J	Bielsky, IF; Hu, SB; Ren, XH; Terwilliger, EF; Young, LJ				Bielsky, IF; Hu, SB; Ren, XH; Terwilliger, EF; Young, LJ			The V1a vasopressin receptor is necessary and sufficient for normal social recognition: A gene replacement study	NEURON			English	Article							ANXIETY-RELATED BEHAVIOR; LATERAL SEPTAL VASOPRESSIN; PAIR-BOND FORMATION; AGGRESSIVE-BEHAVIOR; PATERNAL BEHAVIOR; RAT-BRAIN; OXYTOCIN; MEMORY; BINDING; ANTAGONIST	Vasopressin modulates many social and nonsocial behaviors, including emotionality. We have previously reported that male mice with a null mutation in the V1a receptor (V1aR) exhibit a profound impairment in social recognition and changes in anxiety-like behavior. Using site-specific injections of a V1aR-specific antagonist, we demonstrate that the lateral septum, but not the medial amygdala, is critical for social recognition. Reexpressing V1aR in the lateral septum of V1aR knockout mice (V1aRKO) using a viral vector resulted in a complete rescue of social recognition. Furthermore, overexpression of the V1aR in the lateral septum of wild-type (wt) mice resulted in a potentiation of social recognition behavior and a mild increase in anxiety-related behavior. These results demonstrate that the V1aR in the lateral septum plays a critical role in the neural processing of social stimuli required for complex social behavior.	Emory Univ, Dept Psychiat, Atlanta, GA 30329 USA; Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30329 USA; NIMH, Clin Neuroendocrinol Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Inst Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Bielsky, IF (corresponding author), Emory Univ, Dept Psychiat, Atlanta, GA 30329 USA.	alanwithisa@yahoo.com	Young, Larry/HGE-5031-2022		NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056538, K02MH064692, F31MH070112, R29MH056897, R01MH056897] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00165] Funding Source: Medline; NIMH NIH HHS [MH64692, MH070112, MH056538, MH56897] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 2003, NEUROPSYCHOLOGIA, V41, P516, DOI 10.1016/S0028-3932(03)00004-6; Appenrodt E, 1998, PHYSIOL BEHAV, V64, P543, DOI 10.1016/S0031-9384(98)00119-X; Bamshad M, 1996, J COMP NEUROL, V369, P252; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; Boccia MM, 1998, NEUROBIOL LEARN MEM, V69, P136, DOI 10.1006/nlme.1997.3817; Chu J, 1998, HORM BEHAV, V34, P248, DOI 10.1006/hbeh.1998.1479; CLARKE A, 1982, PHARMACOL BIOCHEM BE, V17, P623, DOI 10.1016/0091-3057(82)90334-3; Daenen EWPM, 2002, BEHAV BRAIN RES, V136, P571, DOI 10.1016/S0166-4328(02)00223-1; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; DANTZER R, 1988, BRAIN RES, V457, P143, DOI 10.1016/0006-8993(88)90066-2; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Engelmann M, 1996, NEUROSCI BIOBEHAV R, V20, P341, DOI 10.1016/0149-7634(95)00059-3; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Everts HGJ, 1997, BRAIN RES, V760, P1, DOI 10.1016/S0006-8993(97)00269-2; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FERRIS CF, 1984, SCIENCE, V224, P521, DOI 10.1126/science.6538700; FERRIS CF, 1986, PHYSIOL BEHAV, V38, P135, DOI 10.1016/0031-9384(86)90143-5; Goodson JL, 1999, J NEUROENDOCRINOL, V11, P19; GREIDANUS TBV, 1983, PHARMACOL THERAPEUT, V20, P437; Greidanus TBV, 1996, BRAIN RES, V713, P153, DOI 10.1016/0006-8993(95)01505-1; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Lai WS, 2002, PHYSIOL BEHAV, V76, P225, DOI 10.1016/S0031-9384(02)00721-7; Landgraf R, 1998, PROG BRAIN RES, V119, P201; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; LEMOAL M, 1987, NEUROSCI LETT, V77, P353, DOI 10.1016/0304-3940(87)90527-1; Liebsch G, 1996, NEUROSCI LETT, V217, P101, DOI 10.1016/0304-3940(96)13069-X; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Nair HP, 2002, METHODS, V28, P195, DOI 10.1016/S1046-2023(02)00223-2; Packard MG, 2004, NEUROBIOL LEARN MEM, V82, P243, DOI 10.1016/j.nlm.2004.06.008; Parker KJ, 2001, HORM BEHAV, V39, P285, DOI 10.1006/hbeh.2001.1655; Parker KJ, 2001, BEHAV NEUROSCI, V115, P1341, DOI 10.1037/0735-7044.115.6.1341; Peel AL, 1997, GENE THER, V4, P16, DOI 10.1038/sj.gt.3300358; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Sheehan Teige, 2000, P175; Stemmelin J, 2005, NEUROPSYCHOPHARMACOL, V30, P35, DOI 10.1038/sj.npp.1300562; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wotjak CT, 1996, J NEUROSCI, V16, P7725; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599	60	275	284	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					503	513		10.1016/j.neuron.2005.06.031	http://dx.doi.org/10.1016/j.neuron.2005.06.031			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102534	Bronze			2022-12-24	WOS:000231411100008
J	Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B				Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B			Activation of p75(NTR) by proBDNF facilitates hippocampal long-term depression	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); ACTIVITY-DEPENDENT SECRETION; NERVE GROWTH-FACTOR; RAT DENTATE GYRUS; SIGNAL-TRANSDUCTION; SYNAPTIC PLASTICITY; AREA CA1; BDNF; MICE; NEURONS	Pro- and mature brain-derived neurotrophic factor (BDNF) activate two distinct receptors: p75 neurotrophin receptor (p75(NTR)) and TrkB. Mature BDNF facilitates hippocampal synaptic potentiation through TrkB. Here we report that proBDNF, by activating p75(NTR), facilitates hippocampal long-term depression (LTD). Electron microscopy showed that p75(NTR) localized in dendritic spines, in addition to afferent terminals, of CA1 neurons. Deletion of p75(NTR) in mice selectively impaired the NMDA receptor - dependent LTD, without affecting other forms of synaptic plasticity. p75(NTR-/-) mice also showed a decrease in the expression of NR2B, an NMDA receptor subunit uniquely involved in LTD. Activation of p75(NTR) by proBDNF enhanced NR2B-dependent LTD and NR2B-mediated synaptic currents. These results show a crucial role for proBDNF-p75(NTR) signaling in LTD and its potential mechanism, and together with the finding that mature BDNF promotes synaptic potentiation, suggest a bidirectional regulation of synaptic plasticity by proBDNF and mature BDNF.	NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; Cornell Univ, Weill Med coll, Dept Med, Div Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med coll, Dept Neurol & Neurosci, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; Cornell University	Lu, B (corresponding author), NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, 35 Lincoln Dr, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18974] Funding Source: Medline; NINDS NIH HHS [NS30658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; Dougherty KD, 1999, J NEUROSCI, V19, P10140; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Ikegaya Y, 2002, EUR J NEUROSCI, V16, P145, DOI 10.1046/j.1460-9568.2002.02051.x; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; LU B, IN PRESS NAT REV NEU; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peters A., 1991, FINE STRUCTURE NERVO; Peters I, 2001, WORLD LITERATURE TOD, V75, P404, DOI 10.2307/40156724; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Wright JW, 2004, BEHAV BRAIN RES, V153, P453, DOI 10.1016/j.bbr.2004.01.001; YAN Q, 1988, J NEUROSCI, V8, P3481	50	595	620	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1069	1077		10.1038/nn1510	http://dx.doi.org/10.1038/nn1510			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025106				2022-12-24	WOS:000230760200019
J	Yuan, Q; Lin, FJ; Zheng, XZ; Sehgal, A				Yuan, Q; Lin, FJ; Zheng, XZ; Sehgal, A			Serotonin modulates circadian entrainment in Drosophila	NEURON			English	Article							SUPRACHIASMATIC NUCLEUS; EXPRESSION PATTERNS; BEHAVIORAL RHYTHMS; LIGHT RESPONSE; CLOCK; PROTEIN; MELANOGASTER; NEURONS; TIMELESS; PERIOD	Entrainment of the Drosophila circadian clock to light involves the light-induced degradation of the clock protein timeless (TIM). We show here that this entrainment mechanism is inhibited by serotonin, acting through the Drosophila serotonin receptor 1B (d5-HT1B). d5-HT1B is expressed in clock neurons, and alterations of its levels affect molecular and behavioral responses of the clock to light. Effects of d5-HT1B are synergistic with a mutation in the circadian photoreceptor cryptochrome (CRY) and are mediated by SHAGGY (SGG), Drosophila glycogen synthase kinase 3 beta (GSK3 beta), which phosphorylates TIM. Levels of serotonin are decreased in flies maintained in extended constant darkness, suggesting that modulation of the clock by serotonin may vary under different environmental conditions. These data identify a molecular connection between serotonin signaling and the central clock component TIM and suggest a homeostatic mechanism for the regulation of circadian photosensitivity in Drosophila.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu	Yuan, Quan/E-7688-2013					Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Albert PR, 2001, TRENDS ENDOCRIN MET, V12, P453, DOI 10.1016/S1043-2760(01)00498-2; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; Boutrel B, 2002, J NEUROSCI, V22, P4686, DOI 10.1523/JNEUROSCI.22-11-04686.2002; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Cymborowski B, 1998, PHYSIOL ENTOMOL, V23, P25, DOI 10.1046/j.1365-3032.1998.2310025.x; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dudley TE, 1998, J NEUROSCI, V18, P5045; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Garabette ML, 2000, BRIT J PHARMACOL, V131, P1569, DOI 10.1038/sj.bjp.0703753; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Glass JD, 2003, J NEUROSCI, V23, P7451; Hall JC, 2000, CURR OPIN NEUROBIOL, V10, P456, DOI 10.1016/S0959-4388(00)00117-3; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Meinertzhagen IA, 1999, MICROSC RES TECHNIQ, V45, P96, DOI 10.1002/(SICI)1097-0029(19990415)45:2<96::AID-JEMT4>3.0.CO;2-L; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Nagayama H, 1997, BRAIN RES, V756, P92, DOI 10.1016/S0006-8993(97)00121-2; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Page T.L., 1987, Journal of Biological Rhythms, V2, P23, DOI 10.1177/074873048700200103; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Pickard GE, 1997, BIOL CELL, V89, P513, DOI 10.1016/S0248-4900(98)80007-5; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saifullah ASM, 2002, J EXP BIOL, V205, P1305; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Shafer OT, 2002, J NEUROSCI, V22, P5946; Smart CM, 2001, NEUROSCI LETT, V305, P33, DOI 10.1016/S0304-3940(01)01797-9; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, J NEUROSCI, V17, P676; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; WINFREE AT, 1972, J COMP PHYSIOL, V77, P418, DOI 10.1007/BF00694944; Wulbeck C, 2005, GENETICS, V169, P751, DOI 10.1534/genetics.104.036244; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	54	177	185	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					115	127		10.1016/j.neuron.2005.05.027	http://dx.doi.org/10.1016/j.neuron.2005.05.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996552	Bronze			2022-12-24	WOS:000230464000012
J	Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR				Avillac, M; Deneve, S; Olivier, E; Pouget, A; Duhamel, JR			Reference frames for representing visual and tactile locations in parietal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL INTRAPARIETAL AREA; PRIMATE SUPERIOR COLLICULUS; EYE POSITION; RECEPTIVE-FIELDS; MACAQUE; NEURONS; RESPONSES; GAZE; SPACE; CONNECTIONS	The ventral intraparietal area (VIP) receives converging inputs from visual, somatosensory, auditory and vestibular systems that use diverse reference frames to encode sensory information. A key issue is how VIP combines those inputs together. We mapped the visual and tactile receptive fields of multimodal VIP neurons in macaque monkeys trained to gaze at three different stationary targets. Tactile receptive fields were found to be encoded into a single somatotopic, or head-centered, reference frame, whereas visual receptive fields were widely distributed between eye-to head-centered coordinates. These findings are inconsistent with a remapping of all sensory modalities in a common frame of reference. Instead, they support an alternative model of multisensory integration based on multidirectional sensory predictions (such as predicting the location of a visual stimulus given where it is felt on the skin and vice versa). This approach can also explain related findings in other multimodal areas.	CNRS, Inst Cognit Sci, F-69675 Bron, France; Catholic Univ Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Centre National de la Recherche Scientifique (CNRS); Universite Catholique Louvain; University of Rochester	Duhamel, JR (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	duhamel@isc.cnrs.fr	Duhamel, Jean-René/M-4723-2017	Duhamel, Jean-René/0000-0003-0210-1027; AVILLAC, Marie/0000-0002-1003-8251; Pouget, Alexandre/0000-0003-3054-6365				ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1999, NEUROREPORT, V10, P873, DOI 10.1097/00001756-199903170-00037; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GARDNER EP, 1984, ELECTROEN CLIN NEURO, V58, P537, DOI 10.1016/0013-4694(84)90044-0; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Graziano Michael S. A., 1995, P1021; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Neppi-Modona M, 2004, CURR BIOL, V14, P1174, DOI 10.1016/j.cub.2004.06.047; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	49	324	328	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					941	949		10.1038/nn1480	http://dx.doi.org/10.1038/nn1480			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951810				2022-12-24	WOS:000230137100022
J	Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR				Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR			5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression	NATURE NEUROSCIENCE			English	Article							SEROTONIN TRANSPORTER; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS; ANTERIOR CINGULATE; GLUCOSE-METABOLISM; MOOD DISORDERS; HUMAN BRAIN	Carriers of the short allele of a functional 5' promoter polymorphism of the serotonin transporter gene have increased anxiety-related temperamental traits, increased amygdala reactivity and elevated risk of depression. Here, we used multimodal neuroimaging in a large sample of healthy human subjects to elucidate neural mechanisms underlying this complex genetic association. Morphometrical analyses showed reduced gray matter volume in short-allele carriers in limbic regions critical for processing of negative emotion, particularly perigenual cingulate and amygdala. Functional analysis of those regions during perceptual processing of fearful stimuli demonstrated tight coupling as a feedback circuit implicated in the extinction of negative affect. Short-allele carriers showed relative uncoupling of this circuit. Furthermore, the magnitude of coupling inversely predicted almost 30% of variation in temperamental anxiety. These genotype-related alterations in anatomy and function of an amygdala-cingulate feedback circuit critical for emotion regulation implicate a developmental, systems- level mechanism underlying normal emotional reactivity and genetic susceptibility for depression.	NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Weinberger, DR (corresponding author), NIMH, Genes Cognit & Psychosis Program, NIH, 10 Ctr Dr 4S235, Bethesda, MD 20892 USA.	weinberd@intra.nimh.nih.gov	Hariri, Ahmad/D-5761-2011; Pezawas, Lukas/A-2367-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Pezawas, Lukas/0000-0002-1329-6352; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002734, ZIAMH002716, Z01MH002716, ZIAMH002734, Z01MH002867] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Keightley ML, 2003, NEUROIMAGE, V20, P2031, DOI 10.1016/j.neuroimage.2003.08.022; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Reif A, 2003, BEHAV BRAIN RES, V139, P1, DOI 10.1016/S0166-4328(02)00267-X; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Shirao N, 2005, BRIT J PSYCHIAT, V186, P48, DOI 10.1192/bjp.186.1.48; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wu JC, 2001, NEUROPSYCHOPHARMACOL, V25, pS74, DOI 10.1016/S0893-133X(01)00336-0	50	1477	1514	2	254	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					828	834		10.1038/nn1463	http://dx.doi.org/10.1038/nn1463			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880108				2022-12-24	WOS:000229345300025
J	Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K				Shepherd, GMG; Stepanyants, A; Bureau, I; Chklovskii, D; Svoboda, K			Geometric and functional organization of cortical circuits	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; QUANTITATIVE-ANALYSIS; SOMATOSENSORY CORTEX; LAYER 4; RAT; PLASTICITY; CELLS; CONNECTIVITY; PROJECTION	Can neuronal morphology predict functional synaptic circuits? In the rat barrel cortex, 'barrels' and 'septa' delineate an orderly matrix of cortical columns. Using quantitative laser scanning photostimulation we measured the strength of excitatory projections from layer 4 (L4) and L5A to L2/3 pyramidal cells in barrel- and septum-related columns. From morphological reconstructions of excitatory neurons we computed the geometric circuit predicted by axodendritic overlap. Within most individual projections, functional inputs were predicted by geometry and a single scale factor, the synaptic strength per potential synapse. This factor, however, varied between projections and, in one case, even within a projection, up to 20-fold. Relationships between geometric overlap and synaptic strength thus depend on the laminar and columnar locations of both the pre- and postsynaptic neurons, even for neurons of the same type. A large plasticity potential appears to be incorporated into these circuits, allowing for functional 'tuning' with fixed axonal and dendritic arbor geometry.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Northeastern University; Northeastern University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010; Bureau, Ingrid/O-3941-2016	Bureau, Ingrid/0000-0001-9166-2250	NINDS NIH HHS [K25 NS047138] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS047138] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender KJ, 2003, J NEUROSCI, V23, P8759; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CAJAL SRY, 1891, CELLULE, V7, P125; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRACE AA, 1985, NEUROSCIENCE, V16, P461, DOI 10.1016/0306-4522(85)90018-1; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Ichinohe N, 2003, J NEUROSCI, V23, P1372, DOI 10.1523/JNEUROSCI.23-04-01372.2003; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kim U, 1999, J COMP NEUROL, V408, P489; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; REN JQ, 1992, EXP BRAIN RES, V92, P1; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SHEPHERD GMG, IN PRESS J NEUROSCI; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STAIGER JF, 2004, CEREB CORTEX; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; UTTLEY AM, 1955, PROC R SOC SER B-BIO, V144, P229, DOI 10.1098/rspb.1955.0054; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	182	187	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					782	790		10.1038/nn1447	http://dx.doi.org/10.1038/nn1447			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880111				2022-12-24	WOS:000229345300019
J	Brenowitz, SD; Regehr, WG				Brenowitz, SD; Regehr, WG			Associative short-term synaptic plasticity mediated by endocannabinoids	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; ENDOGENOUS CANNABINOIDS; RETROGRADE INHIBITION; DENDRITIC SPINES; CALCIUM-RELEASE; SYNAPSES; ACTIVATION; NEURONS; BRAIN	Associative learning is important on rapid timescales, but no suitable form of short-term plasticity has been identified that is both associative and synapse specific. Here, we assess whether endocannabinoids can mediate such plasticity. In the cerebellum, bursts of parallel fiber (PF) activity evoke endocannabinoid release from Purkinje cell dendrites that results in retrograde synaptic inhibition lasting seconds. We find that the powerful climbing fiber (CF) to Purkinje cell synapse regulates this inhibition. Compared to PF stimulation alone, coactivation of PF and CF synapses greatly enhanced endocannabinoid-mediated inhibition of PF synapses. Retrograde inhibition was restricted to PFs activated within several hundred milliseconds of CF activation. This associative plasticity reflects two aspects of calcium-dependent endocannabinoid release. First, PF-mediated activation of metabotropic glutamate receptors locally reduced the dendritic calcium levels required for endocannabinoid release. Second, CF and PF coactivation evoked localized supralinear dendritic calcium signals. Thus, endocannabinoids mediate transient associative synaptic plasticity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wregehr@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044396, F32NS046842] Funding Source: NIH RePORTER; NINDS NIH HHS [NS046842, NS044396] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Alger BE, 2002, PROG NEUROBIOL, V68, P247; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glanz SA, 2002, PRIMER BIOSTATISTICS; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; KAWATO M, 1992, BIOL CYBERN, V68, P95, DOI 10.1007/BF00201431; Kettner RE, 2002, ANN NY ACAD SCI, V978, P455, DOI 10.1111/j.1749-6632.2002.tb07587.x; Kettner RE, 1997, J NEUROPHYSIOL, V77, P2115, DOI 10.1152/jn.1997.77.4.2115; Kim J, 2002, J NEUROSCI, V22, P10182; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Sandberg A, 2003, NETWORK-COMP NEURAL, V14, P789, DOI 10.1088/0954-898X/14/4/309; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Widrow B., 1985, ADAPTIVE SIGNAL PROC; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	57	119	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					419	431		10.1016/j.neuron.2004.12.045	http://dx.doi.org/10.1016/j.neuron.2004.12.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694328	Bronze			2022-12-24	WOS:000226787700014
J	Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E				Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E			Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation	NEURON			English	Article							SYNAPTIC PLASTICITY; BRAIN ACTIVITY; CA1 REGION; ACETYLCHOLINE-RELEASE; PROTEIN-SYNTHESIS; NEURONAL-ACTIVITY; SPATIAL MEMORY; NOVELTY; POTENTIATION; ANTICIPATION	Long-term potentiation in the hippocampus can be enhanced and prolonged by dopaminergic inputs from midbrain structures such as the substantia nigra. This improved synaptic plasticity is hypothesized to be associated with better memory consolidation in the hippocampus. We used a condition that reliably elicits a dopaminergic response, reward anticipation, to study the relationship between activity of dopaminergic midbrain areas and hippocampal long-term memory in healthy adults. Pictures of object drawings that predicted monetary reward were associated with stronger fMRI activity in reward-related brain areas, including the substantia nigra, compared with non-reward-predicting pictures. Three weeks later, recollection and source memory were better for reward-predicting than for non-reward-predicting pictures. FMRI activity in the hippocampus and the midbrain was higher for reward-predicting pictures that were later recognized compared with later forgotten Pictures. These data are consistent with the hypothesis that activation of dopaminergic midbrain regions enhances hippocampus-dependent memory formation, possibly by enhancing consolidation.	Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Ctr Adv Imaging, D-39120 Magdeburg, Germany; Leibniz Neurobiol, D-39118 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Duzel, E (corresponding author), Otto Von Guericke Univ, Dept Neurol 2, Leipziger Str 44, D-39120 Magdeburg, Germany.	emrah.duezel@medizin.uni-magdeburg.de	Schott, Björn H/U-5626-2017; Duzel, Emrah/A-1794-2010; Schott, Björn H/B-9369-2012; Wittmann, Bianca/C-1931-2008	Schott, Björn H/0000-0002-8237-4481; Wittmann, Bianca/0000-0002-2583-3311; Duzel, Emrah/0000-0002-0139-5388				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Backman L, 2000, AM J PSYCHIAT, V157, P635; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Canli T, 2000, J NEUROSCI, V20; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Holscher C, 2003, BEHAV BRAIN RES, V142, P181, DOI 10.1016/S0166-4328(02)00422-9; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kemppainen N, 2003, EUR J NEUROSCI, V18, P149, DOI 10.1046/j.1460-9568.2003.02716.x; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schroder N, 2003, SYNAPSE, V49, P89, DOI 10.1002/syn.10210; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Straube T, 2003, NEUROSCI LETT, V344, P5, DOI 10.1016/S0304-3940(03)00349-5; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Talairach J., 1988, COPLANAR STEREOTAXIC; Tracey I, 2001, J CLIN PHARMACOL, p21S; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Umegaki H, 2001, NEUROSCIENCE, V103, P27, DOI 10.1016/S0306-4522(00)00542-X; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wan HM, 1999, J NEUROSCI, V19, P1142; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	56	482	488	4	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					459	467		10.1016/j.neuron.2005.01.010	http://dx.doi.org/10.1016/j.neuron.2005.01.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694331	Bronze			2022-12-24	WOS:000226787700017
J	Yoshida, W; Ishii, S				Yoshida, Wako; Ishii, Shin			Resolution of uncertainty in prefrontal cortex	NEURON			English	Article							ANTERIOR CINGULATE; BASAL GANGLIA; INFORMATION; SELECTION; CONFLICT; SYSTEMS	Making optimal decisions in the face of uncertain or incomplete information arises as a common problem in everyday behavior, but the neural processes underlying this ability remain poorly understood. A typical case is navigation, in which a subject has to search for a known goal from an unknown location. Navigating under uncertain conditions requires making decisions on the basis of the current belief about location and updating that belief based on incoming information. Here, we use functional magnetic resonance imaging during a maze navigation task to study neural activity relating to the resolution of uncertainty as subjects make sequential decisions to reach a goal. We show that distinct regions of prefrontal cortex are engaged in specific computational functions that are well described by a Bayesian model of decision making. This permits efficient goal-oriented navigation and provides new insights into decision making by humans.	Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Ishii, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, 8916-5 Takayama, Nara 6300192, Japan.	ishii@is.naist.jp		Ishii, Shin/0000-0001-9385-8230				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ASTROM KJ, 1965, J MATH ANAL APPL, V10, P174, DOI 10.1016/0022-247X(65)90154-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MacDonald I.L., 1997, HIDDEN MARKOV OTHER; MacKay D. J. C., 2003, INFORM THEORY INFERE; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; STANKIEWICZ BJ, 2006, IN PRESS J EXP PSYCH; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	34	145	146	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					781	789		10.1016/j.neuron.2006.05.006	http://dx.doi.org/10.1016/j.neuron.2006.05.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731515	Bronze			2022-12-24	WOS:000238165000012
J	Nassi, JJ; Lyon, DC; Callaway, EM				Nassi, JJ; Lyon, DC; Callaway, EM			The parvocellular LGN provides a robust disynaptic input to the visual motion area MT	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; MACAQUE STRIATE CORTEX; CENTRAL-NERVOUS-SYSTEM; TRANSNEURONAL TRACER; SUPERIOR COLLICULUS; RESPONSE PROPERTIES; MEYNERT CELLS; RABIES VIRUS; MONKEY; ORGANIZATION	Dorsal visual cortical areas are thought to be dominated by input from the magnocellular (M) visual pathway, with little or no parvocellular (P) contribution. These relationships are supported by a close correlation between the functional properties of these areas and the M pathway and by a lack of anatomical evidence for P input. Here we use rabies virus as a retrograde transynaptic tracer to show that the dorsal area MT receives strong input, via a single relay, from both M and P cells of the lateral geniculate nucleus. This surprising P input, likely relayed via layer 6 Meynert cells in primary visual cortex, can provide MT with sensitivity to a more complete range of spatial, temporal, and chromatic cues than the M pathway alone. These observations provide definitive evidence for P pathway input to MT and show that convergence of parallel visual pathways occurs in the dorsal stream.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Lyon, David C./0000-0002-4367-5636; Nassi, Jonathan/0000-0002-3144-3846	NEI NIH HHS [R01 EY010742] Funding Source: Medline; NIA NIH HHS [T32 AG000216] Funding Source: Medline; NIMH NIH HHS [T32 MH020002] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; ANDERSON SJ, 1995, P ROY SOC B-BIOL SCI, V261, P129, DOI 10.1098/rspb.1995.0127; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BULLIER J, 1983, EXP BRAIN RES, V53, P168; BURKHALTER A, 1986, VISION RES, V26, P63, DOI 10.1016/0042-6989(86)90071-4; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CASAGRANDE VA, 1994, CEREB CORTEX, P201; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Erwin E, 1999, J COMP NEUROL, V407, P92; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; FRIES W, 1985, EXP BRAIN RES, V58, P613; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; JONES EG, 1989, EUR J NEUROSCI, V1, P222, DOI 10.1111/j.1460-9568.1989.tb00791.x; Kaas J.H., 1988, P327; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kelly RM, 2003, J NEUROSCI, V23, P8432; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Lyon DC, 2002, NEURON, V33, P453, DOI 10.1016/S0896-6273(02)00580-9; LYSAKOWSKI A, 1988, EXP BRAIN RES, V69, P651; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MALPELI JG, 1981, J NEUROPHYSIOL, V46, P1102, DOI 10.1152/jn.1981.46.5.1102; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; Movshon JA, 1996, J NEUROSCI, V16, P7733; Saul AB, 2005, J NEUROPHYSIOL, V94, P282, DOI 10.1152/jn.00868.2004; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sincich LC, 2003, J NEUROSCI, V23, P5684; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; TOOTELL RBH, 1985, J NEUROSCI, V5, P2786; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WELLER RE, 1983, J COMP NEUROL, V220, P253, DOI 10.1002/cne.902200302; WINFIELD DA, 1983, PROC R SOC SER B-BIO, V217, P129, DOI 10.1098/rspb.1983.0002; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	48	99	103	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					319	327		10.1016/j.neuron.2006.03.019	http://dx.doi.org/10.1016/j.neuron.2006.03.019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630841	Green Accepted, Bronze			2022-12-24	WOS:000237176700017
J	Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I				Ramirez-Castillejo, C; Sanchez-Sanchez, F; Andreu-Agullo, C; Ferron, SR; Aroca-Aguilar, JD; Sanchez, P; Mira, H; Escribano, J; Farinas, I			Pigment epithelium-derived factor is a niche signal for neural stem cell renewal	NATURE NEUROSCIENCE			English	Article							ADULT MAMMALIAN BRAIN; IN-VIVO; GROWTH-FACTOR; FACTOR PEDF; STIMULATES NEUROGENESIS; NEUROTROPHIC ACTIVITY; ENDOTHELIAL-CELLS; SELF-RENEWAL; MOUSE BRAIN; NEURONS	Adult stem cells are characterized by self-renewal and multilineage differentiation, and these properties seem to be regulated by signals from adjacent differentiated cell types and by extracellular matrix molecules, which collectively define the stem cell "niche.'' Self-renewal is essential for the lifelong persistence of stem cells, but its regulation is poorly understood. In the mammalian brain, neurogenesis persists in two germinal areas, the subventricular zone (SVZ) and the hippocampus, where continuous postnatal neuronal production seems to be supported by neural stem cells (NSCs). Here we show that pigment epithelium-derived factor (PEDF) is secreted by components of the murine SVZ and promotes self-renewal of adult NSCs in vitro. In addition, intraventricular PEDF infusion activated slowly dividing stem cells, whereas a blockade of endogenous PEDF decreased their cycling. These data demonstrate that PEDF is a niche-derived regulator of adult NSCs and provide evidence for a role for PEDF protein in NSC maintenance.	Univ Castilla La Mancha, Fac Med, Area Genet, Albacete 02006, Spain; Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Valencia, Dept Cellular Biol, E-46100 Burjassot, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Valencia	Farinas, I (corresponding author), Univ Valencia, Fac Med, Oncol Mol Lab, E-46100 Burjassot, Spain.	isabel.farinas@uv.es	Ferrón, Sacri R./I-2958-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Escribano, Julio/D-9742-2015; Aroca-Aguilar, J.Daniel/B-7842-2008; Ramirez-Castillejo, Carmen/S-7276-2019; Sánchez-Gómez, Pilar/K-8256-2014; Farinas, Isabel/L-7118-2014	Ferrón, Sacri R./0000-0003-0854-8575; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Mira, Helena/0000-0001-8574-9544; Farinas, Isabel/0000-0003-2903-4960				Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Aparicio S, 2005, BIOCHEM BIOPH RES CO, V326, P387, DOI 10.1016/j.bbrc.2004.11.041; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Craig CG, 1996, J NEUROSCI, V16, P2649; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pignolo RJ, 2003, J CELL PHYSIOL, V195, P12, DOI 10.1002/jcp.10212; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	46	350	382	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					331	339		10.1038/nn1657	http://dx.doi.org/10.1038/nn1657			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491078				2022-12-24	WOS:000235645600012
J	Schulz, DJ; Goaillard, JM; Marder, E				Schulz, DJ; Goaillard, JM; Marder, E			Variable channel expression in identified single and electrically coupled neurons in different animals	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; STOMATOGASTRIC GANGLION; POTASSIUM CURRENTS; SHAL GENE; I-A; NETWORK; CRAB; CONDUCTANCES; MODULATION	It is often assumed that all neurons of the same cell type have identical intrinsic properties, both within an animal and between animals. We exploited the large size and small number of unambiguously identifiable neurons in the crab stomatogastric ganglion to test this assumption at the level of channel mRNA expression and membrane currents (measured in voltage-clamp experiments). In lateral pyloric (LP) neurons, we saw strong correlations between measured current and the abundance of Shal and BK-KCa mRNAs (encoding the Shal-family voltage-gated potassium channel and large-conductance calcium-activated potassium channel, respectively). We also saw two- to fourfold interanimal variability for three potassium currents and their mRNA expression. Measurements of channel expression in the two electrically coupled pyloric dilator (PD) neurons showed significant interanimal variability, but copy numbers for IH (encoding the hyperpolarization-activated, inward-current channel) and Shal mRNA in the two PD neurons from the same crab were similar, suggesting that the regulation of some currents may be shared in electrically coupled neurons.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Schulz, DJ (corresponding author), Univ Missouri, Columbia, MO 65211 USA.	SchulzD@missouri.edu		Schulz, David/0000-0003-4532-5362	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH070292, R37MH046742, R01MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS017813, R01NS017813] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH070292, MH70292, MH46742] Funding Source: Medline; NINDS NIH HHS [NS17813, R01 NS017813] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Baro DJ, 1998, ANN NY ACAD SCI, V860, P281, DOI 10.1111/j.1749-6632.1998.tb09056.x; Baro DJ, 1997, J NEUROSCI, V17, P6597; Baro DJ, 2001, NEUROSCIENCE, V106, P419, DOI 10.1016/S0306-4522(01)00261-5; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P193; Baro DJ, 1996, J NEUROSCI, V16, P1689; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P350; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Cristobal R, 2005, MOL BRAIN RES, V133, P19, DOI 10.1016/j.molbrainres.2004.10.001; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; French LB, 2004, NEUROSCIENCE, V123, P919, DOI 10.1016/j.neuroscience.2003.08.036; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HOOPER SL, 1986, J COMP PHYSIOL A, V159, P227, DOI 10.1007/BF00612305; Kamme F, 2003, J NEUROSCI, V23, P3607; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu Z, 1998, J NEUROSCI, V18, P2309; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Luther JA, 2003, J NEUROPHYSIOL, V90, P2720, DOI 10.1152/jn.00370.2003; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rozen S, 2000, Methods Mol Biol, V132, P365; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Tietjen I, 2005, INT J DEV BIOL, V49, P201, DOI 10.1387/ijdb.041939it; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	44	299	302	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					356	362		10.1038/nn1639	http://dx.doi.org/10.1038/nn1639			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16444270				2022-12-24	WOS:000235645600015
J	Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ				Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ			Dendritic patterning by Dscam and synaptic partner matching in the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							OLFACTORY PROJECTION NEURONS; ODORANT RECEPTORS; AXON GUIDANCE; WIRING SPECIFICITY; SENSORY MAP; FLY BRAIN; REPRESENTATION; CONNECTIONS; EXPRESSION; GLOMERULI	In the olfactory system of Drosophila melanogaster, axons of olfactory receptor neurons (ORNs) and dendrites of second-order projection neurons typically target 1 of similar to 50 glomeruli. Dscam, an immunoglobulin superfamily protein, acts in ORNs to regulate axon targeting. Here we show that Dscam acts in projection neurons and local interneurons to control the elaboration of dendritic fields. The removal of Dscam selectively from projection neurons or local interneurons led to clumped dendrites and marked reduction in their dendritic field size. Overexpression of Dscam in projection neurons caused dendrites to be more diffuse during development and shifted their relative position in adulthood. Notably, the positional shift of projection neuron dendrites caused a corresponding shift of its partner ORN axons, thus maintaining the connection specificity. This observation provides evidence for a pre- and postsynaptic matching mechanism independent of precise glomerular positioning.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lzipursky@mednet.ucla.edu; lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Zipursky, Stephen/0000-0001-5630-7181	NIDCD NIH HHS [R01-DC005982, R01-DC006485] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485, R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; COUTO A, 2005, CURR BIOL; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	34	124	127	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					349	355		10.1038/nn1652	http://dx.doi.org/10.1038/nn1652			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474389				2022-12-24	WOS:000235645600014
J	Vida, I; Bartos, M; Jonas, P				Vida, I; Bartos, M; Jonas, P			Shunting inhibition improves robustness of gamma oscillations in hippocampal interneuron networks by homogenizing firing rates	NEURON			English	Article							IN-VITRO; SYNAPTIC INHIBITION; EXCITATORY ACTIONS; BEHAVING RAT; K+ CHANNELS; SYNAPSES; NEURONS; GABA; FREQUENCY; VIVO	Networks of GABAergic neurons are key elements in the generation of gamma oscillations in the brain. Computational studies suggested that the emergence of coherent oscillations requires hyperpolarizing inhibition. Here, we show that GABA(A) receptor-mediated inhibition in mature interneurons of the hippocampal dentate gyrus is shunting rather than hyperpolarizing. Unexpectedly, when shunting inhibition is incorporated into a structured interneuron network model with fast and strong synapses, coherent oscillations emerge. In comparison to hyperpolarizing inhibition, networks with shunting inhibition show several advantages. First, oscillations are generated with smaller tonic excitatory drive. Second, network frequencies are tuned to the gamma band. Finally, robustness against heterogeneity in the excitatory drive is markedly improved. In single interneurons, shunting inhibition shortens the interspike interval for low levels of drive but prolongs it for high levels, leading to homogenization of neuronal firing rates. Thus, shunting inhibition may confer increased robustness to gamma oscillations in the brain.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Freiburg, Inst Anat, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de	Vida, Imre/F-8275-2012	Vida, Imre/0000-0003-3214-2233; Jonas, Peter/0000-0001-5001-4804; Bartos, Marlene/0000-0001-9741-1946				ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bazhenov M, 1999, NAT NEUROSCI, V2, P168, DOI 10.1038/5729; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chavas J, 2003, J NEUROSCI, V23, P2019; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; ERMENTROUT GB, 1990, SIAM J APPL MATH, V50, P125, DOI 10.1137/0150009; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lamsa K, 2003, J NEUROPHYSIOL, V90, P1983, DOI 10.1152/jn.00060.2003; Lien CC, 2003, J NEUROSCI, V23, P2058; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maex R, 2003, J NEUROSCI, V23, P10503; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Meyer AH, 2002, J NEUROSCI, V22, P7055; NEITNER L, 2000, NEURAL COMPUT, V12, P1607; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SIK A, 1995, J NEUROSCI, V15, P6651; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; Stiefel KM, 2005, J COMPUT NEUROSCI, V19, P71, DOI 10.1007/s10827-005-0188-3; Tiesinga PHE, 2000, NETWORK-COMP NEURAL, V11, P1, DOI 10.1088/0954-898X/11/1/301; Towers SK, 2002, J NEUROPHYSIOL, V87, P1165, DOI 10.1152/jn.00495.2001; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Traub RD, 1999, FAST OSCILLATIONS CO; van Hooft JA, 2000, J NEUROSCI, V20, P3544, DOI 10.1523/JNEUROSCI.20-10-03544.2000; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	61	247	253	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					107	117		10.1016/j.neuron.2005.11.036	http://dx.doi.org/10.1016/j.neuron.2005.11.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387643	Green Submitted, Bronze			2022-12-24	WOS:000236699300013
J	Hiramoto, M; Hiromi, Y				Hiramoto, M; Hiromi, Y			ROBO directs axon crossing of segmental boundaries by suppressing responsiveness to relocalized Netrin	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; DROSOPHILA DERAILED RECEPTOR; CNS MIDLINE; GENETIC-ANALYSIS; C-ELEGANS; CAENORHABDITIS-ELEGANS; COMMISSURAL AXONS; MOTOR AXONS; S-LAMININ; PROTEIN	Networks in the CNS consist of neural modules that are connected in a repetitive array. Whereas individual modules contain guidance information along which axons track within the unit, these guidance cues hinder axon extension across module boundaries. We investigated how axons solve this 'boundary problem' by analyzing the longitudinal connections of neuromeres in Drosophila melanogaster. The initial trajectory of the longitudinal axons is guided by Netrin, which is localized on commissural axons by its receptor, Frazzled. The Netrin cue on the commissure of the next segment can act as a barrier to longitudinal axons, inhibiting their extension and misguiding them contralaterally along the commissure. We show that, before reaching the segmental boundary, the longitudinal axons' responsiveness to Netrin presented on the commissure is suppressed by Roundabout (ROBO), through counteracting Gq signaling. The absence of suppression causes the robo phenotype: longitudinal axons project toward the midline, as if running around a roundabout (rotary).	Natl Inst Genet, Dept Dev Genet, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Soc Promot Sci, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Hiramoto, M (corresponding author), Natl Inst Genet, Dept Dev Genet, 1111 Yata, Shizuoka 4118540, Japan.	hiramoto@pb3.so-net.ne.jp; yhiromi@lab.nig.ac.jp						Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURROWS M, 1996, NEUROBIOLOGY INSECT, P12; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GOODMAN CS, 1993, DEV DROSOPHILA MELAN, P1171; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; JESSELL TM, 2000, PRINCIPLES NEURAL SC, P1021; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Saheki Y, 2005, BRAIN RES, V1055, P196, DOI 10.1016/j.brainres.2005.06.056; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	50	22	23	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					58	66		10.1038/nn1612	http://dx.doi.org/10.1038/nn1612			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341212				2022-12-24	WOS:000234288000018
J	Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL				Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL			Axons and dendrites originate from neuroepithelial-like processes of retinal bipolar cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; NEURONAL POLARITY; GANGLION-CELLS; MOUSE RETINA; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CHICK RETINA; LOCALIZATION; MGLUR6; DIFFERENTIATION	The cellular mechanisms underlying axogenesis and dendritogenesis are not completely understood. The axons and dendrites of retinal bipolar cells, which contact their synaptic partners within specific laminae in the inner and outer retina, provide a good system for exploring these issues. Using transgenic mice expressing enhanced green fluorescent protein (GFP) in a subset of bipolar cells, we determined that axonal and dendritic arbors of these interneurons develop directly from apical and basal processes attached to the outer and inner limiting membranes, respectively. Selective stabilization of processes contributed to stratification of axonal and dendritic arbors within the appropriate synaptic layer. This unusual mode of axogenesis and dendritogenesis from neuroepithelial-like processes may act to preserve neighbor-neighbor relationships in synaptic wiring between the outer and inner retina.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Pennsylvania	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wongr@pcg.wustl.edu			NEI NIH HHS [EY11105, EY10699] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010699, R01EY011105] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; CAJAL RY, 1960, STUDIES VERTEBRATE N; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Demas J, 2003, J NEUROSCI, V23, P2851; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kirby MA, 1996, PERSPECT DEV NEUROBI, V3, P177; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; LOHMANN C, 2005, IMAGING NEUROSCIENCE, P159; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10288, 10.1002/glia.10238]; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; QUESADA A, 1985, J MORPHOL, V184, P205, DOI 10.1002/jmor.1051840210; QUESADA A, 1981, ZBL VET MED C, V10, P328, DOI 10.1111/j.1439-0264.1981.tb00697.x; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; SNOW RL, 1994, NEUROSCIENCE, V58, P399, DOI 10.1016/0306-4522(94)90046-9; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Tehrani A, 2000, INVEST OPHTH VIS SCI, V41, P314; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	39	120	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					85	92		10.1038/nn1615	http://dx.doi.org/10.1038/nn1615			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341211				2022-12-24	WOS:000234288000021
J	Lee, HK; Min, SS; Gallagher, M; Kirkwood, A				Lee, HK; Min, SS; Gallagher, M; Kirkwood, A			NMDA receptor-independent long-term depression correlates with successful aging in rats	NATURE NEUROSCIENCE			English	Article							POTENTIATION; INDUCTION; PROTEIN; HIPPOCAMPUS; BRAIN	Some individuals maintain high cognitive functioning at older ages. Here we show that mechanisms for long-term depression differ in aged rodents that maintain cognitive performance compared to young adults. Our results imply that cognitive abilities may be sustained in aged individuals by a switch in synaptic plasticity mechanisms.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Gallagher, M (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	michela@jhu.edu; kirkwood@jhu.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG09973] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Norris CM, 1996, J NEUROSCI, V16, P5382; Reyes-Harde M, 1998, NEUROSCI LETT, V252, P155, DOI 10.1016/S0304-3940(98)00496-0; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845	14	101	102	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1657	1659		10.1038/nn1586	http://dx.doi.org/10.1038/nn1586			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286930				2022-12-24	WOS:000233576200011
J	Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M				Eiraku, M; Tohgo, A; Ono, K; Kaneko, M; Fujishima, K; Hirano, T; Kengaku, M			DNER acts as a neuron-specific Notch ligand during Bergmann glial development	NATURE NEUROSCIENCE			English	Article							MULTIPLE FUNCTIONAL ROLES; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; BRAIN-DEVELOPMENT; PROGENITOR CELLS; RECEPTOR; ACTIVATION; EXPRESSION; MIGRATION	Differentiation of CNS glia is regulated by Notch signaling through neuron-glia interaction. Here, we identified Delta/Notch-like EGF-related receptor (DNER), a neuron-specific transmembrane protein, as a previously unknown ligand of Notch during cellular morphogenesis of Bergmann glia in the mouse cerebellum. DNER binds to Notch1 at cell-cell contacts and activates Notch signaling in vitro. In the developing cerebellum, DNER is highly expressed in Purkinje cell dendrites, which are tightly associated with radial fibers of Bergmann glia expressing Notch. DNER specifically binds to Bergmann glia in culture and induces process extension by activating gamma-secretase- and Deltex-dependent Notch signaling. Inhibition of Deltex-dependent, but not RBP-J-dependent, Notch signaling in Bergmann glia suppresses formation and maturation of radial fibers in organotypic slice cultures. Additionally, deficiency of DNER retards the formation of radial fibers and results in abnormal arrangement of Bergmann glia. Thus, DNER mediates neuron-glia interaction and promotes morphological differentiation of Bergmann glia through Deltex-dependent Notch signaling.	RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama 3510198, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448585, Japan	RIKEN; Kyoto University; Japan Science & Technology Agency (JST); Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kengaku, M (corresponding author), RIKEN Brain Sci Inst, Lab Neural Cell Polar, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kengaku@brain.riken.jp		Eiraku, Mototsugu/0000-0002-9433-9085				ALTMAN J, 1997, DEV CEERBELLAR SYSTE; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; DE SB, 1999, NATURE, V398, P518; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; FISHER M, 1984, P NATL ACAD SCI-BIOL, V81, P4414, DOI 10.1073/pnas.81.14.4414; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawaji K, 2004, MOL CELL NEUROSCI, V25, P228, DOI 10.1016/j.mcn.2003.10.006; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; LORDKIPANIDZE T, 2005, GLIA; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Parks AL, 2000, DEVELOPMENT, V127, P1373; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanaka M, 2003, NEUROSCI LETT, V353, P87, DOI 10.1016/j.neulet.2003.08.080; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	50	170	175	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					873	880		10.1038/nn1492	http://dx.doi.org/10.1038/nn1492			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15965470				2022-12-24	WOS:000230137100014
J	Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S				Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S			G beta gamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							G-PROTEIN MODULATION; BLOCK NEUROTRANSMITTER RELEASE; DEPENDENT CALCIUM CHANNELS; BOTULINUM NEUROTOXIN-A; TRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS; FUSION COMPLEX; GLUTAMATERGIC TRANSMISSION; ANGSTROM RESOLUTION; MEMBRANE-FUSION	Presynaptic inhibition mediated by G protein-coupled receptors may involve a direct interaction between G proteins and the vesicle fusion machinery. The molecular target of this pathway is unknown. We demonstrate that G beta gamma-mediated presynaptic inhibition in lamprey central synapses occurs downstream from voltage-gated Ca2+ channels. Using presynaptic microinjections of botulinum toxins (BoNTs) during paired recordings, we find that cleavage of synaptobrevin in unprimed vesicles leads to an eventual exhaustion of synaptic transmission but does not prevent G beta gamma-mediated inhibition. In contrast, cleavage of the C-terminal nine amino acids of the 25 kDa synaptosome-associated protein (SNAP-25) by BoNT A prevents G beta gamma-mediated inhibition. Moreover, a peptide containing the region of SNAP-25 cleaved by BoNT A blocks the G beta gamma inhibitory effect. Finally, removal of the last nine amino acids of the C-terminus of SNAP-25 weakens G beta gamma interactions with soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes. Thus, the C terminus of SNAP-25, which links synaptotagmin I to the SNARE complex, may represent a target of G beta gamma for presynaptic inhibition.	Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor, Chicago, IL 60607 USA.	heidi.hamm@mcmail.vanderbilt.edu; sta@uic.edu	Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246				AHNERTHILGER G, 1995, PROG NEUROBIOL, V46, P83, DOI 10.1016/0301-0082(95)00003-E; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Blanes-Mira C, 2003, BIOCHEM J, V375, P159, DOI 10.1042/BJ20030509; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BRODIN L, 1994, ADV SEC MESS PHOSPH, V29, P205; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; BRODIN L, 1986, NEUROSCI LETT, V67, P53, DOI 10.1016/0304-3940(86)90207-7; Bruns D, 1997, J NEUROSCI, V17, P1898; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOLPHIN AC, 1993, BIOCHEM SOC T, V21, P391, DOI 10.1042/bst0210391; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOLZ GG, 1989, J NEUROSCI, V9, P657; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; MULKEY RM, 1993, J PHYSIOL-LONDON, V462, P243, DOI 10.1113/jphysiol.1993.sp019553; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; PHILLIPS WJ, 1991, J BIOL CHEM, V266, P11017; Pinxteren JA, 1998, EMBO J, V17, P6210, DOI 10.1093/emboj/17.21.6210; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schibeci R, 1999, J MED ETHICS, V25, P335, DOI 10.1136/jme.25.4.335; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Schwartz EJ, 2005, J NEUROPHYSIOL, V93, P980, DOI 10.1152/jn.00669.2004; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Williamson LC, 1996, J BIOL CHEM, V271, P7694, DOI 10.1074/jbc.271.13.7694; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	50	129	133	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					597	605		10.1038/nn1439	http://dx.doi.org/10.1038/nn1439			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834421				2022-12-24	WOS:000228895100020
J	Gardner, SM; Takamiya, K; Xia, J; Suh, JG; Johnson, R; Yu, S; Huganir, RL				Gardner, SM; Takamiya, K; Xia, J; Suh, JG; Johnson, R; Yu, S; Huganir, RL			Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF	NEURON			English	Article							LONG-TERM DEPRESSION; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; INWARD RECTIFICATION; DEPENDENT REGULATION; GLUTAMATE RECEPTORS; MEMBRANE CURVATURE	A recently described form of synaptic plasticity results in dynamic changes in the calcium permeability of synaptic AMPA receptors. Since the AMPA receptor GluR2 subunit confers calcium permeability, this plasticity is thought to occur through the dynamic exchange of synaptic GluR2-lacking and GluR2-containing receptors. To investigate the molecular mechanisms underlying this calcium-permeable (A) under bar MPA (r) under bar eceptor (p) under bar lasticity (CARP), we examined whether AMPA receptor exchange was mediated by subunit-specific protein-protein interactions. We found that two GluR2-interacting proteins, the PDZ domain-containing Protein interacting with (C) under bar (k) under bar inase (PICK1) and (N) under bar -ethy1maleimide (s) under bar ensitive (f) under bar usion protein (NSF), are specifically required for CARP. Furthermore, PICK1, but not NSF, regulates the formation of extrasynaptic plasma membrane pools of GluR2-containing receptors that may be laterally mobilized into synapses during CARP. These results demonstrate that PICK1 and NSF dynamically regulate the synaptic delivery of GluR2-containing receptors during CARP and thus regulate the calcium permeability of AMPA receptors at excitatory synapses.	Johns Hopkins Univ, Howard Hughes Med Inst, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Dept Neurosci, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Suh, Jun Gyo/U-7198-2019; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Takamiya, Kogo/0000-0001-7240-6307	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043061, R01NS036715] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36715, NS43061, R01 NS036715] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAUDE A, 1994, J NEUROSCI, V14, P2830; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V136, P224, DOI 10.1007/BF00519180; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	58	203	217	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					903	915		10.1016/j.neuron.2005.02.026	http://dx.doi.org/10.1016/j.neuron.2005.02.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797551	Bronze			2022-12-24	WOS:000228031300011
J	Zheng, JJ; Lee, S; Zhou, ZJ				Zheng, JJ; Lee, S; Zhou, ZJ			A developmental switch in the excitability and function of the starburst network in the mammalian retina	NEURON			English	Article							CHOLINERGIC AMACRINE CELLS; SELECTIVE GANGLION-CELLS; DEVELOPING RABBIT RETINA; DIRECTIONAL SELECTIVITY; SYNAPTIC ORGANIZATION; DENDRITIC MORPHOLOGY; SYMPATHETIC NEURONS; TRANSMITTER RELEASE; COTRANSPORTER KCC2; NERVOUS-SYSTEM	Dual patch-clamp recording and Ca2+ uncaging revealed Ca2+-dependent corelease of ACh and GABA from, and the presence of reciprocal nicotinic and GABAergic synapses between, starburst cells in the perinatal rabbit retina. With maturation, the nicotinic synapses between starburst cells dramatically diminished, whereas the GABAergic synapses remained and changed from excitatory to inhibitory, indicating a coordinated conversion of the starburst network excitability from an early hyperexcitatory to a mature nonepileptic state. We show that this transition allows the starburst cells to use their neurotransmitters; for two completely different functions. During early development, the starburst network mediates recurrent excitation and spontaneous retinal waves, which are important for visual system development. After vision begins, starburst cells release GABA in a prolonged and Ca2+-dependent manner and inhibit each other laterally via direct GABAergic synapses, which may be important for visual integration, such as the detection of motion direction.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NEI NIH HHS [EY10894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010894] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Amthor FR, 1996, VISUAL NEUROSCI, V13, P303, DOI 10.1017/S0952523800007549; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; Asmus SE, 2000, J NEUROSCI, V20, P1495; Baldridge WH, 1996, J NEUROSCI, V16, P5060; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRANDON C, 1987, BRAIN RES, V426, P119, DOI 10.1016/0006-8993(87)90431-8; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Chiao CC, 2002, J NEUROSCI, V22, P10509; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Firth SI, 2003, J COMP NEUROL, V466, P80, DOI 10.1002/cne.10880; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Guidry G L, 1998, Adv Pharmacol, V42, P895; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; HUTCHINS JB, 1995, EXP EYE RES, V60, P113, DOI 10.1016/S0014-4835(95)80001-8; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keyser KT, 2000, VISUAL NEUROSCI, V17, P743, DOI 10.1017/S095252380017508X; Kim IB, 2000, J COMP NEUROL, V427, P604, DOI 10.1002/1096-9861(20001127)427:4<604::AID-CNE8>3.0.CO;2-C; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; Macneil MA, 1999, J COMP NEUROL, V413, P305; MARIANI AP, 1988, J COMP NEUROL, V267, P269, DOI 10.1002/cne.902670209; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1210, DOI 10.1152/jn.1976.39.6.1210; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MILLAR TJ, 1987, NEUROSCI LETT, V74, P281, DOI 10.1016/0304-3940(87)90310-7; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sernagor E, 2003, J NEUROSCI, V23, P7621; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Vu TQ, 2000, J NEUROSCI, V20, P1414; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WONG ROL, 1989, J COMP NEUROL, V287, P164, DOI 10.1002/cne.902870203; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	61	111	115	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					851	864		10.1016/j.neuron.2004.11.015	http://dx.doi.org/10.1016/j.neuron.2004.11.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572115	Bronze			2022-12-24	WOS:000225548400012
J	Cottrell, JR; Borok, E; Horvath, TL; Nedivi, E				Cottrell, JR; Borok, E; Horvath, TL; Nedivi, E			CPG2: A brain- and synapse-specific protein that regulates the endocytosis of glutamate receptors	NEURON			English	Article							DENDRITIC SPINES; AMPA; INTERNALIZATION; PLASTICITY; TRANSMISSION; EXPRESSION; SYNAPTOJANIN; CYTOSKELETON; ENDOPHILIN; MECHANISMS	Long-term maintenance and modification of synaptic strength involve the turnover of neurotransmitter receptors. Glutamate receptors are constitutively and acutely internalized, presumptively through clathrin-mediated receptor endocytosis. Here, we show that cpg2 is a brain-specific splice variant of the syne-1 gene that encodes a protein specifically localized to a postsynaptic endocytotic zone of excitatory synapses. RNAi-mediated CPG2 knockdown increases the number of postsynaptic clathrin-coated vesicles, some of which traffic NMDA receptors, disrupts the constitutive internalization of glutamate receptors, and inhibits the activity-induced internalization of synaptic AMPA receptors. Manipulating CPG2 levels also affects dendritic spine size, further supporting a function in regulating membrane transport. Our results suggest that CPG2 is a key component of a specialized postsynaptic endocytic mechanism devoted to the internalization of synaptic proteins, including glutamate receptors. The activity dependence and distribution of cpg2 expression further suggest that it contributes to the capacity for postsynaptic plasticity inherent to excitatory synapses.	MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University; Yale University	Nedivi, E (corresponding author), MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021		NEI NIH HHS [R01 EY011894-08, R01 EY011894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011894] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lee WCA, 2002, J NEUROSCI, V22, P1807, DOI 10.1523/JNEUROSCI.22-05-01807.2002; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	85	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					677	690		10.1016/j.neuron.2004.10.025	http://dx.doi.org/10.1016/j.neuron.2004.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541315	Green Accepted, Bronze			2022-12-24	WOS:000225338100013
J	Salehi, A; Delcroix, JD; Belichenko, PV; Zhan, K; Wu, CB; Valletta, JS; Takimoto-Kimura, R; Kleschevnikov, AM; Sambamurti, K; Chung, PP; Xia, WM; Villar, A; Campbell, WA; Kulnane, LS; Nixon, RA; Lamb, BT; Epstein, CJ; Stokin, GB; Goldstein, LSB; Mobley, WC				Salehi, Ahmad; Delcroix, Jean-Dominique; Belichenko, Pavel V.; Zhan, Ke; Wu, Chengbiao; Valletta, Janice S.; Takimoto-Kimura, Ryoko; Kleschevnikov, Alexander M.; Sambamurti, Kumar; Chung, Peter P.; Xia, Weiming; Villar, Angela; Campbell, William A.; Kulnane, Laura Shapiro; Nixon, Ralph A.; Lamb, Bruce T.; Epstein, Charles J.; Stokin, Gorazd B.; Goldstein, Lawrence S. B.; Mobley, William C.			Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; RAT BASAL FOREBRAIN; TRANSGENIC MICE; SIGNALING ENDOSOME; TRKA EXPRESSION; NUCLEUS BASALIS; MESSENGER-RNAS; BETA-PEPTIDES	Degeneration of basal forebrain cholinergic neurons (BFCNs) contributes to cognitive dysfunction in Alzheimer's disease (AD) and Down's syndrome (DS). We used Ts65Dn and Ts1Cje mouse models of DS to show that the increased dose of the amyloid precursor protein gene, App, acts to markedly decrease NGF retrograde transport and cause degeneration of BFCNs. NGF transport was also decreased in mice expressing wild-type human APP or a familial AD-linked mutant APP; while significant, the decreases were less marked and there was no evident degeneration of BFCNs. Because of evidence suggesting that the NGF transport defect was intra-axonal, we explored within cholinergic axons the status of early endosomes (EEs). NGF-containing EEs were enlarged in Ts65Dn mice and their App content was increased. Our study thus provides evidence for a pathogenic mechanism for DS in which increased expression of App, in the context of trisomy, causes abnormal transport of NGF and cholinergic neurodegeneration.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Med Univ S Carolina, Ctr Aging, Charleston, SC 29425 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44195 USA; Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Stanford Univ, Sch Med, Neurosci Inst, Stanford, CA 94305 USA	Stanford University; Medical University of South Carolina; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Case Western Reserve University; Nathan Kline Institute for Psychiatric Research; University of California System; University of California San Diego; Stanford University	Salehi, A (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	asalehi@stanford.edu	xia, weiming/E-5465-2016; Sambamurti, Kumar/A-1620-2012; Stokin, Gorazd Bernard/D-9480-2015; Salehi, Ahmad/H-2746-2019; Salehi, Ahmad/A-1148-2007; Kleschevnikov, Alexander/R-6926-2016	xia, weiming/0000-0002-7463-3295; Sambamurti, Kumar/0000-0001-9507-9214; Stokin, Gorazd Bernard/0000-0001-8430-8755; Salehi, Ahmad/0000-0001-8257-3280; Salehi, Ahmad/0000-0001-8257-3280; Kleschevnikov, Alexander/0000-0002-1562-6706	NIA NIH HHS [AG16999] Funding Source: Medline; NINDS NIH HHS [NS38869] Funding Source: Medline; PHS HHS [31498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016999] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen KS, 1997, J NEUROSCI, V17, P7288; Cobb SR, 1999, J PHYSIOL-LONDON, V518, P131, DOI 10.1111/j.1469-7793.1999.0131r.x; COOPER JD, 1994, NEUROSCIENCE, V62, P625, DOI 10.1016/0306-4522(94)90462-6; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delcroix JD, 2004, PROG BRAIN RES, V146, P3, DOI 10.1016/S0079-6123(03)46001-69; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hodes ME, 2000, AM J HUM GENET, V67, P14, DOI 10.1086/302965; Hof PR., 2000, COMP CYTOARCHITECTON; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Jaffar S, 2000, EXP NEUROL, V170, P227, DOI 10.1006/exnr.2001.7710; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; KISS J, 1993, NEUROSCIENCE, V57, P297, DOI 10.1016/0306-4522(93)90063-L; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KOH SY, 1989, J NEUROSCI, V9, P2999; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANN DMA, 1985, J MENT DEFIC RES, V29, P125; Petanceska SS, 2000, NEUROLOGY, V54, P2212, DOI 10.1212/WNL.54.12.2212; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; SALEHI A, 1994, NEUROSCIENCE, V59, P871, DOI 10.1016/0306-4522(94)90291-7; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seo HY, 2005, EXP NEUROL, V193, P469, DOI 10.1016/j.expneurol.2004.11.017; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOFRONIEW MV, 1993, J NEUROSCI, V13, P5263, DOI 10.1523/JNEUROSCI.13-12-05263.1993; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; YAMADA T, 1989, BIOCHEM BIOPH RES CO, V158, P906, DOI 10.1016/0006-291X(89)92808-8; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zheng H, 1996, ANN NY ACAD SCI, V777, P421, DOI 10.1111/j.1749-6632.1996.tb34456.x; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	67	393	406	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					29	42		10.1016/j.neuron.2006.05.022	http://dx.doi.org/10.1016/j.neuron.2006.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815330	Bronze			2022-12-24	WOS:000239037700008
J	Kleim, JA; Chan, S; Pringle, E; Schallert, K; Procaccio, V; Jimenez, R; Cramer, SC				Kleim, Jeffrey A.; Chan, Sheila; Pringle, Erin; Schallert, Kellan; Procaccio, Vincent; Jimenez, Richard; Cramer, Steven C.			BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN-MEMORY	Motor training can induce profound physiological plasticity within primary motor cortex, including changes in corticospinal output and motor map topography. Using transcranial magnetic stimulation, we show that training-dependent increases in the amplitude of motor-evoked potentials and motor map reorganization are reduced in healthy subjects with a val66met polymorphism in the brain-derived neurotrophic factor gene ( BDNF), as compared to subjects without the polymorphism. The results suggest that BDNF is involved in mediating experience-dependent plasticity of human motor cortex.	Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, Gainesville, FL 32608 USA; Univ Florida, Dept Neurosci, Mcknight Brain Inst, Gainesville, FL 32610 USA; Univ Calif Irvine, Ctr Med, Dept Neurol, Orange, CA 92868 USA; Univ Calif Irvine, Ctr Med, Dept Anat & Neurobiol, Orange, CA 92868 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	State University System of Florida; University of Florida; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kleim, JA (corresponding author), Malcorn Randall VA Hosp, Brain Res Rehabil Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	jkleim@ufl.edu		procaccio, Vincent/0000-0002-1537-4684	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T35NS045563] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01RR 00827-29] Funding Source: Medline; NINDS NIH HHS [NS-45563] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	14	398	402	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					735	737		10.1038/nn1699	http://dx.doi.org/10.1038/nn1699			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680163	Green Published			2022-12-24	WOS:000237895200011
J	Yasuda, M; Mayford, MR				Yasuda, M; Mayford, MR			CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory	NEURON			English	Article							LONG-TERM POTENTIATION; IMPAIRED RECOGNITION MEMORY; II MUTANT MICE; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; CONTEXTUAL FEAR; HIPPOCAMPUS; RAT; ORGANIZATION; CONSOLIDATION	To investigate the role of the entorhinal cortex in memory at a molecular level, we developed transgenic mice in which transgene expression was inducible and limited to the superficial layers of the medial entorhinal cortex, pre- and parasubiculum. We found that expression of a constitutively active mutant form of CaMKII in these structures disrupted spatial memory formation. Immediate post-training activation of the transgene disrupted previously established memory while transgene activation 3 weeks following the training was ineffective. These results demonstrate that, similar to the hippocampus, the entorhinal cortex plays a time-limited role in spatial memory formation but is not a final cortical repository of long-term memory. Moreover, these results suggest that the indiscriminate activation of CaMKII is able to disrupt preexisting memories, possibly by altering the pattern of synaptic weight changes that are thought to form the basis of the memory trace.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Mayford, MR (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmayford@scripps.edu		Mayford, Mark/0000-0002-9001-5024	NIMH NIH HHS [MH57368] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bejar R, 2002, J NEUROSCI, V22, P5719; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Clark RE, 2000, J NEUROSCI, V20, P8853; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Glazewski S, 2001, NEUROPHARMACOLOGY, V41, P771, DOI 10.1016/S0028-3908(01)00097-1; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Reed JM, 1998, J NEUROSCI, V18, P3943; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Schacter D., 1994, MEMORY SYSTEMS; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Spooner R I, 1994, Learn Mem, V1, P203; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Groen T, 2001, HIPPOCAMPUS, V11, P397, DOI 10.1002/hipo.1054; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	44	78	82	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					309	318		10.1016/j.neuron.2006.03.035	http://dx.doi.org/10.1016/j.neuron.2006.03.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630840	Bronze			2022-12-24	WOS:000237176700016
J	Gooley, JJ; Schomer, A; Saper, CB				Gooley, JJ; Schomer, A; Saper, CB			The dorsomedial hypothalamic nucleus is critical for the expression of food- entrainable circadian rhythms	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; ANTICIPATORY ACTIVITY; EFFERENT PROJECTIONS; PREOPTIC NUCLEUS; LESIONS; RATS; ENTRAINMENT; ORGANIZATION; TEMPERATURE	Circadian rhythms of behavior and physiology can be entrained by daily cycles of restricted food availability, but the pathways that mediate food entrainment are unknown. The dorsomedial hypothalamic nucleus (DMH) is critical for the expression of circadian rhythms and receives input from systems that monitor food availability. Here we report that restricted feeding synchronized the daily rhythm of DMH activity in rats such that c-Fos expression in the DMH was highest at scheduled mealtime. During food restriction, unlesioned rats showed a marked preprandial rise in locomotor activity, body temperature and wakefulness, and these responses were blocked by cell-specific lesions in the DMH. Furthermore, the degree of food entrainment correlated with the number of remaining DMH neurons, and lesions in cell groups surrounding the DMH did not block entrainment by food. These results establish that the neurons of the DMH have a critical role in the expression of food-entrainable circadian rhythms.	Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saper, CB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	csaper@caregroup.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067413] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60292] Funding Source: Medline; NIMH NIH HHS [MH67413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Choi SJ, 1998, J NEUROSCI, V18, P3843; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Chou WB, 2002, ACTA PHARMACOL SIN, V23, P691; COMPERATORE CA, 1990, PHYSIOL BEHAV, V47, P671, DOI 10.1016/0031-9384(90)90076-G; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; INOUYE SIT, 1982, BRAIN RES, V250, P183, DOI 10.1016/0006-8993(82)90967-2; INOUYE SIT, 1982, BRAIN RES, V232, P194, DOI 10.1016/0006-8993(82)90625-4; KRIEGER DT, 1980, ENDOCRINOLOGY, V106, P649, DOI 10.1210/endo-106-3-649; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2005, NEUROSCIENCE, V132, P245, DOI 10.1016/j.neuroscience.2005.01.029; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; MOREIRA AC, 1982, PHYSIOL BEHAV, V28, P787, DOI 10.1016/0031-9384(82)90194-9; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1981, J COMP PHYSIOL, V143, P401, DOI 10.1007/BF00609906; STEPHAN FK, 1992, PHYSIOL BEHAV, V52, P985, DOI 10.1016/0031-9384(92)90381-B; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	50	316	324	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					398	407		10.1038/nn1651	http://dx.doi.org/10.1038/nn1651			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491082				2022-12-24	WOS:000235645600020
J	Marella, S; Fischler, W; Kong, P; Asgarian, S; Rueckert, E; Scott, K				Marella, S; Fischler, W; Kong, P; Asgarian, S; Rueckert, E; Scott, K			Imaging taste responses in the fly brain reveals a functional map of taste category and behavior	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; DROSOPHILA-MELANOGASTER; CAPSAICIN RECEPTOR; MAMMALIAN SWEET; NEURAL ACTIVITY; ODOR; CA2+; EXPRESSION; INDICATORS; NEURONS	The sense of taste allows animals to distinguish nutritious and toxic substances and elicits food acceptance or avoidance behaviors. In Drosophila, taste cells that contain the Gr5a receptor are necessary for acceptance behavior, and cells with the Gr66a receptor are necessary for avoidance. To determine the cellular substrates of taste behaviors, we monitored taste cell activity in vivo with the genetically encoded calcium indicator G-CaMP. These studies reveal that Gr5a cells selectively respond to sugars and Gr66a cells to bitter compounds. Flies are attracted to sugars and avoid bitter substances, suggesting that Gr5a cell activity is sufficient to mediate acceptance behavior and that Gr66a cell activation mediates avoidance. As a direct test of this hypothesis, we inducibly activated different taste neurons by expression of an exogenous ligand-gated ion channel and found that cellular activity is sufficient to drive taste behaviors. These studies demonstrate that taste cells are tuned by taste category and are hard-wired to taste behaviors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University; Howard Hughes Medical Institute	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 291 Life Sci Addit, Berkeley, CA 94720 USA.	kscott@berkeley.edu		Fischler-Ruiz, Walter/0000-0003-3998-3588	NIDCD NIH HHS [R01 DC006252, 1R01DC006252-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; RUBIN GM, 1985, TRENDS NEUROSCI, V8, P231, DOI 10.1016/0166-2236(85)90094-3; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Scott TR, 2000, PHYSIOL BEHAV, V69, P65, DOI 10.1016/S0031-9384(00)00189-X; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; Smith DV, 1999, CURR OPIN NEUROBIOL, V9, P427, DOI 10.1016/S0959-4388(99)80064-6; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	242	249	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					285	295		10.1016/j.neuron.2005.11.037	http://dx.doi.org/10.1016/j.neuron.2005.11.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423701	Bronze			2022-12-24	WOS:000234979900014
J	Huber, AB; Kania, A; Tran, TS; Gu, CH; Garcia, ND; Lieberam, I; Johnson, D; Jessell, TM; Ginty, DD; Kolodkin, AL				Huber, AB; Kania, A; Tran, TS; Gu, CH; Garcia, ND; Lieberam, I; Johnson, D; Jessell, TM; Ginty, DD; Kolodkin, AL			Distinct roles for secreted semaphorin signaling in spinal motor axon guidance	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; LIM HOMEOBOX GENES; CHICK HIND LIMB; EMBRYONIC CHICK; GROWTH CONE; POLYSIALIC ACID; DIFFERENTIAL EXPRESSION; NEURITE OUTGROWTH; DIFFERENT SUBSETS; SUBTYPE IDENTITY	Neuropilins, secreted semaphorin coreceptors, are expressed in discrete populations of spinal motor neurons, suggesting they provide critical guidance information for the establishment of functional motor circuitry. We show here that motor axon growth and guidance are impaired in the absence of Sema3A-Npn-1 signaling. Motor axons enter the limb precociously, showing that Sema3A controls the timing of motor axon in-growth to the limb. Lateral motor column (LMC) motor axons within spinal nerves are defasciculated as they grow toward the limb and converge in the plexus region. Medial and lateral LMC motor axons show dorso-ventral guidance defects in the forelimb. In contrast, Sema3F-Npn-2 signaling guides the axons of a medial subset of LMC neurons to the ventral limb, but plays no major role in regulating their fasciculation. Thus, Sema3A-Npn-1 and Sema3F-Npn-2 signaling control distinct steps of motor axon growth and guidance during the formation of spinal motor connections.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Inst Rech Clin Montreal, Neural Circuit Dev Lab, Montreal, PQ H2W 1R7, Canada; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Howard Hughes Medical Institute; Johns Hopkins University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Columbia University; Howard Hughes Medical Institute	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu; kolodkin@jhmi.edu	Lieberam, Ivo/C-5324-2009; Tran, Tracy/M-2173-2019	Lieberam, Ivo/0000-0003-3539-3054; Kania, Artur/0000-0002-5209-2520; Tran, Tracy/0000-0002-2179-5725	NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095825] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; GHOSH A, 1993, DEVELOPMENT, V117, P1031; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; Greene E.C., 1935, ANATOMY RAT, V27; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; HONIG MG, 1986, DEV BIOL, V118, P532, DOI 10.1016/0012-1606(86)90024-2; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; Sahay A, 2003, J NEUROSCI, V23, P6671; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1989, J EXP ZOOL, V251, P232, DOI 10.1002/jez.1402510211; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wang G, 1999, DEV BIOL, V208, P324, DOI 10.1006/dbio.1999.9212; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Watanabe Y, 2004, DEVELOPMENT, V131, P681, DOI 10.1242/dev.00970; WHITELAW V, 1983, J NEUROSCI, V3, P1226; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	71	178	184	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					949	964		10.1016/j.neuron.2005.12.003	http://dx.doi.org/10.1016/j.neuron.2005.12.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364899	Bronze			2022-12-24	WOS:000234301700011
J	de Lafuente, V; Romo, R				de Lafuente, V; Romo, R			Neuronal correlates of subjective sensory experience	NATURE NEUROSCIENCE			English	Article							EARLY VISUAL-CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; PREMOTOR CORTEX; PSYCHOPHYSICAL PERFORMANCE; CORTICAL MICROSTIMULATION; SOMATOSENSORY CORTEX; NEURAL CODES; DISCRIMINATION; MACAQUE	When a near-threshold stimulus is presented, a sensory percept may or may not be produced. The unpredictable outcome of such perceptual judgment is believed to be determined by the activity of neurons in early sensory cortex. We analyzed the responses of neurons in primary somatosensory cortex, recorded while monkeys judged the presence or absence of threshold stimuli. We found that these responses did not covary with the monkeys' perceptual reports. In contrast, the activity of frontal lobe neurons did covary with trial-by-trial judgments. Further control and microstimulation experiments indicated that frontal lobe neurons are closely related to the monkeys' subjective experiences during sensory detection.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx	de la Fuente, Javier/GQP-6328-2022	de Lafuente, Victor/0000-0002-1047-1354; romo, ranulfo/0000-0003-3529-3635				Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	229	232	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1698	1703		10.1038/nn1587	http://dx.doi.org/10.1038/nn1587			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286929				2022-12-24	WOS:000233576200018
J	DeLong, KA; Urbach, TP; Kutas, M				DeLong, KA; Urbach, TP; Kutas, M			Probabilistic word pre-activation during language comprehension inferred from electrical brain activity	NATURE NEUROSCIENCE			English	Article							INCREMENTAL INTERPRETATION; POTENTIALS; CONTEXT; INTEGRATION; INFORMATION; SENTENCES; HYPOTHESIS; EXPECTANCY; DISCOURSE; AGREEMENT	Despite the numerous examples of anticipatory cognitive processes at micro and macro levels in many animal species, the idea that anticipation of specific words plays an integral role in real-time language processing has been contentious. Here we exploited a phonological regularity of English indefinite articles ('an' precedes nouns beginning with vowel sounds, whereas 'a' precedes nouns beginning with consonant sounds) in combination with event-related brain potential recordings from the human scalp to show that readers' brains can pre-activate individual words in a graded fashion to a degree that can be estimated from the probability that each word is given as a continuation for a sentence fragment offline. These findings are evidence that readers use the words in a sentence ( as cues to their world knowledge) to estimate relative likelihoods for upcoming words.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	DeLong, KA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	kadelong@cogsci.ucsd.edu		Urbach, Thomas/0000-0001-7993-142X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008313] Funding Source: NIH RePORTER; NIA NIH HHS [AG08313] Funding Source: Medline; NICHD NIH HHS [HD22614] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; CARROLL J, 1978, HDB PERCEPTION, V7, P299; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; GUNTER TC, 1992, PSYCHOPHYSIOLOGY, V29, P38, DOI 10.1111/j.1469-8986.1992.tb02009.x; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; KING JW, 1995, CRL NEWSLETTER, V10, P1; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KLUENDER R, 1993, LANG COGNITIVE PROC, V8, P573, DOI 10.1080/01690969308407588; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P406; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; MARSLENWILSON WD, 1975, SCIENCE, V189, P226, DOI 10.1126/science.189.4198.226; MITCHELL DC, 1978, Q J EXP PSYCHOL, V30, P609, DOI 10.1080/14640747808400689; OREGAN K, 1979, PERCEPT PSYCHOPHYS, V25, P501, DOI 10.3758/BF03213829; PICKERING MJ, 1994, J PSYCHOLINGUIST RES, V23, P323, DOI 10.1007/BF02145045; Sedivy JC, 1999, COGNITION, V71, P109, DOI 10.1016/S0010-0277(99)00025-6; STANOVICH KE, 1979, MEM COGNITION, V7, P77, DOI 10.3758/BF03197588; Steedman Mark, 1989, LEXICAL REPRESENTATI, P463; Tanenhaus MK, 2000, J PSYCHOLINGUIST RES, V29, P557, DOI 10.1023/A:1026464108329; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Traxler MJ, 1997, Q J EXP PSYCHOL-A, V50, P481, DOI 10.1080/027249897391982; TYLER LK, 1977, J VERB LEARN VERB BE, V16, P683, DOI 10.1016/S0022-5371(77)80027-3; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wicha NYY, 2003, NEUROSCI LETT, V346, P165, DOI 10.1016/S0304-3940(03)00599-8	32	667	675	5	69	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1117	1121		10.1038/nn1504	http://dx.doi.org/10.1038/nn1504			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	16007080				2022-12-24	WOS:000230760200025
J	Legan, PK; Lukashkina, VA; Goodyear, RJ; Lukashkin, AN; Verhoeven, K; Van Camp, G; Russell, IJ; Richardson, GP				Legan, PK; Lukashkina, VA; Goodyear, RJ; Lukashkin, AN; Verhoeven, K; Van Camp, G; Russell, IJ; Richardson, GP			A deafness mutation isolates a second role for the tectorial membrane in hearing	NATURE NEUROSCIENCE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; OUTER HAIR-CELLS; RECEPTOR POTENTIALS; INNER-EAR; COCHLEAR; RESPONSES; ORGAN; ORGANIZATION; MECHANICS; AFFERENT	alpha-tectorin (encoded by Tecta) is a component of the tectorial membrane, an extracellular matrix of the cochlea. In humans, the Y1870C missense mutation in TECTA causes a 50- to 80-dB hearing loss. In transgenic mice with the Y1870C mutation in Tecta, the tectorial membrane's matrix structure is disrupted, and its adhesion zone is reduced in thickness. These abnormalities do not seriously influence the tectorial membrane's known role in ensuring that cochlear feedback is optimal, because the sensitivity and frequency tuning of the mechanical responses of the cochlea are little changed. However, neural thresholds are elevated, neural tuning is broadened, and a sharp decrease in sensitivity is seen at the tip of the neural tuning curve. Thus, using Tecta(Y1870C/+) mice, we have genetically isolated a second major role for the tectorial membrane in hearing: it enables the motion of the basilar membrane to optimally drive the inner hair cells at their best frequency.	Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; Univ Antwerp, Dept Biomed Sci, Ctr Med Genet, B-2610 Antwerp, Belgium	University of Sussex; University of Antwerp	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk; G.P.Richardson@sussex.ac.uk	Lukashkin, Andrei N/N-1447-2017; Van Camp, Guy/F-3386-2013	Lukashkin, Andrei N/0000-0003-4577-8716; Van Camp, Guy/0000-0001-5105-9000; Russell, Ian/0000-0002-4915-2772; Lukashkina, Victoria/0000-0002-9154-8746; Legan, P. Kevin/0000-0002-7403-6415	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; Aranyosi AJ, 2004, BIOPHYS J, V87, P3536, DOI 10.1529/biophysj.104.044404; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BROOKES AJ, 1993, TRANSGENIC RES, V2, P238, DOI 10.1007/BF01977354; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; DAVIS H, 1952, COLD SPRING HARB SYM, V17, P143, DOI 10.1101/SQB.1952.017.01.014; DAVIS H, 1957, LARYNGOSCOPE, V68, P359; Frolenkov GI, 1998, HEARING RES, V126, P67, DOI 10.1016/S0378-5955(98)00150-6; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; KLETSKY EJ, 1980, HEARING RES, V2, P549, DOI 10.1016/0378-5955(80)90092-1; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOSSL M, 1992, J NEUROSCI, V12, P1575; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lin T, 2000, J ACOUST SOC AM, V107, P2615, DOI 10.1121/1.428648; Lukashkin AN, 1998, J ACOUST SOC AM, V103, P973, DOI 10.1121/1.421214; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Lukashkin AN, 2002, J ACOUST SOC AM, V111, P2740, DOI 10.1121/1.1479151; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Mom T, 1999, HEARING RES, V133, P40, DOI 10.1016/S0378-5955(99)00056-8; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; PATUZZI RB, 1987, HEARING RES, V30, P83, DOI 10.1016/0378-5955(87)90186-9; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; ROBERTSON D, 1984, HEARING RES, V15, P113, DOI 10.1016/0378-5955(84)90042-X; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Russell IJ, 1999, J NEUROPHYSIOL, V82, P676, DOI 10.1152/jn.1999.82.2.676; RUSSELL IJ, 1983, J PHYSIOL-LONDON, V338, P179, DOI 10.1113/jphysiol.1983.sp014668; RUSSELL IJ, 1995, ADV HEARING RES, P125; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; Sellick P, 2003, HEARING RES, V176, P42, DOI 10.1016/S0378-5955(02)00716-5; SPOENDLIN H, 1985, AM J OTOLARYNG, V6, P453, DOI 10.1016/S0196-0709(85)80026-0; THALMANN I, 1987, LARYNGOSCOPE, V97, P357; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; ZWISLOCKI JJ, 1980, HEARING RES, V2, P171, DOI 10.1016/0378-5955(80)90055-6; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2	48	102	104	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1035	1042		10.1038/nn1496	http://dx.doi.org/10.1038/nn1496			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995703				2022-12-24	WOS:000230760200015
J	Bayer, HM; Glimcher, PW				Bayer, HM; Glimcher, PW			Midbrain dopamine neurons encode a quantitative reward prediction error signal	NEURON			English	Article							RESPONSES; DEPLETION; SEROTONIN; DECISION	The midbrain dopamine neurons are hypothesized to provide a physiological correlate of the reward prediction error signal required by current models of reinforcement learning. We examined the activity of single dopamine neurons during a task in which subjects learned by trial and error when to make an eye movement for a juice reward. We found that these neurons encoded the difference between the current reward and a weighted average of previous rewards, a reward prediction error, but only for outcomes that were better than expected. Thus, the firing rate of midbrain dopamine neurons is quantitatively predicted by theoretical descriptions of the reward prediction error signal used in reinforcement learning models for circumstances in which this signal has a positive value. We also found that the dopamine system continued to compute the reward prediction error even when the behavioral policy of the animal was only weakly influenced by this computation.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA	New York University; Columbia University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu		Glimcher, Paul/0000-0001-7872-3856; Bayer, Hannah/0000-0002-5644-4124	NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010536, EY-10536] Funding Source: Medline; NIMH NIH HHS [MH12790, F31 MH012790] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Ruwaitea ASA, 1999, PSYCHOPHARMACOLOGY, V144, P264, DOI 10.1007/s002130051002; Bush Robert R., 1955, STOCHASTIC MODELS LE; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Deakin J.F.W., 1983, J PSYCHOPHARMACOL, V43, P563; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Handel A, 1997, J NEUROPHYSIOL, V78, P2164, DOI 10.1152/jn.1997.78.4.2164; Harrison AA, 1999, BEHAV BRAIN RES, V100, P99, DOI 10.1016/S0166-4328(98)00117-X; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	30	793	801	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					129	141		10.1016/j.neuron.2005.05.020	http://dx.doi.org/10.1016/j.neuron.2005.05.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996553	Green Accepted, Bronze			2022-12-24	WOS:000230464000013
J	Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR				Chen, X; Garelick, MG; Wang, HB; Li, V; Athos, J; Storm, DR			PI3 kinase signaling is required for retrieval and extinction of contextual memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEDIATED GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-SYNTHESIS; BEHAVIORAL SENSITIZATION; MOLECULAR MECHANISMS; INHIBITORY AVOIDANCE; GLUTAMATE RECEPTORS; DORSAL HIPPOCAMPUS; RAT HIPPOCAMPUS	Memory retrieval is a dynamic aspect of memory formation that can be studied separately from other stages of memory processing. Although several signal transduction pathways including ERK/MAP kinase have been implicated in memory retrieval, the underlying signaling events are poorly defined. Here we report that re-exposure of mice to context after contextual training stimulates the activity of phosphatidylinositol 3 kinase (PI3K) in the hippocampus. Inhibition of PI3K activity in the hippocampus in vivo blocked contextual memory retrieval and extinction. Inhibitors of PI3K signaling also blocked increases in ERK/MAP kinase activity associated with memory retrieval. This suggests that PI3K activation in the hippocampus is critical for memory retrieval and is required for activation of ERK/MAP kinase during retrieval.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, R01NS037056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS20498, NS37056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Athos J., 2001, CURRENT PROTOCOLS NE; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barros DM, 2004, NEUROSCIENCE, V126, P651, DOI 10.1016/j.neuroscience.2004.03.010; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Blum S, 1999, J NEUROSCI, V19, P3535; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chan D, 1998, NETW COMPUT, V9, P18; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Izquierdo LA, 2001, EUR J NEUROSCI, V13, P1464, DOI 10.1046/j.0953-816x.2001.01530.x; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Opazo P, 2003, J NEUROSCI, V23, P3679; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanna PP, 2002, J NEUROSCI, V22, P3359; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szapiro G, 2000, NEUROSCIENCE, V99, P1, DOI 10.1016/S0306-4522(00)00236-0; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	50	166	166	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					925	931		10.1038/nn1482	http://dx.doi.org/10.1038/nn1482			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937483				2022-12-24	WOS:000230137100020
J	Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY				Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY			An fMRI investigation of race-related amygdala activity in African-American and Caucasian-American individuals	NATURE NEUROSCIENCE			English	Article							NEURAL COMPONENTS; INHIBITION; STIMULI; SYSTEM	Functional magnetic resonance imaging ( fMRI) was used to examine the nature of amygdala sensitivity to race. Both African-American and Caucasian-American individuals showed greater amygdala activity to African-American targets than to Caucasian-American targets, suggesting that race-related amygdala activity may result from cultural learning rather than from the novelty of other races. Additionally, verbal encoding of African-American targets produced significantly less amygdala activity than perceptual encoding of African-American targets.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lieberman, MD (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall, Los Angeles, CA 90095 USA.	lieber@ucla.edu	Lieberman, Matthew/ABD-8197-2020; Jarcho, Johanna/N-8862-2017	Lieberman, Matthew/0000-0002-4447-7359; Jarcho, Johanna/0000-0001-9075-6968; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [RR08655, RR12169, RR13642] Funding Source: Medline; NIMH NIH HHS [MH66709] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066709] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2003, J PERS SOC PSYCHOL, V85, P639, DOI 10.1037/0022-3514.85.4.639; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	15	257	268	1	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					720	722		10.1038/nn1465	http://dx.doi.org/10.1038/nn1465			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880106				2022-12-24	WOS:000229345300010
J	Meier, JC; Henneberger, C; Melnick, I; Racca, C; Harvey, RJ; Heinemann, U; Schmieden, V; Grantyn, R				Meier, JC; Henneberger, C; Melnick, I; Racca, C; Harvey, RJ; Heinemann, U; Schmieden, V; Grantyn, R			RNA editing produces glycine receptor alpha 3(P185L), resulting in high agonist potency	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; SUPERIOR COLLICULUS; GABAERGIC SYNAPSES; DNA METHYLATION; SUBUNIT; ZEBULARINE; BRAIN; IDENTIFICATION; TRANSPORTERS	The function of supramedullary glycine receptors (GlyRs) is still unclear. Using Wistar rat collicular slices, we demonstrate GlyR-mediated inhibition of spike discharge elicited by low glycine ( 10 mu M). Searching for the molecular basis of this phenomenon, we identified a new GlyR isoform. GlyR alpha 3(P185L), a result of cytidine 554 deamination, confers high glycine sensitivity (EC50 similar to 5 mu M) to neurons and thereby promotes the generation of sustained chloride conductances associated with tonic inhibition. The level of GlyR alpha 3-C554U RNA editing is sensitive to experimentally induced brain lesion, inhibition of cytidine deamination by zebularine and inhibition of mRNA transcription by actinomycin D, but not to blockade of protein synthesis by cycloheximide. Conditional regulation of GlyR alpha 3(P185L) is thus likely to be part of a post-transcriptional adaptive mechanism in neurons with enhanced excitability.	Charite, Johannes Mueller Ctr Physiol, Dept Dev Physiol, D-10117 Berlin, Germany; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Charite, Johannes Mueller Ctr Physiol, Dept Cellular Neurophysiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Leeds; University of London; University College London; University of London School of Pharmacy; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meier, JC (corresponding author), Charite, Johannes Mueller Ctr Physiol, Dept Dev Physiol, D-10117 Berlin, Germany.	jochen.meier@charite.de	Harvey, Robert/D-3994-2016; Henneberger, Christian/C-1557-2008	Harvey, Robert/0000-0001-5956-6664; Henneberger, Christian/0000-0002-5391-7387; Meier, Jochen/0000-0001-5574-3336				BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breustedt J, 2004, EUR J NEUROSCI, V19, P1987, DOI 10.1111/j.1460-9568.2004.03266.x; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chattipakorn SC, 2003, J NEUROPHYSIOL, V89, P1339, DOI 10.1152/jn.00908.2002; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Danglot L, 2004, MOL CELL NEUROSCI, V27, P394, DOI 10.1016/j.mcn.2004.05.007; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Grantyn A, 2004, PROG BRAIN RES, V143, P423, DOI 10.1016/S0079-6123(03)43040-9; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Haverkamp S, 2003, J COMP NEUROL, V465, P524, DOI 10.1002/cne.10852; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Juttner R, 2001, EUR J NEUROSCI, V13, P2088, DOI 10.1046/j.0953-816x.2001.01587.x; Kennedy RT, 2002, J NEUROSCI METH, V114, P39, DOI 10.1016/S0165-0270(01)00506-4; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KUHSE J, 1990, J BIOL CHEM, V265, P22317; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Mangin JA, 2003, J PHYSIOL-LONDON, V553, P369, DOI 10.1113/jphysiol.2003.052142; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; Meier J, 2003, NEUROREPORT, V14, P1507, DOI 10.1097/00001756-200308060-00021; Meier J, 2003, MOL CELL NEUROSCI, V23, P600, DOI 10.1016/S1044-7431(03)00079-4; Meier J, 2002, MOL CELL NEUROSCI, V21, P324, DOI 10.1006/mcne.2002.1161; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mori M, 2002, J PHYSIOL-LONDON, V539, P191, DOI 10.1113/jphysiol.2001.013147; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Vannier C, 1997, INT REV CYTOL, V176, P201, DOI 10.1016/S0074-7696(08)61611-3; Vincenzetti S, 2000, PROTEIN ENG, V13, P791, DOI 10.1093/protein/13.11.791; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Whitehead KJ, 2001, BRAIN RES, V910, P192, DOI 10.1016/S0006-8993(01)02684-1; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	50	92	94	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					736	744		10.1038/nn1467	http://dx.doi.org/10.1038/nn1467			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895087				2022-12-24	WOS:000229345300013
J	Bazhenov, M; Stopfer, M; Sejnowski, TJ; Laurent, G				Bazhenov, M; Stopfer, M; Sejnowski, TJ; Laurent, G			Fast odor learning improves reliability of odor responses in the locust antennal lobe	NEURON			English	Article							ENCODING NEURAL ASSEMBLIES; ZEBRAFISH OLFACTORY-BULB; SYNAPTIC DEPRESSION; REPRESENTATIONS; DISCRIMINATION; OSCILLATIONS; NEURONS; SYNCHRONIZATION; INFORMATION; MECHANISMS	Recordings in the locust antennal lobe (AL) reveal activity-dependent, stimulus-specific changes in projection neuron (PN) and local neuron response patterns over repeated odor trials. During the first few trials, PN response intensity decreases, while spike time precision increases, and coherent oscillations, absent at first, quickly emerge. We examined this "fast odor learning" with a realistic computational model of the AL. Activity-dependent facilitation of AL inhibitory synapses was sufficient to simulate physiological recordings of fast learning. In addition, in experiment:; with noisy inputs, a network including synaptic facilitation of both inhibition and excitation responded with reliable spatiotemporal patterns from trial to trial despite the noise. A network lacking fast plasticity, however, responded with patterns that varied across trials, reflecting the input variability. Thus, our study suggests that fast olfactory learning results from stimulus-specific, activity-dependent synaptic facilitation and may improve the signal-to-noise ratio for repeatedly encountered odor stimuli.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; NICHD, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; California Institute of Technology	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Stopfer, Mark/0000-0001-9200-1884	Howard Hughes Medical Institute Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008760] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Mellon D, 1997, J COMP PHYSIOL A, V180, P553, DOI 10.1007/s003590050072; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Sloper J J, 1979, Philos Trans R Soc Lond B Biol Sci, V285, P124; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1982, NEUROSCIENCE, V7, P1233, DOI 10.1016/0306-4522(82)91130-7; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vanderwolf CH, 2001, BRAIN RES, V892, P301, DOI 10.1016/S0006-8993(00)03263-7; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	38	58	59	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					483	492		10.1016/j.neuron.2005.03.022	http://dx.doi.org/10.1016/j.neuron.2005.03.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882647	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000229011400019
J	Myers, CP; Lewcock, JW; Hanson, MG; Gosgnach, S; Aimone, JB; Gage, FH; Lee, KF; Landmesser, LT; Pfaff, SL				Myers, CP; Lewcock, JW; Hanson, MG; Gosgnach, S; Aimone, JB; Gage, FH; Lee, KF; Landmesser, LT; Pfaff, SL			Cholinergic input is required during embryonic development to mediate proper assembly of spinal locomotor circuits	NEURON			English	Article							CENTRAL PATTERN GENERATOR; PROGENITOR-CELL IDENTITY; LEFT-RIGHT COORDINATION; VENTRAL NEURAL-TUBE; IN-VITRO; CORD PREPARATION; NEONATAL RAT; TRANSCRIPTIONAL CODES; NEURONAL IDENTITY; RHYTHMIC ACTIVITY	Rhythmic limb movements are controlled by pattern-generating neurons within the ventral spinal cord, but little is known about how these locomotor circuits are assembled during development. At early stages of embryogenesis, motor neurons are spontaneously active, releasing acetylcholine that triggers the depolarization of adjacent cells in the spinal cord. To investigate whether acetylcholine-driven activity is required for assembly of the central pattern-generating (CPG) circuit, we studied mice lacking the choline acetyltransferase (ChAT) enzyme. Our studies show that a rhythmically active spinal circuit forms in ChAT mutants, but the duration of each cycle period is elongated, and right-left and flexor-extensor coordination are abnormal. In contrast, blocking acetylcholine receptors after the locomotor network is wired does not affect right-left or flexor-extensor coordination. These findings suggest that the cholinergic neurotransmitter pathway is involved in configuring the CPG during a transient period of development.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; Case Western Reserve University	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	pfaff@salk.edu	Aimone, James B/C-7821-2011; Aimone, James Bradley/H-4694-2016	Aimone, James Bradley/0000-0002-7361-253X	FIC NIH HHS [TW005563] Funding Source: Medline; NCI NIH HHS [T32 CA09370, P30 CA14195] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07198] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195, T32CA009370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; Chub N, 1998, J NEUROSCI, V18, P294; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; ECCLES JC, 1954, J PHYSIOL-LONDON, V126, P524, DOI 10.1113/jphysiol.1954.sp005226; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Harrison RG, 1904, AM J ANAT, V3, P197, DOI 10.1002/aja.1000030206; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1338; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kjaerulff O, 1997, J NEUROSCI, V17, P9433; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Milner LD, 1999, J NEUROSCI, V19, P3007; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Nakayama K, 2002, J NEUROSCI, V22, P10388; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; O'Donovan MJ, 1998, ANN NY ACAD SCI, V860, P130; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; PANCHIN YV, 1991, J EXP BIOL, V161, P527; PERRINS R, 1995, J NEUROPHYSIOL, V73, P1013, DOI 10.1152/jn.1995.73.3.1013; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Ritter A, 1999, J NEUROSCI, V19, P3457; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SERNAGOR E, 1995, J NEUROSCI, V15, P7452; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Whelan PJ, 2003, J PHYSIOL-LONDON, V553, P695, DOI 10.1113/jphysiol.2003.046219; WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H	58	118	118	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					37	49		10.1016/j.neuron.2005.02.022	http://dx.doi.org/10.1016/j.neuron.2005.02.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820692	Bronze			2022-12-24	WOS:000228228600007
J	Holtmaat, AJGD; Trachtenberg, JT; Wilbrecht, L; Shepherd, GM; Zhang, XQ; Knott, GW; Svoboda, K				Holtmaat, AJGD; Trachtenberg, JT; Wilbrecht, L; Shepherd, GM; Zhang, XQ; Knott, GW; Svoboda, K			Transient and persistent dendritic spines in the neocortex in vivo	NEURON			English	Article							RAT BARREL CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; CAT VISUAL-CORTEX; CRITICAL PERIOD; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; ADULT CORTEX; BRAIN-SLICES; SYNAPSES	Dendritic spines were imaged over days to months in the apical tufts of neocortical pyramidal neurons (layers 5 and 2/3) in vivo. A fraction of thin spines appeared and disappeared over a few days, while most thick spines persisted for months. In the somatosensory cortex, from postnatal day (PND) 16 to PND 25 spine retractions exceeded additions, resulting in a net loss of spines. The fraction of persistent spines (lifetime ! 8 days) grew gradually during development and into adulthood (PND 16-25,35%; PND 35-80,54%; PND 80-120, 66%; PND 175-225, 73%), providing evidence that synaptic circuits continue to stabilize even in the adult brain, long after the closure of known critical periods. In 6-month-old mice, spines turn over more slowly in visual compared to somatosensory cortex, possibly reflecting differences in the capacity for experience-dependent plasticity in these brain regions.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010; Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Barth AL, 2000, J NEUROSCI, V20, P4206; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; BRAINTENBERG V, 1991, ANATOMY CORTEX, V18; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CHEN B, 2004, LONG TERM HIGH RESOL, P423; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1992, J NEUROSCI, V12, P2685; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; KATZ LC, 1987, J NEUROSCI, V7, P1223; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LORENTE R, 1992, SOMATOSENS MOT RES, V9, P3; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Racca C, 2000, J NEUROSCI, V20, P2512; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	64	803	823	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					279	291		10.1016/j.neuron.2005.01.003	http://dx.doi.org/10.1016/j.neuron.2005.01.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664179	Bronze			2022-12-24	WOS:000226451500014
J	Wiser, O; Qian, X; Ehlers, M; Ja, WW; Roberts, RW; Reuveny, E; Jan, YN; Jan, LY				Wiser, Ofer; Qian, Xiang; Ehlers, Melissa; Ja, William W.; Roberts, Richard W.; Reuveny, Eitan; Jan, Yuh Nung; Jan, Lily Yeh			Modulation of basal and receptor-induced GIRK potassium channel activity and neuronal excitability by the mammalian PINS homolog LGN	NEURON			English	Article							G-PROTEIN SIGNALING-3; HETEROTRIMERIC G-PROTEINS; G-ALPHA SUBUNITS; K+ CHANNEL; DISSOCIATION INHIBITOR; TRANSITION-STATE; GOLOCO MOTIF; TPR DOMAIN; KEY ROLE; AGS3	G protein-activated inwardly rectifying potassium (GIRK) channels mediate slow synaptic inhibition and control neuronal excitability. It is unknown whether GIRK channels are subject to regulation by guanine dissociation inhibitor (GDI) proteins like LGN, a mammalian homolog of Drosophila Partner of Inscuteable (mPINS). Here we report that LGN increases basal GIRK current but reduces GIRK activation by metabotropic transmitter receptors coupled to Gi or Go, but not Gs. Moreover, expression of its N-terminal, TPR-containing protein interaction domains mimics the effects of LGN in mammalian cells, probably by releasing sequestered endogenous LGN. In hippocampal neurons, expression of LGN, or LGN fragments that mimic or enhance LGN activity, hyperpolarizes the resting potential due to increased basal GIRK activity and reduces excitability. Using Lenti virus for LGN RNA! to reduce endogenous LGN levels in hippocampal neurons, we further show an essential role of LGN for maintaining basal GIRK channel activity and for harnessing neuronal excitability.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; California Institute of Technology; Weizmann Institute of Science	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, 1550 4th St, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; QIAN, XIANG/0000-0003-0697-2540; Ja, William/0000-0002-4003-7356	NIMH NIH HHS [MH63981] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH063981] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fuja TJ, 2004, J NEUROSCI RES, V75, P782, DOI 10.1002/jnr.10874; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Ja WW, 2005, J BIOL CHEM, V280, P32057, DOI 10.1074/jbc.C500319200; Ja WW, 2004, BIOCHEMISTRY-US, V43, P9265, DOI 10.1021/bi0498398; Karasinska JM, 2003, BRAIN RES REV, V41, P125, DOI 10.1016/S0165-0173(02)00221-7; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kelley AE, 2004, NEURON, V42, P181, DOI 10.1016/S0896-6273(04)00223-5; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma HZ, 2003, BIOCHEMISTRY-US, V42, P8085, DOI 10.1021/bi034561p; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marty C, 2003, MOL CELL BIOL, V23, P3847, DOI 10.1128/MCB.23.11.3847-3858.2003; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Satoh Kiyotoshi, 1999, Medical Electron Microscopy, V32, P221; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Seeger T, 2001, J PHYSIOL-LONDON, V535, P383, DOI 10.1111/j.1469-7793.2001.00383.x; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505	70	51	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					561	573		10.1016/j.neuron.2006.03.046	http://dx.doi.org/10.1016/j.neuron.2006.03.046			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701207	Bronze			2022-12-24	WOS:000237875200008
J	Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS				Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS			Protein kinase A regulates calcium permeability of NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTOR; DENDRITIC SPINES; VISUAL-CORTEX; CA1 REGION; LATE-PHASE; CHANNELS; LTP; EXPRESSION	Calcium (Ca2+) influx through NMDA receptors (NMDARs) is essential for synaptogenesis, experience-dependent synaptic remodeling and plasticity. The NMDAR-mediated rise in postsynaptic Ca2+ activates a network of kinases and phosphatases that promote persistent changes in synaptic strength, such as long-term potentiation (LTP). Here we show that the Ca2+ permeability of neuronal NMDARs is under the control of the cyclic AMP-protein kinase A (cAMP-PKA) signaling cascade. PKA blockers reduced the relative fractional Ca2+ influx through NMDARs as determined by reversal potential shift analysis and by a combination of electrical recording and Ca2+ influx measurements in rat hippocampal neurons in culture and hippocampal slices from mice. In slices, PKA blockers markedly inhibited NMDAR-mediated Ca21 rises in activated dendritic spines, with no significant effect on synaptic current. Consistent with this, PKA blockers depressed the early phase of NMDAR-dependent LTP at hippocampal Schaffer collateral-CA1 (Sch-CA1) synapses. Our data link PKA-dependent synaptic plasticity to Ca2+ signaling in spines and thus provide a new mechanism whereby PKA regulates the induction of LTP.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, Bronx, NY 10461 USA; Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Howard Hughes Medical Institute	Zukin, RS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zukin@aecom.yu.edu	Lau, C. Geoffrey/G-4036-2014; Bennett, Michael/A-6958-2009	Lau, C. Geoffrey/0000-0001-9750-2514; Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856; Goldberg, Jesse/0000-0003-0422-8902; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	NIDA NIH HHS [DA17392] Funding Source: Medline; NIMH NIH HHS [MH65495] Funding Source: Medline; NINDS NIH HHS [NS20752, NS45287] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS045287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Huang Y Y, 1994, Learn Mem, V1, P74; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scemes E, 2000, J NEUROSCI, V20, P1435; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schneider MC, 1996, MOL MED TODAY, V2, P70, DOI 10.1016/1357-4310(96)88741-7; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Snyder GL, 1998, J NEUROSCI, V18, P10297; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; ZHONG J, 1994, MOL PHARMACOL, V45, P846; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446	50	232	239	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					501	510		10.1038/nn1664	http://dx.doi.org/10.1038/nn1664			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531999				2022-12-24	WOS:000236310700017
J	Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C				Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C			Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens	NATURE NEUROSCIENCE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; MEDIATING MATING BEHAVIOR; CENTRAL NERVOUS-SYSTEM; TREATED MALE-RATS; SEXUAL-DIFFERENTIATION; FEMININE BEHAVIOR; MICE LACKING; GENE; VASOPRESSIN; ESTRADIOL	Two clearly opposing views exist on the function of alpha-fetoprotein ( AFP), a fetal plasma protein that binds estrogens with high affinity, in the sexual differentiation of the rodent brain. AFP has been proposed to either prevent the entry of estrogens or to actively transport estrogens into the developing female brain. The availability of Afp mutant mice ( Afp(-/-)) now finally allows us to resolve this longstanding controversy concerning the role of AFP in brain sexual differentiation, and thus to determine whether prenatal estrogens contribute to the development of the female brain. Here we show that the brain and behavior of female Afp(-/-) mice were masculinized and defeminized. However, when estrogen production was blocked by embryonic treatment with the aromatase inhibitor 1,4,6-androstatriene-3,17-dione, the feminine phenotype of these mice was rescued. These results clearly demonstrate that prenatal estrogens masculinize and defeminize the brain and that AFP protects the female brain from these effects of estrogens.	Univ Liege, Ctr Cellular & Mol Neurobiol, B-4000 Cointe Ougree, Belgium; Univ Libre Bruxelles, Inst Biol & Med Mol, Dev Biol Lab, B-6041 Gosselies, Belgium	University of Liege; Universite Libre de Bruxelles	Bakker, J (corresponding author), Univ Liege, Ctr Cellular & Mol Neurobiol, Ave Hop 1,B36, B-4000 Cointe Ougree, Belgium.	jbakker@ulg.ac.be			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER; NICHD NIH HHS [HD044897] Funding Source: Medline; NIMH NIH HHS [MH50388] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREWS GK, 1982, J BIOL CHEM, V257, P5148; AUSSEL C, 1978, J STEROID BIOCHEM, V9, P547, DOI 10.1016/0022-4731(78)90121-8; Bakker J, 2002, J NEUROSCI, V22, P9104; BAKKER J, 1993, BEHAV NEUROSCI, V107, P480, DOI 10.1037/0735-7044.107.3.480; BAUM MJ, 1979, NEUROSCI BIOBEHAV R, V3, P265, DOI 10.1016/0149-7634(79)90013-7; Bennett JA, 2002, P NATL ACAD SCI USA, V99, P2211, DOI 10.1073/pnas.251667098; BENNO RH, 1978, BRAIN RES, V142, P182; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DEMEES C, IN PRESS CELL MOL BI; DOHLER KD, 1984, PROG BRAIN RES, V61, P99; Dominguez-Salazar E, 2004, HORM BEHAV, V46, P482, DOI 10.1016/j.yhbeh.2004.05.006; FEDER HH, 1965, SCIENCE, V147, P306, DOI 10.1126/science.147.3655.306; Fitch RH, 1998, BEHAV BRAIN SCI, V21, P311, DOI 10.1017/S0140525X98001216; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; GERALL AA, 1973, J COMP PHYSIOL PSYCH, V82, P449, DOI 10.1037/h0034113; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; GRADY KL, 1965, J COMP PHYSIOL PSYCH, V59, P176, DOI 10.1037/h0021824; Han TM, 2003, J NEUROBIOL, V54, P502, DOI 10.1002/neu.10157; Lonstein JS, 1999, J NEUROENDOCRINOL, V11, P441; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MCCALL AL, 1981, J REPROD FERTIL, V61, P103, DOI 10.1530/jrf.0.0610103; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MCEWEN BS, 1975, BRAIN RES, V96, P400, DOI 10.1016/0006-8993(75)90755-6; MEIJSROE.HM, 1973, J ENDOCRINOL, V59, P295, DOI 10.1677/joe.0.0590295; Mesfin FB, 2000, BBA-MOL BASIS DIS, V1501, P33, DOI 10.1016/S0925-4439(00)00008-9; PETRA PH, 1991, J STEROID BIOCHEM, V40, P735, DOI 10.1016/0960-0760(91)90299-K; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Plumari L, 2002, J NEUROENDOCRINOL, V14, P971, DOI 10.1046/j.1365-2826.2002.00866.x; Quadros PS, 2002, J NEUROENDOCRINOL, V14, P761, DOI 10.1046/j.1365-2826.2002.00827.x; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; RAYNAUD JP, 1973, STEROIDS, V21, P249, DOI 10.1016/S0039-128X(73)80009-1; SCHACHTER BS, 1982, DEV BRAIN RES, V5, P93, DOI 10.1016/0165-3806(82)90116-X; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Tobet SA, 1997, CELL MOL NEUROBIOL, V17, P565, DOI 10.1023/A:1022529918810; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; TORANALLERAND CD, 1984, PROG BRAIN RES, V61, P63; TORANALLERAND CD, 1982, DEV BRAIN RES, V5, P213; Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; WHALEN RE, 1967, ANAT RECORD, V157, P173, DOI 10.1002/ar.1091570208; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335	44	216	220	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					220	226		10.1038/nn1624	http://dx.doi.org/10.1038/nn1624			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388309				2022-12-24	WOS:000234990100017
J	Naeini, RS; Witty, MF; Seguela, P; Bourque, CW				Naeini, RS; Witty, MF; Seguela, P; Bourque, CW			An N-terminal variant of Trpv1 channel is required for osmosensory transduction	NATURE NEUROSCIENCE			English	Article							RAT SUPRAOPTIC NEURONS; NONSELECTIVE CATION CHANNEL; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; MICE LACKING; VASOPRESSIN SECRETION; MAGNOCELLULAR NEURONS; OSMOTIC REGULATION; LAMINA TERMINALIS; BLOOD OSMOLALITY	Body fluid homeostasis requires the release of arginine-vasopressin (AVP, an antidiuretic hormone) from the neurohypophysis. This release is controlled by specific and highly sensitive 'osmoreceptors' in the hypothalamus. Indeed, AVP-releasing neurons in the supraoptic nucleus (SON) are directly osmosensitive, and this osmosensitivity is mediated by stretch-inhibited cation channels. However, the molecular nature of these channels remains unknown. Here we show that SON neurons express an N-terminal splice variant of the transient receptor potential vanilloid type-1 (Trpv1), also known as the capsaicin receptor, but not full-length Trpv1. Unlike their wild-type counterparts, SON neurons in Trpv1 knockout (Trpv1(-/-)) mice could not generate ruthenium red-sensitive increases in membrane conductance and depolarizing potentials in response to hyperosmotic stimulation. Moreover, Trpv1(-/-) mice showed a pronounced serum hyperosmolality under basal conditions and severely compromised AVP responses to osmotic stimulation in vivo. These results suggest that the Trpv1 gene may encode a central component of the osmoreceptor.	McGill Univ, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), McGill Univ, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	charles.bourque@mcgill.ca	Naeini, Reza Sharif/K-2402-2019	Naeini, Reza Sharif/0000-0001-8896-5306; Bourque, Charles/0000-0002-1594-742X				Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bourque CW, 1998, PROG BRAIN RES, V119, P59; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2000, NAT NEUROSCI, V3, P572, DOI 10.1038/75744; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grob M, 2004, J NEUROSCI, V24, P3974, DOI 10.1523/JNEUROSCI.3720-03.2004; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; Li Z, 1996, NEUROSCIENCE, V71, P133, DOI 10.1016/0306-4522(95)00434-3; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lu G, 2005, MOL PHARMACOL, V67, P1119, DOI 10.1124/mol.104.009852; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; NAGATOMO T, 1995, J PHYSIOL-LONDON, V485, P87, DOI 10.1113/jphysiol.1995.sp020714; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; Oliet SHR, 1996, NEURON, V16, P175, DOI 10.1016/S0896-6273(00)80034-3; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; ROBERTSON GL, 1976, KIDNEY INT, V10, P25, DOI 10.1038/ki.1976.76; ROBERTSON GL, 1976, J CLIN ENDOCR METAB, V42, P613, DOI 10.1210/jcem-42-4-613; SCHRIER RW, 1979, AM J PHYSIOL, V236, P321; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Shibuya I, 1998, J NEUROENDOCRINOL, V10, P759, DOI 10.1046/j.1365-2826.1998.00260.x; Ster J, 2005, J NEUROSCI, V25, P2267, DOI 10.1523/JNEUROSCI.4053-04.2005; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; VANDESANDE F, 1975, CELL TISSUE RES, V164, P153; Voisin DL, 2002, TRENDS NEUROSCI, V25, P199, DOI 10.1016/S0166-2236(02)02142-2; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wainwright A, 2004, J COMP NEUROL, V474, P24, DOI 10.1002/cne.20100; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582	48	235	246	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					93	98		10.1038/nn1614	http://dx.doi.org/10.1038/nn1614			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327782				2022-12-24	WOS:000234288000022
J	Cirrito, JR; Yamada, KA; Finn, MB; Sloviter, RS; Bales, KR; May, PC; Schoepp, DD; Paul, SM; Mennerick, S; Holtzman, DM				Cirrito, JR; Yamada, KA; Finn, MB; Sloviter, RS; Bales, KR; May, PC; Schoepp, DD; Paul, SM; Mennerick, S; Holtzman, DM			Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo	NEURON			English	Article							TRANSGENIC MOUSE MODEL; A-BETA; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PROTEIN-PRECURSOR; BRAIN; RELEASE; RAT; HIPPOCAMPUS; METABOLISM	Aggregation of the amyloid-beta (A beta) peptide in the extracellular space of the brain is central to Alzheimer's disease pathogenesis. A beta aggregation is concentration dependent and brain region specific. Utilizing in vivo microdialysis concurrently with field potential recordings, we demonstrate that A beta levels in the brain interstitial fluid are dynamically and directly influenced by synaptic activity on a timescale of minutes to hours. Using an acute brain slice model, we show that the rapid effects of synaptic activity on A beta levels are primarily related to synaptic vesicle exocytosis. These results suggest that synaptic activity may modulate a neurodegenerative disease process, in this case by influencing A beta metabolism and ultimately region-specific A beta deposition. The findings also have important implications for treatment development.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Univ Arizona, Dept Pharmacol, Tucson, AZ 85724 USA; Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Arizona; Eli Lilly	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.		Mennerick, Steven/O-2806-2017; Paul, Steve/ABE-5400-2020	Mennerick, Steven/0000-0003-0868-0664; 	NIA NIH HHS [AG11355, AG13956] Funding Source: Medline; NIDA NIH HHS [DA70261] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG011355, R37AG013956, R01AG013956] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Beach TG, 2001, NEUROSCI LETT, V310, P21, DOI 10.1016/S0304-3940(01)02076-6; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fryer JD, 2003, J NEUROSCI, V23, P7889; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hock C, 2003, AMYLOID, V10, P1, DOI 10.3109/13506120308995249; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Nilsen KE, 2005, EPILEPSIA, V46, P179, DOI 10.1111/j.0013-9580.2005.26004.x; Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO;2-J; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheng JG, 2002, J NEUROSCI, V22, P9794; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200	38	862	893	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					913	922		10.1016/j.neuron.2005.10.028	http://dx.doi.org/10.1016/j.neuron.2005.10.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364896	Bronze			2022-12-24	WOS:000234301700008
J	Lear, BC; Lin, JM; Keath, JR; McGill, JJ; Raman, IM; Allada, R				Lear, BC; Lin, JM; Keath, JR; McGill, JJ; Raman, IM; Allada, R			The ion channel narrow abdomen is critical for neural output of the Drosophila circadian pacemaker	NEURON			English	Article							NERVOUS-SYSTEM; TIMELESS GENES; CLOCK GENES; NEURONS; PERIOD; NEUROPEPTIDE; EXPRESSION; RHYTHMS; BRAIN; MELANOGASTER	Circadian clocks consist of transcriptional feedback loops housed in interdependent pacemaker neurons. Yet little is known about the neuronal output components essential for rhythmic behavior. Drosophila mutants of a putative ion channel, narrow abdomen (na), exhibit poor circadian rhythms and suppressed daylight activity. We find that NA is expressed in pacemaker neurons and induced expression within circadian neurons is sufficient to rescue these mutant phenotypes. Selective na rescue in distinct pacemaker neurons influences rhythmicity and timing of behavior. Oscillations of the clock protein PERIOD are intact in na mutants, indicating an output role. Pore residues are required for robust rescue consistent with NA action as an ion channel. In na mutants, expression of potassium currents and the key neuropeptide PDF are elevated, the latter consistent with reduced release. These data implicate NA and the pacemaker neural network in controlling phase and rhythmicity.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Lear, Bridget/A-1350-2013					Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Bahinski A, 1997, MOL CELL BIOCHEM, V166, P125, DOI 10.1023/A:1006847632410; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Christian SL, 2002, GENOMICS, V79, P635, DOI 10.1006/geno.2002.6765; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 1998, J NEUROGENET, V12, P115, DOI 10.3109/01677069809108556; HARDIN PE, 1992, EMBO J, V11, P1; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leibovitch BA, 1995, J NEUROGENET, V10, P1, DOI 10.3109/01677069509083455; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sambrook J, 2001, MOL CLONING LAB MANU; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; TANG SQ, 1993, J BIOL CHEM, V268, P13026; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	44	84	85	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					965	976		10.1016/j.neuron.2005.10.030	http://dx.doi.org/10.1016/j.neuron.2005.10.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364900	Bronze			2022-12-24	WOS:000234301700012
J	Gao, J; Duan, B; Wang, DG; Deng, XH; Zhang, GY; Xu, L; Xu, TL				Gao, J; Duan, B; Wang, DG; Deng, XH; Zhang, GY; Xu, L; Xu, TL			Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death	NEURON			English	Article							PROTEIN-KINASE-II; SUBUNIT MESSENGER-RNAS; D-ASPARTATE RECEPTOR; CELL-DEATH; FOREBRAIN ISCHEMIA; GLUTAMATE NEUROTOXICITY; HIPPOCAMPAL SYNAPSES; GLUCOSE DEPRIVATION; NERVOUS-SYSTEM; NR2B SUBUNIT	Acid-sensing ion channels (ASICs) composed of ASIC1a subunit exhibit a high Ca2+ permeability and play important roles in synaptic plasticity and acid-induced cell death. Here, we show that ischemia enhances ASIC currents through the phosphorylation at Ser478 and Ser479 of ASIC1a, leading to exacerbated ischemic cell death. The phosphorylation is catalyzed by Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity, as a result of activation of NR2B-containing N-methyl-D-aspartate subtype of glutamate receptors (NMDARs) during ischemia. Furthermore, NR2B-specific antagonist, CaMKII inhibitor, or overexpression of mutated form of ASIC1a with Ser478 or Ser479 replaced by alanine (ASICla-S478A, ASIC1a-S479A) in cultured hippocampal neurons prevented ischemia-induced enhancement of ASIC currents, cytoplasmic Ca2+ elevation, as well as neuronal death. Thus, NMDAR-CaMKII cascade is functionally coupled to ASICs and contributes to acidotoxicity during ischemia. Specific blockade of NMDAR/CaMKII-ASIC coupling may reduce neuronal death after ischemia and other pathological conditions involving excessive glutamate release and acidosis.	Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Key Lab Neurobiol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Univ Sci & Technol China, Hefei 230027, Peoples R China; Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Xuzhou 221002, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming 650223, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xuzhou Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology	Xu, TL (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	tlxu@ion.ac.cn	Xu, Lin/T-5531-2017	Xu, Lin/0000-0002-2710-3507				ALLEN NJ, 2002, J PHYSL, V543, P52; ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BERECZKI D, 1993, METAB BRAIN DIS, V8, P125, DOI 10.1007/BF00996926; Biagini G, 2001, NEUROBIOL DIS, V8, P45, DOI 10.1006/nbdi.2000.0331; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHURN SB, 1992, J NEUROCHEM, V59, P1221, DOI 10.1111/j.1471-4159.1992.tb08431.x; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hajimohammadreza I, 1997, J NEUROCHEM, V69, P1006; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; Katsura K, 1999, BRAIN RES, V849, P119, DOI 10.1016/S0006-8993(99)02072-7; Kawabata K, 2000, AM J PHYSIOL-HEART C, V278, pH1008, DOI 10.1152/ajpheart.2000.278.3.H1008; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YAMAMOTO H, 1992, J NEUROCHEM, V58, P1110, DOI 10.1111/j.1471-4159.1992.tb09369.x; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	50	253	277	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					635	646		10.1016/j.neuron.2005.10.011	http://dx.doi.org/10.1016/j.neuron.2005.10.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301179	Bronze			2022-12-24	WOS:000233677300016
J	Hayashi, T; Rumbaugh, G; Huganir, RL				Hayashi, T; Rumbaugh, G; Huganir, RL			Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites	NEURON			English	Article							PROTEIN PALMITOYLATION; SF9 CELLS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; SURFACE EXPRESSION; MEMBRANE SKELETON; PHOSPHORYLATION; CHANNEL; PSD-95; IDENTIFICATION	Modification of AMPA receptor function is a major mechanism for the regulation of synaptic transmission and underlies several forms of synaptic plasticity. Post-translational palmitoylation is a reversible modification that regulates localization of many proteins. Here, we report that palmitoylation of the AMPA receptor regulates receptor trafficking. All AMPA receptor subunits are palmitoylated on two cysteine residues in their transmembrane domain (TMD) 2 and in their C-terminal region. Palmitoylation on TMD 2 is upregulated by the palmitoyl acyl transferase GODZ and leads to an accumulation of the receptor in the Golgi and a reduction of receptor surface expression. C-terminal palmitoylation decreases interaction of the AMPA receptor with the 4.1N protein and regulates AMPA- and NMDA-induced AMPA receptor internalization. Moreover, depalmitoylation of the receptor is regulated by activation of glutamate receptors. These data suggest that regulated palmitoylation of AMPA receptor subunits modulates receptor trafficking and may be important for synaptic plasticity.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Hayashi, Takashi/0000-0003-3591-2109				ALALUF S, 1995, J NEUROCHEM, V64, P1548; ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Coleman SK, 2003, J NEUROSCI, V23, P798; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; NG GYK, 1994, J NEUROCHEM, V63, P1589; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shen L, 2000, J NEUROSCI, V20, P7932; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Walensky LD, 1999, J NEUROSCI, V19, P6457; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9	52	192	204	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					709	723		10.1016/j.neuron.2005.06.035	http://dx.doi.org/10.1016/j.neuron.2005.06.035			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129400	Bronze			2022-12-24	WOS:000231782700012
J	Stauffer, EA; Scarborough, JD; Hirono, M; Miller, ED; Shah, K; Mercer, JA; Holt, JR; Gillespie, PG				Stauffer, EA; Scarborough, JD; Hirono, M; Miller, ED; Shah, K; Mercer, JA; Holt, JR; Gillespie, PG			Fast adaptation in vestibular hair cells requires myosin-1c activity	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; BULLFROGS SACCULUS; FORCE GENERATION; BUNDLE MOVEMENTS; AMPLIFICATION; MECHANISMS; CHANNELS; MOTION; EXTENT; MODEL	In sensory hair cells of the inner ear, mechanical amplification of small stimuli requires fast adaptation, the rapid closing of mechanically activated transduction channels. In frog and mouse vestibular hair cells, we found that the rate of fast adaptation depends on both channel opening and stimulus size and that it is modeled well as a release of a mechanical element in series with the transduction apparatus. To determine whether myosin-1c molecules of the adaptation motor are responsible for the release, we introduced the Y61G mutation into the Myo1c locus and generated mice homozygous for this sensitized allele. Measuring transduction and adaptation in the presence of NMB-ADP, an allele-specific inhibitor, we found that the inhibitor not only blocked slow adaptation, as demonstrated previously in transgenic mice, but also inhibited fast adaptation. These results suggest that mechanical activity of myosin-1c is required for fast adaptation in vestibular hair cells.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA; Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97239 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA	University of Virginia; University of Virginia; Oregon Health & Science University; Oregon Health & Science University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; McLaughlin Research Institute for Biomedical Sciences, Inc.	Holt, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	jeffholt@virginia.edu; gillespp@ohsu.edu		Barr-Gillespie, Peter/0000-0002-9787-5860; Hirono, Moritoshi/0000-0001-6068-1045; Mercer, John/0000-0003-0307-4438	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC005439, R01DC002368, R01DC003279] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002368, R01 DC005439-04, P30 DC005983, R01 DC005439, R01 DC003279] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Benser ME, 1996, J NEUROSCI, V16, P5629; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; CHEUNG EL, 2005, IN PRESS BIOPHYS J; COREY DP, 1983, J NEUROSCI, V3, P962; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GILLESPIE PG, 2005, IN PRESS CURR OPIN N, V15; GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781, DOI 10.1152/jn.1990.63.4.781; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 2003, J NEUROSCI, V23, P4533; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; POLLARD TD, 1982, METHOD ENZYMOL, V85, P123; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	40	112	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					541	553		10.1016/j.neuron.2005.07.024	http://dx.doi.org/10.1016/j.neuron.2005.07.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102537	Green Accepted, Bronze			2022-12-24	WOS:000231411100011
J	Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE				Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE			The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses	NEURON			English	Article							MOTOR-NERVE TERMINALS; HEREDITARY SPASTIC PARAPLEGIA; SYNAPTIC-TRANSMISSION; CYTOCHROME-OXIDASE; CYTOSOLIC CA2+; PROTEIN; MUTATIONS; RELEASE; MICROTUBULES; STIMULATION	We have identified EMS-induced mutations in Drosophila Miro (dMiro), an atypical mitochondrial GTPase that is orthologous to human Miro (hMiro). Mutant dmiro animals exhibit defects in locomotion and die prematurely. Mitochondria in dmiro mutant muscles and neurons are abnormally distributed. Instead of being transported into axons and dendrites mitochondria accumulate in parallel rows in neuronal somata. Mutant neuromuscular junctions (NMJs) lack presynaptic mitochondria, but neurotransmitter release and acute Ca2+ buffering is only impaired during prolonged stimulation. Neuronal, but not muscular, expression of dMiro in dmiro mutants restored viability, transport of mitochondria to NMJs, the structure of synaptic boutons, the organization of presynaptic microtubules, and the size of postsynaptic muscles. In addition, gain of dMiro function causes an abnormal accumulation of mitochondria in distal synaptic boutons of NMJs. Together, our findings suggest that dMiro is required for controlling anterograde transport of mitochondria and their proper distribution within nerve terminals.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Program Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Undergrad Biol Res Program, Tucson, AZ 85721 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Penn, Sch Med, Program Neurosci, Philadelphia, PA 19104 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Toronto; University of Pennsylvania	Zinsmaier, KE (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu		Macleod, Gregory/0000-0003-3782-6968; Wellington, Andrea/0000-0002-8679-9225				Babcock MC, 2003, GENETICS, V165, P171; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bindokas VP, 1998, J NEUROSCI, V18, P4570; BLOOM GS, 1993, J CELL BIOL, V120, P467, DOI 10.1083/jcb.120.2.467; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen B, 1998, GENETICS, V149, P157; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; David G, 2000, J NEUROSCI, V20, P7290; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; David G, 1999, J NEUROSCI, V19, P7495, DOI 10.1523/JNEUROSCI.19-17-07495.1999; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hurd DD, 1996, GENETICS, V144, P1075; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; MORRIS RL, 1993, J CELL SCI, V104, P917; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Ohnuma K, 1999, BIOPHYS J, V76, P1819, DOI 10.1016/S0006-3495(99)77342-X; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Suzuki S, 2002, J NEUROPHYSIOL, V87, P1816, DOI 10.1152/jn.00456.2001; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	52	437	446	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					379	393		10.1016/j.neuron.2005.06.027	http://dx.doi.org/10.1016/j.neuron.2005.06.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055062	Bronze			2022-12-24	WOS:000231051900009
J	Das, A				Das, A			Cortical maps: Where theory meets experiments	NEURON			English	Editorial Material							VISUAL-CORTEX; SELECTIVITY; CAT	Primary visual cortex (V1) has remarkably systematic functional maps. One commonly used class of computational models proposes that such maps are generated by a mechanism that projects the multiple dimensions of neuronal responses smoothly onto the two dimensions of cortex. In this issue of Neuron, Mriganka Sur and colleagues find a close match between such model predictions and measurements from ferret V1.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Das, A (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.				NATIONAL EYE INSTITUTE [P30EY019007, R24EY015634] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634, R24 EY015634-03, R24 EY015634-04, R24 EY015634-02, R24 EY015634-01, P30 EY019007] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hubener M, 1997, J NEUROSCI, V17, P9270; Kohonen T., 2001, SELF ORG MAPS; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; WILLSHAW DJ, 1979, PHILOS T ROY SOC B, V287, P203, DOI 10.1098/rstb.1979.0056; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	14	4	5	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					168	171		10.1016/j.neuron.2005.07.004	http://dx.doi.org/10.1016/j.neuron.2005.07.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039557	Green Accepted, Bronze			2022-12-24	WOS:000230693900002
J	Carey, MR; Medina, JF; Lisberger, SG				Carey, MR; Medina, JF; Lisberger, SG			Instructive signals for motor learning from visual cortical area MT	NATURE NEUROSCIENCE			English	Article							PURSUIT EYE-MOVEMENTS; SYNAPTIC PLASTICITY; MACAQUE MONKEY; BASAL GANGLIA; SMOOTH; MICROSTIMULATION; MOTION; DIRECTION; NEURONS; CEREBELLUM	Sensory error signals have long been proposed to act as instructive signals to guide motor learning. Here we have exploited the temporal specificity of learning in smooth pursuit eye movements and the well-defined anatomical structure of the neural circuit for pursuit to identify a part of sensory cortex that provides instructive signals for motor learning in monkeys. We show that electrical microstimulation in the motion-sensitive middle temporal area (MT) of extrastriate visual cortex instructs learning in smooth eye movements in a way that closely mimics the learning instructed by real visual motion. We conclude that MT provides instructive signals for motor learning in smooth pursuit eye movements under natural conditions, suggesting a similar role for sensory cortices in many kinds of learned behaviors.	Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn Ctr Integrat Neurosci, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carey, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	megan_carey@hms.harvard.edu		Medina, Javier/0000-0001-8708-5315; Carey, Megan/0000-0002-4499-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [NS34835, P01 NS034835, P01 NS034835-09] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLEY K, 1975, BRAIN RES, V98, P582, DOI 10.1016/0006-8993(75)90375-3; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; BOMAN DK, 1992, VISION RES, V32, P675, DOI 10.1016/0042-6989(92)90184-K; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Carey MR, 2004, J NEUROPHYSIOL, V91, P623, DOI 10.1152/jn.00525.2003; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chou IH, 2004, J NEUROSCI, V24, P4124, DOI 10.1523/JNEUROSCI.0172-04.2004; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Distler C, 2002, J COMP NEUROL, V444, P144, DOI 10.1002/cne.10127; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Groh JM, 1997, J NEUROSCI, V17, P4312; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kahlon M, 1996, J NEUROSCI, V16, P7270; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Kodaka Y, 2004, J NEUROPHYSIOL, V91, P2474, DOI 10.1152/jn.01079.2003; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Raymond JL, 1998, J NEUROSCI, V18, P9112; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Tian JR, 1997, J NEUROSCI, V17, P9233; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	47	39	40	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					813	819		10.1038/nn1470	http://dx.doi.org/10.1038/nn1470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908949	Green Accepted			2022-12-24	WOS:000229345300023
J	Sampath, AP; Strissel, KJ; Elias, R; Arshavsky, VY; McGinnis, JF; Chen, J; Kawamura, SU; Rleke, F; Hurley, JB				Sampath, AP; Strissel, KJ; Elias, R; Arshavsky, VY; McGinnis, JF; Chen, J; Kawamura, SU; Rleke, F; Hurley, JB			Recoverin improves rod-mediated vision by enhancing signal transmission in the mouse retina	NEURON			English	Article							SINGLE-PHOTON RESPONSES; CALCIUM-BINDING PROTEINS; BIPOLAR; PHOTORESPONSE; TRANSDUCIN; CELLS; PHOTOTRANSDUCTION; TRANSLOCATION; VARIABILITY; MECHANISMS	Vision in dim light requires that photons absorbed by rod photoreceptors evoke signals that reliably propagate through the retina. We investigated how a perturbation in rod physiology affects propagation of those signals in the retina and ultimately visual sensitivity. Recoverin is a protein in rods that prolongs phototransduction and enhances visual sensitivity. It is not present in neurons postsynaptic to rods, yet we found that light-evoked responses of rod bipolar and ganglion cells were shortened when measured in recoverin-deficient retinas. Unexpectedly, the effect of recoverin on postsynaptic signals could not be explained by its effect on phototransduction. Instead, it is an effect of recoverin downstream of phototransduction in rods that prolongs signal transmission and enhances visual sensitivity. An important implication of our findings is that the recovery phase of the rod photoresponse does not contribute significantly to visual sensitivity near absolute threshold.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Ophthalmol, Los Angeles, CA 90089 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Southern California; Osaka University	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jbhhh@u.washington.edu			NEI NIH HHS [R01 EY006641, EY12703, EY11850, EY12190, EY06641, EY14784, EY10336, EY13050] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012703, R01EY010336, F32EY014784, R01EY006641, R01EY011850, P30EY012190, R01EY013050] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; BARLOW HB, 1971, VISION RES, V23, P87; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HAYES JM, 1993, BEHAV GENET, V23, P395, DOI 10.1007/BF01067442; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; McGinnis JF, 1997, J NEUROSCI RES, V50, P487, DOI 10.1002/(SICI)1097-4547(19971101)50:3<487::AID-JNR15>3.0.CO;2-3; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; STERLING P, 1988, J NEUROSCI, V8, P623; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Walraven J., 1990, NEUROPHYSIOLOGICAL F, P53; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9	40	83	83	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					413	420		10.1016/j.neuron.2005.04.006	http://dx.doi.org/10.1016/j.neuron.2005.04.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882641	Bronze			2022-12-24	WOS:000229011400013
J	Haynes, JD; Rees, G				Haynes, JD; Rees, G			Predicting the orientation of invisible stimuli from activity in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; CORTICAL ACTIVATION; BINOCULAR-RIVALRY; STRIATE CORTEX; FUNCTIONAL MRI; PERCEPTION; REPRESENTATIONS; AWARENESS; VISUALIZATION; ADAPTATION	Humans can experience aftereffects from oriented stimuli that are not consciously perceived, suggesting that such stimuli receive cortical processing. Determining the physiological substrate of such effects has proven elusive owing to the low spatial resolution of conventional human neuroimaging techniques compared to the size of orientation columns in visual cortex. Here we show that even at conventional resolutions it is possible to use fMRI to obtain a direct measure of orientation-selective processing in V1. We found that many parts of V1 show subtle but reproducible biases to oriented stimuli, and that we could accumulate this information across the whole of V1 using multivariate pattern recognition. Using this information, we could then successfully predict which one of two oriented stimuli a participant was viewing, even when masking rendered that stimulus invisible. Our findings show that conventional fMRI can be used to reveal feature-selective processing in human cortex, even for invisible stimuli.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Haynes, JD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 1998, NAT NEUROSCI, V1, P549, DOI 10.1038/2785; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DUDA OR, 2001, PATTERN CLASSIFICATI; Everitt B.S., 1991, APPL MULTIVARIATE DA; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Westheimer G, 2003, VISION RES, V43, P53, DOI 10.1016/S0042-6989(02)00398-X; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107	37	604	612	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					686	691		10.1038/nn1445	http://dx.doi.org/10.1038/nn1445			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852013				2022-12-24	WOS:000228895100031
J	Rogan, MT; Leon, KS; Perez, DL; Kandel, ER				Rogan, MT; Leon, KS; Perez, DL; Kandel, ER			Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR-POTENTIATED STARTLE; INDUCED DOPAMINE RELEASE; PAVLOVIAN CONDITIONED INHIBITION; TONICALLY ACTIVE NEURONS; LONG-TERM DEPRESSION; LATERAL AMYGDALA; GENICULATE-BODY; LATENT INHIBITION; VENTRAL STRIATUM	The ability to identify, develop, and exploit conditions of safety and security is central to survival and mental health, but little is known of the neurobiology of these processes or associated positive modulations of affective state. We studied electrophysiological and affective correlates of learned safety by negatively correlating an auditory conditioned stimulus (CS) with aversive events (US). This CS came to signify a period of protection, reducing fear responses to predictors of the US and increasing adventurous exploration of a novel environment. In nonaversive conditions, mice turn on the CS when given the opportunity. Thus, conditioned safety involves a reduction of learned and instinctive fear, as well as positive affective responses. Concurrent electrophysiological measurements identified a safety learning-induced long-lasting depression of CS-evoked activity in the lateral nucleus of the amygdala, consistent with fear reduction, and an increase of CS-evoked activity in a region of the striatum involved in positive affect, euphoric responses, and reward.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Kavli Inst Brain Sci, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Rogan, MT (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA.	mr522@columbia.edu; erk5@columbia.edu	Perez, David/AAB-6453-2020	Perez, David/0000-0003-2721-583X	NIMH NIH HHS [F32 MH 12752, P01 MH 06970] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012752] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J; CLUGNET MC, 1990, J NEUROSCI, V10, P1055; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Coutureau E, 2001, BRAIN RES BULL, V56, P49, DOI 10.1016/S0361-9230(01)00592-5; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DENNY MR, 1991, FEAR AVOIDANCE PHOBI, P199; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; EDELINE JM, 1992, BEHAV NEUROSCI, V106, P81, DOI 10.1037/0735-7044.106.1.81; FALLS WA, 1995, BEHAV NEUROSCI, V109, P379, DOI 10.1037/0735-7044.109.3.379; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fudge JL, 2004, J COMP NEUROL, V476, P330, DOI 10.1002/cne.20228; Fudge JL, 2002, J NEUROSCI, V22, P10078; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Grillon C, 2001, PSYCHOPHYSIOLOGY, V38, P807, DOI 10.1111/1469-8986.3850807; Heinbockel T, 2000, J NEUROSCI, V20; Heldt SA, 2003, BEHAV BRAIN RES, V144, P175, DOI 10.1016/S0166-4328(03)00092-5; Heldt SA, 1998, BRAIN RES, V813, P274, DOI 10.1016/S0006-8993(98)01047-6; HENDRY DP, 1969, PSYCHONOMIC SOC, V9, P261; Holstege G, 2003, J NEUROSCI, V23, P9185; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IWATA J, 1986, BRAIN RES, V383, P195, DOI 10.1016/0006-8993(86)90020-X; Josselyn SA, 2005, NEUROPSYCHOPHARMACOL, V30, P17, DOI 10.1038/sj.npp.1300530; Konorski J., 1967, INTEGRATIVE ACTIVITY; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LEDOUX JE, 1987, J COMP NEUROL, V264, P123, DOI 10.1002/cne.902640110; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; LEUNG LW, 1990, NEUROMETHODS, V15, P227; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Linke R, 1999, EUR J NEUROSCI, V11, P187, DOI 10.1046/j.1460-9568.1999.00422.x; LOLORDO VM, 1969, PSYCHOL BULL, V72, P193, DOI 10.1037/h0027907; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; MASUDA Y, 1994, PHYSIOL BEHAV, V56, P785, DOI 10.1016/0031-9384(94)90243-7; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MCINTOSH AR, 1994, J NEUROPHYSIOL, V72, P1717, DOI 10.1152/jn.1994.72.4.1717; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MOWRER OH, 1956, PSYCHOL REV, V63, P114, DOI 10.1037/h0040613; ODonnell P, 1996, NEUROPSYCHOPHARMACOL, V15, P87, DOI 10.1016/0893-133X(95)00177-F; OGAN MT, 2001, NEURAL MECH MEMORY F, P58; Pavlov I.P., 1927, CONDITIONED REFLEXES; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pederson CL, 1997, BRAIN RES, V760, P261, DOI 10.1016/S0006-8993(97)00395-8; PETERSON SL, 1986, INT J NEUROSCI, V29, P245, DOI 10.3109/00207458608986154; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; PREMACK D, 1968, NATURE, V217, P288, DOI 10.1038/217288a0; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Ravel S, 2003, J NEUROSCI, V23, P8489; RESCORLA RA, 1971, J COMP PHYSIOL PSYCH, V75, P77, DOI 10.1037/h0030694; RESCORLA RA, 1969, PSYCHOL BULL, V72, P77, DOI 10.1037/h0027760; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Schauz C, 2000, LEARN MEMORY, V7, P393, DOI 10.1101/lm.33800; Schiller D, 2004, NEUROSCIENCE, V128, P15, DOI 10.1016/j.neuroscience.2004.06.020; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tang JR, 2001, BRAIN RES, V919, P232, DOI 10.1016/S0006-8993(01)03020-7; THOMAS E, 1991, BRAIN RES, V547, P303, DOI 10.1016/0006-8993(91)90975-2; Waddell J, 2003, BEHAV BRAIN RES, V142, P115, DOI 10.1016/S0166-4328(02)00405-9; WALASEK G, 1995, ACTA NEUROBIOL EXP, V55, P121; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Weinberger Norman M., 1995, P1071; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; WIERTELAK EP, 1994, BRAIN RES, V634, P214, DOI 10.1016/0006-8993(94)91924-0; WILLIAMS DA, 1992, PSYCHOL BULL, V111, P275, DOI 10.1037/0033-2909.111.2.275; YADIN E, 1981, J COMP PHYSIOL PSYCH, V95, P331, DOI 10.1037/h0077769	82	161	162	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					309	320		10.1016/j.neuron.2005.02.017	http://dx.doi.org/10.1016/j.neuron.2005.02.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848808	Bronze			2022-12-24	WOS:000228674800016
J	Blitz, DM; Regehr, WG				Blitz, DM; Regehr, WG			Timing and specificity of feed-forward inhibition within the LGN	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; RELAY CELLS; POSTSYNAPTIC POTENTIALS; RETINOGENICULATE SYNAPSE; DENDRITIC OUTPUTS; THALAMIC NEURONS; PYRAMIDAL CELLS; RECEPTIVE-FIELD; NATURAL SCENES	Local interneurons provide feed-forward inhibition from retinal ganglion cells (RGCs) to thalamocortical (TC) neurons, but questions remain regarding the timing, magnitude, and functions of this inhibition. Here, we identify two types of inhibition that are suited to play distinctive roles. We recorded excitatory and inhibitory postsynaptic currents (EPSCs/IPSCs) in TC neurons in mouse brain slices and activated individual RGC inputs. In 34% of TC neurons, we identified EPSCs and IPSCs with identical thresholds that were tightly correlated, indicating activation by the same RGC. Such "locked" IPSCs occurred 1 ms after EPSC onset. The remaining neurons had only "nonlocked" inhibition, in which EPSCs and IPSCs had different thresholds, indicating activation by different RGCs. Nonlocked inhibition may refine receptive fields within the LGN by providing surround inhibition. In contrast, dynamic-clamp recordings suggest that locked inhibition improves the precision of synaptically evoked responses in individual TC neurons by eliminating secondary spikes.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NINDS NIH HHS [R01-NS432405] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; Dan Y, 1996, J NEUROSCI, V16, P3351; DOSSI RC, 1992, NEUROSCIENCE, V47, P279, DOI 10.1016/0306-4522(92)90244-V; Godwin DW, 1996, J NEUROSCI, V16, P8181; Govindaiah, 2004, NEURON, V41, P611, DOI 10.1016/S0896-6273(04)00013-3; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; HAMORI J, 1974, BRAIN RES, V80, P379, DOI 10.1016/0006-8993(74)91024-5; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; HIRSCH JC, 1987, NEUROSCIENCE, V23, P457, DOI 10.1016/0306-4522(87)90069-8; HOLDEFER RN, 1989, BRAIN RES, V488, P341, DOI 10.1016/0006-8993(89)90727-0; Hu B, 2000, BRAIN RES, V885, P87, DOI 10.1016/S0006-8993(00)02946-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; NORTON TT, 1992, PROG BRAIN RES, V90, P193; NORTON TT, 1989, BRAIN RES, V488, P348, DOI 10.1016/0006-8993(89)90728-2; OHARA PT, 1983, NEUROSCIENCE, V8, P189, DOI 10.1016/0306-4522(83)90060-X; PARE D, 1991, J NEUROPHYSIOL, V66, P1190, DOI 10.1152/jn.1991.66.4.1190; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 2001, CURR OPIN NEUROBIOL, V11, P437, DOI 10.1016/S0959-4388(00)00231-2; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; SOLTESZ I, 1992, PROG BRAIN RES, V90, P151; STANFORD LR, 1987, J NEUROPHYSIOL, V57, P218, DOI 10.1152/jn.1987.57.1.218; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Steriade M, 1997, THALAMUS, VI; STONE J, 1974, J NEUROPHYSIOL, V37, P722, DOI 10.1152/jn.1974.37.4.722; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; TROY JB, 1994, VISUAL NEUROSCI, V11, P111, DOI 10.1017/S0952523800011159; Ulrich D, 1997, J NEUROSCI, V17, P2348; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Ziburkus J, 2003, J NEUROPHYSIOL, V90, P1063, DOI 10.1152/jn.00178.2003	61	108	109	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					917	928		10.1016/j.neuron.2005.01.033	http://dx.doi.org/10.1016/j.neuron.2005.01.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797552	Bronze			2022-12-24	WOS:000228031300012
J	Singh, KK; Miller, FD				Singh, KK; Miller, FD			Activity regulates positive and negative neurotrophin-derived signals to determine axon competition	NEURON			English	Article							SUPERIOR CERVICAL-GANGLION; SYMPATHETIC NEURONS; NEUROMUSCULAR-JUNCTION; LOCAL-CONTROL; CA2+ INFLUX; INNERVATION; GROWTH; ACTIVATION; DEPOLARIZATION; RECEPTORS	Developmental axon competition plays a key role in sculpting neural circuitry. Here, we have asked how activity and neurotrophins could interact to select one axon over another. Using compartmented cultures of sympathetic neurons, we show that,. in the presence of NGF, local depolarization confers a competitive growth advantage on the depolarized axon collaterals and at the same time disadvantages the growth of unstimulated axons from the same and competing neurons. Depolarization mediates the competitive advantage by activating a CaMKII-MEK pathway, which converges to enhance local NGF-mediated downstream growth signals. Patterned electrical stimulation also acts via this pathway to enhance NGF-promoted axonal growth. In contrast, the competitive disadvantage is due to BDNF secreted from and acting on the unstimulated, competing axons through p75NTR. Thus, activity regulates both positive and negative wneurotrophin-derived signaling cascades to confer a competitive growth advantage on one axon versus another, thereby providing a cellular mechanism for developmental axon selection.	Univ Toronto, Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Miller, FD (corresponding author), Univ Toronto, Hosp Sick Children, Dept Dev Biol, 100 Coll St, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca						Aloyz R, 1999, LEARN MEMORY, V6, P216; [Anonymous], [No title captured]; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Balkowiec A, 2002, J NEUROSCI, V22, P10399; BLACK IB, 1976, BRAIN RES, V101, P503, DOI 10.1016/0006-8993(76)90474-1; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; CAMPENOT RB, 1984, BRAIN RES, V293, P159, DOI 10.1016/0006-8993(84)91463-X; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HILL CE, 1989, INT J DEV NEUROSCI, V7, P539, DOI 10.1016/0736-5748(89)90013-0; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; KANTOR DB, 2000, CURR OPIN NEUROBIOL, V10, P381; Kohn J, 1999, J NEUROSCI, V19, P5393; LAWRENCE JM, 1979, BRAIN RES, V168, P13, DOI 10.1016/0006-8993(79)90124-0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUBIN E, 1985, J NEUROSCI, V5, P685; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SPIRA ME, 1983, DEV BRAIN RES, V8, P311, DOI 10.1016/0165-3806(83)90014-7; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VIDOVIC M, 1987, DEV BRAIN RES, V32, P133, DOI 10.1016/0165-3806(87)90146-5; VIDOVIC M, 1988, J AUTONOM NERV SYST, V22, P57, DOI 10.1016/0165-1838(88)90154-3; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; YAROM Y, 1983, DEV BRAIN RES, V8, P321, DOI 10.1016/0165-3806(83)90015-9	41	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					837	845		10.1016/j.neuron.2005.01.049	http://dx.doi.org/10.1016/j.neuron.2005.01.049			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797546	Bronze			2022-12-24	WOS:000228031300006
J	Betts, LR; Taylor, CP; Sekuler, AB; Bennett, PJ				Betts, LR; Taylor, CP; Sekuler, AB; Bennett, PJ			Aging reduces center-surround antagonism in visual motion processing	NEURON			English	Article							MACAQUE V1 NEURONS; CLASSICAL RECEPTIVE-FIELD; MINI-MENTAL-STATE; PRIMATE AREA MT; AGE; CORTEX; CELLS; INHIBITION; PERCEPTION; DISPARITY	Discriminating the direction of motion of a low-contrast pattern becomes easier with increasing stimulus area. However, increasing the size of a high-contrast pattern makes it more difficult for observers to discriminate motion. This surprising result, termed spatial suppression, is thought to be mediated by a form of center-surround suppression found throughout the visual pathway. Here, we examine the counterintuitive hypothesis that aging alters such center-surround interactions in ways that improve performance in some tasks. We found that older observers required briefer stimulus durations than did younger observers to extract information about stimulus direction in conditions using large, high-contrast patterns. We suggest that this age-related improvement in motion discrimination may be linked to reduced GABAergic functioning in the senescent brain, which reduces center-surround suppression in motion-selective neurons.	McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; CIHR, Training Program Commun & Social Interact Hlth Ag, Mississauga, ON L5L 1C6, Canada; CIHR, Grp Sensory Cognit Aging, Mississauga, ON L5L 1C6, Canada; York Univ, Ctr Vis Res, N York, ON M3J 1P3, Canada	McMaster University; York University - Canada	Sekuler, AB (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.	sekuler@mcmaster.ca; bennett@mcmaster.ca	Taylor, Christopher/W-1808-2019	Taylor, Christopher/0000-0002-6592-6328				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Bair W, 2003, J NEUROSCI, V23, P7690; BALL K, 1986, J GERONTOL, V41, P176, DOI 10.1093/geronj/41.2.176; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradley DC, 1998, J NEUROSCI, V18, P7552; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Caspary DM, 1999, NEUROSCIENCE, V93, P307, DOI 10.1016/S0306-4522(99)00121-9; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lund JS, 1995, J ANAT, V187, P563; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pernberg J, 1998, EUR J NEUROSCI, V10, P3596, DOI 10.1046/j.1460-9568.1998.00364.x; Poe BH, 2001, J COMP NEUROL, V439, P65, DOI 10.1002/cne.1335; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; Sekuler R., 2000, OXFORD TXB GERIATRIC, P874; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Weale R. A., 1992, SENESCENCE HUMAN VIS; WEALE RA, 1961, T ILLUMINATING ENG S, V26, P95, DOI DOI 10.1177/147715356102600204; Wist ER, 2000, EXP BRAIN RES, V134, P295, DOI 10.1007/s002210000466	39	187	189	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					361	366		10.1016/j.neuron.2004.12.041	http://dx.doi.org/10.1016/j.neuron.2004.12.041			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694323	Bronze			2022-12-24	WOS:000226787700009
J	Cai, J; Qi, YC; Hu, XM; Tan, M; Liu, ZJ; Zhang, JS; Li, Q; Sander, M; Qiu, M				Cai, J; Qi, YC; Hu, XM; Tan, M; Liu, ZJ; Zhang, JS; Li, Q; Sander, M; Qiu, M			Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling	NEURON			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; VENTRAL NEURAL-TUBE; SONIC HEDGEHOG; MOTOR-NEURON; PROGENITOR-CELL; GENE-EXPRESSION; VERTEBRATE CNS; FACTOR OLIG2; DIFFERENTIATION; LINEAGE	In the developing spinal cord, early progenitor cells of the oligodendrocyte lineage are induced in the motor neuron progenitor (pMN) domain of the ventral neuroepithelium by the ventral midline signal Sonic hedgehog (Shh). The ventral generation of oligodendrocytes requires Nkx6-regulated expression of the bHLH gene Olig2 in this domain. In the absence of Nkx6 genes or Shh signaling, the initial expression of Olig2 in the pMN domain is completely abolished. In this study, we provide the in vivo evidence for a late phase of Olig gene expression independent of Nkx6 and Shh gene activities and reveal a brief second wave of oligodendrogenesis in the dorsal spinal cord. In addition, we provide genetic evidence that oligodendrogenesis can occur in the absence of hedgehog receptor Smoothened, which is essential for all hedgehog signaling.	Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Louisville; University of California System; University of California Irvine	Qiu, M (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	m0qiu001@louisville.edu	Messier, Claude/A-2322-2008; Sander, Maike/N-6615-2016	Messier, Claude/0000-0002-4791-1763; Sander, Maike/0000-0001-5308-7785; Liu, Zijing/0000-0001-7790-0590; /0000-0003-1721-7786	NINDS NIH HHS [NS37717] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037717] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 1999, DEV DYNAM, V216, P459, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<459::AID-DVDY14>3.3.CO;2-Z; Cai J, 2001, MOL CELL BIOL, V21, P4399, DOI 10.1128/MCB.21.13.4399-4403.2001; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; CHIANG C, 1996, NATURE, V383, P228; Davies JE, 2001, DEV BIOL, V233, P513, DOI 10.1006/dbio.2001.0224; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Fu H, 2002, DEVELOPMENT, V129, P681; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gregori N, 2002, J NEUROSCI, V22, P248, DOI 10.1523/JNEUROSCI.22-01-00248.2002; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Qi YC, 2003, MOL CELL NEUROSCI, V23, P440, DOI 10.1016/S1044-7431(03)00067-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Stiles CD, 2003, NEURON, V40, P447, DOI 10.1016/S0896-6273(03)00683-4; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Sussman CR, 2000, J NEUROSCI RES, V59, P413, DOI 10.1002/(SICI)1097-4547(20000201)59:3<413::AID-JNR16>3.3.CO;2-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Xu XH, 2000, MOL CELL NEUROSCI, V16, P740, DOI 10.1006/mcne.2000.0916; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	56	249	258	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					41	53		10.1016/j.neuron.2004.12.028	http://dx.doi.org/10.1016/j.neuron.2004.12.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629701	Bronze			2022-12-24	WOS:000226217100008
J	Rolls, MM; Doe, CQ				Rolls, MM; Doe, CQ			Baz, Par-6 and aPKC are not required for axon or dendrite specification in Drosophila	NATURE NEUROSCIENCE			English	Article							NEURONAL POLARITY; MUSHROOM BODIES; CELL POLARITY; NEUROBLASTS; PROLIFERATION; COMPLEX	Par-3/Baz, Par-6, and aPKC are evolutionarily conserved regulators of cell polarity, and overexpression experiments implicate them as axon determinants in vertebrate hippocampal neurons. Here we examined their mutant and overexpression phenotypes in Drosophila melanogaster. We found that mutants neurons had normal axon and dendrite morphology and remodeled axons correctly in metamorphosis, and that overexpression did not affect axon or dendrite specification. Baz/Par-6/aPKC are therefore not essential for axon specification in Drosophila.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu	Rolls, Melissa/G-6402-2014	Rolls, Melissa/0000-0002-5021-4360				CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	11	58	59	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1293	1295		10.1038/nn1346	http://dx.doi.org/10.1038/nn1346			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15543144				2022-12-24	WOS:000225353900007
J	Coesmans, M; Weber, JT; De Zeeuw, CI; Hansel, C				Coesmans, M; Weber, JT; De Zeeuw, CI; Hansel, C			Bidirectional parallel fiber plasticity in the cerebellum under climbing fiber control	NEURON			English	Article							LONG-TERM DEPRESSION; PURKINJE-CELL; CALCIUM TRANSIENTS; SYNAPTIC PLASTICITY; POSTSYNAPTIC CA2+; ACTION-POTENTIALS; NITRIC-OXIDE; LTD; INDUCTION; COINCIDENCE	Cerebellar parallel fiber (PF)-Purkinje cell (PC) synapses can undergo postsynaptically expressed long-term depression (LTD) or long-term potentiation (LTP) depending on whether or not the climbing fiber (CF) input is coactivated during tetanization. Here, we show that modifications of the postsynaptic calcium load using the calcium chelator BAPTA or photolytic calcium uncaging result in a reversal of the expected polarity of synaptic gain change. At higher concentrations, BAPTA blocks PF-LTP. These data indicate that PF-LTD requires a higher calcium threshold amplitude than PF-LTP induction and suggest that CF activity acts as a polarity switch by providing dendritic calcium transients. Moreover, previous CF-LTD induction changes the relative PF-LTD versus -LTP induction probability. These findings suggest that bidirectional cerebellar learning is governed by a calcium threshold rule operating "inverse" to the mechanism previously described at other glutamatergic synapses (BCM rule) and that the LTD/LTP induction probability is under heterosynaptic climbing fiber control.	Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hansel, C (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.hansel@erasmusmc.nl						Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 2001, SYNAPSES, P455; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Chen CF, 1997, J NEUROSCI, V17, P8687; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Connor JA, 1999, CAN J PHYSIOL PHARM, V77, P722, DOI 10.1139/cjpp-77-9-722; Cormier RJ, 2001, J NEUROPHYSIOL, V85, P399, DOI 10.1152/jn.2001.85.1.399; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Launey T, 2004, P NATL ACAD SCI USA, V101, P676, DOI 10.1073/pnas.0302914101; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohyama T, 2002, ANN NY ACAD SCI, V978, P425, DOI 10.1111/j.1749-6632.2002.tb07585.x; Reynolds T, 2000, J PHYSIOL-LONDON, V527, P563, DOI 10.1111/j.1469-7793.2000.00563.x; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Shen Y, 2002, NAT NEUROSCI, V5, P725, DOI 10.1038/nn895; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Weber JT, 2003, P NATL ACAD SCI USA, V100, P2878, DOI 10.1073/pnas.0536420100; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	70	286	289	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					691	700		10.1016/j.neuron.2004.10.031	http://dx.doi.org/10.1016/j.neuron.2004.10.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541316	Bronze			2022-12-24	WOS:000225338100014
J	Ding, J; Guzman, JN; Tkatch, T; Chen, SH; Goldberg, JA; Ebert, PJ; Levitt, P; Wilson, CJ; Hamm, HE; Surmeier, DJ				Ding, Jun; Guzman, Jaime N.; Tkatch, Tatiana; Chen, Songhai; Goldberg, Joshua A.; Ebert, Philip J.; Levitt, Pat; Wilson, Charles J.; Hamm, Heidi E.; Surmeier, D. James			RGS4-dependent attenuation of M-4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion	NATURE NEUROSCIENCE			English	Article							RGS MESSENGER-RNAS; REDUCE N-TYPE; BASAL GANGLIA; RECEPTOR SUPERSENSITIVITY; ACETYLCHOLINE-RELEASE; PARKINSONS-DISEASE; SYNTHETIC PEPTIDES; ALPHA-SUBUNITS; CA2+ CURRENTS; RAT STRIATUM	Parkinson disease is a neurodegenerative disorder whose symptoms are caused by the loss of dopaminergic neurons innervating the striatum. As striatal dopamine levels fall, striatal acetylcholine release rises, exacerbating motor symptoms. This adaptation is commonly attributed to the loss of interneuronal regulation by inhibitory D-2 dopamine receptors. Our results point to a completely different, new mechanism. After striatal dopamine depletion, D2 dopamine receptor modulation of calcium (Ca2+) channels controlling vesicular acetylcholine release in interneurons was unchanged, but M-4 muscarinic autoreceptor coupling to these same channels was markedly attenuated. This adaptation was attributable to the upregulation of RGS4-an autoreceptor-associated, GTPase-accelerating protein. This specific signaling adaptation extended to a broader loss of autoreceptor control of interneuron spiking. These observations suggest that RGS4-dependent attenuation of interneuronal autoreceptor signaling is a major factor in the elevation of striatal acetylcholine release in Parkinson disease.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Wilson, Charles/D-2529-2011; Ding, Jun/B-2513-2009; Hamm, Heidi E/G-2374-2014; Goldberg, Joshua/B-3398-2009	Wilson, Charles/0000-0002-9004-2145; Ding, Jun/0000-0003-0690-1312; chen, songhai/0000-0001-7316-7125; Goldberg, Joshua/0000-0002-5740-4087; Ebert, Philip/0000-0002-8945-2948; Tkatch, Tatiana/0000-0001-6626-7435	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS050900, R01NS034696, R37NS037760, R37NS034696, R01NS037760] Funding Source: NIH RePORTER; NICHD NIH HHS [HD15052] Funding Source: Medline; NIMH NIH HHS [MH065215, MH45156, T32 MH065215] Funding Source: Medline; NINDS NIH HHS [NS 37760, 32 NS 050900, NS 34696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; DOLEZAL V, 1990, J PHARMACOL EXP THER, V252, P739; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; FREUND TF, 1985, J NEUROSCI, V5, P603; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Geurts M, 2002, NEUROSCI LETT, V333, P146, DOI 10.1016/S0304-3940(02)01004-2; GOLARD A, 1993, J NEUROSCI, V13, P3884; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HU XT, 1990, J NEUROSCI, V10, P2318; Inanobe A, 2001, J PHYSIOL-LONDON, V535, P133, DOI 10.1111/j.1469-7793.2001.t01-1-00133.x; JOYCE JN, 1991, EXP NEUROL, V113, P277, DOI 10.1016/0014-4886(91)90017-7; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; MACKENZIE RG, 1989, EUR J PHARMACOL, V168, P43, DOI 10.1016/0014-2999(89)90631-6; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MILESON BE, 1991, BRAIN RES, V561, P1, DOI 10.1016/0006-8993(91)90742-E; NASTUK MA, 1985, J COMP NEUROL, V237, P176, DOI 10.1002/cne.902370204; Ni YG, 1999, J NEUROSCI, V19, P3674; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; UEDA H, 1995, BIOMED PHARMACOTHER, V49, P169, DOI 10.1016/0753-3322(96)82617-5; WICHMANN T, 1988, N-S ARCH PHARMACOL, V338, P623, DOI 10.1007/BF00165626; WOOTEN GF, 1990, NEUROBIOL DIS, P454; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yan Z, 1996, J NEUROSCI, V16, P2592; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; ZHANG W, 2000, J NEUROSCI, V22, P1709	49	181	184	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					832	842		10.1038/nn1700	http://dx.doi.org/10.1038/nn1700			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699510				2022-12-24	WOS:000237895200024
J	Koizumi, H; Higginbotham, H; Poon, T; Tanaka, T; Brinkman, BC; Gleeson, JG				Koizumi, Hiroyuki; Higginbotham, Holden; Poon, Tiffany; Tanaka, Teruyuki; Brinkman, Brendan C.; Gleeson, Joseph G.			Doublecortin maintains bipolar shape and nuclear translocation during migration in the adult forebrain	NATURE NEUROSCIENCE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; RAT OLFACTORY-BULB; NEURONAL MIGRATION; DIRECTIONAL GUIDANCE; CELL-MIGRATION; SUBVENTRICULAR ZONE; RADIAL MIGRATION; GRANULE NEURONS; CHAIN-MIGRATION; MAMMALIAN BRAIN	The ability of the mature mammalian nervous system to continually produce neuronal precursors is of considerable importance, as manipulation of this process might one day permit the replacement of cells lost as a result of injury or disease. In mammals, the anterior subventricular zone (SVZa) region is one of the primary sites of adult neurogenesis. Here we show that doublecortin (DCX), a widely used marker for newly generated neurons, when deleted in mice results in a severe morphological defect in the rostral migratory stream and delayed neuronal migration that is independent of direction or responsiveness to Slit chemorepulsion. DCX is required for nuclear translocation and maintenance of bipolar morphology during migration of these cells. Our data identifies a critical function for DCX in the movement of newly generated neurons in the adult brain.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS04387, NS02331, R01 NS041537, R01 NS47101] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BRINON JG, 1992, CELL TISSUE RES, V269, P289, DOI 10.1007/BF00319620; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Corbo JC, 2002, J NEUROSCI, V22, P7548; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Liu GF, 2003, J NEUROSCI, V23, P6651; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Murase S, 2002, J NEUROSCI, V22, P3568; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ward M, 2003, J NEUROSCI, V23, P5170; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619	49	179	185	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					779	786		10.1038/nn1704	http://dx.doi.org/10.1038/nn1704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699506	Green Submitted			2022-12-24	WOS:000237895200018
J	Meshi, D; Drew, MR; Saxe, M; Ansorge, MS; David, D; Santarelli, L; Malapani, C; Moore, H; Hen, R				Meshi, Dar; Drew, Michael R.; Saxe, Michael; Ansorge, Mark S.; David, Denis; Santarelli, Luca; Malapani, Chariklia; Moore, Holly; Hen, Rene			Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; DENTATE GYRUS; EXPRESSION; NEURONS; MICE	Environmental enrichment increases adult hippocampal neurogenesis and alters hippocampal-dependent behavior in rodents. To investigate a causal link between these two observations, we analyzed the effect of enrichment on spatial learning and anxiety-like behavior while blocking adult hippocampal neurogenesis. We report that environmental enrichment alters behavior in mice regardless of their hippocampal neurogenic capability, providing evidence that the newborn cells do not mediate these effects of enrichment.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, Biopsychol Unit, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Univ Paris Sud, Fac Pharm, F-92296 Chatenay Malabry, France	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; UDICE-French Research Universities; Universite Paris Saclay	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	rh95@columbia.edu	DAVID, Denis/K-1173-2014; Drew, Michael R/M-4787-2016; ansorge, mark s/L-1360-2014	DAVID, Denis/0000-0002-0506-6688; Drew, Michael R/0000-0002-3883-1542; Meshi, Dar/0000-0003-0772-037X	NIMH NIH HHS [5T32MH018264-22, 5R01MH068542-03, 5F31MH069089-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018264, R01MH068542, F31MH069089] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	353	367	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					729	731		10.1038/nn1696	http://dx.doi.org/10.1038/nn1696			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16648847				2022-12-24	WOS:000237895200009
J	Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM				Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM			Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MENTAL-RETARDATION; SYNAPTIC PLASTICITY; MISSENSE MUTATION; DENDRITIC SPINES; ACTIN DYNAMICS; DOWN-SYNDROME; MEMORY LOSS; LIM-KINASE; DREBRIN	Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase ( PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid ( A beta) was directly involved in PAK signaling deficits and drebrin loss in A beta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher A beta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.	Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Ste Foy, PQ G1K 7P4, Canada; Educ & Clin Ctr, Sepulveda, CA 91343 USA; Osaka Univ, Sch Med, Div Psychiat & Behav Proteom, Dept Post Genom & Dis, Suita, Osaka 565, Japan; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Laval University; Laval University; Osaka University; University of California System; University of California Los Angeles	Cole, GM (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA.	gmcole@ucla.edu	Calon, Frederic/AAF-4390-2020; Morihara, Takashi/AAK-2709-2021	Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, R01AG013741, P60AG010415, R01AG016793, R01AG010685, P50AG016570, R01AG022080] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG 16570, R01 AG013741, P50 AG016570, P50 AG05142, AG16793, AG022080, AG10685, R01 AG010685, AG10415, R01 AG13741, P01 AG16570] Funding Source: Medline; NINDS NIH HHS [NS43946] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Gedeon AK, 2003, AM J MED GENET A, V120A, P509, DOI 10.1002/ajmg.a.20131; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; MA QL, 2005, IN PRESS J NEUROSCI, V83; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McPhie DL, 2003, J NEUROSCI, V23, P6914; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Ong WY, 2002, EXP BRAIN RES, V144, P189, DOI 10.1007/s00221-002-1016-x; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; TAKAI E, 1986, J IMMUNOL METHODS, V95, P23, DOI 10.1016/0022-1759(86)90313-3; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yang FS, 1998, AM J PATHOL, V152, P379; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	50	246	261	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					234	242		10.1038/nn1630	http://dx.doi.org/10.1038/nn1630			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415866				2022-12-24	WOS:000234990100019
J	Piper, M; Anderson, R; Dwivedy, A; Weinl, C; van Horck, F; Leung, KM; Cogill, E; Holt, C				Piper, M; Anderson, R; Dwivedy, A; Weinl, C; van Horck, F; Leung, KM; Cogill, E; Holt, C			Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; ACTIN MESSENGER-RNA; AXON GUIDANCE; HEPARAN-SULFATE; ROUNDABOUT RECEPTOR; TYROSINE KINASE; VISUAL-SYSTEM; LIM-KINASE; F-ACTIN; ENDOCYTOSIS	Slits mediate multiple axon guidance decisions, but the mechanisms underlying the responses of growth cones to these cues remain poorly defined. We show here that collapse induced by Slit2-conditioned medium (Slit2-CM) in Xenopus retinal growth cones requires local protein synthesis (PS) and endocytosis. Slit2-CM elicits rapid activation of translation regulators and MAP kinases in growth cones, and inhibition of MAPKs or disruption of heparan sulfate blocks Slit2-CM-induced PS and repulsion. Interestingly, Slit2-CM causes a fast PS-dependent decrease in cytoskeletal F-actin concomitant with a PS-dependent increase in the actin-depolymerizing protein cofilin. Our findings reveal an unexpected link between Slit2 and cofilin in growth cones and suggest that local translation of actin regulatory proteins contributes to repulsion.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Holt, C (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ceh@mole.bio.cam.ac.uk	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Agnes F, 2004, NEUROREPORT, V15, P2567; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bassell GJ, 1998, J NEUROSCI, V18, P251; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Erskine L, 2000, J NEUROSCI, V20, P4975; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Niclou SP, 2000, J NEUROSCI, V20, P4962; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Walz A, 1997, DEVELOPMENT, V124, P2421; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong EV, 2004, J NEUROBIOL, V59, P66, DOI 10.1002/neu.10342; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	68	222	227	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					215	228		10.1016/j.neuron.2005.12.008	http://dx.doi.org/10.1016/j.neuron.2005.12.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423696	Green Accepted, Bronze			2022-12-24	WOS:000234979900009
J	Bermingham, JR; Shearin, H; Pennington, J; O'Moore, J; Jaegle, M; Driegen, S; van Zon, A; Darbas, A; Ozkaynak, E; Ryu, EJ; Milbrandt, J; Meijer, D				Bermingham, JR; Shearin, H; Pennington, J; O'Moore, J; Jaegle, M; Driegen, S; van Zon, A; Darbas, A; Ozkaynak, E; Ryu, EJ; Milbrandt, J; Meijer, D			The claw paw mutation reveals a role for Lgi4 in peripheral nerve development	NATURE NEUROSCIENCE			English	Article							DOMINANT PARTIAL EPILEPSY; SCHWANN-CELL MYELINATION; TEMPORAL-LOBE EPILEPSY; RICH REPEAT PROTEINS; AUDITORY FEATURES; DOMAIN; MOUSE; GENE; NEUREGULIN-1; EXPRESSION	Peripheral nerve development results from multiple cellular interactions between axons, Schwann cells and the surrounding mesenchymal tissue. The delayed axonal sorting and hypomyelination throughout the peripheral nervous system of claw paw (clp) mutant mice suggest that the clp gene product is critical for these interactions. Here we identify the clp mutation as a 225-bp insertion in the Lgi4 gene. Lgi4 encodes a secreted and glycosylated leucine-rich repeat protein and is expressed in Schwann cells. The clp mutation affects Lgi4 mRNA splicing, resulting in a mutant protein that is retained in the cell. Additionally, siRNA-mediated downregulation of Lgi4 in wild-type neuron-Schwann cell cocultures inhibits myelination, whereas exogenous Lgi4 restores myelination in clp/clp cultures. Thus, the abnormalities observed in clp mice are attributable to the loss of Lgi4 function, and they identify Lgi4 as a new component of Schwann cell signaling pathway(s) that controls axon segregation and myelin formation.	McLaughlin Res Inst, Great Falls, MT 59405 USA; Erasmus MC Univ Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Dept Psychiat, St Louis, MO 63110 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); Washington University (WUSTL)	Bermingham, JR (corresponding author), McLaughlin Res Inst, 1520 23rd St S, Great Falls, MT 59405 USA.	jrbjr@po.mri.montana.edu; d.meijer@erasmusmc.nl	Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745, R21NS049087, R01NS040751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40751, NS40745, R01 NS040751, NS049087] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHELOS JJ, 1993, J NEUROSCI RES, V35, P46, DOI 10.1002/jnr.490350107; Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berkovic SF, 2004, NEUROLOGY, V62, P1115, DOI 10.1212/01.WNL.0000118213.94650.81; Bermingham JR, 2002, J NEUROSCI, V22, P10217; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Darbas A, 2004, DEV BIOL, V272, P470, DOI 10.1016/j.ydbio.2004.05.017; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gherardi E, 2004, CURR OPIN STRUC BIOL, V14, P669, DOI 10.1016/j.sbi.2004.10.010; Ghislain J, 2002, DEVELOPMENT, V129, P155; Gu WL, 2004, NEUROGENETICS, V5, P41, DOI 10.1007/s10048-003-0158-8; Gu WL, 2002, FEBS LETT, V519, P71, DOI 10.1016/S0014-5793(02)02713-8; HART GW, 1979, J BIOL CHEM, V254, P9747; HENRY EW, 1991, J HERED, V82, P287, DOI 10.1093/oxfordjournals.jhered.a111088; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; JESSEN KR, 2004, MYELIN BIOL DISORDER, V1, P329; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Koszowski AG, 1998, J NEUROSCI, V18, P5859; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nagasawa K, 2001, CURR DRUG METAB, V2, P355, DOI 10.2174/1389200013338243; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; Pisano T, 2005, EPILEPSIA, V46, P118, DOI 10.1111/j.0013-9580.2005.26304.x; Runkel F, 2003, MAMM GENOME, V14, P665, DOI 10.1007/s00335-003-2282-z; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 2001, GLIAL CELL DEV, P223; Wegner M, 2000, GLIA, V29, P118, DOI 10.1002/(SICI)1098-1136(20000115)29:2<118::AID-GLIA4>3.0.CO;2-Q; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	50	77	79	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					76	84		10.1038/nn1598	http://dx.doi.org/10.1038/nn1598			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341215				2022-12-24	WOS:000234288000020
J	Landsberg, RL; Awatramani, RB; Hunter, NL; Farago, AF; DiPietrantonio, HJ; Rodriguez, CI; Dymecki, SM				Landsberg, RL; Awatramani, RB; Hunter, NL; Farago, AF; DiPietrantonio, HJ; Rodriguez, CI; Dymecki, SM			Hindbrain rhombic lip is comprised of discrete progenitor cell populations allocated by Pax6	NEURON			English	Article							DORSAL SPINAL-CORD; NEURAL-TUBE; ROOF PLATE; MEDULLA-OBLONGATA; FLP-RECOMBINASE; MATH1 EXPRESSION; NEURONAL FATES; GENE; MOUSE; CNS	The lower rhombic lip (LRL) is a germinal zone in the dorsal hindbrain productive of tangentially migrating neurons, streaming extramurally (mossy fiber neurons) or intramurally (climbing fiber neurons). Here we show that LRL territory, operationally defined by Wnt1 expression, is parceled into molecular subdomains predictive of cell fate. Progressing dorsoventrally, Lmx1a and Gdf7 expression identifies the primordium for hindbrain choroid plexus epithelial cells; Math 1, for mossy fiber neurons; and immediately ventral to Math1 yet within Wnt1(+)territory, a climbing fiber primordium dominated by Ngn1-expressing cells. Elimination of Pax6 results in expansion of this Ngn1(+) progenitor pool and reduction in the Math1(+) pool, with accompanying later enlargement of the climbing fiber nucleus and reductions in mossy fiber nuclei. Pax6 loss also disrupts Msx expression cell-nonautonomously, suggesting Pax6 may influence LRL progenitor identity indirectly through potentiating BMP signaling. These studies suggest that underlying the diversity and proportions of fates produced by the LRL is a precise suborganization regulated by Pax6.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu	Rodriguez, Carolyn I/K-8479-2014	Rodriguez, Carolyn I/0000-0001-6697-1692	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD049320, R01HD051936] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY12196] Funding Source: Medline; NHGRI NIH HHS [F31 HG000180] Funding Source: Medline; NICHD NIH HHS [P01 HD036379, F31 HD049320, R01 HD051936] Funding Source: Medline; NIDDK NIH HHS [R21 DK618021, R01 DK067826] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; Ambrosiani J, 1996, NEUROREPORT, V7, P1285, DOI 10.1097/00001756-199605170-00013; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Belluardo N, 1997, J COMP NEUROL, V379, P226; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; DYMECKI SM, 2000, SITE SPECIFIC RECOMB; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ELLENBERGER C, 1969, J COMP NEUROL, V137, P71, DOI 10.1002/cne.901370105; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Foletti DL, 2001, J NEUROSCI, V21, P5461, DOI 10.1523/JNEUROSCI.21-15-05461.2001; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Helms AW, 2000, DEVELOPMENT, V127, P1185; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; His W., 1891, ABHANDLUNGEN KONI MP, V29, P1; Horie M, 2003, EUR J NEUROSCI, V17, P49, DOI 10.1046/j.1460-9568.2003.02424.x; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Hunter NL, 2005, GENESIS, V41, P99, DOI 10.1002/gene.20101; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Liu Y, 2004, DEVELOPMENT, V131, P1017, DOI 10.1242/dev.00994; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millen KJ, 2004, DEV BIOL, V270, P382, DOI 10.1016/j.ydbio.2004.03.008; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Osumi N, 1997, DEVELOPMENT, V124, P2961; ROBERTS RC, 1967, GENET RES, V9, P121, DOI 10.1017/S0016672300010387; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; TAN K, 1991, ANAT EMBRYOL, V183, P321; Timmer JR, 2002, DEVELOPMENT, V129, P2459; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	64	111	112	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					933	947		10.1016/j.neuron.2005.11.031	http://dx.doi.org/10.1016/j.neuron.2005.11.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364898	Bronze			2022-12-24	WOS:000234301700010
J	Xie, Z; Huganir, RL; Penzes, P				Xie, Z; Huganir, RL; Penzes, P			Activity-dependent dendritic spine structural plasticity is regulated by small GTPase Rap1 and its target AF-6	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; BINDING PROTEIN; SILENT SYNAPSES; ACTIVATION; DYNAMICS; RAS; DOMAIN; GEF	Activity-dependent remodeling of dendritic spines is essential for neural circuit development and synaptic plasticity, but the mechanisms that coordinate synaptic structural and functional plasticity are not well understood. Here we investigate the signaling pathways that enable excitatory synapses to undergo activity-dependent structural modifications. We report that activation of NMDA receptors in cultured cortical neurons induces spine morphogenesis and activation of the small GTPase Rap1. Rap1 bimodally regulates spine morphology: activated Rap1 recruits the PDZ domain-containing protein AF-6 to the plasma membrane and induces spine neck elongation, while inactive Rap1 dissociates AF-6 from the membrane and induces spine enlargement. Rap1 also regulates spine content of AMPA receptors: thin spines induced by Rap1 activation have reduced GluR1-containing AMPA receptor content, while large spines induced by Rap1 inactivation are rich in AMPA receptors. These results identify a signaling pathway that regulates activity-dependent synaptic structural plasticity and coordinates it with functional plasticity.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016; Xie, Zhong/B-6829-2011	Penzes, Peter/0000-0001-5449-1640; Xie, Zhong/0000-0002-8348-4455				Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Imamura Y, 2003, NEUROREPORT, V14, P1203, DOI 10.1097/00001756-200307010-00003; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wong WT, 2000, J NEUROSCI, V20, P5024; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	61	90	91	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					605	618		10.1016/j.neuron.2005.09.027	http://dx.doi.org/10.1016/j.neuron.2005.09.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301177	Bronze			2022-12-24	WOS:000233677300014
J	Lukaszewicz, A; Savatier, P; Cortay, V; Giroud, P; Huissoud, C; Berland, M; Kennedy, H; Dehay, C				Lukaszewicz, A; Savatier, P; Cortay, V; Giroud, P; Huissoud, C; Berland, M; Kennedy, H; Dehay, C			G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex	NEURON			English	Article							RADIAL GLIAL-CELLS; VISUAL-CORTEX; GENE-EXPRESSION; OLIGODENDROCYTE DIFFERENTIATION; SUBVENTRICULAR ZONE; RESTRICTION POINT; DEPENDENT KINASES; NEOCORTICAL AREAS; CEREBRAL-CORTEX; NERVOUS-SYSTEM	We have investigated the cell cycle-related mechanisms that lead to the emergence of primate areas 17 and 18. These areas are characterized by striking differences in cytoarchitectonics and neuron number. We show in vivo that (1) area 17 precursors of supragranular neurons exhibit a shorter cell cycle duration, a reduced G1 phase, and a higher rate of cell cycle reentry than area 18 precursors; (2) area 17 and area 18 precursors show contrasting and specific levels of expression of cyclin E (high in area 17, low in area 18) and p27(Kip1) (low in area 17, high in area 18); (3) ex vivo up- and downmodulation of cyclin E and P27(Kip1) show that both regulators influence cell cycle kinetics by modifying rates of cell cycle progression and cell cycle reentry; (4) modeling the areal differences in cell cycle parameters suggests that they contribute to areal differences in numbers of precursors and neuron production.	Univ Lyon 1, INSERM, U371, Dept Stem Cell & Cort Dev,IFR19, F-69500 Bron, France; Hop Lyon Sud, F-69495 Pierre Benite, France; PrimaStem, F-69500 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Dehay, C (corresponding author), Univ Lyon 1, INSERM, U371, Dept Stem Cell & Cort Dev,IFR19, 18 Ave Doyen Lepine, F-69500 Bron, France.	dehay@lyon.inserm.fr	SAVATIER, Pierre/J-4663-2014; Dehay, Colette/H-4437-2014; Kennedy, Henry/B-9636-2013; Giroud, Pascale/B-9313-2013; Huissoud, Cyril/B-6146-2013; huissoud, cyril/E-2231-2013	Dehay, Colette/0000-0002-5196-1464; Kennedy, Henry/0000-0002-2796-7663; 				Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; BEAULIEU C, 1989, J COMP NEUROL, V279, P228, DOI 10.1002/cne.902790206; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Craig C, 1997, ONCOGENE, V14, P2283, DOI 10.1038/sj.onc.1201064; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; Dehay C, 2001, J NEUROSCI, V21, P201, DOI 10.1523/JNEUROSCI.21-01-00201.2001; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; GAREY LJ, 1985, J COMP NEUROL, V240, P305, DOI 10.1002/cne.902400307; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Job C, 2003, DEV BIOL, V257, P221, DOI 10.1016/S0012-1606(03)00070-8; KENNEDY H, 1993, CEREB CORTEX, V3, P171, DOI 10.1093/cercor/3.3.171; Kennedy H, 2001, DEVELOPMENTAL SCI, V4, P147; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KOSTOVIC I, 1984, J NEUROSCI, V4, P25; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LUKASZEWICZ A, 2001, STEM PROG CELLS BIOL; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McCullagh P, 1989, GEN LINEAR MODELS; Meyer G, 2000, J NEUROSCI, V20, P1858; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; MUMMERY CL, 1987, DEV BIOL, V121, P10, DOI 10.1016/0012-1606(87)90133-3; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohnuma S, 2002, METHODS, V28, P411, DOI 10.1016/S1046-2023(02)00260-8; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; Polleux F, 1997, J NEUROSCI, V17, P7763; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; RAKIC P, 1973, J COMP NEUROL, V147, P523, DOI 10.1002/cne.901470407; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skoglund TS, 1996, NEUROSCI LETT, V208, P97, DOI 10.1016/0304-3940(96)12569-6; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1982, J ANAT, V134, P415; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WIMMEL A, 1994, ONCOGENE, V9, P995; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	71	233	239	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					353	364		10.1016/j.neuron.2005.06.032	http://dx.doi.org/10.1016/j.neuron.2005.06.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055060	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000231051900007
J	Fryer, JD; Holtzman, DM				Fryer, JD; Holtzman, DM			The bad seed in Alzheimer's disease	NEURON			English	Editorial Material							FAMILIAL BRITISH DEMENTIA; A-BETA; PROTEIN; A-BETA-42(43); PLAQUES	In this issue of Neuron, McGowan et al. report on a new mouse model of amyloid deposition as occurs in Alzheimer's disease. Unlike previous models in which overexpression of the amyloid precursor protein results in amyloid plaque formation, McGowan et al. have produced mice that overexpress only A beta 40 or A beta 42 and prove that A beta 42 is critical for the formation of amyloid deposits in vivo.	Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Neurol & Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Fryer, JD (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Neurol & Mol Biol & Pharmacol, St Louis, MO 63110 USA.							Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Vidal R, 1999, NATURE, V399, P776	12	19	22	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					167	168		10.1016/j.neuron.2005.07.002	http://dx.doi.org/10.1016/j.neuron.2005.07.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039556	Bronze			2022-12-24	WOS:000230693900001
J	Qiu, FTT; von der Heydt, R				Qiu, FTT; von der Heydt, R			Figure and ground in the visual cortex: V2 combines stereoscopic cues with Gestalt rules	NEURON			English	Article							BINOCULAR DEPTH DISCRIMINATION; CONTEXTUAL MODULATION; ILLUSORY CONTOURS; NEURAL MECHANISM; BORDER OWNERSHIP; OCCLUDED OBJECTS; MONKEY; PERCEPTION; RESPONSES; NEURONS	Figure-ground organization is a process by which the visual system identifies some image regions as foreground and others as background, inferring 3D layout from 2D displays. A recent study reported that edge responses of neurons in area V2 are selective for side-of-figure, suggesting that figure-ground organization is encoded in the contour signals (border ownership coding). Here, we show that area V2 combines two strategies of computation, one that exploits binocular stereoscopic information for the definition of local depth order, and another that exploits the global configuration of contours (Gestalt factors). These are combined in single neurons so that the "near" side of the preferred 3D edge generally coincides with the preferred side-of-figure in 2D displays. Thus, area V2 represents the borders of 2D figures as edges of surfaces, as if the figures were objects in 3D space. Even in 3D displays, Gestalt factors influence the responses and can enhance or null the stereoscopic depth information.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	von der Heydt, R (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038034] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002966, EY-02966] Funding Source: Medline; NINDS NIH HHS [P01 NS038034, NS-38034] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Bakin JS, 2000, J NEUROSCI, V20, P8188; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Baumann R, 1997, EUR J NEUROSCI, V9, P1290, DOI 10.1111/j.1460-9568.1997.tb01484.x; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V211, P599, DOI 10.1113/jphysiol.1970.sp009296; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; Freeman RD, 2001, PROG BRAIN RES, V134, P157; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GREGORY RL, 1974, PERCEPT PSYCHOPHYS, V15, P411, DOI 10.3758/BF03199279; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; Heider B, 2002, J COGNITIVE NEUROSCI, V14, P1018, DOI 10.1162/089892902320474472; Heydt R., 2003, J VISUAL-JAPAN, V3, P666, DOI [DOI 10.1167/3.9.666, 10.1167/3.9.666]; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Idesawa M., 1991, JPN J APPL PHYS, V30, P751, DOI [10.1143/JJAP.30.L751, DOI 10.1143/JJAP.30.L751]; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JULESZ B, 1960, AT&T TECH J, V39, P1125, DOI 10.1002/j.1538-7305.1960.tb03954.x; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KAPLAN GA, 1969, PERCEPT PSYCHOPHYS, V6, P193, DOI 10.3758/BF03207015; Koffka K, 1935, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K., 1995, INVITATION COGNITIVE, P1; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Rensink RA, 1998, VISION RES, V38, P2489, DOI 10.1016/S0042-6989(98)00051-0; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Rubin E., 1921, VISUELL WAHRGENOMMEN; Rubin E., 2001, VISUAL PERCEPTION ES, P225; SCHUETZE H, 2003, J VIS, V3, P114; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; SPILLMANN L, 2003, VISUAL NEUROSCIENCES, P1573; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; von der Heydt R, 2004, PERCEPTION, V33, P46; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; VONDERHEYDT R, 1993, BIOMED RES-TOKYO, V14, P1; Wertheimer M., 2001, VISUAL PERCEPTION ES, P216; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; YONAS A, 1987, PERCEPT PSYCHOPHYS, V41, P53, DOI 10.3758/BF03208213; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	47	180	183	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					155	166		10.1016/j.neuron.2005.05.028	http://dx.doi.org/10.1016/j.neuron.2005.05.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996555	Bronze, Green Accepted			2022-12-24	WOS:000230464000015
J	Oh, MC; Derkach, VA				Oh, MC; Derkach, VA			Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; PHOSPHORYLATION; CONDUCTANCE; SWITCH	GluR1 and GluR2 subunits compose AMPA receptors (AMPARs) in the mature hippocampus, and both the GluR1 subunit and Ca2+/calmodulin-dependent protein kinase II (CaMKII) are required for synaptic plasticity, memory and learning. Although GluR1 phosphorylation by CaMKII is preserved, the functional regulation of AMPARs by phosphorylation is lost in the presence of the GluR2 subunit. Our findings define a previously unknown, dominant role of the GluR2 subunit in signaling mediated by CaMKII at AMPARs.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Derkach, VA (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	derkachv@ohsu.edu			NINDS NIH HHS [NS47773, NS27037] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037, F30NS047773] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Schmitt WB, 2003, J NEUROSCI, V23, P3953; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985	15	86	98	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					853	854		10.1038/nn1476	http://dx.doi.org/10.1038/nn1476			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924137				2022-12-24	WOS:000230137100008
J	Chen, L; Feany, MB				Chen, L; Feany, MB			alpha-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease	NATURE NEUROSCIENCE			English	Article							COUPLED RECEPTOR KINASES; HUMAN BRAIN; PROTEIN; MUTATIONS; NEURODEGENERATION; LESIONS; GENE; TAU; SUPPRESSION; HUNTINGTIN	alpha-Synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies. These inclusion bodies are the characteristic pathologic lesions of Parkinson disease. Here we define the role of phosphorylation of Ser129 in alpha-synuclein toxicity and inclusion formation using a Drosophila model of Parkinson disease. Mutation of Ser129 to alanine to prevent phosphorylation completely suppresses dopaminergic neuronal loss produced by expression of human alpha-synuclein. In contrast, altering Ser129 to the negatively charged residue aspartate, to mimic phosphorylation, significantly enhances alpha-synuclein toxicity. The G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity. Blocking phosphorylation at Ser129 substantially increases aggregate formation. Thus Ser129 phosphorylation status is crucial in mediating alpha-synuclein neurotoxicity and inclusion formation. Because increased number of inclusion bodies correlates with reduced toxicity, inclusion bodies may protect neurons from alpha-synuclein toxicity.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970	NIA NIH HHS [AG88001] Funding Source: Medline; NINDS NIH HHS [NS41536] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041536] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Choi JY, 2002, BIOTECHNOL APPL BIOC, V36, P33, DOI 10.1042/BA20020004; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forloni G, 1996, CURR OPIN NEUROL, V9, P492, DOI 10.1097/00019052-199612000-00017; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, ANTIVIR RES, V53, P99, DOI 10.1016/S0166-3542(01)00196-6; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shulman JM, 2003, GENETICS, V165, P1233; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	43	486	504	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					657	663		10.1038/nn1443	http://dx.doi.org/10.1038/nn1443			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834418				2022-12-24	WOS:000228895100027
J	Chen, X; Ye, HH; Kuruvilla, R; Ramanan, N; Scangos, KW; Zhang, C; Johnson, NM; England, PM; Shokat, KM; Ginty, DD				Chen, X; Ye, HH; Kuruvilla, R; Ramanan, N; Scangos, KW; Zhang, C; Johnson, NM; England, PM; Shokat, KM; Ginty, DD			A chemical-genetic approach to studying neurotrophin signaling	NEURON			English	Article							NERVE GROWTH-FACTOR; DEPENDENT PROTEIN-KINASES; RECEPTOR GENE; SYMPATHETIC NEURONS; EMBRYONIC NEURONS; INHIBITOR; K-252A; K252A; TRKA; DISRUPTION	Trk tyrosine kinases are receptors for members of the neurotrophin family and are crucial for growth and survival of specific populations of neurons. Yet, the functions of neurotrophin-Trk signaling in postnatal development as well as maintenance and plasticity of the adult nervous system are less clear. We report here the generation of mice harboring Trk knockin alleles that allow for pharmacological control of Trk kinase activity. Nanomolar concentrations of either 1NMPP1 or 1NaPP1, derivatives of the general kinase inhibitor PP1, inhibit NGF and BDNF signaling in TrkA(F592A) and TrkB(F616A) neurons, respectively, while no such Trk inhibition is observed in wild-type neurons. Moreover, oral administration of 1NMPP1 leads to specific inhibition of TrkA(F592A), TrkB(F616A), and TrkC(F167A) signaling in vivo. Thus, Trk knockin mice provide valuable tools for selective, rapid, and reversible inhibition of neurotrophin signaling in vitro and in vivo.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018	Kuruvilla, Rejji/0000-0002-2851-675X; Ye, Haihong/0000-0001-7282-6280; Scangos, Katherine/0000-0001-7983-7767	NINDS NIH HHS [NS 34814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034814, R01NS034814, R29NS034814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BORASIO GD, 1990, NEUROSCI LETT, V108, P207, DOI 10.1016/0304-3940(90)90732-O; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fagan AM, 1996, J NEUROSCI, V16, P6208; GOEDERT M, 1978, BRAIN RES, V148, P264, DOI 10.1016/0006-8993(78)90401-8; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; NAKANISHI S, 1988, J BIOL CHEM, V263, P6215; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roux PP, 2002, J BIOL CHEM, V277, P49473, DOI 10.1074/jbc.M203428200; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TAPLEY P, 1992, ONCOGENE, V7, P371; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	29	175	184	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					13	21		10.1016/j.neuron.2005.03.009	http://dx.doi.org/10.1016/j.neuron.2005.03.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820690	Bronze			2022-12-24	WOS:000228228600005
J	Brown, TC; Tran, IC; Backos, DS; Esteban, JA				Brown, TC; Tran, IC; Backos, DS; Esteban, JA			NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD	NEURON			English	Article							LONG-TERM DEPRESSION; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; GLUTAMATE RECEPTORS; MEMBRANE ASSOCIATION; EXCITATORY SYNAPSES; ENDOCYTIC PATHWAY; GLUR1 SUBUNIT; KINASE-C; PLASTICITY	The activity-dependent removal of AMPA receptors from synapses underlies long-term depression in hippocampal excitatory synapses. In this study, we have investigated the role of the small GTPase Rab5 during this process. We propose that Rab5 is a critical link between the signaling cascades triggered by LTD induction and the machinery that executes the activity-dependent removal of AMPA receptors. We have found that Rab5 activation drives the specific internalization of synaptic AMPA receptors in a clathrin-dependent manner and that this activity is required for LTD. Interestingly, Rab5 does not participate in the constitutive cycling of AMPA receptors. Rab5 is able to remove both GluR1 and GluR2 AMPA receptor subunits, leading to GluR1 dephosphorylation. Importantly, NMDA receptor-dependent LTD induction produces a rapid and transient increase of active (GTP bound) Rab5. We propose a model in which synaptic activity leads to Rab5 activation, which in turn drives the removal of AMPA receptors from synapses.	Univ Michigan, Sch Med, Program Neurosci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Program Neurosci, Ann Arbor, MI 48109 USA.	estebanj@umich.edu	Esteban, Jose/L-4944-2014; Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019	Esteban, Jose/0000-0002-3759-3300; Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Brown, Tyler/0000-0001-9543-8555	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070417, F31MH070205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008671] Funding Source: NIH RePORTER; NIA NIH HHS [P50-AG08671] Funding Source: Medline; NIMH NIH HHS [MH070417, F31-MH070205] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; KARNEYAMA K, 1998, NEURON, V21, P1163; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rush AM, 2002, J NEUROSCI, V22, P6121; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	78	169	176	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					81	94		10.1016/j.neuron.2004.12.023	http://dx.doi.org/10.1016/j.neuron.2004.12.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629704	Bronze, Green Submitted			2022-12-24	WOS:000226217100011
J	Mann, EO; Suckling, JM; Hajos, N; Greenfield, SA; Paulsen, O				Mann, EO; Suckling, JM; Hajos, N; Greenfield, SA; Paulsen, O			Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro	NEURON			English	Article							GAMMA-FREQUENCY OSCILLATIONS; EVOKED-POTENTIALS; GAP-JUNCTIONS; PYRAMIDAL CELL; BEHAVING RAT; SLICES; INDUCTION; SYNCHRONIZATION; INTERNEURONS; CONNEXIN-36	Gamma frequency network oscillations are assumed to be important in cognitive processes, including hippocampal memory operations, but the precise functions of these oscillations remain unknown. Here, we examine the cellular and network mechanisms underlying carbachol-induced fast network oscillations in the hippocampus in vitro, which closely resemble hippocampal gamma oscillations in the behaving rat. Using a combination of planar multielectrode array recordings, imaging with voltage-sensitive dyes, and recordings from single hippocampal neurons within the CA3 gamma generator, active current sinks and sources were localized to the stratum pyramidale. These proximal currents were driven by phase-locked rhythmic inhibitory inputs to pyramidal cells from identified perisomatic-targeting interneurons. AMPA receptor-mediated recurrent excitation was necessary for the synchronization of interneuronal discharge, which strongly supports a synaptic feedback model for the generation of hippocampal gamma oscillations.	Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	University of Oxford; University of Oxford; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Mann, EO (corresponding author), Univ Oxford, Univ Lab Physiol, Parks Rd, Oxford OX1 3PT, England.	ed.mann@physiol.ox.ac.uk	Hajos, Norbert/U-2640-2019; Paulsen, Ole/ABB-4843-2020	Hajos, Norbert/0000-0002-4582-2708; Paulsen, Ole/0000-0002-2258-5455; Mann, Edward/0000-0002-2468-7148				Batschelet E, 1981, CIRCULAR STAT BIOL; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fischer Y, 2004, J PHYSIOL-LONDON, V554, P156, DOI 10.1113/jphysiol.2003.055558; FREEMAN WJ, 1968, J NEUROPHYSIOL, V31, P337, DOI 10.1152/jn.1968.31.3.337; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; HOLSHEIMER J, 1987, EXP BRAIN RES, V67, P402; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; LEUNG LWS, 1985, ELECTROEN CLIN NEURO, V60, P65, DOI 10.1016/0013-4694(85)90952-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; TARNAWA I, 1993, BIOORG MED CHEM LETT, V3, P99, DOI 10.1016/S0960-894X(00)80100-6; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Tominaga T, 2002, J NEUROPHYSIOL, V88, P1523, DOI 10.1152/jn.2002.88.3.1523; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2003, P NATL ACAD SCI USA, V100, P1370, DOI 10.1073/pnas.0337529100; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zar JH, 1999, BIOSTATISTICAL ANAL	44	228	263	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					105	117		10.1016/j.neuron.2004.12.016	http://dx.doi.org/10.1016/j.neuron.2004.12.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629706	Bronze			2022-12-24	WOS:000226217100013
J	Dyhrfjeld-Johnsen, J; Soltesz, I				Dyhrfjeld-Johnsen, J; Soltesz, I			Dendritic h channelopathy in epileptogenesis	NEURON			English	Editorial Material							EPILEPSY		Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dyhrfjeld-Johnsen, J (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.			Dyhrfjeld-Johnsen, Jonas/0000-0003-0875-909X				Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen K, 2002, TRENDS PHARMACOL SCI, V23, P552, DOI 10.1016/S0165-6147(02)02110-7; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011	8	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					402	403		10.1016/j.neuron.2004.10.018	http://dx.doi.org/10.1016/j.neuron.2004.10.018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504320	Bronze			2022-12-24	WOS:000224771700002
